{"title": "PDF", "author": "PDF", "url": "https://unaids-test.unaids.org/sites/default/files/unaids/contentassets/documents/data-and-analysis/tools/nasa/NASA_Peru_2010_es.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": " 1 \nOficina General \nde Planeamiento y Presupuesto\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\u00a0\n\u00a0\n\u00a0\n\u00a0\nMedici\u00f3n \u00a0del\u00a0Gasto\u00a0en\u00a0SIDA\u00a0\u2010\u00a0MEGAS\u00a0\n\u00a0\nInforme\u00a0final\u00a0\nJunio\u00a02011\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\nElaborado \u00a0por:\u00a0\n\u00a0\nEconomista \u00a0Mar\u00eda\u00a0del\u00a0Carmen\u00a0Navarro\u00a0de\u00a0Acosta\u00a0\u00a0\nSSA\u2010128\u20102010\u00a0 2 \u00cdndice\u00a0\n\u00a0\n\u00a0\n\u00a0 Acr\u00f3nimos \u00a0\u00a0\nA.\u00a0 Introducci\u00f3n \u00a0 \u00a0\nA.1\u00a0 Objetivo\u00a0de\u00a0la\u00a0consultor\u00eda \u00a0\u00a0\nA.2\u00a0\u00a0 Marco\u00a0conceptual \u00a0\u00a0\nA.3\u00a0 Antecedentes \u00a0\u00a0\n\u00a0\u00a0 \u00a0\nB.\u00a0\u00a0 Metodolog\u00eda \u00a0\u00a0 \u00a0\nB.1\u00a0\u00a0 Caracter\u00edsticas \u00a0del\u00a0estudio\u00a0\u00a0 \u00a0\nB.2\u00a0\u00a0 Recopilaci\u00f3n \u00a0de\u00a0informaci\u00f3n \u00a0presupuestal \u00a0\u00a0 \u00a0\nB.3\u00a0 Estimaci\u00f3n \u00a0de\u00a0otros\u00a0gastos\u00a0\u00a0 \u00a0\nB.4\u00a0\u00a0 Mecanismos \u00a0para\u00a0asegurar\u00a0el\u00a0control\u00a0de\u00a0calidad\u00a0\u00a0 \u00a0\nB.5\u00a0\u00a0 T\u00e9cnicas\u00a0de\u00a0procesamiento \u00a0de\u00a0informaci\u00f3n \u00a0\u00a0 \u00a0\n\u00a0\u00a0 \u00a0\nC.\u00a0\u00a0 Metodolog\u00eda \u00a0para\u00a0la\u00a0estimaci\u00f3n \u00a0de\u00a0gasto\u00a0de\u00a0bolsillo\u00a0\u00a0 \u00a0\nC.1\u00a0 Antecedentes \u00a0\u00a0 \u00a0\nC.2\u00a0 \u00c1mbito\u00a0y\u00a0t\u00e9cnicas\u00a0de\u00a0recolecci\u00f3n \u00a0de\u00a0datos\u00a0\u00a0 \u00a0\nC.3\u00a0 Especificaciones \u00a0\u00a0 \u00a0\n\u00a0\u00a0 \u00a0\nD.\u00a0 Enfoque\u00a0de\u00a0g\u00e9nero\u00a0\u00a0 \u00a0\n\u00a0\u00a0 \u00a0\nE.\u00a0\u00a0 Fuentes\u00a0de\u00a0informaci\u00f3n \u00a0\u00a0 \u00a0\n\u00a0\u00a0 \u00a0\nF.\u00a0 Resultados \u00a0 \u00a0\nF.1\u00a0 Principales \u00a0hallazgos\u00a0\u00a0\nF.2\u00a0 Financiamiento \u00a0del\u00a0VIH\u00a0en\u00a0el\u00a0Per\u00fa\u00a0\u00a0 \u00a0\nF.2.1\u00a0Financiamiento \u00a0p\u00fablico\u00a0\u00a0 \u00a0\nF.2.2\u00a0\u00a0Financiamiento \u00a0de\u00a0cooperantes \u00a0\u00a0 \u00a0\nF.2.3\u00a0Gasto\u00a0de\u00a0bolsillo\u00a0\u00a0\nF.3\u00a0 Agentes\u00a0de\u00a0financiamiento \u00a0\u00a0\nF.4\u00a0 Provisi\u00f3n\u00a0de\u00a0servicios\u00a0para\u00a0el\u00a0VIH\u00a0en\u00a0el\u00a0Per\u00fa\u00a0\u00a0 \u00a0\nF.5\u00a0 Funciones: \u00a0intervenciones \u00a0en\u00a0el\u00a0pa\u00eds\u00a0\u00a0 \u00a0\nF.6\u00a0 Recursos: \u00a0factores\u00a0de\u00a0producci\u00f3n \u00a0\u00a0\nF.7\u00a0 Poblaciones \u00a0\u00a0beneficiarias \u00a0\u00a0\nF.8\u00a0 Gasto\u00a0por\u00a0ubicaci\u00f3n \u00a0geogr\u00e1fica \u00a0\u00a0\nF.9\u00a0 Matrices\u00a0por\u00a0g\u00e9nero\u00a0\u00a0\nG.\u00a0 An\u00e1lisis\u00a0y\u00a0discusi\u00f3n \u00a0 \u00a0\nH.\u00a0 Conclusiones \u00a0 \u00a0\nI.\u00a0 Bibliograf\u00eda \u00a0 \u00a0\n 3 \u00a0\u00a0\n\u00a0\n\u00a0\n\u00a0 \u00a0\n\u00a0 Anexos\u00a0\u00a0 \u00a0\n\u00a0 Anexo\u00a01\u00a0\u00a0\u2013\u00a0Definiciones \u00a0\u00a0 \u00a0\n\u00a0 Anexo\u00a02\u00a0\u2013\u00a0Evoluci\u00f3n \u00a0de\u00a0la\u00a0normatividad \u00a0en\u00a0SIDA\u00a0\u00a0por\u00a0categor\u00edas \u00a0de\u00a0gasto\u00a0\u00a0 \u00a0\n\u00a0 Anexo\u00a03\u00a0\u2013\u00a0Proyectos \u00a0de\u00a0inversi\u00f3n\u00a0p\u00fablica\u00a0registrados \u00a0en\u00a0el\u00a0SNIP\u00a0 \u00a0\n\u00a0 Anexo\u00a04\u00a0\u2013\u00a0Ensayos\u00a0cl\u00ednicos\u00a0relacionados \u00a0al\u00a0VIH\u00a0desde\u00a01998\u00a0 \u00a0\n\u00a0Anexo\u00a05\u00a0\u2013\u00a0Financiamiento \u00a0de\u00a0fuentes\u00a0externas\u00a0diferentes \u00a0a\u00a0cooperantes \u00a0de\u00a0Naciones\u00a0\nUnidas\u00a0 \u00a0\n\u00a0 Anexo\u00a06\u00a0\u2013Importaciones \u00a0de\u00a0ARV\u00a0realizadas \u00a0entre\u00a0el\u00a02008\u00a0y\u00a02010\u00a0 \u00a0\n\u00a0 Anexo\u00a07\u00a0\u2010\u00a0Gasto\u00a0en\u00a0medicamentos \u00a0realizado\u00a0del\u00a02005\u00a0al\u00a02010\u00a0 \u00a0\n\u00a0 Anexo\u00a08\u00a0\u2013\u00a0Informe\u00a0de\u00a0campo\u00a0por\u00a0DISA/DIRESA \u00a0 \u00a0\n\u00a0 Anexo\u00a09\u00a0\u2010\u00a0Resultados \u00a0de\u00a0revisi\u00f3n\u00a0de\u00a0Historias\u00a0Cl\u00ednicas\u00a0en\u00a0establecimientos \u00a0 \u00a0\n\u00a0 Anexo\u00a010\u00a0\u2013\u00a0Resultados \u00a0encuestas \u00a0aplicadas \u00a0en\u00a0CERITS\u00a0y\u00a0UAMP\u00a0 \u00a0\n\u00a0 Anexo\u00a011\u00a0\u2010\u00a0Resultados \u00a0de\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0historias\u00a0cl\u00ednicas\u00a0\u00a0de\u00a0PVV\u00a0en\u00a0TARGA\u00a0 \u00a0\n\u00a0 Anexo\u00a012\u00a0\u00a0\u2010\u00a0Matrices\u00a0MEGAS\u00a0 \u00a0\n\u00a0\n\u00a0 4 Acr\u00f3nimos \u00a0\n\u00a0\nAPCI\u00a0\u00a0 \u00a0 Agencia\u00a0Peruana\u00a0de\u00a0Cooperaci\u00f3n \u00a0Internacional \u00a0\u00a0\nARV\u00a0\u00a0 \u00a0 Antirretrovirales \u00a0\nASC\u00a0\u00a0 \u00a0 Categor\u00eda \u00a0de\u00a0gasto\u00a0relativo\u00a0al\u00a0sida\u00a0(por\u00a0sus\u00a0siglas\u00a0en\u00a0ingl\u00e9s)\u00a0\nAUS\u00a0\u00a0 Aseguramiento \u00a0universal\u00a0en\u00a0salud\u00a0\nBM\u00a0\u00a0 \u00a0 Banco\u00a0Mundial\u00a0\nBP\u00a0\u00a0 \u00a0 Poblaciones \u00a0beneficiarias \u00a0(por\u00a0sus\u00a0siglas\u00a0en\u00a0ingl\u00e9s)\u00a0\nCCC\u00a0\u00a0 \u00a0 Comunicaci\u00f3n \u00a0para\u00a0el\u00a0cambio\u00a0de\u00a0comportamiento \u00a0\nCERITS\u00a0\u00a0 Centro\u00a0de\u00a0referencia \u00a0de\u00a0infecciones \u00a0de\u00a0transmisi\u00f3n \u00a0sexual\u00a0\nCONAMUSA \u00a0 Coordinadora \u00a0Nacional\u00a0Multisectorial \u00a0en\u00a0Salud\u00a0(MCP\u00a0del\u00a0Per\u00fa)\u00a0\nCOPRECOS \u00a0 Comit\u00e9\u00a0de\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0de\u00a0VIH\u00a0y\u00a0SIDA\u00a0de\u00a0las\u00a0Fuerzas\u00a0Armadas\u00a0y\u00a0Policiales\u00a0\nCIE\u00a0\u00a0 \u00a0 Clasificaci\u00f3n \u00a0Internacional \u00a0de\u00a0Enfermedades \u00a0\u00a0\nCIIU\u00a0\u00a0 \u00a0 Clasificaci\u00f3n \u00a0Industrial \u00a0Internacional \u00a0Uniforme \u00a0\nDARES\u00a0\u00a0 Direcci\u00f3n \u00a0Administrativa \u00a0de\u00a0Recursos\u00a0Estrat\u00e9gicos \u00a0del\u00a0MINSA\u00a0\nDFID\u00a0\u00a0 \u00a0 Departamento \u00a0para\u00a0el\u00a0Desarrollo \u00a0Internacional \u00a0del\u00a0Reino\u00a0Unido\u00a0\nDISA\u00a0\u00a0 Direcci\u00f3n \u00a0de\u00a0Salud\u00a0(en\u00a0Lima)\u00a0\nDGE\u00a0\u00a0 Direcci\u00f3n \u00a0General\u00a0de\u00a0Epidemiolog\u00eda \u00a0del\u00a0MINSA\u00a0\nDGEI\u00a0\u00a0 Direcci\u00f3n \u00a0General\u00a0de\u00a0Estad\u00edstica \u00a0e\u00a0Inform\u00e1tica \u00a0del\u00a0MINSA\u00a0\nDGSP\u00a0\u00a0 Direcci\u00f3n \u00a0General\u00a0de\u00a0Salud\u00a0de\u00a0las\u00a0Personas\u00a0del\u00a0MINSA\u00a0\nDIGEMID\u00a0 Direcci\u00f3n \u00a0General\u00a0de\u00a0Medicamentos, \u00a0Insumos\u00a0y\u00a0Drogas\u00a0del\u00a0MINSA\u00a0\nDIRESA\u00a0\u00a0 Direcci\u00f3n \u00a0Regional\u00a0de\u00a0Salud\u00a0(en\u00a0provincias= \u00a0\nDNPP\u00a0\u00a0 Direcci\u00f3n \u00a0Nacional\u00a0de\u00a0Presupuesto \u00a0P\u00fablico\u00a0\nENAHO\u00a0\u00a0 Encuesta\u00a0Nacional\u00a0de\u00a0Hogares\u00a0\nEPS\u00a0\u00a0 Entidades \u00a0prestadoras \u00a0de\u00a0salud\u00a0\nESN\u00a0\u00a0 Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Prevenci\u00f3n \u00a0y\u00a0control\u00a0de\u00a0ITS/VIH/SIDA \u00a0del\u00a0MINSA\u00a0\nESNSSR\u00a0\u00a0 Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Salud\u00a0Sexual\u00a0y\u00a0Reproductiva \u00a0del\u00a0MINSA\u00a0\nESSALUD\u00a0 Seguro\u00a0social\u00a0en\u00a0salud\u00a0del\u00a0Per\u00fa\u00a0\nFA\u00a0\u00a0 \u00a0 Agentes\u00a0de\u00a0financiaci\u00f3n \u00a0(por\u00a0sus\u00a0siglas\u00a0en\u00a0ingl\u00e9s)\u00a0\nFMI\u00a0\u00a0 Fondo\u00a0Monetario \u00a0Internacional \u00a0\nFMSTM\u00a0\u00a0\u00a0 Fondo\u00a0Mundial\u00a0para\u00a0la\u00a0Lucha\u00a0contra\u00a0el\u00a0Sida,\u00a0la\u00a0Tuberculosis \u00a0y\u00a0la\u00a0Malaria\u00a0\nFS\u00a0\u00a0 \u00a0 Fuentes\u00a0de\u00a0financiaci\u00f3n \u00a0(por\u00a0sus\u00a0siglas\u00a0en\u00a0ingl\u00e9s)\u00a0\nGTZ\u00a0\u00a0 \u00a0 Cooperaci\u00f3n \u00a0T\u00e9cnica\u00a0Alemana\u00a0\nHNV\u00a0\u00a0 Hu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0vulnerables \u00a0\nHSH\u00a0\u00a0 Hombres\u00a0que\u00a0tienen\u00a0relaciones \u00a0sexuales\u00a0con\u00a0hombres\u00a0\nIEC\u00a0\u00a0 \u00a0 Informaci\u00f3n, \u00a0educaci\u00f3n \u00a0y\u00a0comunicaci\u00f3n \u00a0\nINPE\u00a0\u00a0 Instituto\u00a0Nacional\u00a0Penitenciario \u00a0\u00a0\nINS\u00a0\u00a0 Instituto\u00a0Nacional\u00a0de\u00a0Salud\u00a0\nIO\u00a0\u00a0 Infecci\u00f3n\u00a0oportunista \u00a0\nITS\u00a0\u00a0 \u00a0 Infecciones \u00a0de\u00a0transmisi\u00f3n \u00a0sexual\u00a0\nLAUS\u00a0\u00a0 Ley\u00a0de\u00a0aseguramiento \u00a0universal\u00a0en\u00a0salud\u00a0\nMAIS\u00a0\u00a0 \u00a0 Modelo\u00a0de\u00a0atenci\u00f3n\u00a0integral\u00a0\nMEGAS\u00a0\u00a0\u00a0 Medici\u00f3n \u00a0del\u00a0Gasto\u00a0en\u00a0Sida\u00a0\nMEF\u00a0\u00a0 Ministerio \u00a0de\u00a0Econom\u00eda \u00a0y\u00a0Finanzas\u00a0\nMIMDES\u00a0\u00a0 Ministerio \u00a0de\u00a0la\u00a0Mujer\u00a0y\u00a0Desarrollo \u00a0Social\u00a0\nMINSA\u00a0\u00a0 Ministerio \u00a0de\u00a0Salud\u00a0\nMINEDU\u00a0\u00a0 Ministerio \u00a0de\u00a0Educaci\u00f3n \u00a0\nNASA\u00a0\u00a0 National\u00a0AIDS\u00a0Spending \u00a0Assessment \u00a0(siglas\u00a0en\u00a0Ingl\u00e9s)\u00a0\nOBF\u00a0\u00a0 \u00a0 Organizaci\u00f3n \u00a0basada\u00a0en\u00a0la\u00a0fe\u00a0\nOCDE\u00a0\u00a0 \u00a0 Organizaci\u00f3n \u00a0para\u00a0la\u00a0Cooperaci\u00f3n \u00a0y\u00a0el\u00a0Desarrollo \u00a0Econ\u00f3micos \u00a0\nODM\u00a0\u00a0 \u00a0 Objetivos \u00a0de\u00a0Desarrollo \u00a0del\u00a0Milenio\u00a0\nOGA\u00a0\u00a0 Oficina\u00a0General\u00a0de\u00a0Administraci\u00f3n \u00a0del\u00a0MINSA\u00a0 5 OIT\u00a0\u00a0 \u00a0 Organizaci\u00f3n \u00a0Internacional \u00a0del\u00a0Trabajo\u00a0\nOMS\u00a0\u00a0 \u00a0 Organizaci\u00f3n \u00a0Mundial\u00a0de\u00a0la\u00a0Salud\u00a0\nONG\u00a0\u00a0 Organizaci\u00f3n \u00a0no\u00a0gubernamental \u00a0\nONUDD\u00a0\u00a0Oficina\u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0contra\u00a0la\u00a0Droga\u00a0y\u00a0el\u00a0Delito\u00a0\nONUSIDA \u00a0\u00a0 Programa \u00a0Conjunto\u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0sobre\u00a0el\u00a0VIH/Sida\u00a0\nORE\u00a0\u00a0 Oficina\u00a0de\u00a0Recursos\u00a0Estrat\u00e9gicos \u00a0(Antes\u00a0PAAG,\u00a0ahora\u00a0OGA)\u00a0\nOSC\u00a0\u00a0 \u00a0 Organizaci\u00f3n \u00a0de\u00a0la\u00a0sociedad\u00a0civil\u00a0\nPAAG\u00a0 Programa \u00a0de\u00a0acuerdos\u00a0de\u00a0gesti\u00f3n\u00a0(Ahora\u00a0DGA)\u00a0\nPEAS\u00a0 Plan\u00a0Esencial\u00a0de\u00a0Aseguramiento \u00a0en\u00a0Salud\u00a0\nPEM\u00a0 Plan\u00a0Estrat\u00e9gico \u00a0Multisectorial \u00a02007\u20102011\u00a0para\u00a0la\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0de\u00a0las\u00a0ITS,\u00a0VIH\u00a0y\u00a0\nSIDA\u00a0\nPERM\u00a0\u00a0 Planes\u00a0Estrat\u00e9gicos \u00a0Regionales \u00a0Multisectoriales \u00a0\nPEP\u00a0\u00a0 Promotores \u00a0educadores \u00a0de\u00a0pares\u00a0\nPF\u00a0\u00a0 \u00a0 Factores\u00a0de\u00a0producci\u00f3n/costos \u00a0de\u00a0recursos\u00a0en\u00a0VIH\u00a0(por\u00a0sus\u00a0siglas\u00a0en\u00a0ingl\u00e9s)\u00a0\nPBI\u00a0\u00a0 Producto\u00a0bruto\u00a0interno\u00a0\nPIP\u00a0\u00a0 Proyecto\u00a0de\u00a0inversi\u00f3n\u00a0p\u00fablica\u00a0\nPMA\u00a0\u00a0 \u00a0 Programa \u00a0Mundial\u00a0de\u00a0Alimentos \u00a0\nPME\u00a0\u00a0 \u00a0 Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0\nPNUD\u00a0\u00a0 \u00a0 Programa \u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0para\u00a0el\u00a0Desarrollo \u00a0\nPROCETSS \u00a0\u00a0\u00a0 \u00a0 Programa \u00a0de\u00a0Control\u00a0de\u00a0ETS\u00a0y\u00a0SIDA\u00a0(Ahora\u00a0ESN)\u00a0\nPS\u00a0\u00a0 Proveedor \u00a0(en\u00a0la\u00a0clasificaci\u00f3n \u00a0de\u00a0la\u00a0repuesta\u00a0nacional\u00a0al\u00a0VIH)\u00a0(por\u00a0sus\u00a0siglas\u00a0en\u00a0ingl\u00e9s)\u00a0\nPTMI\u00a0\u00a0 \u00a0 Prevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0materno\u00a0infantil\u00a0\nPVV\u00a0\u00a0 \u00a0 Personas\u00a0que\u00a0con\u00a0VIH\u00a0\nRAM\u00a0\u00a0 Reacciones \u00a0adversas\u00a0a\u00a0medicamentos \u00a0\nRP\u00a0\u00a0 Receptor\u00a0principal\u00a0de\u00a0los\u00a0proyectos \u00a0del\u00a0FMSTM\u00a0\nSEACE\u00a0\u00a0 Sistema\u00a0electr\u00f3nico \u00a0de\u00a0contrataciones \u00a0del\u00a0Estado\u00a0\nSIAF\u00a0\u00a0 Sistema\u00a0Integrado \u00a0de\u00a0Administraci\u00f3n \u00a0Financiera \u00a0\nSIDA\u00a0\u00a0 \u00a0 S\u00edndrome \u00a0de\u00a0inmunodeficiencia \u00a0adquirida \u00a0\nSIDALAC\u00a0\u00a0 Vigilancia \u00a0del\u00a0VIH\u00a0para\u00a0Am\u00e9rica\u00a0Latina\u00a0y\u00a0el\u00a0Caribe\u00a0\nSIS\u00a0\u00a0 Seguro\u00a0integral\u00a0de\u00a0salud\u00a0\nSISFOH\u00a0\u00a0\u00a0 Sistema\u00a0de\u00a0Focalizaci\u00f3n \u00a0de\u00a0Hogares\u00a0\u00a0\nSISMED\u00a0 Sistema\u00a0integrado \u00a0de\u00a0suministros \u00a0de\u00a0medicamentos \u00a0\u00a0e\u00a0insumos\u00a0m\u00e9dicos\u00a0\u2013\u00a0quir\u00fargicos \u00a0\nSMEII\u00a0 Sistema\u00a0de\u00a0Monitoreo \u00a0y\u00a0Evaluaci\u00f3n \u00a0Integrado \u00a0de\u00a0Indicadores \u00a0del\u00a0MINSA\u00a0\nSNIP\u00a0 Sistema\u00a0Nacional\u00a0de\u00a0Inversi\u00f3n\u00a0P\u00fablica\u00a0\nSR\u00a0\u00a0 Sub\u00a0receptor\u00a0de\u00a0los\u00a0proyectos \u00a0del\u00a0FMSTM\u00a0\nSUNAT\u00a0\u00a0 Superintendencia \u00a0Nacional\u00a0de\u00a0\u00a0Administraci\u00f3n \u00a0Tributaria \u00a0\nSUNASA\u00a0Superintendencia \u00a0Nacional\u00a0de\u00a0Aseguramiento \u00a0en\u00a0Salud\u00a0\nTARGA\u00a0\u00a0 Tratamiento \u00a0antirretroviral \u00a0de\u00a0gran\u00a0actividad\u00a0\nTS\u00a0\u00a0 Trabajadores \u00a0sexuales\u00a0\nUAMP\u00a0\u00a0 Unidad\u00a0de\u00a0atenci\u00f3n\u00a0m\u00e9dica\u00a0peri\u00f3dica \u00a0\nUDI\u00a0\u00a0 \u00a0 Usuarios\u00a0de\u00a0drogas\u00a0inyectables \u00a0\nUNESCO\u00a0\u00a0 Organizaci\u00f3n \u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0para\u00a0la\u00a0Educaci\u00f3n, \u00a0la\u00a0Ciencia\u00a0y\u00a0la\u00a0Cultura\u00a0\nUNFPA\u00a0\u00a0 \u00a0 Fondo\u00a0de\u00a0Poblaci\u00f3n \u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0\nUNGASS\u00a0 Per\u00edodo\u00a0extraordinario \u00a0de\u00a0sesiones\u00a0de\u00a0la\u00a0Asamblea \u00a0General\u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0\nUNICEF\u00a0\u00a0Fondo\u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0para\u00a0la\u00a0Infancia\u00a0\nVIH\u00a0\u00a0 \u00a0 Virus\u00a0de\u00a0la\u00a0inmunodeficiencia \u00a0humana\u00a0\n\u00a0 6 Medici\u00f3n \u00a0del\u00a0Gasto\u00a0en\u00a0SIDA\u00a0\u2010\u00a0MEGAS\u00a0\n\u00a0\nA. Introducci\u00f3n \u00a0\n\u00a0\nA.1\u00a0\u00a0 Objetivos \u00a0de\u00a0la\u00a0consultor\u00eda \u00a0\n\uf02d Preparar\u00a0un\u00a0informe\u00a0y\u00a0matrices\u00a0actualizadas \u00a0sobre\u00a0la\u00a0Medici\u00f3n \u00a0del\u00a0Gasto\u00a0en\u00a0SIDA\u00a0(MEGAS), \u00a0con\u00a0todos\u00a0\nsus\u00a0componentes \u00a0aplicados \u00a0a\u00a0nivel\u00a0nacional\u00a0para\u00a0los\u00a0a\u00f1os\u00a02008,\u00a02009\u00a0y\u00a0\u00a0para\u00a0el\u00a02010\u00a0(para\u00a0este\u00a0\u00faltimo\u00a0\na\u00f1o\u00a0se\u00a0podr\u00e1\u00a0completar \u00a0la\u00a0informaci\u00f3n \u00a0con\u00a0proyecciones \u00a0de\u00a0gasto\u00a0del\u00a0cuarto\u00a0trimestre), \u00a0basados\u00a0en\u00a0la\u00a0\nmetodolog\u00eda \u00a0MEGAS\u00a0de\u00a0ONUSIDA \u00a0y\u00a0los\u00a0informes\u00a0previamente \u00a0desarrollados \u00a0en\u00a0esta\u00a0materia\u00a0que\u00a0se\u00a0\nencuentran \u00a0disponibles. \u00a0\u00a0\n\uf02d Utilizando \u00a0la\u00a0metodolog\u00eda \u00a0MEGAS,\u00a0proveer\u00a0informaciones \u00a0\u00fatiles\u00a0sobre\u00a0los\u00a0gastos\u00a0y\u00a0los\u00a0flujos\u00a0de\u00a0\nfinanciamiento \u00a0relativos\u00a0al\u00a0VIH\u00a0para\u00a0el\u00a0informe\u00a0UNGASS\u00a02010\u00a0y\u00a0para\u00a0la\u00a0elaboraci\u00f3n \u00a0de\u00a0los\u00a0planes\u00a0\nregionales \u00a0en\u00a0VIH,\u00a0teniendo\u00a0en\u00a0cuenta\u00a0el\u00a0Plan\u00a0Estrat\u00e9gico \u00a0Multisectorial \u00a02007\u20102011\u00a0para\u00a0la\u00a0Prevenci\u00f3n \u00a0y\u00a0\nel\u00a0Control\u00a0de\u00a0las\u00a0ITS,\u00a0VIH\u00a0y\u00a0SIDA\u00a0en\u00a0el\u00a0Per\u00fa.\u00a0\u00a0\n\uf02d Dise\u00f1ar\u00a0una\u00a0gu\u00eda\u00a0de\u00a0lineamientos \u00a0t\u00e9cnicos\u00a0para\u00a0la\u00a0aplicaci\u00f3n \u00a0del\u00a0informe\u00a0MEGAS\u00a0en\u00a0el\u00a0Per\u00fa,\u00a0adaptando \u00a0\nlos\u00a0\u00a0lineamientos \u00a0de\u00a0la\u00a0sede\u00a0de\u00a0ONUSIDA \u00a0para\u00a0MEGAS\u00a0a\u00a0la\u00a0realidad\u00a0nacional,\u00a0indicando \u00a0las\u00a0fuentes\u00a0de\u00a0\ninformaci\u00f3n \u00a0espec\u00edficas \u00a0y\u00a0toda\u00a0otra\u00a0informaci\u00f3n \u00a0que\u00a0permita\u00a0aplicar\u00a0el\u00a0estudio\u00a0MEGAS\u00a0en\u00a0el\u00a0Per\u00fa\u00a0en\u00a0\nfuturos\u00a0a\u00f1os.\u00a0\u00a0La\u00a0gu\u00eda\u00a0no\u00a0repetir\u00e1\u00a0los\u00a0contenidos \u00a0de\u00a0las\u00a0gu\u00edas\u00a0oficiales\u00a0de\u00a0ONUSIDA, \u00a0sino\u00a0los\u00a0adaptar\u00e1\u00a0y\u00a0\na\u00f1adir\u00e1\u00a0los\u00a0elementos \u00a0de\u00a0contexto\u00a0peruano\u00a0que\u00a0sean\u00a0necesarios \u00a0para\u00a0la\u00a0implementaci\u00f3n \u00a0del\u00a0estudio.\u00a0\n\uf02d Establecer \u00a0recomendaciones \u00a0espec\u00edficas \u00a0para\u00a0el\u00a0Ministerio \u00a0de\u00a0Salud\u00a0(MINSA),\u00a0CONAMUSA, \u00a0Gobiernos \u00a0\nRegionales \u00a0y\u00a0el\u00a0Equipo\u00a0Conjunto\u00a0de\u00a0VIH\u00a0de\u00a0Naciones\u00a0Unidas,\u00a0orientadas \u00a0a\u00a0implementar \u00a0el\u00a0MEGAS\u00a0al\u00a0\nnivel\u00a0nacional\u00a0y\u00a0regional\u00a0para\u00a0los\u00a0pr\u00f3ximos \u00a0a\u00f1os.\u00a0\u00a0\n\u00a0\nA.2\u00a0\u00a0\u00a0 Marco\u00a0conceptual \u00a0\nEn\u00a0la\u00a0Medici\u00f3n \u00a0de\u00a0gasto\u00a0en\u00a0SIDA,\u00a0los\u00a0gastos\u00a0y\u00a0flujos\u00a0financieros \u00a0relacionados \u00a0con\u00a0la\u00a0respuesta \u00a0nacional\u00a0al\u00a0VIH\u00a0\nse\u00a0organizan \u00a0en\u00a0tres\u00a0dimensiones: \u00a0financiamiento, \u00a0provisi\u00f3n\u00a0y\u00a0consumo. \u00a0\n\u00a0\nFinanciamiento\nFuentes\u00a0de\u00a0\nfinanciamiento: \u00a0\nOrigen\u00a0de\u00a0los\u00a0\nfondos\nAgente\u00a0de\u00a0\nfinanciamiento: \u00a0\nDecisores \u00a0de\u00a0\npresupuesto\nProvisi\u00f3n\u00a0de\u00a0\nservicios\nProveedores: \u00a0\nProductores \u00a0de\u00a0\nbienes\u00a0\u2010servicios\nRecursos: \u00a0\nFactores\u00a0de\u00a0\nProducci\u00f3n\nUso\u00a0o\u00a0consumo\nCategor\u00eda \u00a0de\u00a0\ngasto:\u00a0Funciones \u00a0\n\u2010Intervenciones\nPoblaci\u00f3n \u00a0\nbeneficiaria \u00a0\n(Enfoque\u00a0de\u00a0\ng\u00e9nero)\u00a0\n\u00a0\nA\u00a0\u00a0su\u00a0vez\u00a0las\u00a0dimensiones \u00a0se\u00a0encuentran \u00a0organizadas \u00a0seis\u00a0categor\u00edas: \u00a0fuentes\u00a0de\u00a0financiamiento, \u00a0agentes,\u00a0\nfactores\u00a0de\u00a0producci\u00f3n, \u00a0proveedores, \u00a0funciones \u00a0y\u00a0poblaciones \u00a0beneficiarias. \u00a0\u00a0\n\u00a0\nTiene\u00a0como\u00a0objetivo\u00a0proveer\u00a0una\u00a0medici\u00f3n\u00a0completa \u00a0de\u00a0todos\u00a0los\u00a0gastos,\u00a0incluyendo \u00a0informaciones \u00a0sobre\u00a0el\u00a0\norigen,\u00a0el\u00a0destino\u00a0y\u00a0objeto\u00a0del\u00a0gasto.\u00a0Es\u00a0un\u00a0m\u00e9todo\u00a0riguroso\u00a0para\u00a0recopilar, \u00a0clasificar\u00a0y\u00a0realizar\u00a0la\u00a0medici\u00f3n\u00a0\nlos\u00a0flujos\u00a0financieros \u00a0en\u00a0relaci\u00f3n\u00a0con\u00a0todos\u00a0los\u00a0aspectos\u00a0program\u00e1ticos \u00a0de\u00a0VIH:\u00a0prevenci\u00f3n, \u00a0atenci\u00f3n, \u00a0soporte\u00a0\nsocial,\u00a0apoyo,\u00a0tratamiento. \u00a0\u00a0Permite\u00a0contar\u00a0con\u00a0una\u00a0estructura \u00a0de\u00a0monitoreo \u00a0de\u00a0los\u00a0recursos\u00a0para\u00a0el\u00a0an\u00e1lisis\u00a0\ncontinuo\u00a0de\u00a0las\u00a0interacciones \u00a0entre\u00a0ellos.\u00a0\u00a0\n\u00a0\nEspec\u00edficamente \u00a0para\u00a0\u00a0el\u00a0presente\u00a0estudio\u00a0correspondiente \u00a0a\u00a0los\u00a0a\u00f1o\u00a02008\u00a0al\u00a02010,\u00a0\u00a0para\u00a0realizar\u00a0la\u00a0medici\u00f3n\u00a0\ndel\u00a0gasto\u00a0con\u00a0enfoque\u00a0de\u00a0g\u00e9nero\u00a0el\u00a0an\u00e1lisis\u00a0se\u00a0centra\u00a0en\u00a0la\u00a0dimensi\u00f3n \u00a0de\u00a0uso\u00a0y\u00a0en\u00a0la\u00a0categor\u00eda \u00a0de\u00a0Poblaci\u00f3n \u00a0\nbeneficiaria. \u00a0 7 \u00a0\nA.3\u00a0 Antecedentes \u00a0\nLas\u00a0principales \u00a0referencias \u00a0del\u00a0presente\u00a0estudio\u00a0lo\u00a0constituyen \u00a0\u00a0la\u00a0investigaci\u00f3n \u00a0realizada\u00a0en\u00a0el\u00a0Per\u00fa\u00a0en\u00a0el\u00a0\n2001\u00a0y\u00a0las\u00a0realizadas \u00a0en\u00a0el\u00a0contexto\u00a0de\u00a0los\u00a0proyectos \u00a0financiados \u00a0por\u00a0el\u00a0FMSTM.\u00a0\n\u00a0\nEn\u00a0el\u00a0a\u00f1o\u00a02001\u00a0se\u00a0realiz\u00f3\u00a0el\u00a0estudio\u00a0de\u00a0\u201dCuentas\u00a0Nacionales \u00a0en\u00a0VIH\u00a0para\u00a0los\u00a0a\u00f1os\u00a01999\u00a0y\u00a02000\u00a0en\u00a0el\u00a0Per\u00fa\u201d\u00a0\nque\u00a0permiti\u00f3\u00a0analizar\u00a0cualitativa \u00a0y\u00a0cuantitativamente \u00a0las\u00a0fuentes\u00a0de\u00a0gastos,\u00a0los\u00a0proveedores \u00a0de\u00a0servicios\u00a0y\u00a0los\u00a0\nusos\u00a0de\u00a0estos\u00a0recursos,\u00a0cuando\u00a0\u00a0el\u00a0gasto\u00a0de\u00a0tratamiento \u00a0lo\u00a0asum\u00edan\u00a0las\u00a0familias.\u00a0\u00a0Entre\u00a0el\u00a02003\u00a0al\u00a02009\u00a0se\u00a0han\u00a0\nrealizado\u00a0investigaciones \u00a0en\u00a0VIH\u00a0y\u00a0tuberculosis \u00a0sobre\u00a0\u201cInversi\u00f3n \u00a0multisectorial\u201d \u00a0desde\u00a0el\u00a02003\u00a0al\u00a02006\u00a0y\u00a0el\u00a0\nEstudio\u00a0de\u00a0contrapartida \u00a0nacional\u00a02005\u20102009.\u00a0\u00a0El\u00a0objeto\u00a0de\u00a0estos\u00a0estudios\u00a0es\u00a0verificar\u00a0la\u00a0complementariedad \u00a0\ndel\u00a0financiamiento \u00a0del\u00a0FMSTM\u00a0con\u00a0respecto\u00a0al\u00a0gasto\u00a0que\u00a0realiza\u00a0el\u00a0pa\u00eds.\u00a0\n\u00a0\nA\u00a0la\u00a0fecha,\u00a0ONUSIDA \u00a0est\u00e1\u00a0implementando \u00a0a\u00a0nivel\u00a0latino\u2010americano \u00a0la\u00a0metodolog\u00eda \u00a0de\u00a0Medici\u00f3n \u00a0del\u00a0Gasto\u00a0en\u00a0\nSida\u00a0\u2013\u00a0MEGAS.\u00a0(\u00a01\u00a0)\u00a0\u00a0En\u00a0el\u00a0pa\u00eds\u00a0con\u00a0el\u00a0estudio\u00a0MEGAS\u00a0para\u00a0los\u00a0a\u00f1os\u00a02005\u00a0al\u00a02007\u00a0se\u00a0inici\u00f3\u00a0la\u00a0utilizaci\u00f3n \u00a0de\u00a0esta\u00a0\nmetodolog\u00eda, \u00a0bas\u00e1ndose, \u00a0en\u00a0los\u00a0principios \u00a0de\u00a0la\u00a0contabilidad \u00a0utilizados \u00a0por\u00a0la\u00a0OMS\u00a0y\u00a0la\u00a0OCDE,\u00a0se\u00a0propuso\u00a0una\u00a0\ns\u00edntesis\u00a0de\u00a0todos\u00a0los\u00a0aspectos\u00a0(salud,\u00a0social,\u00a0trabajo,\u00a0entre\u00a0otros)\u00a0relacionados \u00a0con\u00a0los\u00a0gastos\u00a0de\u00a0VIH,\u00a0con\u00a0el\u00a0\nprop\u00f3sito \u00a0de\u00a0mejorar\u00a0la\u00a0toma\u00a0de\u00a0decisiones \u00a0sobre\u00a0la\u00a0respuesta \u00a0a\u00a0la\u00a0epidemia. \u00a0\n\u00a0\nEn\u00a0el\u00a0Per\u00fa,\u00a0el\u00a0establecimiento \u00a0de\u00a0un\u00a0sistema\u00a0de\u00a0monitoreo \u00a0de\u00a0los\u00a0gastos\u00a0financieros \u00a0en\u00a0VIH\u00a0es\u00a0necesario \u00a0para\u00a0\nconocer\u00a0el\u00a0avance,\u00a0prioridades \u00a0y\u00a0brechas\u00a0de\u00a0inversi\u00f3n\u00a0en\u00a0la\u00a0respuesta \u00a0nacional\u00a0en\u00a0el\u00a0pa\u00eds\u00a0y\u00a0para\u00a0la\u00a0\nimplementaci\u00f3n \u00a0y\u00a0\u00a0seguimiento \u00a0del\u00a0Plan\u00a0Estrat\u00e9gico \u00a0Multisectorial \u00a02007\u20102011\u00a0para\u00a0la\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0\nde\u00a0las\u00a0ITS,\u00a0VIH\u00a0y\u00a0SIDA\u00a0y\u00a0los\u00a0planes\u00a0regionales. \u00a0\u00a0\n\u00a0\n                                                 \n1 ONUSIDA, \u00a0MEGAS,\u00a0Medici\u00f3n \u00a0del\u00a0gasto\u00a0en\u00a0SIDA:\u00a0Clasificaci\u00f3n \u00a0y\u00a0definiciones, \u00a02009  8 B.\u00a0Metodolog\u00eda \u00a0\n\u00a0\nB.1\u00a0\u00a0 Caracter\u00edsticas \u00a0del\u00a0estudio\u00a0\nLa\u00a0metodolog\u00eda \u00a0corresponde \u00a0a\u00a0una\u00a0evaluaci\u00f3n \u00a0ex\u00a0post\u00a0transversal \u00a0del\u00a0tipo\u00a0descriptiva \u00a0y\u00a0cuantitativa, \u00a0de\u00a0los\u00a0\nhallazgos\u00a0de\u00a0la\u00a0informaci\u00f3n \u00a0a\u00a0ser\u00a0obtenida. \u00a0\u00a0Las\u00a0variables\u00a0a\u00a0ser\u00a0tomadas\u00a0en\u00a0cuenta\u00a0ser\u00e1n\u00a0las\u00a0contempladas \u00a0en\u00a0\nla\u00a0Metodolog\u00eda \u00a0de\u00a0MEGAS,\u00a0realizando \u00a0la\u00a0identificaci\u00f3n \u00a0de\u00a0los\u00a0siguientes \u00a0componentes, \u00a0utilizando \u00a0la\u00a0\nclasificaci\u00f3n \u00a0de\u00a0ONUSIDA: \u00a0fuentes\u00a0de\u00a0financiamiento, \u00a0agentes,\u00a0proveedores, \u00a0funciones, \u00a0factores\u00a0de\u00a0\nproducci\u00f3n \u00a0y\u00a0poblaciones \u00a0beneficiarias. \u00a0\n\u00a0\nEl\u00a0estudio\u00a0abarca\u00a0la\u00a0recolecci\u00f3n \u00a0y\u00a0sistematizaci\u00f3n \u00a0de\u00a0informaci\u00f3n \u00a0cuantitativa \u00a0de\u00a0las\u00a0cuentas\u00a0nacionales \u00a0y\u00a0\npresupuestos \u00a0en\u00a0los\u00a0a\u00f1os\u00a02008,\u00a02009\u00a0y\u00a02010\u00a0de\u00a0diversas\u00a0entidades \u00a0del\u00a0sector\u00a0p\u00fablico,\u00a0de\u00a0ONG\u00a0implicadas \u00a0en\u00a0\nla\u00a0respuesta \u00a0al\u00a0VIH/SIDA, \u00a0de\u00a0la\u00a0cooperaci\u00f3n \u00a0internacional \u00a0(multilateral \u00a0y\u00a0bilateral)\u00a0y\u00a0del\u00a0sector\u00a0privado\u00a0(entre\u00a0\nellos\u00a0el\u00a0gasto\u00a0de\u00a0bolsillo),\u00a0siguiendo \u00a0las\u00a0directrices \u00a0del\u00a0MEGAS.\u00a0\u00a0\n\u00a0\nTambi\u00e9n\u00a0recoge\u00a0la\u00a0\u00a0informaci\u00f3n \u00a0cualitativa \u00a0que\u00a0nos\u00a0permite\u00a0establecer \u00a0los\u00a0flujos\u00a0y\u00a0procesos\u00a0de\u00a0ejecuci\u00f3n \u00a0del\u00a0\ngasto\u00a0y\u00a0la\u00a0interrelaci\u00f3n \u00a0del\u00a0sector\u00a0p\u00fablico\u00a0y\u00a0privado\u00a0en\u00a0la\u00a0provisi\u00f3n\u00a0de\u00a0servicios.\u00a0\n\u00a0\n\u00a0\nB.2\u00a0\u00a0 Recopilaci\u00f3n \u00a0de\u00a0informaci\u00f3n \u00a0\u00a0de\u00a0datos\u00a0p\u00fablicos\u00a0\n\uf02d Dise\u00f1o\u00a0del\u00a0trabajo\u00a0de\u00a0campo\u00a0\nSe\u00a0realiz\u00f3\u00a0una\u00a0revisi\u00f3n\u00a0de\u00a0todos\u00a0los\u00a0documentos \u00a0relacionados \u00a0al\u00a0flujo\u00a0de\u00a0financiamiento \u00a0en\u00a0VIH\u00a0y\u00a0se\u00a0verific\u00f3\u00a0\nla\u00a0lista\u00a0de\u00a0instituciones \u00a0con\u00a0trabajo\u00a0en\u00a0VIH\u00a0basada\u00a0en\u00a0revisi\u00f3n\u00a0de\u00a0trabajos\u00a0anteriores \u00a0y\u00a0en\u00a0coordinaci\u00f3n \u00a0con\u00a0\nlos\u00a0encargados \u00a0del\u00a0seguimiento \u00a0del\u00a0estudio.\u00a0Esta\u00a0lista\u00a0comprende \u00a0Ministerios, \u00a0institutos, \u00a0y\u00a0otras\u00a0instancias \u00a0\ngubernamentales, \u00a0as\u00ed\u00a0como\u00a0las\u00a0ONG,\u00a0universidades \u00a0y\u00a0centros\u00a0de\u00a0investigaci\u00f3n. \u00a0\u00a0\n\u00a0Se\u00a0realiz\u00f3\u00a0una\u00a0revisi\u00f3n\u00a0detenida\u00a0de\u00a0las\u00a0encuestas \u00a0y\u00a0manuales, \u00a0identificando \u00a0simult\u00e1neamente \u00a0las\u00a0personas\u00a0o\u00a0\npuntos\u00a0focales\u00a0con\u00a0quienes\u00a0contactar \u00a0en\u00a0las\u00a0organizaciones.\n\u00a0\u00a0Se\u00a0prepararon \u00a0carpetas\u00a0con\u00a0los\u00a0formatos\u00a0de\u00a0\nrecopilaci\u00f3n \u00a0de\u00a0datos\u00a0y\u00a0las\u00a0instrucciones \u00a0para\u00a0el\u00a0ingreso\u00a0de\u00a0informaci\u00f3n \u00a0sobre\u00a0gasto\u00a0de\u00a0cada\u00a0instituci\u00f3n, \u00a0para\u00a0\nsu\u00a0remisi\u00f3n\u00a0en\u00a0f\u00edsico\u00a0y\u00a0medio\u00a0magn\u00e9tico \u00a0por\u00a0parte\u00a0de\u00a0las\u00a0instituciones. \u00a0\u00a0Estas\u00a0carpetas\u00a0(conjunto \u00a0de\u00a0\ninstrumentos \u00a0y\u00a0manuales) \u00a0fueron\u00a0distribuidas \u00a0a\u00a0las\u00a0instituciones \u00a0p\u00fablicas,\u00a0los\u00a0cooperantes \u00a0\u00a0y\u00a0a\u00a0las\u00a0ONG\u00a0\ninvolucradas \u00a0en\u00a0actividades \u00a0de\u00a0VIH/Sida, \u00a0tanto\u00a0en\u00a0el\u00a0Taller\u00a0de\u00a0presentaci\u00f3n \u00a0como\u00a0por\u00a0correo\u00a0electr\u00f3nico. \u00a0\u00a0\n\u00a0\n\uf02d Taller\u00a0de\u00a0presentaci\u00f3n \u00a0de\u00a0la\u00a0metodolog\u00eda \u00a0MEGAS\u00a0\nSe\u00a0realiz\u00f3\u00a0un\u00a0Taller\u00a0de\u00a0presentaci\u00f3n \u00a0de\u00a0la\u00a0metodolog\u00eda \u00a0MEGAS\u00a0con\u00a0la\u00a0participaci\u00f3n \u00a0de\u00a0los\u00a0\u00a0principales \u00a0actores\u00a0\nque\u00a0participan \u00a0en\u00a0la\u00a0respuesta \u00a0al\u00a0VIH\u00a0en\u00a0el\u00a0pa\u00eds\u00a0a\u00a0quienes\u00a0se\u00a0les\u00a0entreg\u00f3\u00a0\u00a0la\u00a0carpeta\u00a0preparada \u00a0y\u00a0a\u00a0los\u00a0que\u00a0no\u00a0\nasistieron \u00a0se\u00a0les\u00a0remiti\u00f3\u00a0por\u00a0correo.\u00a0\u00a0Los\u00a0datos\u00a0de\u00a0los\u00a0asistentes \u00a0fueron\u00a0obtenidos \u00a0para\u00a0la\u00a0\u00a0Base\u00a0de\u00a0datos\u00a0\nNASA.\u00a0\u00a0\u00a0Adem\u00e1s\u00a0se\u00a0aprovech\u00f3 \u00a0el\u00a0Taller\u00a0para\u00a0averiguar \u00a0por\u00a0la\u00a0existencia \u00a0de\u00a0\u00a0\u00a0instituciones \u00a0con\u00a0trabajo\u00a0en\u00a0VIH\u00a0\nque\u00a0no\u00a0hayan\u00a0sido\u00a0convocadas, \u00a0a\u00a0las\u00a0cuales\u00a0tambi\u00e9n\u00a0\u00a0hicimos\u00a0\u00a0llegar\u00a0las\u00a0encuestas. \u00a0\u00a0\n\u00a0\n\uf02d Aplicaci\u00f3n \u00a0de\u00a0gu\u00edas\u00a0de\u00a0entrevistas \u00a0a\u00a0actores\u00a0clave\u00a0\nLuego\u00a0del\u00a0Taller,\u00a0se\u00a0estableci\u00f3 \u00a0el\u00a0contacto\u00a0con\u00a0las\u00a0instituciones \u00a0para\u00a0las\u00a0entrevistas \u00a0correspondientes \u00a0a\u00a0fin\u00a0de\u00a0\naplicar\u00a0las\u00a0entrevistas \u00a0a\u00a0los\u00a0actores\u00a0clave\u00a0para\u00a0profundizar \u00a0sobre\u00a0el\u00a0relacionamiento \u00a0de\u00a0las\u00a0entidades \u00a0que\u00a0\nconforman \u00a0la\u00a0red\u00a0de\u00a0financiadores, \u00a0proveedores \u00a0y\u00a0usuarios\u00a0en\u00a0VIH.\u00a0\n\u00a0\n\uf02d Aplicaci\u00f3n \u00a0de\u00a0encuestas \u00a0sobre\u00a0gastos\u00a0a\u00a0cooperantes \u00a0y\u00a0ONG\u00a0\nLa\u00a0solicitud\u00a0de\u00a0informaci\u00f3n \u00a0a\u00a0las\u00a0agencias\u00a0cooperantes \u00a0y\u00a0ONG\u00a0se\u00a0realiz\u00f3\u00a0mediante \u00a0comunicaci\u00f3n \u00a0escrita.\u00a0\u00a0\nHubo\u00a0asesor\u00eda\u00a0\u00a0para\u00a0\u00a0el\u00a0llenado\u00a0de\u00a0la\u00a0encuesta\u00a0mediante \u00a0\u00a0v\u00eda\u00a0telef\u00f3nica \u00a0o\u00a0correo\u00a0electr\u00f3nico. \u00a0\u00a0\u00a0\u00a0\n\u00a0\n\uf02d Aplicaci\u00f3n \u00a0de\u00a0encuestas \u00a0para\u00a0determinaci\u00f3n \u00a0de\u00a0gastos\u00a0de\u00a0bolsillo\u00a0\nSe\u00a0aplicaron \u00a0un\u00a0total\u00a0de\u00a0152\u00a0encuestas, \u00a075\u00a0en\u00a0hospitales \u00a0TARGA\u00a0y\u00a077\u00a0a\u00a0usuarios\u00a0de\u00a0servicios\u00a0de\u00a0prevenci\u00f3n \u00a0\n(CERITS\u00a0y\u00a0UAMP).\u00a0\u00a0La\u00a0metodolog\u00eda \u00a0para\u00a0la\u00a0aplicaci\u00f3n \u00a0de\u00a0encuestas \u00a0para\u00a0la\u00a0determinaci\u00f3n \u00a0del\u00a0gasto\u00a0de\u00a0\nbolsillo\u00a0se\u00a0explica\u00a0en\u00a0la\u00a0secci\u00f3n\u00a0C.\u00a0 9 \u00a0\n\uf02d Revisi\u00f3n\u00a0de\u00a0historias\u00a0cl\u00ednicas\u00a0(HC)\u00a0\nSe\u00a0revis\u00f3\u00a0un\u00a0total\u00a0de\u00a0640\u00a0historias\u00a0cl\u00ednicas\u00a0de\u00a0usuarios\u00a0de\u00a0establecimientos \u00a0que\u00a0prestan\u00a0servicios\u00a0de\u00a0\nprevenci\u00f3n \u00a0(464)\u00a0como\u00a0de\u00a0tratamiento \u00a0(176).\u00a0\u00a0\u00a0La\u00a0desagregaci\u00f3n \u00a0se\u00a0puede\u00a0apreciar\u00a0en\u00a0la\u00a0secci\u00f3n\u00a0\nmetodolog\u00eda \u00a0para\u00a0gasto\u00a0de\u00a0bolsillo.\u00a0\n\u00a0\n\uf02d Recopilaci\u00f3n \u00a0de\u00a0informaci\u00f3n \u00a0financiera \u00a0de\u00a0registros\u00a0administrativos \u00a0del\u00a0sector\u00a0p\u00fablico.\u00a0\nEn\u00a0el\u00a0caso\u00a0de\u00a0instituciones \u00a0p\u00fablicas\u00a0adicionalmente \u00a0se\u00a0recopil\u00f3\u00a0informaci\u00f3n \u00a0de\u00a0los\u00a0siguientes \u00a0sistemas: \u00a0SIAF,\u00a0\nSEACE\u00a0y\u00a0SNIP.\u00a0\u00a0Para\u00a0las\u00a0organizaciones \u00a0que\u00a0se\u00a0financian\u00a0con\u00a0recursos\u00a0de\u00a0cooperaci\u00f3n \u00a0internacional \u00a0se\u00a0\nrecopil\u00f3\u00a0informaci\u00f3n \u00a0de\u00a0la\u00a0APCI.\u00a0\u00a0\u00a0\n\u00a0\nPara\u00a0la\u00a0identificaci\u00f3n \u00a0de\u00a0los\u00a0gastos\u00a0del\u00a0sector\u00a0privado\u00a0se\u00a0realiz\u00f3\u00a0una\u00a0investigaci\u00f3n \u00a0previa\u00a0de\u00a0la\u00a0informaci\u00f3n \u00a0de\u00a0\nimportaci\u00f3n \u00a0de\u00a0algunas\u00a0partidas\u00a0arancelarias, \u00a0a\u00a0partir\u00a0de\u00a0la\u00a0cual\u00a0se\u00a0realizaron \u00a0las\u00a0entrevistas \u00a0y\u00a0encuestas \u00a0para\u00a0\ndeterminar \u00a0los\u00a0precios\u00a0de\u00a0mercado\u00a0y\u00a0los\u00a0niveles\u00a0de\u00a0consumo. \u00a0En\u00a0el\u00a0caso\u00a0del\u00a0Sector\u00a0p\u00fablico,\u00a0se\u00a0revis\u00f3\u00a0la\u00a0\ninformaci\u00f3n \u00a0disponible \u00a0en\u00a0las\u00a0p\u00e1ginas\u00a0web\u00a0de\u00a0las\u00a0instituciones \u00a0y\u00a0la\u00a0consulta\u00a0a\u00a0las\u00a0entidades \u00a0que\u00a0realizan\u00a0\ngasto\u00a0en\u00a0VIH\u00a0/SIDA\u00a0(adquisiciones \u00a0y\u00a0contrataciones), \u00a0con\u00a0la\u00a0finalidad\u00a0de\u00a0poder\u00a0establecer \u00a0las\u00a0fuentes\u00a0de\u00a0\ninformaci\u00f3n \u00a0oficiales\u00a0para\u00a0recopilar\u00a0la\u00a0informaci\u00f3n \u00a0de\u00a0gasto.\u00a0\u00a0\u00a0\n\u00a0\nA\u00a0partir\u00a0de\u00a0esta\u00a0informaci\u00f3n, \u00a0teniendo\u00a0en\u00a0cuenta\u00a0las\u00a0referencias \u00a0de\u00a0tipo\u00a0de\u00a0adquisici\u00f3n \u00a0y\u00a0fecha\u00a0de\u00a0ejecuci\u00f3n \u00a0\nse\u00a0revis\u00f3\u00a0la\u00a0informaci\u00f3n \u00a0del\u00a0Sistema\u00a0Integrado \u00a0de\u00a0Administraci\u00f3n \u00a0Financiera \u00a0\u2010\u00a0SIAF,\u00a0del\u00a0Sistema\u00a0de\u00a0inversi\u00f3n\u00a0\np\u00fablica\u00a0\u2010\u00a0SNIP\u00a0y\u00a0\u00a0el\u00a0Sistema\u00a0electr\u00f3nico \u00a0de\u00a0adquisiciones \u00a0y\u00a0contrataciones \u00a0del\u00a0Estado\u00a0\u2013\u00a0SEACE,\u00a0el\u00a0cual\u00a0registra\u00a0\nlas\u00a0compras\u00a0estatales\u00a0que\u00a0administra \u00a0el\u00a0Ministerio \u00a0de\u00a0Econom\u00eda \u00a0y\u00a0Finanzas,\u00a0mediante \u00a0el\u00a0Organismo \u00a0\nSupervisor \u00a0de\u00a0las\u00a0Contrataciones \u00a0del\u00a0Estado\u00a0\u2013\u00a0OSCE\u00a0\u00a02.\u00a0\u00a0Asimismo \u00a0se\u00a0revis\u00f3\u00a0la\u00a0base\u00a0de\u00a0datos\u00a0de\u00a0ensayos\u00a0\ncl\u00ednicos\u00a0registrados \u00a0en\u00a0el\u00a0Instituto\u00a0Nacional\u00a0de\u00a0Salud.\u00a0\n\u00a0\nSistema\u00a0integral\u00a0de\u00a0administraci\u00f3n \u00a0financiera \u00a0\u2013\u00a0SIAF.\u2010\u00a0En\u00a0el\u00a0SIAF\u00a0\u00a0se\u00a0han\u00a0identificado \u00a0\u00a0actividades \u00a0y\u00a0\nproyectos \u00a0vinculados \u00a0a\u00a0VIH\u00a0y\u00a0a\u00a0aquellas\u00a0referentes \u00a0a\u00a0salud\u00a0sexual\u00a0reproductiva \u00a0correspondientes \u00a0del\u00a02007\u00a0al\u00a0\n2011.\u00a0\u00a0\u00a0Cabe\u00a0precisar\u00a0que\u00a0en\u00a0el\u00a0presupuesto \u00a0del\u00a02011\u00a0se\u00a0ha\u00a0incluido\u00a0presupuesto \u00a0en\u00a0el\u00a0Programa \u00a0estrat\u00e9gico \u00a0\nVIH\u00a0\u2013\u00a0Tuberculosis \u00a0elaborado \u00a0en\u00a0el\u00a0marco\u00a0del\u00a0Presupuesto \u00a0por\u00a0resultados \u00a0PPR,\u00a0mecanismo \u00a0de\u00a0asignaci\u00f3n \u00a0de\u00a0\npresupuesto \u00a0que\u00a0se\u00a0utilizar\u00e1\u00a0para\u00a0las\u00a0estrategias \u00a0de\u00a0VIH\u00a0y\u00a0Tuberculosis \u00a0a\u00a0partir\u00a0del\u00a02011.3\u00a0\u00a0\u00a0Se\u00a0espera\u00a0que\u00a0\npara\u00a0este\u00a0a\u00f1o\u00a02011,\u00a0se\u00a0pueda\u00a0ejecutar\u00a0la\u00a0totalidad\u00a0del\u00a0presupuesto \u00a0asignado. \u00a0\n\u00a0\nSistema\u00a0de\u00a0inversi\u00f3n \u00a0p\u00fablica\u00a0\u2013\u00a0SNIP.\u2010\u00a0\u00a0Con\u00a0respecto\u00a0a\u00a0la\u00a0informaci\u00f3n \u00a0proveniente \u00a0del\u00a0SNIP,\u00a0son\u00a0\u00a0\nproyectos \u00a0que\u00a0han\u00a0sido\u00a0formulados \u00a0por\u00a0las\u00a0diferentes \u00a0instituciones \u00a0p\u00fablicas\u00a0y\u00a0aprobados \u00a0por\u00a0las\u00a0instancias \u00a0\ncorrespondientes, \u00a0sin\u00a0embargo, \u00a0en\u00a0este\u00a0sistema\u00a0no\u00a0se\u00a0reporta,\u00a0si\u00a0el\u00a0proyecto\u00a0est\u00e1\u00a0siendo\u00a0ejecutado \u00a0o\u00a0no.\u00a0\u00a0\nCabe\u00a0precisar\u00a0que\u00a0para\u00a0la\u00a0inclusi\u00f3n\u00a0de\u00a0un\u00a0proyecto\u00a0en\u00a0el\u00a0presupuesto \u00a0anual\u00a0es\u00a0obligatorio \u00a0su\u00a0registro\u00a0en\u00a0el\u00a0\nSNIP\u00a0hasta\u00a0el\u00a0mes\u00a0de\u00a0mayo\u00a0del\u00a0a\u00f1o\u00a0anterior\u00a0al\u00a0presupuesto \u00a0que\u00a0se\u00a0formula.\u00a0En\u00a0tal\u00a0sentido\u00a0esta\u00a0informaci\u00f3n \u00a0\nsirve\u00a0como\u00a0referencia \u00a0para\u00a0contextualizar \u00a0la\u00a0importancia \u00a0que\u00a0desde\u00a0las\u00a0diferentes \u00a0regiones\u00a0se\u00a0viene\u00a0dando\u00a0a\u00a0\nla\u00a0problem\u00e1tica \u00a0del\u00a0VIH.\u00a0La\u00a0revisi\u00f3n\u00a0de\u00a0los\u00a0proyectos \u00a0registrados \u00a0en\u00a0el\u00a0SNIP\u00a0facilit\u00f3\u00a0la\u00a0b\u00fasqueda \u00a0de\u00a0ejecuci\u00f3n \u00a0\nde\u00a0gasto\u00a0en\u00a0el\u00a0SIAF.\u00a0\n\u00a0\nAsimismo, \u00a0con\u00a0la\u00a0finalidad\u00a0de\u00a0contar\u00a0con\u00a0mayor\u00a0detalle\u00a0del\u00a0que\u00a0puede\u00a0proporcionar \u00a0la\u00a0informaci\u00f3n \u00a0sobre\u00a0\nejecuci\u00f3n \u00a0presupuestal \u00a0registrada \u00a0en\u00a0el\u00a0SIAF,\u00a0se\u00a0ha\u00a0verificado \u00a0la\u00a0informaci\u00f3n \u00a0registrada \u00a0en\u00a0el\u00a0SEACE\u00a0por\u00a0las\u00a0\nentidades \u00a0p\u00fablicas.\u00a0\n\u00a0\nRegistro\u00a0de\u00a0ensayos\u00a0cl\u00ednicos\u00a0del\u00a0INS.\u2010\u00a0\u00a0El\u00a0Instituto\u00a0Nacional\u00a0de\u00a0Salud\u00a0tiene\u00a0la\u00a0funci\u00f3n\u00a0de\u00a0revisar,\u00a0\nregistrar\u00a0y\u00a0autorizar\u00a0los\u00a0ensayos\u00a0cl\u00ednicos,\u00a0regular\u00a0la\u00a0investigaci\u00f3n \u00a0en\u00a0el\u00a0Per\u00fa\u00a0y\u00a0garantizar \u00a0la\u00a0aplicaci\u00f3n \u00a0de\u00a0las\u00a0\n                                                 \n2\u00a0OSCE\u00a0es\u00a0el\u00a0encargado \u00a0entre\u00a0otros\u00a0temas\u00a0de\u00a0la\u00a0administraci\u00f3n \u00a0de\u00a0la\u00a0informaci\u00f3n \u00a0\u00a0de\u00a0compras\u00a0estatales\u00a0en\u00a0el\u00a0\nSistema\u00a0electr\u00f3nico \u00a0de\u00a0adquisiciones \u00a0y\u00a0contrataciones \u00a0del\u00a0estado\u00a0SEACE.  \n3\u00a0A\u00a0partir\u00a0del\u00a02007\u00a0mediante \u00a0la\u00a0Ley\u00a0de\u00a0presupuesto \u00a0del\u00a0Sector\u00a0p\u00fablico\u00a0para\u00a0el\u00a0a\u00f1o\u00a02007\u00a0\u2013\u00a0Ley\u00a028927,\u00a0\u00a0en\u00a0el\u00a0\nPer\u00fa\u00a0se\u00a0ha\u00a0iniciado\u00a0la\u00a0aplicaci\u00f3n \u00a0de\u00a0la\u00a0gesti\u00f3n\u00a0presupuestal \u00a0basada\u00a0en\u00a0resultados \u00a0PPR,\u00a0la\u00a0cual\u00a0se\u00a0espera\u00a0sea\u00a0el\u00a0\nprincipal\u00a0mecanismo \u00a0de\u00a0financiamiento \u00a0en\u00a0el\u00a0pa\u00eds,\u00a0durante\u00a0los\u00a0pr\u00f3ximos \u00a0a\u00f1os.\u00a0\u00a0  10 normas\u00a0\u00e9ticas\u00a0internacionales \u00a0\u00a0y\u00a0las\u00a0Buenas\u00a0Pr\u00e1cticas\u00a0Cl\u00ednicas\u00a0en\u00a0la\u00a0realizaci\u00f3n \u00a0de\u00a0los\u00a0ensayos\u00a0cl\u00ednicos\u00a0en\u00a0el\u00a0\nPer\u00fa.\u00a0\u00a0\u00a0El\u00a0objetivo\u00a0es\u00a0velar\u00a0por\u00a0los\u00a0derechos, \u00a0bienestar \u00a0e\u00a0integridad \u00a0de\u00a0los\u00a0participantes \u00a0en\u00a0investigaciones, \u00a0\nfomentando \u00a0las\u00a0pr\u00e1cticas\u00a0\u00e9ticas\u00a0y\u00a0la\u00a0calidad\u00a0de\u00a0los\u00a0procesos\u00a0\u00a0y\u00a0difundiendo \u00a0los\u00a0resultados \u00a0derivados \u00a0de\u00a0ellas,\u00a0\na\u00a0trav\u00e9s\u00a0de\u00a0su\u00a0p\u00e1gina\u00a0web.\u00a0\n\u00a0\nEl\u00a0registro\u00a0contiene\u00a0datos\u00a0del\u00a0n\u00famero\u00a0de\u00a0participantes \u00a0de\u00a0los\u00a0ensayos\u00a0cl\u00ednicos,\u00a0profesionales \u00a0de\u00a0salud,\u00a0\ninvestigadores, \u00a0instituciones \u00a0y\u00a0centros\u00a0de\u00a0investigaci\u00f3n \u00a0y\u00a0patrocinadores \u00a0de\u00a0ensayos\u00a0cl\u00ednicos,\u00a0m\u00e1s\u00a0no\u00a0del\u00a0\npresupuesto \u00a0asignado, \u00a0el\u00a0cual\u00a0es\u00a0registrado \u00a0en\u00a0las\u00a0declaraciones \u00a0de\u00a0las\u00a0instituciones \u00a0realizadas \u00a0al\u00a0APCI.\u00a0\u00a0\u00a0Se\u00a0\nha\u00a0identificado \u00a0los\u00a0ensayos\u00a0cl\u00ednicos\u00a0relacionados \u00a0al\u00a0VIH\u00a0registrados \u00a0por\u00a0el\u00a0INS\u00a0desde\u00a0el\u00a0a\u00f1o\u00a01998.\u00a0\n\u00a0\nRegistro\u00a0de\u00a0Importaciones. \u2010\u00a0Se\u00a0revis\u00f3\u00a0informaci\u00f3n \u00a0sobre\u00a0importaciones \u00a0de\u00a0ARV\u00a0que\u00a0han\u00a0sido\u00a0\ninformados \u00a0por\u00a0la\u00a0SUNAT,\u00a0instituci\u00f3n \u00a0encargada \u00a0de\u00a0recaudar\u00a0los\u00a0impuestos \u00a0aduaneros. \u00a0(Ver\u00a0anexo\u00a06).\u00a0\n\u00a0\nFuentes\u00a0complementarias \u00a0de\u00a0informaci\u00f3n. \u2010\u00a0La\u00a0informaci\u00f3n \u00a0complementaria \u00a0de\u00a0las\u00a0fuentes\u00a0de\u00a0\nfinanciamiento \u00a0externas\u00a0de\u00a0las\u00a0Organizaci\u00f3n \u00a0no\u00a0gubernamentales \u00a0sin\u00a0fines\u00a0de\u00a0lucro\u00a0nacionales \u00a0\u2013\u00a0ONG\u00a0y\u00a0\nENIEX,\u00a0corresponde \u00a0a\u00a0la\u00a0consignada \u00a0en\u00a0las\u00a0Declaraciones \u00a0anuales\u00a0presentadas \u00a0a\u00a0la\u00a0Agencia\u00a0Peruana\u00a0de\u00a0\nCooperaci\u00f3n \u00a0Internacional \u00a0\u2013\u00a0APCI.\u00a0\u00a0\u00a0 Se\u00a0incluye\u00a0informaci\u00f3n \u00a0correspondiente \u00a0al\u00a0financiamiento \u00a0\ncorrespondiente \u00a0a\u00a0fuentes\u00a0externas\u00a0diferentes \u00a0a\u00a0los\u00a0cooperantes \u00a0de\u00a0Naciones\u00a0Unidas,\u00a0las\u00a0cuales\u00a0fueron\u00a0\nsolicitadas \u00a0a\u00a0las\u00a0instituciones \u00a0con\u00a0sede\u00a0en\u00a0Lima.\u00a0\n\u00a0\nRevisi\u00f3n\u00a0de\u00a0registros\u00a0program\u00e1ticos \u00a0y\u00a0administrativos. \u2010\u00a0Se\u00a0procedi\u00f3\u00a0a\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0los\u00a0registros\u00a0\nprogram\u00e1ticos \u00a0de\u00a0la\u00a0Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Prevenci\u00f3n \u00a0y\u00a0control\u00a0de\u00a0ITS/VIH/SIDA \u00a0del\u00a0MINSA\u00a0(ESN),\u00a0\nEstrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Salud\u00a0Sexual\u00a0y\u00a0Reproductiva \u00a0del\u00a0MINSA\u00a0(ESNSSR), \u00a0del\u00a0Receptor\u00a0principal\u00a0de\u00a0\nlos\u00a0proyectos \u00a0del\u00a0FMSTM\u00a0(RP)\u00a0y\u00a0de\u00a0otras\u00a0instituciones \u00a0que\u00a0cuentan\u00a0con\u00a0informaci\u00f3n \u00a0que\u00a0permita\u00a0\ncontextualizar \u00a0los\u00a0datos\u00a0financieros. \u00a0\n\u00a0\n\u00a0\nB.3\u00a0 Estimaci\u00f3n \u00a0de\u00a0otros\u00a0gastos\u00a0\n\uf02d Se\u00a0recopil\u00f3\u00a0informaci\u00f3n \u00a0desde\u00a0las\u00a0coordinaciones \u00a0regionales \u00a0de\u00a0la\u00a0Estrategia \u00a0sanitaria,\u00a0\u00a0sobre\u00a0el\u00a0n\u00famero\u00a0\nde\u00a0recursos\u00a0humanos, \u00a0la\u00a0retribuci\u00f3n \u00a0monetaria \u00a0recibida\u00a0independientemente \u00a0de\u00a0su\u00a0denominaci\u00f3n \u00a0y\u00a0la\u00a0\ndedicaci\u00f3n \u00a0a\u00a0las\u00a0labores\u00a0relacionadas \u00a0a\u00a0VIH.\u00a0\n\u00a0\n\uf02d Generalmente \u00a0la\u00a0adquisici\u00f3n \u00a0de\u00a0preservativos \u00a0del\u00a0sector\u00a0p\u00fablico\u00a0es\u00a0realizada\u00a0para\u00a0la\u00a0ESN\u00a0de\u00a0VIH\u00a0y\u00a0la\u00a0\nESNSSR,\u00a0la\u00a0informaci\u00f3n \u00a0de\u00a0la\u00a0distribuci\u00f3n \u00a0del\u00a0consumo\u00a0fue\u00a0realizada\u00a0tomando\u00a0en\u00a0cuenta\u00a0las\u00a0entrevistas, \u00a0\nas\u00ed\u00a0como\u00a0por\u00a0las\u00a0evidencias \u00a0de\u00a0diferentes \u00a0fuentes\u00a0tal\u00a0como\u00a0el\u00a0SISMED.\u00a0\n\u00a0\n\uf02d La\u00a0distribuci\u00f3n \u00a0por\u00a0departamentos \u00a0de\u00a0los\u00a0antirretrovirales \u00a0y\u00a0preservativos \u00a0fue\u00a0realizada\u00a0con\u00a0la\u00a0\ninformaci\u00f3n \u00a0proporcionada \u00a0por\u00a0DARES\u00a0\u2013\u00a0MINSA.\u00a0\n\u00a0\nB.4\u00a0\u00a0 Mecanismos \u00a0para\u00a0asegurar\u00a0el\u00a0control\u00a0de\u00a0calidad\u00a0\nControl\u00a0b\u00e1sico:\u00a0control\u00a0de\u00a0calidad\u00a0de\u00a0los\u00a0datos\u00a0recibidos\u00a0\n\uf02d Despu\u00e9s\u00a0de\u00a0haber\u00a0recibido\u00a0la\u00a0encuesta\u00a0del\u00a0remitente, \u00a0se\u00a0comprob\u00f3 \u00a0\u00a0toda\u00a0la\u00a0informaci\u00f3n \u00a0para\u00a0asegurar\u00a0\u00a0\nque\u00a0el\u00a0remitente \u00a0no\u00a0haya\u00a0cometido \u00a0ning\u00fan\u00a0error.\u00a0Se\u00a0verific\u00f3\u00a0si\u00a0la\u00a0informaci\u00f3n \u00a0es\u00a0consistente, \u00a0\u00a0si\u00a0la\u00a0\ninformaci\u00f3n \u00a0es\u00a0consecuente \u00a0con\u00a0las\u00a0respuestas \u00a0a\u00a0otras\u00a0preguntas \u00a0de\u00a0la\u00a0encuesta, \u00a0\u00a0si\u00a0son\u00a0veros\u00edmiles: \u00a0si\u00a0\nson\u00a0correctos \u00a0los\u00a0c\u00e1lculos,\u00a0si\u00a0es\u00a0pertinente, \u00a0si\u00a0son\u00a0v\u00e1lidos\u00a0los\u00a0tipos\u00a0de\u00a0cambio\u00a0utilizados. \u00a0\n\uf02d Se\u00a0ha\u00a0tratado\u00a0de\u00a0evitar\u00a0el\u00a0duplicado \u00a0de\u00a0informaci\u00f3n, \u00a0ejemplo\u00a0particular \u00a0son\u00a0los\u00a0Proyectos \u00a0financiados \u00a0\npor\u00a0el\u00a0FMSTM,\u00a0donde\u00a0en\u00a0algunos\u00a0casos\u00a0varias\u00a0organizaciones \u00a0informan\u00a0de\u00a0un\u00a0mismo\u00a0proyecto. \u00a0\n\uf02d En\u00a0todos\u00a0los\u00a0casos\u00a0se\u00a0verific\u00f3\u00a0si\u00a0la\u00a0informaci\u00f3n \u00a0contiene: \u00a0datos\u00a0de\u00a0la\u00a0transacci\u00f3n \u00a0(con\u00a0los\u00a0datos\u00a0de\u00a0precio\u00a0\ny\u00a0cantidad\u00a0disponibles) \u00a0y\u00a0del\u00a0proceso\u00a0de\u00a0compra,\u00a0responsables \u00a0del\u00a0gasto\u00a0o\u00a0de\u00a0la\u00a0adquisici\u00f3n, \u00a0\u00a0fuente\u00a0de\u00a0\nfinanciamiento, \u00a0fecha\u00a0de\u00a0la\u00a0transacci\u00f3n \u00a0y\u00a0regi\u00f3n\u00a0beneficiada. \u00a0\n\u00a0\nControl\u00a0avanzado: \u00a0cruce\u00a0de\u00a0informaci\u00f3n \u00a0 11 \uf02d Se\u00a0recopil\u00f3\u00a0informaci\u00f3n \u00a0de\u00a0los\u00a0agentes\u00a0o\u00a0proveedores \u00a0y\u00a0tambi\u00e9n\u00a0se\u00a0realiz\u00f3\u00a0\u00a0la\u00a0consulta\u00a0a\u00a0los\u00a0organismos \u00a0\nfinanciadores \u00a0informados \u00a0por\u00a0los\u00a0primeros, \u00a0\u00a0lo\u00a0cual\u00a0permiti\u00f3\u00a0\u00a0establecer \u00a0la\u00a0consistencia \u00a0\u00a0de\u00a0la\u00a0\ninformaci\u00f3n \u00a0proporcionada \u00a0por\u00a0los\u00a0informantes. \u00a0\n\uf02d EL\u00a0gasto\u00a0del\u00a0sector\u00a0p\u00fablico\u00a0tuvo\u00a0como\u00a0fuente\u00a0primaria\u00a0la\u00a0informaci\u00f3n \u00a0proveniente \u00a0del\u00a0SEACE,\u00a0SIAF\u00a0o\u00a0\nSNIP,\u00a0informaci\u00f3n \u00a0de\u00a0registros\u00a0administrativos \u00a0que\u00a0responde \u00a0al\u00a0sistema\u00a0de\u00a0autorizaci\u00f3n \u00a0de\u00a0gasto\u00a0en\u00a0el\u00a0\nPer\u00fa\u00a0y\u00a0en\u00a0tal\u00a0sentido\u00a0no\u00a0sujeta\u00a0a\u00a0manipulaci\u00f3n \u00a0o\u00a0adulteraci\u00f3n. \u00a0\n\uf02d Los\u00a0gastos\u00a0de\u00a0las\u00a0ONG\u00a0tuvieron\u00a0como\u00a0fuente\u00a0primaria\u00a0de\u00a0informaci\u00f3n \u00a0la\u00a0proveniente \u00a0de\u00a0APCI.\u00a0\n\uf02d La\u00a0informaci\u00f3n \u00a0de\u00a0gastos\u00a0de\u00a0los\u00a0proyectos \u00a0del\u00a0FMSTM\u00a0fue\u00a0solicitada \u00a0al\u00a0Receptor\u00a0principal\u2010\u00a0RP.\u00a0\u00a0\u00a0La\u00a0\ninformaci\u00f3n \u00a0que\u00a0fue\u00a0proporcionada \u00a0conten\u00eda\u00a0el\u00a0detalle\u00a0del\u00a0gasto\u00a0realizado\u00a0por\u00a0el\u00a0RP\u00a0y\u00a0por\u00a0los\u00a0\nSubreceptores \u00a0\u2013\u00a0SR.\u00a0\u00a0En\u00a0algunos\u00a0casos\u00a0fue\u00a0necesario \u00a0recurrir\u00a0a\u00a0consultas \u00a0a\u00a0los\u00a0SR\u00a0cuando\u00a0la\u00a0informaci\u00f3n \u00a0\nque\u00a0proporciono \u00a0el\u00a0RP\u00a0no\u00a0fue\u00a0lo\u00a0suficientemente \u00a0detallada \u00a0como\u00a0para\u00a0realizar\u00a0la\u00a0desagregaci\u00f3n \u00a0\nrequerida \u00a0para\u00a0el\u00a0MEGAS.\u00a0\n\u00a0\u00a0\n\u00a0\nB.5\u00a0\u00a0 T\u00e9cnicas\u00a0de\u00a0procesamiento \u00a0de\u00a0informaci\u00f3n \u00a0\n\u00a0\nLa\u00a0generaci\u00f3n \u00a0de\u00a0las\u00a0matrices\u00a0para\u00a0presentaci\u00f3n \u00a0de\u00a0resultados \u00a0de\u00a0la\u00a0Medici\u00f3n \u00a0del\u00a0Gasto\u00a0en\u00a0SIDA\u00a0\u00a0fue\u00a0\nresultado \u00a0del\u00a0registro\u00a0de\u00a0informaci\u00f3n \u00a0en\u00a0la\u00a0Base\u00a0de\u00a0datos\u00a0con\u00a0las\u00a0categor\u00edas \u00a0NASA.\u00a0\u00a0Previo\u00a0al\u00a0registro\u00a0de\u00a0\ninformaci\u00f3n \u00a0se\u00a0utilizaron \u00a0archivos\u00a0en\u00a0Excel\u00a0de\u00a0soporte,\u00a0para\u00a0consolidar \u00a0y\u00a0realizar\u00a0la\u00a0consistencia \u00a0de\u00a0la\u00a0\ninformaci\u00f3n \u00a0a\u00a0fin\u00a0de\u00a0prepararla \u00a0para\u00a0su\u00a0ingreso\u00a0a\u00a0la\u00a0Base\u00a0de\u00a0datos.\u00a0\u00a0El\u00a0objetivo\u00a0es\u00a0generar\u00a0la\u00a0consistencia \u00a0de\u00a0\nla\u00a0informaci\u00f3n \u00a0por\u00a0cada\u00a0transacci\u00f3n. \u00a0\u00a0\n\u00a0\nSe\u00a0ingres\u00f3\u00a0la\u00a0informaci\u00f3n \u00a0de\u00a0los\u00a0actores\u00a0de\u00a0la\u00a0respuesta \u00a0nacional\u00a0en\u00a0el\u00a0directorio. \u00a0\u00a0Culminada \u00a0la\u00a0recopilaci\u00f3n \u00a0\nde\u00a0informaci\u00f3n \u00a0de\u00a0cada\u00a0transacci\u00f3n \u00a0(por\u00a0a\u00f1o,\u00a0financiador, \u00a0agente\u00a0y\u00a0proveedor), \u00a0se\u00a0realiz\u00f3\u00a0el\u00a0registro\u00a0en\u00a0la\u00a0\nBase\u00a0de\u00a0datos.\u00a0\u00a0El\u00a0registro\u00a0de\u00a0informaci\u00f3n \u00a0se\u00a0realiz\u00f3\u00a0por\u00a0cada\u00a0una\u00a0de\u00a0las\u00a0entidades \u00a0agregada\u00a0por\u00a0a\u00f1o\u00a0para\u00a0las\u00a0\ntransacciones \u00a0identificadas \u00a0con\u00a0igual\u00a0financiador, \u00a0agente\u00a0y\u00a0proveedor, \u00a0sin\u00a0diferenciar \u00a0por\u00a0\u00e1mbito\u00a0geogr\u00e1fico. \u00a0 12 \u00a0\nC.\u00a0Metodolog\u00eda \u00a0para\u00a0la\u00a0estimaci\u00f3n \u00a0de\u00a0gasto\u00a0de\u00a0bolsillo\u00a0\n\u00a0\nC.1\u00a0 Antecedentes \u00a0\nLa\u00a0mayor\u00a0parte\u00a0de\u00a0las\u00a0estimaciones \u00a0de\u00a0gasto\u00a0de\u00a0bolsillo\u00a0en\u00a0VIH\u00a0han\u00a0tomado\u00a0como\u00a0marco\u00a0muestral\u00a0a\u00a0las\u00a0\npersonas\u00a0que\u00a0viven\u00a0con\u00a0VIH\u00a0\u2010\u00a0PVV\u00a0de\u00a0los\u00a0establecimientos \u00a0de\u00a0salud\u00a0del\u00a0MINSA\u00a0\u00a0y\u00a0se\u00a0concentran \u00a0en\u00a0los\u00a0gastos\u00a0\nde\u00a0diagn\u00f3stico \u00a0y\u00a0de\u00a0\u00a0tratamiento. \u00a0\u00a0\u00a0\u00a0\n\u00a0\nPor\u00a0ejemplo,\u00a0en\u00a0las\u00a0Cuentas\u00a0en\u00a0VIH\u00a0realizado\u00a0para\u00a0los\u00a0a\u00f1os\u00a01999\u00a0y\u00a02000\u00a0(\u00a0\u00a04\u00a0\u00a0)\u00a0se\u00a0aplic\u00f3\u00a0una\u00a0encuesta\u00a0a\u00a0230\u00a0PVV\u00a0\nde\u00a0la\u00a0ONG\u00a0PROSA\u00a0(11%),\u00a0de\u00a0los\u00a0diferentes \u00a0grupos\u00a0de\u00a0ayuda\u00a0mutua\u00a0(85%),\u00a0de\u00a0los\u00a0Hospitales \u00a0Arzobispo \u00a0Loayza,\u00a0\nMaria\u00a0Auxiliadora \u00a0y\u00a0en\u00a0la\u00a0Asociaci\u00f3n \u00a0V\u00eda\u00a0Libre\u00a0(4%),\u00a0de\u00a0las\u00a0ciudades\u00a0de\u00a0Lima\u00a0y\u00a0Callao.\u00a0\u00a0\u00a0En\u00a0el\u00a0estudio\u00a0MEGAS\u00a0\n2005\u20102007\u00a0(\u00a05\u00a0)\u00a0se\u00a0realiz\u00f3\u00a0la\u00a0estimaci\u00f3n \u00a0de\u00a0gastos\u00a0de\u00a0bolsillo\u00a0tomando\u00a0como\u00a0base\u00a0una\u00a0encuesta\u00a0a\u00a040\u00a0PVV\u00a0del\u00a0\nHospital\u00a0Hip\u00f3lito\u00a0Unanue\u00a0de\u00a0Lima.\u00a0\n\u00a0\nC.2\u00a0 \u00c1mbito\u00a0y\u00a0t\u00e9cnicas\u00a0de\u00a0recolecci\u00f3n \u00a0de\u00a0datos\u00a0\nEn\u00a0el\u00a0presente\u00a0estudio\u00a0se\u00a0han\u00a0utilizado\u00a0diversas\u00a0\u00a0fuentes\u00a0de\u00a0informaci\u00f3n \u00a0para\u00a0construir\u00a0el\u00a0espectro\u00a0m\u00e1s\u00a0\nfidedigno \u00a0de\u00a0la\u00a0situaci\u00f3n\u00a0del\u00a0gasto\u00a0de\u00a0bolsillo\u00a0en\u00a0VIH.\u00a0\u00a0El\u00a0\u00e1mbito\u00a0y\u00a0t\u00e9cnicas\u00a0de\u00a0recolecci\u00f3n \u00a0de\u00a0datos\u00a0fue:\u00a0\n\uf02d Entrevistas \u00a0 :\u00a0 En\u00a0Lima\u00a0y\u00a0provincias \u00a0\n\uf02d Encuestas \u00a0 :\u00a0 En\u00a0Lima\u00a0\n\uf02d Revisi\u00f3n\u00a0sistem\u00e1tica \u00a0de\u00a0investigaciones \u00a0realizadas \u00a0sobre\u00a0Gastos\u00a0de\u00a0bolsillo\u00a0\u00a0\n\u00a0\nC.3\u00a0 Especificaciones \u00a0\n\uf02d Se\u00a0realizaron \u00a0entrevistas \u00a0a\u00a0informantes \u00a0clave\u00a0para\u00a0establecer \u00a0las\u00a0diversas\u00a0formas\u00a0de\u00a0gasto\u00a0de\u00a0bolsillo\u00a0\nseg\u00fan\u00a0tipo\u00a0de\u00a0poblaci\u00f3n. \u00a0Esta\u00a0entrevista \u00a0se\u00a0llev\u00f3\u00a0a\u00a0cabo\u00a0en\u00a0todas\u00a0las\u00a0ciudades\u00a0que\u00a0se\u00a0visitaron\u00a0durante\u00a0\ndel\u00a0desarrollo \u00a0del\u00a0estudio.\u00a0Los\u00a0entrevistados \u00a0fueron\u00a0los\u00a0profesionales \u00a0de\u00a0salud\u00a0que\u00a0atienden\u00a0en\u00a0los\u00a0\nCERITS\u00a0y\u00a0UAMP\u00a0y\u00a0en\u00a0los\u00a0Hospitales \u00a0que\u00a0atienden\u00a0el\u00a0TARGA.\u00a0\n\uf02d Se\u00a0realiz\u00f3\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0todas\u00a0las\u00a0investigaciones \u00a0realizadas \u00a0en\u00a0el\u00a0Per\u00fa\u00a0\u00a0con\u00a0informaci\u00f3n \u00a0relacionada \u00a0a\u00a0\ncostos\u00a0asumidos \u00a0por\u00a0los\u00a0pacientes. \u00a0\u00a0Por\u00a0ejemplo\u00a0el\u00a0estudio\u00a0realizado\u00a0por\u00a0la\u00a0Organizaci\u00f3n \u00a0Internacional \u00a0\ndel\u00a0Trabajo\u00a0(OIT)\u00a0(\u00a06\u00a0)\u00a0y\u00a0los\u00a0estudios\u00a0realizados \u00a0en\u00a0el\u00a0marco\u00a0de\u00a0los\u00a0proyectos \u00a0del\u00a0FMSTM.\u00a0\n\uf02d Se\u00a0analiz\u00f3\u00a0la\u00a0informaci\u00f3n \u00a0recopilada \u00a0de\u00a0adquisiciones \u00a0e\u00a0importaci\u00f3n \u00a0de\u00a0ARV,\u00a0\u00a0preservativos \u00a0y\u00a0otros\u00a0\ninsumos\u00a0y\u00a0bienes,\u00a0a\u00a0fin\u00a0de\u00a0dimensionar \u00a0el\u00a0consumo\u00a0privado,\u00a0teniendo\u00a0en\u00a0cuenta\u00a0el\u00a0volumen\u00a0de\u00a0\nadquisiciones \u00a0realizadas \u00a0por\u00a0el\u00a0sector\u00a0p\u00fablico.\u00a0\n\uf02d Se\u00a0aplicaron \u00a0encuestas \u00a0directas\u00a0a\u00a0los\u00a0usuarios\u00a0en\u00a0los\u00a0lugares\u00a0de\u00a0prestaci\u00f3n \u00a0del\u00a0servicio\u00a0de\u00a0tratamiento. \u00a0\u00a0\nSe\u00a0utiliz\u00f3\u00a0como\u00a0base\u00a0la\u00a0encuesta\u00a0aplicada\u00a0en\u00a0el\u00a0estudio\u00a0MEGAS\u00a02005\u20102007,\u00a0con\u00a0aportes\u00a0del\u00a0enfoque\u00a0de\u00a0\ng\u00e9nero,\u00a0as\u00ed\u00a0como\u00a0de\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0la\u00a0ENAHO.\u00a0\u00a0Aunque\u00a0se\u00a0env\u00edo\u00a0cartas\u00a0a\u00a0los\u00a0establecimientos \u00a0de\u00a0Lima\u00a0y\u00a0\nde\u00a0las\u00a0provincias \u00a0a\u00a0nivel\u00a0nacional,\u00a0algunos\u00a0establecimientos \u00a0no\u00a0autorizaron \u00a0la\u00a0aplicaci\u00f3n \u00a0de\u00a0encuestas. \u00a0\n\u00a0\nC.4\u00a0Otras\u00a0variables\u00a0\nSe\u00a0tom\u00f3\u00a0en\u00a0cuenta\u00a0algunas\u00a0variables\u00a0adicionales \u00a0a\u00a0fin\u00a0de\u00a0determinar \u00a0el\u00a0nivel\u00a0de\u00a0gasto\u00a0de\u00a0bolsillo,\u00a0tales\u00a0como:\u00a0\n\uf02d Evoluci\u00f3n \u00a0del\u00a0nivel\u00a0de\u00a0aseguramiento \u00a0por\u00a0las\u00a0diferentes \u00a0opciones\u00a0(seguridad \u00a0social,\u00a0seguro\u00a0p\u00fablico)\u00a0\n\uf02d Evoluci\u00f3n \u00a0del\u00a0nivel\u00a0de\u00a0cobertura \u00a0en\u00a0prevenci\u00f3n \u00a0y\u00a0tratamiento. \u00a0\n\uf02d Importaciones \u00a0realizadas \u00a0de\u00a0antirretrovirales \u00a0y\u00a0condones \u00a0\n\uf02d Informaci\u00f3n \u00a0sobre\u00a0condones \u00a0\n\uf02d Encuestas \u00a0nacionales \u00a0realizados \u00a0por\u00a0el\u00a0INEI\u00a0\n\u00a0C.5\u00a0Encuestas \u00a0aplicadas \u00a0y\u00a0historias\u00a0cl\u00ednicas\u00a0revisadas \u00a0\n                                                 \n4 SIDALAC/FUNSALUD,  Flujo\u00a0de\u00a0financiamiento \u00a0y\u00a0gasto\u00a0en\u00a0VIH\u00a0SIDA\u00a0\u2013\u00a0Cuentas\u00a0Nacionales \u00a0en\u00a0VIH\u00a0SIDA,\u00a01999\u20102000,\u00a02001,\u00a0\nPer\u00fa \n5 Medici\u00f3n \u00a0del\u00a0gasto\u00a0en\u00a0VIH\u00a02005\u20102007,\u00a0ONUSIDA  \n6 OIT,\u00a0Encuesta\u00a0personas\u00a0que\u00a0viven\u00a0con\u00a0VIH\u00a0sobre\u00a0su\u00a0condici\u00f3n \u00a0laboral\u00a0en\u00a0Lima\u00a0y\u00a0Callao,\u00a02009  13 Se\u00a0aplicaron \u00a0un\u00a0total\u00a0de\u00a0152\u00a0encuestas, \u00a075\u00a0en\u00a0hospitales \u00a0TARGA\u00a0y\u00a077\u00a0a\u00a0usuarios\u00a0de\u00a0servicios\u00a0de\u00a0prevenci\u00f3n \u00a0\n(CERITS\u00a0y\u00a0UAMP).\u00a0\n\u00a0\nN\u00famero\u00a0de\u00a0encuestas \u00a0en\u00a0Hospitales \u00a0TARGA\u00a0\nCiudad\u00a0 Establecimiento \u00a0de\u00a0Salud\u00a0 Hombre\u00a0Mujer\u00a0 Total\u00a0\nLima\u00a0 Hospital\u00a0Hip\u00f3lito\u00a0Unanue\u00a0 18\u00a0 23\u00a0 41\u00a0\nLima\u00a0 Impacta\u00a0 19\u00a0\u00a0 19\u00a0\nLima\u00a0 V\u00eda\u00a0Libre\u00a0 1\u00a0\u00a0 1\u00a0\nHuancayo \u00a0 Hospital\u00a0Daniel\u00a0A.\u00a0Carri\u00f3n\u00a0 6\u00a0 1\u00a0 7\u00a0\nPucallpa\u00a0 Hospital\u00a0Materno\u00a0Infantil\u00a0San\u00a0Jos\u00e9\u00a0 1\u00a0 1\u00a0 2\u00a0\nLambayeque \u00a0 Hospital\u00a0Las\u00a0Mercedes \u00a01/\u00a0 5\u00a0\u00a0\u00a0\nTotal\u00a0 50\u00a0 25\u00a0 75\u00a0\n1/\u00a0Las\u00a0encuestas \u00a0aplicadas \u00a0en\u00a0el\u00a0Hospital\u00a0Las\u00a0mercedes \u00a0no\u00a0fueron\u00a0incluidas\u00a0en\u00a0la\u00a0tabulaci\u00f3n \u00a0puesto\u00a0\nque\u00a0sirvieron\u00a0para\u00a0validar\u00a0la\u00a0encuesta. \u00a0\n\u00a0\nN\u00famero\u00a0de\u00a0encuestas \u00a0en\u00a0CERITS\u00a0\nCiudad\u00a0 Establecimiento \u00a0de\u00a0Salud\u00a0 Hombre\u00a0Mujer\u00a0Total\u00a0\nCallao\u00a0 Centro\u00a0de\u00a0Referencia \u00a0Alberto\u00a0Bart\u00f3n\u00a0 23\u00a0 15\u00a0 38\u00a0\nLima\u00a0 Asociaci\u00f3n \u00a0civil\u00a0Impacta\u00a0 1\u00a0\u00a0 1\u00a0\nLima\u00a0 C.\u00a0S.\u00a0Ra\u00fal\u00a0Patrucco\u00a0 15\u00a0 23\u00a0 38\u00a0\nTotal\u00a0general\u00a0\u00a0 39\u00a0 38\u00a0 77\u00a0\n\u00a0\nSe\u00a0revis\u00f3\u00a0un\u00a0total\u00a0de\u00a0640\u00a0historias\u00a0cl\u00ednicas\u00a0de\u00a0usuarios\u00a0de\u00a0establecimientos \u00a0que\u00a0prestan\u00a0servicios\u00a0de\u00a0\nprevenci\u00f3n \u00a0(464)\u00a0como\u00a0de\u00a0tratamiento \u00a0(176).\u00a0\u00a0\u00a0\u00a0\n\u00a0\nHistoria\u00a0cl\u00ednicas\u00a0revisadas \u00a0de\u00a0personas\u00a0en\u00a0tratamiento \u00a0(TARGA)\u00a0\nDepartamento \u00a0Ciudad\u00a0 Establecimiento \u00a0de\u00a0salud\u00a0 Hombre Mujer Total\u00a0Proceso\u00a0de\u00a0selecci\u00f3n\u00a0\nmuestra\u00a0\nLambayeque \u00a0Chiclayo\u00a0Hospital\u00a0Las\u00a0Mercedes \u00a0 22\u00a0 14\u00a036\u00a0 Aleatorio\u00a0\nAncash\u00a0 Chimbote \u00a0Hospital\u00a0La\u00a0Caleta\u00a0 9\u00a0 6\u00a015\u00a0 Aleatorio\u00a0\nJun\u00edn\u00a0 Huancayo \u00a0Hospital\u00a0Daniel\u00a0A.\u00a0Carri\u00f3n\u00a0 27\u00a0 9\u00a036\u00a0 Aleatorio\u00a0\nIca\u00a0 Ica\u00a0 Hospital\u00a0Regional\u00a0de\u00a0Ica\u00a0 4\u00a0 6\u00a010\u00a0Los\u00a0que\u00a0se\u00a0atienden\nLoreto\u00a0 Iquitos\u00a0Hospital\u00a0Regional\u00a0de\u00a0Loreto\u00a0 31\u00a0 7\u00a038\u00a0 Aleatorio\u00a0\nUcayali\u00a0 Pucallpa\u00a0Centro\u00a0Materno\u00a0Infantil\u00a0San\u00a0Jos\u00e9\u00a0 30\u00a0 11\u00a041\u00a0 Aleatorio\u00a0\nTotal\u00a0general 123\u00a053\u00a0176 \u00a0\n\u00a0\nHistorias\u00a0cl\u00ednicas\u00a0revisadas \u00a0de\u00a0personas\u00a0en\u00a0prevenci\u00f3n \u00a0(CERITS)\u00a0\nDepartament oCiudad\u00a0 Establecimiento \u00a0de\u00a0salud\u00a0 Hombre Mujer Total\u00a0Proceso\u00a0de\u00a0\nselecci\u00f3n\u00a0muestra\nCallao\u00a0 Callao\u00a0 Centro\u00a0de\u00a0Referencia \u00a0Alberto\u00a0Bart\u00f3n\u00a0 31\u00a0 49\u00a0 80\u00a0Aleatorio\u00a0\nLima\u00a0 Lima\u00a0 C.\u00a0S.\u00a0Ra\u00fal\u00a0Patrucco\u00a0 123\u00a0106\u00a0229\u00a0Aleatorio\u00a0\nLambayeque \u00a0Chiclayo\u00a0C.\u00a0S.\u00a0Jos\u00e9\u00a0Olaya\u00a0 14\u00a0 14\u00a0 28\u00a0Aleatorio\u00a0\nLoreto\u00a0 Iquitos\u00a0Centro\u00a0de\u00a0Salud\u00a0San\u00a0Juan\u00a0 17\u00a0 21\u00a0 38\u00a0Aleatorio\u00a0\nJun\u00edn\u00a0 Huancayo \u00a0Hospital\u00a0Daniel\u00a0A.\u00a0Carri\u00f3n\u00a0 20\u00a0 10\u00a0 30\u00a0Los\u00a0que\u00a0se\u00a0atiende n\nUcayali\u00a0 Pucallpa\u00a0Hospital\u00a0Regional\u00a0de\u00a0Pucallpa\u00a0 1\u00a0 10\u00a0 11\u00a0Los\u00a0que\u00a0se\u00a0atiende n\nIca\u00a0 Ica\u00a0 Hospital\u00a0Regional\u00a0de\u00a0Ica\u00a0 7\u00a0\u00a0 7\u00a0Los\u00a0que\u00a0se\u00a0atiende n\nIca\u00a0 Ica\u00a0 Centro\u00a0de\u00a0Salud\u00a0de\u00a0Parcona\u00a0\u00a0 9\u00a0 9\u00a0Los\u00a0que\u00a0se\u00a0atiende n\nAncash\u00a0 Chimbote \u00a0Hospital\u00a0Apoyo\u00a0La\u00a0Caleta\u00a0\u2013\u00a0Chimbote \u00a0 13\u00a0 19\u00a0 32\u00a0Aleatorio\u00a0\nTotal\u00a0general\u00a0 226\u00a0238\u00a0464\u00a0\u00a0\n\u00a0 14 D.\u00a0\u00a0Enfoque\u00a0de\u00a0g\u00e9nero7\u00a0\n\u00a0\nLa\u00a0categor\u00eda \u00a0g\u00e9nero\u00a0nos\u00a0permite\u00a0incorporar \u00a0una\u00a0forma\u00a0nueva\u00a0de\u00a0analizar\u00a0la\u00a0realidad\u00a0\u00a0para\u00a0ubicar\u00a0los\u00a0\nproblemas \u00a0desde\u00a0un\u00a0punto\u00a0de\u00a0vista\u00a0m\u00e1s\u00a0amplio,\u00a0a\u00a0fin\u00a0de\u00a0entender\u00a0y\u00a0visualizar\u00a0que\u00a0existen\u00a0profundas \u00a0\ndiferencias \u00a0entre\u00a0los\u00a0seres\u00a0humanos, \u00a0producto\u00a0de\u00a0las\u00a0relaciones \u00a0que\u00a0determinan \u00a0distintos\u00a0roles\u00a0y\u00a0asimetr\u00edas \u00a0\nde\u00a0poder\u00a0entre\u00a0los\u00a0g\u00e9neros,\u00a0lo\u00a0cual\u00a0se\u00a0constituye \u00a0en\u00a0un\u00a0hecho\u00a0cultural\u00a0que\u00a0puede\u00a0y\u00a0debe\u00a0ser\u00a0cambiado\u201d. \u00a08\u00a0\n\u00a0\nMientras, \u00a0el\u00a0marco\u00a0legal\u00a0nacional\u00a0que\u00a0propicia\u00a0la\u00a0igualdad\u00a0de\u00a0g\u00e9nero\u00a0entre\u00a0hombres\u00a0y\u00a0mujeres\u00a0est\u00e1\u00a0bastante\u00a0\navanzado; \u00a09\u00a0en\u00a0lo\u00a0que\u00a0se\u00a0refiere\u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0con\u00a0diferentes \u00a0opciones, \u00a0comportamientos \u00a0o\u00a0identidades \u00a0de\u00a0\ng\u00e9nero\u00a0con\u00a0una\u00a0evidente\u00a0no\u00a0correspondencia \u00a0sexual,\u00a0en\u00a0la\u00a0normativa \u00a0nacional,\u00a0no\u00a0existir\u00eda\u00a0ning\u00fan\u00a0sustento; \u00a0\npor\u00a0cuanto\u00a0el\u00a0marco\u00a0legal\u00a0peruano\u00a0s\u00f3lo\u00a0reconoce \u00a0a\u00a0los\u00a0g\u00e9neros\u00a0\u201cfemenino\u201d \u00a0o\u00a0\u201cmasculino\u201d, \u00a0identificados \u00a0con\u00a0\nel\u00a0sexo\u00a0\u201chombre\u201d \u00a0o\u00a0\u201cmujer\u201d;\u00a0tal\u00a0como\u00a0los\u00a0utiliza\u00a0la\u00a0oficina\u00a0de\u00a0Registro\u00a0Nacional\u00a0de\u00a0Identificaci\u00f3n \u00a0y\u00a0Estado\u00a0\nCivil\u00a0\u2010\u00a0RENIEC\u00a0que\u00a0discrimina \u00a0al\u00a0sexo\u00a0como\u00a0femenino \u00a0o\u00a0masculino. \u00a0Por\u00a0tanto,\u00a0al\u00a0no\u00a0ser\u00a0reconocidos \u00a0con\u00a0\nidentidad \u00a0legal,\u00a0se\u00a0podr\u00eda\u00a0suponer\u00a0que\u00a0por\u00a0esa\u00a0raz\u00f3n\u00a0no\u00a0son\u00a0sujetos\u00a0de\u00a0pol\u00edticas\u00a0p\u00fablicas\u00a0espec\u00edficas. \u00a0\u00a0\n\u00a0\nEl\u00a0objetivo\u00a0\u00a0del\u00a0enfoque\u00a0de\u00a0g\u00e9nero\u00a0en\u00a0este\u00a0documento \u00a0no\u00a0es\u00a0la\u00a0formulaci\u00f3n \u00a0o\u00a0la\u00a0construcci\u00f3n \u00a0\u00a0de\u00a0una\u00a0nueva\u00a0\ndefinici\u00f3n \u00a0del\u00a0concepto \u00a0de\u00a0g\u00e9nero,\u00a0sino\u00a0de\u00a0utilizar\u00a0uno\u00a0que\u00a0permita\u00a0identificar \u00a0si\u00a0existe\u00a0\u00a0inequidad \u00a0en\u00a0el\u00a0\ngasto\u00a0en\u00a0VIH/sida\u00a0en\u00a0las\u00a0diferentes \u00a0intervenciones \u00a0\u00a0hacia\u00a0las\u00a0poblaciones \u00a0afectadas \u00a0y\u00a0si\u00a0esta\u00a0informaci\u00f3n \u00a0es\u00a0\nposible\u00a0de\u00a0ser\u00a0captada\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0los\u00a0estudios\u00a0MEGAS.\u00a0\n\u00a0\nEn\u00a0este\u00a0contexto, \u00a0la\u00a0pregunta\u00a0es\u00a0\u00bfpor\u00a0qu\u00e9\u00a0es\u00a0importante \u00a0incorporar \u00a0este\u00a0marco\u00a0conceptual \u00a0y\u00a0c\u00f3mo\u00a0aporta\u00a0el\u00a0\nenfoque\u00a0de\u00a0g\u00e9nero\u00a0en\u00a0la\u00a0lucha\u00a0contra\u00a0el\u00a0VIH/SIDA? \u00a0Previa\u00a0a\u00a0la\u00a0respuesta, \u00a0es\u00a0pertinente \u00a0replantear \u00a0que\u00a0el\u00a0\nenfoque\u00a0de\u00a0g\u00e9nero\u00a0en\u00a0VIH/SIDA, \u00a0no\u00a0s\u00f3lo\u00a0compete\u00a0a\u00a0hombres\u00a0y\u00a0mujeres\u00a0sino\u00a0a\u00a0personas\u00a0con\u00a0otras\u00a0opciones, \u00a0\ncomportamientos \u00a0e\u00a0identidades \u00a0de\u00a0g\u00e9nero\u00a0diferenciados. \u00a0Actualmente \u00a0aceptado \u00a0es\u00a0que\u00a0el\u00a0sexo\u00a0es\u00a0una\u00a0\ncondici\u00f3n \u00a0f\u00edsica,\u00a0una\u00a0diferencia \u00a0biol\u00f3gica\u00a0entre\u00a0hombres\u00a0y\u00a0mujeres,\u00a0y\u00a0g\u00e9nero\u00a0es\u00a0un\u00a0conjunto\u00a0de\u00a0\ncaracter\u00edsticas \u00a0sociales\u00a0y\u00a0culturales \u00a0atribuidas \u00a0a\u00a0una\u00a0persona\u00a0seg\u00fan\u00a0su\u00a0sexo,\u00a0forjada\u00a0en\u00a0funci\u00f3n\u00a0a\u00a0modelos\u00a0\nideol\u00f3gicos, \u00a0pol\u00edticos\u00a0y\u00a0econ\u00f3micos, \u00a0y\u00a0por\u00a0tanto\u00a0factibles\u00a0de\u00a0modificar, \u00a0ya\u00a0que\u00a0se\u00a0refieren\u00a0a\u00a0comportamientos \u00a0\nesperados \u00a0o\u00a0\u201csocialmente \u00a0aceptados\u201d \u00a0para\u00a0cada\u00a0sexo,\u00a0es\u00a0decir\u00a0les\u00a0asignan\u00a0roles,\u00a0en\u00a0los\u00a0cuales\u00a0es\u00a0posible\u00a0\nidentificar \u00a0relaciones \u00a0de\u00a0poder.\u00a0\u00a0\n\u00a0\n\u00bfPor\u00a0qu\u00e9\u00a0es\u00a0importante \u00a0incorporar \u00a0este\u00a0marco\u00a0conceptual \u00a0en\u00a0la\u00a0lucha\u00a0contra\u00a0el\u00a0VIH/SIDA? \u00a0\u00a0Un\u00a0primer\u00a0intento\u00a0\nde\u00a0respuesta, \u00a0es\u00a0que\u00a0el\u00a0VIH/SIDA\u00a0es\u00a0una\u00a0enfermedad \u00a0directamente \u00a0relacionada \u00a0al\u00a0comportamiento \u00a0social,\u00a0\nprincipalmente \u00a0sexual;\u00a0al\u00a0haberse\u00a0convertido \u00a0esta\u00a0v\u00eda\u00a0en\u00a0una\u00a0de\u00a0las\u00a0principales \u00a0v\u00edas\u00a0de\u00a0transmisi\u00f3n. \u00a0En\u00a0ese\u00a0\nsentido,\u00a0interesa\u00a0conocer\u00a0cu\u00e1les\u00a0son\u00a0los\u00a0patrones\u00a0de\u00a0comportamiento \u00a0construidos \u00a0y\u00a0socialmente \u00a0\n\u201caceptados\u201d \u00a0en\u00a0lo\u00a0que\u00a0se\u00a0refiere\u00a0al\u00a0comportamiento \u00a0sexual\u00a0seg\u00fan\u00a0\u201cg\u00e9nero\u201d, \u00a0este\u00a0reconocimiento \u00a0permitir\u00e1 \u00a0\nidentificar \u00a0el\u00a0sustento\u00a0que\u00a0da\u00a0origen\u00a0a\u00a0inequidades \u00a0tanto\u00a0para\u00a0la\u00a0transmisi\u00f3n \u00a0como\u00a0para\u00a0la\u00a0atenci\u00f3n\u00a0del\u00a0\nVIH/SIDA. \u00a0\n\u00a0\nDebe\u00a0mencionarse \u00a0que\u00a0en\u00a0este\u00a0\u00a0estudio\u00a0se\u00a0han\u00a0incorporado \u00a0modificaciones \u00a0en\u00a0la\u00a0recolecci\u00f3n \u00a0de\u00a0informaci\u00f3n \u00a0\n(tanto\u00a0en\u00a0el\u00a0proceso\u00a0e\u00a0instrumentos), \u00a0\u00a0para\u00a0que\u00a0nos\u00a0permitan\u00a0visibilizar\u00a0diferencias \u00a0en\u00a0la\u00a0intensidad \u00a0de\u00a0uso\u00a0\nde\u00a0los\u00a0servicios\u00a0por\u00a0parte\u00a0de\u00a0las\u00a0diferentes \u00a0poblaciones, \u00a0HSH,\u00a0mujeres,\u00a0sin\u00a0embargo\u00a0se\u00a0ha\u00a0podido\u00a0determinar \u00a0\nque\u00a0en\u00a0los\u00a0propios\u00a0registros\u00a0administrativos \u00a0es\u00a0dif\u00edcil\u00a0capturar\u00a0esta\u00a0informaci\u00f3n, \u00a0como\u00a0se\u00a0menciono \u00a0\nanteriormente. \u00a0\n\u00a0\nEn\u00a0lo\u00a0referente \u00a0a\u00a0la\u00a0transmisi\u00f3n, \u00a0el\u00a0comportamiento \u00a0\u201cveladamente \u00a0aceptado\u201d \u00a0por\u00a0la\u00a0sociedad, \u00a0para\u00a0los\u00a0\nhombres, \u00a0es\u00a0que\u00a0estos\u00a0pueden\u00a0tener\u00a0varias\u00a0parejas\u00a0paralelas\u00a0o\u00a0simult\u00e1neas; \u00a0mientras\u00a0que\u00a0para\u00a0las\u00a0mujeres\u00a0\n                                                 \n7 La\u00a0inclusi\u00f3n\u00a0de\u00a0este\u00a0segmento \u00a0corresponde \u00a0a\u00a0la\u00a0Consultor\u00eda \u00a0que\u00a0en\u00a0paralelo\u00a0se\u00a0desarrollo \u00a0en\u00a0el\u00a0pa\u00eds\u00a0para\u00a0analizar\u00a0el\u00a0\nenfoque\u00a0de\u00a0g\u00e9nero\u00a0en\u00a0la\u00a0medici\u00f3n \u00a0del\u00a0gasto\u00a0en\u00a0SIDA.  \n8 Consultor\u00eda \u00a0\u201cIncorporaci\u00f3n \u00a0del\u00a0Enfoque\u00a0de\u00a0G\u00e9nero\u00a0en\u00a0el\u00a0Presupuesto \u00a0P\u00fablico\u00a0en\u00a0el\u00a0Marco\u00a0Nacional\u00a0del\u00a0Plan\u00a0de\u00a0\nIgualdad\u00a0de\u00a0\u00a0Oportunidades\u201d. \u00a0MIMDES\u2010\u00a0UNIFEM\u2010MEF.2008  \n9 Ley\u00a0de\u00a0igualdad\u00a0de\u00a0oportunidades \u00a0entre\u00a0hombres\u00a0y\u00a0mujeres\u00a0\u2013\u00a0Ley\u00a028983   15 este\u00a0tipo\u00a0de\u00a0comportamiento, \u00a0si\u00a0bien\u00a0contin\u00faa\u00a0siendo\u00a0desaprobado, \u00a0los\u00a0mecanismos \u00a0de\u00a0control\u00a0social\u00a0\ndecididamente \u00a0se\u00a0han\u00a0modificado; \u00a0y\u00a0para\u00a0las\u00a0personas\u00a0con\u00a0otras\u00a0opciones, \u00a0comportamientos \u00a0e\u00a0identidades \u00a0\nde\u00a0g\u00e9nero,\u00a0\u00a0en\u00a0lo\u00a0sexual\u00a0alguno\u00a0de\u00a0ellos\u00a0tambi\u00e9n\u00a0tiene\u00a0varias\u00a0parejas\u00a0sexuales\u00a0durante\u00a0su\u00a0vida.\u00a0\u00a0\n\u00a0\nSi\u00a0aceptamos \u00a0que\u00a0en\u00a0los\u00a0roles\u00a0de\u00a0g\u00e9nero\u00a0se\u00a0encuentran \u00a0impl\u00edcitas \u00a0relaciones \u00a0de\u00a0poder,\u00a0\u00bfc\u00f3mo\u00a0se\u00a0expresan\u00a0\n\u00e9stas\u00a0en\u00a0lo\u00a0relacionado \u00a0al\u00a0VIH/SIDA? \u00a0\u00a0\n\u00a0\nUn\u00a0diagn\u00f3stico, \u00a0con\u00a0enfoque\u00a0de\u00a0g\u00e9nero,\u00a0enriquecer\u00eda \u00a0esta\u00a0respuesta \u00a0al\u00a0tomar\u00a0en\u00a0cuenta\u00a0la\u00a0din\u00e1mica\u00a0real\u00a0del\u00a0\nconcepto \u00a0de\u00a0g\u00e9nero,\u00a0como\u00a0los\u00a0cambios\u00a0de\u00a0comportamiento \u00a0en\u00a0los\u00a0hombres\u00a0y\u00a0mujeres\u00a0que\u00a0ya\u00a0no\u00a0se\u00a0ajustan\u00a0a\u00a0\nlos\u00a0patrones\u00a0tradicionales \u00a0y\u00a0seguramente \u00a0se\u00a0obtendr\u00edan \u00a0respuestas \u00a0m\u00e1s\u00a0finas\u00a0para\u00a0entender\u00a0c\u00f3mo\u00a0se\u00a0\nrelacionan \u00a0con\u00a0la\u00a0expansi\u00f3n \u00a0del\u00a0VIH/SIDA. \u00a0\n\u00a0\nPara\u00a0el\u00a0caso\u00a0de\u00a0los\u00a0hombres\u00a0que\u00a0tienen\u00a0sexo\u00a0con\u00a0hombres\u2010HSH,\u00a0una\u00a0de\u00a0las\u00a0poblaciones \u00a0m\u00e1s\u00a0afectadas \u00a0en\u00a0el\u00a0\nPer\u00fa,\u00a0la\u00a0definici\u00f3n \u00a0de\u00a0g\u00e9nero\u00a0no\u00a0est\u00e1\u00a0social\u00a0y\u00a0formalmente \u00a0construida; \u00a0sin\u00a0embargo, \u00a0se\u00a0les\u00a0caracteriza \u00a0como\u00a0\nuna\u00a0poblaci\u00f3n \u00a0con\u00a0\u00a0comportamientos \u00a0sexuales\u00a0de\u00a0riesgo\u00a0\u00a0que\u00a0s\u00ed\u00a0inciden\u00a0en\u00a0el\u00a0VIH/SIDA. \u00a0Al\u00a0no\u00a0contar\u00a0con\u00a0\ninformaci\u00f3n \u00a0sobre\u00a0los\u00a0diferentes \u00a0subgrupos \u00a0que\u00a0conforman \u00a0esta\u00a0poblaci\u00f3n, \u00a0no\u00a0facilita\u00a0identificar \u00a0como\u00a0se\u00a0\nexpresan\u00a0en\u00a0su\u00a0comportamiento \u00a0las\u00a0relaciones \u00a0de\u00a0poder\u00a0entre\u00a0ellos\u00a0y\u00a0con\u00a0los\u00a0\u201chombres\u201d \u00a0y\u00a0de\u00a0c\u00f3mo\u00a0se\u00a0\nafectan\u00a0por\u00a0el\u00a0VIH/SIDA. \u00a0\u00a0\n\u00a0\nLa\u00a0importancia \u00a0de\u00a0incorporar \u00a0el\u00a0enfoque\u00a0de\u00a0g\u00e9nero,\u00a0en\u00a0lo\u00a0que\u00a0respecta\u00a0a\u00a0la\u00a0transmisi\u00f3n, \u00a0reside\u00a0en\u00a0que\u00a0\npermitir\u00eda \u00a0identificar \u00a0el\u00a0comportamiento \u00a0que\u00a0se\u00a0busca\u00a0modificar \u00a0en\u00a0las\u00a0poblaciones \u00a0afectadas \u00a0o\u00a0en\u00a0riesgo;\u00a0sin\u00a0\nembargo, \u00a0se\u00a0reconoce \u00a0que\u00a0una\u00a0estrategia \u00a0de\u00a0este\u00a0tipo\u00a0de\u00a0por\u00a0s\u00ed\u00a0es\u00a0a\u00a0largo\u00a0plazo;\u00a0ejemplo:\u00bfC\u00f3mo \u00a0lograr\u00a0que\u00a0\nuna\u00a0mujer\u00a0llegue\u00a0al\u00a0nivel\u00a0de\u00a0exigirle\u00a0a\u00a0su\u00a0pareja\u00a0el\u00a0uso\u00a0del\u00a0cond\u00f3n?, \u00a0m\u00e1s\u00a0a\u00fan\u00a0cuando\u00a0son\u00a0pareja\u00a0\nestable;\u00bfC\u00f3mo \u00a0lograr\u00a0que\u00a0una\u00a0poblaci\u00f3n \u00a0con\u00a0comportamiento \u00a0sexual\u00a0de\u00a0riesgo,\u00a0cambie\u00a0y/o\u00a0a\u00a0la\u00a0vez\u00a0utilice\u00a0el\u00a0\ncond\u00f3n\u00a0como\u00a0medida\u00a0de\u00a0prevenci\u00f3n?; \u00a0\u00bfC\u00f3mo\u00a0lograr\u00a0que\u00a0los\u00a0ni\u00f1os\u00a0o\u00a0j\u00f3venes\u00a0homosexuales \u00a0pobres\u00a0se\u00a0\nsientan\u00a0con\u00a0posibilidades \u00a0de\u00a0desarrollo \u00a0personal\u00a0no\u00a0estigmatizado \u00a0y\u00a0no\u00a0expuestos \u00a0a\u00a0la\u00a0explotaci\u00f3n \u00a0sexual?\u00a0\u00a0\n\u00a0\nEstos\u00a0hechos\u00a0evidencian \u00a0que\u00a0enfrentar \u00a0el\u00a0VIH/SIDA, \u00a0con\u00a0enfoque\u00a0de\u00a0g\u00e9nero,\u00a0supera\u00a0lo\u00a0ofertado\u00a0por\u00a0el\u00a0sector\u00a0\nsalud;\u00a0por\u00a0tanto,\u00a0implica\u00a0una\u00a0intervenci\u00f3n \u00a0intersectorial, \u00a0que\u00a0proyecte\u00a0contenidos \u00a0claros\u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0en\u00a0\nriesgo\u00a0para\u00a0que\u00a0asuma\u00a0las\u00a0medidas\u00a0de\u00a0prevenci\u00f3n \u00a0promocionadas \u00a0o\u00a0no.\u00a0\n\u00a0\nEn\u00a0cuanto\u00a0a\u00a0la\u00a0atenci\u00f3n ,\u00a0incorporar \u00a0el\u00a0enfoque\u00a0de\u00a0g\u00e9nero,\u00a0permitir\u00eda \u00a0identificar \u00a0las\u00a0inequidades \u00a0en\u00a0la\u00a0\ndistribuci\u00f3n \u00a0de\u00a0los\u00a0recursos,\u00a0bienes\u00a0y\u00a0servicios\u00a0entre\u00a0hombres, \u00a0mujeres\u00a0y\u00a0las\u00a0personas\u00a0con\u00a0otras\u00a0opciones, \u00a0\ncomportamientos \u00a0e\u00a0identidades \u00a0de\u00a0g\u00e9nero,\u00a0contribuyendo \u00a0a\u00a0mejorar\u00a0la\u00a0intervenci\u00f3n \u00a0del\u00a0sector\u00a0p\u00fablico\u00a0y\u00a0\nprivado\u00a0con\u00a0resultados \u00a0m\u00e1s\u00a0eficientes, \u00a0eficaces,\u00a0justos\u00a0y\u00a0equitativos. \u00a0\u00a0\n\u00a0\nSe\u00a0plantea\u00a0como\u00a0conceptos \u00a0de\u00a0referencia \u00a0lo\u00a0siguiente: \u00a0\u00a0\u00a0Se\u00a0entender\u00e1 \u00a0por\u00a0Enfoque\u00a0de\u00a0G\u00e9nero\u00a0en\u00a0los\u00a0estudios\u00a0\nMEGAS\u00a0a\u00a0\u201cContribuir \u00a0a\u00a0la\u00a0erradicaci\u00f3n \u00a0de\u00a0todas\u00a0las\u00a0formas,\u00a0mecanismos \u00a0y\u00a0canales\u00a0que\u00a0generan\u00a0o\u00a0refuerzan \u00a0\nsituaciones \u00a0de\u00a0dependencia \u00a0y\u00a0desventaja \u00a0entre\u00a0las\u00a0mujeres,\u00a0hombres\u00a0y\u00a0las\u00a0personas\u00a0que\u00a0tienen\u00a0diferentes \u00a0\nopciones\u00a0en\u00a0cumplimiento \u00a0de\u00a0las\u00a0pol\u00edticas\u00a0nacionales \u00a0que\u00a0establecen \u00a0su\u00a0igualdad10.\u00a0Y\u00a0considera \u00a0el\u00a0impacto\u00a0\ndiferenciado \u00a0del\u00a0gasto,\u00a0comportamientos \u00a0e\u00a0identidades \u00a0de\u00a0g\u00e9nero,\u00a0prioritariamente \u00a0de\u00a0los\u00a0hombres\u00a0que\u00a0\ntienen\u00a0sexo\u00a0con\u00a0hombres\u00a0(HSH)\u00a0y\u00a0\u00a0que\u00a0se\u00a0expresan\u00a0en\u00a0brechas\u00a0entre\u00a0estos\u00a0y\u00a0obstaculizan \u00a0las\u00a0acciones\u00a0de\u00a0\nprevenci\u00f3n \u00a0y\u00a0tratamiento \u00a0del\u00a0VIH/SIDA\u201d \u00a0\n\u00a0\nAsimismo, \u00a0que\u00a0\u201cEl\u00a0gasto\u00a0en\u00a0VIH/SIDA\u00a0es\u00a0Sensible\u00a0al\u00a0G\u00e9nero,\u00a0cuando\u00a0se\u00a0ha\u00a0incorporado \u00a0en\u00a0el\u00a0ciclo\u00a0\npresupuestario \u00a0el\u00a0enfoque\u00a0de\u00a0g\u00e9nero,\u00a0permitiendo \u00a0asegurar\u00a0y\u00a0visibilizar\u00a0una\u00a0\u00f3ptima\u00a0orientaci\u00f3n \u00a0del\u00a0gasto\u00a0\npara\u00a0la\u00a0reducci\u00f3n \u00a0de\u00a0la\u00a0desigualdad \u00a0entre\u00a0hombres, \u00a0mujeres\u00a0y\u00a0las\u00a0personas\u00a0que\u00a0tienen\u00a0diferentes \u00a0opciones, \u00a0\ncomportamientos \u00a0e\u00a0identidades \u00a0de\u00a0g\u00e9nero\u00a0en\u00a0todas\u00a0las\u00a0intervenciones \u00a0para\u00a0enfrentar \u00a0el\u00a0VIH/SIDA,\u201d. \u00a0\n\u00a0\nSi\u00a0bien\u00a0en\u00a0un\u00a0primer\u00a0momento, \u00a0se\u00a0relacion\u00f3 \u00a0la\u00a0incorporaci\u00f3n \u00a0del\u00a0enfoque\u00a0de\u00a0g\u00e9nero\u00a0a\u00a0la\u00a0orientaci\u00f3n \u00a0del\u00a0\n\u201cgasto\u201d\u00a0en\u00a0t\u00e9rminos\u00a0de\u00a0\u201catenci\u00f3n\u201d ;\u00a0ahora\u00a0este\u00a0concepto \u00a0se\u00a0ampl\u00eda\u00a0hasta\u00a0utilizarlo\u00a0en\u00a0la\u00a0identificaci\u00f3n \u00a0de\u00a0las\u00a0\n                                                 \n10 Se\u00a0plantea\u00a0en\u00a0t\u00e9rminos\u00a0de\u00a0proyecci\u00f3n, \u00a0por\u00a0cuanto\u00a0actualmente \u00a0no\u00a0es\u00a0posible\u00a0aludir\u00a0a\u00a0ninguna\u00a0pol\u00edtica\u00a0nacional .  16 \u201crelaciones \u00a0de\u00a0poder\u201d\u00a0al\u00a0interior\u00a0de\u00a0las\u00a0poblaciones \u00a0afectadas \u00a0con\u00a0implicancias \u00a0en\u00a0la\u00a0\u201ctransmisi\u00f3n \u00a0del\u00a0\nVIH/SIDA\u201d ;\u00a0es\u00a0decir\u00a0obliga\u00a0o\u00a0exige\u00a0comprender \u00a0las\u00a0formas\u00a0en\u00a0las\u00a0que\u00a0se\u00a0expresan\u00a0las\u00a0relaciones \u00a0de\u00a0poder\u00a0al\u00a0\ninterior\u00a0de\u00a0esta\u00a0poblaci\u00f3n \u00a0y\u00a0cuyo\u00a0sustento\u00a0se\u00a0encuentra \u00a0en\u00a0el\u00a0concepto \u00a0de\u00a0g\u00e9nero\u00a0reconocido \u00a0socialmente. \u00a0\u00a0\n\u00a0\nEs\u00a0decir\u00a0\u201cincorporar \u00a0el\u00a0enfoque\u00a0de\u00a0g\u00e9nero\u201d\u00a0implica\u00a0identificar, \u00a0a\u00a0trav\u00e9s\u00a0de\u00a0diagn\u00f3sticos, \u00a0cuales\u00a0son\u00a0las\u00a0\ncausas\u00a0relacionadas \u00a0con\u00a0el\u00a0comportamiento \u00a0esperado \u00a0y\u00a0socialmente \u00a0aceptado \u00a0o\u00a0no\u00a0de\u00a0g\u00e9nero\u00a0que\u00a0facilitan\u00a0\nla\u00a0expansi\u00f3n \u00a0del\u00a0VIH/SIDA\u00a0en\u00a0determinados \u00a0sectores\u00a0de\u00a0la\u00a0poblaci\u00f3n; \u00a0y\u00a0con\u00a0base\u00a0en\u00a0este\u00a0conocimiento \u00a0\nproponer \u00a0nuevas\u00a0estrategias; \u00a0por\u00a0ejemplo,\u00a0si\u00a0son\u00a0las\u00a0mujeres\u00a0el\u00a0sector\u00a0m\u00e1s\u00a0afectado\u00a0y\u00a0en\u00a0ellas\u00a0inciden\u00a0\nfactores\u00a0como\u00a0la\u00a0educaci\u00f3n, \u00a0cuyo\u00a0resultado \u00a0es\u00a0la\u00a0sumisi\u00f3n; \u00a0deber\u00e1\u00a0buscarse\u00a0estrategias \u00a0a\u00a0corto\u00a0y\u00a0mediano\u00a0\nplazo\u00a0que\u00a0tomen\u00a0en\u00a0cuenta\u00a0que\u00a0lograr\u00a0cambios\u00a0de\u00a0actitud\u00a0o\u00a0comportamiento \u00a0son\u00a0procesos\u00a0m\u00e1s\u00a0largos.\u00a0\n\u00a0\u00a0\nDe\u00a0igual\u00a0manera\u00a0con\u00a0la\u00a0poblaci\u00f3n \u00a0HSH,\u00a0la\u00a0m\u00e1s\u00a0afectada\u00a0en\u00a0el\u00a0caso\u00a0del\u00a0Per\u00fa,\u00a0el\u00a0diagn\u00f3stico \u00a0nos\u00a0debe\u00a0orientar\u00a0\nsobre\u00a0los\u00a0subgrupos \u00a0con\u00a0los\u00a0que\u00a0se\u00a0debe\u00a0trabajar\u00a0m\u00e1s\u00a0directamente \u00a0y\u00a0bajo\u00a0que\u00a0t\u00e9rminos, \u00a0ya\u00a0que\u00a0es\u00a0un\u00a0tema\u00a0\nque\u00a0pasa\u00a0por\u00a0la\u00a0conciencia \u00a0y\u00a0condiciones \u00a0de\u00a0esta\u00a0poblaci\u00f3n. \u00a0Adem\u00e1s\u00a0es\u00a0\u00a0\u00a0interesante \u00a0comprobar \u00a0cu\u00e1l\u00a0es\u00a0el\u00a0\nconcepto \u00a0de\u00a0g\u00e9nero\u00a0que\u00a0ellos\u00a0construyen \u00a0para\u00a0s\u00ed\u00a0y\u00a0cu\u00e1l\u00a0es\u00a0el\u00a0que\u00a0creen\u00a0que\u00a0la\u00a0poblaci\u00f3n \u00a0en\u00a0general\u00a0\nimpl\u00edcitamente \u00a0ya\u00a0la\u00a0han\u00a0construido \u00a0en\u00a0relaci\u00f3n\u00a0a\u00a0sus\u00a0opciones, \u00a0comportamientos \u00a0e\u00a0identidades \u00a0de\u00a0g\u00e9nero.\u00a0\u00a0\n\u00a0\nEl\u00a0proceso\u00a0de\u00a0incorporar \u00a0el\u00a0enfoque\u00a0de\u00a0g\u00e9nero,\u00a0no\u00a0s\u00f3lo\u00a0debe\u00a0involucrar \u00a0a\u00a0los\u00a0instrumentos \u00a0de\u00a0medici\u00f3n\u00a0del\u00a0\ngasto\u00a0en\u00a0SIDA\u00a0formulados \u00a0por\u00a0ONUSIDA; \u00a0sino\u00a0a\u00a0toda\u00a0la\u00a0planificaci\u00f3n \u00a0de\u00a0acciones\u00a0de\u00a0lucha\u00a0contra\u00a0el\u00a0VIH/SIDA; \u00a0\npor\u00a0cuanto\u00a0debe\u00a0existir\u00a0coherencia \u00a0entre\u00a0lo\u00a0programado, \u00a0medido\u00a0y\u00a0evaluado. \u00a0En\u00a0ese\u00a0sentido,\u00a0la\u00a0primera\u00a0\npropuesta \u00a0es\u00a0asumir\u00a0las\u00a0siguientes \u00a0fases\u00a0en\u00a0el\u00a0proceso\u00a0de\u00a0programaci\u00f3n: \u00a0\u00a0\n\u00a0\nEl\u00a0desarrollo \u00a0de\u00a0los\u00a0conceptos \u00a0de\u00a0referencia \u00a0\u00a0se\u00a0ha\u00a0realizado\u00a0luego\u00a0de\u00a0una\u00a0amplia\u00a0revisi\u00f3n\u00a0bibliogr\u00e1fica \u00a0\u00a0y\u00a0un\u00a0\nan\u00e1lisis\u00a0de\u00a0los\u00a0diferentes \u00a0\u00a0documentos \u00a0\u00a0que\u00a0orientan\u00a0la\u00a0lucha\u00a0contra\u00a0el\u00a0VIH\u00a0en\u00a0el\u00a0pa\u00eds,\u00a0as\u00ed\u00a0como\u00a0el\u00a0PEM;\u00a0el\u00a0\n\u00faltimo\u00a0informe\u00a0UNGASS,\u00a0\u00a0el\u00a0Informe\u00a0MEGAS\u00a02005\u20102007\u00a0teniendo\u00a0en\u00a0cuenta\u00a0lo\u00a0siguiente: \u00a0\n\uf02d Identificaci\u00f3n \u00a0y\u00a0priorizaci\u00f3n \u00a0de\u00a0la\u00a0poblaci\u00f3n \u00a0objetivo,\u00a0que\u00a0en\u00a0este\u00a0caso\u00a0estamos\u00a0hablando \u00a0de\u00a0las\u00a0mujeres\u00a0\ny\u00a0los\u00a0HSH\u00a0\n\uf02d Tomar\u00a0en\u00a0cuenta\u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0objetivo\u00a0adem\u00e1s\u00a0de\u00a0la\u00a0prevalencia \u00a0de\u00a0cada\u00a0una,\u00a0el\u00a0lugar\u00a0de\u00a0residencia, \u00a0\npor\u00a0cuanto\u00a0en\u00a0el\u00a0caso\u00a0de\u00a0las\u00a0mujeres\u00a0la\u00a0incidencia \u00a0cultural\u00a0es\u00a0un\u00a0factor\u00a0importante. \u00a0\n\uf02d Obtener\u00a0\u00a0las\u00a0estad\u00edsticas \u00a0de\u00a0captaci\u00f3n \u00a0de\u00a0la\u00a0informaci\u00f3n \u00a0por\u00a0sexo\u00a0y\u00a0luego\u00a0por\u00a0identidad \u00a0sexual,\u00a0ya\u00a0que\u00a0es\u00a0\nuna\u00a0informaci\u00f3n \u00a0que\u00a0muchas\u00a0veces\u00a0los\u00a0establecimientos \u00a0lo\u00a0tienen\u00a0pero\u00a0no\u00a0lo\u00a0consideran \u00a0dentro\u00a0del\u00a0\nan\u00e1lisis.\u00a0\n\uf02d Convalidar \u00a0la\u00a0identificaci\u00f3n \u00a0de\u00a0funciones \u00a0de\u00a0las\u00a0gu\u00edas\u00a0de\u00a0ONUSIDA \u00a0que\u00a0clasifica\u00a0el\u00a0gasto\u00a0en:\u00a0Prevenci\u00f3n \u00a0\n(desde\u00a0el\u00a0enfoque\u00a0de\u00a0salud\u00a0y\u00a0diferencian \u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0objetivo\u00a0en\u00a0base\u00a0a\u00a0estimaciones), \u00a0atenci\u00f3n\u00a0y\u00a0\ntratamiento \u00a0(desde\u00a0las\u00a0medicinas \u00a0adquiridas) \u00a0e\u00a0investigaci\u00f3n; \u00a0\u00a0con\u00a0las\u00a0l\u00edneas\u00a0de\u00a0intervenci\u00f3n \u00a0del\u00a0MINSA\u00a0\nque\u00a0considera: \u00a0Promoci\u00f3n, \u00a0prevenci\u00f3n, \u00a0tratamiento \u00a0y\u00a0rehabilitaci\u00f3n. \u00a0\n\uf02d Dise\u00f1o\u00a0de\u00a0instrumentos \u00a0\u00a0para\u00a0recoger\u00a0los\u00a0resultados \u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0objetivo.\u00a0\n\u00a0Sobre\u00a0este\u00a0\u00faltimo,\u00a0si\u00a0bien\u00a0se\u00a0ha\u00a0contado\u00a0con\u00a0informaci\u00f3n \u00a0diferenciada \u00a0por\u00a0hombres\u00a0y\u00a0mujeres\u00a0para\u00a0algunos\u00a0\ntipos\u00a0de\u00a0intervenci\u00f3n, \u00a0\u00a0es\u00a0muy\u00a0escasa\u00a0la\u00a0con\u00a0informaci\u00f3n \u00a0presupuestal \u00a0desagregada \u00a0de\u00a0subgrupos \u00a0respecto\u00a0a\u00a0\nHSH,\u00a0quedando \u00a0la\u00a0tarea\u00a0pendiente \u00a0para\u00a0que\u00a0los\u00a0registros\u00a0administrativos \u00a0permitan\u00a0en\u00a0el\u00a0\nfuturo\u00a0contar\u00a0con\u00a0la\u00a0\ninformaci\u00f3n \u00a0desglosada \u00a0requerida \u00a0para\u00a0establecer \u00a0brechas\u00a0en\u00a0prevenci\u00f3n \u00a0y\u00a0atenci\u00f3n\u00a0por\u00a0grupo\u00a0de\u00a0poblaci\u00f3n \u00a0\nque\u00a0permitan\u00a0orientar\u00a0\u00a0una\u00a0mejor\u00a0asignaci\u00f3n \u00a0de\u00a0recursos.\u00a0Este\u00a0informe\u00a0por\u00a0tanto\u00a0trata\u00a0de\u00a0\u00a0reflejar\u00a0los\u00a0\ncriterios\u00a0utilizados \u00a0para\u00a0la\u00a0desagregaci\u00f3n \u00a0del\u00a0gasto\u00a0por\u00a0tipo\u00a0de\u00a0poblaci\u00f3n \u00a0teniendo\u00a0en\u00a0cuenta\u00a0las\u00a0\ncaracter\u00edsticas \u00a0de\u00a0la\u00a0epidemia \u00a0en\u00a0el\u00a0pa\u00eds.\u00a0\n\u00a0 17 \u00a0\n\u00a0\nE.\u00a0\u00a0Fuentes\u00a0de\u00a0informaci\u00f3n \u00a0\n\u00a0\nPara\u00a0la\u00a0etapa\u00a0de\u00a0recopilaci\u00f3n \u00a0de\u00a0informaci\u00f3n \u00a0se\u00a0recab\u00f3\u00a0informaci\u00f3n \u00a0de\u00a0las\u00a0siguientes \u00a0fuentes:\u00a0\n\u00a0\nE.1\u00a0 Ministerio \u00a0de\u00a0Salud,\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0entrevistas \u00a0con\u00a0Jefes\u00a0de\u00a0Oficinas,\u00a0Direcciones \u00a0e\u00a0Institutos: \u00a0\u00a0\n\uf02d Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0de\u00a0ITS/VIH/SIDA \u00a0(ESN\u00a0PC\u00a0ITS/VIH/SIDA) \u00a0\u00a0\n\uf02d Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Salud\u00a0Sexual\u00a0y\u00a0Reproductiva \u00a0(ESNSSR). \u00a0\n\uf02d Oficina\u00a0de\u00a0Cooperaci\u00f3n \u00a0Internacional \u00a0(OCI)\u00a0\n\uf02d Direcci\u00f3n \u00a0General\u00a0de\u00a0Epidemiolog\u00eda \u00a0(DGE)\u00a0\n\uf02d Direcci\u00f3n \u00a0General\u00a0de\u00a0Estad\u00edstica \u00a0e\u00a0Inform\u00e1tica \u00a0(DGEI)\u00a0\u00a0\n\uf02d Seguro\u00a0Integral\u00a0de\u00a0Salud\u00a0(SIS)\u00a0\n\uf02d Instituto\u00a0Nacional\u00a0de\u00a0Salud\u00a0(INS)\u00a0\n\uf02d PRONAHEBAS \u00a0\nM\u00e9todo:\u00a0\u00a0 Formato\u00a01\u00a0\u2010\u00a0Gu\u00eda\u00a0de\u00a0entrevistas \u00a0a\u00a0informantes \u00a0clave\u00a0(\u00a011\u00a0)\u00a0\nFormato\u00a02\u00a0\u2010\u00a0Gu\u00eda\u00a0de\u00a0entrevistas \u00a0\u2013\u00a0Gasto\u00a0por\u00a0instituci\u00f3n \u00a0\nFormato\u00a03\u00a0\u2010\u00a0Encuesta\u00a0sobre\u00a0Gasto\u00a0\n\u00a0\nE.2\u00a0 Otras\u00a0instituciones \u00a0\u00a0pertenecientes \u00a0al\u00a0Sector\u00a0P\u00fablico\u00a0\n\uf02d Seguro\u00a0Social\u00a0de\u00a0Salud\u00a0(ESSALUD) \u00a0\n\uf02d Comisi\u00f3n \u00a0de\u00a0Prevenci\u00f3n \u00a0contra\u00a0el\u00a0Sida\u00a0de\u00a0las\u00a0Fuerzas\u00a0Armadas\u00a0y\u00a0Policiales\u00a0(COPRECOS) \u00a0\n\uf02d Instituto\u00a0Nacional\u00a0Penitenciario \u00a0(INPE)\u00a0\n\uf02d Ministerio \u00a0de\u00a0educaci\u00f3n \u00a0(MINEDU) \u00a0\n\uf02d Ministerio \u00a0de\u00a0la\u00a0Mujer\u00a0y\u00a0desarrollo \u00a0social\u00a0(MIMDES) \u00a0\nM\u00e9todo:\u00a0\u00a0 Formato\u00a01\u00a0\u2010\u00a0Gu\u00eda\u00a0de\u00a0entrevistas \u00a0a\u00a0informantes \u00a0clave\u00a0\nFormato\u00a02\u00a0\u2010\u00a0Gu\u00eda\u00a0de\u00a0entrevistas \u00a0\u2013\u00a0Gasto\u00a0por\u00a0instituci\u00f3n \u00a0\nFormato\u00a03\u00a0\u2010\u00a0Encuesta\u00a0sobre\u00a0Gasto\u00a0\n\u00a0\nE.3\u00a0 Instituciones \u00a0no\u00a0pertenecientes \u00a0al\u00a0Sector\u00a0P\u00fablico\u00a0\n\uf02d CARE\u00a0PERU:\u00a0Receptor\u00a0principal\u00a0de\u00a0los\u00a0tres\u00a0proyectos \u00a0del\u00a0FMSTM\u00a0en\u00a0VIH\u00a0\n\uf02d Organismos \u00a0de\u00a0Naciones\u00a0unidas\u00a0\n\uf02d Organismos \u00a0bilaterales: \u00a0USAID,\u00a0GTZ,\u00a0Cooperaci\u00f3n \u00a0belga,\u00a0Cooperaci\u00f3n \u00a0espa\u00f1ola\u00a0y\u00a0otras\u00a0\n\uf02d ONG,\u00a0por\u00a0su\u00a0financiamiento \u00a0con\u00a0el\u00a0FMSTM\u00a0(si\u00a0el\u00a0RP\u00a0no\u00a0cuenta\u00a0con\u00a0el\u00a0detalle)\u00a0\n\uf02d ONG\u00a0y\u00a0otras\u00a0instituciones \u00a0por\u00a0su\u00a0financiamiento \u00a0diferente \u00a0al\u00a0FMSTM,\u00a0en\u00a0el\u00a0caso\u00a0de\u00a0ser\u00a0referidos\u00a0\npor\u00a0los\u00a0informantes \u00a0clave\u00a0o\u00a0encontrarse \u00a0registrados \u00a0en\u00a0los\u00a0a\u00f1os\u00a02007,\u00a02008\u00a0y\u00a02009\u00a0APCI,\u00a0tales\u00a0\ncomo\u00a0organizaciones \u00a0de\u00a0afectados, \u00a0universidades \u00a0y\u00a0centros\u00a0de\u00a0investigaci\u00f3n. \u00a0(\u00a012\u00a0)\u00a0\nM\u00e9todo:\u00a0\u00a0 Formato\u00a02\u00a0\u2010\u00a0Gu\u00eda\u00a0de\u00a0entrevistas \u00a0\u2013\u00a0Gasto\u00a0por\u00a0instituci\u00f3n \u00a0\nFormato\u00a03\u00a0\u2010\u00a0Encuesta\u00a0sobre\u00a0Gasto\u00a0\n\u00a0\nE.4\u00a0 Fuentes\u00a0p\u00fablicas\u00a0de\u00a0informaci\u00f3n, \u00a0donde\u00a0se\u00a0registra\u00a0la\u00a0informaci\u00f3n \u00a0de\u00a0compras,\u00a0importaciones \u00a0de\u00a0\nmedicamentos \u00a0e\u00a0insumos\u00a0y\u00a0presupuesto \u00a0ejecutado \u00a0por\u00a0las\u00a0diferentes \u00a0ONG\u00a0del\u00a0pa\u00eds,\u00a0as\u00ed\u00a0como\u00a0el\u00a0\nregistro\u00a0de\u00a0ensayos\u00a0cl\u00ednicos:\u00a0\n\uf02d Organismo \u00a0superior\u00a0de\u00a0contrataciones \u00a0del\u00a0Estado\u00a0(OSCE)\u00a0\n\uf02d Agencia\u00a0Peruana\u00a0de\u00a0Cooperaci\u00f3n \u00a0Internacional \u00a0(APCI\u00a0)\u00a0\n\uf02d Superintendencia \u00a0Nacional\u00a0de\u00a0\u00a0Administraci\u00f3n \u00a0Tributaria \u00a0(SUNAT)\u00a0\n\uf02d Sistema\u00a0Nacional\u00a0de\u00a0Inversi\u00f3n\u00a0P\u00fablica\u00a0(SNIP)\u00a0\u00a0\n                                                 \n11 Se\u00a0aplica\u00a0a\u00a0algunos\u00a0de\u00a0los\u00a0responsables \u00a0de\u00a0las\u00a0instituciones \u00a0de\u00a0la\u00a0respuesta \u00a0nacional  \n12 Entre\u00a0los\u00a0identificados \u00a0a\u00a0la\u00a0fecha\u00a0se\u00a0encuentran \u00a0IMPACTA, \u00a0INMENSA, \u00a0NMRD,\u00a0IESSDEH,\u00a0Institutos \u00a0de\u00a0Medicina \u00a0Tropical\u00a0\nde\u00a0UNMSM\u00a0y\u00a0de\u00a0UPCH,\u00a0PREVEN,\u00a0M\u00e9dicos\u00a0del\u00a0Mundo,\u00a0Cruz\u00a0Roja.  18 \uf02d Sistema\u00a0Integrado \u00a0de\u00a0Administraci\u00f3n \u00a0Financiera \u00a0(SIAF)\u00a0\n\uf02d Instituto\u00a0Nacional\u00a0de\u00a0Salud\u00a0(INS)\u00a0\nM\u00e9todo:\u00a0\u00a0 Formato\u00a04\u00a0\u2010\u00a0Recopilaci\u00f3n \u00a0de\u00a0informaci\u00f3n \u00a0cuantitativa \u00a0\n\u00a0\nE.5\u00a0 Revisi\u00f3n\u00a0de\u00a0las\u00a0p\u00e1ginas\u00a0web\u00a0de\u00a0entidades \u00a0que\u00a0financian\u00a0actividades \u00a0en\u00a0VIH:\u00a0\n\uf02d Fondo\u00a0mundial\u00a0de\u00a0lucha\u00a0contra\u00a0el\u00a0SIDA,\u00a0tuberculosis \u00a0y\u00a0malaria\u00a0\n\uf02d Instituto\u00a0Nacional\u00a0de\u00a0Salud\u00a0de\u00a0los\u00a0Estados\u00a0Unidos\u00a0\n\uf02d Universidad \u00a0de\u00a0Washington \u00a0\u00a0\n\uf02d Terre\u00a0des\u00a0Hommes\u00a0\u00a0\n\uf02d AJWS\u2010American \u00a0Jewish\u00a0World\u00a0Service\u00a0\n\uf02d HIVOS\u00a0\u00a0\n\uf02d Uni\u00f3n\u00a0Europea\u00a0\n\uf02d Organizaci\u00f3n \u00a0panamericana \u00a0de\u00a0la\u00a0salud\u00a0(OPS)\u00a0\n\uf02d Otros\u00a0financiadores \u00a0referidos\u00a0por\u00a0los\u00a0informantes \u00a0clave\u00a0\nM\u00e9todo:\u00a0\u00a0 Formato\u00a04\u00a0\u2010\u00a0Recopilaci\u00f3n \u00a0de\u00a0informaci\u00f3n \u00a0cuantitativa \u00a0\n\u00a0\nE.6\u00a0 Para\u00a0la\u00a0estimaci\u00f3n \u00a0de\u00a0gastos\u00a0de\u00a0bolsillo\u00a0\n\uf02d M\u00e9dicos\u00a0que\u00a0atienden\u00a0pacientes \u00a0en\u00a0establecimientos \u00a0del\u00a0sector\u00a0p\u00fablico\u00a0\n\uf02d Coordinadores \u00a0de\u00a0ESR\u00a0\n\uf02d PVV\u00a0\nM\u00e9todo:\u00a0\u00a0 Formato\u00a05\u00a0\u2010\u00a0Gu\u00eda\u00a0de\u00a0entrevistas \u00a0\u2013\u00a0Gasto\u00a0de\u00a0bolsillo\u00a0\nFormato\u00a06\u00a0\u2010\u00a0Encuesta\u00a0\u00a0sobre\u00a0Gasto\u00a0de\u00a0bolsillo\u00a0\n\u00a0\nE.7\u00a0 Para\u00a0la\u00a0estimaci\u00f3n \u00a0de\u00a0gastos\u00a0regionales \u00a0\n\uf02d Coordinadores \u00a0de\u00a0la\u00a0ESN\u00a0PC\u00a0ITS/VIH/SIDA \u00a0de\u00a0las\u00a0DISA\u00a0y\u00a0DIRESA\u00a0\u00a0\nM\u00e9todo:\u00a0\u00a0 Formato\u00a07\u00a0\u2013\u00a0Detalle\u00a0\u00a0de\u00a0Recursos\u00a0humanos \u00a0\nFormato\u00a0\u00a08\u00a0\u2013\u00a0Detalle\u00a0de\u00a0Gastos\u00a0regionales \u00a0\n\u00a0\nE.8\u00a0 Informaci\u00f3n \u00a0de\u00a0datos\u00a0program\u00e1ticos \u00a0y\u00a0administrativos \u00a02008,\u00a02009\u00a0y\u00a02010\u00a0\n\uf02d Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0de\u00a0ITS/VIH/SIDA: \u00a0Revisi\u00f3n\u00a0de\u00a0registros\u00a0\nsobre\u00a0n\u00famero\u00a0de\u00a0PVV,\u00a0de\u00a0HSH\u00a0y\u00a0TS\u00a0atendidos \u00a0en\u00a0el\u00a0sistema\u00a0p\u00fablico,\u00a0Plan\u00a0operativo \u00a02008,\u00a02009\u00a0\ny\u00a02010\u00a0\n\uf02d Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Salud\u00a0Sexual\u00a0y\u00a0Reproductiva: \u00a0Revisi\u00f3n\u00a0de\u00a0registros\u00a0de\u00a0gestantes \u00a0\natendidas \u00a0en\u00a0el\u00a0sistema\u00a0p\u00fablico,\u00a0Plan\u00a0operativo \u00a02008,\u00a02009\u00a0y\u00a02010\u00a0\n\uf02d UNICEF:\u00a0Revisi\u00f3n\u00a0de\u00a0registros\u00a0sobre\u00a0ni\u00f1os\u00a0con\u00a0VIH\u00a0y\u00a0centros\u00a0de\u00a0provisi\u00f3n\u00a0de\u00a0servicios\u00a0\n\uf02d CARE\u00a0PERU:\u00a0Revisi\u00f3n\u00a0de\u00a0registros\u00a0sobre\u00a0cumplimiento \u00a0de\u00a0metas\u00a0al\u00a0FMSTM\u00a0y\u00a0Plan\u00a0de\u00a0compras\u00a0\nde\u00a0insumos\u00a0y\u00a0medicamentos \u00a0\n\uf02d Instituto\u00a0Nacional\u00a0de\u00a0Salud:\u00a0Revisi\u00f3n\u00a0de\u00a0registros\u00a0de\u00a0pruebas\u00a0de\u00a0laboratorio \u00a0realizadas \u00a0e\u00a0\ninvestigaciones \u00a0registradas. \u00a0 19 F.\u00a0Resultados \u00a0\u00a0obtenidos \u00a0\n\u00a0\nF.1.\u00a0Principales \u00a0hallazgos \u00a0\n\u00a0\nEl\u00a0Gasto\u00a0en\u00a0VIH\u00a0\u00a0en\u00a0el\u00a0pa\u00eds\u00a0se\u00a0ha\u00a0incrementado \u00a0en\u00a0el\u00a0periodo\u00a0comprendido \u00a0entre\u00a0los\u00a0a\u00f1os\u00a02005\u00a0\u20102007\u00a0al\u00a0\nperiodo\u00a02008\u00a0\u20102010,\u00a0para\u00a0este\u00a0periodo\u00a0el\u00a0gasto\u00a0p\u00fablico\u00a0en\u00a0VIH\u00a0represento \u00a0el\u00a00.6%\u00a0del\u00a0gasto\u00a0total\u00a0en\u00a0salud.\u00a0\n\u00a0\n28,157\u00a036,587\u00a041,443\u00a055,598\u00a062,242\u00a0\n36,427\u00a0\n2005 2006 2007 2008 2009 2010Gasto\u00a0en\u00a0VIH\u00a0\u00a0\u2010A\u00f1os\u00a02005\u00a0al\u00a02008\u00a0(en\u00a0miles\u00a0de\u00a0US\u00a0$)\n\u00a0\n106.2\u00a0154.3\u00a0\n2005\u20102007 2008 \u20102010Gasto\u00a0en\u00a0VIH\u00a0\u00a0\n(en\u00a0miles\u00a0de\u00a0US\u00a0$)\n\u00a0\n\u00a0\nEn\u00a0los\u00a0\u00faltimos\u00a0\u00a0a\u00f1os,\u00a0el\u00a0financiamiento \u00a0del\u00a0tratamiento \u00a0y\u00a0la\u00a0atenci\u00f3n\u00a0del\u00a0VIH\u00a0en\u00a0el\u00a0pa\u00eds\u00a0ha\u00a0sido\u00a0asumido\u00a0\nfundamentalmente \u00a0por\u00a0el\u00a0Ministerio \u00a0de\u00a0salud,\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0la\u00a0compra\u00a0de\u00a0productos \u00a0calificados \u00a0como\u00a0\nestrat\u00e9gicos: \u00a0medicamentos \u00a0antirretrovirales, \u00a0pruebas\u00a0diagn\u00f3stico \u00a0de\u00a0VIH,\u00a0condones \u00a0y\u00a0medicamentos \u00a0para\u00a0\nITS\u00a0y\u00a0con\u00a0la\u00a0cobertura \u00a0del\u00a0Seguro\u00a0integral\u00a0de\u00a0salud\u00a0a\u00a0las\u00a0gestantes, \u00a0mientras\u00a0que\u00a0la\u00a0mayor\u00a0parte\u00a0del\u00a0gasto\u00a0en\u00a0\nprevenci\u00f3n \u00a0ha\u00a0sido\u00a0realizado\u00a0con\u00a0recursos\u00a0de\u00a0la\u00a0cooperaci\u00f3n \u00a0internacional, \u00a0en\u00a0especial\u00a0por\u00a0el\u00a0FMSTM.\u00a0\u00a0El\u00a0\nprincipal\u00a0proveedor \u00a0contin\u00faa\u00a0siendo\u00a0el\u00a0sector\u00a0p\u00fablico.\u00a0\u00a0\u00a0\n\u00a0La\u00a0evoluci\u00f3n \u00a0de\u00a0la\u00a0distribuci\u00f3n \u00a0del\u00a0gasto\u00a0por\u00a0fuente\u00a0de\u00a0financiamiento, \u00a0\nproveedores \u00a0y\u00a0tipo\u00a0de\u00a0Intervenci\u00f3n \u00a0se\u00a0\naprecia\u00a0en\u00a0los\u00a0siguientes \u00a0cuadros,\u00a0donde\u00a0se\u00a0ha\u00a0agrupado \u00a0la\u00a0informaci\u00f3n \u00a0correspondiente \u00a0a\u00a0los\u00a0a\u00f1os\u00a02005\u2010\n2007\u00a0fecha\u00a0del\u00a0anterior\u00a0estudio\u00a0y\u00a0la\u00a0correspondiente \u00a0a\u00a0los\u00a0a\u00f1os\u00a02008\u20102010,\u00a0correspondiente \u00a0al\u00a0presente\u00a0\nestudio.13\u00a0\n\u00a0\n13%19%42%27%0%39%61%14%52%35%\n0% 10% 20% 30% 40% 50% 60% 70 %Funciones Proveedores FinanciaDistribuci\u00f3n \u00a0del\u00a0Gasto\u00a0en\u00a0SIDA\u00a0por\u00a0Fuente\u00a0de\u00a0financiamiento, \u00a0\nProveedores \u00a0y\u00a0\u00a0Funciones \u00a0\n2005\u20102007\n\u00a0\n                                                 \n13 Para\u00a0realizar\u00a0la\u00a0comparaci\u00f3n \u00a0entre\u00a0ambos\u00a0estudios\u00a0se\u00a0tuvo\u00a0que\u00a0homogenizar \u00a0la\u00a0informaci\u00f3n \u00a0de\u00a0los\u00a0a\u00f1os\u00a02005\u00a0al\u00a02007.   20 \n13%13%38%37%0%30%70% 16%47%38%\n0% 10% 20% 30% 40% 50% 60% 70%Funciones Proveedores FinanciaDistribuci\u00f3n \u00a0del\u00a0Gasto\u00a0en\u00a0SIDA\u00a0por\u00a0Fuente\u00a0de\u00a0financiamiento, \u00a0\nProveedores \u00a0y\u00a0\u00a0Funciones \u00a0\n2008\u00a0\u20102010\n\u00a0\n\u00a0\nEl\u00a0siguiente\u00a0cuadro\u00a0muestra\u00a0los\u00a0flujos\u00a0entre\u00a0las\u00a0fuentes\u00a0de\u00a0financiamiento, \u00a0\u00a0proveedores \u00a0y\u00a0principales \u00a0\nfunciones \u00a0de\u00a0los\u00a0a\u00f1os\u00a0correspondientes \u00a0a\u00a0los\u00a0a\u00f1os\u00a02008\u00a0al\u00a02010.\u00a0\n\u00a0\n17\n12\n38 0.3 0.5 10\n57 19\n45 4 19\n10\n10 31 4 18\n14\n39 33\n58 13\n11\nProveedores Prestador \u00a0\np\u00fablico\u00a0(108)Prestador \u00a0\nprivado\u00a0(46)Prestador \u00a0\nprivado\u00a0(46)\nSector\u00a0externo\u00a0\n(72)Prestador \u00a0\np\u00fablico\u00a0(108)\nSector\u00a0p\u00fablico\u00a0\n(58)Prevenci\u00f3n \u00a0(54) Otros \u00a0(22)Tratamiento \u00a0(58)Investigaci\u00f3n \u00a0\n(19)\nSector\u00a0privado\u00a0\n(24)\nFinanciamiento\nIntervenciones\n\u00a0 21 Con\u00a0respecto\u00a0a\u00a0las\u00a0principales \u00a0interrogantes \u00a0que\u00a0se\u00a0plantearon \u00a0en\u00a0este\u00a0estudio\u00a0en\u00a0el\u00a0Per\u00fa,\u00a0relacionadas \u00a0a\u00a0las\u00a0\ndimensiones \u00a0del\u00a0MEGAS\u00a0se\u00a0puede\u00a0realizar\u00a0los\u00a0siguientes \u00a0comentarios: \u00a0\n\u00a0\nEn\u00a0financiamiento: \u00a0fuentes\u00a0y\u00a0agentes\u00a0de\u00a0financiamiento \u00a0\n\u00a0\nExiste\u00a0un\u00a0leve\u00a0incremento \u00a0en\u00a0el\u00a0gasto\u00a0en\u00a0bolsillo\u00a0en\u00a0VIH,\u00a0fundamentalmente \u00a0como\u00a0resultado \u00a0del\u00a0incremento \u00a0\nde\u00a0la\u00a0cobertura \u00a0del\u00a0tratamiento \u00a0antirretroviral \u00a0\u00a0y\u00a0a\u00a0una\u00a0expansi\u00f3n \u00a0del\u00a0mercado\u00a0privado\u00a0de\u00a0condones.14\u00a0\u00a0\u00a0\u00a0Del\u00a0\n2005\u20102007\u00a0al\u00a02008\u20102010,\u00a0la\u00a0importaci\u00f3n \u00a0de\u00a0condones \u00a0\u00a0del\u00a0sector\u00a0privado\u00a0se\u00a0increment\u00f3 \u00a0en\u00a024.6%.\u00a0\n\u00a0\nEsto\u00a0es\u00a0consistente \u00a0con\u00a0los\u00a0resultados \u00a0de\u00a0las\u00a0encuestas \u00a0nacionales \u00a0que\u00a0reportan\u00a0que\u00a0cada\u00a0vez\u00a0es\u00a0mayor\u00a0el\u00a0\nporcentaje \u00a0de\u00a0personas\u00a0que\u00a0buscan\u00a0atenci\u00f3n\u00a0ante\u00a0un\u00a0problema \u00a0de\u00a0salud\u00a0y\u00a0\u00a0de\u00a0los\u00a0que\u00a0por\u00a0tal\u00a0motivo\u00a0acuden\u00a0\na\u00a0servicios\u00a0privados:\u00a0\u00a0\u00a0Mientras\u00a0el\u00a0porcentaje \u00a0de\u00a0los\u00a0que\u00a0no\u00a0buscan\u00a0atenci\u00f3n\u00a0por\u00a0falta\u00a0de\u00a0dinero\u00a0est\u00e1\u00a0\ndisminuyendo \u00a0sostenidamente. \u00a0\n\u00a0\nPer\u00fa\u00a0Urbano\u00a0\u2013\u00a0Poblaci\u00f3n \u00a0con\u00a0alg\u00fan\u00a0problema \u00a0de\u00a0salud\u00a0(porcentaje) \u00a0\nLugar\u00a0o\u00a0establecimiento \u00a0de\u00a0\nconsulta\u00a0en\u00a0salud\u00a0\u00a0 Busco\u00a0\natenci\u00f3n\u00a0\nParticular \u00a01/\u00a0 Farmacia\u00a0No\u00a0busco\u00a0\natenci\u00f3n\u00a0por\u00a0falta\u00a0\nde\u00a0dinero\u00a0\n2004\u00a0 44.9\u00a0 5.1\u00a0 12.5\u00a0 23.4\u00a0\n2005\u00a0 42.2\u00a0 5.5\u00a0 12.6\u00a0 21.3\u00a0\n2006\u00a0 42.5\u00a0 5.9\u00a0 12.9\u00a0 19.2\u00a0\n2007\u00a0 45.2\u00a0 6.5\u00a0 15.2\u00a0 20.3\u00a0\n2008\u00a0 49.9\u00a0 6.9\u00a0 18.7\u00a0 18.8\u00a0\n2009\u00a0 51.2\u00a0 7.5\u00a0 18.1\u00a0 13.8\u00a0\n2010\u00a0 50.6\u00a0 7.2\u00a0 18.9\u00a0 12.4\u00a0\n1/\u00a0Incluye\u00a0cl\u00ednica\u00a0particular \u00a0y\u00a0consultorio \u00a0m\u00e9dico\u00a0particular. \u00a0\u00a0\nFuente:\u00a0Encuesta\u00a0Nacional\u00a0de\u00a0Hogares\u00a0\u00a0ENAHO\u00a02004\u20102011\u00a0\n\u00a0\nEl\u00a0ahorro\u00a0realizado\u00a0por\u00a0la\u00a0exoneraci\u00f3n \u00a0de\u00a0impuestos \u00a0a\u00a0los\u00a0ARV15\u00a0\u00a0se\u00a0estima\u00a0en\u00a08.3\u00a0millones\u00a0de\u00a0US\u00a0$\u00a0\u00a0para\u00a0el\u00a0\nperiodo\u00a02008\u2010\u00a02010\u00a0y\u00a0en\u00a07.5\u00a0millones\u00a0de\u00a0US$\u00a0para\u00a0el\u00a0periodo\u00a02005\u20102007.\u00a0\n\u00a0\nSobre\u00a0la\u00a0dependencia \u00a0de\u00a0los\u00a0recursos\u00a0de\u00a0cooperaci\u00f3n \u00a0externa\u00a0para\u00a0las\u00a0estrategias \u00a0de\u00a0intervenci\u00f3n \u00a0que\u00a0se\u00a0\nimplementan \u00a0en\u00a0el\u00a0pa\u00eds,\u00a0cabe\u00a0precisar\u00a0que\u00a0para\u00a0los\u00a0a\u00f1os\u00a02008\u00a0y\u00a02009\u00a0un\u00a0importante \u00a0fuente\u00a0de\u00a0\nfinanciamiento \u00a0la\u00a0a\u00a0representado \u00a0los\u00a0recursos\u00a0del\u00a0FMSTM,\u00a0cuyas\u00a0actividades \u00a0han\u00a0estado\u00a0enfocadas \u00a0a\u00a0la\u00a0\nprevenci\u00f3n, \u00a0sin\u00a0embargo\u00a0para\u00a0el\u00a02010,\u00a0donde\u00a0se\u00a0vienen\u00a0ejecutando \u00a0solo\u00a0dos\u00a0proyectos, \u00a0el\u00a0gasto\u00a0total\u00a0ha\u00a0\ndisminuido \u00a0en\u00a042%.\u00a0\n\u00a0\nRevisando \u00a0los\u00a0flujos\u00a0de\u00a0financiamientos, \u00a0se\u00a0identifica \u00a0cu\u00e1les\u00a0son\u00a0los\u00a0principales \u00a0costos\u00a0asumidos \u00a0en\u00a0el\u00a0pa\u00eds\u00a0\nson\u00a0asumidos \u00a0por\u00a0el\u00a0sector\u00a0p\u00fablico,\u00a0la\u00a0principal\u00a0fuente\u00a0de\u00a0financiamiento \u00a0es\u00a0el\u00a0Ministerio \u00a0de\u00a0salud,\u00a0quien\u00a0a\u00a0\nsu\u00a0vez\u00a0es\u00a0el\u00a0principal\u00a0proveedor \u00a0de\u00a0servicios\u00a0(conjuntamente \u00a0con\u00a0la\u00a0red\u00a0de\u00a0establecimientos \u00a0del\u00a0sistema\u00a0\np\u00fablico\u00a0de\u00a0salud\u00a0a\u00a0cargo\u00a0de\u00a0los\u00a0gobiernos \u00a0regionales). \u00a0\u00a0\u00a0\u00a0En\u00a0el\u00a0cuadro\u00a0a\u00a0continuaci\u00f3n \u00a0se\u00a0puede\u00a0ver\u00a0el\u00a0flujo\u00a0de\u00a0\nfinanciamiento \u00a0por\u00a0tipo\u00a0de\u00a0poblaci\u00f3n, \u00a0por\u00a0procedimiento \u00a0y\u00a0seg\u00fan\u00a0la\u00a0etapa\u00a0de\u00a0la\u00a0enfermedad. \u00a0\n\u00a0\n                                                 \n14 Seg\u00fan\u00a0la\u00a0Memoria\u00a0anual\u00a02010\u00a0de\u00a0APROPO,\u00a0l\u00edder\u00a0del\u00a0mercado\u00a0privado\u00a0de\u00a0condones, \u00a0a\u00a0nivel\u00a0de\u00a0ventas,\u00a0la\u00a0\u00faltima\u00a0d\u00e9cada\u00a0\nmuestra\u00a0un\u00a0notable\u00a0tendencia \u00a0de\u00a0crecimiento \u00a0sostenido, \u00a0que\u00a0solo\u00a0en\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os\u00a0asciende\u00a0al\u00a055.4%\u00a0de\u00a0crecimiento \u00a0\nacumulado.  \n15 En\u00a0la\u00a0actualidad \u00a0la\u00a0importaci\u00f3n \u00a0de\u00a0medicamentos \u00a0e\u00a0insumos\u00a0para\u00a0la\u00a0fabricaci\u00f3n \u00a0de\u00a0medicamentos \u00a0antirretrovirales \u00a0se\u00a0\nencuentra \u00a0exonerado \u00a0de\u00a0aranceles \u00a0aduaneros \u00a0y\u00a0del\u00a0Impuesto \u00a0General\u00a0a\u00a0las\u00a0Ventas\u00a0(IGV),\u00a0significando \u00a0esto\u00a0el\u00a0aporte\u00a0del\u00a0\nestado\u00a0para\u00a0disminuir \u00a0el\u00a0costo\u00a0de\u00a0los\u00a0antirretrovirales. \u00a0De\u00a0no\u00a0existir\u00a0la\u00a0exoneraci\u00f3n, \u00a0el\u00a0costo\u00a0de\u00a0los\u00a0antirretrovirales \u00a0seria\u00a0\n30%\u00a0superior\u00a0(arancel\u00a09%,\u00a0tasa\u00a0del\u00a0IGV\u00a019%).\u00a0\u00a0La\u00a0base\u00a0imponible \u00a0del\u00a0Impuesto \u00a0General\u00a0a\u00a0las\u00a0Ventas\u00a0es\u00a0el\u00a0Valor\u00a0de\u00a0\nimportaci\u00f3n \u00a0CIF\u00a0m\u00e1s\u00a0el\u00a0arancel   22 Flujos\u00a0de\u00a0financiamiento \u00a0por\u00a0principales \u00a0\u00a0tipo\u00a0de\u00a0poblaci\u00f3n \u00a0y\u00a0procedimientos \u00a0\u2013\u00a0A\u00f1os\u00a0\u00a02008\u00a0al\u00a0201016\u00a0\nGastos\u00a0de\u00a0bolsillo\u00a0\nen:\u00a0Sector\u00a0Salud\u00a0P\u00fablico\u00a0\n\u00a0Solo\u00a0para\u00a0\nasegurados \u00a0Tipo\u00a0de\u00a0poblaci\u00f3n \u00a0\u2013\u00a0Procedimiento \u00a0Sector\u00a0\nprivadoSector\u00a0\np\u00fablico\u00a0NacionalEESS\u00a0\nRegi\u00f3nEESS\u00a0\nExonera\u00a0SIS\u00a0EssaludOtros\u00a0\nPersonas\u00a0con\u00a0VIH\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nAntes\u00a0del\u00a0diagn\u00f3stico \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nAtenciones \u00a0m\u00e9dicas X\u00a0 X\u00a0 \u00a0 \u00a0\u00a0 X\u00a0 X\u00a0\u00a0\nMedicamentos x\u00a0 X\u00a0 \u00a0 \u00a0\u00a0 x\u00a0 X\u00a0\u00a0\nPruebas\u00a0diagn\u00f3stico \u00a0VIH\u00a0y\u00a0pruebas\u00a0\nconfirmatorias(a)\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 X\u00a0 ONG\nHasta\u00a0a\u00f1o\u00a02010 \u00a0 X\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nA\u00a0partir\u00a02011\u00a0(s\u00f3lo\u00a0\u00a0poblaci\u00f3n \u00a0pobre) \u00a0 \u00a0 \u00a0 PPR\u00a0\u00a0\u00a0\u00a0\u00a0\n(poblaci\u00f3n \u00a0no\u00a0pobre) \u00a0 X\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nDespu\u00e9s\u00a0del\u00a0diagn\u00f3stico \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0 (b)\u00a0\u00a0\nEvaluaci\u00f3n \u00a0cl\u00ednica\u00a0\u2010\u00a0Gasto\u00a0en\u00a0consulta (a)\u00a0 (e)\u00a0\u00a0 x \u00a0\u00a0 X\u00a0\u00a0\nConsulta\u00a0psicolog\u00eda \u00a0 (e)\u00a0\u00a0 x \u00a0\u00a0 X\u00a0\u00a0\nConsulta\u00a0en\u00a0nutrici\u00f3n \u00a0 \u00a0 x \u00a0\u00a0 X\u00a0\u00a0\nConsulta\u00a0dentista \u00a0 (e) \u00a0 x \u00a0\u00a0 X\u00a0\u00a0\nConsulta\u00a0planificaci\u00f3n \u00a0familiar \u00a0 \u00a0 \u00a0 x\u00a0\u00a0\u00a0 X\u00a0\u00a0\nOtras\u00a0consultas \u00a0(diabetes, \u00a0h\u00edgado) (a)\u00a0 X\u00a0 \u00a0 \u00a0 X\u00a0\u00a0 X\u00a0\u00a0\nMedicamentos \u00a0antirretrovirales(productos \u00a0\nestrat\u00e9gicos)(a)\u00a0\u00a0 MINSA\u00a0\u00a0\u00a0\u00a0 X\u00a0 ONG\nEx\u00e1menes \u00a0auxiliares \u00a0(en\u00a0el\u00a0sector\u00a0p\u00fablico\u00a0\ncosto\u00a0subsidiado)(a)\u00a0 X\u00a0 \u00a0\u00a0\u00a0\u00a0 X\u00a0\u00a0\nOtras\u00a0pruebas\u00a0pre\u00a0TARGA (a)\u00a0\u00a0 \u00a0 x\u00a0\u00a0\u00a0\u00a0\u00a0\nRadiograf\u00eda \u00a0del\u00a0t\u00f3rax\u00a0(Rayos\u00a0X) X\u00a0 X\u00a0 \u00a0 \u00a0\u00a0\u00a0 X\u00a0\u00a0\nPruebas\u00a0monitoreo  \u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nCD4.\u00a0En\u00a0el\u00a0Instituto\u00a0Nacional\u00a0de\u00a0salud\u00a0(INS)\u00a0\ny\u00a0en\u00a0laboratorios \u00a0regionales(a)\u00a0 (a)\u00a0 X\u00a0\u00a0\u00a0\u00a0En\u00a0Lima\u00a0\nCarga\u00a0viral.\u00a0En\u00a0el\u00a0Instituto\u00a0Nacional\u00a0de\u00a0salud\u00a0\n(INS)\u00a0(a)\u00a0 (a)\u00a0 X\u00a0\u00a0\u00a0\u00a0En\u00a0Lima\u00a0\nGenotificaci\u00f3n. \u00a0En\u00a0el\u00a0Instituto\u00a0Nacional\u00a0de\u00a0\nsalud\u00a0(INS)\u00a0 \u00a0 X\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nPrevenci\u00f3n \u00a0positiva\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nMedicamentos \u00a0para\u00a0ITS\u00a0(productos \u00a0\nestrat\u00e9gicos)\u00a0 \u00a0 MINSA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nCondones \u00a0 \u00a0 MINSA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nConsejer\u00eda \u00a0 \u00a0 \u00a0 x\u00a0\u00a0\u00a0\u00a0\u00a0\nCanasta\u00a0de\u00a0Alimentos \u00a0para\u00a0algunos\u00a0\n(PRONAA \u00a0y\u00a0Programa \u00a0mundial\u00a0de\u00a0alimentos)\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 PMA\u00a0\nInfecciones \u00a0oportunistas \u00a0y\u00a0reacciones \u00a0\nadversas\u00a0\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nMedicamentos \u00a0para\u00a0IO\u00a0y\u00a0RASH\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nHasta\u00a0el\u00a02010 \u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 FM\u00a0\nA\u00a0partir\u00a0del\u00a02011 \u00a0 \u00a0 \u00a0 PPR\u00a0\u00a0\u00a0\u00a0\u00a0\nHospitalizaci\u00f3n x\u00a0 X\u00a0 \u00a0\u00a0\u00a0 Event\nual\u00a0X\u00a0\u00a0\n                                                 \n16\u00a0No\u00a0incluye\u00a0costos\u00a0de\u00a0personas\u00a0que\u00a0han\u00a0sido\u00a0exoneradas \u00a0del\u00a0pago\u00a0de\u00a0atenci\u00f3n, \u00a0de\u00a0ex\u00e1menes \u00a0auxiliares \u00a0o\u00a0de\u00a0\nhospitalizaci\u00f3n \u00a0en\u00a0los\u00a0establecimientos \u00a0de\u00a0salud.   23 Gastos\u00a0de\u00a0bolsillo\u00a0\nen:\u00a0Sector\u00a0Salud\u00a0P\u00fablico\u00a0\n\u00a0Solo\u00a0para\u00a0\nasegurados \u00a0Tipo\u00a0de\u00a0poblaci\u00f3n \u00a0\u2013\u00a0Procedimiento \u00a0Sector\u00a0\nprivadoSector\u00a0\np\u00fablico\u00a0NacionalEESS\u00a0\nRegi\u00f3nEESS\u00a0\nExonera\u00a0SIS\u00a0EssaludOtros\u00a0\nConsultas \u00a0 \u00a0 \u00a0 x\u00a0\u00a0\u00a0\u00a0\u00a0\nPoblaciones \u00a0vulnerables \u00a0HSH\u00a0\u2013\u00a0TS\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0 (c)\u00a0\u00a0\nHistoria\u00a0cl\u00ednica\u00a0(con\u00a0historia\u00a0cl\u00ednica\u00a0es\u00a0\ngratuito\u00a0el\u00a0paquete\u00a0de\u00a0atenci\u00f3n)\u00a0 \u00a0 \u00a0 x\u00a0\u00a0\u00a0\u00a0\u00a0\nTarjeta\u00a0(si\u00a0se\u00a0pierde\u00a0el\u00a0n\u00famero\u00a0de\u00a0historia) \u00a0 \u00a0 \u00a0 x\u00a0\u00a0\u00a0\u00a0\u00a0\nConsulta\u00a0\u2013\u00a0Evaluaci\u00f3n \u00a0cl\u00ednica \u00a0 \u00a0 \u00a0 x\u00a0\u00a0\u00a0\u00a0\u00a0\nAlgunos\u00a0insumos\u00a0cuando\u00a0el\u00a0servicio\u00a0no\u00a0\ndispone\u00a0de\u00a0ellos)\u00a0(Guantes, \u00a0agujas)\u00a0 X\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nEx\u00e1menes \u00a0de\u00a0Laboratorio \u00a0(RPR;\u00a0otros) \u00a0 Eventual \u00a0 x\u00a0\u00a0\u00a0\u00a0\u00a0\nCondones x\u00a0\u00a0 MINSA\u00a0 x\u00a0\u00a0\u00a0\u00a0 FM\u00a0\nPrueba\u00a0VIH\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nHasta\u00a0a\u00f1o\u00a02010 \u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 FM\u00a0\nA\u00a0partir\u00a02011 \u00a0 \u00a0 \u00a0 PPR\u00a0\u00a0\u00a0\u00a0\u00a0\nMedicamentos \u00a0para\u00a0ITS\u00a0(soporte,\u00a0se\u00a0\nadquiere\u00a0mediante \u00a0compras\u00a0corporativas)\u00a0 \u00a0 \u00a0PPR\u00a0\u00a0\u00a0\u00a0\u00a0\nPara\u00a0s\u00edfilis \u00a0 \u00a0 MINSA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nPersonas\u00a0privadas\u00a0de\u00a0la\u00a0libertad \u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nPrueba\u00a0VIH\u00a0 \u00a0 \u00a0 PPR\u00a0\u00a0\u00a0\u00a0\u00a0\nMedicamentos \u00a0antirretrovirales \u00a0(productos \u00a0\nestrat\u00e9gicos)\u00a0 \u00a0 MINSA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nCondones \u00a0 \u00a0 INPE\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nGestantes \u00a0(prevenci\u00f3n \u00a0transmisi\u00f3n \u00a0vertical) \u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nPrueba\u00a0VIH\u00a0 \u00a0 \u00a0 \u00a0\u00a0 x\u00a0 X\u00a0\u00a0\nConsultas \u00a0m\u00e9dicas \u00a0 \u00a0 \u00a0 \u00a0\u00a0 X\u00a0 X\u00a0\u00a0\nConsulta\u00a0especialistas \u00a0 \u00a0 \u00a0 \u00a0\u00a0 X\u00a0 X\u00a0\u00a0\nHospitalizaci\u00f3n \u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 X\u00a0 X\u00a0\u00a0\nProfilaxis\u00a0ARV(productos \u00a0estrat\u00e9gicos) \u00a0 \u00a0MINSA\u00a0\n(d)\u00a0\u00a0 \u00a0(d)\u00a0 X\u00a0\u00a0\nPoblaci\u00f3n \u00a0general \u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nPrueba\u00a0VIH\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0 X\u00a0\u00a0\nHombre\u00a0(hasta\u00a0el\u00a0a\u00f1o\u00a02010) x\u00a0 x\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nHombre\u00a0a\u00a0partir\u00a0del\u00a02011 \u00a0 \u00a0 \u00a0 PPR\u00a0\u00a0\u00a0\u00a0\u00a0\nMujer\u00a0en\u00a0edad\u00a0f\u00e9rtil\u00a0atendida\u00a0en\u00a0salud\u00a0\nsexual\u00a0y\u00a0reproductiva \u00a0(hasta\u00a0el\u00a0a\u00f1o\u00a02010)\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 FM\u00a0\nMujer\u00a0en\u00a0edad\u00a0f\u00e9rtil\u00a0(\u00a0a\u00a0partir\u00a02011) \u00a0 \u00a0 \u00a0 PPR\u00a0\u00a0\u00a0\u00a0\u00a0\nMedicamentos \u00a0para\u00a0ITS\u00a0(soporte,\u00a0se\u00a0\nadquiere\u00a0mediante \u00a0compras\u00a0corporativas)\u00a0 \u00a0 MINSA\u00a0\u00a0\u00a0\u00a0 X\u00a0\u00a0\nCondones X\u00a0\u00a0 \u00a0 \u00a0\u00a0\u00a0 X\u00a0\u00a0\nConsulta\u00a0para\u00a0ITS x\u00a0 x\u00a0 \u00a0 \u00a0\u00a0\u00a0 X\u00a0\u00a0\na. Se\u00a0ha\u00a0identificado \u00a0que\u00a0si\u00a0bien\u00a0existe\u00a0provisi\u00f3n \u00a0de\u00a0servicios\u00a0en\u00a0el\u00a0sector\u00a0privado\u00a0para\u00a0la\u00a0atenci\u00f3n\u00a0y\u00a0tratamiento \u00a0de\u00a0\nVIH\u00a0(consultorios \u00a0y\u00a0m\u00e9dicos\u00a0privados), \u00a0no\u00a0es\u00a0representativo \u00a0con\u00a0respecto\u00a0a\u00a0la\u00a0atenci\u00f3n\u00a0que\u00a0se\u00a0realiza\u00a0en\u00a0el\u00a0sector\u00a0\np\u00fablico\u00a0\u00a0(incluido\u00a0ESSALUD).\u00a0\nb. Se\u00a0ha\u00a0detectado \u00a0afiliados\u00a0en\u00a0ESSALUD\u00a0que\u00a0reciben\u00a0tratamiento \u00a0en\u00a0los\u00a0establecimientos \u00a0de\u00a0salud\u00a0p\u00fablica\u00a0(MINSA\u00a0y\u00a0\ngobiernos \u00a0regionales.\u00a0\nc. En\u00a0ESSALUD\u00a0no\u00a0existe\u00a0ninguna\u00a0intervenci\u00f3n \u00a0dise\u00f1ada\u00a0para\u00a0poblaci\u00f3n \u00a0vulnerable\u00a0\nd. La\u00a0profilaxis\u00a0de\u00a0acuerdo\u00a0a\u00a0la\u00a0normatividad \u00a0es\u00a0financiada \u00a0por\u00a0el\u00a0Seguro\u00a0integral\u00a0de\u00a0salud\u00a0(SIS),\u00a0sin\u00a0embargo\u00a0el\u00a0MINSA\u00a0\nadquiri\u00f3\u00a0los\u00a0ARV\u00a0en\u00a0los\u00a0a\u00f1os\u00a02009\u00a0y\u00a02010\u00a0debido\u00a0a\u00a0la\u00a0dificultad \u00a0para\u00a0la\u00a0adquisici\u00f3n \u00a0de\u00a0ARV\u00a0por\u00a0parte\u00a0de\u00a0los\u00a0\ngobiernos \u00a0regionales\u00a0 24 e. Algunos\u00a0establecimiento \u00a0realizan\u00a0el\u00a0cobro\u00a0por\u00a0estas\u00a0consultas, \u00a0sin\u00a0embargo\u00a0esto\u00a0no\u00a0est\u00e1\u00a0de\u00a0acuerdo\u00a0a\u00a0lo\u00a0establecido \u00a0\nen\u00a0las\u00a0normas\u00a0t\u00e9cnicas\u00a0\n\u00a0\n\u00a0\nEn\u00a0provisi\u00f3n: \u00a0proveedores \u00a0y\u00a0recursos\u00a0\n\u00a0\nSobre\u00a0magnitud \u00a0de\u00a0la\u00a0provisi\u00f3n\u00a0de\u00a0servicios\u00a0privados\u00a0en\u00a0VIH\u00a0(oferta\u00a0privada),\u00a0se\u00a0estima\u00a0un\u00a0porcentaje \u00a0que\u00a0no\u00a0\nsupera\u00a0el\u00a01%\u00a0de\u00a0los\u00a0PVV\u00a0que\u00a0asumen\u00a0totalmente \u00a0el\u00a0costo\u00a0de\u00a0tratamiento. \u00a0\u00a0La\u00a0informaci\u00f3n \u00a0recopilada \u00a0nos\u00a0\nlleva\u00a0a\u00a0determinar \u00a0que\u00a0en\u00a0provincias \u00a0la\u00a0mayor\u00a0parte\u00a0de\u00a0los\u00a0PVV\u00a0(sino\u00a0la\u00a0totalidad) \u00a0recibe\u00a0ARV\u00a0del\u00a0sector\u00a0\np\u00fablico.\u00a0Los\u00a0profesionales \u00a0de\u00a0salud\u00a0entrevistados \u00a0manifiestan \u00a0que\u00a0durante\u00a0los\u00a0primeros\u00a0meses\u00a0del\u00a0\ntratamiento \u00a0algunos\u00a0PVV\u00a0realizan\u00a0el\u00a0gasto\u00a0en\u00a0servicios\u00a0privados,\u00a0sin\u00a0embargo\u00a0entre\u00a0los\u00a0seis\u00a0meses\u00a0a\u00a0un\u00a0a\u00f1o\u00a0\ningresan\u00a0a\u00a0los\u00a0enrolados \u00a0por\u00a0el\u00a0sector\u00a0p\u00fablico,\u00a0estando\u00a0la\u00a0\u00a0oferta\u00a0privada\u00a0concentrada \u00a0en\u00a0Lima.\u00a0\u00a0Se\u00a0\ndesconoce \u00a0el\u00a0protocolo \u00a0utilizado\u00a0en\u00a0el\u00a0sector\u00a0privado.\u00a0\u00a0\u00a0El\u00a0gasto\u00a0en\u00a0el\u00a0sector\u00a0privado\u00a0es\u00a0resultado \u00a0de\u00a0la\u00a0\nelecci\u00f3n\u00a0de\u00a0los\u00a0usuarios\u00a0y\u00a0no\u00a0se\u00a0encuentra \u00a0asociado\u00a0a\u00a0problemas \u00a0de\u00a0acceso\u00a0o\u00a0es\u00a0consecuencia \u00a0de\u00a0la\u00a0falta\u00a0de\u00a0\noferta\u00a0p\u00fablica,\u00a0sin\u00a0embargo\u00a0uno\u00a0de\u00a0las\u00a0dificultades \u00a0para\u00a0el\u00a0acceso\u00a0de\u00a0las\u00a0poblaciones \u00a0m\u00e1s\u00a0expuestas, \u00a0\u00a0es\u00a0el\u00a0\nestigma\u00a0y\u00a0la\u00a0discriminaci\u00f3n. \u00a0\u00a0\u00a0\n\u00a0\nPara\u00a0aquellos\u00a0con\u00a0mayores\u00a0recursos\u00a0exista\u00a0la\u00a0posibilidad \u00a0de\u00a0la\u00a0oferta\u00a0privada\u00a0(nivel\u00a0socioecon\u00f3mico \u00a0estrato\u00a0\nA),\u00a0sin\u00a0embargo\u00a0para\u00a0aquellos\u00a0con\u00a0niveles\u00a0de\u00a0ingreso\u00a0m\u00e1s\u00a0bajos\u00a0solo\u00a0existe\u00a0la\u00a0opci\u00f3n\u00a0del\u00a0sector\u00a0p\u00fablico.\u00a0\u00a0\u00a0\nAquellos\u00a0que\u00a0no\u00a0califican\u00a0en\u00a0AUS,\u00a0deben\u00a0asumir\u00a0algunos\u00a0gastos\u00a0de\u00a0bolsillo\u00a0principalmente \u00a0cuando\u00a0dada\u00a0la\u00a0\ntoxicidad\u00a0de\u00a0los\u00a0medicamentos \u00a0se\u00a0desarrollaran \u00a0complicaciones \u00a0y\u00a0se\u00a0requiere\u00a0hospitalizaci\u00f3n. \u00a0\u00a0De\u00a0acuerdo\u00a0a\u00a0\nlas\u00a0estad\u00edsticas \u00a0ENDES\u00a0y\u00a0ENAHO,\u00a0un\u00a0porcentaje \u00a0importante \u00a0de\u00a0la\u00a0poblaci\u00f3n \u00a0no\u00a0cuenta\u00a0con\u00a0ning\u00fan\u00a0tipo\u00a0de\u00a0\nseguro\u00a0(35.3%\u00a0de\u00a0la\u00a0poblaci\u00f3n \u00a0total),\u00a0por\u00a0lo\u00a0cual\u00a0a\u00a0este\u00a0grupo\u00a0es\u00a0el\u00a0que\u00a0afecta\u00a0en\u00a0mayor\u00a0medida\u00a0el\u00a0gasto\u00a0de\u00a0\nbolsillo.\u00a0\n\u00a0\nCabe\u00a0precisar\u00a0sobre\u00a0este\u00a0tema\u00a0que\u00a0al\u00a0haber\u00a0iniciado\u00a0tratamiento \u00a0hace\u00a0m\u00e1s\u00a0de\u00a020\u00a0a\u00f1os\u00a0el\u00a0seguro\u00a0social,\u00a0los\u00a0\nmedicamentos \u00a0que\u00a0adquiere\u00a0\u00a0pueden\u00a0diferir\u00a0de\u00a0los\u00a0esquemas \u00a0utilizados \u00a0en\u00a0el\u00a0sistema\u00a0p\u00fablico\u00a0de\u00a0salud\u00a0\n(iniciado\u00a0en\u00a0el\u00a02004).\u00a0\u00a0\u00a0La\u00a0proporci\u00f3n \u00a0de\u00a0los\u00a0asegurados \u00a0que\u00a0se\u00a0atiende\u00a0en\u00a0el\u00a0sistema\u00a0p\u00fablico\u00a0de\u00a0salud\u00a0se\u00a0\nestima\u00a0entre\u00a0el\u00a02\u00a0y\u00a04%.\u00a0\u00a0En\u00a0el\u00a0estudio\u00a0MEGAS\u00a02005\u20102007,\u00a0se\u00a0hab\u00eda\u00a0identificado \u00a0afiliados\u00a0a\u00a0ESSALUD\u00a0\u00a0que\u00a0\nrecib\u00edan\u00a0tratamiento \u00a0en\u00a0el\u00a0MINSA,\u00a0pues\u00a0manifestaban \u00a0que\u00a0en\u00a0el\u00a0MINSA\u00a0\u00a0no\u00a0exist\u00edan\u00a0problemas \u00a0de\u00a0\ndesabastecimiento. \u00a0\n\u00a0\nCon\u00a0respecto\u00a0a\u00a0la\u00a0provisi\u00f3n\u00a0de\u00a0servicios\u00a0financiado \u00a0por\u00a0el\u00a0sector\u00a0p\u00fablico,\u00a0cabe\u00a0precisar\u00a0que\u00a0la\u00a0estructura \u00a0de\u00a0\ngasto\u00a0en\u00a0VIH\u00a0en\u00a0los\u00a0servicios\u00a0que\u00a0provee\u00a0no\u00a0ha\u00a0cambiado \u00a0sustancialmente \u00a0en\u00a0los\u00a0dos\u00a0periodos\u00a0analizados. \u00a0\n\u00a0\nEstructura \u00a0de\u00a0Gasto\u00a0en\u00a0VIH\u00a0del\u00a0Sector\u00a0P\u00fablico\u00a0por\u00a0grupo\u00a0de\u00a0a\u00f1os\u00a0\n  2005\u20102007\u00a02008\u20102010\u00a0\nPrevenci\u00f3n \u00a0 22.3% 19.7%\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 72.5% 76.8%\nOtros\u00a0 5.1% 3.5%\n\u00a0\nEstructura \u00a0de\u00a0Gasto\u00a0en\u00a0VIH\u00a0del\u00a0Sector\u00a0P\u00fablico\u00a0detallada \u00a0por\u00a0a\u00f1o\u00a0\n 2005\u00a0 2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2010\u00a0\nPrevenci\u00f3n \u00a0 19.6%\u00a0 20.7%\u00a0 26.1%\u00a0 16.2%\u00a0 10%\u00a0 27.9%\u00a0\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 75.4%\u00a0 77.8%\u00a0 64.9%\u00a0 82.0%\u00a0 84.3%\u00a0 58.7%\u00a0\nOtros\u00a0 5%\u00a0 1.5%\u00a0 9%\u00a0 1.7%\u00a0 5.7%\u00a0 13.5%\u00a0\n\u00a0\n\u00a0\nEn\u00a0uso:\u00a0categor\u00edas \u00a0de\u00a0intervenci\u00f3n \u00a0y\u00a0poblaci\u00f3n \u00a0beneficiaria \u00a0\n(enfoque \u00a0de\u00a0g\u00e9nero)\u00a0\n\u00a0 25 El\u00a0gasto\u00a0\u00a0en\u00a0prevenci\u00f3n \u00a0en\u00a0general\u00a0ha\u00a0experimentado \u00a0un\u00a0importante \u00a0incremento, \u00a0principalmente \u00a0como\u00a0\nresultado \u00a0de\u00a0la\u00a0inversi\u00f3n\u00a0realizada\u00a0por\u00a0el\u00a0FMSTM.\u00a0\u00a0Cabe\u00a0precisar\u00a0que\u00a0el\u00a0proyecto\u00a0financiado \u00a0por\u00a0la\u00a06ta\u00a0ronda\u00a0\ndel\u00a02008\u00a0al\u00a02012,\u00a0s\u00f3lo\u00a0considera \u00a0acciones\u00a0de\u00a0prevenci\u00f3n. \u00a0\u00a0\u00a0Sin\u00a0embargo, \u00a0la\u00a0estructura \u00a0del\u00a0gasto\u00a0en\u00a0los\u00a0\n\u00faltimos\u00a0seis\u00a0a\u00f1os\u00a0no\u00a0ha\u00a0respondido \u00a0necesariamente \u00a0a\u00a0la\u00a0situaci\u00f3n\u00a0de\u00a0la\u00a0epidemia \u00a0en\u00a0el\u00a0Per\u00fa.\u00a0\u00a0El\u00a0gasto\u00a0\nrealizado\u00a0por\u00a0el\u00a0sector\u00a0p\u00fablico\u00a0para\u00a0las\u00a0poblaciones \u00a0de\u00a0HSH\u00a0y\u00a0TS,\u00a0se\u00a0concentra \u00a0en\u00a0lo\u00a0asignado\u00a0a\u00a0los\u00a0CERITS\u00a0y\u00a0\nUAMP,\u00a0mientras\u00a0que\u00a0los\u00a0tres\u00a0proyectos \u00a0del\u00a0FMSTM\u00a0han\u00a0considerado \u00a0actividades \u00a0y\u00a0objetivos\u00a0espec\u00edficos \u00a0para\u00a0\nacciones\u00a0de\u00a0prevenci\u00f3n \u00a0en\u00a0estas\u00a0poblaciones17.\u00a0\n\u00a0La\u00a0tendencia \u00a0del\u00a0gasto\u00a0evidencia \u00a0que\u00a0las\u00a0intervenciones \u00a0en\u00a0mujeres\u00a0(en\u00a0edad\u00a0f\u00e9rtil\u00a0y\u00a0gestantes) \u00a0\u00a0ha\u00a0sido\u00a0\npriorizada \u00a0durante\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os.\u00a0\u00a0Esto\u00a0es\u00a0producto\u00a0del\u00a0importante \u00a0rol\u00a0impulsor\u00a0de\u00a0las\u00a0pol\u00edticas\u00a0p\u00fablicas\u00a0\ndirigidas\u00a0a\u00a0disminuir \u00a0la\u00a0mortalidad \u00a0materna\u00a0y\u00a0la\u00a0transmisi\u00f3n \u00a0vertical\u00a0del\u00a0VIH,\u00a0en\u00a0el\u00a0marco\u00a0de\u00a0las\n\u00a0cuales\u00a0el\u00a0pa\u00eds\u00a0\nha\u00a0destinado \u00a0recursos\u00a0para\u00a0la\u00a0detecci\u00f3n \u00a0oportuna \u00a0del\u00a0VIH\u00a0en\u00a0mujeres\u00a0en\u00a0edad\u00a0f\u00e9rtil\u00a0y\u00a0en\u00a0gestantes. \u00a0Otro\u00a0\nfactor\u00a0catalizador \u00a0lo\u00a0han\u00a0constituido \u00a0los\u00a0proyectos \u00a0financiados \u00a0por\u00a0el\u00a0FMSTM,\u00a0que\u00a0en\u00a0la\u00a02da\u00a0y\u00a06ta\u00a0ronda\u00a0\nconsideraron \u00a0objetivos\u00a0espec\u00edficos \u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0vertical\u00a0y\u00a0tamizaje\u00a0gratuito\u00a0de\u00a0\nmujeres\u00a0en\u00a0edad\u00a0f\u00e9rtil.\u00a0\n\u00a0\nCon\u00a0respecto\u00a0a\u00a0las\u00a0principales \u00a0actividades \u00a0de\u00a0prevenci\u00f3n \u00a0destinadas \u00a0al\u00a0grupo\u00a0donde\u00a0la\u00a0epidemia \u00a0se\u00a0\nencuentra \u00a0focalizada \u00a0(HSH),\u00a0cabe\u00a0precisar\u00a0que\u00a0el\u00a0\u00a0cambio\u00a0\u00a0de\u00a0Programas \u00a0nacionales \u00a0al\u00a0modelo\u00a0de\u00a0Atenci\u00f3n\u00a0\nintegral\u00a0MAIS,\u00a0dio\u00a0lugar\u00a0a\u00a0la\u00a0disminuci\u00f3n \u00a0de\u00a0los\u00a0recursos\u00a0humanos \u00a0y\u00a0materiales \u00a0asignados \u00a0al\u00a0VIH\u00a0en\u00a0el\u00a0\nMinisterio \u00a0de\u00a0Salud,\u00a0como\u00a0por\u00a0ejemplo\u00a0\u00a0la\u00a0disminuci\u00f3n \u00a0del\u00a0n\u00famero\u00a0de\u00a0promotores \u00a0educadores \u00a0de\u00a0pares,\u00a0que\u00a0\nconstituyen \u00a0\u00a0la\u00a0parte\u00a0\u00a0muy\u00a0activa\u00a0\u00a0en\u00a0la\u00a0estrategia \u00a0de\u00a0prevenci\u00f3n \u00a0dirigida\u00a0tanto\u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0HSH\u00a0como\u00a0TS.\u00a0\u00a0\nDesde\u00a0los\u00a0proyectos \u00a0financiados \u00a0por\u00a0el\u00a0FMSTM\u00a0se\u00a0pudo\u00a0compensar \u00a0esta\u00a0reducci\u00f3n \u00a0en\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os,\u00a0y\u00a0m\u00e1s\u00a0\nrecientemente \u00a0el\u00a0Ministerio \u00a0de\u00a0Salud\u00a0ha\u00a0transferido \u00a0el\u00a0presupuesto \u00a0de\u00a0movilidad \u00a0de\u00a0los\u00a0promotores \u00a0de\u00a0pares\u00a0\na\u00a0las\u00a0regiones\u00a0en\u00a0el\u00a0marco\u00a0del\u00a0proceso\u00a0de\u00a0descentralizaci\u00f3n, \u00a0con\u00a0lo\u00a0cual\u00a0la\u00a0decisi\u00f3n\u00a0de\u00a0financiamiento \u00a0de\u00a0lo\u00a0\npromotores \u00a0de\u00a0pares\u00a0(es\u00a0decir,\u00a0su\u00a0incremento, \u00a0mantenimiento \u00a0o\u00a0disminuci\u00f3n) \u00a0se\u00a0tomar\u00e1\u00a0desde\u00a0el\u00a0a\u00f1o\u00a02011\u00a0\nde\u00a0manera\u00a0descentralizada. \u00a0\u00a0\n\u00a0\nEvoluci\u00f3n \u00a0del\u00a0n\u00famero\u00a0de\u00a0Promotores \u00a0educadores \u00a0de\u00a0pares\u00a0\u2013PEPs\u00a0\u2013\u00a0A\u00f1o\u00a02000\u00a0al\u00a02010\u00a0\n2000 2003 2007 2008 2010\nHSH 217 107 207 502 294\nHSH\u2010FM 0 0 100 400 192\nHSH\u2010MINSA 217 107 107 102 102100400\n192217\n107\n107 102102\n0100200300400N\u00famero\u00a0de\u00a0PEP\u00a0HSH\nA\u00f1os\u00a02000\u00a0al\u00a02010\n2000 2003 2007 2008 2010\nTS 140 101 101 224 160\nTS\u2010FM 0 0 0 113 49\nTS\u2010MINSA 140 101 101 111 1110113\n49140\n101\n101111111\n050100150N\u00famero\u00a0de\u00a0PEP\u00a0TS\nA\u00f1os\u00a02000\u00a0al\u00a02010\n\u00a0\nFuente:\u00a0Evaluaci\u00f3n \u00a0de\u00a0la\u00a0Estrategia \u00a0de\u00a0PEPs,\u00a0Objetivo\u00a01,\u00a0FMSTM\u00a0\n\u00a0\n\u00a0\n                                                 \n17\u00a0Si\u00a0bien\u00a0existen\u00a0diversas\u00a0acciones\u00a0de\u00a0promoci\u00f3n, \u00a0prevenci\u00f3n \u00a0y\u00a0tratamiento \u00a0de\u00a0ITS,\u00a0VIH\u00a0y\u00a0sida\u00a0del\u00a0sector\u00a0p\u00fablico\u00a0(en\u00a0\nparticular \u00a0del\u00a0Ministerio \u00a0de\u00a0Salud)\u00a0que\u00a0alcanzan\u00a0entre\u00a0sus\u00a0beneficiarios \u00a0a\u00a0los\u00a0HSH\u00a0y\u00a0TS\u00a0entre\u00a0otras\u00a0poblaciones \u00a0\n(incluyendo \u00a0poblaci\u00f3n \u00a0general),\u00a0hasta\u00a0el\u00a0a\u00f1o\u00a02010\u00a0esto\u00a0no\u00a0se\u00a0vio\u00a0reflejado\u00a0de\u00a0manera\u00a0espec\u00edfica \u00a0en\u00a0las\u00a0contabilidad \u00a0de\u00a0\nlos\u00a0sectores\u00a0y/o\u00a0en\u00a0otras\u00a0fuentes\u00a0que\u00a0sirvieron\u00a0de\u00a0insumo\u00a0para\u00a0este\u00a0estudio.\u00a0\u00a0Con\u00a0la\u00a0incorporaci\u00f3n \u00a0del\u00a0programa \u00a0\nestrat\u00e9gico \u00a0de\u00a0VIH\u00a0y\u00a0tuberculosis \u00a0al\u00a0PPR,\u00a0desde\u00a0el\u00a0a\u00f1o\u00a02011\u00a0ser\u00e1\u00a0posible\u00a0realizar\u00a0an\u00e1lisis\u00a0m\u00e1s\u00a0finos\u00a0a\u00a0nivel\u00a0de\u00a0actividades \u00a0\ny\u00a0poblaciones \u00a0gracias\u00a0al\u00a0mayor\u00a0desagregado \u00a0que\u00a0habr\u00e1\u00a0en\u00a0la\u00a0informaci\u00f3n \u00a0contable. \u00a0\u00a0\u00a0  26 Seg\u00fan\u00a0la\u00a0Gu\u00eda\u00a0operacional \u00a0de\u00a0G\u00e9nero\u00a0en\u00a0VIH\u00a0( 18 ) no\u00a0se\u00a0puede\u00a0abordar\u00a0con\u00a0eficacia\u00a0el\u00a0control\u00a0y\u00a0reducir\u00a0la\u00a0\nvulnerabilidad \u00a0del\u00a0VIH\u00a0\u00a0a\u00a0menos\u00a0que\u00a0los\u00a0derechos\u00a0humanos \u00a0y\u00a0la\u00a0promoci\u00f3n \u00a0de\u00a0la\u00a0igualdad\u00a0de\u00a0g\u00e9nero\u00a0se\u00a0\ntomen\u00a0en\u00a0cuenta,\u00a0los\u00a0cuales\u00a0son:\u00a0\na. Minimizar \u00a0las\u00a0caracter\u00edsticas \u00a0espec\u00edficas \u00a0que\u00a0generan\u00a0vulnerabilidad \u00a0al\u00a0VIH\u00a0en\u00a0mujeres,\u00a0ni\u00f1as,\u00a0hombres\u00a0y\u00a0\nni\u00f1os\u00a0\nb. Asegurar\u00a0que\u00a0mujeres,\u00a0hombres, \u00a0ni\u00f1as\u00a0y\u00a0ni\u00f1os\u00a0con\u00a0VIH\u00a0tengan\u00a0igualdad\u00a0de\u00a0acceso\u00a0y\u00a0al\u00a0uso\u00a0de\u00a0los\u00a0\nservicios\u00a0de\u00a0calidad.\u00a0\nc. Minimizar \u00a0el\u00a0impacto\u00a0del\u00a0VIH\u00a0en\u00a0mujeres,\u00a0hombres, \u00a0ni\u00f1as\u00a0y\u00a0ni\u00f1os\u00a0y\u00a0fortalecer \u00a0sus\u00a0capacidades \u00a0para\u00a0\nafrontar\u00a0las\u00a0consecuencias \u00a0del\u00a0VIH.\u00a0\n\u00a0\nLas\u00a0siguientes \u00a0l\u00edneas\u00a0describen \u00a0los\u00a0principales \u00a0hallazgos\u00a0relacionados \u00a0a\u00a0los\u00a0puntos\u00a0anteriores: \u00a0\n\uf02d En\u00a0provisi\u00f3n: \u00a0La\u00a0epidemia \u00a0en\u00a0el\u00a0Per\u00fa\u00a0es\u00a0concentrada \u00a0en\u00a0hombres\u00a0que\u00a0tienen\u00a0sexo\u00a0con\u00a0hombres\u00a0HSH,\u00a0por\u00a0\nlo\u00a0cual\u00a0la\u00a0infecci\u00f3n\u00a0se\u00a0asocia\u00a0principalmente \u00a0al\u00a0sexo\u00a0sin\u00a0protecci\u00f3n \u00a0en\u00a0este\u00a0grupo,\u00a0pero\u00a0tambi\u00e9n\u00a0\u00a0\u00a0a\u00a0las\u00a0\nrelaciones \u00a0sexuales\u00a0con\u00a0profesionales \u00a0del\u00a0sexo\u00a0sin\u00a0protecci\u00f3n, \u00a0\u00a0y\u00a0entre\u00a0las\u00a0parejas\u00a0sexuales\u00a0de\u00a0las\u00a0\npersonas\u00a0que\u00a0mantienen \u00a0conductas \u00a0de\u00a0riesgo.\u00a0( 19 )\u00a0\u00a0Las\u00a0comunidades \u00a0GTB\u00a0\u00a0desde\u00a0algunos\u00a0a\u00f1os\u00a0vienen\u00a0\nsolicitando \u00a0el\u00a0dise\u00f1o\u00a0de\u00a0intervenciones \u00a0diferenciadas \u00a0para\u00a0cada\u00a0uno\u00a0de\u00a0ellas.\u00a0Una\u00a0de\u00a0las\u00a0poblaciones \u00a0\ndonde\u00a0existe\u00a0una\u00a0necesidad \u00a0real\u00a0de\u00a0intervenciones \u00a0es\u00a0la\u00a0poblaci\u00f3n \u00a0Trans;\u00a0si\u00a0bien\u00a0se\u00a0han\u00a0realizado\u00a0\nestudios\u00a0a\u00a0nivel\u00a0nacional\u00a0que\u00a0exponen\u00a0sus\u00a0necesidades, \u00a0aun\u00a0no\u00a0se\u00a0ha\u00a0dise\u00f1ado\u00a0un\u00a0protocolo \u00a0especial\u00a0\nque\u00a0contemple \u00a0sus\u00a0caracter\u00edsticas \u00a0especiales, \u00a0que\u00a0permita\u00a0a\u00a0su\u00a0vez\u00a0determinar \u00a0los\u00a0recursos\u00a0materiales \u00a0\nque\u00a0requerir\u00eda \u00a0la\u00a0intervenci\u00f3n. \u00a0\n\uf02d Uso\u00a0de\u00a0recursos:\u00a0Con\u00a0respecto\u00a0al\u00a0uso\u00a0de\u00a0recursos\u00a0en\u00a0prevenci\u00f3n \u00a0s\u00f3lo\u00a0se\u00a0conoce\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0\nhistorias\u00a0cl\u00ednicas\u00a0de\u00a0los\u00a0CERITS\u00a0y\u00a0UAMP\u00a0que\u00a0las\u00a0TS\u00a0asisten\u00a0m\u00e1s\u00a0frecuentemente \u00a0a\u00a0realizar\u00a0la\u00a0AMP\u00a0que\u00a0los\u00a0\nhombres\u00a0y\u00a0que\u00a0de\u00a0requerirse \u00a0asumen\u00a0el\u00a0gasto\u00a0por\u00a0los\u00a0servicios\u00a0en\u00a0mayor\u00a0proporci\u00f3n \u00a0que\u00a0los\u00a0HSH.\u00a0\n\u00a0\n\u00a0\n0%10%20%30%40%50%60%70%80%90%100%\n81 83 85 90 93 97 101 105 108 111 124 128 135 139 145 151 162 170 175 183 190 197 206 214 221 242 245 270 278 298 319 345 376 415 451N\u00famero\u00a0de\u00a0personas\u00a0464\u00a0(238\u00a0\u00a0Mujeres\u00a0y\u00a0226\u00a0Hombres)Cumplimiento \u00a0en\u00a0asistencia \u00a0a\u00a0los\u00a0CERITS:\u00a0Visitas\n%\u00a0Cumplimiento \u00a0acumulado %\u00a0personas\u00a0acumulado Mujeres Hombres\n17.5%75%\n50%\n22.7%100%\n34.8%25%51.2%\n\u00a0\nNota:\u00a0El\u00a0cuadro\u00a0muestra\u00a0la\u00a0diferencia \u00a0entre\u00a0hombres\u00a0y\u00a0mujeres\u00a0en\u00a0la\u00a0asistencia \u00a0a\u00a0los\u00a0CERITS.\u00a0\u00a0Mientras\u00a0que\u00a0el\u00a023.7%\u00a0\nde\u00a0las\u00a0mujeres\u00a0acude\u00a0a\u00a0los\u00a0CERITS\u00a0por\u00a0lo\u00a0menos\u00a04\u00a0veces\u00a0al\u00a0a\u00f1o,\u00a0s\u00f3lo\u00a0el\u00a011.0%\u00a0de\u00a0los\u00a0hombres\u00a0lo\u00a0hace.\u00a0\u00a0El\u00a0protocolo \u00a0\nindica\u00a0que\u00a0deben\u00a0realizarse \u00a0por\u00a0lo\u00a0menos\u00a04\u00a0AMP\u00a0por\u00a0a\u00f1o,\u00a0sin\u00a0embargo\u00a0en\u00a0la\u00a0revisi\u00f3n\u00a0se\u00a0registro\u00a0que\u00a0para\u00a0cumplir\u00a0\ncon\u00a0la\u00a0AMP\u00a0se\u00a0realizan\u00a0varias\u00a0visitas\u00a0por\u00a0\u00a0diferentes \u00a0causas\u00a0(no\u00a0disponibilidad \u00a0de\u00a0reactivos, \u00a0entre\u00a0otros).\u00a0Fuente:\u00a0\nRevisi\u00f3n\u00a0de\u00a0Historias\u00a0cl\u00ednicas\u00a0de\u00a0los\u00a0CERITS\u00a0y\u00a0UAMPS\u00a0en\u00a0Lima,\u00a0Lambayeque, \u00a0Ancash,\u00a0Ica,\u00a0Jun\u00edn,\u00a0Ucayali\u00a0y\u00a0Loreto.\u00a0\n\u00a0\n\u00a0\n                                                 \n18 Operational \u00a0guide\u00a0on\u00a0Gender\u00a0and\u00a0HIV/AIDS\u2010\u00a0A\u00a0rights\u00a0\u2013\u00a0based\u00a0approach. \u00a0\u00a0\u00a0UNAIDS\u00a0Interagency \u00a0Task\u00a0Team\u00a0on\u00a0Gender\u00a0&\u00a0\nHIV\u00a0/\u00a0AIDS \n19 Las\u00a0mujeres,\u00a0las\u00a0ni\u00f1as\u00a0y\u00a0la\u00a0igualdad\u00a0de\u00a0G\u00e9nero\u00a0\u2013\u00a0Nota\u00a0informativa \u00a0\u2013\u00a0Fondo\u00a0Mundial\u00a0para\u00a0la\u00a010\u00b0\u00a0ronda\u00a0de\u00a0subvenciones   27 Porcentaje \u00a0de\u00a0cumplimiento \u00a0en\u00a0la\u00a0asistencia \u00a0(Optimo\u00a04\u00a0visitas\u00a0por\u00a0a\u00f1o)\u00a0\nCumplimiento \u00a0 %\u00a0Cumplimiento \u00a0Mujeres\u00a0Hombres\u00a0Total\u00a0\nAl\u00a0menos\u00a04\u00a0visitas\u00a0 100%\u00a0 23.7%\u00a0 11.0%\u00a0 17.5%\u00a0\nAl\u00a0menos\u00a03\u00a0visitas\u00a0 75%\u00a0 29.7%\u00a0 15.4%\u00a0 22.7%\u00a0\nAl\u00a0menos\u00a02\u00a0visitas\u00a0 50%\u00a0 38.6%\u00a0 30.8%\u00a0 34.8%\u00a0\nAl\u00a0menos\u00a01\u00a0visita\u00a0 25%\u00a0 55.5%\u00a0 46.7%\u00a0 51.2%\u00a0\n\u00a0\n\uf02d De\u00a0acuerdo\u00a0a\u00a0estad\u00edsticas \u00a0de\u00a0la\u00a0ESN\u00a0de\u00a0VIH\u00a0los\u00a0hombres\u00a0representan \u00a0el\u00a069%\u00a0de\u00a0las\u00a0personas\u00a0en\u00a0\ntratamiento, \u00a0sin\u00a0embargo\u00a0de\u00a0todos\u00a0los\u00a0casos\u00a0notificados \u00a0de\u00a0SIDA\u00a0desde\u00a0el\u00a0a\u00f1o\u00a01983\u00a0a\u00a0la\u00a0fecha,\u00a0el\u00a080%\u00a0\nson\u00a0hombres\u00a0y\u00a0el\u00a020%\u00a0mujeres,\u00a0\u00a0surge\u00a0la\u00a0interrogante \u00a0si\u00a0\u00a0la\u00a0proporci\u00f3n \u00a0de\u00a0\u00a0\u00a0ingreso\u00a0al\u00a0tratamiento \u00a0\u00a0es\u00a0la\u00a0\nmisma\u00a0\u00a0en\u00a0hombres\u00a0que\u00a0en\u00a0mujeres,\u00a0o\u00a0si\u00a0los\u00a0hombres\u00a0\u00a0ingresan\u00a0en\u00a0un\u00a0estado\u00a0m\u00e1s\u00a0avanzado \u00a0de\u00a0la\u00a0\nenfermedad \u00a0que\u00a0las\u00a0mujeres.\u00a0\u00a0\u00a0Por\u00a0otro\u00a0lado,\u00a0para\u00a0saber\u00a0el\u00a0gasto\u00a0en\u00a0tratamiento \u00a0por\u00a0sexo,\u00a0deber\u00eda\u00a0\nconocerse \u00a0si\u00a0las\u00a0mujeres\u00a0son\u00a0m\u00e1s\u00a0adherentes \u00a0al\u00a0tratamiento, \u00a0con\u00a0lo\u00a0cual\u00a0\u00a0estas\u00a0\u00a0har\u00edan\u00a0un\u00a0mayor\u00a0uso\u00a0de\u00a0\nrecursos\u00a0en\u00a0tratamiento \u00a0que\u00a0los\u00a0hombres. \u00a0En\u00a0los\u00a0registros\u00a0administrativos \u00a0de\u00a0los\u00a0prestadores \u00a0de\u00a0salud,\u00a0\nse\u00a0realiza\u00a0una\u00a0desagregaci\u00f3n \u00a0entre\u00a0gays,\u00a0trans,\u00a0en\u00a0algunos,\u00a0pero\u00a0no\u00a0en\u00a0todos\u00a0los\u00a0casos,\u00a0sin\u00a0embargo\u00a0esto\u00a0\ndif\u00edcilmente \u00a0puede\u00a0vincularse \u00a0a\u00a0conceptos \u00a0de\u00a0gastos.\u00a0\n\uf02d En\u00a0el\u00a0Per\u00fa\u00a0son\u00a0dos\u00a0las\u00a0poblaciones \u00a0que\u00a0han\u00a0recibido\u00a0m\u00e1s\u00a0atenci\u00f3n\u00a0pero\u00a0que\u00a0su\u00a0planteamiento \u00a0es\u00a0\ndiferente: \u00a0las\u00a0mujeres\u00a0heterosexuales \u00a0y\u00a0la\u00a0poblaci\u00f3n \u00a0HSH;\u00a0para\u00a0la\u00a0primera\u00a0poblaci\u00f3n \u00a0se\u00a0cuenta\u00a0con\u00a0\nmarcos\u00a0legales\u00a0vigentes\u00a0orientados \u00a0a\u00a0la\u00a0igualdad\u00a0de\u00a0g\u00e9nero;\u00a0pese\u00a0a\u00a0ello\u00a0no\u00a0se\u00a0ha\u00a0implementado \u00a0una\u00a0\npol\u00edtica\u00a0que\u00a0incorpore \u00a0a\u00a0las\u00a0parejas\u00a0y\u00a0por\u00a0tanto\u00a0no\u00a0tiene\u00a0expresi\u00f3n \u00a0en\u00a0las\u00a0l\u00edneas\u00a0de\u00a0acci\u00f3n\u00a0o\u00a0estrategias \u00a0\npara\u00a0enfrentar \u00a0el\u00a0VIH\u00a0que\u00a0tome\u00a0en\u00a0cuenta\u00a0sus\u00a0necesidades, \u00a0salvo\u00a0en\u00a0aquellas\u00a0a\u00a0las\u00a0que\u00a0pudieran\u00a0tener\u00a0\nacceso\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0otros\u00a0servicios;\u00a0por\u00a0lo\u00a0que\u00a0es\u00a0necesario \u00a0destacar\u00a0su\u00a0nivel\u00a0de\u00a0afectaci\u00f3n \u00a0y\u00a0proponer \u00a0las\u00a0\nacciones\u00a0de\u00a0intervenci\u00f3n \u00a0necesarias. \u00a0Y\u00a0para\u00a0los\u00a0HSH,\u00a0si\u00a0bien\u00a0se\u00a0proponen \u00a0resultados \u00a0por\u00a0ejemplo\u00a0en\u00a0el\u00a0\nPPR\u00a02011,\u00a0es\u00a0en\u00a0las\u00a0estrategias \u00a0identificadas \u00a0en\u00a0la\u00a0Estructura \u00a0Funcional \u00a0Program\u00e1tica \u00a0Presupuestal \u00a0del\u00a0\nprograma \u00a0estrat\u00e9gico, \u00a0donde\u00a0se\u00a0encuentra \u00a0la\u00a0mayor\u00a0debilidad; \u00a0al\u00a0no\u00a0evidenciarse \u00a0una\u00a0mayor\u00a0coherencia \u00a0\nentre\u00a0\u00e9stas\u00a0con\u00a0el\u00a0resultado \u00a0propuesto \u00a0y\u00a0la\u00a0asignaci\u00f3n \u00a0presupuestal \u00a0respectiva. \u00a0\u00a0\n\uf02d En\u00a0las\u00a0categor\u00edas \u00a0MEGAS\u00a0para\u00a0poblaciones \u00a0beneficiarias: \u00a0\u201cProfesionales \u00a0femeninas \u00a0del\u00a0sexo\u00a0y\u00a0sus\u00a0\nclientes\u201d\u00a0y\u00a0\u00a0\u201cNi\u00f1os\u00a0nacidos\u00a0o\u00a0por\u00a0nacer\u00a0de\u00a0mujeres\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u201d,\u00a0la\u00a0caracter\u00edstica \u00a0com\u00fan\u00a0\u00a0de\u00a0\nestas\u00a0intervenciones \u00a0en\u00a0el\u00a0Per\u00fa,\u00a0es\u00a0que\u00a0ambas\u00a0se\u00a0centran\u00a0fundamentalmente \u00a0en\u00a0el\u00a0rol\u00a0de\u00a0la\u00a0mujer\u00a0\u00a0y\u00a0en\u00a0\nsu\u00a0responsabilidad \u00a0para\u00a0acudir\u00a0al\u00a0servicio,\u00a0cumplir\u00a0con\u00a0el\u00a0tratamiento \u00a0y\u00a0otras\u00a0disposiciones \u00a0emanadas \u00a0\npor\u00a0los\u00a0servicios\u00a0de\u00a0salud.\u00a0\u00a0El\u00a0dise\u00f1o\u00a0de\u00a0intervenciones \u00a0como\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0madre\u00a0\u2010\u00a0\u00a0\nhijo,\u00a0no\u00a0explora\u00a0la\u00a0contribuci\u00f3n \u00a0del\u00a0var\u00f3n\u00a0por\u00a0ejemplo\u00a0si\u00a0la\u00a0gestante\u00a0resulta\u00a0infectada \u00a0luego\u00a0que\u00a0se\u00a0\nrealice\u00a0la\u00a0prueba\u00a0de\u00a0VIH\u00a0(generalmente \u00a0el\u00a0primer\u00a0trimestre \u00a0de\u00a0gestaci\u00f3n). \u00a0\u00a0\u00a0Por\u00a0otro\u00a0lado\u00a0no\u00a0se\u00a0ha\u00a0\ndise\u00f1ado\u00a0intervenciones \u00a0dirigidas\u00a0a\u00a0los\u00a0clientes\u00a0de\u00a0las\u00a0trabajadoras \u00a0sexuales,\u00a0por\u00a0lo\u00a0cual\u00a0todas\u00a0las\u00a0\nestrategias \u00a0de\u00a0prevenci\u00f3n \u00a0se\u00a0centran\u00a0en\u00a0la\u00a0mujer\u00a0como\u00a0\u00a0la\u00a0negociaci\u00f3n \u00a0del\u00a0cond\u00f3n,\u00a0entre\u00a0otros.\u00a0\n\uf02d Con\u00a0respecto\u00a0a\u00a0las\u00a0estrategias \u00a0destinadas \u00a0a\u00a0la\u00a0promoci\u00f3n \u00a0de\u00a0igualdad\u00a0de\u00a0g\u00e9nero:\u00a0encontramos \u00a0que\u00a0para\u00a0\nminimizar \u00a0las\u00a0caracter\u00edsticas \u00a0de\u00a0vulnerabilidad \u00a0falta\u00a0masificar\u00a0acciones\u00a0preventivas \u00a0en\u00a0hombres\u00a0y\u00a0\nmujeres\u00a0j\u00f3venes\u00a0(no\u00a0se\u00a0encuentra \u00a0mayor\u00a0gasto\u00a0en\u00a0este\u00a0rubro);\u00a0\u00a0articular\u00a0esfuerzos \u00a0desde\u00a0diferentes \u00a0\nsectores\u00a0para\u00a0erradicar\u00a0la\u00a0explotaci\u00f3n \u00a0sexual\u00a0principalmente \u00a0en\u00a0ni\u00f1as\u00a0(algunos\u00a0proyectos \u00a0han\u00a0contado\u00a0\ncon\u00a0financiamiento \u00a0para\u00a0este\u00a0tema\u00a0durante\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os).\u00a0\u00a0\n\uf02d En\u00a0referente \u00a0a\u00a0la\u00a0igualdad\u00a0de\u00a0acceso,\u00a0los\u00a0principales \u00a0problemas \u00a0est\u00e1n\u00a0referidos\u00a0por\u00a0el\u00a0n\u00famero\u00a0limitado\u00a0\nde\u00a0puntos\u00a0de\u00a0atenci\u00f3n\u00a0dirigido\u00a0espec\u00edficamente \u00a0a\u00a0las\u00a0poblaciones \u00a0HSH\u00a0y\u00a0TS\u00a0y\u00a0a\u00a0los\u00a0problemas \u00a0de\u00a0estigma\u00a0\ny\u00a0discriminaci\u00f3n \u00a0en\u00a0\u00e1reas\u00a0diferentes \u00a0a\u00a0estos\u00a0lugares\u00a0y\u00a0la\u00a0minimizaci\u00f3n \u00a0del\u00a0impacto\u00a0del\u00a0VIH,\u00a0algunas\u00a0de\u00a0\nestas\u00a0acciones\u00a0han\u00a0sido\u00a0apoyadas \u00a0con\u00a0presupuesto \u00a0de\u00a0la\u00a0cooperaci\u00f3n, \u00a0pero\u00a0es\u00a0necesario \u00a0sea\u00a0asumido\u00a0en\u00a0\nsu\u00a0totalidad\u00a0por\u00a0el\u00a0Estado.\u00a0\u00a0\u00a0\n\uf02d Con\u00a0respecto\u00a0al\u00a0gasto\u00a0en\u00a0acciones\u00a0orientadas \u00a0a\u00a0fortalecer \u00a0las\u00a0capacidades \u00a0para\u00a0afrontar\u00a0las\u00a0\nconsecuencias \u00a0del\u00a0VIH,\u00a0se\u00a0ha\u00a0realizado\u00a0\u00a0gasto\u00a0en\u00a0promotores \u00a0de\u00a0pares\u00a0y\u00a0actividades \u00a0para\u00a0incrementar \u00a0el\u00a0\ningreso\u00a0de\u00a0PVV,\u00a0la\u00a0mayor\u00eda\u00a0de\u00a0las\u00a0cuales\u00a0estuvieron \u00a0financiadas \u00a0por\u00a0proyectos \u00a0de\u00a0cooperaci\u00f3n \u00a0\ninternacional \u00a0hasta\u00a0el\u00a0a\u00f1o\u00a0201020.\u00a0\u00a0La\u00a0ESN\u00a0ha\u00a0informado \u00a0que\u00a0la\u00a0estructura \u00a0funcional \u00a0program\u00e1tica \u00a0del\u00a0\n                                                 \n20\u00a0No\u00a0se\u00a0incluye\u00a0en\u00a0este\u00a0an\u00e1lisis\u00a0a\u00a0los\u00a0consejeros \u00a0de\u00a0pares\u00a0que\u00a0forman\u00a0parte\u00a0de\u00a0los\u00a0equipos\u00a0multidisciplinarios \u00a0que\u00a0\nbrindan\u00a0TARGA\u00a0en\u00a0los\u00a0hospitales \u00a0y\u00a0establecimientos \u00a0de\u00a0salud,\u00a0y\u00a0que\u00a0son\u00a0parte\u00a0de\u00a0la\u00a0estructura \u00a0de\u00a0dichos\u00a0equipos\u00a0seg\u00fan\u00a0 28 presupuesto \u00a0de\u00a0la\u00a0ESN\u00a0est\u00e1\u00a0dise\u00f1ada\u00a0para\u00a0permitir\u00a0que\u00a0las\u00a0unidades\u00a0ejecutoras \u00a0de\u00a0los\u00a0niveles\u00a0operativos \u00a0\nprogramen \u00a0seg\u00fan\u00a0su\u00a0necesidad \u00a0la\u00a0inclusi\u00f3n\u00a0de\u00a0los\u00a0promotores \u00a0de\u00a0pares\u00a0de\u00a0pares21,\u00a0sin\u00a0embargo\u00a0ello\u00a0no\u00a0\nasegura\u00a0que\u00a0dichas\u00a0unidades\u00a0ejecutoras \u00a0incluyan\u00a0esta\u00a0necesidad \u00a0de\u00a0su\u00a0presupuesto \u00a0en\u00a0los\u00a0pr\u00f3ximos \u00a0\na\u00f1os.\u00a0\u00a0\u00a0\n\u00a0\nF.2\u00a0\u00a0Por\u00a0fuente\u00a0de\u00a0financiamiento \u00a0\n\u00a0\nEntre\u00a0las\u00a0fuentes\u00a0de\u00a0financiamiento \u00a0del\u00a0sector\u00a0p\u00fablico\u00a0se\u00a0encuentran \u00a0el\u00a0presupuesto \u00a0asignado\u00a0a\u00a0las\u00a0\nentidades \u00a0del\u00a0Gobierno \u00a0central\u00a0y\u00a0de\u00a0los\u00a0Gobiernos \u00a0Locales,\u00a0las\u00a0transferencias \u00a0realizadas \u00a0a\u00a0los\u00a0Gobiernos \u00a0\nRegionales \u00a0y\u00a0los\u00a0aportes\u00a0de\u00a0la\u00a0seguridad \u00a0social\u00a0pagados\u00a0por\u00a0los\u00a0empleadores. \u00a0\u00a0\u00a0\n\u00a0\nGasto\u00a0por\u00a0Fuente\u00a0de\u00a0Financiamiento \u00a02005\u20102010\u00a0\u2010\u00a0En\u00a0miles\u00a0US\u00a0$\u00a0\nSector\u00a0 2,005\u00a0 2,006\u00a0 2,007\u00a0 2,008\u00a02,009\u00a02,010\u00a0Total\u00a0\nSector\u00a0p\u00fablico\u00a0 9,516\u00a014,021\u00a013,317\u00a017,812\u00a024,887 15,441\u00a094,993\u00a0\nSector\u00a0externo\u00a0 14,341\u00a018,137\u00a022,294\u00a029,910\u00a029,543 12,474\u00a0126,699\u00a0\nSector\u00a0privado\u00a0 4,300\u00a0 4,428\u00a0 5,832\u00a0 7,876\u00a07,813\u00a08,512\u00a038,762\u00a0\nTotal\u00a0 28,157\u00a036,587\u00a041,443\u00a055,598\u00a062,242 36,427\u00a0260,454\u00a0\n\u00a0\nLa\u00a0distribuci\u00f3n \u00a0del\u00a0gasto\u00a0por\u00a0sector\u00a0de\u00a0la\u00a0fuente\u00a0de\u00a0financiamiento \u00a0se\u00a0presenta\u00a0en\u00a0el\u00a0siguiente\u00a0cuadro.\u00a0\n9,516\u00a014,021\u00a0 13,317\u00a017,812\u00a024,887\u00a0\n15,441\u00a014,341\u00a018,137\u00a0 22,294\u00a029,910\u00a029,543\u00a0\n12,474\u00a04,300\u00a04,428\u00a05,832\u00a07,876\u00a07,813\u00a0\n8,512\u00a0\n2005 2006 2007 2008 2009 2010Gasto\u00a0en\u00a0VIH\u00a0\u2010Por\u00a0fuente\u00a0de\u00a0financiamiento\nSector\u00a0p\u00fablico\n Internacional\n Privado\n\u00a0\n20.3%\n1.2%0.2%13.0%\n7.6%\n2.8%15.4%25.8%\n1.2%12.5%27.2%\n2.0%0.0%8.5%6.7%\n1.6%25.2%\n13.1%\n1.2%14.5%\nGobierno \u00a0\nNacionalGobierno \u00a0\nRegionalGobierno \u00a0Local Seguridad \u00a0\nSocialBilateral Naciones \u00a0\nUnidasFondo\u00a0Mundial Otros \u00a0externos Empresas \u00a0\nprivadasGastos\u00a0de\u00a0\nbolsilloParticipaci\u00f3n \u00a0\u00a0por\u00a0Sector\u00a0en\u00a0el\u00a0Gasto\u00a0en\u00a0VIH\u00a0\n2005\u20102007\n 2008\u20102010\n \n                                                                                                                                                     \nla\u00a0Norma\u00a0T\u00e9cnica\u00a0de\u00a0articulaci\u00f3n \u00a0del\u00a0servicio\u00a0de\u00a0consejeros \u00a0de\u00a0pares\u00a0(RM\u00a0N\u00ba\u00a01328\u20102003\u2010SA/DM)\u00a0y\u00a0de\u00a0\u00a0adherencia \u00a0al\u00a0\nTARGA\u00a0(Resoluci\u00f3n \u00a0Ministerial \u00a0N\u00b0\u00a0725\u20102004/MINSA) \u00a0por\u00a0lo\u00a0tanto\u00a0asumidos \u00a0por\u00a0el\u00a0presupuesto \u00a0del\u00a0sector.   \n21\u00a0Informe\u00a0N\u00ba\u00a0113\u20102011\u2010DGSP/ESN \u00a0PC\u00a0ITS\u2010VIH\u2010SIDA/MINSA   29 \n22%\n2%0%7% 7%\n2%28%\n17%\n1%13%30%\n1%0%9%\n6%\n2%26%\n14%\n1%12%30%\n3%\n0%10%\n7%\n1%20%\n6%\n2%22%\nGobierno \u00a0\nNacionalGobierno \u00a0\nRegionalGobierno \u00a0\nLocalSeguridad \u00a0\nSocialBilateral Naciones \u00a0\nUnidasFondo\u00a0\nMundialOtros\u00a0\nexternosEmpresas \u00a0\nprivadasGastos\u00a0de\u00a0\nbolsilloParticipaci\u00f3n \u00a0\u00a0por\u00a0Sector\u00a0en\u00a0el\u00a0Gasto\u00a0en\u00a0VIH\u00a0\n2008\n 2009\n 2010\n  Gasto\u00a0en\u00a0VIH\u00a0por\u00a0Fuente\u00a0de\u00a0financiamiento \u00a0(en\u00a0miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2,005\u00a0 2,006\u00a0 2,007\u00a0 2,008\u00a0 2,009\u00a0 2,010\u00a0 Total\u00a02005\u2010\n2007\u00a02008\u2010\n2010\u00a0Total\u00a0\nSECTOR\u00a0PUBLICO\u00a0 9,516\u00a014,021\u00a013,317\u00a017,812\u00a024,887\u00a015,441\u00a094,993\u00a034.7%\u00a037.7%\u00a036.5%\u00a0\nFS.01.01.01 \u00a0Renta\u00a0del\u00a0gobierno\u00a0central\u00a0 3,465\u00a0 7,215\u00a0 8,502\u00a010,986\u00a017,889\u00a09,809\u00a0 57,868\u00a018.1%\u00a025.1%\u00a022.2%\u00a0\nFS.01.01.02 \u00a0Renta\u00a0del\u00a0gobierno\u00a0estatal/provincial \u00a0 147\u00a0 387\u00a0 777\u00a0 1,354\u00a0 636\u00a0 1,085\u00a0 4,387\u00a0 1.2%\u00a0 2.0%\u00a0 1.7%\u00a0\nFS.01.01.03 \u00a0Renta\u00a0del\u00a0gobierno\u00a0local/municipal \u00a0 72\u00a0 42\u00a0 51\u00a0 21\u00a0 2\u00a0\u00a0 188\u00a0 0.2%\u00a0 0.0%\u00a0 0.1%\u00a0\nFS.01.02.01 \u00a0Aportaciones \u00a0patronales \u00a0obligatorias \u00a0a\u00a0la\u00a0seguridad \u00a0social\u00a0 5,430\u00a0 5,434\u00a0 2,950\u00a0 4,121\u00a0 5,452\u00a0 3,551\u00a0 26,940\u00a013.0%\u00a08.5%\u00a010.3%\u00a0\nFS.01.99\u00a0Otros\u00a0fondos\u00a0p\u00fablicos\u00a0s.c.o.\u00a0 401\u00a0 943\u00a0 1,037\u00a0 1,329\u00a0 907\u00a0 995\u00a0 5,611\u00a0 2.2%\u00a0 2.1%\u00a0 2.2%\u00a0\nINTERNACIONAL \u00a0 14,341\u00a018,028\u00a022,294\u00a029,910\u00a029,543\u00a012,474\u00a0126,589\u00a051.5%\u00a046.6%\u00a048.6%\u00a0\nFS.03.01.04 \u00a0Gobierno \u00a0de\u00a0Canad\u00e1\u00a0 30\u00a0\u00a0 \u00a0 8\u00a0 13\u00a0\u00a0 51\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nFS.03.01.08 \u00a0Gobierno \u00a0de\u00a0Alemania \u00a0 88\u00a0 88\u00a0 338\u00a0 464\u00a0 133\u00a0\u00a0 1,111\u00a0 0.5%\u00a0 0.4%\u00a0 0.4%\u00a0\nFS.03.01.11 \u00a0Gobierno \u00a0de\u00a0Italia\u00a0 84\u00a0 361\u00a0 1,052\u00a0 378\u00a0 368\u00a0 390\u00a0 2,633\u00a0 1.4%\u00a0 0.7%\u00a0 1.0%\u00a0\nFS.03.01.14 \u00a0Gobierno \u00a0de\u00a0Pa\u00edses\u00a0Bajos\u00a0 1\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 1\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nFS.03.01.17 \u00a0Gobierno \u00a0de\u00a0Portugal\u00a0\u00a0 23\u00a0 5\u00a0\u00a0\u00a0\u00a0 28\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nFS.03.01.18 \u00a0Gobierno \u00a0de\u00a0Espa\u00f1a\u00a0 1\u00a0 \u00a0\u00a0\u00a0 57\u00a0\u00a0 59\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nFS.03.01.19 \u00a0Gobierno \u00a0de\u00a0Suecia\u00a0 50\u00a0 59\u00a0 67\u00a0\u00a0 \u00a0 \u00a0 175\u00a0 0.2%\u00a0 0.0%\u00a0 0.1%\u00a0\nFS.03.01.21 \u00a0Gobierno \u00a0del\u00a0Reino\u00a0Unido\u00a0 50\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 50\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nFS.03.01.22 \u00a0Gobierno \u00a0de\u00a0los\u00a0Estados\u00a0Unidos\u00a0de\u00a0Am\u00e9rica\u00a0 1,150\u00a0 1,157\u00a0 3,447\u00a0 2,760\u00a0 2,721\u00a0 1,762\u00a0 12,996\u00a0 5.4%\u00a0 4.7%\u00a0 5.0%\u00a0\nFS.03.02.04 \u00a0Organizaci\u00f3n \u00a0Internacional \u00a0del\u00a0Trabajo\u00a0(OIT)\u00a0\u00a0 \u00a0 60\u00a0 48\u00a0 104\u00a0\u00a0 212\u00a0 0.1%\u00a0 0.1%\u00a0 0.1%\u00a0\nFS.03.02.07 \u00a0Fondo\u00a0Mundial\u00a0de\u00a0Lucha\u00a0contra\u00a0el\u00a0Sida,\u00a0la\u00a0Tuberculosis \u00a0y\u00a0la\u00a0Malaria\u00a0 5,714\u00a0 6,050\u00a0 4,580\u00a015,991\u00a016,414\u00a07,701\u00a0 56,449\u00a015.4%\u00a026.0%\u00a021.7%\u00a0\nFS.03.02.08 \u00a0Secretar\u00eda \u00a0del\u00a0ONUSIDA \u00a0 23\u00a0 198\u00a0 367\u00a0 105\u00a0 253\u00a0 90\u00a0 1,035\u00a0 0.6%\u00a0 0.3%\u00a0 0.4%\u00a0\nFS.03.02.09 \u00a0Fondo\u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0para\u00a0la\u00a0Infancia\u00a0(UNICEF)\u00a0 300\u00a0 187\u00a0 460\u00a0 134\u00a0 126\u00a0 51\u00a0 1,259\u00a0 0.9%\u00a0 0.2%\u00a0 0.5%\u00a0\nFS.03.02.11 \u00a0Programa \u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0para\u00a0el\u00a0Desarrollo \u00a0(PNUD)\u00a0 22\u00a0 41\u00a0 20\u00a0\u00a0 \u00a0 \u00a0 84\u00a0 0.1%\u00a0 0.0%\u00a0 0.0%\u00a0\nFS.03.02.12 \u00a0Naciones\u00a0Unidas\u00a0para\u00a0la\u00a0Educaci\u00f3n, \u00a0la\u00a0Ciencia\u00a0y\u00a0la\u00a0cultura\u00a0(UNESCO) \u00a0 24\u00a0 30\u00a0 60\u00a0 40\u00a0 53\u00a0\u00a0 207\u00a0 0.1%\u00a0 0.1%\u00a0 0.1%\u00a0\nFS.03.02.17 \u00a0Fondo\u00a0de\u00a0Poblaci\u00f3n \u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0(UNFPA)\u00a0 46\u00a0 20\u00a0 3\u00a0 302\u00a0 235\u00a0 210\u00a0 817\u00a0 0.1%\u00a0 0.5%\u00a0 0.3%\u00a0\nFS.03.02.18 \u00a0Banco\u00a0Mundial\u00a0(BM)\u00a0 76\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 76\u00a0 0.1%\u00a0 0.0%\u00a0 0.0%\u00a0\nFS.03.02.19 \u00a0Programa \u00a0Mundial\u00a0de\u00a0Alimentos \u00a0(PMA)\u00a0 221\u00a0 242\u00a0 299\u00a0 320\u00a0 300\u00a0 20\u00a0 1,402\u00a0 0.7%\u00a0 0.4%\u00a0 0.5%\u00a0\nFS.03.02.20 \u00a0Organizaci\u00f3n \u00a0Mundial\u00a0de\u00a0la\u00a0Salud\u00a0(OMS)\u00a0 24\u00a0 165\u00a0 28\u00a0 35\u00a0 32\u00a0 33\u00a0 316\u00a0 0.2%\u00a0 0.1%\u00a0 0.1%\u00a0\nFS.03.03.01 \u00a0International \u00a0HIV/AIDS\u00a0Alliance\u00a0\u00a0 55\u00a0 354\u00a0 145\u00a0 144\u00a0 5\u00a0 702\u00a0 0.4%\u00a0 0.2%\u00a0 0.3%\u00a0\nFS.03.03.18 \u00a0Sociedades \u00a0nacionales \u00a0de\u00a0la\u00a0cruz\u00a0roja\u00a0 50\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 50\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nFS.03.03.20 \u00a0M\u00e9dicos\u00a0sin\u00a0Fronteras \u00a0 488\u00a0 1,119\u00a0 737\u00a0\u00a0 \u00a0 \u00a0 2,344\u00a0 2.2%\u00a0 0.0%\u00a0 0.9%\u00a0\nFS.03.03.26 \u00a0Fundaci\u00f3n \u00a0Ford\u00a0 145\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 145\u00a0 0.1%\u00a0 0.0%\u00a0 0.1%\u00a0\nFS.03.03.32 \u00a0Wellcome \u00a0Trust\u00a0 600\u00a0 1,250\u00a0 150\u00a0\u00a0 \u00a0 \u00a0 2,000\u00a0 1.9%\u00a0 0.0%\u00a0 0.8%\u00a0\nFS.03.03.99 \u00a0Otras\u00a0organizaciones \u00a0y\u00a0fundaciones \u00a0internacionales \u00a0sin\u00a0fines\u00a0de\u00a0lucro\u00a0 1,246\u00a0 2,856\u00a0 3,932\u00a0 2,478\u00a0 2,204\u00a0 918\u00a0 13,633\u00a0 7.6%\u00a0 3.6%\u00a0 5.2%\u00a0\nFS.03.04\u00a0Organizaciones \u00a0internacionales \u00a0con\u00a0fines\u00a0de\u00a0lucro\u00a0 3,909\u00a0 4,128\u00a0 6,336\u00a0 6,701\u00a0 6,386\u00a0 1,294\u00a0 28,754\u00a013.5%\u00a09.3%\u00a011.0%\u00a0\nSECTOR\u00a0PRIVADO\u00a0 4,300\u00a0 4,428\u00a0 5,832\u00a0 7,876\u00a0 7,813\u00a0 8,512\u00a0 38,762\u00a013.7%\u00a015.7%\u00a014.9%\u00a0\nFS.02.02\u00a0Fondos\u00a0de\u00a0hogares\u00a0 4,037\u00a0 4,007\u00a0 5,209\u00a0 7,292\u00a0 7,231\u00a0 7,863\u00a0 35,638\u00a012.5%\u00a014.5%\u00a013.7%\u00a0\nFS.02.03\u00a0Instituciones \u00a0sin\u00a0fines\u00a0de\u00a0lucro\u00a0(distintas\u00a0del\u00a0seguro\u00a0social)\u00a0 263\u00a0 422\u00a0 623\u00a0 585\u00a0 582\u00a0 649\u00a0 3,124\u00a0 1.2%\u00a0 1.2%\u00a0 1.2%\u00a0\nTotal\u00a0 28,157\u00a036,477\u00a041,443\u00a055,598\u00a062,242\u00a036,427\u00a0260,345\u00a0100%\u00a0100%\u00a0100%\u00a0 31 \u00a0\nLa\u00a0principal\u00a0fuente\u00a0de\u00a0financiamiento \u00a0en\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os\u00a0fue\u00a0la\u00a0cooperaci\u00f3n \u00a0externa\u00a0\u00a0\u00a0(51.6%\u00a0para\u00a0el\u00a02005\u2010\n2007\u00a0y\u00a046.6%\u00a0para\u00a0el\u00a02008\u20102010),\u00a0sin\u00a0embargo\u00a0el\u00a0sector\u00a0p\u00fablico\u00a0incremento \u00a0su\u00a0participaci\u00f3n \u00a0de\u00a0\u00a034.7%\u00a0a\u00a0\n37.7%\u00a0en\u00a0los\u00a0periodos\u00a0examinados, \u00a0lo\u00a0cual\u00a0implica\u00a0que\u00a0el\u00a0Estado\u00a0est\u00e1\u00a0asumiendo \u00a0un\u00a0gran\u00a0porcentaje \u00a0del\u00a0\ngasto\u00a0en\u00a0Sida,\u00a0especialmente \u00a0\u00a0el\u00a0financiamiento \u00a0dirigido\u00a0a\u00a0la\u00a0\u00a0compra\u00a0de\u00a0ARV,\u00a0que\u00a0en\u00a0un\u00a0inicio\u00a0estaba\u00a0\ncubierto\u00a0por\u00a0el\u00a0FMSTM\u00a0para\u00a0luego\u00a0pasar\u00a0a\u00a0ser\u00a0financiado \u00a0por\u00a0el\u00a0Estado.\u00a0\n\u00a0\nFuentes\u00a0de\u00a0financiamiento \u00a0\u2013\u00a0Estructura \u00a0porcentual \u00a0por\u00a0grupo\u00a0de\u00a0a\u00f1os\u00a0\nSector\u00a0 2005\u20102007\u00a02008\u20102010\u00a0 Total\u00a0\nSector\u00a0p\u00fablico\u00a0 34.7% 37.7% 36.5%\u00a0\nSector\u00a0externo\u00a0 51.6% 46.6% 48.6%\u00a0\nSector\u00a0privado\u00a0 13.7% 15.7% 14.9%\u00a0\nTotal\u00a0 100.0% 100.0% 100.0%\u00a0\n\u00a0\n\u00a0\nFuentes\u00a0de\u00a0financiamiento \u00a0\u2010\u00a0\u00a0Estructura \u00a0porcentual \u00a0detallado \u00a0por\u00a0a\u00f1os\u00a0\nSector\u00a0 2005\u00a0 2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2010\u00a0\nSector\u00a0p\u00fablico\u00a0 33.8% 38.4% 32.1% 32% 40%\u00a0 42.4%\nSector\u00a0externo\u00a0 50.9% 49.4% 53.8% 53.8% 47.5%\u00a0 34.2%\nSector\u00a0privado\u00a0 15.3% 12.1% 14.1% 14.1% 12.6%\u00a0 23.4%\nTotal\u00a0 100.0% 100.0% 100.0% 100.0% 100.0%\u00a0 100.0%\n\u00a0\n\u00a0\nF.2.1\u00a0\u00a0Sector\u00a0P\u00fablico\u00a0\n\u00a0\nHasta\u00a0el\u00a02000,\u00a0\u00a0el\u00a0gasto\u00a0en\u00a0VIH\u00a0era\u00a0asumido\u00a0por\u00a0el\u00a0Ministerio \u00a0de\u00a0Salud\u00a0\u2010MINSA\u00a0con\u00a0recursos\u00a0asignados \u00a0al\u00a0\nPrograma \u00a0de\u00a0Control\u00a0de\u00a0ETS\u00a0y\u00a0SIDA\u00a0(PROCETSS). \u00a0\u00a0\u00a0A\u00a0partir\u00a0del\u00a02003\u00a0se\u00a0estableci\u00f3 \u00a0en\u00a0el\u00a0Per\u00fa\u00a0el\u00a0Modelo\u00a0de\u00a0\nAtenci\u00f3n\u00a0Integral\u00a0de\u00a0Salud\u00a0(MAIS)\u00a0y\u00a0se\u00a0eliminaron \u00a0los\u00a0programas \u00a0nacionales \u00a0de\u00a0la\u00a0estructura \u00a0org\u00e1nica\u00a0del\u00a0\nMINSA.\u00a0\u00a0\n\u00a0\nEste\u00a0cambio\u00a0dio\u00a0lugar\u00a0a\u00a0la\u00a0disminuci\u00f3n \u00a0de\u00a0los\u00a0recursos\u00a0humanos \u00a0y\u00a0materiales \u00a0asignados \u00a0al\u00a0VIH,\u00a0como\u00a0por\u00a0\nejemplo\u00a0\u00a0la\u00a0disminuci\u00f3n \u00a0del\u00a0n\u00famero\u00a0de\u00a0promotores \u00a0educadores \u00a0de\u00a0pares,\u00a0que\u00a0constituyen \u00a0\u00a0la\u00a0parte\u00a0\u00a0muy\u00a0\nactiva\u00a0\u00a0en\u00a0la\u00a0estrategia \u00a0de\u00a0prevenci\u00f3n \u00a0dirigida\u00a0tanto\u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0HSH\u00a0como\u00a0TS.\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0Aunque\u00a0el\u00a0gasto\u00a0en\u00a0VIH\u00a0disminuy\u00f3, \u00a0no\u00a0es\u00a0posible\u00a0identificar \u00a0claramente \u00a0la\u00a0magnitud \u00a0de\u00a0la\u00a0reducci\u00f3n \u00a0debido\u00a0a\u00a0\nque\u00a0\u00a0las\u00a0Estrategias \u00a0sanitarias \u00a0nacionales \u00a0creadas\u00a0a\u00a0ra\u00edz\u00a0del\u00a0nuevo\u00a0modelo\u00a0del\u00a0MAIS,\u00a0s\u00f3lo\u00a0tienen\u00a0un\u00a0rol\u00a0\nnormativo \u00a0y\u00a0de\u00a0planeamiento. \u00a0\u00a0\u00a0Paralelamente, \u00a0en\u00a0el\u00a02002\u00a0en\u00a0el\u00a0marco\u00a0del\u00a0proceso\n\u00a0de\u00a0descentralizaci\u00f3n, \u00a0se\u00a0\ntraslad\u00f3\u00a0\u00a0la\u00a0funci\u00f3n\u00a0salud\u00a0hacia\u00a0las\u00a0regiones\u00a0(\u00a022\u00a0)\u00a0lo\u00a0cual\u00a0origin\u00f3\u00a0tambi\u00e9n\u00a0la\u00a0descentralizaci\u00f3n \u00a0del\u00a0presupuesto \u00a0\ndel\u00a0nivel\u00a0central\u00a0hacia\u00a0las\u00a0regiones.\u00a0\u00a0\u00a0\n\u00a0\nSin\u00a0embargo\u00a0el\u00a0MINSA\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0sus\u00a0a\u00e9reas\u00a0administrativas \u00a0(PAAG,\u00a0ORE\u00a0y\u00a0Oficina\u00a0General\u00a0de\u00a0\nAdministraci\u00f3n \u00a0sucesivamente) \u00a0continu\u00f3\u00a0haci\u00e9ndose \u00a0cargo\u00a0de\u00a0la\u00a0compra\u00a0de\u00a0los\u00a0denominados \u00a0\u201cproductos \u00a0\nestrat\u00e9gicos\u201d: \u00a0ARV\u00a0para\u00a0las\u00a0PVV\u00a0adultas,\u00a0Condones, \u00a0pruebas\u00a0r\u00e1pidas\u00a0de\u00a0VIH,\u00a0insumos\u00a0y\u00a0pago\u00a0de\u00a0PEP\u00a0a\u00a0nivel\u00a0\nnacional.\u00a0\u00a0\u00a0Los\u00a0ARV\u00a0para\u00a0la\u00a0poblaci\u00f3n \u00a0pedi\u00e1trica \u00a0deber\u00edan\u00a0\u00a0adquirir\u00a0cada\u00a0uno\u00a0de\u00a0los\u00a0hospitales \u00a0de\u00a0acuerdo\u00a0a\u00a0\nsus\u00a0necesidades, \u00a0por\u00a0estar\u00a0comprendidas \u00a0en\u00a0el\u00a0Listado\u00a0Priorizado \u00a0de\u00a0Intervenciones \u00a0Sanitarias \u00a0LPIS.\u00a0\u00a0Debido\u00a0\na\u00a0que\u00a0la\u00a0cantidad\u00a0por\u00a0adquirir\u00a0era\u00a0\u00ednfima\u00a0por\u00a0establecimientos \u00a0y\u00a0no\u00a0se\u00a0encontraban \u00a0proveedores, \u00a0se\u00a0acord\u00f3\u00a0\n                                                 \n22 Ley\u00a0de\u00a0Bases\u00a0de\u00a0la\u00a0Descentralizaci\u00f3n \u00a0\u2010\u00a0Ley\u00a027783,\u00a02002  32 la\u00a0compra\u00a0centralizada, \u00a0por\u00a0la\u00a0cual\u00a0el\u00a0MINSA\u00a0est\u00e1\u00a0proporcionando \u00a0los\u00a0ARV.\u00a0( 23 )  Las\u00a0regiones\u00a0adquieren \u00a0\nalgunos\u00a0de\u00a0los\u00a0\u201cproductos \u00a0estrat\u00e9gicos\u201d \u00a0con\u00a0el\u00a0financiamiento \u00a0del\u00a0Seguro\u00a0integral\u00a0de\u00a0Salud\u00a0\u2013\u00a0SIS\u00a0(\u00a024\u00a0)\u00a0pero\u00a0\nb\u00e1sicamente \u00a0corresponde \u00a0a\u00a0prestaciones \u00a0realizadas \u00a0a\u00a0gestantes \u00a0con\u00a0VIH.\u00a0\n\u00a0\nHasta\u00a0la\u00a0fecha\u00a0el\u00a0MINSA\u00a0continua\u00a0asumiendo \u00a0el\u00a0gasto\u00a0de\u00a0la\u00a0mayor\u00a0parte\u00a0de\u00a0los\u00a0insumos\u00a0y\u00a0\u00a0ARV,\u00a0aunque\u00a0en\u00a0el\u00a0\na\u00f1o\u00a02009\u00a0se\u00a0realiz\u00f3\u00a0la\u00a0transferencia \u00a0\u00a0del\u00a0\u00a0pago\u00a0PEPs\u00a0\u00a0a\u00a0las\u00a0regiones,\u00a0los\u00a0cuales\u00a0han\u00a0adoptado \u00a0diferentes \u00a0\nmodalidades \u00a0de\u00a0contrataci\u00f3n \u00a0(como\u00a0servicios\u00a0no\u00a0personales, \u00a0contrato\u00a0de\u00a0administraci\u00f3n \u00a0de\u00a0servicios\u00a0o\u00a0\ningreso\u00a0a\u00a0planilla).\u00a0\u00a0\u00a0\u00a0\n\u00a0\nEl\u00a0gasto\u00a0realizado\u00a0por\u00a0las\u00a0Instituciones \u00a0que\u00a0forman\u00a0parte\u00a0del\u00a0Sector\u00a0p\u00fablico\u00a0peruano\u00a0para\u00a0la\u00a0prevenci\u00f3n, \u00a0\ndiagn\u00f3stico \u00a0y\u00a0tratamiento \u00a0del\u00a0VIH,\u00a0ascendieron \u00a0a\u00a0\u00a09.5\u00a0\u00a0millones\u00a0US$\u00a0en\u00a0el\u00a02005,\u00a0\u00a014.0\u00a0millones\u00a0US$\u00a0\u00a0en\u00a0el\u00a0\n2006,\u00a0\u00a013.3\u00a0millones\u00a0US$\u00a0en\u00a0el\u00a02007,\u00a0\u00a0\u00a017.8\u00a0millones\u00a0US$\u00a0\u00a0en\u00a0el\u00a02008,\u00a0\u00a0\u00a024.9\u00a0millones\u00a0US$\u00a0en\u00a0el\u00a02009\u00a0y\u00a015.4\u00a0\nmillones\u00a0US$\u00a0\u00a0en\u00a0el\u00a02010.\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\nGasto\u00a0del\u00a0sector\u00a0p\u00fablico\u00a0por\u00a0categor\u00eda \u00a0de\u00a0gasto\u00a0\u00a0(miles\u00a0de\u00a0US\u00a0$)\u00a0\nFunci\u00f3n\u00a0\u00a0 2005 2006\u00a02007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 1,862 2,904\u00a03,471\u00a02,892\u00a02,486\u00a04,301\u00a017,915\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 7,177 10,903 8,642\u00a014,611 20,990\u00a09,063\u00a071,387\n\u00a0\u00a0\u00a0\u00a0Antirretrovirales \u00a0 5,889 8,588\u00a03,140\u00a08,768\u00a013,862\u00a03,508\u00a043,754\n\u00a0\u00a0\u00a0\u00a0Reactivos \u00a0y\u00a0materiales \u00a0 694\u00a01,347\u00a04,273\u00a04,583\u00a05,896\u00a04,241\u00a021,035\n\u00a0\u00a0\u00a0\u00a0Otros\u00a0 594\u00a0968\u00a01,230\u00a01,260\u00a01,232\u00a01,314\u00a06,597\u00a0\nIncentivos \u00a0de\u00a0retenci\u00f3n \u00a0 \u00a0 7\u00a0 15\u00a0\u00a0\u00a0\u00a0 22\u00a0\nGesti\u00f3n\u00a0de\u00a0programa \u00a0\u00a0 258\u00a0201\u00a0 397\u00a0 290\u00a0 615\u00a0 305\u00a02,065\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\u00a0 3\u00a0 4\u00a0 31\u00a0\u00a0\u00a0\u00a0 38\u00a0\nDesarrollo \u00a0comunitario \u00a0y\u00a0ambiente \u00a0mejorado \u00a0 216\u00a0 2\u00a0 762\u00a0\u00a0 568\u00a01,762\u00a03,310\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0sida\u00a0 \u00a0\u00a0\u00a0 18\u00a0 228\u00a0 11\u00a0 257\u00a0\nTotal\u00a0 9,516 14,021 13,317 17,812 24,887\u00a015,441\u00a094,993\nNota:\u00a0en\u00a0el\u00a0a\u00f1o\u00a02009\u00a0se\u00a0realiz\u00f3\u00a0el\u00a0Foro\u00a0latinoamericano \u00a0en\u00a0VIH\u00a0en\u00a0el\u00a0Per\u00fa\u00a0\u00a0\n\u00a0\nEn\u00a0tratamiento, \u00a0si\u00a0bien\u00a0el\u00a0gasto\u00a0se\u00a0ha\u00a0incrementado \u00a0hasta\u00a0el\u00a02009,\u00a0se\u00a0ve\u00a0una\u00a0disminuci\u00f3n \u00a0marcada\u00a0\u00a0en\u00a0el\u00a0a\u00f1o\u00a0\n2010,\u00a0debido\u00a0a\u00a0la\u00a0compra\u00a0de\u00a0ARV\u00a0realizada\u00a0para\u00a0dos\u00a0a\u00f1os\u00a0(2009\u00a0y\u00a02010),\u00a0\u00a0a\u00a0la\u00a0tendencia \u00a0de\u00a0la\u00a0disminuci\u00f3n \u00a0de\u00a0\nprecios\u00a0de\u00a0los\u00a0ARV.\u00a0\u00a0Los\u00a0ARV\u00a0se\u00a0adquieren \u00a0de\u00a0forma\u00a0\u00a0centralizada \u00a0y\u00a0por\u00a0subasta\u00a0inversa.\u00a0\u00a0Cabe\u00a0precisar\u00a0que\u00a0el\u00a0\nn\u00famero\u00a0de\u00a0\u00a0PVV\u00a0que\u00a0reciben\u00a0TARGA\u00a0est\u00e1\u00a0aumentando \u00a0y\u00a0tambi\u00e9n\u00a0los\u00a0PVV\u00a0en\u00a0tratamiento \u00a0de\u00a0rescate\u00a0tambi\u00e9n\u00a0\nest\u00e1n\u00a0en\u00a0aumento, \u00a0pero\u00a0no\u00a0se\u00a0est\u00e1\u00a0traduciendo \u00a0en\u00a0un\u00a0incremento \u00a0del\u00a0gasto\u00a0en\u00a0este\u00a0rubro.\u00a0\u00a0\u00a0El\u00a0gasto\u00a0en\u00a0\nprevenci\u00f3n \u00a0desde\u00a0el\u00a0sector\u00a0p\u00fablico\u00a0se\u00a0increment\u00f3 \u00a0considerable \u00a0a\u00a0partir\u00a0del\u00a02007.\u00a0A\u00a0pesar\u00a0del\u00a0incremento \u00a0del\u00a0\ngasto\u00a0en\u00a0prevenci\u00f3n \u00a0durante\u00a0\u00a0estos\u00a0\u00faltimos\u00a0\u00a0a\u00f1os,\u00a0el\u00a0gasto\u00a0en\u00a0tratamiento \u00a0sigue\u00a0siendo\u00a0mucho\u00a0mayor.\u00a0\u00a0\u00a0\u00a0\n\u00a0\nEn\u00a0el\u00a0siguiente\u00a0cuadro\u00a0podemos \u00a0ver\u00a0la\u00a0evoluci\u00f3n \u00a0de\u00a0los\u00a0gastos\u00a0agrupados \u00a0por\u00a0los\u00a0periodos\u00a02005\u20102006,\u00a02007\u2010\n2008\u00a0y\u00a02009\u20102010,\u00a0se\u00a0puede\u00a0apreciar\u00a0que\u00a0el\u00a0gasto\u00a0se\u00a0ha\u00a0incrementado \u00a0de\u00a0manera\u00a0sostenida, \u00a0pero\u00a0con\u00a0\nvariaciones \u00a0\u00a0en\u00a0las\u00a0respectivas \u00a0categor\u00edas \u00a0de\u00a0gasto.\u00a0Los\u00a0gastos\u00a0m\u00e1s\u00a0representativos \u00a0son\u00a0los\u00a0referentes \u00a0a\u00a0los\u00a0\ncostos\u00a0de\u00a0tratamiento \u00a0y\u00a0prevenci\u00f3n, \u00a0los\u00a0cuales\u00a0se\u00a0han\u00a0incrementado \u00a0desde\u00a0el\u00a02005\u00a0al\u00a02010.\u00a0\n\u00a0\n                                                 \n23 La\u00a0Resoluci\u00f3n \u00a0Ministerial \u00a0608\u20102007/MINSA \u00a0modifica\u00a0la\u00a0Directiva\u00a0administrativa \u00a0112\u20102007\u2010MINSA/SIS \u2010V.01\u00a0que\u00a0regula\u00a0\nel\u00a0pago\u00a0para\u00a0las\u00a0prestaciones \u00a0del\u00a0Seguro\u00a0Integral\u00a0de\u00a0Salud\u00a0\u2010\u00a0SIS:\u00a0\u201cLa\u00a0transferencia \u00a0de\u00a0recursos\u00a0a\u00a0las\u00a0unidades\u00a0ejecutoras \u00a0\npor\u00a0concepto \u00a0de\u00a0pago\u00a0de\u00a0las\u00a0prestaciones \u00a0de\u00a0salud\u00a0y\u00a0administrativas \u00a0ser\u00e1\u00a0efectuada \u00a0por\u00a0la\u00a0Oficina\u00a0general\u00a0de\u00a0\nAdministraci\u00f3n \u00a0previa\u00a0autorizaci\u00f3n \u00a0previa\u00a0autorizaci\u00f3n \u00a0del\u00a0jefe\u00a0Institucional \u00a0del\u00a0SIS,\u00a0efectuada \u00a0mediante \u00a0Resoluci\u00f3n \u00a0\nJefatural. \u00a0\u00a0En\u00a0el\u00a0caso\u00a0del\u00a0pago\u00a0por\u00a0medicamentos \u00a0ARV\u00a0e\u00a0insumos\u00a0para\u00a0ni\u00f1os\u00a0y\u00a0para\u00a0profilaxis\u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0vertical\u00a0y\u00a0\nsu\u00a0correspondiente \u00a0distribuci\u00f3n, \u00a0cuya\u00a0adquisici\u00f3n \u00a0y\u00a0entrega\u00a0se\u00a0haya\u00a0efectuado \u00a0por\u00a0la\u00a0Unidad\u00a0ejecutora \u00a01\u00a0del\u00a0MINSA,\u00a0la\u00a0\ntransferencia \u00a0de\u00a0recursos\u00a0se\u00a0efectuara \u00a0a\u00a0esta\u00a0Unidad\u00a0ejecutora. \u00a0\u00a0El\u00a0costo\u00a0de\u00a0los\u00a0procedimientos \u00a0realizados \u00a0continuara \u00a0\nsiendo\u00a0reembolsado \u00a0por\u00a0el\u00a0SIS\u00a0\u00a0a\u00a0cada\u00a0Unidad\u00a0ejecutora.\u201d  \n24 El\u00a0SIS\u00a0administra \u00a0los\u00a0fondos\u00a0para\u00a0el\u00a0financiamiento \u00a0de\u00a0prestaciones \u00a0de\u00a0salud\u00a0individual. \u00a0  33 \n4,765\u00a06,363\u00a0 6,787\u00a018,080\u00a023,254\u00a030,052\u00a0\n2005\u20102006 2007 \u20102008 2009 \u20102010Gasto\u00a0P\u00fablico\u00a02005\u20102010\n(miles\u00a0de\u00a0US\u00a0$)\nPrevenci\u00f3n\n Tratamiento\n\u00a0\n\u00a0\nEn\u00a0prevenci\u00f3n, \u00a0el\u00a0mayor\u00a0gasto\u00a0se\u00a0realizo\u00a0en\u00a0prevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0vertical,\u00a0que\u00a0ten\u00eda\u00a0Objetivos \u00a0\nespec\u00edficos \u00a0en\u00a0los\u00a0proyectos \u00a0financiados \u00a0por\u00a0el\u00a0FMSTM\u00a0de\u00a0subvenciones \u00a0de\u00a02da\u00a0y\u00a06ta\u00a0ronda.\u00a0\n\u00a0\nEn\u00a0Desarrollo \u00a0comunitario \u00a0y\u00a0ambiente \u00a0mejorado \u00a0\u00a0se\u00a0registra\u00a0492\u00a0mil\u00a0US\u00a0$\u00a0por\u00a0la\u00a0realizaci\u00f3n \u00a0del\u00a0V\u00a0Foro\u00a0\nLatinoamericano \u00a0de\u00a0VIH/Sida\u00a0que\u00a0se\u00a0llev\u00f3\u00a0a\u00a0cabo\u00a0en\u00a0noviembre \u00a0de\u00a02009\u00a0con\u00a0sede\u00a0ac\u00e1\u00a0en\u00a0Lima\u00a0y\u00a0el\u00a0MINSA\u00a0\nestuvo\u00a0encargado \u00a0de\u00a0la\u00a0organizaci\u00f3n. \u00a0El\u00a0gasto\u00a0en\u00a0diagn\u00f3stico \u00a0tambi\u00e9n\u00a0se\u00a0increment\u00f3 \u00a0en\u00a0el\u00a02008,\u00a0debido\u00a0al\u00a0\nmayor\u00a0uso\u00a0de\u00a0pruebas\u00a0r\u00e1pidas\u00a0tanto\u00a0en\u00a0poblaci\u00f3n \u00a0gestante\u00a0como\u00a0en\u00a0HSH\u00a0y\u00a0TS.\u00a0\n\u00a0\nEn\u00a0el\u00a0cuadro\u00a0siguiente\u00a0se\u00a0aprecia\u00a0el\u00a0Gasto\u00a0en\u00a0VIH\u00a0por\u00a0fuente\u00a0de\u00a0financiamiento \u00a0y\u00a0tipo\u00a0de\u00a0atenci\u00f3n. \u00a0\u00a0\n\u00a0\nGasto\u00a0en\u00a0VIH\u00a0por\u00a0Fuente\u00a0de\u00a0financiamiento \u00a0y\u00a0Tipo\u00a0de\u00a0atenci\u00f3n\u00a0Periodo\u00a02005\u00a0al\u00a02010\u00a0\u00a0(En\u00a0US\u00a0$)\u00a0\nFunci\u00f3n\u00a0 Nacional Regional Local\u00a0Seguro\u00a0\nsocial\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 13,397\u00a02,014\u00a0 101\u00a02,403\u00a017,915\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 45,067\u00a01,735\u00a0 80\u00a024,505 71,387\nIncentivos \u00a0de\u00a0retenci\u00f3n \u00a0 0\u00a0 22\u00a0\u00a0\u00a0 22\u00a0\nGesti\u00f3n\u00a0de\u00a0programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0administraci\u00f3n \u00a0 1,429\u00a0 605\u00a0\u00a0 31\u00a0 2,065\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0(excluyendo \u00a0hu\u00e9rfanos) \u00a0\u00a0 34\u00a0 4\u00a0\u00a0 38\u00a0\nDesarrollo \u00a0comunitario \u00a0y\u00a0ambiente \u00a0mejorado \u00a0 3,309\u00a0 1\u00a0\u00a0\u00a0 3,310\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0sida\u00a0\u00a0 253\u00a0\u00a0 3\u00a0\u00a0 257\u00a0\nTotal\u00a0 63,455\u00a04,411\u00a0 188\u00a026,940 94,993\n\u00a0\nGasto\u00a0en\u00a0VIH\u00a0por\u00a0Fuente\u00a0de\u00a0financiamiento \u00a0y\u00a0Tipo\u00a0de\u00a0atenci\u00f3n\u00a0(2008)\u00a0\nFunci\u00f3n\u00a0 Nacional Regional Local\u00a0Seguro\u00a0\nsocial\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 2,186\u00a0 415\u00a0 10\u00a0 280\u00a02,892\u00a0\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 10.003\u00a0 760\u00a0 7\u00a0 3,841\u00a014,611\nGesti\u00f3n\u00a0de\u00a0programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0administraci\u00f3n \u00a0 91\u00a0 199\u00a0\u00a0\u00a0 290\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0sida\u00a0\u00a0 15\u00a0\u00a0 3\u00a0\u00a0 18\u00a0\nTotal\u00a0 12,295\u00a01,374\u00a0 21\u00a0 4,121\u00a017,812\n\u00a0\nGasto\u00a0en\u00a0VIH\u00a0por\u00a0Fuente\u00a0de\u00a0financiamiento \u00a0y\u00a0Tipo\u00a0de\u00a0atenci\u00f3n\u00a0(2009)\u00a0\nFunci\u00f3n\u00a0 Nacional Regional Local\u00a0Seguro\u00a0\nsocial\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 1,700\u00a0 355\u00a0\u00a0 431\u00a02,486\u00a0\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 15,879\u00a0 87\u00a0 2\u00a0 5,021\u00a020,990\nGesti\u00f3n\u00a0de\u00a0programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0administraci\u00f3n \u00a0 421\u00a0 194\u00a0\u00a0\u00a0 615\u00a0\nDesarrollo \u00a0comunitario \u00a0y\u00a0ambiente \u00a0mejorado \u00a0 568\u00a0\u00a0 \u00a0\u00a0 568\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0sida\u00a0\u00a0 228\u00a0\u00a0 \u00a0\u00a0 228\u00a0 34 Funci\u00f3n\u00a0 Nacional Regional Local\u00a0Seguro\u00a0\nsocial\u00a0Total\u00a0\nTotal\u00a0 18,796\u00a0 636\u00a0 2\u00a0 5,452\u00a024,887\n\u00a0\nGasto\u00a0en\u00a0VIH\u00a0por\u00a0Fuente\u00a0de\u00a0financiamiento \u00a0y\u00a0Tipo\u00a0de\u00a0atenci\u00f3n\u00a0(2010)\u00a0\nFunci\u00f3n\u00a0 Nacional RegionalLocal\u00a0Seguro\u00a0\nsocial\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 3,467\u00a0 707\u00a0 0\u00a0 127\u00a04,301\u00a0\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 5,467\u00a0 171\u00a0\u00a0 3,424\u00a09,063\u00a0\nGesti\u00f3n\u00a0de\u00a0programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0administraci\u00f3n \u00a0 94\u00a0 211\u00a0\u00a0\u00a0 305\u00a0\nDesarrollo \u00a0comunitario \u00a0y\u00a0ambiente \u00a0mejorado \u00a0 1,762\u00a0\u00a0\u00a0\u00a0 11,762\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0sida\u00a0\u00a0 11\u00a0\u00a0\u00a0\u00a0 11\u00a0\nTotal\u00a0 10,801\u00a01,089\u00a0 0\u00a0 3,551\u00a015,441\n\u00a0\n\u00a0\nEn\u00a0el\u00a0periodo\u00a0del\u00a02005\u00a0a\u00a02010\u00a0el\u00a0gasto\u00a0realizado\u00a0por\u00a0el\u00a0Gobierno \u00a0Nacional\u00a0ascendi\u00f3\u00a0a\u00a063.5\u00a0millones\u00a0de\u00a0US\u00a0$.\u00a0\u00a0\nEl\u00a0gasto\u00a0de\u00a0los\u00a0Gobiernos \u00a0Regionales \u00a0ascendi\u00f3\u00a0a\u00a04.4\u00a0\u00a0millones\u00a0de\u00a0nuevos\u00a0soles\u00a0y\u00a0\u00a0el\u00a0de\u00a0los\u00a0Gobiernos \u00a0Locales\u00a0\n0.2\u00a0millones\u00a0de\u00a0nuevos\u00a0soles.\u00a0\u00a0\u00a0El\u00a0gasto\u00a0de\u00a0ESSALUD\u00a0ascendi\u00f3\u00a0a\u00a026.9\u00a0millones\u00a0de\u00a0US\u00a0$.\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\nEl\u00a0gasto\u00a0del\u00a0gobierno\u00a0nacional\u00a0\u00a0es\u00a0\u00a0aproximadamente \u00a0la\u00a0cuarta\u00a0parte\u00a0del\u00a0total\u00a0del\u00a0gasto\u00a0realizado\u00a0en\u00a0Sida\u00a0en\u00a0\nel\u00a0pa\u00eds\u00a0\u00a0desde\u00a0el\u00a02005\u00a0al\u00a02010\u00a0(63.5\u00a0/260.5\u00a0US\u00a0$).\u00a0\u00a0\u00a0El\u00a0gasto\u00a0realizado\u00a0por\u00a0ESSALUD\u00a0en\u00a0prevenci\u00f3n \u00a0se\u00a0\nmantiene \u00a0a\u00a0lo\u00a0largo\u00a0de\u00a0los\u00a0a\u00f1os,\u00a0llegando\u00a0a\u00a0ser\u00a0aproximadamente \u00a0el\u00a014%\u00a0del\u00a0total\u00a0del\u00a0gasto\u00a0del\u00a0Estado.\u00a0\u00a0\u00a0Por\u00a0\notro\u00a0lado\u00a0el\u00a0tratamiento \u00a0represent\u00f3 \u00a0el\u00a0principal\u00a0concepto \u00a0de\u00a0gasto\u00a0del\u00a0estado\u00a0el\u00a0cual\u00a0en\u00a0el\u00a0periodo\u00a02005\u2010\n2010\u00a0represent\u00f3 \u00a0el\u00a0\u00a071%\u00a0\u00a0de\u00a0los\u00a0gastos\u00a0totales\u00a0asumidos \u00a0por\u00a0el\u00a0MINSA,\u00a0\u00a0y\u00a0el\u00a091%\u00a0\u00a0de\u00a0los\u00a0gastos\u00a0asumidos \u00a0por\u00a0\nESSALUD. \u00a0\n\u00a0\nGasto\u00a0en\u00a0ARV,\u00a0reactivos\u00a0y\u00a0condones \u00a0del\u00a0Gobierno \u00a0nacional\u00a0y\u00a0ESSALUD\u00a0\u2010\u00a0Periodo\u00a02005\u00a0al\u00a02010\u00a0\u00a0(En\u00a0US\u00a0$)\u00a0\nRecursos\u00a0/Fuente\u00a0de\u00a0financiamiento \u00a0 2005\u00a0 2006\u00a0 2007\u00a02008\u00a02009\u00a0 2010\u00a0 Total\u00a0\nAntirretrovirales \u00a0 5,920\u00a0 8,923\u00a03,280\u00a08,900\u00a013,877\u00a03,529\u00a044,429\u00a0\n\u00a0\u00a0Gobierno \u00a0nacional 801\u00a0 5,107\u00a02,116\u00a06,919\u00a09,759\u00a01,943\u00a026,644\u00a0\nESSALUD 5,119\u00a0 3,816\u00a01,164\u00a01,981\u00a04,118\u00a01,586\u00a017,785\u00a0\nReactivos \u00a0y\u00a0materiales \u00a0 1,352\u00a0 2,281\u00a05,649\u00a04,481\u00a06,039\u00a04,332\u00a024,133\u00a0\n\u00a0\u00a0Gobierno \u00a0nacional 1,133\u00a0 1,107\u00a03,957\u00a02,579\u00a05,089\u00a02,441\u00a016,305\u00a0\n\u00a0\u00a0ESSALUD 219\u00a0 1,174\u00a01,693\u00a01,902\u00a0950\u00a0 1,891\u00a0 7,828\u00a0\nCondones \u00a0 442\u00a0 328\u00a0 1,445\u00a0239\u00a0 526\u00a0 3,204\u00a0 6,183\u00a0\n\u00a0\u00a0Gobierno \u00a0nacional 442\u00a0 23\u00a0 1,439\u00a0 6\u00a0 156\u00a0 3,204\u00a0 5,270\u00a0\n\u00a0\u00a0ESSALUD \u00a0 305\u00a0 6\u00a0 233\u00a0 369\u00a0\u00a0 913\u00a0\n\u00a0\nSe\u00a0puede\u00a0apreciar\u00a0un\u00a0gasto\u00a0importante \u00a0en\u00a0reactivos\u00a0en\u00a0el\u00a0seguro\u00a0social.\u00a0Para\u00a0los\u00a0afiliados\u00a0al\u00a0Seguro\u00a0Social\u00a0\neste\u00a0cubre\u00a0todos\u00a0los\u00a0an\u00e1lisis\u00a0a\u00a0diferencia \u00a0de\u00a0las\u00a0personas\u00a0que\u00a0acuden\u00a0a\u00a0los\u00a0servicios\u00a0p\u00fablicos\u00a0que\u00a0tienen\u00a0un\u00a0\ngasto\u00a0de\u00a0bolsillo\u00a0\u00a0m\u00e1s\u00a0alto\u00a0antes\u00a0del\u00a0diagn\u00f3stico \u00a0y\u00a0que\u00a0luego\u00a0muchos\u00a0de\u00a0ellos\u00a0pasan\u00a0al\u00a0SIS\u00a0y\u00a0actualmente \u00a0\nest\u00e1n\u00a0migrando \u00a0al\u00a0AUS,\u00a0sin\u00a0embargo\u00a0hay\u00a0un\u00a0grupo\u00a0que\u00a0no\u00a0pertenece \u00a0ni\u00a0a\u00a0ESSALUD\u00a0ni\u00a0al\u00a0SIS\u00a0y\u00a0que\u00a0debe\u00a0\nrealizar\u00a0el\u00a0gasto\u00a0de\u00a0bolsillo\u00a0antes\u00a0y\u00a0despu\u00e9s\u00a0del\u00a0diagn\u00f3stico. \u00a0\n\u00a0 35 \u00a0\n\u00a0\nF.2.2\u00a0Cooperaci\u00f3n \u00a0Internacional \u00a0\n\u00a0\n\u00a0\nGasto\u00a0del\u00a0sector\u00a0externo\u00a0(miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2,005\u00a02,006\u00a02,007\u00a02,008\u00a02,009\u00a02,010\u00a0Total\u00a0Estructura\nBilateral\u00a0 1,455\u00a01,687\u00a04,908\u00a04,017\u00a03,688\u00a02,575\u00a018,329\u00a0 14.5%\nNaciones\u00a0unidas\u00a0 735\u00a0 884\u00a01,297\u00a0 985\u00a01,103\u00a0404\u00a0 5,406\u00a0 4.3%\nFondo\u00a0mundial\u00a0 5,714\u00a06,050\u00a04,580\u00a015,584 16,018 7,279\u00a055,224\u00a0 43.6%\nOtros\u00a0 6,438\u00a09,407\u00a011,509\u00a09,325\u00a08,734\u00a02,217\u00a047,629\u00a0 37.6%\nTotal\u00a0 14,341\u00a018,028 22,294\u00a029,910 29,543 12,474 126,589\u00a0 100.0%\n\u00a0\nCon\u00a0la\u00a0implementaci\u00f3n \u00a0de\u00a0los\u00a0Programas \u00a0del\u00a0Fondo\u00a0Mundial\u00a0de\u00a0lucha\u00a0contra\u00a0el\u00a0SIDA,\u00a0Tuberculosis \u00a0y\u00a0malaria\u00a0\na\u00a0partir\u00a0de\u00a0noviembre \u00a0del\u00a02003,\u00a0\u00a0se\u00a0movilizaron \u00a0mayores\u00a0recursos\u00a0para\u00a0impulsar\u00a0la\u00a0respuesta \u00a0nacional\u00a0al\u00a0VIH\u00a0\nen\u00a0el\u00a0pa\u00eds,\u00a0en\u00a0especial\u00a0para\u00a0la\u00a0incorporaci\u00f3n \u00a0del\u00a0tratamiento \u00a0antirretroviral \u00a0como\u00a0una\u00a0intervenci\u00f3n \u00a0de\u00a0salud\u00a0\np\u00fablica\u00a0y\u00a0para\u00a0escalar\u00a0estrategias \u00a0preventivas \u00a0con\u00a0diferentes \u00a0grupos\u00a0poblacionales: \u00a0\u00a0\n\u00a0\n\uf02d En\u00a0el\u00a02003\u00a0fue\u00a0aceptado \u00a0el\u00a0Proyecto\u00a0Fortalecimiento \u00a0de\u00a0la\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0del\u00a0SIDA\u00a0y\u00a0la\u00a0\nTuberculosis \u00a0en\u00a0el\u00a0Per\u00fa\u00a0(II\u00a0Ronda),\u00a0con\u00a0un\u00a0presupuesto \u00a0de\u00a0US$\u00a023,6\u00a0millones\u00a0para\u00a0VIH/SIDA\u00a0el\u00a0que\u00a0\nculmin\u00f3\u00a0en\u00a0el\u00a02008.\u00a0\u00a0\u00a0\n\uf02d En\u00a0el\u00a02005\u00a0se\u00a0aprob\u00f3\u00a0el\u00a0Proyecto\u00a0\u201cCerrando \u00a0brechas:\u00a0Para\u00a0alcanzar\u00a0los\u00a0Objetivos \u00a0del\u00a0Milenio\u00a0en\u00a0TB\u00a0y\u00a0\nVIH/SIDA. \u00a0Propuesta \u00a0con\u00a0participaci\u00f3n \u00a0Multisectorial \u00a0en\u00a0el\u00a0marco\u00a0de\u00a0la\u00a0descentralizaci\u00f3n\u201d \u00a0(V\u00a0Ronda)\u00a0con\u00a0\nun\u00a0presupuesto \u00a0de\u00a0US$\u00a012,9\u00a0millones\u00a0para\u00a05\u00a0a\u00f1os,\u00a0actualmente \u00a0en\u00a0el\u00a0\u00faltimo\u00a0a\u00f1o\u00a0de\u00a0ejecuci\u00f3n. \u00a0\n\uf02d En\u00a0el\u00a02006\u00a0fue\u00a0aprobado \u00a0el\u00a0proyecto\u00a0\u201cPlanes\u00a0multisectoriales \u00a0integrando \u00a0recursos\u00a0para\u00a0la\u00a0lucha\u00a0contra\u00a0el\u00a0\nVIH/SIDA\u00a0en\u00a0el\u00a0Per\u00fa\u201d\u00a0(VI\u00a0Ronda)\u00a0con\u00a0un\u00a0presupuesto \u00a0de\u00a0US$\u00a040,8\u00a0millones\u00a0para\u00a05\u00a0a\u00f1os,\u00a0actualmente \u00a0en\u00a0\nla\u00a0Fase\u00a02\u00a0de\u00a0ejecuci\u00f3n. \u00a0\n\u00a0\nLa\u00a0\u00a0Cooperaci\u00f3n \u00a0Internacional \u00a0\u00a0bilateral\u00a0(14.5%),\u00a0las\u00a0diferentes \u00a0organizaciones \u00a0de\u00a0\u00a0las\u00a0Naciones\u00a0Unidas\u00a0(4.3%)\u00a0\nel\u00a0FMSTM\u00a0\u00a0cuyo\u00a0financiamiento \u00a0representa \u00a0el\u00a043.6%.\u00a0son\u00a0las\u00a0principales \u00a0fuentes,\u00a0destacando \u00a0entre\u00a0ellas\u00a0la\u00a0\ngran\u00a0importancia \u00a0del\u00a0FM.\u00a0\u00a0Las\u00a0otras\u00a0fuentes\u00a0que\u00a0representaban \u00a0son\u00a0\u00a0las\u00a0entidades \u00a0que\u00a0financiaban \u00a0los\u00a0\nensayos\u00a0cl\u00ednicos\u00a0y\u00a0ONG\u00a0europeas \u00a0y\u00a0americanas. \u00a0\u00a0En\u00a0el\u00a0caso\u00a0del\u00a0financiamiento \u00a0de\u00a0los\u00a0ensayos\u00a0cl\u00ednicos\u00a0cuyo\u00a0\nregistro\u00a0\u00a0de\u00a0acuerdo\u00a0a\u00a0la\u00a0normatividad \u00a0peruana\u00a0es\u00a0responsabilidad \u00a0del\u00a0Instituto\u00a0Nacional\u00a0de\u00a0Salud,\u00a0no\u00a0fue\u00a0\nposible\u00a0obtener\u00a0la\u00a0informaci\u00f3n \u00a0de\u00a0la\u00a0citada\u00a0fuente,\u00a0habiendo \u00a0utilizado\u00a0la\u00a0informaci\u00f3n \u00a0proporcionada \u00a0por\u00a0las\u00a0\npropias\u00a0entidades \u00a0y\u00a0aquellas\u00a0registradas \u00a0en\u00a0APCI.\u00a0\u00a0Por\u00a0lo\u00a0cual\u00a0sobre\u00a0todo\u00a0para\u00a0el\u00a0a\u00f1o\u00a02010,\u00a0podr\u00eda\u00a0existir\u00a0un\u00a0\nsub\u2010registro\u00a0de\u00a0informaci\u00f3n. \u00a0\n\u00a0\nOtros\u00a0donantes \u00a0que\u00a0han\u00a0tenido\u00a0presencia \u00a0en\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os\u00a0son\u00a0las\u00a0agencias\u00a0de\u00a0cooperaci\u00f3n \u00a0multilaterales \u00a0\n(Naciones \u00a0Unidas)\u00a0y\u00a0otras\u00a0bilaterales, \u00a0como\u00a0USAID,\u00a0la\u00a0cooperaci\u00f3n \u00a0italiana\u00a0y\u00a0la\u00a0cooperaci\u00f3n \u00a0belga,\u00a0\u00a0as\u00ed\u00a0como\u00a0\notras\u00a0instituciones \u00a0externas\u00a0que\u00a0financian\u00a0los\u00a0ensayos\u00a0cl\u00ednicos.\u00a0\n\u00a0\nLa\u00a0Cooperaci\u00f3n \u00a0Internacional \u00a0es\u00a0una\u00a0\u00a0fuente\u00a0de\u00a0financiamiento \u00a0importante \u00a0en\u00a0VIH\u00a0en\u00a0el\u00a0pa\u00eds,\u00a0pero\u00a0ya\u00a0no\u00a0\ntiene\u00a0el\u00a0peso\u00a0que\u00a0ten\u00eda\u00a0en\u00a0el\u00a0periodo\u00a0anterior\u00a0que\u00a0era\u00a0\u00a0aproximadamente \u00a0el\u00a051.1%\u00a0del\u00a0gasto\u00a0en\u00a0Sida\u00a0en\u00a0el\u00a0\npa\u00eds\u00a0durante\u00a02005\u00a0al\u00a02007\u00a0\u00a0(46.6%\u00a0para\u00a0los\u00a0a\u00f1os\u00a02008\u00a0al\u00a02010).\u00a0\u00a0Cabe\u00a0precisar\u00a0que\u00a0en\u00a0el\u00a0estudio\u00a0de\u00a0Cuentas\u00a0\nNacionales \u00a0en\u00a0VIH/Sida\u00a0realizado\u00a0en\u00a0el\u00a0Per\u00fa\u00a0para\u00a0los\u00a0a\u00f1os\u00a01999\u00a0y\u00a02000,\u00a0la\u00a0cooperaci\u00f3n \u00a0externa\u00a0era\u00a0\u00a0s\u00f3lo\u00a0el\u00a0\n1%\u00a0en\u00a0el\u00a0a\u00f1o\u00a01999\u00a0y\u00a02%\u00a0en\u00a0el\u00a0a\u00f1o\u00a02000,\u00a0lo\u00a0cual\u00a0indica\u00a0que\u00a0existe\u00a0todav\u00eda\u00a0\u00a0movilizaci\u00f3n \u00a0de\u00a0recursos\u00a0\nprovenientes \u00a0de\u00a0cooperantes \u00a0externos\u00a0y\u00a0que\u00a0en\u00a0el\u00a0futuro\u00a0mucho\u00a0de\u00a0estos\u00a0gastos\u00a0deber\u00eda\u00a0ser\u00a0asumido\u00a0por\u00a0el\u00a0\nEstado,\u00a0al\u00a0culminar\u00a0los\u00a0proyectos \u00a0financiados \u00a0por\u00a0el\u00a0FMSTM.\u00a0\n\u00a0 36 Durante\u00a0el\u00a0periodo\u00a0comprendido \u00a0entre\u00a0los\u00a0a\u00f1os\u00a02008\u00a0al\u00a02010\u00a0ha\u00a0existido\u00a0un\u00a0descenso \u00a0del\u00a0monto\u00a0de\u00a0la\u00a0\ncooperaci\u00f3n \u00a0internacional \u00a0\n\u00a0\nGasto\u00a0del\u00a0sector\u00a0externo\u00a0por\u00a0categor\u00eda \u00a0de\u00a0gasto\u00a0\u00a0(miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2005\u00a02006\u00a02007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 3,016\u00a03,102\u00a05,540\u00a011,038 12,800\u00a06,714\u00a042,210\u00a0\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 3,760\u00a04,992\u00a02,827\u00a03,105\u00a0769\u00a0 123\u00a015,576\u00a0\nIncentivos \u00a0de\u00a0retenci\u00f3n \u00a0 213\u00a0 24\u00a0 1\u00a0 191\u00a0 52\u00a0 17\u00a0 498\u00a0\nGesti\u00f3n\u00a0de\u00a0programa \u00a0 1,617\u00a01,742\u00a01,174\u00a02,894\u00a04,020\u00a02,647\u00a014,095\u00a0\nHu\u00e9rfanos \u00a0 \u00a0 59\u00a0 171\u00a0 16\u00a0 8\u00a0 9\u00a0 263\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0 303\u00a0 598\u00a01,475\u00a01,498\u00a01,278\u00a0549\u00a0 5,702\u00a0\nDesarrollo \u00a0comunitario \u00a0y\u00a0ambiente \u00a0mejorado 682\u00a01,535\u00a01,810\u00a01,852\u00a02,053\u00a01,170\u00a09,102\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0sida\u00a0 4,749\u00a05,975\u00a09,295\u00a09,315\u00a08,564\u00a01,245\u00a039,143\u00a0\nTotal\u00a0 14,341 18,028 22,294 29,910 29,543\u00a012,474\u00a0126,589\n\u00a0\n\u00a0\n\u00a0\nF.2.3\u00a0\u00a0 Sector\u00a0Privado \u00a0\n\u00a0\nGasto\u00a0Privado\u00a0\u00a0en\u00a0VIH\u00a0\u00a0(miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2005\u00a0 2006\u00a0 2007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a0 %\u00a0\nEmpresas \u00a0 263\u00a0 422\u00a0 623\u00a0 585\u00a0 582\u00a0 649\u00a03,124\u00a08.1%\u00a0\nConsumidores \u00a0 4,037\u00a0 4,007\u00a0 5,209\u00a07,292\u00a07,231\u00a07,863\u00a035,638 91.9%\u00a0\n\u00a0 4,300\u00a0 4,428\u00a0 5,832\u00a07,876\u00a07,813\u00a08,512\u00a038,762 100.0%\u00a0\n\u00a0\nSe\u00a0ha\u00a0identificado \u00a0como\u00a0fuente\u00a0de\u00a0financiamiento \u00a0en\u00a0el\u00a0sector\u00a0privado\u00a0\u00a0en\u00a0periodo\u00a0del\u00a02008\u00a0al\u00a02010:\u00a0\n\uf02d Gasto\u00a0de\u00a0empresas, \u00a0que\u00a0representan \u00a0el\u00a0\u00a08.1%\u00a0\u00a0del\u00a0sector\u00a0privado\u00a0\n\uf02d Gasto\u00a0de\u00a0hogares\u00a0o\u00a0gasto\u00a0de\u00a0bolsillo\u00a0que\u00a0representan \u00a0el\u00a091.9%\u00a0del\u00a0sector\u00a0privado\u00a0\n\u00a0\nLo\u00a0correspondiente \u00a0a\u00a0empresas \u00a0b\u00e1sicamente \u00a0corresponde \u00a0a\u00a0la\u00a0provisi\u00f3n \u00a0de\u00a0condones \u00a0realizado\u00a0por\u00a0\nel\u00a0sector\u00a0privado\u00a0mediante \u00a0el\u00a0mercadeo \u00a0social\u00a0del\u00a0cond\u00f3n.\u00a0\n\u00a0\nImportaci\u00f3n \u00a0de\u00a0condones \u00a0(en\u00a0millones)\u00a0\n\u00a0 2005\u00a02006\u00a02007\u00a02008\u00a02009\u00a020102005\u20102007\n(1)\u00a02008\u20102010\u00a0\n(2)\u00a0Incremento \u00a0\n(2\u00a0/\u00a01)\u00a0\u00a0\nCondones \u00a0 33,3\u00a0 35,7\u00a052,7\u00a049,5\u00a049,3\u00a052,9\u00a0 121,7\u00a0 151,6\u00a0 24.6%\u00a0\nFuente :\u00a0Memoria\u00a0anual\u00a0APROPO\u00a0 37 \u00a0\n\u00a0\nF.2.4\u00a0\u00a0 Gasto\u00a0de\u00a0bolsillo\u00a0\n\u00a0\nEl\u00a0gasto\u00a0de\u00a0bolsillo\u00a0por\u00a0poblaci\u00f3n \u00a0beneficiaria \u00a0\u00a0y\u00a0por\u00a0proveedor \u00a0se\u00a0presenta\u00a0en\u00a0los\u00a0siguientes \u00a0cuadros:\u00a0\n\u00a0\nGasto\u00a0de\u00a0bolsillo\u00a0en\u00a0VIH\u00a0\u00a0por\u00a0poblaci\u00f3n \u00a0beneficiaria \u00a0\u00a0(miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2005\u00a02006 2007 2008 2009\u00a02010\u00a0Total\u00a0\nPersonas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\u00a0 1,659\u00a01,807 2,093 2,791 2,804 3,087\u00a014,241\u00a0\nPoblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 318\u00a0361\u00a0425\u00a0467\u00a0573\u00a0701\u00a02,845\u00a0\nPoblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas 194\u00a0218\u00a0290\u00a0304\u00a0295\u00a0314\u00a01,614\u00a0\nPoblaci\u00f3n \u00a0general\u00a0 1,865\u00a01,621 2,402 3,730 3,559 3,761\u00a016,938\u00a0\nTotal\u00a0 4,037\u00a04,007 5,209 7,292 7,231 7,863\u00a035,638\u00a0\n\u00a0\nGasto\u00a0de\u00a0bolsillo\u00a0en\u00a0VIH\u00a0\u00a0por\u00a0proveedor \u00a0\u00a0(miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2005\u00a02006 2007 2008 2009 2010\u00a0Total\u00a0\nProveedores \u00a0p\u00fablicos\u00a0 1,096\u00a01,330 1,654 2,360 2,500 2,862\u00a011,802\u00a0\nLaboratorios \u00a0p\u00fablicos\u00a0 805\u00a0876\u00a01,009 1,058 1,028 1,096\u00a05,872\u00a0\nProveedores \u00a0privados\u00a0 2,135\u00a01,801 2,546 3,874 3,703 3,905\u00a017,964\u00a0\nTotal\u00a0 4,037\u00a04,007 5,209 7,292 7,231 7,863\u00a035,638\u00a0\n\u00a0\nPara\u00a0la\u00a0estimaci\u00f3n \u00a0de\u00a0los\u00a0gastos\u00a0de\u00a0bolsillo\u00a0se\u00a0realiz\u00f3\u00a0una\u00a0encuesta\u00a0en\u00a0CERITS\u00a0y\u00a0UAMPS\u00a0Y\u00a0Hospitales \u00a0TARGA\u00a0y\u00a0\u00a0\nrevisi\u00f3n\u00a0de\u00a0historias\u00a0cl\u00ednicas.\u00a0\u00a0Parte\u00a0de\u00a0los\u00a0resultados \u00a0se\u00a0presentan \u00a0en\u00a0esta\u00a0secci\u00f3n\u00a0y\u00a0otra\u00a0parte\u00a0en\u00a0la\u00a0secci\u00f3n\u00a0\nde\u00a0Gasto\u00a0por\u00a0poblaci\u00f3n \u00a0beneficiaria. \u00a0\u00a0Cabe\u00a0precisar\u00a0que\u00a0entre\u00a0las\u00a0personas\u00a0que\u00a0buscan\u00a0atenci\u00f3n\u00a0ante\u00a0un\u00a0\nproblema \u00a0de\u00a0salud\u00a0de\u00a0acuerdo\u00a0a\u00a0la\u00a0ENAHO\u00a02010,\u00a0el\u00a034%\u00a0\u00a0busca\u00a0a\u00a0los\u00a0establecimientos \u00a0de\u00a0salud\u00a0p\u00fablica,\u00a0el\u00a0\n34%\u00a0acude\u00a0a\u00a0las\u00a0farmacias, \u00a0el\u00a013%\u00a0a\u00a0ESSALUD, \u00a016%\u00a0a\u00a0consultorios \u00a0privados\u00a0y\u00a04%\u00a0a\u00a0otros\u00a0(FFAA,\u00a0FFPP,\u00a0\ncuranderos \u00a0y\u00a0varios\u00a0de\u00a0los\u00a0mencionados). \u00a0\n\u00a0\nGasto\u00a0en\u00a0bolsillo\u00a0en\u00a0Prevenci\u00f3n \u00a0\nSe\u00a0\u00a0revisaron \u00a0las\u00a0historias\u00a0cl\u00ednicas\u00a0de\u00a0los\u00a0usuarios\u00a0de\u00a0los\u00a0CERITS\u00a0y\u00a0UAMPS\u00a0de\u00a0las\u00a0ciudades\u00a0visitadas\u00a0y\u00a0\u00a0se\u00a0\nrealiz\u00f3\u00a0una\u00a0encuesta\u00a0a\u00a077\u00a0usuarios\u00a0de\u00a0CERITS\u00a0y\u00a0UAMP,\u00a0con\u00a0el\u00a0objetivo\u00a0de\u00a0identificar \u00a0los\u00a0conceptos \u00a0por\u00a0los\u00a0\ncuales\u00a0realizan\u00a0gastos\u00a0de\u00a0bolsillos.\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\nN\u00famero\u00a0de\u00a0historias\u00a0cl\u00ednicas\u00a0revisadas \u00a0\u00a0en\u00a0CERITS\u00a0y\u00a0UAMP\u2010\u00a0Datos\u00a0de\u00a0la\u00a0muestra\u00a0\nSexo/\u00a0A\u00f1o\u00a0del\u00a0caso\u00a0 2003\u00a02004\u00a02005\u00a02006 2007 2008 2009 2010\u00a0Total\u00a0\nHombres\u00a0 4\u00a0 17\u00a0 19\u00a0 31\u00a0 27\u00a0 50\u00a0 53\u00a0 25\u00a0226\u00a0\nMujeres\u00a0 3\u00a0 15\u00a0 12\u00a0 22\u00a0 31\u00a0 68\u00a0 55\u00a0 32\u00a0238\u00a0\nTotal\u00a0 7\u00a0 32\u00a0 31\u00a0 53\u00a0 58\u00a0118\u00a0108\u00a057\u00a0464\u00a0\nFuente:\u00a09\u00a0CERITS\u00a0Bart\u00f3n,\u00a0Patruco,\u00a0Jos\u00e9\u00a0Olaya,\u00a0San\u00a0Juan,\u00a0Carri\u00f3n,\u00a0Pucallpa,\u00a0Ica,\u00a0Ica\u2010\u00a0Parcona,\u00a0Chimbote \u00a0\n\u00a0\nN\u00famero\u00a0de\u00a0personas\u00a0encuestadas \u00a0en\u00a0CERITS\u00a0y\u00a0UAMP\u00a0por\u00a0edad\u00a0\nSexo\u00a0Menos\u00a0de\u00a0\n20\u00a0a\u00f1os\u00a0De\u00a020\u00a0a\u00a030\u00a0\na\u00f1os\u00a0De\u00a030\u00a0a\u00a040\u00a0\na\u00f1os\u00a0De\u00a040\u00a0a\u00a0\n50\u00a0a\u00f1os\u00a0De\u00a050\u00a0a\u00a060\u00a0\na\u00f1os\u00a0M\u00e1s\u00a0de\u00a060\u00a0\na\u00f1os\u00a0Total\u00a0\nHombre\u00a0\u00a0 20\u00a0 16\u00a0 2\u00a0 1\u00a0\u00a0 39\u00a0\nMujer\u00a0 2\u00a0 19\u00a0 11\u00a0 4\u00a0 1\u00a0 1\u00a0 38\u00a0\nTotal\u00a0 2\u00a0 39\u00a0 27\u00a0 6\u00a0 2\u00a0 1\u00a0 77\u00a0\nFuente:\u00a0IMPACTA, \u00a0CERITS\u00a0Bart\u00f3n,\u00a0CERITS\u00a0Patruco\u00a0\u00a0\n\u00a0\nLos\u00a0principales \u00a0resultados \u00a0de\u00a0la\u00a0encuesta\u00a0y\u00a0revisi\u00f3n\u00a0de\u00a0historias\u00a0cl\u00ednicas\u00a0en\u00a0CERITS\u00a0son\u00a0los\u00a0siguientes \u00a0 38 \uf02d Antes\u00a0de\u00a0acudir\u00a0al\u00a0CERITS\u00a0/UAMP\u00a0\u00a0el\u00a053.2%\u00a0se\u00a0atend\u00eda\u00a0en\u00a0puestos\u00a0de\u00a0salud,\u00a0el\u00a07.8%\u00a0en\u00a0ESSALUD, \u00a07.8%\u00a0en\u00a0\nhospitales \u00a0MINSA,\u00a06.5%\u00a0en\u00a0cl\u00ednicas\u00a0privada\u00a0y\u00a023.4%\u00a0no\u00a0se\u00a0atend\u00eda\u00a0en\u00a0ning\u00fan\u00a0lugar.\u00a0\n\uf02d El\u00a011.7%\u00a0se\u00a0realiz\u00f3\u00a0por\u00a0primera\u00a0vez\u00a0la\u00a0prueba\u00a0de\u00a0VIH\u00a0en\u00a0el\u00a0CERITS\u00a0(gratuita). \u00a0\n\uf02d Los\u00a0procedimientos \u00a0que\u00a0m\u00e1s\u00a0se\u00a0realizaron \u00a0en\u00a0el\u00a0CERITS\u00a0/UAMP\u00a0\u00a0fueron\u00a0evaluaci\u00f3n \u00a0cl\u00ednica\u00a0(27%),\u00a0prueba\u00a0\nde\u00a0VIH\u00a0(25%),\u00a0RPR\u00a0(24%),\u00a0secreci\u00f3n \u00a0(17%),\u00a0consejer\u00eda \u00a0(13%)\u00a0y\u00a0an\u00e1lisis\u00a0de\u00a0orina\u00a0(5%).\u00a0\n\uf02d Entre\u00a0el\u00a060\u00a0al\u00a076%\u00a0\u00a0refiri\u00f3\u00a0gasto\u00a0\u00a0en\u00a0consulta,\u00a0historia\u00a0cl\u00ednica\u00a0o\u00a0tarjeta.\u00a0\u00a0A\u00a0veces\u00a0el\u00a0monto\u00a0s\u00f3lo\u00a0representa \u00a0\nun\u00a0nuevo\u00a0sol.\u00a0El\u00a099%\u00a0gasto\u00a0en\u00a0guantes\u00a0y\u00a0el\u00a049%\u00a0en\u00a0agujas.\u00a0\n\uf02d El\u00a017%\u00a0de\u00a0los\u00a0hombres\u00a0y\u00a0el\u00a028%\u00a0de\u00a0las\u00a0mujeres\u00a0acude\u00a0a\u00a0otro\u00a0establecimiento. \u00a0\n\uf02d Aparte\u00a0de\u00a0las\u00a0atenciones \u00a0que\u00a0reciben\u00a0en\u00a0el\u00a0CERITS/UAMP, \u00a0\u00a0otro\u00a0tipo\u00a0de\u00a0gasto\u00a0que\u00a0realizan\u00a0para\u00a0cuidarse\u00a0\nde\u00a0las\u00a0infecciones \u00a0de\u00a0transmisi\u00f3n \u00a0sexual\u00a0y\u00a0del\u00a0VIH\u00a0son\u00a0condones, \u00a0gastos\u00a0en\u00a0an\u00e1lisis\u00a0(2%),\u00a0gastos\u00a0en\u00a0\nconsulta\u00a0(5%),\u00a0\u00f3vulos\u00a0(21%),\u00a0lubricantes \u00a0(14%),\u00a0gastos\u00a0en\u00a0planificaci\u00f3n \u00a0familiar\u00a0(2%),\u00a0medicamentos \u00a0\n(16%),\u00a0cremas\u00a0vaginales\u00a0(19%).\u00a0Las\u00a0que\u00a0m\u00e1s\u00a0gastan\u00a0son\u00a0las\u00a0mujeres.\u00a0\n\uf02d S\u00f3lo\u00a0el\u00a03.8%\u00a0recibi\u00f3\u00a0apoyo\u00a0econ\u00f3mico \u00a0para\u00a0sus\u00a0gastos\u00a0en\u00a0el\u00a0establecimiento \u00a0(asistenta \u00a0social).\u00a0\u00a0S\u00f3lo\u00a06.5%\u00a0\nno\u00a0gastaron\u00a0en\u00a0transporte \u00a0para\u00a0acudir\u00a0al\u00a0establecimiento. \u00a0\n\uf02d En\u00a0general\u00a0el\u00a096%\u00a0no\u00a0perciben\u00a0discriminaci\u00f3n \u00a0cuando\u00a0son\u00a0atendidos \u00a0en\u00a0el\u00a0CERITS/UAMP \u00a0\n\uf02d El\u00a097%\u00a0manifest\u00f3 \u00a0utilizar\u00a0condones \u00a0regularmente. \u00a0Los\u00a0hombres\u00a0que\u00a0gastan\u00a0en\u00a0condones \u00a0en\u00a0el\u00a0\nhotel/trabajo \u00a0gastan\u00a0un\u00a0promedio \u00a0de\u00a020\u00a0soles\u00a0mientras\u00a0que\u00a0las\u00a0mujeres\u00a0gastan\u00a0106\u00a0nuevos\u00a0soles.\u00a0\u00a0\nCuando\u00a0se\u00a0les\u00a0pregunto \u00a0donde\u00a0los\u00a0adquieren: \u00a0\n\u00a0\nLugar\u00a0de\u00a0adquisici\u00f3n \u00a0de\u00a0condones \u00a0\n\u00bfD\u00f3nde\u00a0los\u00a0adquiere? \u00a0 Hombre\u00a0Mujer\u00a0 Total\u00a0\nFarmacia\u00a0 74.4%\u00a0 42.1%\u00a0 58.4%\u00a0\nSolo\u00a0en\u00a0CERITS\u00a0 23.1%\u00a0 36.8%\u00a0 29.9%\u00a0\nHotel\u00a0/Trabajo\u00a0 2.6%\u00a0 21.1%\u00a0 11.7%\u00a0\nTotal\u00a0general\u00a0 100.0%\u00a0100.0%\u00a0 100.0%\u00a0\nFuente:\u00a0encuesta\u00a0CERITS\u00a0\n\u00a0\nGasto\u00a0en\u00a0bolsillo\u00a0en\u00a0Tratamiento \u00a0\nSe\u00a0revis\u00f3\u00a0las\u00a0Historias\u00a0cl\u00ednicas\u00a0de\u00a0\u00a0un\u00a0total\u00a0de\u00a0176\u00a0personas, \u00a0de\u00a0las\u00a0cuales\u00a0\u00a036%\u00a0\u00a0fueron\u00a0mujeres\u00a0y\u00a064%\u00a0\u00a0\nhombres. \u00a0\u00a0De\u00a0estos\u00a0\u00faltimos\u00a0Gay\u00a053%,\u00a0bisexual\u00a02%,\u00a0Trans\u00a02%\u00a0y\u00a0heterosexual \u00a042%.\u00a0Asimismo \u00a0se\u00a0encuesto\u00a0un\u00a0\ntotal\u00a0de\u00a077\u00a0PVV\u00a0en\u00a0tratamiento \u00a0del\u00a0Hospital\u00a0Hip\u00f3lito\u00a0Unanue\u00a0y\u00a0de\u00a0la\u00a0Asociaci\u00f3n \u00a0civil\u00a0IMPACTA. \u00a0\n\u00a0\nN\u00famero\u00a0de\u00a0historias\u00a0cl\u00ednicas\u00a0revisadas \u00a0\u00a0PVV\u00a0en\u00a0tratamiento \u2010\u00a0Datos\u00a0de\u00a0la\u00a0muestra\u00a0\nSexo\u00a0 Chiclayo\u00a0Chimbote Huancayo Ica\u00a0 Iquitos\u00a0Pucallpa\u00a0Total\u00a0\nHombre\u00a0 22\u00a0 9\u00a0 27\u00a0 4\u00a0 31\u00a0 30\u00a0 123\u00a0\nMujer\u00a0 14\u00a0 6\u00a0 9\u00a0 6\u00a0 7\u00a0 11\u00a0 53\u00a0\nTotal\u00a0 36\u00a0 15\u00a0 36\u00a0 10\u00a0 38\u00a0 41\u00a0 176\u00a0\nFuente:\u00a0Hospital\u00a0regionales \u00a0que\u00a0brindan\u00a0TARGA,\u00a0no\u00a0se\u00a0realiz\u00f3\u00a0revisi\u00f3n\u00a0de\u00a0Historias\u00a0cl\u00ednicas\u00a0en\u00a0Lima\u00a0\n\u00a0\nPara\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0HC\u00a0se\u00a0tuvo\u00a0en\u00a0cuenta\u00a0el\u00a0N\u00b0\u00a0de\u00a0personas\u00a0que\u00a0reciben\u00a0TARGA\u00a0\u00a0por\u00a0a\u00f1o\u00a0desde\u00a0el\u00a02005\u00a0hasta\u00a0\nel\u00a02010\u00a0obteni\u00e9ndose \u00a0\u00a0el\u00a0tama\u00f1o\u00a0de\u00a0muestra:\u00a0123\u00a0varones\u00a0y\u00a053\u00a0mujeres.\u00a0El\u00a0mayor\u00a0n\u00famero\u00a0de\u00a0encuestados \u00a0\u00a0\nse\u00a0encuentra \u00a0entre\u00a0los\u00a030\u00a0y\u00a045\u00a0a\u00f1os.\u00a0\u00a0\u00a0Cabe\u00a0precisar\u00a0que\u00a0la\u00a0muestra\u00a0refleja\u00a0la\u00a0proporci\u00f3n \u00a0\u00a0entre\u00a0hombres\u00a0y\u00a0\nmujeres\u00a0que\u00a0actualmente \u00a0se\u00a0encuentran \u00a0en\u00a0tratamiento. \u00a0\n\u00a0\nPersonas\u00a0que\u00a0iniciaron\u00a0TARGA\u00a0\nDatos\u00a0de\u00a0la\u00a0poblaci\u00f3n \u00a0 \u00a0\u00a02005\u00a0 2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2010\u00a0 %\u00a0\u00a0Datos\u00a0de\u00a0la\u00a0\nMuestra\u00a0%\u00a0\nInician\u00a0TX\u00a0 2,987\u00a0 4,660\u00a0 8,155\u00a09,842\u00a014,482\u00a016,003\u00a0100%\u00a0 176\u00a0 100%\u00a0\nHombres\u00a0 2,033\u00a0 3,165\u00a0 5,566\u00a06,751\u00a0 9,752\u00a011,042\u00a069%\u00a0\u00a0 123\u00a0 70%\u00a0\nMujeres\u00a0 954\u00a0 1,495\u00a0 2,589\u00a03,091\u00a0 4,730\u00a0 4,961\u00a031%\u00a0\u00a0 53\u00a0 30%\u00a0\nFuente:\u00a0ESN\u00a0PC\u00a0ITS/VIH/SIDA \u00a0 39 \u00a0\n\u00a0\nNi\u00f1os\u00a0que\u00a0iniciaron\u00a0TARGA\u00a0 \u00a0\u00a0\u00a0\u00a0 N\u00famero\u00a0de\u00a0esquemas \u00a0\nRango\u00a0edades\u00a0 N\u00a0\u00b0\u00a0Esquemas \u00a0Ni\u00f1os\u00a0\u00a0 Esquemas \u00a0N\u00a0\u00b0\u00a0Esquemas \u00a0Personas\u00a0\n1\u00a0a\u00a04\u00a0a\u00f1os\u00a0 13\u00a0 183\u00a0\u00a0 NAIVE\u00a0 9\u00a0 13,090\u00a0\n3\u00a0a\u00a010\u00a0a\u00f1os\u00a0 1\u00a0 26\u00a0\u00a0 Especial\u00a0 83\u00a0 1,891\u00a0\n5\u00a0a\u00a010\u00a0a\u00f1os\u00a0 14\u00a0 151\u00a0\u00a0 Rescate\u00a0 10\u00a0 1,022\u00a0\nM\u00e1s\u00a0de\u00a010\u00a0a\u00f1os\u00a0 16\u00a0 179\u00a0\u00a0 Total\u00a0\u00a0 102\u00a0 16,003\u00a0\nTotal\u00a0 44\u00a0 539\u00a0\u00a0 \u00a0 \u00a0 \u00a0\nFuente:\u00a0ESN\u00a0PC\u00a0ITS/VIH/SIDA \u00a0\n\u00a0\nN\u00famero\u00a0de\u00a0PPV\u00a0en\u00a0tratamiento \u00a0encuestado \u00a0seg\u00fan\u00a0antig\u00fcedad \u00a0de\u00a0atenci\u00f3n\u00a0\nCantidad\u00a0de\u00a0a\u00f1os\u00a0de\u00a0atenci\u00f3n\u00a0\nSexo\u00a0Menos\u00a0de\u00a01\u00a0Entre\u00a01\u00a0y\u00a0\n2\u00a0Entre\u00a03\u00a0y\u00a05\u00a0Mas\u00a0de\u00a06\u00a0Total\u00a0\nHombre\u00a0 10\u00a0 3\u00a0 15\u00a0 11\u00a0 39\u00a0\nMujer\u00a0 4\u00a0 17\u00a0 10\u00a0 7\u00a0 38\u00a0\nTotal\u00a0 14\u00a0 20\u00a0 25\u00a0 18\u00a0 77\u00a0\n\u00a0\n\u00a0\nLos\u00a0principales \u00a0resultados \u00a0de\u00a0la\u00a0encuesta\u00a0y\u00a0revisi\u00f3n\u00a0de\u00a0historias\u00a0cl\u00ednicas\u00a0en\u00a0Hospitales \u00a0TARGA\u00a0son\u00a0los\u00a0\nsiguientes: \u00a0\n\uf02d 10%\u00a0de\u00a0los\u00a0hombres\u00a0y\u00a044%\u00a0de\u00a0las\u00a0mujeres\u00a0refirieron \u00a0estar\u00a0en\u00a0el\u00a0Seguro\u00a0integral\u00a0de\u00a0salud.\u00a0\n\uf02d Cuando\u00a0sintieron\u00a0los\u00a0primeros\u00a0s\u00edntomas\u00a0el\u00a060%\u00a0acudi\u00f3\u00a0a\u00a0establecimientos \u00a0p\u00fablicos,\u00a017%\u00a0a\u00a0privados,\u00a03%\u00a0\na\u00a0ESSALUD, \u00a01%\u00a0FFAA/FFPP \u00a0Y\u00a019%\u00a0a\u00a0ning\u00fan\u00a0lugar\u00a0porque\u00a0no\u00a0tuvo\u00a0s\u00edntomas. \u00a0\n\uf02d El\u00a016%\u00a0estuvo\u00a0hospitalizado \u00a0antes\u00a0de\u00a0recibir\u00a0tratamiento \u00a0para\u00a0VIH.\u00a0\u00a0Los\u00a0que\u00a0no\u00a0estuvieron \u00a0hospitalizados \u00a0\nse\u00a0hicieron\u00a0la\u00a0prueba\u00a0de\u00a0VIH,\u00a0por\u00a0diarreas\u00a0baja\u00a0de\u00a0peso\u00a019%,\u00a0por\u00a0pareja\u00a0VIH+\u00a014%,\u00a0entre\u00a0otras\u00a0razones,\u00a0\nel\u00a020%\u00a0de\u00a0las\u00a0mujeres\u00a0por\u00a0control\u00a0prenatal.\u00a0\n\uf02d El\u00a023%\u00a0acude\u00a0una\u00a0vez\u00a0al\u00a0mes,\u00a0el\u00a029%\u00a0acude\u00a0m\u00e1s\u00a0de\u00a0una\u00a0vez\u00a0al\u00a0mes\u00a0y\u00a0el\u00a048%\u00a0restante\u00a0acude\u00a0menos\u00a0de\u00a0\nuna\u00a0vez\u00a0al\u00a0mes.\u00a0\n\uf02d El\u00a057%\u00a0recibi\u00f3\u00a0apoyo\u00a0econ\u00f3mico \u00a0para\u00a0sus\u00a0gastos\u00a0en\u00a0el\u00a0establecimiento. \u00a0El\u00a019%\u00a0acude\u00a0a\u00a0otros\u00a0\nestablecimientos. \u00a0\n\uf02d A\u00a0la\u00a0mayor\u00eda\u00a0se\u00a0les\u00a0realizo\u00a0baciloscop\u00eda \u00a0y\u00a0el\u00a032%\u00a0se\u00a0realizo\u00a0radiograf\u00eda \u00a0de\u00a0t\u00f3rax\u00a0(rayos\u00a0x).\u00a0\n\u00a0\nLos\u00a0resultados \u00a0de\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0las\u00a0historias\u00a0cl\u00ednicas\u00a0de\u00a0los\u00a0hospitales \u00a0que\u00a0brindan\u00a0tratamiento \u00a0indican\u00a0que\u00a0\nen\u00a0el\u00a0primer\u00a0a\u00f1o\u00a0de\u00a0tratamiento \u00a0acuden\u00a0en\u00a0promedio \u00a0los\u00a0hombres\u00a013.5\u00a0veces\u00a0y\u00a0las\u00a0mujeres\u00a014.3\u00a0veces.\u00a0\u00a0\nMientras\u00a0que\u00a0para\u00a0el\u00a0siguiente\u00a0a\u00f1os\u00a0los\u00a0hombres\u00a0van\u00a010.1\u00a0veces,\u00a0las\u00a0mujeres\u00a0van\u00a012\u00a0veces.\u00a0\u00a0Esta\u00a0informaci\u00f3n \u00a0\nsirvi\u00f3\u00a0para\u00a0calcular\u00a0los\u00a0gastos\u00a0de\u00a0bolsillo\u00a0por\u00a0desplazamiento. \u00a0\n\u00a0\nUno\u00a0de\u00a0los\u00a0gastos\u00a0m\u00e1s\u00a0importantes \u00a0son\u00a0los\u00a0realizados \u00a0para\u00a0el\u00a0ingreso\u00a0al\u00a0TARGA,\u00a0por\u00a0la\u00a0necesidad \u00a0de\u00a0realizar\u00a0\nex\u00e1menes \u00a0auxiliares \u00a0y\u00a0consultas \u00a0a\u00a0varios\u00a0servicios.\u00a0\u00a0La\u00a0mayor\u00eda\u00a0de\u00a0las\u00a0personas\u00a0antes\u00a0del\u00a0diagnostico \u00a0no\u00a0se\u00a0\nencuentra \u00a0afiliados\u00a0a\u00a0ning\u00fan\u00a0sistema\u00a0de\u00a0salud,\u00a0por\u00a0lo\u00a0cual\u00a0es\u00a0la\u00a0oportunidad \u00a0para\u00a0afiliarse\u00a0al\u00a0AUS\u00a0si\u00a0se\u00a0cumplo\u00a0\ncon\u00a0los\u00a0criterios\u00a0establecidos \u00a0por\u00a0el\u00a0SIFOH,\u00a0para\u00a0poder\u00a0afiliarse.\u00a0\n\u00a0\nCabe\u00a0precisar\u00a0que\u00a0casi\u00a0la\u00a0totalidad\u00a0de\u00a0establecimientos \u00a0han\u00a0dise\u00f1ado\u00a0un\u00a0paquete\u00a0de\u00a0ex\u00e1menes \u00a0auxiliares \u00a0a\u00a0\nun\u00a0costo\u00a0subsidiado, \u00a0pero\u00a0que\u00a0de\u00a0todas\u00a0maneras\u00a0debe\u00a0ser\u00a0pagado\u00a0por\u00a0los\u00a0usuarios\u00a0y\u00a0tambi\u00e9n\u00a0que\u00a0no\u00a0todos\u00a0\nlos\u00a0servicios\u00a0son\u00a0cubiertos \u00a0por\u00a0el\u00a0SIS\u00a0para\u00a0sus\u00a0afiliados.\u00a0\n\u00a0 40 \u00a0\n\u00a0\n\u00a0\nF.3\u00a0Agentes\u00a0de\u00a0Financiamiento \u00a0\n\u00a0\nGasto\u00a0por\u00a0Agentes\u00a0\u00a0de\u00a0Financiamiento \u00a02005\u20102010\u00a0\u2010\u00a0En\u00a0miles\u00a0US\u00a0$\u00a0\n\u00a0 2005\u00a02006\u00a02007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a0\nSector\u00a0p\u00fablico\u00a0sin\u00a0seguro\u00a0social\u00a05,045\u00a09,058\u00a010,501 14,240 20,055 12,453\u00a071,352\u00a0\nSeguridad \u00a0social\u00a0 5,430\u00a05,434\u00a02,950\u00a04,121\u00a05,452\u00a03,551\u00a026,940\u00a0\nHogares\u00a0 4,300\u00a04,428\u00a05,832\u00a07,876\u00a07,813\u00a08,512\u00a038,762\u00a0\nSector\u00a0privado\u00a0 12,390 15,443 17,774 27,488 26,641 11,130\u00a0110,865\nOrganizaciones \u00a0internacionales \u00a0992\u00a02,114\u00a04,385\u00a01,872\u00a02,281\u00a0781\u00a012,425\u00a0\nTotal\u00a0 28,157 36,477 41,443 55,598 62,242 36,427\u00a0260,345\n\u00a0\nLos\u00a0agentes\u00a0son\u00a0entidades \u00a0que\u00a0concentran \u00a0recursos\u00a0financieros \u00a0\u00a0de\u00a0diferentes \u00a0fuentes\u00a0y\u00a0los\u00a0transfieren \u00a0para\u00a0\npagar\u00a0o\u00a0para\u00a0comprar\u00a0cuidados\u00a0de\u00a0salud\u00a0u\u00a0otros\u00a0bienes\u00a0y\u00a0servicios.\u00a0\u00a0\n\u00a0\nEn\u00a0el\u00a0periodo\u00a02005\u00a0al\u00a02010\u00a0el\u00a0sector\u00a0p\u00fablico,\u00a0incluido\u00a0la\u00a0Seguridad \u00a0Social\u00a0en\u00a0Salud\u00a0\u00a0\u00a0ha\u00a0sido\u00a0responsable \u00a0del\u00a0\n37.7%\u00a0de\u00a0los\u00a0gastos\u00a0(36.2%\u00a0en\u00a0el\u00a02005\u00a0\u20102007\u00a0y\u00a038.8%\u00a0en\u00a0el\u00a02008\u20102010).\u00a0\u00a0\u00a0Sin\u00a0embargo\u00a0\u00a0el\u00a0sector\u00a0privado\u00a0en\u00a0\nlos\u00a0\u00faltimos\u00a0a\u00f1os\u00a0a\u00a0representado \u00a0\u00a0el\u00a0principal\u00a0agente\u00a0o\u00a0comprador \u00a0de\u00a0recursos\u00a0en\u00a0el\u00a0Per\u00fa\u00a0con\u00a0el\u00a042.6%\u00a0\u00a0(43%\u00a0\nen\u00a0el\u00a02005\u00a0\u20102007\u00a0y\u00a042.3%\u00a0en\u00a0el\u00a02008\u20102010).\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\nTambi\u00e9n\u00a0\u00a0es\u00a0importante \u00a0considerar \u00a0que\u00a0los\u00a0Hogares\u00a0como\u00a0agente\u00a0de\u00a0financiamiento \u00a0est\u00e1\u00a0alrededor \u00a0del\u00a0\n13.7%\u00a0del\u00a0gasto\u00a0total\u00a0en\u00a0Sida\u00a0en\u00a0el\u00a0pa\u00eds\u00a0del\u00a02005\u20102007\u00a0y\u00a0en\u00a0este\u00a0\u00faltimo\u00a0periodo\u00a0se\u00a0encuentra \u00a0alrededor \u00a0de\u00a0\n15.7%.\u00a0\n\u00a0\nAgentes\u00a0\u00a0de\u00a0financiamiento \u00a0\u2010\u00a0\u00a0Estructura \u00a0porcentual \u00a0por\u00a0grupos\u00a0de\u00a0a\u00f1os\u00a0\n\u00a0 2005\u20102007\u00a02008\u20102010\u00a0 Total\u00a0\nSector\u00a0p\u00fablico\u00a0 36.2%\u00a0 38.8%\u00a0 37.7%\u00a0\n\u00a0\u00a0Sector\u00a0publico\u00a0 23.2%\u00a0 30.3%\u00a0 27.4%\u00a0\n\u00a0\u00a0Seguridad \u00a0social\u00a0 13.0%\u00a0 8.5%\u00a0 10.3%\u00a0\nHogares\u00a0 13.7%\u00a0 15.7%\u00a0 14.9%\u00a0\nSector\u00a0privado\u00a0 43.0%\u00a0 42.3%\u00a0 42.6%\u00a0\nOrganizaciones \u00a0internacionales \u00a0 7.1%\u00a0 3.2%\u00a0 4.8%\u00a0\nTotal\u00a0 100.0%\u00a0 100.0%\u00a0 100.0%\u00a0\n\u00a0\n\u00a0\nAgentes\u00a0\u00a0de\u00a0financiamiento \u00a0\u2010\u00a0\u00a0Estructura \u00a0porcentual \u00a0por\u00a0a\u00f1os\u00a0\n\u00a0 2005\u00a02006\u00a02007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a0\nSector\u00a0p\u00fablico\u00a0 37.2%\u00a039.7%\u00a032.5%\u00a033%\u00a0 41%\u00a043.9%\u00a037.7%\u00a0\n\u00a0\u00a0Sector\u00a0publico\u00a0 17.9%\u00a024.8%\u00a025.3%\u00a025.6%\u00a032.2%\u00a034.2%\u00a027.4%\u00a0\n\u00a0\u00a0Seguridad \u00a0social\u00a0 19.3%\u00a014.9%\u00a07.1%\u00a07.4%\u00a08.8%\u00a09.7%\u00a010.3%\u00a0\nHogares\u00a0 15.3%\u00a012.1%\u00a014.1%\u00a014.2%\u00a012.6%\u00a023.4%\u00a014.9%\u00a0\nSector\u00a0privado\u00a0 44%\u00a042.3%\u00a042.9%\u00a049.4%\u00a042.8%\u00a030.6%\u00a042.6%\u00a0\nOrganizaciones \u00a0internacionales \u00a0 3.5%\u00a05.8%\u00a010.6%\u00a03.4%\u00a03.7%\u00a02.1%\u00a04.8%\u00a0\nTotal\u00a0 100.0% 100.0% 100.0% 100.0% 100.0%\u00a0100.0%\u00a0100.0%\n\u00a0\n\u00a0 41 Las\u00a0entidades \u00a0del\u00a0Sector\u00a0P\u00fablico,\u00a0que\u00a0se\u00a0han\u00a0identificado \u00a0como\u00a0Agentes\u2010compradores \u00a0realizan\u00a0sus\u00a0\nadquisiciones \u00a0mediante \u00a0los\u00a0procedimientos \u00a0establecidos \u00a0en\u00a0la\u00a0Ley\u00a0de\u00a0contrataciones \u00a0y\u00a0adquisiciones \u00a0del\u00a0\nEstado:\u00a0Ministerio \u00a0de\u00a0Salud,\u00a025Ministerio \u00a0de\u00a0Defensa,\u00a0Ministerio \u00a0del\u00a0Interior,\u00a0otros\u00a0ministerios \u00a0y\u00a0otras\u00a0\nentidades \u00a0centrales, \u00a026\u00a0\u00a0ESSALUD\u00a0y\u00a0los\u00a0Gobiernos \u00a0regionales \u00a0y\u00a0locales.\u00a0\u00a0\u00a0\n\u00a0\nEl\u00a0monto\u00a0correspondiente \u00a0al\u00a0sector\u00a0privado\u00a0corresponde \u00a0a\u00a0las\u00a0compras\u00a0realizadas \u00a0por\u00a0las\u00a0ONG\u00a0con\u00a0recursos\u00a0\nde\u00a0cooperaci\u00f3n \u00a0externa\u00a0y\u00a0las\u00a0adquisiciones \u00a0para\u00a0las\u00a0investigaciones \u00a0cl\u00ednicas\u00a0con\u00a0financiamiento \u00a0externo.\u00a0\n\u00a0\n                                                 \n25 Se\u00a0consideran \u00a0los\u00a0gastos\u00a0realizados \u00a0a\u00a0trav\u00e9s\u00a0de:\u00a0\n\uf02d Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0de\u00a0\u00a0ITS/VIH/SIDA \u00a0quien\u00a0es\u00a0responsables \u00a0de\u00a0la\u00a0asignaci\u00f3n \u00a0de\u00a0\ngastos\u00a0de\u00a0la\u00a0Oficina\u00a0de\u00a0Recursos\u00a0Estrat\u00e9gicos \u2010ORE\u00a0para\u00a0prevenci\u00f3n \u00a0en\u00a0grupos\u00a0m\u00e1s\u00a0\u00a0expuestos. \u00a0\u00a0\n\uf02d Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Salud\u00a0Sexual\u00a0y\u00a0Reproductiva \u00a0\n\uf02d Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0de\u00a0TB\u00a0\n\uf02d Programa \u00a0Nacional\u00a0de\u00a0Hemoterapia \u00a0y\u00a0Banco\u00a0de\u00a0Sangre\u00a0\n\uf02d Hospitales \u00a0que\u00a0proveen\u00a0TARGA\u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0pedi\u00e1trica \u00a0\n\uf02d  \n26 Los\u00a0otros\u00a0Ministerios \u00a0identificados \u00a0como\u00a0agentes\u00a0son\u00a0el\u00a0Ministerio \u00a0de\u00a0Educaci\u00f3n, \u00a0el\u00a0Ministerio \u00a0de\u00a0la\u00a0Mujer\u00a0y\u00a0\nDesarrollo \u00a0Social\u00a0y\u00a0el\u00a0Ministerio \u00a0de\u00a0Comercio \u00a0Exterior\u00a0y\u00a0Turismo.\u00a0\u00a0En\u00a0las\u00a0otras\u00a0entidades \u00a0centrales\u00a0incluidas\u00a0los\u00a0\nOrganismos \u00a0P\u00fablicos\u00a0Descentralizados: \u00a0Instituto\u00a0Nacional\u00a0de\u00a0Salud\u00a0e\u00a0Instituto\u00a0Nacional\u00a0Penitenciario. \u00a0\n  Gasto\u00a0en\u00a0VIH\u00a0por\u00a0Agente\u00a0de\u00a0financiamiento \u00a0(en\u00a0miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2005\u00a0 2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a02010\u00a0Total\u00a02005\u2010\n2007\u00a02008\u2010\n2010\u00a0Total\u00a0\nSECTOR\u00a0PUBLICO\u00a0 5,045\u00a09,058\u00a010,501\u00a014,240\u00a020,055\u00a012,453 71,352\u00a0 23.2%\u00a0 30.3%\u00a027.4%\u00a0\nFA.01.01.01.01 \u00a0Ministerio \u00a0de\u00a0Salud\u00a0(o\u00a0entidad\u00a0equivalente \u00a0del\u00a0sector)\u00a0 3,095\u00a07,207\u00a07,831\u00a012,755\u00a019,181\u00a011,537 61,605\u00a0 17.1%\u00a0 28.2%\u00a023.7%\u00a0\nFA.01.01.01.02 \u00a0Ministerio \u00a0de\u00a0Educaci\u00f3n \u00a0(o\u00a0entidad\u00a0equivalente \u00a0del\u00a0sector)\u00a0 16\u00a0 26\u00a0 10\u00a0 40\u00a0 86\u00a0\u00a0 179\u00a0 0.0%\u00a0 0.1%\u00a0 0.1%\u00a0\nFA.01.01.01.03 \u00a0Ministerio \u00a0de\u00a0Desarrollo \u00a0Social\u00a0(o\u00a0entidad\u00a0equivalente \u00a0del\u00a0sector)\u00a0 2\u00a0\u00a0 12\u00a0 3\u00a0 8\u00a0\u00a0 26\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nFA.01.01.01.04 \u00a0Ministerio \u00a0de\u00a0Defensa\u00a0(o\u00a0entidad\u00a0equivalente \u00a0del\u00a0sector)\u00a0 1,271\u00a0 714\u00a0 1,079\u00a0 401\u00a0 377\u00a0 163\u00a0 4,005\u00a0 2.9%\u00a0 0.6%\u00a0 1.5%\u00a0\nFA.01.01.01.07 \u00a0Ministerio \u00a0de\u00a0Justicia\u00a0(o\u00a0entidad\u00a0equivalente \u00a0del\u00a0sector)\u00a0 1\u00a0 2\u00a0 1\u00a0 8\u00a0 139\u00a0 53\u00a0 205\u00a0 0.0%\u00a0 0.1%\u00a0 0.1%\u00a0\nFA.01.01.01.08 \u00a0Otros\u00a0ministerios \u00a0(o\u00a0entidades \u00a0equivalentes \u00a0del\u00a0sector)\u00a0\u00a0 2\u00a0 57\u00a0\u00a0 \u00a0 6\u00a0 65\u00a0 0.1%\u00a0 0.0%\u00a0 0.0%\u00a0\nFA.01.01.01.10 \u00a0Autoridad \u00a0Nacional\u00a0Coordinadora \u00a0del\u00a0Sida\u00a0 83\u00a0 170\u00a0 10\u00a0 35\u00a0 32\u00a0 33\u00a0 364\u00a0 0.2%\u00a0 0.1%\u00a0 0.1%\u00a0\nFA.01.01.01.99 \u00a0Entidades \u00a0de\u00a0autoridades \u00a0centrales\u00a0o\u00a0federales \u00a0s.c.o.\u00a0 77\u00a0 50\u00a0 55\u00a0 22\u00a0\u00a0 5\u00a0 209\u00a0 0.2%\u00a0 0.0%\u00a0 0.1%\u00a0\nFA.01.01.02.01 \u00a0Ministerio \u00a0de\u00a0Salud\u00a0(o\u00a0entidad\u00a0equivalente \u00a0del\u00a0sector)\u00a0 428\u00a0 846\u00a0 1,394\u00a0 956\u00a0 229\u00a0 656\u00a0 4,508\u00a0 2.5%\u00a0 1.2%\u00a0 1.7%\u00a0\nFA.01.01.03.01 \u00a0Departamento \u00a0de\u00a0Salud\u00a0(o\u00a0entidad\u00a0local\u00a0equivalente \u00a0del\u00a0sector)\u00a0 66\u00a0 36\u00a0 39\u00a0 21\u00a0 2\u00a0\u00a0 164\u00a0 0.1%\u00a0 0.0%\u00a0 0.1%\u00a0\nFA.01.01.03.03 \u00a0Departamento \u00a0de\u00a0Desarrollo \u00a0Social\u00a0(o\u00a0entidad\u00a0local\u00a0equivalente \u00a0del\u00a0sector)\u00a0 6\u00a0 6\u00a0 12\u00a0\u00a0 \u00a0 \u00a0 24\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nSEGURIDAD \u00a0SOCIAL\u00a0 5,430\u00a05,434\u00a02,950\u00a04,121\u00a05,452\u00a03,551\u00a026,940\u00a0 13.0%\u00a0 8.5%\u00a010.3%\u00a0\nFA.01.02\u00a0Seguridad \u00a0social\u00a0p\u00fablica\u00a0 5,430\u00a05,434\u00a02,950\u00a04,121\u00a05,452\u00a03,551\u00a026,940\u00a0 13.0%\u00a0 8.5%\u00a010.3%\u00a0\nSECTOR\u00a0PRIVADO\u00a0 12,390\u00a015,443\u00a017,774\u00a027,488\u00a026,641\u00a011,130 110,865 43.0%\u00a0 42.3%\u00a042.6%\u00a0\nFA.02.05\u00a0Instituciones \u00a0sin\u00a0fines\u00a0de\u00a0lucro\u00a0(distintas\u00a0del\u00a0seguro\u00a0social)\u00a0 11,790\u00a014,143\u00a016,974\u00a027,488\u00a026,641\u00a011,130 108,165 40.4%\u00a0 42.3%\u00a041.5%\u00a0\nFA.02.99\u00a0Otros\u00a0agentes\u00a0privados\u00a0de\u00a0financiaci\u00f3n \u00a0s.c.o.\u00a0 600\u00a0 1,300\u00a0 800\u00a0\u00a0 \u00a0 \u00a0 2,700\u00a0 2.5%\u00a0 0.0%\u00a0 1.0%\u00a0\nHOGARES \u00a0 4,300\u00a04,428\u00a05,832\u00a07,876\u00a07,813\u00a08,512\u00a038,762\u00a0 13.7%\u00a0 15.7%\u00a014.9%\u00a0\nFA.02.04\u00a0Hogares\u00a0privados\u00a0(pagos\u00a0personales) \u00a0 4,300\u00a04,428\u00a05,832\u00a07,876\u00a07,813\u00a08,512\u00a038,762\u00a0 13.7%\u00a0 15.7%\u00a014.9%\u00a0\nORGANIZACIONES \u00a0INTERNACIONALES \u00a0 992\u00a0 2,114\u00a04,385\u00a01,872\u00a02,281\u00a0 781\u00a012,425\u00a0 7.1%\u00a0 3.2%\u00a0 4.8%\u00a0\nFA.03.01.11 \u00a0Gobierno \u00a0de\u00a0Italia\u00a0 84\u00a0 361\u00a0 1,052\u00a0 378\u00a0 368\u00a0 390\u00a0 2,633\u00a0 1.4%\u00a0 0.7%\u00a0 1.0%\u00a0\nFA.03.01.14 \u00a0Gobierno \u00a0de\u00a0Pa\u00edses\u00a0Bajos\u00a0 1\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 1\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nFA.03.02.04 \u00a0Organizaci\u00f3n \u00a0Internacional \u00a0del\u00a0Trabajo\u00a0(OIT)\u00a0\u00a0 \u00a0 66\u00a0 55\u00a0 112\u00a0 10\u00a0 243\u00a0 0.1%\u00a0 0.1%\u00a0 0.1%\u00a0\nFA.03.02.07 \u00a0Secretar\u00eda \u00a0del\u00a0ONUSIDA \u00a0 23\u00a0 126\u00a0 364\u00a0 205\u00a0 353\u00a0 90\u00a0 1,160\u00a0 0.5%\u00a0 0.4%\u00a0 0.4%\u00a0\nFA.03.02.08 \u00a0Fondo\u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0para\u00a0la\u00a0Infancia\u00a0(UNICEF)\u00a0\u00a0 122\u00a0 249\u00a0 134\u00a0 126\u00a0 51\u00a0 682\u00a0 0.3%\u00a0 0.2%\u00a0 0.3%\u00a0\nFA.03.02.10 \u00a0Programa \u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0para\u00a0el\u00a0Desarrollo \u00a0(PNUD)\u00a0\u00a0 \u00a0 20\u00a0\u00a0 \u00a0 \u00a0 20\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nFA.03.02.16 \u00a0Fondo\u00a0de\u00a0Poblaci\u00f3n \u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0(UNFPA)\u00a0\u00a0 \u00a0 22\u00a0 70\u00a0 93\u00a0\u00a0 185\u00a0 0.0%\u00a0 0.1%\u00a0 0.1%\u00a0\nFA.03.02.18 \u00a0Programa \u00a0Mundial\u00a0de\u00a0Alimentos \u00a0(PMA)\u00a0 221\u00a0 227\u00a0 295\u00a0 320\u00a0 300\u00a0 20\u00a0 1,382\u00a0 0.7%\u00a0 0.4%\u00a0 0.5%\u00a0\nFA.03.02.19 \u00a0Organizaci\u00f3n \u00a0Mundial\u00a0de\u00a0la\u00a0Salud\u00a0(OMS)\u00a0 5\u00a0 22\u00a0 17\u00a0\u00a0 \u00a0 \u00a0 44\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nFA.03.03.20 \u00a0M\u00e9dicos\u00a0sin\u00a0Fronteras \u00a0 488\u00a0 1,119\u00a0 737\u00a0\u00a0 \u00a0 \u00a0 2,344\u00a0 2.2%\u00a0 0.0%\u00a0 0.9%\u00a0\nFA.03.04\u00a0Organizaciones \u00a0internacionales \u00a0con\u00a0fines\u00a0de\u00a0lucro\u00a0 169\u00a0 138\u00a0 1,564\u00a0 709\u00a0 929\u00a0 220\u00a0 3,730\u00a0 1.8%\u00a0 1.2%\u00a0 1.4%\u00a0\nTotal\u00a0 28,157\u00a036,477\u00a041,443\u00a055,598\u00a062,242\u00a036,427 260,345 100.0%\u00a0100.0%\u00a0100.0%\u00a0 43 F.4\u00a0Provisi\u00f3n \u00a0de\u00a0servicios\u00a0para\u00a0el\u00a0VIH\u00a0en\u00a0el\u00a0Per\u00fa\u00a0\u00a0\n\u00a0\nGasto\u00a0por\u00a0Proveedor \u00a0\u00a02005\u20102010\u00a0\u2010\u00a0En\u00a0miles\u00a0US\u00a0$\u00a0\n\u00a0 2,005\u00a02,006\u00a02,007\u00a02,008\u00a02,009\u00a02,010\u00a0Total\u00a0\nProveedores \u00a0p\u00fablicos\u00a0 16,649\u00a021,424 17,470 34,097 38,023 24,546\u00a0152,208\u00a0\nLaboratorios \u00a0p\u00fablicos\u00a0 2,041\u00a02,353\u00a03,970\u00a02,041\u00a05,979\u00a03,225\u00a019,609\u00a0\nBanco\u00a0p\u00fablico\u00a0de\u00a0sangre\u00a0191\u00a0 377\u00a0 709\u00a0 32\u00a0 29\u00a0 148\u00a0 1,485\u00a0\nProveedores \u00a0privados\u00a0 9,277\u00a012,323 19,293 19,428 18,212 8,508\u00a087,042\u00a0\nTotal\u00a0 28,157\u00a036,477 41,443 55,598 62,242 36,427\u00a0260,345\u00a0\n\u00a0\nLa\u00a0provisi\u00f3n\u00a0de\u00a0servicios\u00a0de\u00a0salud\u00a0para\u00a0VIH\u00a0se\u00a0realiza\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0las\u00a0instituciones \u00a0del\u00a0sector\u00a0p\u00fablico,\u00a0de\u00a0la\u00a0\nseguridad \u00a0social\u00a0y\u00a0de\u00a0instituciones \u00a0sin\u00a0fines\u00a0de\u00a0lucro.\u00a0\u00a0La\u00a0provisi\u00f3n\u00a0de\u00a0tratamiento \u00a0en\u00a0el\u00a0sector\u00a0p\u00fablico\u00a0se\u00a0\nrealiza\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0los\u00a0establecimientos \u00a0\u00a0de\u00a0salud\u00a0\u00a0nacionales \u00a0\u00a0y\u00a0las\u00a0ONG\u00a0que\u00a0brindan\u00a0el\u00a0tratamiento \u00a0\nantirretroviral \u00a0TARGA\u00a0y\u00a0en\u00a0la\u00a0seguridad \u00a0social\u00a0ESSALUD, \u00a0a\u00a0trav\u00e9s\u00a0de\u00a0los\u00a0hospitales \u00a0de\u00a0la\u00a0red\u00a0de\u00a0\nestablecimientos \u00a0a\u00a0nivel\u00a0nacional.\u00a0No\u00a0existe\u00a0descentralizaci\u00f3n \u00a0de\u00a0la\u00a0administraci\u00f3n \u00a0de\u00a0tratamientos \u00a0en\u00a0los\u00a0\nestablecimientos \u00a0del\u00a0primer\u00a0nivel.\u00a0\u00a0Si\u00a0bien\u00a0existe\u00a0oferta\u00a0sanitaria\u00a0en\u00a0el\u00a0sector\u00a0privado,\u00a0\u00e9sta\u00a0generalmente \u00a0se\u00a0\nbrinda\u00a0en\u00a0los\u00a0consultorios \u00a0privados\u00a0de\u00a0los\u00a0profesionales \u00a0de\u00a0la\u00a0salud,\u00a0m\u00e1s\u00a0que\u00a0en\u00a0cl\u00ednicas\u00a0privadas\u00a0algunas\u00a0de\u00a0\nlas\u00a0cuales\u00a0\u00a0trabajan\u00a0con\u00a0EPS\u00a0(\u00a027\u00a0).\u00a0\n\u00a0\nLos\u00a0servicios\u00a0preventivos \u00a0y\u00a0promocionales \u00a0se\u00a0ofrecen\u00a0en\u00a0los\u00a0centros\u00a0de\u00a0referencia \u00a0de\u00a0ITS\u00a0\u2013\u00a0CERITS\u00a0y\u00a0en\u00a0las\u00a0\nUnidades \u00a0de\u00a0atenci\u00f3n\u00a0m\u00e9dica\u00a0peri\u00f3dica \u00a0\u2013\u00a0UAMP.\u00a0\u00a0\u00a0\u00a0La\u00a0servicios\u00a0tambi\u00e9n\u00a0son\u00a0ofrecidos \u00a0por\u00a0Organizaciones \u00a0no\u00a0\ngubernamentales \u00a0sin\u00a0fines\u00a0de\u00a0lucro\u00a0\u2013ONG.\u00a0\u00a0\n\u00a0\nLa\u00a0detecci\u00f3n \u00a0de\u00a0VIH,\u00a0mediante \u00a0pruebas\u00a0r\u00e1pidas\u00a0y\u00a0ELISA\u00a0se\u00a0realiza\u00a0de\u00a0forma\u00a0descentralizada \u00a0en\u00a0los\u00a0\nlaboratorios \u00a0de\u00a0los\u00a0establecimientos \u00a0de\u00a0salud\u00a0p\u00fablicos\u00a0y\u00a0privados\u00a0y\u00a0por\u00a0los\u00a0menos\u00a0en\u00a0la\u00a0tercera\u00a0parte\u00a0de\u00a0las\u00a0\nregiones\u00a0geogr\u00e1ficas \u00a0del\u00a0pa\u00eds,\u00a0se\u00a0realizan\u00a0pruebas\u00a0confirmatorias. \u00a0\u00a0Mientras\u00a0que\u00a0las\u00a0pruebas\u00a0de\u00a0monitoreo \u00a0\nCD4\u00a0y\u00a0carga\u00a0viral\u00a0se\u00a0realizan\u00a0en\u00a0el\u00a0Instituto\u00a0Nacional\u00a0de\u00a0Salud\u00a0y\u00a0en\u00a0ESSALUD\u00a0de\u00a0forma\u00a0centralizada. \u00a0\u00a0\u00a0Solo\u00a0en\u00a0\nel\u00a0caso\u00a0de\u00a0MINSA\u00a0dos\u00a0regiones\u00a0est\u00e1n\u00a0preparadas \u00a0para\u00a0realizarlas. \u00a0Aunque\u00a0en\u00a0el\u00a0sistema\u00a0privado\u00a0se\u00a0proveen\u00a0\nservicios\u00a0por\u00a0VIH,\u00a0no\u00a0se\u00a0conoce\u00a0la\u00a0magnitud \u00a0de\u00a0la\u00a0oferta,\u00a0ni\u00a0totalidad\u00a0de\u00a0servicios\u00a0brindados. \u00a0\n\u00a0\nEl\u00a0sector\u00a0p\u00fablico\u00a0durante\u00a0el\u00a0periodo\u00a02005\u20102010\u00a0provey\u00f3\u00a0\u00a0el\u00a066.6%\u00a0\u00a0del\u00a0total\u00a0\u00a0de\u00a0bienes\u00a0y\u00a0servicios\u00a0para\u00a0\nVIH/Sida. \u00a0\u00a0(61.4%\u00a0\u00a0en\u00a0el\u00a02005\u20102008\u00a0\u00a0y\u00a070.1%\u00a0en\u00a0el\u00a02008\u20102010)\u00a0\u00a0La\u00a0diferencia \u00a0(33.4%)\u00a0corresponde \u00a0a\u00a0la\u00a0\nprovisi\u00f3n\u00a0de\u00a0servicios\u00a0privadas,\u00a0por\u00a0cuanto\u00a0en\u00a0el\u00a0Per\u00fa\u00a0se\u00a0vienen\u00a0desarrollando \u00a0varios\u00a0proyectos \u00a0en\u00a0los\u00a0cuales\u00a0\nse\u00a0tiene\u00a0una\u00a0mayor\u00a0participaci\u00f3n \u00a0de\u00a0las\u00a0ONG\u00a0como\u00a0los\u00a0proyectos \u00a0del\u00a0FMSTM\u00a0y\u00a0otros\u00a0cooperantes, \u00a0en\u00a0los\u00a0\ncuales\u00a0las\u00a0ONG\u00a0han\u00a0realizado\u00a0actividades \u00a0de\u00a0\u00a0sensibilizaci\u00f3n, \u00a0abogac\u00eda\u00a0y\u00a0capacitaci\u00f3n \u00a0e\u00a0incluso\u00a0tratamiento \u00a0\n(Impacta, \u00a0V\u00eda\u00a0Libre,\u00a0San\u00a0Camilo).\u00a0\n\u00a0\u00a0\nProveedores \u00a0\u2010\u00a0\u00a0Estructura \u00a0porcentual \u00a0\n\u00a0 2005\u20102007 2008\u20102010 Total\u00a0\nProveedores \u00a0p\u00fablicos\u00a0 61.4%\u00a0 70.1%\u00a0 66.6%\u00a0\nEstablecimientos \u00a0de\u00a0salud\u00a0y\u00a0Ministerios \u00a0 52.4%\u00a0 62.7%\u00a0 58.5%\u00a0\nLaboratorios \u00a0p\u00fablicos\u00a0 7.9%\u00a0 7.3%\u00a0 7.5%\u00a0\nBanco\u00a0p\u00fablico\u00a0de\u00a0sangre\u00a0 1.2%\u00a0 0.1%\u00a0 0.6%\u00a0\nProveedores \u00a0privados\u00a0 38.6%\u00a0 29.9%\u00a0 33.4%\u00a0\nTotal\u00a0 100.0%\u00a0 100.0%\u00a0100.0%\u00a0\n\u00a0\n\u00a0\n                                                 \n27 En\u00a0el\u00a0estudio\u00a0MEGAS\u00a02005\u20102007\u00a0se\u00a0realizaron \u00a0entrevistas \u00a0a\u00a0m\u00e9dicos\u00a0los\u00a0cuales\u00a0manifestaron \u00a0que\u00a0las\u00a0EPS\u00a0prove\u00edan\u00a0\ntratamiento, \u00a0lo\u00a0cual\u00a0estaba\u00a0sujeto\u00a0al\u00a0tipo\u00a0de\u00a0plan\u00a0contratado \u00a0por\u00a0el\u00a0usuario.   Gasto\u00a0en\u00a0VIH\u00a0por\u00a0Proveedores \u00a0(en\u00a0miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2,005\u00a0 2,006\u00a02,007\u00a02,008\u00a02,009\u00a02,010\u00a0Total\u00a02005\u2010\n2007\u00a02008\u2010\n2010\u00a0Total\u00a0\nPROVEEDORES \u00a0PUBLICOS \u00a0 16,649\u00a021,424\u00a017,470\u00a034,097 38,023\u00a024,546 152,208 52.4%\u00a062.7%\u00a058.5%\u00a0\nPS.01.01.01 \u00a0Hospitales \u00a0 10,258\u00a015,062\u00a08,032\u00a014,830 18,019\u00a08,810\u00a075,011\u00a031.4%\u00a027.0%\u00a028.8%\u00a0\nPS.01.01.02 \u00a0Atenci\u00f3n\u00a0ambulatoria \u00a0 4,504\u00a0 5,086\u00a07,434\u00a015,985 16,897\u00a014,618 64,524\u00a016.0%\u00a030.8%\u00a024.8%\u00a0\nPS.01.01.14.01 \u00a0Comisi\u00f3n \u00a0Nacional\u00a0del\u00a0Sida\u00a0 471\u00a0 454\u00a0 256\u00a0 110\u00a0 715\u00a0 151\u00a0 2,156\u00a0 1.1%\u00a0 0.6%\u00a0 0.8%\u00a0\nPS.01.01.14.02 \u00a0Departamentos \u00a0dependientes \u00a0del\u00a0Ministerio \u00a0de\u00a0Salud\u00a0 822\u00a0 339\u00a0 1,022\u00a01,876\u00a0 946\u00a0 796\u00a0 5,800\u00a0 2.1%\u00a0 2.3%\u00a0 2.2%\u00a0\nPS.01.01.14.03 \u00a0Departamentos \u00a0dependientes \u00a0del\u00a0Ministerio \u00a0de\u00a0Educaci\u00f3n \u00a0 303\u00a0 256\u00a0 302\u00a0 1,169\u00a01,169\u00a0 83\u00a0 3,281\u00a0 0.8%\u00a0 1.6%\u00a0 1.3%\u00a0\nPS.01.01.14.04 \u00a0Departamentos \u00a0dependientes \u00a0del\u00a0Ministerio \u00a0de\u00a0Desarrollo \u00a0Social\u00a0 2\u00a0 6\u00a0 69\u00a0 19\u00a0 8\u00a0\u00a0 104\u00a0 0.1%\u00a0 0.0%\u00a0 0.0%\u00a0\nPS.01.01.14.07 \u00a0Departamentos \u00a0dependientes \u00a0del\u00a0Ministerio \u00a0de\u00a0Trabajo\u00a0\u00a0 \u00a0 66\u00a0 55\u00a0 112\u00a0 10\u00a0 243\u00a0 0.1%\u00a0 0.1%\u00a0 0.1%\u00a0\nPS.01.01.14.08 \u00a0Departamentos \u00a0dependientes \u00a0del\u00a0Ministerio \u00a0de\u00a0Justicia\u00a0 265\u00a0 176\u00a0 163\u00a0 8\u00a0 139\u00a0 53\u00a0 804\u00a0 0.6%\u00a0 0.1%\u00a0 0.3%\u00a0\nPS.01.01.99 \u00a0Organizaciones \u00a0gubernamentales \u00a0sin\u00a0clasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a0 24\u00a0 46\u00a0 126\u00a0 46\u00a0 17\u00a0 25\u00a0 286\u00a0 0.2%\u00a0 0.1%\u00a0 0.1%\u00a0\nLABORATORIOS \u00a0PUBLICOS \u00a0 2,041\u00a0 2,353\u00a03,970\u00a02,041\u00a05,979\u00a03,225\u00a019,609\u00a07.9%\u00a0 7.3%\u00a0 7.5%\u00a0\nPS.01.01.05 \u00a0Centros\u00a0de\u00a0laboratorio \u00a0y\u00a0diagn\u00f3stico \u00a0por\u00a0im\u00e1genes \u00a0 2,041\u00a0 2,353\u00a03,970\u00a02,041\u00a05,979\u00a03,225\u00a019,609\u00a07.9%\u00a0 7.3%\u00a0 7.5%\u00a0\nBANCO\u00a0PUBLICO\u00a0DE\u00a0SANGRE\u00a0 191\u00a0 377\u00a0 709\u00a0 32\u00a0 29\u00a0 148\u00a0 1,485\u00a0 1.2%\u00a0 0.1%\u00a0 0.6%\u00a0\nPS.01.01.06 \u00a0Bancos\u00a0de\u00a0sangre\u00a0 191\u00a0 377\u00a0 709\u00a0 32\u00a0 29\u00a0 148\u00a0 1,485\u00a0 1.2%\u00a0 0.1%\u00a0 0.6%\u00a0\nPROVEEDORES \u00a0PRIVADOS \u00a0 9,277\u00a0 12,323\u00a019,293\u00a019,428 18,212\u00a08,508\u00a087,042\u00a038.6%\u00a029.9%\u00a033.4%\u00a0\nPS.02.01.01.11 \u00a0Hogares\u00a0de\u00a0acogida/albergues \u00a0 85\u00a0 364\u00a0 1,064\u00a0 378\u00a0 368\u00a0 390\u00a0 2,649\u00a0 1.4%\u00a0 0.7%\u00a0 1.0%\u00a0\nPS.02.01.01.13 \u00a0Instituciones \u00a0de\u00a0investigaci\u00f3n \u00a0 4,749\u00a0 6,044\u00a08,137\u00a09,404\u00a08,668\u00a01,356\u00a038,357\u00a017.8%\u00a012.6%\u00a014.7%\u00a0\nPS.02.01.01.15 \u00a0Organizaciones \u00a0de\u00a0la\u00a0sociedad\u00a0civil\u00a0 95\u00a0 177\u00a0 421\u00a0 172\u00a0 258\u00a0 90\u00a0 1,212\u00a0 0.7%\u00a0 0.3%\u00a0 0.5%\u00a0\nPS.02.01.01.99 \u00a0Proveedores \u00a0no\u00a0basados\u00a0en\u00a0la\u00a0fe\u00a0sin\u00a0fines\u00a0de\u00a0lucro\u00a0sin\u00a0clasificar\u00a0en\u00a0otras\u00a0\ncategor\u00edas \u00a01,950\u00a0 3,484\u00a06,490\u00a05,017\u00a04,634\u00a02,118\u00a023,692\u00a011.2%\u00a07.6%\u00a0 9.1%\u00a0\nPS.02.02.08 \u00a0Farmacias \u00a0y\u00a0proveedores \u00a0de\u00a0art\u00edculos\u00a0m\u00e9dicos\u00a0 2,399\u00a0 2,255\u00a03,181\u00a04,458\u00a04,285\u00a04,554\u00a021,132\u00a07.4%\u00a0 8.6%\u00a0 8.1%\u00a0\nTotal\u00a0 28,157\u00a036,477\u00a041,443\u00a055,598 62,242\u00a036,427 260,345 100.0% 100.0% 100.0%\u00a0 45 \u00a0\nLos\u00a0principales \u00a0proveedores \u00a0p\u00fablicos\u00a0para\u00a0los\u00a0a\u00f1os\u00a0analizados \u00a0fueron\u00a0los\u00a0establecimientos \u00a0de\u00a0salud\u00a0\ndependientes \u00a0del\u00a0Ministerio \u00a0de\u00a0salud\u00a0y\u00a0de\u00a0los\u00a0gobiernos \u00a0regionales. \u00a0\n\u00a0\nHospitales \u00a0TARGA.\u2010\u00a0Son\u00a0los\u00a0hospitales \u00a0\u00a0dependientes \u00a0que\u00a0brindan\u00a0el\u00a0tratamiento \u00a0antirretroviral, \u00a0\u00a0a\u00a0nivel\u00a0\nnacional.\u00a0El\u00a0programa \u00a0TARGA\u00a0dirigido\u00a0por\u00a0la\u00a0ESN\u00a0de\u00a0VIH/Sida\u00a0ofrece\u00a0\u00a0el\u00a0tratamiento \u00a0\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0sus\u00a0\nestablecimientos \u00a0de\u00a0salud\u00a0designados, \u00a0cuatro\u00a0ONG\u00a0y\u00a0tres\u00a0centros\u00a0penitenciarios; \u00a0representa \u00a0el\u00a0avance\u00a0m\u00e1s\u00a0\nsignificativo \u00a0en\u00a0la\u00a0respuesta \u00a0nacional\u00a0al\u00a0VIH/Sida\u00a0en\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os.\u00a0De\u00a0un\u00a025%\u00a0de\u00a0cobertura \u00a0\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0\nESSSALUD \u00a0y\u00a0COPRECOS \u00a0en\u00a0el\u00a02004,\u00a0se\u00a0increment\u00f3 \u00a0a\u00a085%\u00a0a\u00a0finales\u00a0del\u00a02006,\u00a0con\u00a0un\u00a0gran\u00a0componente \u00a0del\u00a0\nMinisterio \u00a0de\u00a0Salud.\u00a0\n\u00a0\nCantidad\u00a0de\u00a0Establecimientos \u00a0que\u00a0proveen\u00a0TARGA\u00a0\u00a0a\u00a0nivel\u00a0nacional\u00a0\u2013\u00a0Cantidad\u00a0de\u00a0enrolados28\u00a0\nEstablecimientos \u00a0que\u00a0proveen\u00a0\nTARGA\u00a0Enrolados \u00a0VIH+\u00a0Departamento \u00a0\n2005\u00a0 2007\u00a0 2010\u00a0 2005\u00a0 2007\u00a0 2010\u00a0\nAmazonas \u00a0\u00a0 2\u00a0 2\u00a0\u00a0 12\u00a0 30\u00a0\nAncash\u00a0 1\u00a0 2\u00a0 2\u00a0 44\u00a0 91\u00a0 218\u00a0\nApur\u00edmac \u00a0\u00a0 1\u00a0 2\u00a0\u00a0 11\u00a0 21\u00a0\nArequipa\u00a0 1\u00a0 3\u00a0 3\u00a0 13\u00a0 148\u00a0 429\u00a0\nAyacucho \u00a0\u00a0 1\u00a0 1\u00a0\u00a0 20\u00a0 42\u00a0\nCajamarca \u00a0\u00a0 4\u00a0 4\u00a0\u00a0 10\u00a0 46\u00a0\nCallao\u00a0 3\u00a0 3\u00a0 3\u00a0 282\u00a0 736\u00a0 1,231\u00a0\nCusco\u00a0\u00a0 2\u00a0 2\u00a0\u00a0 23\u00a0 113\u00a0\nHuancavelica \u00a0\u00a0 1\u00a0 1\u00a0\u00a0 7\u00a0 15\u00a0\nHu\u00e1nuco\u00a0\u00a0 3\u00a0 3\u00a0\u00a0 26\u00a0 99\u00a0\nIca\u00a0 1\u00a0 1\u00a0 1\u00a0 40\u00a0 105\u00a0 334\u00a0\nJun\u00edn\u00a0 1\u00a0 4\u00a0 4\u00a0 16\u00a0 83\u00a0 265\u00a0\nLa\u00a0Libertad\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 193\u00a0 469\u00a0\nLambayeque \u00a0 1\u00a0 1\u00a0 1\u00a0 70\u00a0 135\u00a0 432\u00a0\nLima\u00a0 10\u00a0 13\u00a0 16\u00a0 1,455\u00a0 7,112\u00a0 9,617\u00a0\nLima\u2010\u00a0ONG\u00a0 3\u00a0 3\u00a0 3\u00a0 308\u00a0 1,137\u00a0 2,302\u00a0\nLima\u00a0Regi\u00f3n\u00a0 1\u00a0 2\u00a0 3\u00a0 26\u00a0 166\u00a0 448\u00a0\nLoreto\u00a0 1\u00a0 2\u00a0 4\u00a0 48\u00a0 202\u00a0 1,025\u00a0\nMadre\u00a0de\u00a0Dios\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 29\u00a0 87\u00a0\nMoquegua \u00a0\u00a0 2\u00a0 2\u00a0\u00a0 16\u00a0 36\u00a0\nPasco\u00a0 1\u00a0 1\u00a0 2\u00a0 4\u00a0 11\u00a0 30\u00a0\nPiura\u00a0\u00a0 2\u00a0 2\u00a0\u00a0 158\u00a0 495\u00a0\nPuno\u00a0\u00a0 3\u00a0 5\u00a0\u00a0 4\u00a0 18\u00a0\nSan\u00a0Martin\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 57\u00a0 343\u00a0\nTacna\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 22\u00a0 77\u00a0\nTumbes\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 59\u00a0 191\u00a0\nUcayali\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 35\u00a0 246\u00a0\nTotal\u00a0\u00a0 24\u00a0 62\u00a0 72\u00a0 2,306\u00a0 10,608\u00a0 18,659\u00a0\nA\u00f1o\u00a02007:\u00a0A\u00a0mayo\u00a02007,\u00a02010:\u00a0A\u00a0setiembre \u00a02011.\u00a0Fuente:\u00a0ESN\u00a0PC\u00a0ITS/VIH/SIDA \u00a0\nNota\u00a0:\u00a0S\u00f3lo\u00a0datos\u00a0de\u00a0enrolamiento \u00a0y\u00a0no\u00a0de\u00a0los\u00a0fallecidos \u00a0ni\u00a0los\u00a0que\u00a0abandonan \u00a0el\u00a0tratamiento. \u00a0\n\u00a0\n                                                 \n28\u00a0La\u00a0informaci\u00f3n \u00a0de\u00a0enrolado\u00a0se\u00a0captura\u00a0a\u00a0trav\u00e9s\u00a0del\u00a0Sistema\u00a0de\u00a0Monitoreo \u00a0y\u00a0Evaluaci\u00f3n \u00a0de\u00a0Indicadores \u00a0Integrados \u00a0\nSMEII.\u00a0Que\u00a0en\u00a0estos\u00a0\u00faltimos\u00a0a\u00f1os\u00a0se\u00a0ha\u00a0instalado\u00a0en\u00a0los\u00a0centros\u00a0que\u00a0entregan\u00a0TARGA,\u00a0habiendo \u00a0dificultades, \u00a0ya\u00a0que\u00a0\ndichos\u00a0centros\u00a0\u00a0no\u00a0lo\u00a0usan,\u00a0porque\u00a0no\u00a0\u00a0conocen\u00a0muy\u00a0bien\u00a0la\u00a0informaci\u00f3n \u00a0que\u00a0se\u00a0digita\u00a0en\u00a0este\u00a0sistema,\u00a0ni\u00a0tampoco\u00a0la\u00a0\nforma\u00a0de\u00a0hacer\u00a0el\u00a0an\u00e1lisis\u00a0de\u00a0los\u00a0datos\u00a0introducidos. \u00a0\n  46 Centros\u00a0de\u00a0referencia \u00a0de\u00a0ITS\u00a0\u2013\u00a0CERITS.\u2010\u00a0Son\u00a0los\u00a0centros\u00a0que\u00a0brindan\u00a0atenci\u00f3n\u00a0m\u00e9dica\u00a0peri\u00f3dica, \u00a0\nespecialmente \u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0HSH\u00a0y\u00a0TS\u00a0a\u00a0nivel\u00a0nacional.\u00a0\u00a0\u00a0Existen\u00a027\u00a0CERITS\u00a0a\u00a0nivel\u00a0nacional\u00a0al\u00a02010.\u00a0\n\u00a0\nUnidad\u00a0de\u00a0Atenci\u00f3n\u00a0M\u00e9dica\u00a0Peri\u00f3dica \u00a0\u2013\u00a0UAMP.\u2010\u00a0Son\u00a0los\u00a0centros\u00a0que\u00a0realizan\u00a0la\u00a0atenci\u00f3n\u00a0m\u00e9dica\u00a0peri\u00f3dica \u00a0\nespecialmente \u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0HSH\u00a0y\u00a0TS\u00a0a\u00a0nivel\u00a0nacional,\u00a0siendo\u00a0la\u00a0diferencia \u00a0con\u00a0los\u00a0CERITS,\u00a0que\u00a0en\u00a0estas\u00a0\nunidades\u00a0no\u00a0se\u00a0realizan\u00a0cultivos\u00a0para\u00a0el\u00a0diagn\u00f3stico \u00a0etiol\u00f3gico. \u00a0Existen\u00a0al\u00a02010,\u00a0\u00a067\u00a0UAMP\u00a0a\u00a0nivel\u00a0nacional.\u00a0\n\u00a0\nCantidad\u00a0de\u00a0CERITS\u00a0y\u00a0UAMPS\u00a0\u00a0a\u00a0nivel\u00a0nacional\u00a0del\u00a02007\u00a0al\u00a02010\u00a0\n\u00a0 Al\u00a02007\u00a0 Al\u00a02010\u00a0 Incremento \u00a0\nDepartamento \u00a0 CERITS\u00a0UAMP\u00a0Total\u00a0CERITS UAMP\u00a0Total\u00a0 Absoluto\u00a0 %\u00a0\nAmazonas \u00a0\u00a0 2\u00a0 2\u00a0\u00a0 2\u00a0 2\u00a0 0\u00a0 0%\u00a0\nAncash\u00a0 1\u00a0 1\u00a0 2\u00a0 1\u00a0 1\u00a0 2\u00a0 0\u00a0 0%\u00a0\nApur\u00edmac \u00a0\u00a0 1\u00a0 1\u00a0\u00a0 1\u00a0 1\u00a0 0\u00a0 0%\u00a0\nArequipa\u00a0 1\u00a0 2\u00a0 3\u00a0 1\u00a0 4\u00a0 5\u00a0 2\u00a0 67%\u00a0\nAyacucho \u00a0 1\u00a0\u00a0 1\u00a0 1\u00a0 4\u00a0 5\u00a0 4\u00a0 400%\u00a0\nCajamarca \u00a0 1\u00a0 5\u00a0 6\u00a0 1\u00a0 5\u00a0 6\u00a0 0\u00a0 0%\u00a0\nCallao\u00a0 1\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 1\u00a0 0\u00a0 0%\u00a0\nCusco\u00a0 1\u00a0 2\u00a0 3\u00a0 1\u00a0 2\u00a0 3\u00a0 0\u00a0 0%\u00a0\nHuancavelica \u00a0\u00a0 1\u00a0 1\u00a0\u00a0 1\u00a0 1\u00a0 0\u00a0 0%\u00a0\nHu\u00e1nuco\u00a0 1\u00a0 1\u00a0 2\u00a0 1\u00a0 3\u00a0 4\u00a0 2\u00a0 100%\u00a0\nIca\u00a0 1\u00a0 2\u00a0 3\u00a0 1\u00a0 6\u00a0 7\u00a0 4\u00a0 133%\u00a0\nJun\u00edn\u00a0 1\u00a0 7\u00a0 8\u00a0 1\u00a0 8\u00a0 9\u00a0 1\u00a0 13%\u00a0\nLa\u00a0Libertad\u00a0 1\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 1\u00a0 0\u00a0 0%\u00a0\nLambayeque \u00a0 2\u00a0\u00a0 2\u00a0 2\u00a0\u00a0 2\u00a0 0\u00a0 0%\u00a0\nLima\u00a0\u00a0 5\u00a0 4\u00a0 9\u00a0 6\u00a0 5\u00a0 11\u00a0 2\u00a0 22%\u00a0\nLima\u00a0Provincias \u00a0 2\u00a0 2\u00a0 4\u00a0 2\u00a0 5\u00a0 7\u00a0 3\u00a0 75%\u00a0\nLoreto\u00a0 1\u00a0 1\u00a0 2\u00a0 1\u00a0 5\u00a0 6\u00a0 4\u00a0 200%\u00a0\nMadre\u00a0de\u00a0dios\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 3\u00a0 3\u00a0 2\u00a0 200%\u00a0\nMoquegua \u00a0 1\u00a0 1\u00a0 2\u00a0 1\u00a0 2\u00a0 3\u00a0 1\u00a0 50%\u00a0\nPasco\u00a0\u00a0 3\u00a0 3\u00a0\u00a0 6\u00a0 6\u00a0 3\u00a0 100%\u00a0\nPiura\u00a0 2\u00a0\u00a0 2\u00a0 2\u00a0\u00a0 2\u00a0 0\u00a0 0%\u00a0\nPuno\u00a0 2\u00a0\u00a0 2\u00a0 2\u00a0\u00a0 2\u00a0 0\u00a0 0%\u00a0\nSan\u00a0Mart\u00edn\u00a0\u00a0 3\u00a0 3\u00a0\u00a0 3\u00a0 3\u00a0 0\u00a0 0%\u00a0\nTacna\u00a0 1\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 1\u00a0 0\u00a0 0%\u00a0\nTumbes\u00a0\u00a0 1\u00a0 1\u00a0\u00a0 1\u00a0 1\u00a0 0\u00a0 0%\u00a0\nUcayali\u00a0 1\u00a0 1\u00a0 2\u00a0 1\u00a0 1\u00a0 2\u00a0 0\u00a0 0%\u00a0\nTotal\u00a0general\u00a0 27\u00a0 41\u00a0 68\u00a0 28\u00a0 68\u00a0 96\u00a0 28\u00a0 41%\u00a0\nFuente:\u00a0ESN\u00a0PC\u00a0ITS/VIH/SIDA \u00a0\n\u00a0Finalmente, \u00a0algunas\u00a0de\u00a0las\u00a0estrategias \u00a0como\u00a0el\u00a0manejo\u00a0sindr\u00f3mico \u00a0de\u00a0ITS\u00a0para\u00a0poblaci\u00f3n \u00a0general\u00a0se\u00a0proveen\u00a0\nen\u00a0casi\u00a0la\u00a0totalidad\u00a0de\u00a0los\u00a0\u00a07,382\u00a0establecimientos \u00a0que\u00a0corresponden \u00a0al\u00a0sector\u00a0p\u00fablico\u00a0de\u00a0salud\u00a0\n\u00a0\nCantidad\u00a0de\u00a0Establecimientos \u00a0de\u00a0salud\u00a0a\u00a0diciembre \u00a02009\u00a0\nDepartamento \u00a0 Total\u00a0 Hospital\u00a0Centro\u00a0de\u00a0\nsalud\u00a0Puesto\u00a0\nde\u00a0salud\u00a0\nTotal\u00a0 7382\u00a0 155\u00a0 1321\u00a0 5906\u00a0\nAmazonas \u00a0 436\u00a0 5\u00a0 51\u00a0 380\u00a0\nAncash\u00a0 400\u00a0 12\u00a0 55\u00a0 333\u00a0\nApur\u00edmac \u00a0 320\u00a0 7\u00a0 45\u00a0 268\u00a0\nArequipa\u00a0 249\u00a0 5\u00a0 62\u00a0 182\u00a0\nAyacucho \u00a0 361\u00a0 8\u00a0 52\u00a0 301\u00a0 47 Departamento \u00a0 Total\u00a0 Hospital\u00a0Centro\u00a0de\u00a0\nsalud\u00a0Puesto\u00a0\nde\u00a0salud\u00a0\nCajamarca \u00a0 750\u00a0 9\u00a0 113\u00a0 628\u00a0\nCallao\u00a0 55\u00a0 4\u00a0 49\u00a0 2\u00a0\nCusco\u00a0 299\u00a0 6\u00a0 49\u00a0 244\u00a0\nHuancavelica \u00a0 331\u00a0 1\u00a0 51\u00a0 279\u00a0\nHu\u00e1nuco\u00a0 249\u00a0 2\u00a0 43\u00a0 204\u00a0\nIca\u00a0 139\u00a0 6\u00a0 36\u00a0 97\u00a0\nJun\u00edn\u00a0 446\u00a0 7\u00a0 51\u00a0 388\u00a0\nLa\u00a0libertad\u00a0 229\u00a0 10\u00a0 45\u00a0 174\u00a0\nLambayeque \u00a0 172\u00a0 3\u00a0 43\u00a0 126\u00a0\nLima\u00a0 686\u00a0 30\u00a0 228\u00a0 428\u00a0\nLoreto\u00a0 347\u00a0 3\u00a0 51\u00a0 293\u00a0\nMadre\u00a0de\u00a0dios\u00a0 110\u00a0 2\u00a0 12\u00a0 96\u00a0\nMoquegua \u00a0 59\u00a0 1\u00a0 25\u00a0 33\u00a0\nPasco\u00a0 245\u00a0 3\u00a0 20\u00a0 222\u00a0\nPiura\u00a0 386\u00a0 4\u00a0 72\u00a0 310\u00a0\nPuno\u00a0 443\u00a0 11\u00a0 81\u00a0 351\u00a0\nSan\u00a0Mart\u00edn\u00a0 360\u00a0 12\u00a0 42\u00a0 306\u00a0\nTacna\u00a0 72\u00a0 1\u00a0 17\u00a0 54\u00a0\nTumbes\u00a0 43\u00a0 1\u00a0 14\u00a0 28\u00a0\nUcayali\u00a0 195\u00a0 2\u00a0 14\u00a0 179\u00a0\n\u00a0\nMinisterio \u00a0de\u00a0Educaci\u00f3n. \u2010\u00a0La\u00a0provisi\u00f3n\u00a0de\u00a0servicios\u00a0en\u00a0el\u00a0tema\u00a0de\u00a0VIH\u00a0en\u00a0el\u00a0sector\u00a0educaci\u00f3n \u00a0se\u00a0proporciona \u00a0\nb\u00e1sicamente \u00a0a\u00a0trav\u00e9s\u00a0de\u00a0las\u00a0clases\u00a0de\u00a0Tutor\u00eda,\u00a0en\u00a0las\u00a0cuales\u00a0se\u00a0incluye\u00a0los\u00a0temas\u00a0de\u00a0educaci\u00f3n \u00a0sexual.\u00a0El\u00a0tema\u00a0\nde\u00a0la\u00a0educaci\u00f3n \u00a0sexual\u00a0se\u00a0encuentra \u00a0planteado \u00a0dentro\u00a0de\u00a0los\u00a0contenidos \u00a0del\u00a0Dise\u00f1o\u00a0Curricular \u00a0Nacional\u00a0\naprobado \u00a0en\u00a0200.\u00a0\u00a0\u00a0Sin\u00a0embargo\u00a0s\u00f3lo\u00a0la\u00a0tercera\u00a0parte\u00a0de\u00a0las\u00a0escuelas\u00a0p\u00fablicas\u00a0(unas\u00a019,900\u00a0escuelas\u00a0p\u00fablicas)\u00a0\ny\u00a0la\u00a0mitad\u00a0de\u00a0las\u00a0privadas\u00a0(10,340)\u00a0cumple\u00a0con\u00a0el\u00a0curr\u00edculo\u00a0escolar\u00a0de\u00a0la\u00a0educaci\u00f3n \u00a0b\u00e1sica\u00a0seg\u00fan\u00a0un\u00a0estudio\u00a0\nde\u00a0la\u00a0Unidad\u00a0de\u00a0Medici\u00f3n \u00a0de\u00a0la\u00a0Calidad\u00a0de\u00a0la\u00a0ense\u00f1anza \u00a0del\u00a0MINEDU.\u00a0\u00a0\n\u00a0\nLa\u00a0educaci\u00f3n \u00a0sexual\u00a0integral\u00a0se\u00a0trabaja\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0la\u00a0tutor\u00eda\u00a0y\u00a0orientaci\u00f3n \u00a0educativa, \u00a0que\u00a0constituye \u00a0un\u00a0\nasunto\u00a0transversal \u00a0a\u00a0todos\u00a0los\u00a0niveles\u00a0de\u00a0las\u00a0\u00e1reas\u00a0de\u00a0la\u00a0divisi\u00f3n\u00a0curricular \u00a0nacional.29\u00a0Durante\u00a0el\u00a02006\u00a0m\u00e1s\u00a0\nde\u00a0seis\u00a0millones\u00a0de\u00a0estudiantes \u00a0de\u00a0educaci\u00f3n \u00a0secundaria \u00a0han\u00a0recibido\u00a0textos\u00a0y\u00a0libros\u00a0de\u00a0las\u00a0\u00e1reas\u00a0\u2013por\u00a0\nejemplo\u2010\u00a0persona,\u00a0familia\u00a0y\u00a0relaciones \u00a0humanas, \u00a0y\u00a0de\u00a0ciencia\u00a0y\u00a0tecnolog\u00eda, \u00a0que\u00a0contienen \u00a0ya\u00a0unidades\u00a0de\u00a0\naprendizaje \u00a0en\u00a0relaci\u00f3n\u00a0a\u00a0la\u00a0educaci\u00f3n \u00a0sexual.\u00a0\n\u00a0\nDe\u00a0acuerdo\u00a0al\u00a0Plan\u00a0Estrat\u00e9gico \u00a0Institucional \u00a02007\u00a0al\u00a02011,\u00a0se\u00a0espera\u00a0que\u00a0el\u00a0\u00a050%\u00a0de\u00a0Instituciones \u00a0educativas \u00a0\nimplementen \u00a0adecuadamente \u00a0la\u00a0tutor\u00eda\u00a0y\u00a040%\u00a0de\u00a0ellas\u00a0cuenten\u00a0con\u00a0un\u00a0Comit\u00e9\u00a0de\u00a0Tutor\u00eda\u00a0que\u00a0promueve \u00a0la\u00a0\norientaci\u00f3n \u00a0en\u00a0los\u00a0estudiantes, \u00a0llegando\u00a0a\u00a0100%\u00a0en\u00a0el\u00a02011.30\u00a0\n\u00a0\nPara\u00a0el\u00a02008\u00a0se\u00a0ha\u00a0publicado \u00a0los\u00a0Lineamientos \u00a0educativos \u00a0y\u00a0orientaciones \u00a0Pedag\u00f3gicas \u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0\nlas\u00a0Infecciones \u00a0de\u00a0transmisi\u00f3n \u00a0sexual,\u00a0VIH\u00a0y\u00a0sida\u00a0\u2010\u00a0Educaci\u00f3n \u00a0primaria\u00a0y\u00a0secundaria. \u00a0Los\u00a0principales \u00a0conceptos \u00a0\nde\u00a0gasto\u00a0han\u00a0estado\u00a0concentrados \u00a0en\u00a0Talleres\u00a0de\u00a0capacitaci\u00f3n \u00a0a\u00a0docentes\u00a0e\u00a0impresi\u00f3n \u00a0de\u00a0material\u00a0educativo \u00a0\nrealizado\u00a0con\u00a0presupuesto \u00a0del\u00a0Ministerio \u00a0de\u00a0educaci\u00f3n \u00a0y\u00a0con\u00a0el\u00a0apoyo\u00a0de\u00a0algunos\u00a0cooperantes \u00a0\ninternacionales. \u00a0\u00a0\u00a0\n\u00a0\nCon\u00a0respecto\u00a0a\u00a0la\u00a0provisi\u00f3n\u00a0de\u00a0servicios\u00a0del\u00a0sector\u00a0privado\u00a0diferente \u00a0a\u00a0las\u00a0ONG,\u00a0se\u00a0consideran \u00a0los\u00a0hospitales \u00a0\nprivados\u00a0que\u00a0atienden\u00a0a\u00a0pacientes, \u00a0consultas \u00a0privadas,\u00a0laboratorios, \u00a0los\u00a0que\u00a0suministran \u00a0condones \u00a0y\u00a0los\u00a0que\u00a0\nrealizan\u00a0la\u00a0venta\u00a0privada\u00a0de\u00a0condones. \u00a0Se\u00a0incluye\u00a0en\u00a0este\u00a0rubro\u00a0el\u00a0gasto\u00a0realizado\u00a0por\u00a0los\u00a0hogares\u00a0para\u00a0la\u00a0\n                                                 \n29\u00a0Declaraciones \u00a0del\u00a0Viceministro \u00a0de\u00a0Gesti\u00f3n\u00a0Pedag\u00f3gica \u00a0del\u00a0citado\u00a0portafolio, \u00a0Idel\u00a0Vexler.\u00a0Agosto,11 \u00a0del\u00a02007 \n30\u00a0Se\u00a0espera\u00a040%\u00a0para\u00a0el\u00a02007,\u00a060%\u00a0al\u00a02008,\u00a080%\u00a0al\u00a02009,\u00a090%\u00a0al\u00a02010\u00a0y\u00a0100%\u00a0al\u00a02011.  48 atenci\u00f3n\u00a0de\u00a0infecciones \u00a0oportunistas \u00a0que\u00a0en\u00a0los\u00a0a\u00f1os\u00a0estudiados \u00a0no\u00a0ha\u00a0sido\u00a0provista\u00a0por\u00a0el\u00a0Estado.\u00a0Reci\u00e9n\u00a0a\u00a0\npartir\u00a0del\u00a0proyecto\u00a0de\u00a0la\u00a0Quinta\u00a0Ronda\u00a0del\u00a0FMSTM\u00a0se\u00a0est\u00e1\u00a0proporcionando \u00a0tratamiento \u00a0gratuito\u00a0para\u00a0la\u00a0\nmayor\u00eda\u00a0de\u00a0las\u00a0IO,\u00a0sin\u00a0embargo\u00a0no\u00a0hay\u00a0una\u00a0norma\u00a0que\u00a0establezca \u00a0que\u00a0a\u00a0la\u00a0finalizaci\u00f3n \u00a0del\u00a0proyecto\u00a0el\u00a0\nMinisterio \u00a0de\u00a0Salud\u00a0asuma\u00a0este\u00a0gasto.\u00a0Cabe\u00a0precisar\u00a0que\u00a0de\u00a0acuerdo\u00a0a\u00a0las\u00a0entrevistas \u00a0realizadas \u00a0a\u00a0pacientes \u00a0\nse\u00a0ha\u00a0podido\u00a0determinar \u00a0que\u00a0el\u00a0porcentaje \u00a0de\u00a0personas\u00a0que\u00a0reconocen \u00a0que\u00a0pueden\u00a0asumir\u00a0el\u00a0gasto\u00a0de\u00a0una\u00a0\nenfermedad \u00a0oportunista \u00a0no\u00a0llega\u00a0al\u00a015%\u00a0(en\u00a0el\u00a0grupo\u00a0entrevistado) \u00a0convirti\u00e9ndose \u00a0en\u00a0el\u00a0principal\u00a0factor\u00a0de\u00a0\nmuerte\u00a0de\u00a0las\u00a0PVV.\u00a0\n\u00a0 49 \u00a0\nF.5\u00a0\u00a0Funciones \u00a0\u2010\u00a0Categor\u00eda \u00a0de\u00a0gasto\u00a0\u2010\u00a0Intervenciones \u00a0\n\u00a0\nGasto\u00a0por\u00a0Categor\u00eda \u00a0de\u00a0gasto\u00a0\u2010\u00a02005\u20102010\u00a0\u2010\u00a0En\u00a0miles\u00a0US\u00a0$\u00a0\nFunci\u00f3n\u00a0 2005\u00a02006\u00a02007\u00a02008\u00a02009\u00a02010\u00a0 Total\u00a0\nPrevenci\u00f3n \u00a0 7,325 8,410 12,461 18,711 20,000\u00a016,125\u00a083,033\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 12,790 17,920 13,852 20,812 24,857\u00a012,587\u00a0102,818\nIncentivos \u00a0de\u00a0retenci\u00f3n \u00a0 213 31 16 191 52\u00a0 17\u00a0 520\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0vulnerables \u00a0 59 171 16 8\u00a0 9\u00a0 263\nGesti\u00f3n\u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0administraci\u00f3n \u00a01,876 1,943 1,570 3,184 4,635\u00a02,952\u00a016,160\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0 306 603 1,505 1,498 1,278\u00a0 549\u00a0 5,740\nDesarrollo \u00a0comunitario \u00a0y\u00a0ambiente \u00a0mejorado \u00a0\u00a0 898 1,538 2,571 1,852 2,621\u00a02,932\u00a012,411\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0sida\u00a0\u00a0 4,749 5,975 9,295 9,333 8,792\u00a01,256\u00a039,399\nTotal\u00a0 28,157 36,477 41,443 55,598 62,242\u00a036,427\u00a0260,345\n\u00a0\nEn\u00a0el\u00a0periodo\u00a02008\u20102010\u00a0el\u00a0gasto\u00a0sigue\u00a0siendo\u00a0mayor\u00a0en\u00a0Atenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0\u00a0el\u00a0cual\u00a0comprende \u00a0\nespecialmente \u00a0la\u00a0compra\u00a0de\u00a0ARV;\u00a0\u00a0en\u00a0segundo\u00a0lugar\u00a0se\u00a0encuentra \u00a0el\u00a0gasto\u00a0\u00a0en\u00a0prevenci\u00f3n \u00a0y\u00a0en\u00a0tercer\u00a0lugar\u00a0el\u00a0\ngasto\u00a0en\u00a0investigaci\u00f3n \u00a0relacionada \u00a0al\u00a0VIH.\u00a0\u00a0\u00a0\n\u00a0\n7,325\u00a0 8,410\u00a012,461\u00a018,711\u00a0 20,000\u00a0 17,887\u00a012,790\u00a017,920\u00a013,852\u00a020,812\u00a024,857\u00a0\n12,587\u00a04,749\u00a05,975\u00a09,295\u00a09,333\u00a08,792\u00a0\n1,256\u00a0\n3,293\u00a04,283\u00a05,834\u00a06,742\u00a08,593\u00a0\n4,697\u00a0\n2005 2006 2007 2008 2009 2010Gasto\u00a0en\u00a0VIH\u00a0\u2010Principales \u00a0conceptos\nPrevenci\u00f3n\n Atenci\u00f3n\u00a0y\u00a0tratamiento\n Investigaci\u00f3n\n Otros\n\u00a0\n28.2\u00a044.6\u00a0\n0.2\u00a05.5\u00a00.3\u00a02.4\u00a05.0\u00a020.0\u00a056.6\u00a0 58.3\u00a0\n0.0\u00a010.8\u00a0\n0.3\u00a03.3\u00a05.6\u00a019.4\u00a0\nPrevenci\u00f3n Atenci\u00f3n \u00a0y\u00a0\ntratamientoHu\u00e9rfanos Gesti\u00f3n \u00a0de\u00a0\nprogramaIncentivos \u00a0RRHH Protecci\u00f3n \u00a0social Desarrollo \u00a0\ncomunitarioInvestigaci\u00f3nCategor\u00edas \u00a0de\u00a0Gasto\u00a0(millones \u00a0de\u00a0US\u00a0$)\n2005\u20102007\n 2008\u20102010\n\u00a0 50 \n34%37%\n0%5.7%0.3%2.7%\n3.3%17%32%40%\n0%7.4%\n0.1%2.1%4.2%14%44%\n35%\n0%8.1%\n1.5%8.0%\n3%\nPrevenci\u00f3n Atenci\u00f3n \u00a0y\u00a0\ntratamientoHu\u00e9rfanos Gesti\u00f3n \u00a0de\u00a0\nprogramaIncentivos \u00a0RRHH Protecci\u00f3n \u00a0\nsocialDesarrollo \u00a0\ncomunitarioInvestigaci\u00f3nCategor\u00edas \u00a0de\u00a0Gasto\u00a0(en\u00a0porcentaje)\n2008\n 2009\n 2010\n\u00a0\n\u00a0\nGasto\u00a0por\u00a0Funci\u00f3n\u00a0\u2013\u00a0Estructura \u00a0porcentual \u00a0\nFunci\u00f3n\u00a0 2005\u20102007\u00a0 2008\u20102010\u00a0 Total\u00a0\nPrevenci\u00f3n \u00a0 26.6%\u00a0 35.5%\u00a0 31.9%\u00a0\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 42.0%\u00a0 37.8%\u00a0 39.5%\u00a0\nIncentivos \u00a0de\u00a0retenci\u00f3n \u00a0 0.2%\u00a0 0.2%\u00a0 0.2%\u00a0\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0vulnerables \u00a0 0.2%\u00a0 0.0%\u00a0 0.1%\u00a0\nGesti\u00f3n\u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0administraci\u00f3n \u00a0 5.1%\u00a0 7.0%\u00a0 6.2%\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0 2.3%\u00a0 2.2%\u00a0 2.2%\u00a0\nDesarrollo \u00a0comunitario \u00a0y\u00a0ambiente \u00a0mejorado \u00a0\u00a0 4.7%\u00a0 4.8%\u00a0 4.8%\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0sida\u00a0\u00a0 18.9%\u00a0 12.6%\u00a0 15.1%\u00a0\nTotal\u00a0 100.0%\u00a0 100.0%\u00a0 100.0%\u00a0\n\u00a0\n\uf02d Prevenci\u00f3n \u00a0\n\u00a0\nLas\u00a0cifras\u00a0de\u00a0gasto\u00a0en\u00a0prevenci\u00f3n \u00a0a\u00fan\u00a0siguen\u00a0siendo\u00a0insuficientes \u00a0para\u00a0el\u00a0cumplimiento \u00a0de\u00a0los\u00a0ODM\u00a0al\u00a02015,\u00a0\npues\u00a0seg\u00fan\u00a0\u00a0la\u00a0Resoluci\u00f3n \u00a0\u00a0WHA63.19 \u00a0\u201cEstrategia \u00a0OMS\u00a0contra\u00a0el\u00a0VIH/sida\u00a0para\u00a02011\u20102015\u00a0se\u00a0insta:\u00a0\u201c2)\u00a0a\u00a0que\u00a0\nrefuercen \u00a0el\u00a0compromiso \u00a0de\u00a0los\u00a0gobiernos \u00a0con\u00a0los\u00a0programas \u00a0de\u00a0lucha\u00a0contra\u00a0el\u00a0VIH/sida,\u00a0incluso\u00a0\naumentando \u00a0los\u00a0esfuerzos \u00a0de\u00a0prevenci\u00f3n \u00a0y\u00a0adopten\u00a0medidas\u00a0para\u00a0acelerar\u00a0la\u00a0armonizaci\u00f3n \u00a0de\u00a0la\u00a0\ncontribuci\u00f3n \u00a0de\u00a0los\u00a0donantes \u00a0y\u00a0la\u00a0observancia \u00a0de\u00a0los\u00a0compromisos \u00a0con\u00a0la\u00a0eficacia\u00a0de\u00a0la\u00a0ayuda\u201d\u00a0\n\u00a0\nLos\u00a0esfuerzos \u00a0dirigidos\u00a0a\u00a0poblaciones \u00a0m\u00e1s\u00a0expuestas, \u00a0o\u00a0conformado \u00a0por\u00a0individuos \u00a0en\u00a0mayor\u00a0probabilidad \u00a0de\u00a0\nadquirir\u00a0el\u00a0VIH\u00a0y\u00a0en\u00a0mayor\u00a0vulnerabilidad \u00a0captan\u00a0todav\u00eda\u00a0una\u00a0peque\u00f1a\u00a0proporci\u00f3n \u00a0del\u00a0gasto\u00a0preventivo. \u00a0La\u00a0\nprincipal\u00a0intervenci\u00f3n \u00a0para\u00a0la\u00a0poblaci\u00f3n \u00a0m\u00e1s\u00a0expuesta\u00a0realizada\u00a0por\u00a0el\u00a0MINSA\u00a0es\u00a0la\u00a0Atenci\u00f3n\u00a0m\u00e9dica\u00a0\nperi\u00f3dica \u00a0\u2013\u00a0AMP.\u00a0Este\u00a0servicio\u00a0se\u00a0provee\u00a0en\u00a0los\u00a0CERITS\u00a0y\u00a0UAMP\u00a0del\u00a0MINSA,\u00a0no\u00a0existe\u00a0establecimientos \u00a0que\u00a0\npresten\u00a0servicios\u00a0equivalentes \u00a0en\u00a0ESSALUD\u00a0o\u00a0en\u00a0ninguna\u00a0otra\u00a0entidad.\u00a0(Objetivo \u00a0VIH\u00a01)\u00a0\n\u00a0\nCabe\u00a0precisar\u00a0que\u00a0el\u00a0pa\u00eds\u00a0cuenta\u00a0con\u00a0un\u00a0Plan\u00a0de\u00a0Mercadeo \u00a0Social\u00a0del\u00a0Cond\u00f3n\u00a02009\u00a0a\u00a02011,\u00a0sin\u00a0embargo\u00a0las\u00a0\nactividades \u00a0que\u00a0se\u00a0vienen\u00a0ejecutando \u00a0actualmente \u00a0son\u00a0las\u00a0financiadas \u00a0por\u00a0el\u00a0proyecto\u00a0aprobado \u00a0por\u00a0el\u00a0\nFMSTM\u00a0en\u00a0sexta\u00a0ronda\u00a0\u00a0(iniciado\u00a0en\u00a0el\u00a02008)\u00a0las\u00a0cuales\u00a0est\u00e1n\u00a0dirigidas\u00a0a\u00a0la\u00a0promoci\u00f3n \u00a0del\u00a0uso\u00a0adecuado \u00a0y\u00a0\nprovisi\u00f3n\u00a0de\u00a0condones. \u00a0\u00a0En\u00a0t\u00e9rminos\u00a0generales \u00a0esta\u00a0estrategia \u00a0se\u00a0ha\u00a0visto\u00a0afectada\u00a0por\u00a0la\u00a0ruptura\u00a0de\u00a0stocks\u00a0\nresultado \u00a0de\u00a0las\u00a0demoras\u00a0en\u00a0las\u00a0importaciones \u00a0realizadas \u00a0por\u00a0el\u00a0UNFPA\u00a0desde\u00a0el\u00a02006\u00a0a\u00a0la\u00a0fecha\u00a0y\u00a0tambi\u00e9n\u00a0\npor\u00a0los\u00a0problemas \u00a0del\u00a0propio\u00a0sistema\u00a0p\u00fablico\u00a0de\u00a0distribuci\u00f3n \u00a0del\u00a0pa\u00eds.\u00a0(\u00a0\u00a031\u00a0\u00a0)\u00a0\n\u00a0\nLa\u00a0estrategia \u00a0de\u00a0prevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0vertical\u00a0se\u00a0est\u00e1\u00a0institucionalizando \u00a0en\u00a0todos\u00a0los\u00a0\nestablecimientos \u00a0a\u00a0nivel\u00a0nacional,\u00a0fundamentalmente \u00a0con\u00a0el\u00a0apoyo\u00a0financiero \u00a0del\u00a0FMSTM\u00a0y\u00a0en\u00a0coordinaci\u00f3n \u00a0\ncon\u00a0la\u00a0Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Salud\u00a0Sexual\u00a0y\u00a0Reproductiva \u00a0\u2013\u00a0ESNSSR.\u00a0A\u00a0partir\u00a0del\u00a0proyecto\u00a0del\u00a0\n                                                 \n31 Fuente:  CARE,  Evaluaci\u00f3n \u00a0de\u00a0los\u00a0\u00a0sistemas\u00a0de\u00a0distribuci\u00f3n \u00a0y\u00a0almacenamiento \u00a0de\u00a0\u00a0preservativos, \u00a02008  51 FMSTM\u00a0de\u00a06ta.\u00a0Ronda\u00a0desde\u00a0el\u00a02008\u00a0se\u00a0vienen\u00a0realizando \u00a0pruebas\u00a0de\u00a0VIH\u00a0de\u00a0forma\u00a0masiva\u00a0a\u00a0las\u00a0mujeres\u00a0en\u00a0\nedad\u00a0f\u00e9rtil\u00a0(Objetivo \u00a0VIH\u00a03\u00a0del\u00a0FMSTM\u00a0VI\u00a0Ronda).\u00a0\n\u00a0\nPara\u00a0la\u00a0poblaci\u00f3n \u00a0general\u00a0se\u00a0vienen\u00a0implementando \u00a0intervenciones \u00a0con\u00a0financiamiento \u00a0del\u00a0FMSTM,\u00a0\ndestinadas \u00a0a\u00a0difundir\u00a0informaci\u00f3n \u00a0sobre\u00a0comportamientos \u00a0y\u00a0estilos\u00a0de\u00a0vida\u00a0saludables, \u00a0orientados \u00a0a\u00a0\nescolares \u00a0en\u00a0colaboraci\u00f3n \u00a0con\u00a0el\u00a0Ministerio \u00a0de\u00a0Educaci\u00f3n \u00a0(MINEDU) \u00a0y\u00a0las\u00a0organizaciones \u00a0sociales\u00a0de\u00a0base\u00a0de\u00a0\nmujeres.\u00a0 Gasto\u00a0en\u00a0VIH\u00a0por\u00a0Categor\u00eda \u00a0de\u00a0gasto\u00a0\u2010\u00a0Funciones \u00a0(en\u00a0miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2005\u00a02006 2007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a02005\u2010\n2007\u00a02008\u2010\n2010\u00a0Total\u00a0\nPREVENCION \u00a0 7,325\u00a08,410 12,461 18,711 20,000 16,125 83,033 26.6% 35.5% 31.9%\u00a0\nASC.01.01.01 \u00a0Comunicaci\u00f3n \u00a0relacionada \u00a0con\u00a0la\u00a0salud\u00a0para\u00a0cambio\u00a0social\u00a0y\u00a0comportamental \u00a0 66\u00a0127\u00a01,651\u00a0953\u00a0 820\u00a0702\u00a04,320\u00a01.7%\u00a01.6%\u00a01.7%\u00a0\nASC.01.02 \u00a0Movilizaci\u00f3n \u00a0de\u00a0la\u00a0comunidad \u00a0 179\u00a0106\u00a0 58\u00a0 210\u00a0 70\u00a0 53\u00a0 676\u00a00.3%\u00a00.2%\u00a00.3%\u00a0\nASC.01.03 \u00a0Asesoramiento \u00a0y\u00a0pruebas\u00a0voluntarias \u00a0(APV)\u00a0 \u00a0\u00a0\u00a0 59\u00a0 58\u00a0 62\u00a0 179\u00a00.0%\u00a00.1%\u00a00.1%\u00a0\nASC.01.04.01 \u00a0APV\u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0para\u00a0poblaciones \u00a0vulnerables \u00a0y\u00a0accesibles \u00a0 110\u00a015\u00a0 56\u00a0 84\u00a0 445\u00a0 29\u00a0 739\u00a00.2%\u00a00.4%\u00a00.3%\u00a0\nASC.01.04.02 \u00a0Comercializaci\u00f3n \u00a0social\u00a0del\u00a0preservativo \u00a0y\u00a0suministro \u00a0de\u00a0preservativos \u00a0masculinos \u00a0y\u00a0\nfemeninos \u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0para\u00a0poblaciones \u00a0vulnerables \u00a0y\u00a0accesibles \u00a08\u00a0 34\u00a0 50\u00a0\u00a0 156\u00a0 53\u00a0 301\u00a00.1%\u00a00.1%\u00a00.1%\u00a0\nASC.01.04.03 \u00a0Prevenci\u00f3n \u00a0y\u00a0tratamiento \u00a0de\u00a0ITS\u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0para\u00a0poblaciones \u00a0\nvulnerables \u00a0y\u00a0accesibles \u00a026\u00a0 15\u00a0 143\u00a0 70\u00a0 130\u00a0 27\u00a0 411\u00a00.2%\u00a00.1%\u00a00.2%\u00a0\nASC.01.04.04 \u00a0Comunicaci\u00f3n \u00a0para\u00a0el\u00a0cambio\u00a0de\u00a0comportamiento \u00a0(CCC)\u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0\npara\u00a0poblaciones \u00a0vulnerables \u00a0y\u00a0accesibles \u00a025\u00a0 8\u00a0\u00a0 184\u00a0 40\u00a0 71\u00a0 327\u00a00.0%\u00a00.2%\u00a00.1%\u00a0\nASC.01.04.98 \u00a0Intervenciones \u00a0program\u00e1ticas \u00a0para\u00a0poblaciones \u00a0vulnerables \u00a0y\u00a0accesibles \u00a0no\u00a0\ndesglosadas \u00a0por\u00a0tipo\u00a0255\u00a0260\u00a0762\u00a0 267\u00a0 732\u00a02,148 4,423\u00a01.2%\u00a02.0%\u00a01.7%\u00a0\nASC.01.05 \u00a0Prevenci\u00f3n \u00a0\u2013\u00a0j\u00f3venes\u00a0escolarizados \u00a0 509\u00a01,071 661\u00a02,373\u00a01,733\u00a0557\u00a06,903\u00a02.1%\u00a03.0%\u00a02.7%\u00a0\nASC.01.06 \u00a0Prevenci\u00f3n \u00a0\u2013\u00a0j\u00f3venes\u00a0no\u00a0escolarizados \u00a0 280\u00a0331\u00a0398\u00a0 91\u00a0 106\u00a0 35\u00a01,241\u00a01.0%\u00a00.2%\u00a00.5%\u00a0\nASC.01.07 \u00a0Prevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0del\u00a0VIH\u00a0dirigida\u00a0a\u00a0personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0(PVV)\u00a0 194\u00a0161\u00a0313\u00a0 39\u00a0 32\u00a0 33\u00a0 771\u00a00.6%\u00a00.1%\u00a00.3%\u00a0\nASC.01.08.03 \u00a0Prevenci\u00f3n \u00a0y\u00a0tratamiento \u00a0de\u00a0ITS\u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0para\u00a0profesionales \u00a0del\u00a0\nsexo\u00a0y\u00a0sus\u00a0clientes\u00a0484\u00a0553\u00a01,013\u00a02,487\u00a01,393\u00a01,806 7,737\u00a01.9%\u00a03.7%\u00a03.0%\u00a0\nASC.01.08.04 \u00a0Comunicaci\u00f3n \u00a0para\u00a0el\u00a0cambio\u00a0de\u00a0comportamiento \u00a0(CCC)\u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0\npara\u00a0profesionales \u00a0del\u00a0sexo\u00a0y\u00a0sus\u00a0clientes\u00a0301\u00a0227\u00a0184\u00a0 929\u00a01,100\u00a0\u00a0 2,741\u00a00.7%\u00a01.3%\u00a01.1%\u00a0\nASC.01.08.98 \u00a0Intervenciones \u00a0program\u00e1ticas \u00a0para\u00a0profesionales \u00a0del\u00a0sexo\u00a0y\u00a0sus\u00a0clientes\u00a0no\u00a0\ndesglosadas \u00a0por\u00a0tipo\u00a017\u00a0 23\u00a0 101\u00a0 23\u00a0\u00a0\u00a0 165\u00a00.1%\u00a00.0%\u00a00.1%\u00a0\nASC.01.08.99 \u00a0Otras\u00a0intervenciones \u00a0program\u00e1ticas \u00a0para\u00a0profesionales \u00a0del\u00a0sexo\u00a0y\u00a0sus\u00a0clientes,\u00a0s.c.o. 130\u00a0158\u00a0124\u00a0\u00a0\u00a0\u00a0 412\u00a00.4%\u00a00.0%\u00a00.2%\u00a0\nASC.01.09.01 \u00a0APV\u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0para\u00a0HSH\u00a0 \u00a0\u00a0 242\u00a0\u00a0\u00a0 8\u00a0 250\u00a00.2%\u00a00.0%\u00a00.1%\u00a0\nASC.01.09.02 \u00a0Comercializaci\u00f3n \u00a0social\u00a0del\u00a0preservativo \u00a0y\u00a0suministro \u00a0de\u00a0preservativos \u00a0masculinos \u00a0y\u00a0\nfemeninos \u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0para\u00a0HSH\u00a074\u00a0 19\u00a0 266\u00a0 372\u00a0\u00a0 505\u00a01,236\u00a00.3%\u00a00.6%\u00a00.5%\u00a0\nASC.01.09.03 \u00a0Prevenci\u00f3n \u00a0y\u00a0tratamiento \u00a0de\u00a0ITS\u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0para\u00a0HSH\u00a0 21\u00a0 50\u00a0 172\u00a0 728\u00a0 542\u00a0666\u00a02,178\u00a00.2%\u00a01.3%\u00a00.8%\u00a0\nASC.01.09.04 \u00a0Comunicaci\u00f3n \u00a0para\u00a0el\u00a0cambio\u00a0de\u00a0comportamiento \u00a0(CCC)\u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0\npara\u00a0HSH\u00a0252\u00a0274\u00a0212\u00a0 244\u00a01,108\u00a01,050 3,139\u00a00.7%\u00a01.6%\u00a01.2%\u00a0\nASC.01.09.98 \u00a0Intervenciones \u00a0program\u00e1ticas \u00a0para\u00a0HSH\u00a0no\u00a0desglosadas \u00a0por\u00a0tipo\u00a0 15\u00a0 23\u00a0 202\u00a0\u00a0\u00a0 351\u00a0590\u00a00.2%\u00a00.2%\u00a00.2%\u00a0\nASC.01.09.99 \u00a0Otras\u00a0intervenciones \u00a0program\u00e1ticas \u00a0para\u00a0HSH\u00a0s.c.o.\u00a0 168\u00a079\u00a0 130\u00a0\u00a0\u00a0\u00a0 378\u00a00.4%\u00a00.0%\u00a00.1%\u00a0\nASC.01.11 \u00a0Programas \u00a0de\u00a0prevenci\u00f3n \u00a0en\u00a0el\u00a0lugar\u00a0de\u00a0trabajo\u00a0 \u00a0\u00a0 66\u00a0 55\u00a0 112\u00a0 10\u00a0 243\u00a00.1%\u00a00.1%\u00a00.1%\u00a0\nASC.01.11.98 \u00a0Intervenciones \u00a0program\u00e1ticas \u00a0en\u00a0el\u00a0lugar\u00a0de\u00a0trabajo\u00a0no\u00a0desglosadas \u00a0por\u00a0tipo\u00a0 \u00a0\u00a0 3\u00a0\u00a0\u00a0\u00a0 3\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nASC.01.12 \u00a0Comercializaci\u00f3n \u00a0social\u00a0del\u00a0preservativo \u00a0 275\u00a0 7\u00a0 109\u00a0 65\u00a0 83\u00a0 95\u00a0 635\u00a00.4%\u00a00.2%\u00a00.2%\u00a0 \u00a0 2005\u00a02006 2007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a02005\u2010\n2007\u00a02008\u2010\n2010\u00a0Total\u00a0\nASC.01.13 \u00a0Suministro \u00a0de\u00a0preservativos \u00a0masculinos \u00a0en\u00a0el\u00a0sector\u00a0p\u00fablico\u00a0y\u00a0comercial \u00a0 2,437\u00a02,530 3,058\u00a04,547\u00a04,510\u00a04,410 21,492 7.6%\u00a08.7%\u00a08.3%\u00a0\nASC.01.16 \u00a0Prevenci\u00f3n, \u00a0diagn\u00f3stico \u00a0y\u00a0tratamiento \u00a0de\u00a0infecciones \u00a0de\u00a0transmisi\u00f3n \u00a0sexual\u00a0(ITS)\u00a0 157\u00a0514\u00a0654\u00a01,022\u00a02,684\u00a01,010 6,040\u00a01.2%\u00a03.1%\u00a02.3%\u00a0\nASC.01.17.01 \u00a0Asesoramiento \u00a0y\u00a0pruebas\u00a0para\u00a0mujeres\u00a0embarazadas \u00a0en\u00a0programas \u00a0de\u00a0PTMI\u00a0 571\u00a0619\u00a0474\u00a03,149\u00a03,881\u00a01,550 10,244 1.6%\u00a05.6%\u00a03.9%\u00a0\nASC.01.17.02 \u00a0Profilaxis\u00a0antirretrov\u00edrica \u00a0para\u00a0embarazadas \u00a0VIH\u2010positivas\u00a0y\u00a0reci\u00e9n\u00a0nacidos\u00a0 72\u00a0335\u00a0141\u00a0 268\u00a0 16\u00a0 21\u00a0 852\u00a00.5%\u00a00.2%\u00a00.3%\u00a0\nASC.01.17.03 \u00a0Pr\u00e1cticas\u00a0seguras\u00a0de\u00a0alimentaci\u00f3n \u00a0de\u00a0lactantes\u00a0(incluidos \u00a0los\u00a0suced\u00e1neos \u00a0de\u00a0la\u00a0leche\u00a0\nmaterna) \u00a090\u00a0165\u00a0123\u00a0 4\u00a0 44\u00a0 265\u00a0692\u00a00.4%\u00a00.2%\u00a00.3%\u00a0\nASC.01.17.98 \u00a0PTMI\u00a0no\u00a0desglosada \u00a0por\u00a0intervenci\u00f3n \u00a0 66\u00a0163\u00a0179\u00a0 440\u00a0 69\u00a0 53\u00a0 971\u00a00.4%\u00a00.4%\u00a00.4%\u00a0\nASC.01.17.99 \u00a0Actividades \u00a0de\u00a0PTMI\u00a0s.c.o.\u00a0 338\u00a0138\u00a0169\u00a0\u00a0\u00a0\u00a0 645\u00a00.6%\u00a00.0%\u00a00.2%\u00a0\nASC.01.19 \u00a0Seguridad \u00a0hematol\u00f3gica \u00a0 189\u00a0376\u00a0706\u00a0\u00a0 123\u00a0558\u00a01,952\u00a01.2%\u00a00.4%\u00a00.7%\u00a0\nASC.01.21 \u00a0Precauciones \u00a0universales \u00a0 14\u00a0 8\u00a0 31\u00a0 2\u00a0 8\u00a0\u00a0 63\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nASC.01.22.01 \u00a0PPE\u00a0en\u00a0\u00e1mbitos\u00a0de\u00a0atenci\u00f3n\u00a0sanitaria\u00a0 \u00a0 10\u00a0\u00a0\u00a0\u00a0\u00a0 10\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nASC.01.99 \u00a0Actividades \u00a0de\u00a0prevenci\u00f3n \u00a0s.c.o.\u00a0 1\u00a0 10\u00a0 12\u00a0 43\u00a0 5\u00a0\u00a0 72\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nATENCION \u00a0Y\u00a0TRATAMIENTO \u00a0 12790\u00a017920 13,852 20,812 24,857 12,587 102,818 42.0% 37.8% 39.5%\u00a0\nASC.01.08.03 \u00a0Prevenci\u00f3n \u00a0y\u00a0tratamiento \u00a0de\u00a0ITS\u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0para\u00a0profesionales \u00a0del\u00a0\nsexo\u00a0y\u00a0sus\u00a0clientes\u00a0\u00a0\u00a0\u00a0\u00a0 25\u00a0 48\u00a0 72\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nASC.01.09.03 \u00a0Prevenci\u00f3n \u00a0y\u00a0tratamiento \u00a0de\u00a0ITS\u00a0como\u00a0parte\u00a0de\u00a0programas \u00a0para\u00a0HSH\u00a0 \u00a0\u00a0\u00a0 96\u00a0\u00a0\u00a0 96\u00a0 0.0%\u00a00.1%\u00a00.0%\u00a0\nASC.02.01.01 \u00a0Asesoramiento \u00a0y\u00a0pruebas\u00a0por\u00a0iniciativa\u00a0del\u00a0proveedor \u00a0(APIP)\u00a0 855\u00a01,272 1,975\u00a03,670\u00a01,513\u00a02,040 11,325 3.9%\u00a04.7%\u00a04.3%\u00a0\nASC.02.01.02.01 \u00a0Profilaxis\u00a0ambulatoria \u00a0de\u00a0IO\u00a0 2\u00a0 3\u00a0 11\u00a0 26\u00a0 2\u00a0\u00a0 43\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nASC.02.01.02.02 \u00a0Tratamiento \u00a0ambulatorio \u00a0de\u00a0IO\u00a0 611\u00a0659\u00a01,322\u00a01,828\u00a01,447\u00a01,165 7,032\u00a02.4%\u00a02.9%\u00a02.7%\u00a0\nASC.02.01.03.01.01 \u00a0Terapia\u00a0antirretrov\u00edrica \u00a0de\u00a0primera\u00a0l\u00ednea\u00a0\u2013\u00a0adultos\u00a0 4,436\u00a03,586 493\u00a04,871\u00a02,486\u00a01,927 17,799 8.0%\u00a06.0%\u00a06.8%\u00a0\nASC.02.01.03.01.02 \u00a0Terapia\u00a0antirretrov\u00edrica \u00a0de\u00a0segunda\u00a0l\u00ednea\u00a0\u2013\u00a0adultos\u00a0 3,392\u00a07,411 2,137\u00a04,655\u00a011,376 1,565 30,536 12.2% 11.4% 11.7%\u00a0\nASC.02.01.03.01.98 \u00a0Terapia\u00a0antirretrov\u00edrica \u00a0para\u00a0adultos\u00a0no\u00a0desglosada \u00a0por\u00a0l\u00ednea\u00a0de\u00a0tratamiento \u00a0475\u00a0998\u00a01,276\u00a0800\u00a0 778\u00a0829\u00a05,156\u00a02.6%\u00a01.6%\u00a02.0%\u00a0\nASC.02.01.03.02.98 \u00a0Terapia\u00a0antirretrov\u00edrica \u00a0pedi\u00e1trica \u00a0no\u00a0desglosada \u00a0por\u00a0l\u00ednea\u00a0de\u00a0tratamiento \u00a0 96\u00a0212\u00a0550\u00a0 404\u00a0 426\u00a0267\u00a01,955\u00a00.8%\u00a00.7%\u00a00.8%\u00a0\nASC.02.01.03.98 \u00a0Terapia\u00a0antirretrov\u00edrica \u00a0no\u00a0desglosada \u00a0por\u00a0edad\u00a0ni\u00a0por\u00a0l\u00ednea\u00a0de\u00a0tratamiento \u00a0 898\u00a0669\u00a0741\u00a0 144\u00a0 144\u00a0144\u00a02,740\u00a02.2%\u00a00.3%\u00a01.1%\u00a0\nASC.02.01.04 \u00a0Apoyo\u00a0nutricional \u00a0asociado\u00a0con\u00a0la\u00a0terapia\u00a0antirretrov\u00edrica \u00a0 \u00a0\u00a0\u00a0 7\u00a0 7\u00a0 7\u00a0 21\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nASC.02.01.05 \u00a0Vigilancia \u00a0de\u00a0laboratorio \u00a0espec\u00edfica \u00a0relacionada \u00a0con\u00a0el\u00a0VIH\u00a0 737\u00a01,238 2,935\u00a01,533\u00a04,991\u00a02,858 14,293 4.6%\u00a06.1%\u00a05.5%\u00a0\nASC.02.01.07 \u00a0Tratamiento \u00a0psicol\u00f3gico \u00a0y\u00a0servicios\u00a0de\u00a0apoyo\u00a0 \u00a0\u00a0\u00a0 81\u00a0 79\u00a0 84\u00a0 243\u00a00.0%\u00a00.2%\u00a00.1%\u00a0\nASC.02.01.08 \u00a0Atenci\u00f3n\u00a0paliativa\u00a0ambulatoria \u00a0 360\u00a0949\u00a0612\u00a0 43\u00a0 43\u00a0 28\u00a02,035\u00a01.8%\u00a00.1%\u00a00.8%\u00a0\nASC.02.02.01 \u00a0Tratamiento \u00a0hospitalario \u00a0de\u00a0infecciones \u00a0oportunistas \u00a0(IO)\u00a0 701\u00a0755\u00a0936\u00a01,424\u00a01,420\u00a01,560 6,796\u00a02.3%\u00a02.9%\u00a02.6%\u00a0\nASC.02.02.99 \u00a0Servicios\u00a0de\u00a0atenci\u00f3n\u00a0hospitalaria \u00a0s.c.o.\u00a0 227\u00a0170\u00a0127\u00a0 6\u00a0 6\u00a0 6\u00a0 541\u00a00.5%\u00a00.0%\u00a00.2%\u00a0\nASC.02.99 \u00a0Servicios\u00a0de\u00a0atenci\u00f3n\u00a0y\u00a0tratamiento \u00a0s.c.o.\u00a0 \u00a0\u00a0 737\u00a01,223\u00a0115\u00a0 59\u00a02,134\u00a00.7%\u00a00.9%\u00a00.8%\u00a0\nHUERFANOS \u00a0Y\u00a0NI\u00d1OS\u00a0MAS\u00a0VULNERABLES \u00a0 \u00a0 59\u00a0 171\u00a0 16\u00a0 8\u00a0 9\u00a0 263\u00a00.2%\u00a00.0%\u00a00.1%\u00a0\nASC.03.02 \u00a0Atenci\u00f3n\u00a0b\u00e1sica\u00a0de\u00a0la\u00a0salud\u00a0para\u00a0HNV\u00a0 \u00a0 59\u00a0 131\u00a0 16\u00a0 8\u00a0 9\u00a0 223\u00a00.2%\u00a00.0%\u00a00.1%\u00a0\nASC.03.03 \u00a0Apoyo\u00a0a\u00a0la\u00a0familia/al \u00a0hogar\u00a0para\u00a0HNV\u00a0 \u00a0\u00a0 40\u00a0\u00a0\u00a0\u00a0 40\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nGESTION\u00a0DE\u00a0PROGRAMA \u00a0Y\u00a0FORTALECIMIENTO \u00a0DE\u00a0LA\u00a0ADMINISTRACION \u00a0 1876\u00a01,943 1,571\u00a03,184\u00a04,635\u00a02,952 16,160 5.1%\u00a07.0%\u00a06.2%\u00a0 \u00a0 2005\u00a02006 2007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a02005\u2010\n2007\u00a02008\u2010\n2010\u00a0Total\u00a0\nASC.01.08.99 \u00a0Otras\u00a0intervenciones \u00a0program\u00e1ticas \u00a0para\u00a0profesionales \u00a0del\u00a0sexo\u00a0y\u00a0sus\u00a0clientes,\u00a0s.c.o. 2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nASC.04.01 \u00a0Planificaci\u00f3n, \u00a0coordinaci\u00f3n \u00a0y\u00a0gesti\u00f3n\u00a0de\u00a0programas \u00a0 273\u00a0281\u00a0137\u00a02,578\u00a03,738\u00a02,400 9,407\u00a00.7%\u00a05.7%\u00a03.6%\u00a0\nASC.04.02 \u00a0Costos\u00a0de\u00a0administraci\u00f3n \u00a0y\u00a0transacci\u00f3n \u00a0asociados \u00a0con\u00a0la\u00a0gesti\u00f3n\u00a0y\u00a0el\u00a0desembolso \u00a0de\u00a0\nfondos\u00a0180\u00a0675\u00a0651\u00a0 243\u00a0 122\u00a0271\u00a02,142\u00a01.4%\u00a00.4%\u00a00.8%\u00a0\nASC.04.03 \u00a0Vigilancia \u00a0y\u00a0evaluaci\u00f3n \u00a0 359\u00a0246\u00a0359\u00a0 204\u00a0 168\u00a0103\u00a01,438\u00a00.9%\u00a00.3%\u00a00.6%\u00a0\nASC.04.05 \u00a0Vigilancia \u00a0serol\u00f3gica \u00a0(serovigilancia) \u00a0 118\u00a095\u00a0 47\u00a0 91\u00a0 365\u00a0 33\u00a0 748\u00a00.2%\u00a00.3%\u00a00.3%\u00a0\nASC.04.06 \u00a0Vigilancia \u00a0de\u00a0la\u00a0farmacorresistencia \u00a0al\u00a0VIH\u00a0 417\u00a0431\u00a0298\u00a0 31\u00a0 49\u00a0 55\u00a01,281\u00a01.1%\u00a00.1%\u00a00.5%\u00a0\nASC.04.07 \u00a0Sistemas\u00a0de\u00a0suministros \u00a0de\u00a0f\u00e1rmacos\u00a0 \u00a0\u00a0\u00a0\u00a0 41\u00a0 26\u00a0 67\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nASC.04.08 \u00a0Tecnolog\u00eda \u00a0de\u00a0la\u00a0informaci\u00f3n \u00a0 497\u00a0215\u00a0 57\u00a0 25\u00a0 152\u00a0 11\u00a0 956\u00a00.7%\u00a00.1%\u00a00.4%\u00a0\nASC.04.10.01 \u00a0Mejora\u00a0de\u00a0infraestructura \u00a0de\u00a0laboratorio \u00a0y\u00a0equipos\u00a0nuevos\u00a0de\u00a0laboratorio \u00a0 1\u00a0\u00a0\u00a0 13\u00a0\u00a0 34\u00a0 48\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nASC.04.10.99 \u00a0Mejora\u00a0y\u00a0construcci\u00f3n \u00a0de\u00a0infraestructura \u00a0s.c.o.\u00a0 30\u00a0\u00a0 22\u00a0\u00a0\u00a0 19\u00a0 71\u00a0 0.0%\u00a00.0%\u00a00.0%\u00a0\nCONTRATACION \u00a0DE\u00a0RECURSOS \u00a0HUMANOS \u00a0E\u00a0INCENTIVOS \u00a0DE\u00a0RETENCION \u00a0 213\u00a031\u00a0 16\u00a0 191\u00a0 52\u00a0 17\u00a0 520\u00a00.2%\u00a00.2%\u00a00.2%\u00a0\nASC.01.08.99 \u00a0Otras\u00a0intervenciones \u00a0program\u00e1ticas \u00a0para\u00a0profesionales \u00a0del\u00a0sexo\u00a0y\u00a0sus\u00a0clientes,\u00a0s.c.o. 107\u00a011\u00a0\u00a0\u00a0\u00a0\u00a0 117\u00a00.1%\u00a00.0%\u00a00.0%\u00a0\nASC.05.03 \u00a0Capacitaci\u00f3n \u00a0 106\u00a020\u00a0 16\u00a0 191\u00a0 52\u00a0 17\u00a0 402\u00a00.1%\u00a00.2%\u00a00.2%\u00a0\nPROTECCION \u00a0SOCIAL\u00a0Y\u00a0SERVICIOS \u00a0SOCIALES \u00a0(EXCLUYENDO \u00a0HUERFANOS) \u00a0 306\u00a0603\u00a01,505\u00a01,498\u00a01,278\u00a0549\u00a05,740\u00a02.3%\u00a02.2%\u00a02.2%\u00a0\nASC.06.02 \u00a0Protecci\u00f3n \u00a0social\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0beneficios \u00a0en\u00a0especie\u00a0 221\u00a0237\u00a0299\u00a0 320\u00a0 300\u00a0 20\u00a01,397\u00a00.7%\u00a00.4%\u00a00.5%\u00a0\nASC.06.03 \u00a0Protecci\u00f3n \u00a0social\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0la\u00a0provisi\u00f3n\u00a0de\u00a0servicios\u00a0sociales\u00a0 85\u00a0365\u00a01,181\u00a0601\u00a0 843\u00a0390\u00a03,467\u00a01.5%\u00a01.2%\u00a01.3%\u00a0\nASC.06.04 \u00a0Proyectos \u00a0de\u00a0generaci\u00f3n \u00a0de\u00a0ingresos\u00a0espec\u00edficos \u00a0del\u00a0VIH\u00a0 \u00a0\u00a0 25\u00a0 577\u00a0 135\u00a0139\u00a0876\u00a00.0%\u00a00.6%\u00a00.3%\u00a0\nDESARROLLO \u00a0COMUNITARIO \u00a0Y\u00a0AMBIENTE \u00a0MEJORADO \u00a0 898\u00a01,538 2,571\u00a01,852\u00a02,621\u00a02,932 12,411 4.7%\u00a04.8%\u00a04.8%\u00a0\nASC.01.05 \u00a0Prevenci\u00f3n \u00a0\u2013\u00a0j\u00f3venes\u00a0escolarizados \u00a0 \u00a0\u00a0\u00a0 123\u00a0\u00a0\u00a0 123\u00a00.0%\u00a00.1%\u00a00.0%\u00a0\nASC.01.08.99 \u00a0Otras\u00a0intervenciones \u00a0program\u00e1ticas \u00a0para\u00a0profesionales \u00a0del\u00a0sexo\u00a0y\u00a0sus\u00a0clientes,\u00a0s.c.o. \u00a0 19\u00a0 7\u00a0\u00a0\u00a0 351\u00a0377\u00a00.0%\u00a00.2%\u00a00.1%\u00a0\nASC.07.01 \u00a0Sensibilizaci\u00f3n \u00a0 84\u00a0437\u00a0592\u00a0 582\u00a01,092\u00a0628\u00a03,416\u00a01.0%\u00a01.5%\u00a01.3%\u00a0\nASC.07.02.03 \u00a0Desarrollo \u00a0de\u00a0la\u00a0capacidad \u00a0en\u00a0derechos\u00a0humanos \u00a0 8\u00a0 63\u00a0 439\u00a0 437\u00a0 231\u00a0 3\u00a0 1,180\u00a00.5%\u00a00.4%\u00a00.5%\u00a0\nASC.07.03 \u00a0Desarrollo \u00a0institucional \u00a0espec\u00edfico \u00a0del\u00a0sida\u00a0 65\u00a0235\u00a0594\u00a0 690\u00a01,297\u00a0183\u00a03,065\u00a00.8%\u00a01.4%\u00a01.2%\u00a0\nASC.07.04 \u00a0Programas \u00a0espec\u00edficos \u00a0del\u00a0sida\u00a0orientados \u00a0a\u00a0las\u00a0mujeres\u00a0 741\u00a0784\u00a0939\u00a0 20\u00a0\u00a0 1,766 4,251\u00a02.3%\u00a01.2%\u00a01.6%\u00a0\nINVESTIGACION \u00a0RELACIONADA \u00a0CON\u00a0VIH\u00a0SIDA\u00a0(EXCLUYE \u00a0INVESTIGACION \u00a0OPERATIVA) \u00a0 4,749\u00a05,975 9,295\u00a09,333\u00a08,792\u00a01,256 39,399 18.9% 12.6% 15.1%\u00a0\nASC.08.02 \u00a0Investigaci\u00f3n \u00a0cl\u00ednica\u00a0 4,143\u00a04,693 7,985\u00a08,476\u00a07,829\u00a01,210 34,337 15.9% 11.4% 13.2%\u00a0\nASC.08.04.01 \u00a0Investigaci\u00f3n \u00a0comportamental \u00a0 600\u00a01,270 1,293\u00a0753\u00a0 958\u00a0\u00a0 4,874\u00a03.0%\u00a01.1%\u00a01.9%\u00a0\nASC.08.04.98 \u00a0Investigaci\u00f3n \u00a0en\u00a0ciencias\u00a0sociales\u00a0no\u00a0desglosada \u00a0por\u00a0tipo\u00a0 5\u00a0 12\u00a0 17\u00a0 104\u00a0 5\u00a0 45\u00a0 188\u00a00.0%\u00a00.1%\u00a00.1%\u00a0\nTotal\u00a0 28157\u00a036477 41443 55598 62242 36427 260345 100%\u00a0100%\u00a0100%\u00a0 55 \u00a0\n\uf02d Atenci\u00f3n\u00a0y\u00a0tratamiento \u00a0\n\u00a0\nDesde\u00a0el\u00a02004\u00a0se\u00a0brinda\u00a0de\u00a0forma\u00a0gratuita\u00a0el\u00a0tratamiento \u00a0antirretroviral \u00a0de\u00a0gran\u00a0actividad\u00a0(TARGA),\u00a0el\u00a0cual\u00a0\nfue\u00a0asumido\u00a0por\u00a0el\u00a0Estado\u00a0Peruano\u00a0desde\u00a0el\u00a0a\u00f1o\u00a02006(\u00a032\u00a0).\u00a0Asimismo, \u00a0el\u00a0apoyo\u00a0del\u00a0FMSTM\u00a0permiti\u00f3\u00a0que\u00a0\ngastos\u00a0asociados \u00a0al\u00a0tratamiento \u00a0antirretroviral, \u00a0como\u00a0son\u00a0el\u00a0tratamiento \u00a0para\u00a0infecciones \u00a0oportunistas \u00a0y\u00a0el\u00a0\ntratamiento \u00a0de\u00a0las\u00a0reacciones \u00a0adversas\u00a0a\u00a0los\u00a0medicamentos \u00a0(RAM),\u00a0tambi\u00e9n\u00a0sean\u00a0gratuitos\u00a0hasta\u00a0que\u00a0\nculmin\u00f3\u00a0el\u00a0programa \u00a0de\u00a0la\u00a05ta\u00a0Ronda.\u00a0\u00a0Durante\u00a0el\u00a0a\u00f1o\u00a02010\u00a0y\u00a0hasta\u00a0el\u00a0cierre\u00a0de\u00a0este\u00a0reporte,\u00a0s\u00f3lo\u00a0se\u00a0pudo\u00a0\nregistrar\u00a0el\u00a0per\u00edodo\u00a0de\u00a0tr\u00e1nsito\u00a0en\u00a0que\u00a0\u00a0los\u00a0medicamentos \u00a0ya\u00a0no\u00a0eran\u00a0asumidos \u00a0por\u00a0el\u00a0FMSTM\u00a0pero\u00a0tampoco\u00a0\nestaban\u00a0incluidos\u00a0en\u00a0el\u00a0petitorio\u00a0nacional,\u00a0motivo\u00a0por\u00a0el\u00a0cual\u00a0los\u00a0gastos\u00a0colaterales \u00a0que\u00a0demandaba \u00a0el\u00a0\ntratamiento \u00a0de\u00a0las\u00a0personas\u00a0con\u00a0VIH\u00a0(PVV)\u00a0estaban\u00a0siendo\u00a0asumidos, \u00a0transitoriamente, \u00a0en\u00a0parte\u00a0por\u00a0las\u00a0\nfamilias\u00a0y\u00a0en\u00a0parte\u00a0por\u00a0el\u00a0Estado.\u00a0\u00a0Solamente \u00a0las\u00a0personas\u00a0que\u00a0se\u00a0encontraban \u00a0en\u00a0ese\u00a0momento \u00a0afiliadas\u00a0a\u00a0la\u00a0\nSeguridad \u00a0Social\u00a0contaban \u00a0con\u00a0cobertura \u00a0total,\u00a0siempre\u00a0y\u00a0cuando\u00a0la\u00a0PVV\u00a0se\u00a0encontrase \u00a0acreditada(\u00a033\u00a0).\u00a0La\u00a0\nsituaci\u00f3n\u00a0ha\u00a0sido\u00a0corregida \u00a0en\u00a0el\u00a0a\u00f1o\u00a02011,\u00a0en\u00a0que\u00a0los\u00a0medicamentos \u00a0para\u00a0infecciones \u00a0oportunistas \u00a0y\u00a0\nreacciones \u00a0adversas\u00a0se\u00a0han\u00a0incluido\u00a0ya\u00a0en\u00a0el\u00a0Programa \u00a0de\u00a0Compras\u00a0Estrat\u00e9gicas \u00a0del\u00a0Ministerio \u00a0de\u00a0Salud34.\u00a0\n\u00a0\nDe\u00a0acuerdo\u00a0a\u00a0la\u00a0clasificaci\u00f3n \u00a0MEGAS\u00a0las\u00a0pruebas\u00a0para\u00a0diagn\u00f3stico \u00a0se\u00a0encuentran \u00a0en\u00a0esta\u00a0categor\u00eda. \u00a0\u00a0En\u00a0el\u00a0\nPer\u00fa\u00a0se\u00a0ha\u00a0establecido \u00a0que\u00a0el\u00a0diagn\u00f3stico \u00a0de\u00a0VIH\u00a0debe\u00a0acompa\u00f1arse \u00a0de\u00a0una\u00a0consejer\u00eda \u00a0pre\u2010test\u00a0y\u00a0una\u00a0post\u2010\ntest,\u00a0sin\u00a0embargo\u00a0esto\u00a0no\u00a0es\u00a0aplicado\u00a0en\u00a0la\u00a0oferta\u00a0privada\u00a0(laboratorios \u00a0cl\u00ednicos).\u00a0\n\u00a0\nCantidad\u00a0de\u00a0enrolados \u00a0en\u00a0el\u00a0sistema\u00a0de\u00a0salud\u00a01/\u00a0\nDepartamento \u00a0En\u00a0\ntratamiento \u00a0Fallecidos \u00a0En\u00a0espera\u00a0\nInicio\u00a0ARV\u00a0En\u00a0proceso\u00a0de\u00a0\nEvaluaci\u00f3n \u00a0Total\u00a0\nenrolados \u00a0\nAmazonas \u00a0 21\u00a0 9\u00a0 4\u00a0 2\u00a0 30\u00a0\nAncash\u00a0 156\u00a0 44\u00a0 9\u00a0 66\u00a0 218\u00a0\nApur\u00edmac \u00a0 15\u00a0 5\u00a0 1\u00a0 2\u00a0 21\u00a0\nArequipa\u00a0 321\u00a0 63\u00a0 14\u00a0 18\u00a0 429\u00a0\nAyacucho \u00a0 25\u00a0 8\u00a0 3\u00a0 6\u00a0 42\u00a0\nCajamarca \u00a0 40\u00a0 1\u00a0 9\u00a0 36\u00a0 46\u00a0\nCallao\u00a0 1,016\u00a0 115\u00a0 34\u00a0 194\u00a0 1,231\u00a0\nCusco\u00a0 68\u00a0 28\u00a0 2\u00a0 22\u00a0 113\u00a0\nHuancavelica \u00a0 12\u00a0 3\u00a0\u00a0 1\u00a0 15\u00a0\nHu\u00e1nuco\u00a0 75\u00a0 12\u00a0 28\u00a0 20\u00a0 99\u00a0\nIca\u00a0 263\u00a0\u00a0 4\u00a0 4\u00a0 334\u00a0\nJun\u00edn\u00a0 179\u00a0 43\u00a0 8\u00a0 14\u00a0 265\u00a0\nLa\u00a0Libertad\u00a0 409\u00a0 41\u00a0 8\u00a0 393\u00a0 469\u00a0\nLambayeque \u00a0 301\u00a0 77\u00a0 101\u00a0\u00a0 432\u00a0\nLima\u00a0 7,447\u00a0 950\u00a0 144\u00a0 325\u00a0 9,617\u00a0\nLima\u2010\u00a0ONG\u00a0 1,883\u00a0 118\u00a0 40\u00a0 354\u00a0 2,302\u00a0\nLima\u00a0Regi\u00f3n\u00a0 313\u00a0 40\u00a0 25\u00a0 13\u00a0 448\u00a0\nLoreto\u00a0 752\u00a0 167\u00a0 24\u00a0 529\u00a0 1,025\u00a0\nMadre\u00a0de\u00a0Dios\u00a0 55\u00a0 19\u00a0 3\u00a0 36\u00a0 87\u00a0\nMoquegua \u00a0 27\u00a0 8\u00a0 1\u00a0 3\u00a0 36\u00a0\nPasco\u00a0 24\u00a0 4\u00a0 3\u00a0 6\u00a0 30\u00a0\nPiura\u00a0 327\u00a0 67\u00a0 13\u00a0 37\u00a0 495\u00a0\nPuno\u00a0 14\u00a0 1\u00a0 7\u00a0 24\u00a0 18\u00a0\n                                                 \n32 Resoluci\u00f3n \u00a0ministerial \u00a0752\u20102004/MINSA, \u00a0\u00a0\"Norma\u00a0T\u00e9cnica\u00a0para\u00a0la\u00a0Adherencia \u00a0al\u00a0Tratamiento \u00a0Antirretroviral \u00a0de\u00a0Gran\u00a0\nActividad \u2010TARGA\u00a0\u2010\u00a0en\u00a0adultos\u00a0infectados \u00a0por\u00a0el\u00a0virus\u00a0de\u00a0la\u00a0inmunodeficiencia \u00a0humana\", \u00a08\u00a0enero\u00a0del\u00a02004 \n33 La\u00a0acreditaci\u00f3n \u00a0es\u00a0posible\u00a0cuando\u00a0una\u00a0persona\u00a0ha\u00a0trabajado \u00a0durante\u00a0tres\u00a0meses\u00a0continuos \u00a0o\u00a0cuatro\u00a0alternos\u00a0en\u00a0\u00a0el\u00a0\ntranscurso \u00a0de\u00a0seis\u00a0meses.  \n34 Informe\u00a0N\u00ba\u00a0113\u20102011\u2010DGSP/ESN \u00a0PC\u00a0ITS\u2010VIH\u2010SIDA/MINSA.   56 Departamento \u00a0En\u00a0\ntratamiento \u00a0Fallecidos \u00a0En\u00a0espera\u00a0\nInicio\u00a0ARV\u00a0En\u00a0proceso\u00a0de\u00a0\nEvaluaci\u00f3n \u00a0Total\u00a0\nenrolados \u00a0\nSan\u00a0Martin\u00a0 233\u00a0 56\u00a0 0\u00a0 25\u00a0 343\u00a0\nTacna\u00a0 51\u00a0\u00a0 4\u00a0 20\u00a0 77\u00a0\nTumbes\u00a0 135\u00a0 35\u00a0 6\u00a0 27\u00a0 191\u00a0\nUcayali\u00a0 179\u00a0 32\u00a0 2\u00a0 132\u00a0 246\u00a0\nTotal\u00a0\u00a0 14,341\u00a0 1,946\u00a0 497\u00a0 2,309\u00a0 18,659\u00a0\n1/Incluye \u00a0enrolados \u00a0de\u00a0fuerzas\u00a0armadas\u00a0y\u00a0policiales\u00a0y\u00a0atendidos \u00a0en\u00a0ONG.\u00a0No\u00a0incluye\u00a0ESSALUD. \u00a0A\u00a0\nsetiembre \u00a02010\u00a0\n\u00a0\n\uf02d Hu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0vulnerables \u00a0\nNo\u00a0se\u00a0han\u00a0desarrollado \u00a0intervenciones \u00a0espec\u00edficas \u00a0para\u00a0hu\u00e9rfanos. \u00a0Con\u00a0respecto\u00a0a\u00a0los\u00a0ni\u00f1os\u00a0afectados \u00a0por\u00a0\ntener\u00a0VIH\u00a0o\u00a0por\u00a0tener\u00a0padres\u00a0con\u00a0VIH,\u00a0existen\u00a0hasta\u00a03\u00a0albergues \u00a0dirigidas\u00a0por\u00a0organizaciones \u00a0basadas\u00a0en\u00a0la\u00a0fe\u00a0\n(OBF),\u00a0la\u00a0atenci\u00f3n\u00a0es\u00a0gratuita\u00a0y\u00a0apoyado\u00a0con\u00a0recursos\u00a0de\u00a0cooperaci\u00f3n. \u00a0\u00a0Tambi\u00e9n\u00a0se\u00a0ha\u00a0desarrollado \u00a0\nintervenciones \u00a0apoyadas \u00a0por\u00a0UNICEF,\u00a0vinculadas \u00a0a\u00a0tratamiento \u00a0ARV\u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0pedi\u00e1trica. \u00a0\n\u00a0\n\uf02d Gesti\u00f3n\u00a0y\u00a0administraci\u00f3n \u00a0de\u00a0los\u00a0programas \u00a0\nLa\u00a0conducci\u00f3n \u00a0de\u00a0las\u00a0estrategias \u00a0es\u00a0realizada\u00a0por\u00a0la\u00a0Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Prevenci\u00f3n \u00a0y\u00a0control\u00a0de\u00a0\nITS/VIH/SIDA \u00a0quien\u00a0tiene\u00a0un\u00a0rol\u00a0normativo \u00a0y\u00a0de\u00a0planeamiento \u00a0y\u00a0en\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os\u00a0ha\u00a0liderado\u00a0las\u00a0\nactividades \u00a0de\u00a0los\u00a0programas \u00a0del\u00a0FMSTM.\u00a0\u00a0Los\u00a0estudios\u00a0de\u00a0vigilancia\u00a0(concepto \u00a0incluido\u00a0en\u00a0este\u00a0rubro\u00a0seg\u00fan\u00a0\nla\u00a0clasificaci\u00f3n \u00a0MEGAS)\u00a0se\u00a0encuentran \u00a0a\u00a0cargo\u00a0de\u00a0la\u00a0Direcci\u00f3n \u00a0General\u00a0de\u00a0Epidemiolog\u00eda, \u00a0quien\u00a0ha\u00a0conducido \u00a0\nen\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os\u00a0estudios\u00a0de\u00a0vigilancia\u00a0en\u00a0HSH\u00a0(2006),\u00a0en\u00a0parejas\u00a0de\u00a0gestantes \u00a0(2005)\u00a0y\u00a0TS\u00a0(2002).\u00a0\n\u00a0\n\uf02d Protecciones \u00a0sociales\u00a0y\u00a0servicios\u00a0sociales\u00a0\nSe\u00a0han\u00a0desarrollado \u00a0programas \u00a0de\u00a0apoyo\u00a0alimentario \u00a0e\u00a0intervenciones \u00a0educativas \u00a0que\u00a0permiten \u00a0generar\u00a0\ncapacidades \u00a0para\u00a0mejorar\u00a0la\u00a0alimentaci\u00f3n \u00a0y\u00a0nutrici\u00f3n\u00a0de\u00a0las\u00a0familias\u00a0beneficiarias, \u00a0\u00a0\u00a0financiadas \u00a0por\u00a0\norganismos \u00a0de\u00a0cooperaci\u00f3n \u00a0e\u00a0implementados \u00a0por\u00a0el\u00a0PRONAA\u00a0entidad\u00a0dependiente \u00a0del\u00a0\u00a0Ministerio \u00a0de\u00a0la\u00a0\nmujer\u00a0y\u00a0desarrollo \u00a0social\u00a0(MIMDES). \u00a0(\u00a035\u00a0)\u00a0\u00a0\u00a0\u00a0\u00a0En\u00a0Lima,\u00a0la\u00a0capital\u00a0del\u00a0pa\u00eds\u00a0y\u00a0en\u00a0Iquitos,\u00a0segunda\u00a0ciudad\u00a0con\u00a0m\u00e1s\u00a0\nalta\u00a0prevalencia \u00a0de\u00a0VIH,\u00a0existen\u00a0albergues \u00a0para\u00a0PVV,\u00a0conducidos \u00a0por\u00a0OBF\u00a0y\u00a0auxiliados \u00a0por\u00a0voluntarios. \u00a0\u00a0\n\u00a0\n\uf02d Entorno\u00a0favorable \u00a0\nEn\u00a0el\u00a0a\u00f1o\u00a02003\u00a0se\u00a0form\u00f3\u00a0el\u00a0\u00a0Mecanismo \u00a0de\u00a0Coordinaci\u00f3n \u00a0del\u00a0Pa\u00eds\u00a0que\u00a0en\u00a0nuestro\u00a0pa\u00eds\u00a0adopt\u00f3\u00a0el\u00a0nombre\u00a0de\u00a0\nCoordinadora \u00a0Nacional\u00a0Multisectorial \u00a0en\u00a0Salud\u00a0(CONAMUSA), \u00a0articulando \u00a0sectores\u00a0del\u00a0Gobierno \u00a0y\u00a0de\u00a0la\u00a0\nsociedad\u00a0civil.\u00a0\u00a0Este\u00a0espacio\u00a0se\u00a0orienta\u00a0a\u00a0generar\u00a0sinergias\u00a0en\u00a0las\u00a0estrategias \u00a0dise\u00f1adas \u00a0y\u00a0las\u00a0formas\u00a0de\u00a0su\u00a0\nimplementaci\u00f3n. \u00a0\n\u00a0\nEn\u00a0el\u00a0a\u00f1o\u00a02007\u00a0se\u00a0aprob\u00f3\u00a0el\u00a0Plan\u00a0Estrat\u00e9gico \u00a0Multisectorial \u00a02007\u20102011\u00a0para\u00a0la\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0de\u00a0las\u00a0\nITS,\u00a0VIH\u00a0y\u00a0SIDA\u00a0\u00a0(\u00a036\u00a0)\u00a0luego\u00a0de\u00a0un\u00a0proceso\u00a0que\u00a0convoc\u00f3\u00a0a\u00a0entidades \u00a0del\u00a0sector\u00a0p\u00fablico\u00a0y\u00a0sociedad\u00a0civil.\u00a0\u00a0\n                                                 \n35 El\u00a0MIMDES\u00a0es\u00a0la\u00a0instituci\u00f3n \u00a0p\u00fablica\u00a0encargada \u00a0\u00a0de\u00a0la\u00a0protecci\u00f3n \u00a0social.  Las\u00a0competencias \u00a0rectoras\u00a0del\u00a0MIMDES\u00a0se\u00a0\ndirigen\u00a0a\u00a0disminuir \u00a0las\u00a0brechas\u00a0de\u00a0exclusi\u00f3n, \u00a0desarrollar \u00a0y\u00a0promover \u00a0redes\u00a0de\u00a0protecci\u00f3n \u00a0social,\u00a0as\u00ed\u00a0como\u00a0promover \u00a0\ncapacidades \u00a0de\u00a0gesti\u00f3n\u00a0local\u00a0y\u00a0productiva \u00a0de\u00a0la\u00a0poblaci\u00f3n \u00a0en\u00a0pobreza\u00a0y\u00a0pobreza\u00a0extrema.  \n36 Los\u00a0objetivo\u00a0estrat\u00e9gicos \u00a0del\u00a0PEM\u00a0son: \n\uf02d Reducir\u00a0en\u00a050%\u00a0el\u00a0n\u00famero\u00a0de\u00a0nuevos\u00a0casos\u00a0de\u00a0VIH\u00a0y\u00a0en\u00a050%\u00a0la\u00a0prevalencia \u00a0de\u00a0ITS\u00a0en\u00a0poblaciones \u00a0HSH,\u00a0TS,\u00a0PPL\u00a0al\u00a0a\u00f1o\u00a0\n2011.\u00a0\n\uf02d Reducir\u00a0en\u00a050%\u00a0la\u00a0prevalencia \u00a0de\u00a0ITS\u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0general\u00a0al\u00a02011\u00a0\n\uf02d Promover \u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0ITS/VIH,\u00a0la\u00a0educaci\u00f3n \u00a0sexual\u00a0y\u00a0estilos\u00a0de\u00a0vida\u00a0y\u00a0conductas \u00a0sexuales\u00a0saludables \u00a0en\u00a0\nadolescentes \u00a0y\u00a0j\u00f3venes.\u00a0\u00a0\n\uf02d Reducir\u00a0la\u00a0transmisi\u00f3n \u00a0vertical\u00a0a\u00a0\u00a0menos\u00a0del\u00a02%\u00a0al\u00a02011\u00a0\n\uf02d Garantizar \u00a0100%\u00a0de\u00a0tamizaje\u00a0de\u00a0paquetes\u00a0sangu\u00edneos \u00a0al\u00a02011\u00a0\n\uf02d Alcanzar\u00a0un\u00a090%\u00a0de\u00a0acceso\u00a0de\u00a0las\u00a0\u00a0PVVS\u00a0(adultos\u00a0y\u00a0ni\u00f1os)\u00a0\u00a0a\u00a0una\u00a0atenci\u00f3n\u00a0integral\u00a0y\u00a0de\u00a0calidad\u00a0 57 Posteriormente \u00a0se\u00a0han\u00a0aprobado \u00a0Planes\u00a0estrat\u00e9gicos \u00a0regionales \u00a0multisectoriales \u00a0(PERM)\u00a0en\u00a0las\u00a0principales \u00a0\nregiones\u00a0del\u00a0pa\u00eds\u00a0en\u00a0procesos\u00a0similares. \u00a0El\u00a0costeo\u00a0de\u00a0los\u00a0planes\u00a0regionales \u00a0ha\u00a0sido\u00a0apoyado\u00a0por\u00a0ONUSIDA \u00a0y\u00a0el\u00a0\nproceso\u00a0de\u00a0implementaci\u00f3n \u00a0de\u00a0los\u00a0PERM\u00a0viene\u00a0siendo\u00a0\u00a0reforzado \u00a0por\u00a0la\u00a0presencia \u00a0en\u00a0las\u00a0regiones\u00a0de\u00a0sub\u2010\nreceptores \u00a0que\u00a0implementan \u00a0\u00a0los\u00a0proyectos \u00a0del\u00a0FMSTM.\u00a0\n\u00a0\nPara\u00a0el\u00a0a\u00f1o\u00a02010 se\u00a0encuentran \u00a0en\u00a0funcionamiento \u00a0siete\u00a0Coordinadoras \u00a0Regionales \u00a0Multisectoriales \u00a0en\u00a0\nSalud\u00a0(COREMUSAS) \u00a0:\u00a0Lima\u00a0Metropolitana, \u00a0Callao,\u00a0Chimbote, \u00a0Ica,\u00a0Piura,\u00a0Loreto\u00a0y\u00a0Pucallpa.\u00a0En\u00a0estas\u00a0instancias \u00a0\nse\u00a0trabajan\u00a0propuestas \u00a0en\u00a0los\u00a0ejes\u00a0de\u00a0Gesti\u00f3n,\u00a0Comunicaciones, \u00a0Vigilancia \u00a0Social\u00a0y\u00a0Sostenibilidad. \u00a0\n\u00a0\n\uf02d Investigaci\u00f3n \u00a0\u00a0(\u00a0\u00a037\u00a0\u00a0)\u00a0\nLa\u00a0epidemia \u00a0de\u00a0VIH\u00a0en\u00a0el\u00a0Per\u00fa\u00a0es\u00a0y\u00a0ha\u00a0sido\u00a0una\u00a0de\u00a0las\u00a0m\u00e1s\u00a0estudiadas \u00a0de\u00a0Am\u00e9rica\u00a0latina.\u00a0\u00a0Desde\u00a01997\u00a0y\u00a0en\u00a0\nalgunos\u00a0casos\u00a0con\u00a0el\u00a0apoyo\u00a0de\u00a0promotores \u00a0de\u00a0pares\u00a0\u00a0se\u00a0ha\u00a0desarrollado \u00a0ensayos\u00a0cl\u00ednicos\u00a0como\u00a0parte\u00a0de\u00a0\nestudios\u00a0internacionales, \u00a0dirigidos\u00a0por\u00a0el\u00a0MINSA\u00a0o\u00a0por\u00a0ESSALUD. \u00a0\u00a0\n\u00a0\nEl\u00a0Instituto\u00a0Nacional\u00a0de\u00a0Salud\u00a0(INS)\u00a0tiene\u00a0la\u00a0funci\u00f3n\u00a0de\u00a0revisar,\u00a0registrar\u00a0y\u00a0autorizar\u00a0los\u00a0ensayos\u00a0cl\u00ednicos\u00a0y\u00a0\ngarantizar \u00a0la\u00a0aplicaci\u00f3n \u00a0de\u00a0las\u00a0normas\u00a0\u00e9ticas\u00a0internacionales \u00a0\u00a0y\u00a0las\u00a0Buenas\u00a0Pr\u00e1cticas\u00a0Cl\u00ednicas\u00a0en\u00a0la\u00a0realizaci\u00f3n \u00a0\nde\u00a0los\u00a0ensayos\u00a0cl\u00ednicos\u00a0en\u00a0el\u00a0Per\u00fa .\u00a0\u00a0(\u00a038)\u00a0\u00a0.\u00a0\u00a0Para\u00a0el\u00a0presente\u00a0informe\u00a0el\u00a0INS\u00a0no\u00a0proporciono \u00a0informaci\u00f3n \u00a0sobre\u00a0el\u00a0\npresupuesto \u00a0que\u00a0disponen\u00a0los\u00a0ensayos\u00a0cl\u00ednicos,\u00a0por\u00a0lo\u00a0que\u00a0s\u00f3lo\u00a0se\u00a0puedo\u00a0considerar \u00a0la\u00a0informaci\u00f3n \u00a0remitido\u00a0\npor\u00a0las\u00a0propias\u00a0instituciones \u00a0y\u00a0la\u00a0informaci\u00f3n \u00a0de\u00a0APCI.\u00a0\u00a0\n\u00a0\nEntre\u00a0los\u00a0principales \u00a0investigadores \u00a0\u00a0y\u00a0estudios\u00a0en\u00a0el\u00a0pa\u00eds\u00a0tenemos: \u00a0\n\u00a0\n\uf02d Jorge\u00a0Sanchez,\u00a0MD,\u00a0MPH,*\u00a0Javier\u00a0R.\u00a0Lama,\u00a0MD,\u00a0MPH,*\u00a0Lourdes\u00a0Kusunoki, \u00a0MD,\u2020Hugo \u00a0Manrique, \u00a0MD,\u2021\u00a0\nPedro\u00a0Goicochea, \u00a0MSc,\u00a0MA,*\u00a0Aldo\u00a0Lucchetti, \u00a0MD,*\u00a0Manuel\u00a0Rouillon,\u00a0BSc,\u00a7\u00a0Monica\u00a0Pun,\u00a0MD,k\u00a0Luis\u00a0\nSuarez,\u00a0MD,k\u00a0Silvia\u00a0Montano, \u00a0MD,\u00a0MPH,\u00b6\u00a0Jose\u00a0L.\u00a0Sanchez,\u00a0MD,\u00a0MPH,\u00a0Stephen\u00a0Tabet,\u00a0MD,\u00a0MPH,**\u00a7\u00a7 \u00a0\nJames\u00a0P.\u00a0Hughes,\u00a0PhD,\u2020\u2020\u00a0and\u00a0Connie\u00a0Celum,\u00a0MD,\u00a0MPH**\u00a0for\u00a0the\u00a0Peruvian\u00a0HIV\u00a0Sentinel\u00a0Surveillance \u00a0\nWorking\u00a0Group.\u00a0HIV\u20101,\u00a0Sexually\u00a0Transmitted \u00a0Infections, \u00a0and\u00a0Sexual\u00a0Behavior\u00a0Trends\u00a0Among\u00a0Men\u00a0Who\u00a0\nHave\u00a0Sex\u00a0With\u00a0Men\u00a0in\u00a0Lima,\u00a0Peru.\u00a0Epidemiology \u00a0and\u00a0\u00a0Social\u00a0Science.\u00a0J\u00a0Acquir\u00a0Immune\u00a0Defic\u00a0Syndr\u00a0_\u00a0\nVolume\u00a044,\u00a0Number\u00a05,\u00a0April\u00a015,\u00a02007\u00a0\n\uf02d C\u00a0T\u00a0Bautista,\u00a0J\u00a0L\u00a0Sanchez,\u00a0S\u00a0M\u00a0Montano, \u00a0V\u00a0A\u00a0Laguna\u2010Torres,\u00a0J\u00a0R\u00a0Lama,\u00a0J\u00a0L\u00a0Sanchez,\u00a0L\u00a0Kusunoki, \u00a0H\u00a0\nManrique, \u00a0J\u00a0Acosta,\u00a0O\u00a0Montoya, \u00a0A\u00a0M\u00a0Tambare, \u00a0M\u00a0M\u00a0Avila,\u00a0J\u00a0Vi\u00f1oles,\u00a0N\u00a0Aguayo,\u00a0J\u00a0G\u00a0Olson\u00a0and\u00a0J\u00a0K\u00a0Carr.\u00a0\nSeroprevalence \u00a0of\u00a0and\u00a0risk\u00a0factors\u00a0for\u00a0HIV\u20101\u00a0infection\u00a0among\u00a0South\u00a0American \u00a0men\u00a0who\u00a0have\u00a0sex\u00a0with\u00a0\nmen.\u00a0Sex\u00a0Transm\u00a0Infect\u00a02004;80:498 \u2010504\u00a0\u00a0\n\uf02d J\u00a0Lama,\u00a0J\u00a0Sanchez,\u00a0R\u00a0Galvan,\u00a0L\u00a0Kusunoki, \u00a0H\u00a0Manrique, \u00a0M\u00a0Pun,\u00a0L\u00a0Su\u00e1rez,\u00a0S\u00a0Montano, \u00a0JL\u00a0S\u00e1nchez:\u00a0Trends\u00a0in\u00a0\nHIV,\u00a0sexually\u00a0transmitted \u00a0infections \u00a0and\u00a0risk\u00a0behaviors \u00a0among\u00a0men\u00a0who\u00a0have\u00a0sex\u00a0with\u00a0men\u00a0in\u00a0Lima,\u00a0\nPeru.\u00a0XV\u00a0International \u00a0IDS\u00a0Conference \u00a0Bangkok,\u00a0Thailand\u00a0on\u00a0July\u00a011\u201016th.\u00a02004.\u00a0N|\u00a0WePe\u00a0C6167\u00a0\n                                                                                                                                                     \n\uf02d Promover \u00a0un\u00a0entorno\u00a0pol\u00edtico,\u00a0social\u00a0y\u00a0legal\u00a0favorable \u00a0para\u00a0el\u00a0abordaje\u00a0integral\u00a0del\u00a0VIH/SIDA\u00a0y\u00a0la\u00a0diversidad \u00a0sexual\u00a0\ndesde\u00a0una\u00a0perspectiva \u00a0de\u00a0derechos\u00a0humanos, \u00a0con\u00a0la\u00a0participaci\u00f3n \u00a0de\u00a0las\u00a0comunidades \u00a0con\u00a0mayor\u00a0prevalencia \u00a0(HSH,\u00a0TS\u00a0\ny\u00a0PPL)\u00a0y\u00a0las\u00a0PVVS.\u00a0\n\uf02d Asegurar\u00a0una\u00a0respuesta \u00a0multisectorial \u00a0amplia\u00a0y\u00a0articulada \u00a0para\u00a0el\u00a0desarrollo \u00a0intersectorial \u00a0e\u00a0interinstitucional \u00a0de\u00a0\nactividades \u00a0conjuntas \u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0y\u00a0control\u00a0de\u00a0las\u00a0ITS\u00a0y\u00a0el\u00a0VIH/SIDA. \u00a0\n\uf02d Fortalecer \u00a0los\u00a0sistemas\u00a0de\u00a0informaci\u00f3n \u00a0y\u00a0establecer \u00a0un\u00a0sistema\u00a0de\u00a0monitoreo \u00a0y\u00a0evaluaci\u00f3n \u00a0para\u00a0permitir\u00a0la\u00a0toma\u00a0de\u00a0\ndecisiones \u00a0oportuna \u00a0y\u00a0la\u00a0medici\u00f3n\u00a0de\u00a0los\u00a0logros\u00a0obtenidos.  \n37  Entidades \u00a0financiadores \u00a0de\u00a0ensayos\u00a0cl\u00ednicos\u00a0en\u00a0el\u00a0pa\u00eds\u00a0seg\u00fan\u00a0el\u00a0estudio\u00a0MEGAS\u00a02005\u00a0\u20102007\u00a0son:\u00a0Instituto\u00a0Nacional\u00a0de\u00a0\nSalud\u00a0de\u00a0Estados\u00a0Unidos\u00a0(NHI),\u00a0Merck\u00a0Sharp\u00a0&\u00a0Dohme,\u00a0Schering\u2010Plough,\u00a0Bristol\u00a0Myers\u00a0Squibb\u00a0Company, \u00a0Pfizer\u00a0SA,\u00a0\nUniversidad \u00a0de\u00a0Washington, \u00a0The\u00a0J.\u00a0David\u00a0Gladstone \u00a0Institutes, \u00a0The\u00a0Harvard\u00a0Medical\u00a0School\u00a0Center\u00a0for\u00a0Aids\u00a0Research, \u00a0\nFred\u00a0Hutchinson \u00a0Cancer\u00a0Research\u00a0Center,\u00a0Social\u00a0Systems\u00a0Scientific, \u00a0General\u00a0Hospital\u00a0Massachusetts, \u00a0GlaxoSmithKline \u00a0\nBiologica  \n38 Funci\u00f3n\u00a0establecida \u00a0en\u00a0el\u00a0D.S.\u00a0N\u00b0\u00a0013\u20102003\u2010SA,\u00a0Reglamento \u00a0de\u00a0\u00a0la\u00a0Ley\u00a0N\u00b0\u00a027657\u00a0\u2010\u00a0Ley\u00a0del\u00a0Ministerio \u00a0de\u00a0Salud\u00a0y\u00a0el\u00a0D.S.\u00a0\nN\u00ba\u00a0017\u20102006\u2010SA.\u00a0Reglamento \u00a0de\u00a0ensayos\u00a0cl\u00ednicos\u00a0en\u00a0el\u00a0Per\u00fa  58 \uf02d JL\u00a0S\u00e1nchez,\u00a0K\u00a0Russell,\u00a0M\u00a0Negrete,\u00a0S\u00a0Montano, \u00a0VA\u00a0Laguna\u2010Torres,\u00a0J\u00a0S\u00e1nchez,\u00a0L\u00a0Kusunoki, \u00a0M\u00a0Avila,\u00a0H\u00a0\nSalom\u00f3n, \u00a0M\u00a0\u00a0\u00a0Weissenbacher, \u00a0L\u00a0Mart\u00ednez\u2010Peralta,\u00a0J\u00a0Vi\u00f1oles,\u00a0M\u00a0Serra,\u00a0H\u00a0Abreu,\u00a0A\u00a0Alava,\u00a0C\u00a0Cepeda,\u00a0A.\u00a0\nSurveillance \u00a0for\u00a0HIV\u20101\u00a0Sutbypes\u00a0In\u00a0South\u00a0America.\u00a0\u00a0\u00a0\n  \n\u00a0 59 \u00a0\nF.6\u00a0\u00a0Factores\u00a0de\u00a0Producci\u00f3n: \u00a0recursos\u00a0humanos, \u00a0\nconocimiento \u00a0t\u00e9cnico\u00a0y\u00a0otros\u00a0factores\u00a0\n\u00a0\nEl\u00a0Gasto\u00a0en\u00a0VIH\u00a0por\u00a0Factores\u00a0de\u00a0Producci\u00f3n \u00a0se\u00a0presenta\u00a0en\u00a0el\u00a0siguiente\u00a0cuadro:\u00a0\n\u00a0\nGasto\u00a0por\u00a0Factores\u00a0de\u00a0producci\u00f3n \u00a02005\u20102010\u00a0\u2010\u00a0En\u00a0miles\u00a0US\u00a0$\u00a0\n\u00a0 2005\u00a0 2006\u00a0 2007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a0\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 4,021\u00a05,500\u00a0 6,315\u00a07,431\u00a010,581\u00a07,831\u00a041,679\u00a0\nAntirretrovirales \u00a0 8,894\u00a012,151\u00a03,997\u00a010,001 14,083\u00a03,677\u00a052,804\u00a0\nCondones \u00a0 2,872\u00a02,610\u00a0 4,606\u00a06,655\u00a04,667\u00a07,621\u00a029,031\u00a0\nReactivos \u00a0y\u00a0materiales \u00a0 2,597\u00a03,932\u00a0 6,663\u00a07,418\u00a06,859\u00a04,770\u00a032,238\u00a0\nOtros\u00a0gastos\u00a0corrientes \u00a0 8,458\u00a011,101\u00a017,687\u00a020,022 21,634\u00a011,038\u00a089,939\u00a0\nGastos\u00a0de\u00a0capital\u00a0 1,314\u00a01,184\u00a0 2,175\u00a04,070\u00a04,418\u00a01,491\u00a014,653\u00a0\nTotal\u00a0 28,157 36,477\u00a041,443\u00a055,598 62,242\u00a036,427\u00a0260,345\n\u00a0\n\u00a0\nLos\u00a0principales \u00a0cambios\u00a0en\u00a0la\u00a0estructura \u00a0de\u00a0gasto\u00a0por\u00a0factores\u00a0de\u00a0producci\u00f3n \u00a0est\u00e1\u00a0constituido \u00a0por\u00a0el\u00a0\nporcentaje \u00a0de\u00a0gastos\u00a0en\u00a0antirretrovirales \u00a023.7%\u00a0para\u00a0el\u00a02005\u20102007\u00a0\u00a0que\u00a0disminuyo \u00a0en\u00a018%\u00a0para\u00a0el\u00a0periodo\u00a0\nentre\u00a0el\u00a02008\u20102010.\u00a0\n\u00a0\n\u00a0\nGasto\u00a0por\u00a0Factores\u00a0de\u00a0producci\u00f3n \u00a0\u2013\u00a0Estructura \u00a0porcentual \u00a0\n\u00a0 2005\u20102007\u00a0 2008\u20102010\u00a0 Total\u00a0\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 14.9%\u00a0 16.8%\u00a0 16.0%\u00a0\nAntirretrovirales \u00a0 23.6%\u00a0 18.0%\u00a0 20.3%\u00a0\nCondones \u00a0 9.5%\u00a0 12.3%\u00a0 11.2%\u00a0\nReactivos \u00a0y\u00a0materiales \u00a0 12.4%\u00a0 12.3%\u00a0 12.4%\u00a0\nOtros\u00a0gastos\u00a0corrientes \u00a0 35.1%\u00a0 34.2%\u00a0 34.5%\u00a0\nOtros\u00a0f\u00e1rmacos 3.9%\u00a0 5.1%\u00a0 4.6\u00a0\nSuministro \u00a0materiales 9.8%\u00a0 6.2%\u00a0 7.7%\u00a0\nServicios\u00a0consultor\u00eda 2.6%\u00a0 2.4%\u00a0 2.5%\u00a0\nOtros\u00a0no\u00a0desagregados 4.4%\u00a0 11.3%\u00a0 8.5%\u00a0\nOtros\u00a0(transporte, \u00a0eventos) 14.4%\u00a0 9.2%\u00a0 11.2%\u00a0\nGastos\u00a0de\u00a0capital\u00a0 4.4%\u00a0 6.5%\u00a0 5.6%\u00a0\nTotal\u00a0 100.0%\u00a0 100.0%\u00a0 100.0%\u00a0\n\u00a0\nEntre\u00a0los\u00a0recursos\u00a0que\u00a0representan \u00a0el\u00a0mayor\u00a0concepto \u00a0se\u00a0encuentra \u00a0los\u00a0otros\u00a0gastos\u00a0corrientes \u00a0los\u00a0cuales\u00a0\nincluye\u00a0el\u00a0gasto\u00a0en\u00a0medicamentos \u00a0diferentes \u00a0a\u00a0antirretrovirales \u00a0y\u00a0suministro \u00a0m\u00e9dicos,\u00a0suministros \u00a0de\u00a0\nmateriales \u00a0y\u00a0los\u00a0otros\u00a0gastos\u00a0no\u00a0desagregados \u00a0por\u00a0tipo,\u00a0servicios\u00a0de\u00a0consultor\u00eda, \u00a0viajes,\u00a0material\u00a0de\u00a0difusi\u00f3n,\u00a0\nformatos, \u00a0entre\u00a0otros. Gasto\u00a0en\u00a0VIH\u00a0por\u00a0Factores\u00a0de\u00a0producci\u00f3n \u00a0(en\u00a0miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2005\u00a02006\u00a02007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a02005\u2010\n2007\u00a02008\u2010\n2010\u00a0Total\u00a0\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 4,021\u00a05,500\u00a06,315\u00a07,431\u00a010,581 7,831\u00a041,679\u00a014.9%\u00a0 16.8%\u00a0 16.0%\u00a0\nPF.01.01.01 \u00a0Salarios\u00a0 2,672\u00a03,684\u00a04,651\u00a05,839\u00a07,911\u00a03,877\u00a028,635\u00a010.4%\u00a0 11.4%\u00a0 11.0%\u00a0\nPF.01.01.03 \u00a0Renta\u00a0de\u00a0trabajo\u00a0no\u00a0salarial\u00a0 1,350\u00a01,816\u00a01,664\u00a01,592\u00a02,670\u00a03,953\u00a013,044\u00a04.6%\u00a0 5.3%\u00a0 5.0%\u00a0\nAntirretrovirales \u00a0 8,894\u00a012,151\u00a03,997\u00a010,001 14,083 3,677\u00a052,804\u00a023.6%\u00a0 18.0%\u00a0 20.3%\u00a0\nPF.01.02.01.01 \u00a0F\u00e1rmacos \u00a0antirretrov\u00edricos \u00a0 8,894\u00a012,151\u00a03,997\u00a010,001 14,083 3,677\u00a052,804\u00a023.6%\u00a0 18.0%\u00a0 20.3%\u00a0\nCondones \u00a0 2,872\u00a02,610\u00a04,606\u00a06,655\u00a04,667\u00a07,621\u00a029,031\u00a09.5%\u00a0 12.3%\u00a0 11.2%\u00a0\nPF.01.02.01.04 \u00a0Preservativos \u00a0 2,872\u00a02,610\u00a04,606\u00a06,655\u00a04,667\u00a07,621\u00a029,031\u00a09.5%\u00a0 12.3%\u00a0 11.2%\u00a0\nReactivos \u00a0y\u00a0materiales \u00a0 2,597\u00a03,932\u00a06,663\u00a07,418\u00a06,859\u00a04,770\u00a032,238\u00a012.4%\u00a0 12.3%\u00a0 12.4%\u00a0\nPF.01.02.01.05 \u00a0Reactivos \u00a0y\u00a0materiales \u00a0 2,597\u00a03,932\u00a06,663\u00a07,418\u00a06,859\u00a04,770\u00a032,238\u00a012.4%\u00a0 12.3%\u00a0 12.4%\u00a0\nOtros\u00a0gastos\u00a0corrientes \u00a0 8,458\u00a011,101\u00a017,687\u00a020,022 21,634 11,038 89,939\u00a035.1%\u00a0 34.2%\u00a0 34.5%\u00a0\nPF.01.02.01.02 \u00a0Otros\u00a0f\u00e1rmacos \u00a0y\u00a0productos \u00a0farmac\u00e9uticos \u00a0(excluidos \u00a0los\u00a0antirretrov\u00edricos) \u00a0 959\u00a01,264\u00a01,900\u00a02,847\u00a02,425\u00a02,666\u00a012,062\u00a03.9%\u00a0 5.1%\u00a0 4.6%\u00a0\nPF.01.02.01.03 \u00a0Suministros \u00a0m\u00e9dicos\u00a0y\u00a0quir\u00fargicos \u00a0 80\u00a0 141\u00a0 119\u00a0 295\u00a01,138\u00a01,914\u00a03,687\u00a0 0.3%\u00a0 2.2%\u00a0 1.4%\u00a0\nPF.01.02.01.06 \u00a0Alimentos \u00a0y\u00a0nutrientes \u00a0 311\u00a0 386\u00a0 418\u00a0 324\u00a0 344\u00a0 265\u00a0 2,048\u00a0 1.1%\u00a0 0.6%\u00a0 0.8%\u00a0\nPF.01.02.01.07 \u00a0Uniformes \u00a0y\u00a0materiales \u00a0escolares \u00a0 0\u00a0 0\u00a0\u00a0\u00a0\u00a0\u00a0 0\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nPF.01.02.01.98 \u00a0Suministros \u00a0materiales \u00a0no\u00a0desglosados \u00a0por\u00a0tipo\u00a0 2,987\u00a04,425\u00a03,021\u00a02,794\u00a05,252\u00a01,499\u00a019,977\u00a09.8%\u00a0 6.2%\u00a0 7.7%\u00a0\nPF.01.02.01.99 \u00a0Otros\u00a0suministros \u00a0materiales \u00a0s.c.o.\u00a0 577\u00a0 457\u00a0 1,582\u00a01,232\u00a01,262\u00a0113\u00a0 5,223\u00a0 2.5%\u00a0 1.7%\u00a0 2.0%\u00a0\nPF.01.02.02.02 \u00a0Servicios\u00a0de\u00a0mantenimiento \u00a0y\u00a0reparaci\u00f3n \u00a0 9\u00a0 2\u00a0 26\u00a0 \u00a0\u00a0\u00a0 37\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nPF.01.02.02.03 \u00a0Servicios\u00a0de\u00a0editores,\u00a0pel\u00edculas, \u00a0tele\u00a0radiodifusi\u00f3n \u00a0y\u00a0programaci\u00f3n \u00a0\u00a0 \u00a0 \u00a0 117\u00a0 321\u00a0 4\u00a0 443\u00a0 0.0%\u00a0 0.3%\u00a0 0.2%\u00a0\nPF.01.02.02.04 \u00a0Servicios\u00a0de\u00a0consultor\u00eda \u00a0 545\u00a0 980\u00a0 1,276\u00a02,001\u00a01,301\u00a0326\u00a0 6,429\u00a0 2.6%\u00a0 2.4%\u00a0 2.5%\u00a0\nPF.01.02.02.05 \u00a0Servicios\u00a0de\u00a0transporte \u00a0y\u00a0viajes\u00a0 87\u00a0 390\u00a0 1,125\u00a01,275\u00a01,506\u00a0422\u00a0 4,805\u00a0 1.5%\u00a0 2.1%\u00a0 1.8%\u00a0\nPF.01.02.02.07 \u00a0Log\u00edstica\u00a0de\u00a0eventos,\u00a0incluidos\u00a0servicios\u00a0de\u00a0catering\u00a0 925\u00a0 321\u00a0 394\u00a0 647\u00a0 341\u00a0 329\u00a0 2,958\u00a0 1.5%\u00a0 0.9%\u00a0 1.1%\u00a0\nPF.01.02.02.98 \u00a0Servicios\u00a0no\u00a0desglosados \u00a0por\u00a0tipo\u00a0 482\u00a0 720\u00a0 811\u00a0 417\u00a0 965\u00a0 420\u00a0 3,815\u00a0 1.9%\u00a0 1.2%\u00a0 1.5%\u00a0\nPF.01.02.02.99 \u00a0Servicios\u00a0s.c.o\u00a0 1,495\u00a01,900\u00a02,435\u00a0 525\u00a0 7\u00a0\u00a0 6,363\u00a0 5.5%\u00a0 0.3%\u00a0 2.4%\u00a0\nPF.98\u00a0Factores\u00a0de\u00a0producci\u00f3n \u00a0no\u00a0desglosados \u00a0por\u00a0tipo\u00a0\u00a0 114\u00a0 4,579\u00a07,547\u00a06,772\u00a03,080\u00a022,092\u00a04.4%\u00a0 11.3%\u00a0 8.5%\u00a0\nGastos\u00a0de\u00a0capital\u00a0 1,314\u00a01,184\u00a02,175\u00a04,070\u00a04,418\u00a01,491\u00a014,653\u00a04.4%\u00a0 6.5%\u00a0 5.6%\u00a0\nPF.02.01.01 \u00a0Mejora\u00a0de\u00a0laboratorios \u00a0y\u00a0otra\u00a0infraestructura \u00a0 24\u00a0\u00a0 649\u00a0 2,381\u00a02,560\u00a0\u00a0 5,613\u00a0 0.6%\u00a0 3.2%\u00a0 2.2%\u00a0\nPF.02.01.02 \u00a0Construcci\u00f3n \u00a0de\u00a0nuevos\u00a0centros\u00a0de\u00a0salud\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 19\u00a0 19\u00a0 0.0%\u00a0 0.0%\u00a0 0.0%\u00a0\nPF.02.02.02 \u00a0Tecnolog\u00eda \u00a0de\u00a0la\u00a0informaci\u00f3n \u00a0(hardware \u00a0y\u00a0software) \u00a0 376\u00a0 135\u00a0 58\u00a0 142\u00a0 254\u00a0 50\u00a0 1,015\u00a0 0.5%\u00a0 0.3%\u00a0 0.4%\u00a0\nPF.02.02.03 \u00a0Equipos\u00a0de\u00a0laboratorio \u00a0y\u00a0otros\u00a0equipos\u00a0m\u00e9dicos\u00a0 137\u00a0 81\u00a0 238\u00a0\u00a0 52\u00a0 62\u00a0 569\u00a0 0.4%\u00a0 0.1%\u00a0 0.2%\u00a0\nPF.02.02.98 \u00a0Equipos\u00a0no\u00a0desglosados \u00a0por\u00a0tipo\u00a0\u00a0 \u00a0 \u00a0 257\u00a0 299\u00a0 24\u00a0 580\u00a0 0.0%\u00a0 0.4%\u00a0 0.2%\u00a0\nPF.02.99\u00a0Gastos\u00a0de\u00a0capital\u00a0s.c.o.\u00a0 778\u00a0 969\u00a0 1,230\u00a01,290\u00a01,254\u00a01,336\u00a06,856\u00a0 2.8%\u00a0 2.5%\u00a0 2.6%\u00a0\nTotal\u00a0 28,157\u00a036,477\u00a041,443\u00a055,598 62,242 36,427 260,345 100.0%\u00a0100.0%\u00a0100.0%\u00a0 61 \u00a0\nF.6.1\u00a0Recursos\u00a0humanos \u00a0\n\u00a0\nAl\u00a0haberse\u00a0expandido \u00a0el\u00a0tratamiento \u00a0antirretroviral \u00a0y\u00a0al\u00a0haberse\u00a0incrementado \u00a0la\u00a0cantidad\u00a0de\u00a0\nCERITS\u00a0y\u00a0UAMP\u00a0a\u00a0nivel\u00a0nacional,\u00a0el\u00a0gasto\u00a0en\u00a0recursos\u00a0humanos \u00a0se\u00a0ha\u00a0incrementado \u00a0principalmente \u00a0\npara\u00a0la\u00a0prevenci\u00f3n \u00a0y\u00a0atenci\u00f3n. \u00a0\u00a0\n\u00a0\nGasto\u00a0en\u00a0recursos\u00a0humanos \u00a0por\u00a0Prevenci\u00f3n \u00a0y\u00a0tratamiento \u00a0\u00a0(en\u00a0miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2005\u00a02006 2007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a0\nGasto\u00a0total\u00a0 4,021\u00a05,500 6,315\u00a07,431\u00a010,581 7,831\u00a041,679\u00a0\nPrevenci\u00f3n \u00a0 797\u00a0838\u00a01,156\u00a03,059\u00a04,642\u00a05,213\u00a015,706\u00a0\nSector\u00a0publico\u00a0 561\u00a0591\u00a0708\u00a01,442\u00a01,467\u00a01,754\u00a06,524\u00a0\nInternacional \u00a0 236\u00a0247\u00a0448\u00a01,617\u00a03,176\u00a03,459\u00a09,182\u00a0\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 959\u00a01,951 1,844\u00a01,950\u00a01,264\u00a01,290\u00a09,258\u00a0\nSector\u00a0publico\u00a0 586\u00a0958\u00a01,195\u00a01,220\u00a01,167\u00a01,251\u00a06,378\u00a0\nInternacional \u00a0 372\u00a0993\u00a0649\u00a0 730\u00a0 97\u00a0 39\u00a0 2,880\u00a0\nTotal\u00a0en\u00a0prevenci\u00f3n \u00a0y\u00a0tratamiento \u00a0 1,756\u00a02,789 3,000\u00a05,010\u00a05,906\u00a06,503\u00a024,964\u00a0\nNota:\u00a0solo\u00a0incluye\u00a0el\u00a0gasto\u00a0correspondiente \u00a0a\u00a0Las\u00a0principales \u00a0intervenciones: \u00a0prevenci\u00f3n \u00a0y\u00a0tratamiento \u00a0\nPara\u00a0el\u00a0a\u00f1o\u00a02010\u00a0no\u00a0se\u00a0ha\u00a0podido\u00a0calcular\u00a0las\u00a0remuneraciones \u00a0en\u00a0Investigaci\u00f3n. \u00a0\n\u00a0\nPara\u00a0la\u00a0estimaci\u00f3n \u00a0de\u00a0los\u00a0recursos\u00a0humanos \u00a0se\u00a0entrevisto \u00a0a\u00a0los\u00a0coordinadores \u00a0regionales \u00a0de\u00a0estrategia \u00a0a\u00a0fin\u00a0\nde\u00a0determinar \u00a0la\u00a0cantidad\u00a0de\u00a0recursos\u00a0humanos \u00a0y\u00a0la\u00a0dedicaci\u00f3n \u00a0al\u00a0servicio.\u00a0\u00a0Cabe\u00a0precisar\u00a0que\u00a0el\u00a0incremento \u00a0\nde\u00a0recursos\u00a0humanos \u00a0a\u00fan\u00a0no\u00a0compensa \u00a0la\u00a0cantidad\u00a0de\u00a0recursos\u00a0que\u00a0estuvieron \u00a0en\u00a0el\u00a0Programa \u00a0hasta\u00a0la\u00a0\ndesintegraci\u00f3n \u00a0del\u00a0programa. \u00a0\u00a0\u00a0Durante\u00a0los\u00a0\u00a0a\u00f1os\u00a090,\u00a0\u00a0el\u00a0MINSA,\u00a0a\u00a0trav\u00e9s\u00a0del\u00a0Programa \u00a0Nacional\u00a0de\u00a0sida\u00a0y\u00a0ETS\u00a0\nde\u00a0entonces, \u00a0desarroll\u00f3 \u00a0procesos\u00a0de\u00a0capacitaci\u00f3n \u00a0que\u00a0produjeron \u00a0una\u00a0generaci\u00f3n \u00a0de\u00a0personal\u00a0de\u00a0salud\u00a0\nespecialistas \u00a0en\u00a0el\u00a0tema.\u00a0\u00a0En\u00a0el\u00a0a\u00f1o\u00a02002,\u00a0estudios\u00a0cl\u00ednicos\u00a0sobre\u00a0vacunas\u00a0contra\u00a0el\u00a0VIH\u00a0se\u00a0iniciaron\u00a0en\u00a0el\u00a0\nPer\u00fa,\u00a0como\u00a0parte\u00a0de\u00a0un\u00a0esfuerzo\u00a0mundial\u00a0de\u00a0la\u00a0Red\u00a0de\u00a0Ensayos\u00a0Cl\u00ednicos\u00a0de\u00a0Vacunas\u00a0contra\u00a0el\u00a0VIH\u00a0(HIV\u00a0\nVaccine\u00a0Trials\u00a0Network, \u00a0HVTN),\u00a0patrocinada \u00a0por\u00a0los\u00a0Institutos \u00a0Nacionales \u00a0de\u00a0Salud\u00a0de\u00a0los\u00a0Estados\u00a0Unidos,\u00a0con\u00a0\n30\u00a0sedes\u00a0en\u00a0el\u00a0mundo,\u00a0siendo\u00a0uno\u00a0de\u00a0ellos\u00a0el\u00a0pa\u00eds.\u00a0\u00a0\u00a0\n\u00a0\nA\u00a0partir\u00a0de\u00a0la\u00a0implementaci\u00f3n \u00a0de\u00a0los\u00a0proyectos \u00a0del\u00a0FMSTM\u00a0se\u00a0ha\u00a0capacitado \u00a0equipos\u00a0especializados \u00a0en\u00a0la\u00a0\natenci\u00f3n\u00a0y\u00a0provisi\u00f3n\u00a0del\u00a0TARGA,\u00a0en\u00a0manejo\u00a0de\u00a0infecciones \u00a0oportunistas \u00a0y\u00a0reacciones \u00a0adversas\u00a0a\u00a0\nmedicamentos \u00a0(RAM),\u00a0\u00a0as\u00ed\u00a0como\u00a0en\u00a0detecci\u00f3n \u00a0de\u00a0se\u00f1ales\u00a0de\u00a0alerta\u00a0para\u00a0establecimientos \u00a0no\u00a0especializados. \u00a0\u00a0\u00a0\nEn\u00a0el\u00a0\u00e1rea\u00a0preventiva \u00a0se\u00a0han\u00a0desarrollado \u00a0capacidades \u00a0para\u00a0la\u00a0evaluaci\u00f3n \u00a0cl\u00ednica,\u00a0consejer\u00eda \u00a0y\u00a0ex\u00e1menes \u00a0de\u00a0\nlaboratorio. \u00a0\n\u00a0\nDe\u00a0acuerdo\u00a0a\u00a0las\u00a0vistas\u00a0de\u00a0campo\u00a0de\u00a0campo\u00a0se\u00a0ha\u00a0podido\u00a0determinar \u00a0los\u00a0roles\u00a0y\u00a0la\u00a0dedicaci\u00f3n \u00a0de\u00a0los\u00a0\ndiferentes \u00a0tipos\u00a0de\u00a0profesionales \u00a0por\u00a0tipo\u00a0de\u00a0atenci\u00f3n. \u00a0\n\u00a0\nRol\u00a0del\u00a0m\u00e9dico\u00a0\nRealiza\u00a0las\u00a0evaluaciones \u00a0cl\u00ednicas\u00a0peri\u00f3dicas \u00a0programadas. \u00a0Ninguno\u00a0de\u00a0los\u00a0establecimientos \u00a0cuenta\u00a0\ncon\u00a0un\u00a0m\u00e9dico\u00a0a\u00a0dedicaci\u00f3n \u00a0exclusiva, \u00a0generalmente \u00a0atienden\u00a0de\u00a02\u00a0o\u00a03\u00a0d\u00edas\u00a0a\u00a0la\u00a0semana.\u00a0\u00a0En\u00a0algunos\u00a0\ncasos\u00a0atienden\u00a0todos\u00a0los\u00a0d\u00edas\u00a0pero\u00a02\u00a0o\u00a03\u00a0horas\u00a0solamente. \u00a0\u00a0\u00a0Su\u00a0labor\u00a0es\u00a0interpretaci\u00f3n \u00a0de\u00a0resultado \u00a0de\u00a0\nlos\u00a0an\u00e1lisis\u00a0y\u00a0prescripci\u00f3n. \u00a0Dedican\u00a0entre\u00a0el\u00a010\u00a0y\u00a0al\u00a030%\u00a0(como\u00a0m\u00e1ximo)\u00a0de\u00a0su\u00a0tiempo\u00a0al\u00a0servicio.\u00a0En\u00a0tratamiento \u00a0\nRol\u00a0de\u00a0la\u00a0enfermera \u00a0\nEn\u00a0todos\u00a0los\u00a0lugares\u00a0visitados\u00a0la\u00a0enfermera \u00a0es\u00a0la\u00a0que\u00a0tiene\u00a0contacto\u00a0permanente \u00a0con\u00a0los\u00a0pacientes \u00a0y\u00a0\ndedica\u00a0el\u00a0100%\u00a0de\u00a0su\u00a0tiempo\u00a0al\u00a0Programa. \u00a0\u00a0Al\u00a0ser\u00a0entrevistadas \u00a0conocen\u00a0las\u00a0ocurrencias \u00a0de\u00a0eventos\u00a0\nde\u00a0cada\u00a0paciente. \u00a0Organiza\u00a0el\u00a0servicio\u00a0y\u00a0al\u00a0personal\u00a0que\u00a0all\u00ed\u00a0labora,\u00a0realiza\u00a0las\u00a0labores\u00a0de\u00a0consejer\u00eda \u00a0y\u00a0\nes\u00a0responsable \u00a0de\u00a0la\u00a0actualizaci\u00f3n \u00a0de\u00a0la\u00a0informaci\u00f3n \u00a0de\u00a0los\u00a0libros\u00a0y\u00a0registros\u00a0solicitados \u00a0por\u00a0el\u00a0hospital\u00a0\ny\u00a0la\u00a0ESN.\u00a0\u00a0Realiza\u00a0las\u00a0consejer\u00edas. \u00a0Esta\u00a0labor\u00a0le\u00a0permite\u00a0actualizar \u00a0algunos\u00a0datos\u00a0requeridos \u00a0para\u00a0\ncapturar\u00a0informaci\u00f3n \u00a0sobre\u00a0g\u00e9nero,\u00a0sin\u00a0embargo\u00a0no\u00a0todas\u00a0lo\u00a0realizan.\u00a0 62 En\u00a0los\u00a0hospitales \u00a0generalmente \u00a0cuenta\u00a0con\u00a0el\u00a0apoyo\u00a0de\u00a0internas\u00a0o\u00a0serumistas \u00a0y\u00a0t\u00e9cnicas\u00a0de\u00a0\nenfermer\u00edas, \u00a0quienes\u00a0se\u00a0encargan\u00a0de\u00a0registrar\u00a0a\u00a0los\u00a0pacientes, \u00a0entre\u00a0otras\u00a0labores.\u00a0\nRol\u00a0del\u00a0m\u00e9dico\u00a0u\u00a0obstetriz\u00a0\nSe\u00a0encarga\u00a0de\u00a0la\u00a0evaluaci\u00f3n \u00a0cl\u00ednica,\u00a0sin\u00a0embargo\u00a0algunos\u00a0CERITS\u00a0y\u00a0UAMP\u00a0no\u00a0cuentan\u00a0con\u00a0m\u00e9dico,\u00a0\nsino\u00a0con\u00a0obstetriz. \u00a0En\u00a0el\u00a0caso\u00a0del\u00a0m\u00e9dico\u00a0dedica\u00a0entre\u00a0el\u00a05\u00a0y\u00a0al\u00a010%\u00a0(como\u00a0m\u00e1ximo)\u00a0de\u00a0su\u00a0tiempo\u00a0al\u00a0\nservicio.\u00a0En\u00a0el\u00a0caso\u00a0de\u00a0la\u00a0obstetriz\u00a0dedica\u00a0el\u00a0100%.\u00a0\u00a0En\u00a0el\u00a0caso\u00a0de\u00a0no\u00a0contarse\u00a0con\u00a0m\u00e9dico\u00a0es\u00a0necesaria \u00a0\nla\u00a0presencia \u00a0de\u00a0la\u00a0obstetriz, \u00a0por\u00a0cuanto\u00a0puede\u00a0prescribir \u00a0medicamentos, \u00a0mientras\u00a0que\u00a0la\u00a0enfermera \u00a0\nno\u00a0puede\u00a0hacerlo.\u00a0\nRol\u00a0de\u00a0la\u00a0enfermera \u00a0\nApoya\u00a0al\u00a0m\u00e9dico\u00a0o\u00a0la\u00a0obstetriz, \u00a0se\u00a0encarga\u00a0del\u00a0seguimiento \u00a0de\u00a0los\u00a0pacientes \u00a0y\u00a0apoya\u00a0en\u00a0la\u00a0evaluaci\u00f3n \u00a0\ncl\u00ednica.\u00a0Si\u00a0est\u00e1\u00a0\u00a0asignada\u00a0al\u00a0servicio\u00a0dedica\u00a0el\u00a0100%\u00a0de\u00a0su\u00a0tiempo.\u00a0\nRol\u00a0del\u00a0responsable \u00a0del\u00a0laboratorio \u00a0\nGeneralmente \u00a0atiende\u00a0a\u00a0todo\u00a0el\u00a0establecimiento \u00a0por\u00a0lo\u00a0que\u00a0dedica\u00a0entre\u00a0el\u00a05\u00a0al\u00a015%\u00a0de\u00a0su\u00a0tiempo\u00a0a\u00a0\neste\u00a0servicio,\u00a0salvo\u00a0el\u00a0caso\u00a0de\u00a0Chiclayo,\u00a0donde\u00a0atiene\u00a0el\u00a0100%\u00a0de\u00a0su\u00a0tiempo.\u00a0En\u00a0prevenci\u00f3n \u00a0\nRol\u00a0del\u00a0promotor \u00a0educadores \u00a0de\u00a0pares\u00a0\nApoya\u00a0la\u00a0labor\u00a0en\u00a0algunos\u00a0casos\u00a0como\u00a0anfitri\u00f3n\u00a0(Chiclayo, \u00a0Iquitos)\u00a0y\u00a0en\u00a0otros\u00a0casos\u00a0captando \u00a0a\u00a0sus\u00a0\npares.\u00a0\u00a0El\u00a0monto\u00a0que\u00a0percibe\u00a0es\u00a0pagado\u00a0por\u00a0CAS\u00a0en\u00a0Chiclayo\u00a0\u00a0cuando\u00a0son\u00a0contratados \u00a0por\u00a0las\u00a0DIRESAs\u00a0\ny\u00a0en\u00a0otros\u00a0\u00a0por\u00a0locaci\u00f3n\u00a0de\u00a0servicios\u00a0por\u00a0el\u00a0FMSTM.\u00a0\n\u00a0\nEntre\u00a0los\u00a0gastos\u00a0corrientes, \u00a0tenemos\u00a0los\u00a0salarios,\u00a0suministros \u00a0y\u00a0servicios\u00a0y\u00a0la\u00a0asistencia \u00a0social\u00a0a\u00a0la\u00a0poblaci\u00f3n. \u00a0\nEn\u00a0nuestro\u00a0pa\u00eds\u00a0el\u00a0proveedor \u00a0m\u00e1s\u00a0grande\u00a0de\u00a0servicios\u00a0a\u00a0las\u00a0PVV\u00a0son\u00a0los\u00a0hospitales \u00a0y\u00a0los\u00a0centros\u00a0de\u00a0Salud\u00a0\nproveedores \u00a0de\u00a0TARGA\u00a0y\u00a0en\u00a0caso\u00a0de\u00a0las\u00a0poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0HSH\u00a0y\u00a0TS,\u00a0los\u00a0CERITS\u00a0y\u00a0UAMPs.\u00a0\u00a0Dentro\u00a0\ndel\u00a0rubro\u00a0de\u00a0suministros \u00a0y\u00a0servicios\u00a0tenemos\u00a0identificado \u00a0las\u00a0compras\u00a0de\u00a0medicamentos \u00a0ARV,\u00a0medicamentos \u00a0\npara\u00a0ITS,\u00a0condones, \u00a0reactivos. \u00a0Entre\u00a0los\u00a0gastos\u00a0de\u00a0capitales\u00a0\u00a0se\u00a0considera \u00a0infraestructura, \u00a0equipamiento, \u00a0\ntecnolog\u00eda. \u00a0\u00a0\n\u00a0\n\u00a0\nF.6.2\u00a0Antirretrovirales \u00a0\u00a0\n\u00a0\nEl\u00a0Ministerio \u00a0de\u00a0salud\u00a0representa \u00a0el\u00a0principal\u00a0comprador \u00a0de\u00a0antirretrovirales \u00a0en\u00a0el\u00a0periodo\u00a0comprendido \u00a0\nentre\u00a0los\u00a0a\u00f1os\u00a02004\u00a0al\u00a0\u00a02010,\u00a0desplazando \u00a0a\u00a0ESSALUD, \u00a0que\u00a0fue\u00a0la\u00a0entidad\u00a0que\u00a0inici\u00f3\u00a0el\u00a0tratamiento \u00a0ARV\u00a0y\u00a0\u00a0\nrealiz\u00f3\u00a0la\u00a0mayor\u00a0compra\u00a0de\u00a0ARV\u00a0hasta\u00a0el\u00a0a\u00f1o\u00a02008.\u00a0Pero,\u00a0ambos\u00a0son\u00a0los\u00a0compradores \u00a0m\u00e1s\u00a0grandes\u00a0de\u00a0ARV\u00a0\nen\u00a0el\u00a0pa\u00eds,\u00a0pues\u00a0representan \u00a0el\u00a092%\u00a0del\u00a0gasto\u00a0en\u00a0ARV;\u00a052%\u00a0del\u00a0total\u00a0corresponde \u00a0al\u00a0MINSA\u00a0y\u00a0el\u00a040%\u00a0a\u00a0\nESSALUD. \u00a0\n\u00a0\nCon\u00a0respecto\u00a0a\u00a0las\u00a0adquisiciones \u00a0de\u00a0ARV\u00a0realizadas \u00a0en\u00a0el\u00a0\u00faltimo\u00a0trimestre \u00a0del\u00a02009,\u00a0se\u00a0puede\u00a0identificar \u00a0a\u00a0la\u00a0\ncompra\u00a0del\u00a0Proceso\u00a0por\u00a0exoneraci\u00f3n \u00a0\u00a033\u20102009\u2010MINSA\u20101\u00a0del\u00a024\u00a0de\u00a0noviembre \u00a0del\u00a02009,\u00a0en\u00a0la\u00a0cual\u00a0se\u00a0adquiri\u00f3\u00a0\nel\u00a0medicamento \u00a0Atazanavir \u00a0por\u00a012,\u00a0851,910\u00a0nuevos\u00a0soles.\u00a0\n\u00a0\nCabe\u00a0precisar\u00a0que\u00a0la\u00a0adquisici\u00f3n \u00a0de\u00a0antirretrovirales \u00a0el\u00a0MINSA\u00a0ha\u00a0sido\u00a0asumido\u00a0de\u00a0manera\u00a0integral,\u00a0luego\u00a0del\u00a0\napoyo\u00a0realizado\u00a0por\u00a0el\u00a0FMSTM\u00a0entre\u00a0el\u00a02004\u00a0y\u00a0el\u00a02006,\u00a0el\u00a0monto\u00a0acumulado \u00a0\u00a0del\u00a02005\u00a0al\u00a02010\u00a0realizado\u00a0por\u00a0\nel\u00a0MINSA\u00a0supera\u00a0lo\u00a0invertido\u00a0por\u00a0ESSALUD. \u00a0\n\u00a0\nEn\u00a0el\u00a0Per\u00fa\u00a0se\u00a0adquieren \u00a0medicamentos, \u00a0en\u00a0algunos\u00a0casos\u00a0para\u00a0periodos\u00a0mayores\u00a0a\u00a0un\u00a0a\u00f1o.\u00a0\u00a0Debido\u00a0a\u00a0la\u00a0\nlimitada\u00a0capacidad \u00a0de\u00a0almacenamiento \u00a0de\u00a0la\u00a0sede\u00a0central\u00a0estas\u00a0son\u00a0distribuidas \u00a0a\u00a0la\u00a034\u00a0Direcciones \u00a0\nRegionales39\u00a0del\u00a0pa\u00eds,\u00a0las\u00a0cuales\u00a0a\u00a0su\u00a0vez\u00a0distribuyen \u00a0a\u00a0los\u00a072\u00a0establecimientos \u00a0de\u00a0salud\u00a0que\u00a0actualmente \u00a0\nproveen\u00a0TARGA\u00a0a\u00a0nivel\u00a0nacional.\u00a0\u00a0La\u00a0distribuci\u00f3n \u00a0por\u00a0departamentos \u00a0est\u00e1\u00a0disponible \u00a0en\u00a0el\u00a0sistema\u00a0de\u00a0\n                                                 \n39 \u00a0En\u00a0la\u00a0mayor\u00eda\u00a0de\u00a0los\u00a0casos\u00a0se\u00a0pacta\u00a0con\u00a0los\u00a0proveedores \u00a0que\u00a0los\u00a0medicamentos \u00a0sean\u00a0entregados \u00a0en\u00a0los\u00a0\nalmacenes \u00a0de\u00a0las\u00a0Direcciones \u00a0regionales.  De\u00a0la\u00a0totalidad\u00a0de\u00a0Direcciones \u00a0Regionales \u00a04\u00a0corresponden \u00a0a\u00a0Lima\u00a0la\u00a0\ncapital\u00a0del\u00a0pa\u00eds\u00a0y\u00a030\u00a0a\u00a0los\u00a024\u00a0departamentos, \u00a0cabe\u00a0precisar\u00a0que\u00a0en\u00a0algunos\u00a0departamentos \u00a0tienen\u00a0m\u00e1s\u00a0de\u00a0\nuna\u00a0Direcci\u00f3n \u00a0regional,\u00a0la\u00a0cual\u00a0constituye \u00a0la\u00a0sede\u00a0administrativa \u00a0del\u00a0sector\u00a0salud\u00a0por\u00a0zona\u00a0territorial.   63 informaci\u00f3n \u00a0de\u00a0DIGEMID\u00a0SISMED,\u00a0sin\u00a0embargo\u00a0no\u00a0es\u00a0posible\u00a0determinar \u00a0el\u00a0uso\u00a0de\u00a0los\u00a0medicamentos \u00a0o\u00a0\ndeterminar \u00a0el\u00a0valor\u00a0de\u00a0los\u00a0medicamentos \u00a0que\u00a0se\u00a0encuentran \u00a0vencidos. \u00a0\n\u00a0\n5,908\u00a09,034\u00a011,702\u00a0\n8,935\u00a0\n3,146\u00a05,704\u00a0\n2005\u20102006 2007 \u20102008 2009 \u20102010Gasto\u00a0en\u00a0ARV\u00a02005\u00a0\u20102010\n(miles\u00a0de\u00a0US\u00a0$)\nMINSA\n ESSALUD\n\u00a0\u00a0\u00a0\u00a0\n801\u00a05,908\u00a08,024\u00a014,942\u00a024,701\u00a026,644\u00a0\n5,119\u00a08,935\u00a010,100\u00a012,081\u00a016,199\u00a017,785\u00a0\n2005 al \u00a02006 al \u00a02007 al \u00a02008 al \u00a02009 al \u00a02010Sector\u00a0p\u00fablico\u00a0\u2010Gasto\u00a0acumulado \u00a0ARV\u00a0\n(miles\u00a0de\u00a0US\u00a0$)\nMINSA\n ESSALUD\n\u00a0\n\u00a0\nTambi\u00e9n\u00a0se\u00a0observa\u00a0que\u00a0hay\u00a0compra\u00a0de\u00a0ARV\u00a0a\u00a0nivel\u00a0de\u00a0algunas\u00a0Regiones\u00a0\u00a0\u00a0especialmente \u00a0en\u00a0el\u00a0a\u00f1o\u00a02008,\u00a0aunque\u00a0\nes\u00a0un\u00a0porcentaje \u00a0muy\u00a0peque\u00f1o, \u00a0alrededor \u00a0del\u00a00,23%.\u00a0El\u00a0a\u00f1o\u00a02009\u00a0y\u00a02010\u00a0no\u00a0\u00a0registran\u00a0\u00a0compra\u00a0de\u00a0ARV\u00a0en\u00a0\nRegiones, \u00a0las\u00a0que\u00a0lo\u00a0adquir\u00edan \u00a0para\u00a0la\u00a0estrategia \u00a0de\u00a0prevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0vertical.\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nGasto\u00a0en\u00a0antirretrovirales \u00a0por\u00a0Instituci\u00f3n \u00a0(en\u00a0US\u00a0$)\u00a0\nEntidad\u00a0 2,005 2,006\u00a02,007\u00a02,008 2,009\u00a02,010\u00a0Total\u00a0\nMinisterio \u00a0de\u00a0salud\u00a0\u00a0 4,378\u00a01,055\u00a06,564 9,448\u00a01,880\u00a023,324\u00a0\nSeguro\u00a0social\u00a0de\u00a0salud\u00a0 5,119 3,816\u00a01,164\u00a01,981 4,118\u00a01,586\u00a017,785\u00a0\nFuerzas\u00a0armadas/policiales \u00a0 770\u00a0287\u00a0 461\u00a0220\u00a0296\u00a0 26\u00a0 2,059\u00a0\nHospitales \u00a0 31\u00a0 402\u00a0 584\u00a0135\u00a0 16\u00a0 37\u00a0 1,204\u00a0\nGobiernos \u00a0regionales \u00a0\u2010 \u00a0 41\u00a0 15\u00a0 21\u00a0\u2010 \u00a0 \u2010 \u00a0 76\u00a0\nGobierno \u00a0local\u00a0(Callao)\u00a0 41\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 41\u00a0\nTotal\u00a0 5,960 8,923\u00a03,280\u00a08,920 13,877 3,529\u00a044,490\u00a0\n\u00a0\nEl\u00a0gasto\u00a0en\u00a0ARV\u00a0por\u00a0productos \u00a0se\u00a0presenta\u00a0en\u00a0el\u00a0siguiente\u00a0cuadro.\u00a0\n\u00a0\nGasto\u00a0en\u00a0antirretrovirales \u00a0por\u00a0producto\u00a0(en\u00a0US\u00a0$)\u00a0\n\u00a0 2,005\u00a02,006\u00a02,007 2,008\u00a02,009\u00a02,010\u00a0Total\u00a0\nABACAVIR \u00a0 61\u00a0 343\u00a0211\u00a0264\u00a0 23\u00a0 124\u00a01,026\u00a0\nABACAVIR+ZIDOVUDINA+LAMIVUDINA \u00a0 9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 9\u00a0\nAMPRENAVIR \u00a0\u00a0 \u00a0 \u00a0 3\u00a0\u00a0\u00a0 3\u00a0\nARV\u00a0 898\u00a0 597\u00a0717\u00a0204\u00a0 206\u00a0148\u00a02,769\u00a0\nATAZANAVIR \u00a0 190\u00a0 461\u00a01,411 885\u00a09,136\u00a0 7\u00a012,089\nATAZANAVIR \u00a0+LOPINAVIR \u00a0 2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2\u00a0\nDARUNAVIR \u00a0\u00a0 \u00a0 \u00a0 \u00a0 31\u00a0 64\u00a0 95\u00a0\nDIDANOSINA \u00a0 546\u00a0 272\u00a0 55\u00a0 590\u00a0 150\u00a0829\u00a02,444\u00a0\nEFAVIRENZ \u00a0 1,580\u00a01,109\u00a0119\u00a0764\u00a0 784\u00a0 10\u00a04,365\u00a0\nESTAVUDINA \u00a0 94\u00a0 51\u00a0 21\u00a0 72\u00a0 50\u00a0\u00a0 288\u00a0\nINDINAVIR \u00a0 415\u00a0 11\u00a0\u00a0 199\u00a0\u00a0 \u00a0 624\u00a0\nLAMIVUDINA \u00a0 457\u00a0 122\u00a0159\u00a0408\u00a0 283\u00a0 86\u00a01,515\u00a0\nLAMIVUDINA \u00a0+\u00a0ESTAVUDINA \u00a0\u00a0 4\u00a0\u00a0\u00a0 \u00a0\u00a0 4\u00a0\nLAMIVUDINA \u00a0+\u00a0ESTAVUDINA \u00a0+\u00a0NEVIRAPINA \u00a0 41\u00a0 195\u00a0132\u00a0176\u00a0 227\u00a0\u00a0 771\u00a0\nLAMIVUDINA \u00a0+\u00a0ZIDOVUDINA \u00a0 98\u00a0 768\u00a0 16\u00a0 441\u00a0 910\u00a0 9\u00a0 2,243\u00a0\nLAMIVUDINA \u00a0+\u00a0ZIDOVUDINA \u00a0+\u00a0NEVIRAPINA \u00a0 689\u00a0 980\u00a0 49\u00a01,227\u00a0\u00a0 925\u00a03,871\u00a0\nLOPINAVIR \u00a0+\u00a0RITONAVIR \u00a0 1,389\u00a04,727\u00a0392\u00a02,797\u00a01,506\u00a021\u00a010,832\nNELFINAVIR \u00a0 1,290\u00a0584\u00a0318\u00a0964\u00a0\u00a0 \u00a0 3,156\u00a0\nNEVIRAPINA \u00a0 74\u00a0 103\u00a0 51\u00a0 84\u00a0 12\u00a0\u00a0 324\u00a0\nRITONAVIR \u00a0 182\u00a0 742\u00a0 48\u00a0 114\u00a0 84\u00a0 389\u00a01,558\u00a0\nSAQUINAVIR \u00a0 288\u00a0 881\u00a0109\u00a0393\u00a0 603\u00a0998\u00a03,271\u00a0 64 \u00a0 2,005\u00a02,006\u00a02,007 2,008\u00a02,009\u00a02,010\u00a0Total\u00a0\nTENOFOVIR \u00a0\u00a0 \u00a0 \u00a0 20\u00a0\u00a0 58\u00a0 77\u00a0\nZIDOVUDINA \u00a0 591\u00a0 200\u00a0190\u00a0397\u00a0 79\u00a0 10\u00a01,468\u00a0\nTotal\u00a0 8,894\u00a012,151 3,997 10,001 14,083\u00a03,677\u00a052,804\n\u00a0\nF.6.3\u00a0\u00a0Gasto\u00a0en\u00a0preservativos \u00a0\n\u00a0\nCon\u00a0respecto\u00a0a\u00a0la\u00a0adquisici\u00f3n \u00a0de\u00a0condones \u00a0se\u00a0presenta\u00a0en\u00a0el\u00a0cuadro\u00a0siguiente\u00a0la\u00a0cantidad\u00a0de\u00a0condones \u00a0y\u00a0el\u00a0\nmonto\u00a0invertido. \u00a0Present\u00e1ndose \u00a0por\u00a0un\u00a0lado\u00a0las\u00a0compras\u00a0adquiridas \u00a0por\u00a0el\u00a0Ministerio \u00a0de\u00a0Salud\u00a0con\u00a0Convenio \u00a0\ncon\u00a0el\u00a0Fondo\u00a0de\u00a0Poblaci\u00f3n \u00a0de\u00a0Naciones\u00a0Unidas\u00a0y\u00a0las\u00a0compras\u00a0\u00a0adquiridas \u00a0por\u00a0otras\u00a0Instituciones \u00a0con\u00a0los\u00a0\nprocesos\u00a0de\u00a0SEACE.\u00a0\u00a0Se\u00a0ve\u00a0que\u00a0no\u00a0hay\u00a0una\u00a0tendencia \u00a0marcada\u00a0en\u00a0la\u00a0compra\u00a0de\u00a0condones, \u00a0\u00a0pero\u00a0si\u00a0llama\u00a0la\u00a0\natenci\u00f3n\u00a0el\u00a0gasto\u00a0realizado\u00a0en\u00a0el\u00a02009\u00a0que\u00a0asciende\u00a0a\u00a0\u00a0S/.\u00a0500,000\u00a0y\u00a0se\u00a0relaciona\u00a0con\u00a0el\u00a0n\u00famero\u00a0de\u00a0condones \u00a0\nadquiridos \u00a0y\u00a0con\u00a0la\u00a0falta\u00a0de\u00a0preservativos \u00a0a\u00a0nivel\u00a0nacional.\u00a0Pero,\u00a0para\u00a0el\u00a02010\u00a0se\u00a0ve\u00a0el\u00a0incremento \u00a0\u00a0de\u00a0\u00a0gasto\u00a0\nrealizado\u00a0en\u00a0la\u00a0adquisici\u00f3n \u00a0de\u00a0condones \u00a0lo\u00a0cual\u00a0tambi\u00e9n\u00a0se\u00a0traduce\u00a0en\u00a0n\u00fameros\u00a0absolutos, \u00a0pues\u00a0va\u00a0desde\u00a0\n1,123,045 \u00a0\u00a0en\u00a0el\u00a02009\u00a0\u00a0a\u00a0\u00a065,557,343 \u00a0en\u00a0el\u00a02010.\u00a0Lo\u00a0que\u00a0no\u00a0est\u00e1\u00a0muy\u00a0claro\u00a0si\u00a0es\u00a0que\u00a0todos\u00a0los\u00a0a\u00f1os\u00a0se\u00a0\u00a0van\u00a0a\u00a0\ncomprar\u00a0estas\u00a0cantidades \u00a0o\u00a0esta\u00a0compra\u00a0realizada\u00a0es\u00a0para\u00a0un\u00a0n\u00famero\u00a0determinado \u00a0de\u00a0a\u00f1os.\u00a0\n\u00a0\nEn\u00a0el\u00a0siguiente\u00a0cuadro\u00a0se\u00a0visualiza\u00a0el\u00a0gasto\u00a0en\u00a0preservativos \u00a0realizado\u00a0por\u00a0el\u00a0sector\u00a0p\u00fablico.\u00a0\u00a0\u00a0\u00a0\n\u00a0\n616\u00a0722\u00a01,399\u00a0\n444\u00a0341\u00a01,457\u00a0\n244\u00a0526\u00a03,212\u00a0\n2002 2003 2004 2005 2006 2007 2008 2009 2010Sector\u00a0p\u00fablico\u00a0\u2010Gasto\u00a0en\u00a0Preservativos\nEn\u00a0miles\u00a0de\u00a0US\u00a0$\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nComo\u00a0se\u00a0explico\u00a0anteriormente \u00a0en\u00a0el\u00a0Per\u00fa\u00a0la\u00a0distribuci\u00f3n \u00a0de\u00a0insumos\u00a0se\u00a0realiza\u00a0en\u00a034\u00a0Direcciones \u00a0\nRegionales, \u00a0en\u00a0el\u00a0caso\u00a0de\u00a0preservativos, \u00a0a\u00a0su\u00a0vez\u00a0se\u00a0distribuyen \u00a0en\u00a0\u00a0los\u00a0\u00a07,382\u00a0establecimientos \u00a0de\u00a0salud\u00a0\u00a0(155\u00a0\nhospitales, \u00a01,321\u00a0centros\u00a0de\u00a0salud\u00a0y\u00a05,906\u00a0puestos\u00a0de\u00a0salud).\u00a0\u00a0El\u00a0proceso\u00a0log\u00edstico\u00a0se\u00a0inicia\u00a0desde\u00a0el\u00a0\u00a0ingreso\u00a0\nde\u00a0insumos\u00a0en\u00a0el\u00a0almac\u00e9n\u00a0central,\u00a0la\u00a0distribuci\u00f3n \u00a0a\u00a0los\u00a0almacenes \u00a0especializados \u00a0y\u00a0de\u00a0all\u00ed\u00a0a\u00a0los\u00a0\nestablecimientos \u00a0de\u00a0salud.\u00a0\u00a0\u00a0El\u00a0almac\u00e9n\u00a0central\u00a0\u00a0considera \u00a0como\u00a0distribuido \u00a0una\u00a0vez\u00a0se\u00a0ingresa\u00a0en\u00a0los\u00a0\nalmacenes \u00a0especializados \u00a0(que\u00a0se\u00a0encuentran \u00a0en\u00a0los\u00a0departamentos \u00a0del\u00a0pa\u00eds)40\u00a0a\u00a0su\u00a0vez\u00a0estos\u00a0los\u00a0distribuyen \u00a0\na\u00a0los\u00a0establecimientos \u00a0de\u00a0salud,\u00a0los\u00a0cuales\u00a0tambi\u00e9n\u00a0tienen\u00a0almacenes \u00a0aunque\u00a0de\u00a0menores\u00a0dimensiones. \u00a0\u00a0\u00a0\n\u00a0\nEn\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os,\u00a0debido\u00a0a\u00a0que\u00a0no\u00a0ingresaron \u00a0condones \u00a0al\u00a0pa\u00eds\u00a0de\u00a0acuerdo\u00a0a\u00a0lo\u00a0programado \u00a0por\u00a0varios\u00a0\nproblemas, \u00a0(tal\u00a0como\u00a0la\u00a0demora\u00a0en\u00a0la\u00a0entrega\u00a0de\u00a0UNFPA,\u00a0demora\u00a0en\u00a0la\u00a0compra\u00a0con\u00a0recursos\u00a0del\u00a0FMSTM)\u00a0se\u00a0\nha\u00a0producido \u00a0un\u00a0sobreabastecimiento \u00a0que\u00a0genero\u00a0problemas \u00a0de\u00a0almacenamiento \u00a0y\u00a0por\u00a0otro\u00a0lado,\u00a0obligo\u00a0a\u00a0\n                                                 \n40 En\u00a0el\u00a02008,\u00a0\u00a0se\u00a0realizo\u00a0la\u00a0Evaluaci\u00f3n \u00a0de\u00a0los\u00a0sistemas\u00a0de\u00a0distribuci\u00f3n \u00a0y\u00a0almacenamiento \u00a0de\u00a0preservativos, \u00a0en\u00a0la\u00a0cual\u00a0se\u00a0\ndetermino \u00a0que\u00a0si\u00a0bien\u00a0se\u00a0entregan\u00a0condones \u00a0en\u00a0forma\u00a0gratuita\u00a0a\u00a0las\u00a0poblaciones \u00a0expuestas, \u00a0\u00a0la\u00a0cobertura \u00a0a\u00fan\u00a0ser\u00eda\u00a0baja,\u00a0\npor\u00a0diferentes \u00a0razones,\u00a0que\u00a0se\u00a0pudieron\u00a0visualizar \u00a0en\u00a0las\u00a0encuestas \u00a0y\u00a0entrevistas \u00a0realizadas \u00a0en\u00a0ese\u00a0estudio\u00a0a\u00a0lo\u00a0largo\u00a0de\u00a0la\u00a0\ncadena\u00a0de\u00a0suministro \u00a0del\u00a0cond\u00f3n.\u00a0\u00a0El\u00a0estudio\u00a0evidenci\u00f3 \u00a0la\u00a0existencia \u00a0de\u00a0cantidades \u00a0importantes \u00a0de\u00a0condones \u00a0a\u00a0nivel\u00a0del\u00a0\nAlmac\u00e9n\u00a0Central\u00a0y\u00a0de\u00a0Almacenes \u00a0Especializados \u00a0de\u00a0Medicamentos, \u00a0debido\u00a0a\u00a0que\u00a0ingreso\u00a0realizado\u00a0en\u00a0el\u00a02007\u00a0de\u00a0\nimportaciones \u00a0realizadas \u00a0por\u00a0UNFPA\u00a0por\u00a0encargo\u00a0del\u00a0estado\u00a0peruano.\u00a0\u00a0Fuente:\u00a0Evaluaci\u00f3n \u00a0de\u00a0los\u00a0sistemas\u00a0de\u00a0\ndistribuci\u00f3n \u00a0y\u00a0almacenamiento \u00a0de\u00a0preservativos \u00a02008,\u00a0en\u00a0el\u00a0marco\u00a0del\u00a0Proyecto\u00a0del\u00a0Fondo\u00a0Mundial\u00a06ta.\u00a0Ronda.   65 tomar\u00a0medidas\u00a0para\u00a0cumplir\u00a0con\u00a0la\u00a0meta\u00a0de\u00a0distribuci\u00f3n \u00a0establecido \u00a0en\u00a0el\u00a0programa \u00a0de\u00a06ta\u00a0ronda\u00a0del\u00a0\nFMSTM\u00a0(incremento \u00a0de\u00a0cantidad\u00a0de\u00a0preservativos \u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0m\u00e1s\u00a0expuesta\u00a0o\u00a0campa\u00f1as \u00a0de\u00a0distribuci\u00f3n \u00a0\nde\u00a0preservativos). \u00a0\n\u00a0\n\u00a0\nEvoluci\u00f3n \u00a0del\u00a0gasto\u00a0y\u00a0cantidad\u00a0de\u00a0condones \u00a0adquirida \u00a0por\u00a0el\u00a0sector\u00a0p\u00fablico\u00a0\nPeriodo\u00a02002\u00a0al\u00a02010\u00a0(En\u00a0nuevos\u00a0soles)\u00a0\nCantidad\u00a0de\u00a0condones \u00a0 Monto\u00a0en\u00a0soles\u00a0A\u00f1o\u00a0Por\u00a0UNFPA\u00a0Por\u00a0SEACE\u00a0 Total\u00a0 Por\u00a0UNFPA\u00a0 Por\u00a0SEACE\u00a0 Total\u00a0\n2002\u00a0 15,958,897 \u00a0\u00a0 15,958,897 \u00a0 1,847,873 \u00a0\u00a0 1,847,873 \u00a0\n2003\u00a0 18,699,885 \u00a0\u00a0 18,699,885 \u00a0 2,165,260 \u00a0\u00a0 2,165,260 \u00a0\n2004\u00a0 37,000,000 \u00a0\u00a0 37,000,000 \u00a0 4,195,800 \u00a0\u00a0 4,195,800 \u00a0\n2005\u00a0 8,401,267 \u00a0 123,467\u00a0 8,524,734 \u00a0 924,139\u00a0 52,612\u00a0 976,751\u00a0\n2006\u00a0\u2010 \u00a0 4,356,904 \u00a0 4,356,904 \u00a0\u2010 \u00a0 1,096,286 \u00a0 1,096,286 \u00a0\n2007\u00a0 63,247,716 \u00a0 245,135\u00a0 63,492,851 \u00a0 6,357,665 \u00a0 72,124\u00a0 6,429,789 \u00a0\n2008\u00a0 43,916,976 \u00a0 103,482\u00a0 44,020,458 \u00a0 4,686,381 \u00a0 30,886\u00a0 4,717,267 \u00a0\n2009\u00a0\u2010 \u00a0 1,123,045 \u00a0 1,123,045 \u00a0\u00a0 471,479\u00a0 471,479\u00a0\n2010\u00a0\u00a0 65,557,343 \u00a065,557,343 \u00a0\u00a0 9,225,166 \u00a0 9,225,166 \u00a0\nTotal\u00a0 187,224,741 \u00a071,509,376 \u00a0193,075,837 \u00a020,177,118 \u00a010,948,553 \u00a021,738,691 \u00a0\nFuente:\u00a0Ministerio \u00a0de\u00a0salud\u00a0y\u00a0SEACE\u00a0\n\u00a0\n\u00a0\n\u00a0\nF.6.4\u00a0\u00a0Reactivos \u00a0y\u00a0materiales \u00a0\n\u00a0\nEn\u00a0este\u00a0rubro\u00a0se\u00a0incluyen\u00a0los\u00a0reactivos\u00a0\u00a0para\u00a0diagn\u00f3stico \u00a0(prueba\u00a0ELISA,\u00a0prueba\u00a0r\u00e1pida),\u00a0\u00a0para\u00a0confirmaci\u00f3n; \u00a0\nCD4\u00a0y\u00a0carga\u00a0viral\u00a0y\u00a0pruebas\u00a0de\u00a0genotipificaci\u00f3n. \u00a0\u00a0De\u00a0acuerdo\u00a0a\u00a0la\u00a0metodolog\u00eda \u00a0MEGAS,\u00a0la\u00a0aplicaci\u00f3n \u00a0de\u00a0\npruebas\u00a0a\u00a0poblaciones \u00a0espec\u00edficas \u00a0y\u00a0m\u00e1s\u00a0expuestas \u00a0es\u00a0clasificada \u00a0como\u00a0prevenci\u00f3n, \u00a0las\u00a0otras\u00a0pruebas\u00a0que\u00a0no\u00a0\nson\u00a0asociadas \u00a0a\u00a0un\u00a0programa \u00a0de\u00a0prevenci\u00f3n \u00a0espec\u00edfico \u00a0son\u00a0clasificadas \u00a0en\u00a0el\u00a0rubro\u00a0de\u00a0Tratamiento \u00a0(Pruebas\u00a0\niniciadas\u00a0por\u00a0el\u00a0proveedor). \u00a0\n\u00a0\nEl\u00a0gasto\u00a0en\u00a0reactivos\u00a0es\u00a0asumido\u00a0\u00a0por\u00a0el\u00a0Ministerio \u00a0de\u00a0Salud,\u00a0Seguro\u00a0Integral\u00a0de\u00a0Salud,\u00a0Seguro\u00a0Social\u00a0de\u00a0\nSalud,\u00a0Fuerzas\u00a0armadas\u00a0y\u00a0por\u00a0los\u00a0laboratorios \u00a0privados41.\u00a0\n\u00a0\nPodemos \u00a0observar\u00a0que\u00a0el\u00a0monto\u00a0m\u00e1s\u00a0importante \u00a0es\u00a0el\u00a0resultado \u00a0de\u00a0la\u00a0LP.1\u20102007/OPD/INS \u00a0que\u00a0realizo\u00a0el\u00a0\nInstituto\u00a0Nacional\u00a0de\u00a0Salud\u00a0(INS)\u00a0y\u00a0que\u00a0fue\u00a0espec\u00edficamente \u00a0para\u00a0el\u00a0tema\u00a0de\u00a0monitorizaci\u00f3n \u00a0de\u00a0PVV\u00a0por\u00a0m\u00e1s\u00a0\nde\u00a02\u00a0millones\u00a0de\u00a0US\u00a0$,\u00a0la\u00a0\u00a0cual\u00a0est\u00e1\u00a0incluida\u00a0en\u00a0el\u00a02007\u00a0y\u00a0la\u00a0adquisici\u00f3n \u00a0por4\u00a0millones\u00a0de\u00a0US\u00a0$\u00a0en\u00a0el\u00a0a\u00f1o\u00a02009\u00a0\nrealizada\u00a0por\u00a0la\u00a0misma\u00a0instituci\u00f3n \u00a0por\u00a0el\u00a0mismo\u00a0concepto \u00a0mediante \u00a0la\u00a0LP.1\u20102009/OPE/INS \u00a0y\u00a0otras\u00a0\nadquisiciones \u00a0realizadas \u00a0en\u00a0el\u00a02009.\u00a0\u00a0Es\u00a0m\u00e1s\u00a0en\u00a0este\u00a0se\u00a0apertura\u00a0una\u00a0actividad\u00a0presupuestal \u00a0que\u00a0se\u00a0registra\u00a0\nen\u00a0el\u00a0SIAF\u00a01040226: \u00a0Monitoreo \u00a0de\u00a0laboratorio \u00a0de\u00a0tratamiento \u00a0con\u00a0antiretrovirales \u00a0de\u00a0los\u00a0pacientes \u00a0con\u00a0VIH\u00a0\nSIDA,\u00a0lo\u00a0cual\u00a0demuestra \u00a0la\u00a0importancia \u00a0para\u00a0esta\u00a0entidad\u00a0de\u00a0este\u00a0concepto \u00a0de\u00a0gasto.\u00a0\n\u00a0\nGasto\u00a0en\u00a0reactivos\u00a0por\u00a0Fuente\u00a0de\u00a0financiamiento \u00a0\u00a0(miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 2,005 2,006\u00a02,007 2,008 2009\u00a02010\u00a0Total\u00a0\nRenta\u00a0del\u00a0gobierno\u00a0central\u00a0 817\u00a0737\u00a03,656 2,230 5,007\u00a02,385\u00a014,831\nRenta\u00a0del\u00a0gobierno\u00a0estatal/provincial \u00a0 18\u00a0 55\u00a0 128\u00a0770\u00a062\u00a0124\u00a01,156\u00a0\nRenta\u00a0del\u00a0gobierno\u00a0local/municipal \u00a0 20\u00a0 31\u00a0 34\u00a0 10\u00a0 2\u00a0\u00a0 96\u00a0\nAportaciones \u00a0patronales \u00a0\u00a0a\u00a0la\u00a0seguridad \u00a0social\u00a0 219\u00a01,174\u00a01,693 1,902 950\u00a01,891\u00a07,828\u00a0\n                                                 \n41 En el caso de laboratorios privad os, solo se incluye el gasto en prue bas de diagnostico realizado por los \nhogares para fines de conocer su estado, no incluye el solicitado para fines de tr abajo y otros fines similares.   66 \u00a0 2,005 2,006\u00a02,007 2,008 2009\u00a02010\u00a0Total\u00a0\nOtros\u00a0fondos\u00a0p\u00fablicos\u00a0s.c.o.\u00a0 316\u00a0370\u00a0301\u00a0349\u00a083\u00a0 56\u00a01,474\u00a0\nFondos\u00a0de\u00a0hogares\u00a0 194\u00a0218\u00a0290\u00a0304\u00a0295\u00a0314\u00a01,614\u00a0\nGobierno \u00a0de\u00a0los\u00a0Estados\u00a0Unidos\u00a0de\u00a0Am\u00e9rica\u00a0 3\u00a0 3\u00a0\u00a0\u00a0\u00a0\u00a0 6\u00a0\nFondo\u00a0Mundial\u00a0\u00a0contra\u00a0el\u00a0Sida,\u00a0TB\u00a0y\u00a0malaria\u00a0 1,011 1,282\u00a0196\u00a01,854 461\u00a0\u00a0 4,803\u00a0\nNaciones\u00a0Unidas\u00a0para\u00a0la\u00a0Infancia\u00a0(UNICEF)\u00a0\u00a0 63\u00a0 125\u00a0\u00a0 \u00a0 \u00a0 187\u00a0\nOtras\u00a0organizaciones \u00a0sin\u00a0fines\u00a0de\u00a0lucro\u00a0\u00a0 \u00a0 242\u00a0\u00a0 \u00a0 \u00a0 242\u00a0\nOrganizaciones \u00a0internacionales \u00a0con\u00a0fines\u00a0de\u00a0lucro\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u2010\u00a0 \u2010\u00a0\nTotal\u00a0 2,597 3,932\u00a06,663 7,418 6,859\u00a04,770\u00a032,238 67 \u00a0\nF.7\u00a0Poblaciones \u00a0beneficiarias \u00a0\n\u00a0\nGasto\u00a0por\u00a0Poblaciones \u00a0beneficiarias \u00a02005\u20102010\u00a0\u2010\u00a0En\u00a0miles\u00a0US\u00a0$\u00a0\n\u00a0 2005\u00a02006\u00a02007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a0\nPersonas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0 13,459 22,398 18,063 20,906\u00a025,590\u00a011,900 112,317\nPoblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 2,132\u00a02,600\u00a05,724\u00a010,733\u00a08,613\u00a05,788\u00a035,591\u00a0\nOtras\u00a0poblaciones \u00a0clave\u00a0 1,769\u00a02,045\u00a01,962\u00a02,573\u00a04,244\u00a01,867\u00a014,461\u00a0\nPoblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0 2,286\u00a03,995\u00a05,044\u00a06,913\u00a07,867\u00a05,963\u00a032,068\u00a0\nPoblaci\u00f3n \u00a0general\u00a0 3,667\u00a03,868\u00a07,194\u00a010,931\u00a010,003\u00a07,747\u00a043,411\u00a0\nIntervenciones \u00a0no\u00a0dirigidas\u00a0 504\u00a0 894\u00a0 914\u00a03,219\u00a05,545\u00a02,786\u00a013,861\u00a0\nPoblaciones \u00a0sin\u00a0clasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a0 4,340\u00a0678\u00a02,541\u00a0323\u00a0 380\u00a0 374\u00a0 8,637\u00a0\nTotal\u00a0 28,157 36,477 41,443 55,598\u00a062,242\u00a036,427 260,345\n\u00a0\nLa\u00a0clasificaci\u00f3n \u00a0de\u00a0gasto\u00a0por\u00a0Poblaciones \u00a0Beneficiarias \u00a0permite\u00a0identificar \u00a0\u00a0cu\u00e1nto\u00a0son\u00a0los\u00a0recursos\u00a0dirigidos\u00a0a\u00a0\npoblaciones \u00a0espec\u00edficas \u00a0como\u00a0parte\u00a0de\u00a0una\u00a0intervenci\u00f3n. \u00a0Las\u00a0Poblaciones \u00a0Beneficiarias \u00a0se\u00a0determinan \u00a0\u00a0seg\u00fan\u00a0\nla\u00a0intenci\u00f3n \u00a0y\u00a0objetivo\u00a0de\u00a0la\u00a0intervenci\u00f3n \u00a0program\u00e1tica. \u00a0\n\u00a0\n13,459\u00a022,398\u00a018,063\u00a020,906\u00a025,590\u00a0\n11,900\u00a02,132\u00a02,600\u00a05,724\u00a010,719\u00a08,378\u00a0\n5,788\u00a03,667\u00a03,868\u00a0 7,194\u00a010,945\u00a010,239\u00a0\n7,747\u00a08,899\u00a07,611\u00a010,461\u00a013,029\u00a018,036\u00a0\n10,991\u00a0\n2005 2006 2007 2008 2009 2010Gasto\u00a0en\u00a0VIH\u00a0\u2010Poblaci\u00f3n \u00a0beneficiaria\nPVV\n Poblaciones \u00a0m\u00e1s\u00a0expuestas\n Poblaci\u00f3n \u00a0general\n Otros\n\u00a0\n\u00a0\n\uf02d Perfil\u00a0de\u00a0la\u00a0epidemia \u00a0\n\u00a0\nLa\u00a0situaci\u00f3n\u00a0del\u00a0VIH/SIDA\u00a0en\u00a0el\u00a0Per\u00fa,\u00a0es\u00a0lo\u00a0que\u00a0el\u00a0Banco\u00a0Mundial\u00a0ha\u00a0definido\u00a0como\u00a0epidemia \u00a0concentrada. \u00a0(\u00a042\u00a0\n)\u00a0\u00a0Esta\u00a0afirmaci\u00f3n \u00a0se\u00a0basa\u00a0en\u00a0las\u00a0\u00a0prevalencias \u00a0de\u00a0VIH\u00a0obtenidas \u00a0por\u00a0las\u00a0vigilancias \u00a0centinelas \u00a0tanto\u00a0en\u00a0\ngestantes \u00a0como\u00a0en\u00a0las\u00a0diferentes \u00a0poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0\u00a0para\u00a0VIH.\u00a0\u00a0Estos\u00a0estudios\u00a0arrojan\u00a0prevalencias \u00a0\nde\u00a0entre\u00a010%\u00a0y\u00a020%\u00a0para\u00a0Hombres\u00a0que\u00a0tienen\u00a0sexo\u00a0con\u00a0hombres\u00a0(HSH),\u00a0entre\u00a01\u00a0y\u00a02%\u00a0entre\u00a0mujeres\u00a0\ntrabajadoras \u00a0sexuales\u00a0(TS)\u00a0y\u00a0por\u00a0debajo\u00a0de\u00a00.3%\u00a0en\u00a0mujeres\u00a0embarazadas. \u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\nAl\u00a0evaluar\u00a0las\u00a0v\u00edas\u00a0de\u00a0transmisi\u00f3n \u00a0del\u00a0virus,\u00a0se\u00a0evidencia \u00a0que\u00a0la\u00a0transmisi\u00f3n \u00a0de\u00a0la\u00a0epidemia \u00a0en\u00a0el\u00a0Per\u00fa\u00a0es\u00a0casi\u00a0\nexclusivamente \u00a0sexual\u00a0ya\u00a0que\u00a0representa \u00a0el\u00a097%\u00a0de\u00a0la\u00a0v\u00eda\u00a0de\u00a0transmisi\u00f3n \u00a0de\u00a0los\u00a0casos\u00a0de\u00a0SIDA,\u00a0\naproximadamente \u00a0el\u00a050%\u00a0de\u00a0los\u00a0casos\u00a0se\u00a0dan\u00a0en\u00a0personas\u00a0que\u00a0reportan\u00a0ser\u00a0homosexuales \u00a0o\u00a0bisexuales; \u00a0\nmientras\u00a0la\u00a0transmisi\u00f3n \u00a0materno\u00a0infantil\u00a0(perinatal \u00a0o\u00a0vertical)\u00a0el\u00a02%\u00a0y\u00a0la\u00a0transmisi\u00f3n \u00a0parenteral \u00a0el\u00a01%.\u00a0\n\u00a0\nTeniendo \u00a0el\u00a0pa\u00eds\u00a0una\u00a0epidemia \u00a0concentrada \u00a0especialmente \u00a0en\u00a0poblaci\u00f3n \u00a0HSH\u00a0y\u00a0TS\u00a0(hombres \u00a0que\u00a0tienen\u00a0sexo\u00a0\ncon\u00a0hombres\u00a0y\u00a0trabajadores \u00a0sexuales), \u00a0\u00a0el\u00a0gasto\u00a0en\u00a0las\u00a0poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0a\u00a0la\u00a0epidemia \u00a0de\u00a0VIH\u00a0solo\u00a0\nrepresent\u00f3 \u00a0el\u00a013.6%\u00a0del\u00a0total\u00a0del\u00a0gasto,\u00a0\u00a0alrededor \u00a0del\u00a03.2%\u00a0para\u00a0HSH\u00a0y\u00a05.2%\u00a0para\u00a0TS;\u00a0\u00a0(5.1%\u00a0est\u00e1\u00a0dirigido\u00a0a\u00a0\npoblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0pero\u00a0sin\u00a0determinar \u00a0a\u00a0qu\u00e9\u00a0grupo\u00a0\u00a0corresponde \u00a0el\u00a0gasto),el\u00a0gasto\u00a0en\u00a0las\u00a0PVV\u00a0\nrepresenta \u00a0el\u00a047%\u00a0del\u00a0gasto\u00a0total\u00a0en\u00a0Sida\u00a0en\u00a0el\u00a0pa\u00eds\u00a0y\u00a0el\u00a0gasto\u00a0en\u00a0poblaci\u00f3n \u00a0general\u00a0\u00a0es\u00a0alrededor \u00a0del\u00a025,2%.\u00a0\n                                                 \n42\u00a0Fuente:\u00a0Basado\u00a0en\u00a0el\u00a0\u00a0documento: \u00a0Banco\u00a0Mundial,\u00a0Confronting \u00a0AIDS\u00a0by\u00a0Joseph\u00a0Stiglitz,\u00a01997  68 \u00a0\nGasto\u00a0por\u00a0Poblaci\u00f3n \u00a0beneficiaria \u00a0\u2013\u00a0Estructura \u00a0porcentual \u00a0\n\u00a0 2005\u20102007\u00a02008\u20102010\u00a0 Total\u00a0\nPersonas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0 50.8% 37.9%\u00a0 43.1%\nPoblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 9.9% 16.3%\u00a0 13.7%\nOtras\u00a0poblaciones \u00a0clave\u00a0 5.4% 5.6%\u00a0 5.6%\nPoblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0 10.7% 13.4%\u00a0 12.3%\nPoblaci\u00f3n \u00a0general\u00a0 13.9% 18.6%\u00a0 16.7%\nIntervenciones \u00a0no\u00a0dirigidas\u00a0 2.2% 7.5%\u00a0 5.3%\nPoblaciones \u00a0sin\u00a0clasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a0 7.1% 0.7%\u00a0 3.3%\nTotal\u00a0 100.0% 100.0%\u00a0 100.0%\n\u00a0\n\u00a0\n\uf02d Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n\u00a0\nLa\u00a0poblaci\u00f3n \u00a0beneficiaria \u00a0m\u00e1s\u00a0importante \u00a0en\u00a0el\u00a0pa\u00eds\u00a0\u00a0es\u00a0la\u00a0de\u00a0las\u00a0PVV,\u00a0alrededor \u00a0del\u00a040%\u00a0del\u00a0gasto\u00a0total\u00a0en\u00a0\nSida\u00a0en\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os\u00a0(32.9%\u00a0para\u00a0el\u00a02008\u20102010\u00a0\u00a0disminuyendo \u00a0con\u00a0respecto\u00a0al\u00a0periodo\u00a02005\u20102007\u00a0que\u00a0\nllegaba\u00a0al\u00a050.8\u00a0%\u00a0del\u00a0gasto\u00a0en\u00a0VIH\u00a0en\u00a0el\u00a0pa\u00eds)\u00a0.\u00a0Esto\u00a0va\u00a0en\u00a0relaci\u00f3n\u00a0al\u00a0mayor\u00a0gasto\u00a0en\u00a0Atenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0\ncuyo\u00a0gran\u00a0componente \u00a0es\u00a0el\u00a0\u00a0gasto\u00a0que\u00a0se\u00a0realiza\u00a0en\u00a0TARGA.\u00a0\u00a0\n\u00a0\nHasta\u00a0el\u00a02009,\u00a0recib\u00edan\u00a0TARGA\u00a012,473\u00a0de\u00a0los\u00a0cuales\u00a0el\u00a073%\u00a0corresponde \u00a0al\u00a0MINSA,\u00a025%\u00a0a\u00a0ESSALUD\u00a0y\u00a02%\u00a0\u00a0\notras\u00a0Instituciones \u00a0(3\u00a0ONG\u00a0acreditadas \u00a0por\u00a0el\u00a0MINSA)\u00a0y\u00a0penales.\u00a0\u00a0\u00a0Si\u00a0tomamos \u00a0en\u00a0cuenta\u00a0la\u00a0estimaci\u00f3n \u00a0del\u00a0\u00a0\nMINSA\u00a0sobre\u00a0personas\u00a0\u00a0que\u00a0necesitan \u00a0TARGA,\u00a0\u00a0lo\u00a0anterior\u00a0significa\u00a0que\u00a0la\u00a0cobertura \u00a0de\u00a0tratamiento \u00a0en\u00a0el\u00a0\npa\u00eds\u00a0ser\u00eda\u00a0aproximadamente \u00a0de\u00a073.1%\u00a0\u00a0sin\u00a0considerar \u00a0los\u00a0fallecidos \u00a0y\u00a0abandonos. \u00a0(\u00a0\u00a043\u00a0\u00a0)\u00a0\n\u00a0\nDel\u00a0total\u00a0de\u00a0las\u00a0personas\u00a0que\u00a0reciben\u00a0TARGA\u00a0en\u00a0el\u00a0pa\u00eds,\u00a0\u00a0el\u00a069%\u00a0son\u00a0varones\u00a0y\u00a0el\u00a031%\u00a0mujeres44,\u00a0proporci\u00f3n \u00a0\nque\u00a0se\u00a0mantiene \u00a0desde\u00a0el\u00a02004;\u00a0considerando \u00a0que\u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0de\u00a0varones\u00a0se\u00a0encuentran \u00a0incluida\u00a0\ntambi\u00e9n\u00a0la\u00a0poblaci\u00f3n \u00a0HSH.\u00a0Lo\u00a0que\u00a0no\u00a0tenemos\u00a0datos\u00a0muy\u00a0claros\u00a0es\u00a0el\u00a0porcentaje \u00a0de\u00a0HSH\u00a0dentro\u00a0de\u00a0los\u00a0que\u00a0\nreciben\u00a0TARGA,\u00a0porque\u00a0es\u00a0un\u00a0dato\u00a0que\u00a0no\u00a0se\u00a0recoge\u00a0en\u00a0todos\u00a0los\u00a0establecimientos, \u00a0y\u00a0si\u00a0se\u00a0recoge\u00a0no\u00a0se\u00a0\nconsidera \u00a0dentro\u00a0los\u00a0registros. \u00a0\n\u00a0\nPersonas\u00a0con\u00a0VIH\u00a0en\u00a0tratamiento \u00a0\u00a0\nHombres\u00a0 Mujeres\u00a0 TOTAL\u00a0 TX\u00a0A\u00f1o\u00a0inicio\u00a0\ntratamiento \u00a0Inician\u00a0Acumu\u2010\nlado\u00a0%\u00a0 Inician\u00a0Acumu\u2010\nlado\u00a0%\u00a0 Inician\u00a0Acumu\u2010\nlado\u00a0H/M\u00a0Acumu\u2010\nlado\u00a0\nH/M\u00a0\n2000\u00a0 3\u00a0 3\u00a0 75%\u00a0 1\u00a0 1\u00a0 25%\u00a0 4\u00a0 4\u00a0 3.0\u00a0 3.0\u00a0\n2001\u00a0 1\u00a0 4\u00a0 57%\u00a0 2\u00a0 3\u00a0 43%\u00a0 3\u00a0 7\u00a0 0.5\u00a0 1.3\u00a0\n2002\u00a0 14\u00a0 18\u00a0 55%\u00a0 12\u00a0 15\u00a0 45%\u00a0 26\u00a0 33\u00a0 1.2\u00a0 1.2\u00a0\n2003\u00a0 30\u00a0 48\u00a0 56%\u00a0 23\u00a0 38\u00a0 44%\u00a0 53\u00a0 86\u00a0 1.3\u00a0 1.3\u00a0\n2004\u00a0 691\u00a0 739\u00a0 65%\u00a0 366\u00a0 404\u00a0 35%\u00a0 1,057\u00a0 1,143\u00a01.9\u00a0 1.8\u00a0\n2005\u00a0 1,294\u00a0 2,033\u00a068%\u00a0 550\u00a0 954\u00a0 32%\u00a0 1,844\u00a0 2,987\u00a02.4\u00a0 2.1\u00a0\n2006\u00a0 1,132\u00a0 3,165\u00a068%\u00a0 541\u00a0 1,495\u00a032%\u00a0 1,673\u00a0 4,660\u00a02.1\u00a0 2.1\u00a0\n2007\u00a0 2,401\u00a0 5,566\u00a068%\u00a0 1,094\u00a0 2,589\u00a032%\u00a0 3,495\u00a0 8,155\u00a02.2\u00a0 2.1\u00a0\n2008\u00a0 1,185\u00a0 6,751\u00a069%\u00a0 502\u00a0 3,091\u00a031%\u00a0 1,687\u00a0 9,842\u00a02.4\u00a0 2.2\u00a0\n2009\u00a0 3,001\u00a0 9,752\u00a067%\u00a0 1,639\u00a0 4,730\u00a033%\u00a0 4,640\u00a014,482\u00a01.8\u00a0 2.1\u00a0\n2010\u00a0 1,290\u00a011,042\u00a069%\u00a0 231\u00a0 4,961\u00a031%\u00a0 1,521\u00a016,003\u00a05.6\u00a0 2.2\u00a0\nTotal\u00a0 11,042\u00a011,042\u00a069%\u00a0 4,961\u00a0 4,961\u00a031%\u00a0 16,003\u00a016,003\u00a02.2\u00a0 0.3\u00a0\nFuente:\u00a0ESN\u00a0PC\u00a0ITS/VIH/SIDA \u00a0\n                                                 \n43\u00a0Fuente:\u00a0Informe\u00a0UNGASS.\u00a02010\u2010\u00a0ONUSIDA. \u00a0 \n44\u00a0Fuente:\u00a0ESN\u00a0de\u00a0P\u00a0y\u00a0C\u00a0de\u00a0ITS/VIH/Sida   69 Algunos\u00a0dato\u00a0indicativos \u00a0sobre\u00a0las\u00a0diferentes \u00a0poblaciones \u00a0\u00a0y\u00a0la\u00a0cobertura \u00a0de\u00a0tamizaje\u00a0nos\u00a0permiten\u00a0\naproximarnos \u00a0hac\u00eda\u00a0la\u00a0orientaci\u00f3n \u00a0de\u00a0gasto\u00a0hac\u00eda\u00a0determinado \u00a0grupos\u00a0de\u00a0poblaci\u00f3n. \u00a0\n\u00a0\n\u00a0\nCobertura \u00a0de\u00a0tamizaje\u00a0y\u00a0prevalencia \u00a0por\u00a0grupos\u00a0poblacionales \u00a0\n\u00a0Tamizaje\u00a0\u00a0\nde\u00a0VIH\u00a0Poblaci\u00f3n \u00a0\nestimada\u00a0Cobertura \u00a0\nde\u00a0\ntamizaje\u00a0%\u00a0de\u00a0casos\u00a0\npositivos\u00a0Fuente\u00a0\nGestantes \u00a0292,876\u00a0\n(a)\u00a0600,000\u00a0\nanual\u00a0(b)\u00a049%\u00a0 0.27%\u00a0(a)\u00a0(a)\u00a0Hoja\u00a0de\u00a0Monitorizaci\u00f3n \u00a02006:\u00a0Reactivos \u00a0\n/tamizados \u00a0\n(b)\u00a0ESN\u00a0SSR\u00a0\nTS\u00a0mujeres\u00a024,284\u00a0\n(a)\u00a060,000\u00a0(b)\u00a0 40%\u00a0 0.40%\u00a0(\u00a0c\u00a0)\u00a0\u00a0(a)\u00a0Hoja\u00a0de\u00a0Monitorizaci\u00f3n \u00a02006\u00a0\n(b)\u00a0Plan\u00a0de\u00a0acceso\u00a0universal\u00a02006\u20102010\u00a0\n(Kusunoki \u00a0y\u00a0Navarro,\u00a02006)\u00a0\n(c)\u00a0Estudio\u00a0de\u00a0vigilancia\u00a0centinela\u00a0para\u00a0\nb\u00fasqueda \u00a0de\u00a0Prevalencia \u00a0de\u00a0VIH\u00a0en\u00a0TS.\u00a0\nMINSA\u2010UPCH.\u00a02006.\u00a0\nHSH\u00a019,576\u00a0\n(a)\u00a0200,000\u00a0\n(b)\u00a010%\u00a0 10.8%\u00a0(c\u00a0)\u00a0(a)\u00a0Hoja\u00a0de\u00a0Monitorizaci\u00f3n \u00a02006\u00a0\n(b)\u00a0Plan\u00a0de\u00a0acceso\u00a0universal\u00a02006\u20102010\u00a0\n(idem\u00a0supra)\u00a0\n\u00a0(c\u00a0)\u00a0Vigilancia \u00a0Centinela \u00a0de\u00a0\u201cTercera\u00a0\nGeneraci\u00f3n\u201d \u00a0\u2013\u00a0CIPRA\u00a03B\u00a0\u2013\u00a0Andean\u00a0CIPRA\u00a0/\u00a0\nDirecci\u00f3n \u00a0General\u00a0de\u00a0Epidemiolog\u00eda. \u00a0MINSA.\u00a0\nTS\u00a0hombres\u00a03,738\u00a0(a)\u00a010,000\u00a0(b)\u00a0 37%\u00a0Mayor\u00a0a\u00a0\n10.8\u00a0%\u00a0(a)\u00a0Hoja\u00a0de\u00a0Monitorizaci\u00f3n \u00a02006\u00a0\n(b)\u00a0Plan\u00a0de\u00a0acceso\u00a0universal\u00a02006\u20102010\u00a0\n(Idem\u00a0supra)\u00a0\nPPL\u00a0mujeres\u00a01,190\u00a0(a)\u00a02,897\u00a0(b)\u00a0 41%\u00a0 7.39%\u00a0(a)45\u00a0\nPPL\u00a0\nhombres\u00a01,726\u00a0(a)\u00a038,848\u00a0(b)\u00a0 4%\u00a0 13.09%\u00a0(a)46\u00a0(a)\u00a0Hoja\u00a0de\u00a0Monitorizaci\u00f3n \u00a02006:\u00a0Reactivos \u00a0\n/tamizados \u00a0\n(b)\u00a0www.inpe.gob.pe \u00a0\n\u00a0\n\u00a0\n\uf02d Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0\n\u00a0\nLas\u00a0poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0HSH\u00a0y\u00a0TS\u00a0reciben\u00a0AMP\u00a0en\u00a0los\u00a0CERITS\u00a0a\u00a0nivel\u00a0nacional,\u00a0seg\u00fan\u00a0la\u00a0hoja\u00a0de\u00a0\nmonitorizaci\u00f3n \u00a0la\u00a0mayor\u00a0cobertura \u00a0referida\u00a0a\u00a0la\u00a0atenci\u00f3n, \u00a0tamizaje\u00a0y\u00a0condones \u00a0entregados \u00a0corresponde \u00a0a\u00a0las\u00a0\nTrabajadoras \u00a0sexuales.\u00a0\n\u00a0\nConcentraci\u00f3n \u00a0de\u00a0la\u00a0atenci\u00f3n\u00a0por\u00a0tipo\u00a0de\u00a0poblaci\u00f3n \u00a0a\u00f1o\u00a02006\u00a0\n\u00a0\u00a0 TS\u00a0mujeres\u00a0TS\u00a0hombres\u00a0Hombres\u00a0 Total\u00a0\n\u00a0Atendidas \u00a0\u00a0 59%\u00a0 9%\u00a0 32%\u00a0 100%\u00a0\n\u00a0Tamizadas \u00a0\u00a0 51%\u00a0 8%\u00a0 41%\u00a0 100%\u00a0\n\u00a0Condones \u00a0entregados \u00a0\u00a0 71%\u00a0 10%\u00a0 19%\u00a0 100%\u00a0\nFuente:\u00a0Hoja\u00a0de\u00a0monitorizaci\u00f3n \u00a02006\u00a0\n\u00a0\nEl\u00a0principal\u00a0hallazgo\u00a0cuando\u00a0se\u00a0revisan\u00a0las\u00a0\u00a0Historias\u00a0cl\u00ednicas,\u00a0es\u00a0que\u00a0las\u00a0mujeres\u00a0acuden\u00a0m\u00e1s\u00a0a\u00a0los\u00a0CERITS,\u00a0\nhacen\u00a0m\u00e1s\u00a0visitas\u00a0y\u00a0reciben\u00a0m\u00e1s\u00a0AMP.\u00a0\u00a0Si\u00a0se\u00a0analiza\u00a0la\u00a0distribuci\u00f3n \u00a0de\u00a0visitas\u00a0en\u00a0el\u00a0primer\u00a0a\u00f1o,\u00a0el\u00a028%\u00a0de\u00a0los\u00a0\nusuarios,\u00a0realiza\u00a0el\u00a059%\u00a0de\u00a0las\u00a0visitas\u00a0que\u00a0recibe\u00a0el\u00a0CERITS\u00a0y\u00a067%\u00a0de\u00a0las\u00a0AMP\u00a0que\u00a0se\u00a0completan. \u00a0\n                                                 \n45\u00a0Este\u00a0dato\u00a0representa \u00a0el\u00a0n\u00famero\u00a0de\u00a0casos\u00a0positivos\u00a0reportados \u00a0por\u00a0los\u00a0penales\u00a0en\u00a0un\u00a0grupo\u00a0de\u00a0personas\u00a0tamizadas \u00a0en\u00a0\nun\u00a0per\u00edodo\u00a0de\u00a0tiempo\u00a0dado,\u00a0en\u00a0el\u00a0marco\u00a0de\u00a0la\u00a0informaci\u00f3n \u00a0provista\u00a0por\u00a0los\u00a0registros\u00a0administrativos \u00a0correspondientes. \u00a0\u00a0\nPor\u00a0tanto,\u00a0NO\u00a0representa \u00a0la\u00a0prevalencia \u00a0en\u00a0la\u00a0poblaci\u00f3n.  \n46 Idem supra.  70 \u00a0\nDurante\u00a0toda\u00a0su\u00a0\npermanencia \u00a0En\u00a0el\u00a0primer\u00a0a\u00f1o\u00a0\u00a0\nHombre Mujer\u00a0Total\u00a0Hombre\u00a0Mujer\u00a0Total\u00a0\nAtendidos \u00a0\u00a0al\u00a0a\u00f1o\u00a0por\u00a0caso\u00a0 1.7\u00a0 2.0\u00a0 1.9\u00a0\u00a0\u00a0 \u00a0\nVisitas\u00a0por\u00a0persona\u00a0todo\u00a0el\u00a0tratamiento \u00a0 4.9\u00a0 8.9\u00a0 6.9\u00a0 2.6\u00a0 3.0\u00a0 2.8\u00a0\nVisitas\u00a0por\u00a0persona\u00a0a\u00f1o\u00a0 2.8\u00a0 4.5\u00a0 3.7\u00a0 2.6\u00a0 3.0\u00a0 2.8\u00a0\nAMP/\u00a0Visitas\u00a0 55%\u00a0 67%\u00a063%\u00a0 49%\u00a0 59%\u00a054%\u00a0\nComo\u00a0%\u00a0de\u00a0las\u00a0visitas\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\nEvaluaci\u00f3n \u00a0cl\u00ednica\u00a0 88%\u00a0 96%\u00a093%\u00a0 86%\u00a0 93%\u00a090%\u00a0\nConsejer\u00eda \u00a0 85%\u00a0 89%\u00a088%\u00a0 82%\u00a0 93%\u00a082%\u00a0\nLaboratorio \u00a0 61%\u00a0 73%\u00a068%\u00a0 56%\u00a0 75%\u00a063%\u00a0\n\u00a0\nSe\u00a0puede\u00a0observar\u00a0que\u00a0la\u00a0\u00a0personas\u00a0que\u00a0acuden\u00a0a\u00a0recibir\u00a0\u00a0atenci\u00f3n\u00a0en\u00a0el\u00a0CERITS,\u00a0\u00a0el\u00a041%\u00a0\u00a0s\u00f3lo\u00a0acude\u00a0una\u00a0vez,\u00a0\nel\u00a021%\u00a0dos\u00a0veces,\u00a0siendo\u00a0\u00a0lo\u00a0normado\u00a0es\u00a0por\u00a0lo\u00a0menos\u00a04\u00a0veces\u00a0al\u00a0a\u00f1o.\u00a0Pero\u00a0lo\u00a0m\u00e1s\u00a0importante \u00a0es\u00a0que\u00a0cada\u00a0\nvisita\u00a0pueda\u00a0resultar\u00a0en\u00a0una\u00a0AMP,\u00a0lo\u00a0cual\u00a0no\u00a0es\u00a0as\u00ed,\u00a0pues\u00a0al\u00a0revisar\u00a0las\u00a0HC,\u00a0vemos\u00a0que\u00a0las\u00a0AMP\u00a0se\u00a0encuentran \u00a0\nen\u00a0el\u00a0rango\u00a0del\u00a036%\u00a0al\u00a0\u00a073%\u00a0\u00a0de\u00a0todas\u00a0las\u00a0visitas\u00a0realizadas \u00a0al\u00a0establecimiento \u00a0durante\u00a0el\u00a0primer\u00a0a\u00f1o.\u00a0El\u00a067%\u00a0\nde\u00a0las\u00a0AMP\u00a0se\u00a0da\u00a0a\u00a0\u00a0mujeres\u00a0y\u00a0el\u00a0\u00a055%\u00a0a\u00a0\u00a0varones.\u00a0\u00a0Es\u00a0decir\u00a0que\u00a0las\u00a0visitas\u00a0que\u00a0realizan\u00a0las\u00a0mujeres\u00a0concluyen \u00a0\nen\u00a0una\u00a0AMP\u00a0\u00a0completa \u00a0en\u00a0mayor\u00a0cantidad\u00a0que\u00a0las\u00a0visitas\u00a0de\u00a0los\u00a0varones.\u00a0\n\u00a0\n41%\n21%\n11%9%\n5%5%3% 2%1% 1%0% 1%\n0%10%20%30%40%50%60%70%80%90%100%\n0%10%20%30%40%50%\n123456789 1 0 1 1 1 2N\u00famero\u00a0de\u00a0visitas\u00a0en\u00a0el\u00a0primer\u00a0a\u00f1o\n(Muestra: \u00a0464\u00a0personas)\n%\u00a0Personas %\u00a0\u00a0acumulado\n 55%67%63%\n10%20%30%40%50%60%70%\nHombre Mujer TotalAMP/\u00a0Visitas\n\u00a0\n226\u00a0 238\u00a0464\u00a0 394470864111321153228\n60714172024\nHombre Mujer TotalCasos,\u00a0atendidos, \u00a0visitas\u00a0y\u00a0AMP\nCasos\n Atendidos\n Visitas\n AMP\n41% 21% 11% 28% 14% 15% 11% 59% 13% 10% 10% 67%188\n97\n49128188 194\n147773\n94 7070474\n1\u00a0visita 2 \u00a0visitas 3 \u00a0visitas 4 \u00a0o\u00a0m\u00e1sDistribuci\u00f3n \u00a0de\u00a0visitas\u00a0en\u00a0primer\u00a0a\u00f1o\nPersonas Visitas AMP\n\u00a0\n\u00a0El\u00a031%\u00a0de\u00a0las\u00a0mujeres\u00a0realizan\u00a0al\u00a0menos\u00a04\u00a0visitas\u00a0al\u00a0a\u00f1o,\u00a0mientras\u00a0que\u00a0los\u00a0hombres\u00a024%\u00a0las\u00a0realizan.\u00a0\n\u00a0\nPorcentaje \u00a0de\u00a0personas\u00a0que\u00a0realizan\u00a0m\u00e1s\u00a0de\u00a04\u00a0visitas\u00a0al\u00a0a\u00f1o\u00a0\n\u00a0\u00a0 Personas\u00a0 Visitas\u00a0 AMP\u00a0\nTotal\u00a0 28%\u00a0 59%\u00a0 67%\u00a0\nHombres\u00a0 24%\u00a0 52%\u00a0 59%\u00a0 71 Mujeres\u00a0 31%\u00a0 66%\u00a0 72%\u00a0\nEn\u00a0conclusi\u00f3n \u00a0las\u00a0mujeres\u00a0asisten\u00a0en\u00a0mayor\u00a0porcentaje \u00a0a\u00a0sus\u00a0controles \u00a0que\u00a0los\u00a0hombres. \u00a0\n\u00a0\nGasto\u00a0por\u00a0poblaciones \u00a0menos\u00a0expuestas \u00a0al\u00a0VIH\u00a0\u2013\u00a0Estructura \u00a0porcentual \u00a0\n\u00a0 2005\u20102007\u00a02008\u20102010\u00a0 Total\u00a0\nOtras\u00a0poblaciones \u00a0clave\u00a0 5.4% 5.6%\u00a0 5.6%\nPoblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0 10.7% 13.4%\u00a0 12.3%\nPoblaci\u00f3n \u00a0general\u00a0 13.9% 18.8%\u00a0 16.8%\nTotal\u00a0 30.0% 37.8%\u00a034.6%\u00a0\n\u00a0\nEl\u00a0gasto\u00a0en\u00a0las\u00a0poblaciones \u00a0que\u00a0de\u00a0acuerdo\u00a0a\u00a0los\u00a0estudios\u00a0epidemiol\u00f3gicos \u00a0resultan\u00a0menos\u00a0expuestas \u00a0al\u00a0VIH\u00a0\nrepresentaron \u00a0el\u00a037.8%\u00a0del\u00a0gasto\u00a0en\u00a0los\u00a0a\u00f1os\u00a02008\u00a0al\u00a02010,\u00a0habiendo \u00a0aumentado \u00a0la\u00a0participaci\u00f3n \u00a0en\u00a0los\u00a0\n\u00faltimos\u00a0tres\u00a0a\u00f1os.\u00a0\n\u00a0\u00a0\nEn\u00a0la\u00a0categor\u00eda \u00a0de\u00a0\u201cOtras\u00a0poblaciones \u00a0clave\u201d\u00a0encuentra \u00a0la\u00a0poblaci\u00f3n \u00a0beneficiaria \u00a0de\u00a0la\u00a0estrategia \u00a0de\u00a0\nprevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0vertical\u00a0(ni\u00f1os\u00a0de\u00a0madres\u00a0VIH\u00a0positivas). \u00a0Cabe\u00a0precisar\u00a0que\u00a0los\u00a0proyectos \u00a0\ndel\u00a0FMSTM\u00a0han\u00a0tenido\u00a0objetivos\u00a0espec\u00edficos \u00a0para\u00a0esta\u00a0intervenci\u00f3n. \u00a0Esta\u00a0categor\u00eda \u00a0tambi\u00e9n\u00a0incluye\u00a0\na\u00a0las\u00a0personas\u00a0privadas\u00a0de\u00a0la\u00a0libertad,\u00a0ind\u00edgenas \u00a0y\u00a0\u00a0ni\u00f1os\u00a0que\u00a0viven\u00a0en\u00a0la\u00a0calle\u00a0y\u00a0no\u00a0escolarizados. \u00a0\n\u00a0El\u00a0gasto\u00a0en\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0\nrepresento \u00a0el\u00a0\u00a013.4%\u00a0\u00a0del\u00a0gasto\u00a0total,\u00a0en\u00a0el\u00a02008\u20102010,\u00a0\neste\u00a0corresponde \u00a0al\u00a0gasto\u00a0en\u00a0acciones\u00a0dirigidas\u00a0a\u00a0estudiantes, \u00a0militares, \u00a0polic\u00edas\u00a0y\u00a0asegurados, \u00a0\u00a0personas\u00a0que\u00a0\nasisten\u00a0a\u00a0dispensarios \u00a0de\u00a0ITS.\u00a0\u00a0Mientras\u00a0que\u00a0el\u00a0gasto\u00a0en\u00a0poblaci\u00f3n \u00a0general\u00a0signific\u00f3\u00a0el\u00a018.8%\u00a0del\u00a0gasto\u00a0en\u00a0el\u00a0\nperiodo\u00a0examinado \u00a0(2008\u20102010),\u00a0habi\u00e9ndose \u00a0incrementado \u00a0en\u00a0los\u00a0\u00faltimos\u00a0tres\u00a0a\u00f1os.\u00a0\n\u00a0\nHabr\u00eda\u00a0que\u00a0reflexionar \u00a0para\u00a0ver\u00a0si\u00a0el\u00a0gasto\u00a0en\u00a0sida\u00a0en\u00a0el\u00a0pa\u00eds\u00a0est\u00e1\u00a0siendo\u00a0dirigido\u00a0a\u00a0las\u00a0poblaciones \u00a0clave\u00a0\u00a0para\u00a0\ncontrolar\u00a0la\u00a0epidemia \u00a0del\u00a0VIH.\u00a0\u00a0\u00a0\n\u00a0\n\u00a0 Gasto\u00a0en\u00a0VIH\u00a0por\u00a0Poblaci\u00f3n \u00a0beneficiaria \u00a0(en\u00a0miles\u00a0de\u00a0US\u00a0$)47\u00a0\n\u00a0 2005\u00a02006\u00a02007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a02005\u2010\n2007\u00a02008\u2010\n2010\u00a0Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0un\u00a0diagn\u00f3stico \u00a0\nm\u00e9dico/cl\u00ednico \u00a0del\u00a0sida)\u00a013,459 22,398\u00a018,063 20,906 25,590 11,900 112,31750.8% 37.9% 43.1%\u00a0\nBP.01.01.98 \u00a0Adultos\u00a0y\u00a0j\u00f3venes\u00a0(de\u00a015\u00a0a\u00f1os\u00a0en\u00a0adelante) \u00a0con\u00a0el\u00a0VIH\u00a0no\u00a0desglosadas \u00a0por\u00a0sexo\u00a013,371 22,131\u00a017,340 20,599 25,297 11,634 110,372 49.8% 37.3% 42.4%\u00a0\nBP.01.02.98 \u00a0Ni\u00f1os\u00a0(menores \u00a0de\u00a015\u00a0a\u00f1os)\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0no\u00a0desglosados \u00a0por\u00a0sexo\u00a0 88\u00a0 267\u00a0 724\u00a0 307\u00a0 293\u00a0 267\u00a0 1,945\u00a0 1.0% 0.6% 0.7%\u00a0\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 2,132\u00a02,600\u00a05,724\u00a010,733 8,613\u00a05,788\u00a035,591\u00a09.9% 16.3% 13.7%\u00a0\nBP.02.02.01 \u00a0Profesionales \u00a0femeninas \u00a0del\u00a0sexo\u00a0y\u00a0sus\u00a0clientes\u00a0 1,505\u00a01,859\u00a01,927\u00a03,509\u00a02,523\u00a02,245\u00a013,567\u00a05.0% 5.4% 5.2%\u00a0\nBP.02.03\u00a0Hombres\u00a0que\u00a0tienen\u00a0relaciones \u00a0sexuales\u00a0con\u00a0hombres\u00a0(HSH)\u00a0 627\u00a0 586\u00a01,322\u00a01,440\u00a01,649\u00a02,762\u00a08,386\u00a0 2.4% 3.8% 3.2%\u00a0\nBP.02.98\u00a0\u00abPoblaciones \u00a0m\u00e1s\u00a0expuestas\u00bb \u00a0no\u00a0desglosadas \u00a0por\u00a0tipo\u00a0 \u00a0 156\u00a02,476\u00a05,784\u00a04,441\u00a0781\u00a013,638\u00a02.5% 7.1% 5.2%\u00a0\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 1,769\u00a02,045\u00a01,962\u00a02,573\u00a04,244\u00a01,867\u00a014,461\u00a05.4% 5.6% 5.6%\u00a0\nBP.03.02\u00a0Ni\u00f1os\u00a0nacidos\u00a0o\u00a0por\u00a0nacer\u00a0de\u00a0mujeres\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0 1,137\u00a01,462\u00a01,123\u00a02,264\u00a03,692\u00a01,809\u00a011,488\u00a03.5% 5.0% 4.4%\u00a0\nBP.03.04\u00a0Poblaciones \u00a0desplazadas \u00a0internas\u00a0(debido\u00a0a\u00a0una\u00a0emergencia) \u00a0 \u00a0 23\u00a0 131\u00a0 \u00a0\u00a0\u00a0 154\u00a0 0.1% 0.0% 0.1%\u00a0\nBP.03.06\u00a0Grupos\u00a0ind\u00edgenas \u00a0 5\u00a0\u00a0 66\u00a0 104\u00a0 260\u00a0\u00a0 436\u00a0 0.1% 0.2% 0.2%\u00a0\nBP.03.07\u00a0Prisioneros \u00a0y\u00a0otras\u00a0personas\u00a0institucionalizadas \u00a0 265\u00a0 177\u00a0 274\u00a0 83\u00a0 139\u00a0 53\u00a0 992\u00a0 0.7% 0.2% 0.4%\u00a0\nBP.03.09\u00a0Ni\u00f1os\u00a0y\u00a0j\u00f3venes\u00a0que\u00a0viven\u00a0en\u00a0la\u00a0calle\u00a0 82\u00a0 28\u00a0 28\u00a0 \u00a0\u00a0\u00a0 137\u00a0 0.1% 0.0% 0.1%\u00a0\nBP.03.11\u00a0Ni\u00f1os\u00a0y\u00a0j\u00f3venes\u00a0no\u00a0escolarizados \u00a0 280\u00a0 355\u00a0 340\u00a0 122\u00a0 152\u00a0 5\u00a0 1,254\u00a0 0.9% 0.2% 0.5%\u00a0\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0 2,286\u00a03,995\u00a05,044\u00a06,913\u00a07,867\u00a05,963\u00a032,068\u00a010.7% 13.4% 12.3%\u00a0\nBP.04.01\u00a0Personas\u00a0que\u00a0asisten\u00a0a\u00a0dispensarios \u00a0de\u00a0ITS\u00a0 1,115\u00a01,371\u00a02,344\u00a02,525\u00a03,569\u00a02,113\u00a013,037\u00a04.6% 5.3% 5.0%\u00a0\nBP.04.03\u00a0Estudiantes \u00a0de\u00a0escuela\u00a0secundaria \u00a0 400\u00a01,097\u00a0688\u00a02,495\u00a01,750\u00a0 83\u00a0 6,514\u00a0 2.1% 2.8% 2.5%\u00a0\nBP.04.05\u00a0Agentes\u00a0sanitarios \u00a0 10\u00a0 12\u00a0 5\u00a0 0\u00a0\u00a0 \u00a0 28\u00a0 0.0% 0.0% 0.0%\u00a0\nBP.04.06\u00a0Marinos\u00a0 57\u00a0 27\u00a0 73\u00a0 41\u00a0 11\u00a0 64\u00a0 273\u00a0 0.1% 0.1% 0.1%\u00a0\nBP.04.07\u00a0Personal\u00a0militar\u00a0 359\u00a0 324\u00a0 393\u00a0 23\u00a0 19\u00a0 34\u00a0 1,151\u00a0 1.0% 0.0% 0.4%\u00a0\nBP.04.08\u00a0Polic\u00eda\u00a0y\u00a0otros\u00a0servicios\u00a0uniformados \u00a0(que\u00a0no\u00a0sea\u00a0personal\u00a0militar)\u00a0 85\u00a0 76\u00a0 190\u00a0\u00a0 35\u00a0\u00a0 386\u00a0 0.3% 0.0% 0.1%\u00a0\nBP.04.99\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0s.c.o.\u00a0 259\u00a01,088\u00a01,351\u00a01,830\u00a02,483\u00a03,668\u00a010,679\u00a02.5% 5.2% 4.1%\u00a0\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 3,667\u00a03,868\u00a07,194\u00a010,931 10,003 7,747\u00a043,411\u00a013.9% 18.6% 16.7%\u00a0\nBP.05.01.01 \u00a0Poblaci\u00f3n \u00a0de\u00a0adultos\u00a0varones\u00a0 \u00a0 271\u00a01,748\u00a03,786\u00a04,399\u00a0324\u00a010,528\u00a01.9% 5.5% 4.0%\u00a0\nBP.05.01.02 \u00a0Poblaci\u00f3n \u00a0de\u00a0mujeres\u00a0adultas\u00a0 1,041\u00a0919\u00a01,137\u00a01,595\u00a0 89\u00a0 1,852\u00a06,633\u00a0 2.9% 2.3% 2.5%\u00a0\nBP.05.01.98 \u00a0Poblaci\u00f3n \u00a0adulta\u00a0general\u00a0(mayores \u00a0de\u00a024\u00a0a\u00f1os)\u00a0no\u00a0desglosada \u00a0por\u00a0sexo\u00a0 263\u00a0 438\u00a0 336\u00a0 55\u00a0 112\u00a0 10\u00a0 1,214\u00a0 1.0% 0.1% 0.5%\u00a0\nBP.05.02.02 \u00a0Ni\u00f1as\u00a0 3\u00a0 94\u00a0 449\u00a0 119\u00a0 70\u00a0 74\u00a0 808\u00a0 0.5% 0.2% 0.3%\u00a0\nBP.05.02.98 \u00a0Ni\u00f1os\u00a0(menores \u00a0de\u00a015\u00a0a\u00f1os)\u00a0no\u00a0desglosados \u00a0por\u00a0sexo\u00a0 248\u00a0 250\u00a0 261\u00a0 283\u00a0 261\u00a0 464\u00a0 1,767\u00a0 0.7% 0.7% 0.7%\u00a0\n                                                 \n47\u00a0A\u00a0fin\u00a0de\u00a0facilitar\u00a0su\u00a0adecuado \u00a0entendimiento, \u00a0el\u00a0cuadro\u00a0de\u00a0gasto\u00a0en\u00a0VIH\u00a0por\u00a0Poblaci\u00f3n \u00a0que\u00a0se\u00a0presenta\u00a0en\u00a0este\u00a0ac\u00e1pite\u00a0debe\u00a0ser\u00a0analizado \u00a0tomando\u00a0en\u00a0cuenta\u00a0que\u00a0las\u00a0\ncategor\u00edas \u00a0no\u00a0son\u00a0estrictamente \u00a0excluyentes, \u00a0por\u00a0lo\u00a0tanto\u00a0los\u00a0porcentajes \u00a0tampoco\u00a0lo\u00a0son.\u00a0\u00a0As\u00ed,\u00a0la\u00a0precisi\u00f3n\u00a0de\u00a0los\u00a0porcentajes \u00a0que\u00a0se\u00a0presenta\u00a0en\u00a0este\u00a0cuadro\u00a0depende\u00a0en\u00a0mucha\u00a0\nmedida\u00a0de\u00a0la\u00a0existencia \u00a0de\u00a0registros\u00a0contables \u00a0y\u00a0registros\u00a0de\u00a0beneficiarios \u00a0que\u00a0diferencien \u00a0adecuadamente \u00a0a\u00a0las\u00a0poblaciones \u00a0y\u00a0sub\u00a0poblaciones, \u00a0lo\u00a0que\u00a0en\u00a0la\u00a0pr\u00e1ctica\u00a0a\u00fan\u00a0no\u00a0existe\u00a0\nen\u00a0el\u00a0pa\u00eds.\u00a0\u00a0Ejemplos\u00a0de\u00a0esto\u00a0\u00a0son\u00a0\u00a0el\u00a0hecho\u00a0que\u00a0un\u00a0elevado\u00a0porcentaje \u00a0de\u00a0gasto\u00a0que\u00a0no\u00a0haya\u00a0podido\u00a0ser\u00a0desglosado \u00a0por\u00a0sexo\u00a0(72%,\u00a0ver\u00a0p\u00e1gina\u00a076),\u00a0o\u00a0que\u00a0los\u00a0gastos\u00a0de\u00a0tratamiento \u00a0\ndestinados \u00a0a\u00a0HSH\u00a0y\u00a0TS\u00a0no\u00a0est\u00e9n\u00a0visibilizados \u00a0en\u00a0el\u00a0an\u00e1lisis\u00a0debido\u00a0a\u00a0que\u00a0los\u00a0registros\u00a0de\u00a0tratamiento \u00a0a\u00fan\u00a0no\u00a0incluyen\u00a0la\u00a0variable\u00a0sexo\u00a0o\u00a0pertenencia \u00a0a\u00a0un\u00a0sub\u00a0grupo\u00a0poblacional \u00a0\n(HSH,\u00a0TS,\u00a0trans).\u00a0\u00a0Asimismo, \u00a0la\u00a0existencia \u00a0de\u00a0poblaciones \u00a0mixtas\u00a0(como\u00a0los\u00a0PPL,\u00a0personal\u00a0militar\u00a0\u00f3\u00a0ind\u00edgenas \u00a0que\u00a0son\u00a0HSH)\u00a0\u00fa\u00a0ocultas\u00a0a\u00a0las\u00a0intervenciones \u00a0(como\u00a0por\u00a0ejemplo\u00a0los\u00a0\nhombres\u00a0heterosexuales \u00a0que\u00a0tienen\u00a0sexo\u00a0con\u00a0otros\u00a0hombres) \u00a0\u00a0presenta\u00a0un\u00a0\u00a0desaf\u00edo\u00a0adicional\u00a0a\u00a0la\u00a0metodolog\u00eda \u00a0aplicada\u00a0en\u00a0el\u00a0estudio.   BP.05.03.98 \u00a0J\u00f3venes\u00a0(entre\u00a015\u00a0y\u00a024\u00a0a\u00f1os)\u00a0no\u00a0desglosados \u00a0por\u00a0sexo\u00a0 8\u00a0 35\u00a0 24\u00a0 336\u00a0 302\u00a0 684\u00a0 1,389\u00a0 0.1% 0.9% 0.5%\u00a0\nBP.05.98\u00a0Poblaci\u00f3n \u00a0general\u00a0no\u00a0desglosada \u00a0por\u00a0edad\u00a0ni\u00a0por\u00a0sexo\u00a0 2,104\u00a01,861\u00a03,239\u00a04,757\u00a04,771\u00a04,340\u00a021,071\u00a06.8% 9.0% 8.1%\u00a0\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 504\u00a0 894\u00a0 914\u00a03,219\u00a05,545\u00a02,786\u00a013,861\u00a02.2% 7.5% 5.3%\u00a0\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 504\u00a0 894\u00a0 914\u00a03,219\u00a05,545\u00a02,786\u00a013,861\u00a02.2% 7.5% 5.3%\u00a0\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0clasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a0 4,340\u00a0678\u00a02,541\u00a0323\u00a0 380\u00a0 374\u00a0 8,637\u00a0 7.1% 0.7% 3.3%\u00a0\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0clasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a0 4,340\u00a0678\u00a02,541\u00a0323\u00a0 380\u00a0 374\u00a0 8,637\u00a0 7.1% 0.7% 3.3%\u00a0\nTotal\u00a0 28,157 36,477\u00a041,443 55,598 62,242 36,427 260,345 100% 100%  100%   74 \u00a0\n\u00a0\nF.8\u00a0Gasto\u00a0por\u00a0ubicaci\u00f3n \u00a0geogr\u00e1fica \u00a0\n\u00a0\nSi\u00a0bien\u00a0el\u00a0proceso\u00a0de\u00a0descentralizaci\u00f3n \u00a0ha\u00a0brindado\u00a0autonom\u00eda \u00a0en\u00a0el\u00a0gasto\u00a0a\u00a0los\u00a0Gobiernos \u00a0regionales \u00a0y\u00a0les\u00a0\nha\u00a0permitido \u00a0establecer \u00a0prioridades \u00a0sanitarias, \u00a0por\u00a0otro\u00a0lado\u00a0tambi\u00e9n\u00a0ha\u00a0dado\u00a0como\u00a0resultado \u00a0un\u00a0menor\u00a0\ngasto\u00a0en\u00a0VIH.\u00a0\u00a0\u00a0\n\u00a0\nLa\u00a0explicaci\u00f3n \u00a0de\u00a0lo\u00a0ocurrido\u00a0en\u00a0el\u00a0\u00a0gasto\u00a0de\u00a0los\u00a0gobiernos \u00a0regionales \u00a0\u00a0en\u00a0VIH\u00a0en\u00a0estos\u00a0\u00faltimos\u00a0a\u00f1os,\u00a0se\u00a0\nencuentra \u00a0en\u00a0el\u00a0mecanismo \u00a0de\u00a0asignaci\u00f3n \u00a0de\u00a0recursos.\u00a0Hasta\u00a0abril\u00a0del\u00a02009\u00a0se\u00a0remitieron \u00a0remesas\u00a0a\u00a0las\u00a0\nregiones\u00a0para\u00a0los\u00a0gastos\u00a0operativos \u00a0de\u00a0las\u00a0Estrategias \u00a0sanitarias \u00a0nacionales \u00a0\u00a0(entre\u00a0ellas\u00a0la\u00a0estrategia \u00a0de\u00a0\nprevenci\u00f3n \u00a0de\u00a0VIH\u00a0y\u00a0Tuberculosis \u00a0y\u00a0para\u00a0vigilancia\u00a0epidemiol\u00f3gica), \u00a0sin\u00a0embargo\u00a0a\u00a0partir\u00a0del\u00a02010\u00a0\u00a0el\u00a0\npresupuesto \u00a0ha\u00a0sido\u00a0transferido \u00a0directamente \u00a0desde\u00a0el\u00a0MEF\u00a0a\u00a0los\u00a0gobiernos \u00a0regionales, \u00a0por\u00a0lo\u00a0cual\u00a0\u00e9stos\u00a0\npueden\u00a0realizar\u00a0la\u00a0distribuci\u00f3n \u00a0de\u00a0sus\u00a0gastos\u00a0de\u00a0acuerdo\u00a0a\u00a0sus\u00a0prioridades \u00a0de\u00a0salud.\u00a0\u00a0\n\u00a0\nEn\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os\u00a0el\u00a0MINSA\u00a0no\u00a0\u00a0ha\u00a0podido\u00a0garantizar \u00a0que\u00a0se\u00a0ejecute\u00a0el\u00a0gasto\u00a0en\u00a0esta\u00a0prioridad\u00a0sanitaria,\u00a0\ndebido\u00a0a\u00a0que\u00a0se\u00a0transfiere \u00a0el\u00a0presupuesto \u00a0\u00a0directamente \u00a0a\u00a0los\u00a0gobiernos \u00a0regionales, \u00a0sin\u00a0embargo\u00a0se\u00a0espera\u00a0\nque\u00a0esta\u00a0situaci\u00f3n\u00a0se\u00a0revierta\u00a0con\u00a0el\u00a0mecanismo \u00a0de\u00a0asignaci\u00f3n \u00a0de\u00a0presupuesto \u00a0por\u00a0resultados \u00a0PPR,\u00a0efectivo\u00a0a\u00a0\npartir\u00a0del\u00a0a\u00f1o\u00a02011.\u00a0\u00a0\u00a0Situaciones \u00a0excepcionales \u00a0se\u00a0\u00a0presentan \u00a0en\u00a0el\u00a0Gobierno \u00a0regional\u00a0del\u00a0Callao\u00a0donde\u00a0se\u00a0ha\u00a0\ningresado \u00a0a\u00a0la\u00a0planilla\u00a0a\u00a0los\u00a0promotores \u00a0educadores \u00a0de\u00a0pares\u00a0\u2013\u00a0PEPs\u00a0y\u00a0el\u00a0Gobierno \u00a0regional\u00a0de\u00a0Lambayeque \u00a0\nque\u00a0ha\u00a0suscrito\u00a0contratos \u00a0de\u00a0administraci\u00f3n \u00a0de\u00a0servicios\u00a0\u00a0CAS\u00a0con\u00a0los\u00a0PEPs.\u00a0\n\u00a0\n\u00a0\nGasto\u00a0por\u00a0departamentos \u00a0\u2010\u00a0En\u00a0miles\u00a0de\u00a0US\u00a0d\u00f3lares\u00a0\nDepartamento \u00a0 2005\u00a0 2006\u00a02007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a0Promedio \u00a0\n2005\u20102010\u00a0%\u00a0\nMulti\u2010depart.\u00a0 17,452\u00a022,612\u00a022,403 45,004\u00a041,695 22,777 171,944\u00a028,657\u00a0 66.0\u00a0\nLima\u00a0 8,975\u00a010,574\u00a012,045 6,587\u00a017,661 12,682 68,523\u00a0 11,421\u00a0 26.3\u00a0\nLoreto\u00a0 294\u00a0 733\u00a0 1,559\u00a01,627\u00a01,946\u00a0 88\u00a0 6,247\u00a0 1,041\u00a0 2.4\u00a0\nUcayali\u00a0 31\u00a0 349\u00a0 2,436\u00a0141\u00a0 14\u00a0 12\u00a0 2,984\u00a0 497\u00a0 1.2\u00a0\nCallao\u00a0 483\u00a0 718\u00a0 488\u00a0 860\u00a0 264\u00a0 37\u00a0 2,850\u00a0 475\u00a0 1.1\u00a0\nArequipa\u00a0 182\u00a0 402\u00a0 334\u00a0 274\u00a0 287\u00a0 61\u00a0 1,538\u00a0 256\u00a0 0.6\u00a0\nPiura\u00a0 103\u00a0 115\u00a0 355\u00a0 167\u00a0 10\u00a0 27\u00a0 776\u00a0 129\u00a0 0.3\u00a0\nCusco\u00a0 103\u00a0 176\u00a0 265\u00a0 67\u00a0 51\u00a0 29\u00a0 691\u00a0 115\u00a0 0.3\u00a0\nTumbes\u00a0 18\u00a0 59\u00a0 48\u00a0 84\u00a0 1\u00a0 432\u00a0 641\u00a0 107\u00a0 0.3\u00a0\nLa\u00a0Libertad\u00a0 129\u00a0 145\u00a0 165\u00a0 98\u00a0 47\u00a0 32\u00a0 616\u00a0 103\u00a0 0.2\u00a0\nAncash\u00a0 42\u00a0 138\u00a0 182\u00a0 96\u00a0 57\u00a0 16\u00a0 530\u00a0 88\u00a0 0.2\u00a0\nLambayeque \u00a0 91\u00a0 163\u00a0 163\u00a0 70\u00a0 16\u00a0 13\u00a0 516\u00a0 86\u00a0 0.2\u00a0\nJun\u00edn\u00a0 41\u00a0 59\u00a0 119\u00a0 55\u00a0 28\u00a0 18\u00a0 320\u00a0 53\u00a0 0.1\u00a0\nIca\u00a0 31\u00a0 89\u00a0 151\u00a0 30\u00a0 5\u00a0 9\u00a0 316\u00a0 53\u00a0 0.1\u00a0\nHu\u00e1nuco\u00a0 13\u00a0 27\u00a0 60\u00a0 150\u00a0 23\u00a0 32\u00a0 305\u00a0 51\u00a0 0.1\u00a0\nSan\u00a0Mart\u00edn\u00a0 18\u00a0 42\u00a0 112\u00a0 67\u00a0 15\u00a0 16\u00a0 270\u00a0 45\u00a0 0.1\u00a0\nCajamarca \u00a0 31\u00a0 24\u00a0 80\u00a0 47\u00a0 8\u00a0 9\u00a0 199\u00a0 33\u00a0 0.08\u00a0\nPuno\u00a0 5\u00a0 24\u00a0 114\u00a0 33\u00a0 4\u00a0 4\u00a0 184\u00a0 31\u00a0 0.07\u00a0\nTacna\u00a0 52\u00a0 27\u00a0 48\u00a0 35\u00a0 9\u00a0 4\u00a0 175\u00a0 29\u00a0 0.07\u00a0\nAyacucho \u00a0 8\u00a0 16\u00a0 82\u00a0 11\u00a0 15\u00a0 39\u00a0 171\u00a0 29\u00a0 0.07\u00a0 75 Departamento \u00a0 2005\u00a0 2006\u00a02007\u00a02008\u00a02009\u00a02010\u00a0Total\u00a0Promedio \u00a0\n2005\u20102010\u00a0%\u00a0\nMoquegua \u00a0 16\u00a0 20\u00a0 48\u00a0 4\u00a0 1\u00a0 62\u00a0 151\u00a0 25\u00a0 0.06\u00a0\nApur\u00edmac \u00a0 16\u00a0 16\u00a0 42\u00a0 15\u00a0 22\u00a0 3\u00a0 114\u00a0 19\u00a0 0.04\u00a0\nAmazonas \u00a0 6\u00a0 19\u00a0 36\u00a0 19\u00a0 10\u00a0 16\u00a0 105\u00a0 18\u00a0 0.04\u00a0\nMadre\u00a0de\u00a0Dios\u00a0 6\u00a0 12\u00a0 48\u00a0 24\u00a0 6\u00a0 6\u00a0 103\u00a0 17\u00a0 0.04\u00a0\nHuancavelica \u00a0 12\u00a0 7\u00a0 25\u00a0 15\u00a0 28\u00a0 1\u00a0 88\u00a0 15\u00a0 0.03\u00a0\nPasco\u00a0 0\u00a0 19\u00a0 28\u00a0 17\u00a0 18\u00a0 2\u00a0 84\u00a0 14\u00a0 0.03\u00a0\nTotal\u00a0 28,157\u00a036,584\u00a041,437 55,598\u00a062,242 36,427 260,445\u00a043,408\u00a0 100.0\u00a0\n\u00a0\nLoreto\nUcayali\nCallao\nArequipa\nPiura\nCusco\nTumbes\nLa\u00a0Libertad\nAncash\nLambayeque\nJun\u00edn\nIca\nHuanuco\nSan\u00a0Mart\u00edn\nCajamarca\nPuno\nTacna\nAyacucho\nMoquegua\nApurimac\nAmazonas\nMadre\u00a0de\u00a0Dios\nHuancavelica\nPascoGasto por departamento\n2005-2010\n\u00a0\nNota.\u00a0El\u00a0grafico\u00a0no\u00a0incluye\u00a0Lima 76 \u00a0\nF.9\u00a0\u00a0Matrices\u00a0por\u00a0g\u00e9nero\u00a0\n\u00a0\nComo\u00a0se\u00a0expreso\u00a0l\u00edneas\u00a0arriba\u00a0la\u00a0mayor\u00a0parte\u00a0de\u00a0los\u00a0gastos\u00a0no\u00a0se\u00a0encuentra \u00a0desglosada \u00a0por\u00a0sexo.\u00a0Esto\u00a0es\u00a0\nporque\u00a0la\u00a0informaci\u00f3n \u00a0se\u00a0obtiene\u00a0de\u00a0registros\u00a0de\u00a0compras\u00a0de\u00a0productos \u00a0como\u00a0es\u00a0el\u00a0caso\u00a0del\u00a0SEACE\u00a0que\u00a0\nregistra\u00a0las\u00a0compras\u00a0de\u00a0las\u00a0entidades \u00a0\u00a0o\u00a0de\u00a0registros\u00a0p\u00fablicos\u00a0como\u00a0el\u00a0APCI\u00a0\u00a0o\u00a0SIAF\u00a0que\u00a0registran\u00a0la\u00a0\ninformaci\u00f3n \u00a0de\u00a0presupuesto \u00a0o\u00a0gasto\u00a0pero\u00a0por\u00a0proyectos \u00a0o\u00a0actividades \u00a0seg\u00fan\u00a0corresponda. \u00a0\u00a0Sin\u00a0embargo\u00a0de\u00a0\nacuerdo\u00a0a\u00a0la\u00a0metodolog\u00eda \u00a0del\u00a0MEGAS,\u00a0se\u00a0debe\u00a0identificar \u00a0a\u00a0que\u00a0intervenci\u00f3n \u00a0corresponden \u00a0los\u00a0gastos.\u00a0\u00a0Esto\u00a0\nde\u00a0alguna\u00a0manera\u00a0permite\u00a0asumir\u00a0los\u00a0gastos\u00a0por\u00a0determinado \u00a0tipo\u00a0de\u00a0poblaci\u00f3n, \u00a0con\u00a0lo\u00a0cual\u00a0se\u00a0estar\u00e1\u00a0en\u00a0\ncondiciones \u00a0de\u00a0determinar \u00a0el\u00a0porcentaje \u00a0de\u00a0gasto\u00a0que\u00a0cuenta\u00a0con\u00a0el\u00a0desglose\u00a0de\u00a0sexo.\u00a0\n\u00a0\nEn\u00a0el\u00a0periodo\u00a0en\u00a0an\u00e1lisis\u00a0se\u00a0ha\u00a0determinado \u00a0que\u00a0el\u00a0\u00a0\u00a072%\u00a0de\u00a0los\u00a0gastos\u00a0no\u00a0pueden\u00a0ser\u00a0desglosados \u00a0por\u00a0sexo.\u00a0\u00a0\nLas\u00a0categor\u00edas \u00a0de\u00a0gasto\u00a0donde\u00a0se\u00a0dificulta\u00a0la\u00a0desagregaci\u00f3n \u00a0es\u00a0el\u00a0rubro\u00a0de\u00a0atenci\u00f3n\u00a0y\u00a0tratamiento, \u00a0debido\u00a0a\u00a0\nque\u00a0las\u00a0compras\u00a0de\u00a0ARV,\u00a0pruebas\u00a0diagn\u00f3sticos \u00a0no\u00a0van\u00a0asociadas \u00a0a\u00a0un\u00a0grupo\u00a0especifico \u00a0de\u00a0personas. \u00a0\u00a0En\u00a0los\u00a0\nsiguientes \u00a0cuadros\u00a0se\u00a0aprecia\u00a0las\u00a0categor\u00edas \u00a0de\u00a0gasto\u00a0\u00a0desglosadas \u00a0por\u00a0sexo.\u00a0\n\u00a0\nGasto\u00a0por\u00a0funci\u00f3n\u00a0y\u00a0desglose\u00a0de\u00a0g\u00e9nero\u00a0(miles\u00a0de\u00a0US\u00a0$)\u00a0\nFunci\u00f3n\u00a0 Hombre Mujer\u00a0HSH\u00a0Ni\u00f1os\u00a0y\u00a0\nni\u00f1as\u00a0No\u00a0\ndesglosado \u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 1,759\u00a026,590 7,718 1,317\u00a0 45,648\u00a0 83,033\u00a0\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0 1,286\u00a0 90\u00a0 96\u00a0 363\u00a0 100,983\u00a0102,818\nIncentivos \u00a0de\u00a0retenci\u00f3n \u00a0 \u00a0 \u00a0\u00a0 200\u00a0 63\u00a0 263\u00a0\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0vulnerables \u00a0 4,215\u00a0 211\u00a0 72\u00a0 99\u00a0 11,564\u00a0 16,160\u00a0\nGesti\u00f3n\u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0administraci\u00f3n \u00a0\u00a0 117\u00a0 61\u00a0\u00a0 341\u00a0 520\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0 \u00a0 43\u00a0\u00a0 50\u00a0 5,646\u00a0 5,740\u00a0\nDesarrollo \u00a0comunitario \u00a0y\u00a0ambiente \u00a0mejorado \u00a0 6\u00a0 5,041\u00a0306\u00a0 176\u00a0 6,883\u00a0 12,411\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0sida\u00a0 22,698\u00a01,828\u00a0\u00a0\u00a0 14,874\u00a0 39,399\u00a0\nTotal\u00a0 29,964\u00a033,921 8,253 2,205\u00a0 186,001\u00a0260,345\n\u00a0\nGasto\u00a0por\u00a0Recurso\u00a0\u00a0y\u00a0desglose\u00a0de\u00a0g\u00e9nero\u00a0(miles\u00a0de\u00a0US\u00a0$)\u00a0\n\u00a0 Hombre Mujer\u00a0HSH\u00a0Ni\u00f1os\u00a0y\u00a0\nni\u00f1as\u00a0No\u00a0\ndesglosado \u00a0Total\u00a0\nAntirretrovirales \u00a0 \u00a0 852\u00a0\u00a0 128\u00a0 51,824\u00a0 52,804\u00a0\nCondones \u00a0 248\u00a0 6,489\u00a01,236\u00a0\u00a0 21,057\u00a0 29,031\u00a0\nReactivos \u00a0y\u00a0materiales \u00a0 926\u00a0 3,073\u00a0 435\u00a0 4\u00a0 27,800\u00a0 32,238\u00a0\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 8,775\u00a0 7,032\u00a02,526\u00a0 128\u00a0 23,219\u00a0 41,679\u00a0\nOtros\u00a0gastos\u00a0corrientes \u00a0 14,396\u00a016,320\u00a03,892\u00a01,939\u00a0 53,393\u00a0 89,939\u00a0\nGastos\u00a0de\u00a0capital\u00a0 5,619\u00a0 155\u00a0 164\u00a0 6\u00a0 8,709\u00a0 14,653\u00a0\nTotal\u00a0 29,964\u00a033,921\u00a08,253\u00a02,205\u00a0 186,001\u00a0 260,345\n\u00a0\nGasto\u00a0por\u00a0Fuente\u00a0de\u00a0financiamiento \u00a0y\u00a0desglose\u00a0de\u00a0g\u00e9nero\u00a0(miles\u00a0de\u00a0US\u00a0$)\u00a0\nSector\u00a0 Hombre\u00a0Mujer HSH\u00a0Ni\u00f1os\u00a0y\u00a0\nni\u00f1as\u00a0No\u00a0\ndesglosado \u00a0Total\u00a0\nSector\u00a0publico\u00a0 1,976\u00a0 9,429\u00a01,994\u00a0 38\u00a0 81,556\u00a0 94,993\u00a0\nInternacional \u00a0 27,988\u00a021,902 6,004\u00a02,167\u00a0 68,528\u00a0 126,589\nSector\u00a0privado\u00a0 \u00a0 2,590\u00a0 255\u00a0\u00a0 35,917\u00a0 38,762\u00a0\nTotal\u00a0 29,964\u00a033,921 8,253\u00a02,205\u00a0 186,001\u00a0260,345 77 \u00a0\n\u00a0G.\u00a0\u00a0\u00a0\u00a0\u00a0An\u00e1lisis\u00a0y\u00a0discusi\u00f3n\n\u00a0\n\u00a0\nFinanciamiento \u00a0\n\u00a0\nSi\u00a0bien\u00a0en\u00a0el\u00a0presente\u00a0estudio\u00a0se\u00a0analiza\u00a0la\u00a0evoluci\u00f3n \u00a0del\u00a0gasto\u00a0de\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os,\u00a0en\u00a0el\u00a0financiamiento \u00a0\np\u00fablico\u00a0en\u00a0salud\u00a0se\u00a0han\u00a0producido \u00a0algunos\u00a0cambios\u00a0importantes \u00a0que\u00a0cabe\u00a0mencionar, \u00a0los\u00a0principales \u00a0son\u00a0el\u00a0\nPresupuesto \u00a0por\u00a0resultados \u00a0(PPR)\u00a0y\u00a0\u00a0el\u00a0\u00a0Aseguramiento \u00a0Universal \u00a0en\u00a0Salud\u00a0(AUS).\u00a0\u00a0Estos\u00a0procesos\u00a0y\u00a0otros\u00a0\ntemas\u00a0que\u00a0impactan \u00a0en\u00a0el\u00a0financiamiento \u00a0del\u00a0VIH\u00a0se\u00a0tratar\u00e1n\u00a0en\u00a0esta\u00a0secci\u00f3n.\u00a0\n\u00a0\n\u2010 Estructura \u00a0program\u00e1tica \u00a0funcional \u00a0\n\u00a0\nLos\u00a0recursos\u00a0p\u00fablicos,\u00a0se\u00a0clasifica\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0la\u00a0estructura \u00a0program\u00e1tica \u00a0funcional. \u00a0\u00a0De\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0los\u00a0\nsistemas\u00a0administrativos \u00a0se\u00a0pudo\u00a0determinar \u00a0que\u00a0a\u00a0partir\u00a0del\u00a0a\u00f1o\u00a02007\u00a0se\u00a0han\u00a0incorporado \u00a0algunas\u00a0\nactividades \u00a0y\u00a0proyectos \u00a0en\u00a0la\u00a0estructura \u00a0program\u00e1tica \u00a0funcional \u00a0del\u00a0presupuesto \u00a0del\u00a0sector\u00a0p\u00fablico\u00a0\nrelacionados \u00a0a\u00a0VIH,\u00a0en\u00a0los\u00a0cuales\u00a0se\u00a0incorpora \u00a0gasto\u00a0en\u00a0recursos\u00a0humanos, \u00a0insumos,\u00a0medicamentos, \u00a0entre\u00a0\notros,\u00a0as\u00ed\u00a0como\u00a0se\u00a0han\u00a0formulado \u00a0proyectos \u00a0de\u00a0inversi\u00f3n\u00a0p\u00fablica\u00a0\u00a0que\u00a0se\u00a0encuentran \u00a0registrado \u00a0en\u00a0el\u00a0SNIP.\u00a0\nCabe\u00a0precisar\u00a0que\u00a0para\u00a0los\u00a0a\u00f1os\u00a02003\u00a0al\u00a02006\u00a0no\u00a0era\u00a0posible\u00a0ubicar\u00a0gastos\u00a0espec\u00edficos \u00a0para\u00a0VIH\u00a0en\u00a0la\u00a0\nestructura \u00a0program\u00e1tica \u00a0funcional. \u00a0\u00a0\u00a0Sin\u00a0embargo\u00a0a\u00a0partir\u00a0del\u00a02011,\u00a0la\u00a0mayor\u00a0cantidad\u00a0de\u00a0presupuesto \u00a0se\u00a0\nencuentra \u00a0concentrado \u00a0en\u00a0el\u00a0Programa \u00a0estrat\u00e9gico \u00a0de\u00a0VIH.\u00a0\n\u00a0\n\uf02d Presupuesto \u00a0por\u00a0resultados \u00a0(PPR)\u00a0\n\u00a0\nA\u00a0partir\u00a0del\u00a02007\u00a0(\u00a048\u00a0)\u00a0\u00a0el\u00a0Per\u00fa\u00a0\u00a0ha\u00a0iniciado\u00a0la\u00a0aplicaci\u00f3n \u00a0de\u00a0la\u00a0gesti\u00f3n\u00a0presupuestal \u00a0basada\u00a0en\u00a0resultados \u00a0PPR,\u00a0\nla\u00a0cual\u00a0se\u00a0espera\u00a0sea\u00a0el\u00a0principal\u00a0mecanismo \u00a0de\u00a0financiamiento \u00a0en\u00a0el\u00a0pa\u00eds,\u00a0durante\u00a0los\u00a0pr\u00f3ximos \u00a0a\u00f1os.\u00a0\u00a0\u00a0El\u00a0\npresupuesto \u00a0por\u00a0resultados \u00a0es\u00a0un\u00a0mecanismo \u00a0de\u00a0asignaci\u00f3n \u00a0de\u00a0recursos,\u00a0que\u00a0vincula\u00a0la\u00a0asignaci\u00f3n \u00a0de\u00a0\nrecursos\u00a0y\u00a0los\u00a0resultados \u00a0esperados \u00a0de\u00a0la\u00a0intervenci\u00f3n \u00a0del\u00a0Estado,\u00a0a\u00a0trav\u00e9s\u00a0del\u00a0financiamiento \u00a0de\u00a0\u201cProgramas \u00a0\nestrat\u00e9gicos\u201d. \u00a0\n\u00a0\nDurante\u00a0el\u00a0a\u00f1o\u00a02010\u00a0la\u00a0ESN\u00a0del\u00a0MINSA\u00a0ha\u00a0elaborado, \u00a0conjuntamente \u00a0con\u00a0\u00a0el\u00a0Ministerio \u00a0de\u00a0Econom\u00eda \u00a0y\u00a0\nFinanzas\u00a0y\u00a0la\u00a0Oficina\u00a0General\u00a0de\u00a0Planeamiento \u00a0del\u00a0MINSA,\u00a0el\u00a0\u201cPrograma \u00a0Estrat\u00e9gico \u00a0TBC/VIH\u2010SIDA\u00a0y\u00a0\nTuberculosis\u201d \u00a0que\u00a0est\u00e1\u00a0vigente\u00a0a\u00a0partir\u00a0del\u00a0a\u00f1o\u00a0presupuestal \u00a02011.\u00a0\u00a0\u00a0Este\u00a0Programa \u00a0Estrat\u00e9gico \u00a0vincula\u00a0todas\u00a0\nlas\u00a0acciones\u00a0desarrolladas \u00a0desde\u00a0el\u00a0Estado\u00a0por\u00a0diversas\u00a0instituciones, \u00a0a\u00a0la\u00a0vez\u00a0que\u00a0da\u00a0sostenibilidad \u00a0a\u00a0muchas\u00a0\nde\u00a0las\u00a0intervenciones \u00a0sanitarias \u00a0que\u00a0est\u00e1n\u00a0siendo\u00a0desarrolladas \u00a0con\u00a0apoyo\u00a0del\u00a0FMSTM49.\u00a0\u00a0\u00a0\n\u00a0\nCon\u00a0este\u00a0mecanismo, \u00a0la\u00a0rendici\u00f3n \u00a0de\u00a0cuentas\u00a0y\u00a0resultados, \u00a0son\u00a0b\u00e1sicas\u00a0para\u00a0la\u00a0asignaci\u00f3n \u00a0de\u00a0recursos.\u00a0\u00a0\u00a0Del\u00a0\nan\u00e1lisis\u00a0del\u00a0Programa \u00a0Estrat\u00e9gico, \u00a0\u00a0en\u00a0el\u00a0marco\u00a0del\u00a0PPR,\u00a0principal\u00a0fuente\u00a0de\u00a0financiamiento \u00a0\u00a0para\u00a0el\u00a0control\u00a0\nVIH\u00a0para\u00a0el\u00a02011,\u00a0podemos \u00a0realizar\u00a0las\u00a0siguientes \u00a0apreciaciones: \u00a0\n\u00a0\na. El\u00a0presupuesto \u00a0para\u00a0el\u00a02011,\u00a0representa \u00a0el\u00a0mayor\u00a0presupuesto \u00a0de\u00a0los\u00a0\u00faltimos\u00a0a\u00f1os\u00a0para\u00a0el\u00a0programa \u00a0de\u00a0\nVIH.\u00a0\n                                                 \n48 Ley\u00a0de\u00a0presupuesto \u00a0del\u00a0Sector\u00a0p\u00fablico\u00a0para\u00a0el\u00a0a\u00f1o\u00a02007\u00a0\u2013\u00a0Ley\u00a028927,\u00a02007 \n49 El\u00a0PPR\u00a0es\u00a0un\u00a0modelo\u00a0de\u00a0gesti\u00f3n\u00a0basado\u00a0en\u00a0resultados \u00a0que\u00a0el\u00a0Ministerio \u00a0de\u00a0Econom\u00eda \u00a0y\u00a0Finanzas\u00a0est\u00e1\u00a0implementando \u00a0\nen\u00a0el\u00a0Per\u00fa\u00a0desde\u00a0el\u00a0a\u00f1o\u00a02008.\u00a0Diversos\u00a0programas \u00a0del\u00a0Estado\u00a0se\u00a0han\u00a0incorporado \u00a0progresivamente \u00a0a\u00a0este\u00a0modelo\u00a0de\u00a0\ngesti\u00f3n\u00a0desde\u00a0el\u00a0a\u00f1o\u00a02008,\u00a0y\u00a0a\u00a0partir\u00a0del\u00a0a\u00f1o\u00a02011\u00a0fueron\u00a0integradas \u00a0a\u00a0este\u00a0modelo\u00a0de\u00a0gesti\u00f3n\u00a0las\u00a0Estrategias \u00a0Sanitarias \u00a0\nNacionales \u00a0de\u00a0ITS,\u00a0VIH/SIDA\u00a0y\u00a0de\u00a0Tuberculosis, \u00a0permitiendo \u00a0sentar\u00a0la\u00a0base\u00a0para\u00a0la\u00a0sostenibilidad \u00a0de\u00a0los\u00a0programas \u00a0que\u00a0\u00a0\nhab\u00edan\u00a0venido\u00a0siendo\u00a0implementados \u00a0en\u00a0el\u00a0Per\u00fa\u00a0desde\u00a0el\u00a0a\u00f1o\u00a02003\u00a0por\u00a0el\u00a0Ministerio \u00a0de\u00a0Salud\u00a0en\u00a0el\u00a0marco\u00a0de\u00a0programas \u00a0\nde\u00a02da,\u00a05ta,\u00a06ta\u00a0y\u00a08va\u00a0ronda\u00a0financiados \u00a0por\u00a0el\u00a0FMSTM.   78 b. Una\u00a0de\u00a0las\u00a0principales \u00a0caracter\u00edsticas \u00a0del\u00a0PPR\u00a0es\u00a0la\u00a0ejecuci\u00f3n \u00a0es\u00a0descentralizada \u00a0y\u00a0algunos\u00a0\u00a0de\u00a0las\u00a0\nregiones\u00a0no\u00a0est\u00e1n\u00a0suficientemente \u00a0entrenadas \u00a0para\u00a0\u00a0relacionar \u00a0gasto\u00a0con\u00a0resultados, \u00a0as\u00ed\u00a0como\u00a0se\u00a0corre\u00a0\nel\u00a0riesgo\u00a0que\u00a0por\u00a0la\u00a0autonom\u00eda \u00a0pol\u00edtica\u00a0y\u00a0administrativa \u00a0de\u00a0los\u00a0Gobiernos \u00a0regionales \u00a0los\u00a0recursos\u00a0no\u00a0sean\u00a0\nnecesariamente \u00a0\u00a0priorizados \u00a0en\u00a0las\u00a0necesidades \u00a0reales,\u00a0por\u00a0ejemplo\u00a0seg\u00fan\u00a0la\u00a0ENDES\u00a02010,\u00a0el\u00a032.2\u00a0de\u00a0la\u00a0\nmujeres\u00a0de\u00a0Huancavelica \u00a0registr\u00f3\u00a0el\u00a0mayor\u00a0porcentaje \u00a0de\u00a0desconocimiento \u00a0sobre\u00a0VIH,\u00a0por\u00a0lo\u00a0cual\u00a0\ndeber\u00eda\u00a0considerarse \u00a0un\u00a0gasto\u00a0en\u00a0difusi\u00f3n.\u00a0\nc. Una\u00a0revisi\u00f3n\u00a0del\u00a0programa, \u00a0permite\u00a0afirmar\u00a0que\u00a0no\u00a0ha\u00a0se\u00a0ha\u00a0incluido\u00a0el\u00a0enfoque\u00a0de\u00a0g\u00e9nero,\u00a0se\u00a0puede\u00a0\nafirmar\u00a0pues\u00a0no\u00a0se\u00a0encuentra \u00a0un\u00a0diagn\u00f3stico \u00a0que\u00a0identifique \u00a0las\u00a0brechas\u00a0en\u00a0atenci\u00f3n\u00a0de\u00a0los\u00a0diferentes \u00a0\ngrupos\u00a0poblaciones, \u00a0entre\u00a0ellos\u00a0los\u00a0m\u00e1s\u00a0afectados \u00a0por\u00a0la\u00a0epidemia, \u00a0los\u00a0HSH.\u00a0\nEn\u00a0relaci\u00f3n\u00a0a\u00a0las\u00a0actividades \u00a0preventivas, \u00a0\u00a0\nd. \u00a0El\u00a0presupuesto \u00a0no\u00a0se\u00a0encuentra \u00a0expresamente \u00a0enfocado \u00a0en\u00a0HSH\u00a0y\u00a0en\u00a0TS,\u00a0grupos\u00a0en\u00a0los\u00a0que\u00a0se\u00a0\nencuentra \u00a0focalizada \u00a0la\u00a0epidemia \u00a0\u00a0en\u00a0el\u00a0Per\u00fa\u00a0de\u00a0acuerdo\u00a0a\u00a0los\u00a0estudios\u00a0epidemiol\u00f3gicos. \u00a0\n\u00a0\n\u00a0\n\uf02d Aseguramiento \u00a0universal \u00a0(AUS)\u00a0\u00a0\n\u00a0\nEl\u00a0aseguramiento \u00a0universal\u00a0es\u00a0un\u00a0proceso\u00a0orientado \u00a0a\u00a0lograr\u00a0que\u00a0toda\u00a0la\u00a0poblaci\u00f3n \u00a0residente \u00a0en\u00a0el\u00a0territorio\u00a0\nnacional\u00a0disponga\u00a0de\u00a0un\u00a0seguro\u00a0de\u00a0salud\u00a0(50) sobre\u00a0la\u00a0base\u00a0del\u00a0Plan\u00a0Esencial\u00a0de\u00a0Aseguramiento \u00a0en\u00a0Salud\u00a0\n(PEAS).\u00a0\u00a0\u00a0\u00a0Para\u00a0definir\u00a0el\u00a0PEAS\u00a0ha\u00a0sido\u00a0necesario \u00a0establecer \u00a0condiciones \u00a0de\u00a0salud\u00a0prioritarias, \u00a0definir\u00a0las\u00a0\nprestaciones \u00a0basadas\u00a0en\u00a0evidencias, \u00a0estimar\u00a0los\u00a0costos\u00a0de\u00a0las\u00a0intervenciones \u00a0y\u00a0el\u00a0c\u00e1lculo\u00a0actuarial\u00a0del\u00a0\nrequerimiento \u00a0financiero \u00a0anual\u00a0per\u2010c\u00e1pita.\u00a0\u00a0En\u00a0el\u00a0PEAS,\u00a0por\u00a0ejemplo\u00a0se\u00a0ha\u00a0incluido\u00a0la\u00a0cobertura \u00a0total\u00a0a\u00a0la\u00a0\ngestante, \u00a0m\u00e1s\u00a0no\u00a0la\u00a0prevenci\u00f3n \u00a0en\u00a0poblaci\u00f3n \u00a0m\u00e1s\u00a0expuesta\u00a0al\u00a0VIH.\u00a0\n\u00a0\nLa\u00a0Ley\u00a0(\u00a051\u00a0)\u00a0ha\u00a0establecido \u00a0que\u00a0las\u00a0instituciones \u00a0administradoras \u00a0de\u00a0fondos\u00a0de\u00a0aseguramiento \u00a0en\u00a0salud\u00a0\u00a0\n(IAFAS),\u00a0estar\u00e1n\u00a0encargadas \u00a0de\u00a0administrar \u00a0fondos\u00a0destinados \u00a0a\u00a0la\u00a0prestaci\u00f3n \u00a0de\u00a0salud\u00a0u\u00a0ofrecer\u00a0coberturas \u00a0a\u00a0\nde\u00a0riesgos\u00a0de\u00a0salud\u00a0a\u00a0sus\u00a0afiliados.\u00a0Dichas\u00a0instituciones \u00a0son\u00a0el\u00a0Seguro\u00a0integral\u00a0de\u00a0salud\u00a0(SIS),\u00a0Seguro\u00a0social\u00a0de\u00a0\nsalud\u00a0(ESSALUD), \u00a0Sanidades \u00a0de\u00a0las\u00a0Fuerzas\u00a0Armadas\u00a0y\u00a0Fuerzas\u00a0Policiales, \u00a0Entidades \u00a0prestadoras \u00a0de\u00a0Salud\u00a0\n(EPS),\u00a0compa\u00f1\u00edas \u00a0de\u00a0seguros\u00a0privados\u00a0de\u00a0salud,\u00a0entidades \u00a0de\u00a0salud\u00a0que\u00a0ofrecen\u00a0servicios\u00a0de\u00a0salud\u00a0pre\u00a0\npagadas\u00a0y\u00a0otras\u00a0modalidades \u00a0de\u00a0aseguramiento. \u00a0\u00a0\n\u00a0\nEn\u00a0este\u00a0escenario, \u00a0\u00a0el\u00a0Seguro\u00a0Social\u00a0de\u00a0Salud\u00a0ESSALUD\u00a0cubre\u00a0\u00a0el\u00a020.7%\u00a0de\u00a0la\u00a0poblaci\u00f3n \u00a0econ\u00f3micamente \u00a0\nactiva\u00a0(incluye\u00a0titular\u00a0y\u00a0derechohabientes) \u00a0;\u00a0el\u00a0Seguro\u00a0Integral\u00a0\u00a0de\u00a0Salud\u00a0\u2013\u00a0SIS\u00a0del\u00a0Ministerio \u00a0de\u00a0Salud\u00a0con\u00a0una\u00a0\ncubertura \u00a0de\u00a039.3%,\u00a0cubre\u00a0a\u00a0la\u00a0gestante\u00a0y\u00a0al\u00a0ni\u00f1o;\u00a0un\u00a02.4\u00a0%\u00a0de\u00a0la\u00a0poblaci\u00f3n \u00a0es\u00a0cubierta\u00a0por\u00a0las\u00a0Fuerzas\u00a0\nPoliciales\u00a0\u00a0y\u00a0un\u00a00.3%\u00a0por\u00a0las\u00a0Fuerzas\u00a0armadas\u00a0y\u00a02%\u00a0es\u00a0cubierta\u00a0por\u00a0otros\u00a0seguros.\u00a0\n\u00a0\nPoblaci\u00f3n \u00a0afiliada\u00a0por\u00a0tipo\u00a0de\u00a0seguro\u00a0de\u00a0salud\u2010\u00a0IV\u00a0trimestre \u00a02010\u00a0\nSeguro\u00a0 Per\u00fa\u00a0Lima\u00a0\nmetropolitana \u00a0Per\u00fa\u00a0\nurbano\u00a0Per\u00fa\u00a0rural\u00a0\n\u00danicamente \u00a0SIS\u00a0 39.3\u00a0 12.3\u00a0 24.9\u00a0 74.6\u00a0\n\u00danicamente \u00a0ESSALUD\u00a0 20.7\u00a0 30.0\u00a0 36.1\u00a0 3.9\u00a0\nOtros\u00a0seguros\u00a0*\u00a0 4.7\u00a0 9.1\u00a0 3.9\u00a0 0.9\u00a0\nSin\u00a0seguro\u00a0 35.3\u00a0 48.6\u00a0 35.1\u00a0 20.6\u00a0\nFuente\u00a0Bolet\u00edn\u00a0SUNASA\u00a0\u2013\u00a0INEI\u2010\u00a0\u00a0\nEncuesta\u00a0Nacional\u00a0de\u00a0Hogares\u00a02010\u00a0\u201cInforme\u00a0T\u00e9cnico\u00a0N\u00b001\u2010\u00a0Marzo\u00a02011\u00a0\n\u00a0\n\u00a0\n\uf02d Seguro\u00a0Integral\u00a0de\u00a0salud\u00a0(SIS)\u00a0(\u00a052\u00a0)\u00a0\n                                                 \n50 Seguro\u00a0que\u00a0\u00a0permita\u00a0\u00a0a\u00a0las\u00a0personas\u00a0acceder\u00a0a\u00a0un\u00a0conjunto\u00a0de\u00a0prestaciones \u00a0de\u00a0salud\u00a0de\u00a0car\u00e1cter\u00a0preventivo, \u00a0\npromocional, \u00a0recuperativo \u00a0y\u00a0de\u00a0rehabilitaci\u00f3n, \u00a0en\u00a0condiciones \u00a0adecuadas \u00a0de\u00a0eficiencia, \u00a0equidad,\u00a0oportunidad, \u00a0calidad\u00a0y\u00a0\ndignidad  \n51 Ley\u00a0Marco\u00a0de\u00a0Aseguramiento \u00a0Universal \u00a0en\u00a0Salud\u00a0\u2010\u00a0Ley\u00a029344,\u00a0aprobada \u00a0el\u00a030\u00a0de\u00a0marzo\u00a0del\u00a02009 \n52 Ley\u00a0del\u00a0Ministerio \u00a0de\u00a0Salud\u00a0\u2010\u00a0Ley\u00a027657,\u00a02002  79 \u00a0\nEl\u00a0SIS\u00a0es\u00a0el\u00a0principal\u00a0administrador \u00a0de\u00a0fondos\u00a0destinados \u00a0a\u00a0salud,\u00a0se\u00a0enfoca\u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0en\u00a0condici\u00f3n \u00a0de\u00a0\nextrema\u00a0pobreza.\u00a0\u00a0Actualmente \u00a0en\u00a0marco\u00a0del\u00a0AUS\u00a0los\u00a0establecimientos \u00a0de\u00a0salud\u00a0est\u00e1n\u00a0interconectados \u00a0a\u00a0la\u00a0\nbase\u00a0de\u00a0datos\u00a0del\u00a0Sistema\u00a0de\u00a0Focalizaci\u00f3n \u00a0de\u00a0Hogares\u00a0(SISFOH)\u00a0que\u00a0administra \u00a0el\u00a0Ministerio \u00a0de\u00a0Econom\u00eda \u00a0y\u00a0\nFinanzas\u00a0(MEF),\u00a0por\u00a0lo\u00a0que\u00a0se\u00a0podr\u00e1\u00a0saber\u00a0si\u00a0las\u00a0personas\u00a0est\u00e1n\u00a0en\u00a0condici\u00f3n \u00a0de\u00a0pobreza\u00a0y\u00a0por\u00a0lo\u00a0tanto\u00a0\ncalifica\u00a0para\u00a0asegurarse \u00a0a\u00a0trav\u00e9s\u00a0del\u00a0AUS.\u00a0\u00a0El\u00a0mecanismo \u00a0de\u00a0pago\u00a0a\u00a0los\u00a0prestadores \u00a0de\u00a0salud\u00a0es\u00a0retrospectivo \u00a0\ny\u00a0por\u00a0prestaci\u00f3n \u00a0realizada, \u00a0siempre\u00a0en\u00a0cuando\u00a0se\u00a0encuentra \u00a0en\u00a0el\u00a0Plan\u00a0que\u00a0financia\u00a0el\u00a0SIS.\u00a0\n\u00a0No\u00a0se\u00a0ha\u00a0podido\u00a0determinar \u00a0el\u00a0porcentaje \u00a0de\u00a0PVV\u00a0que\u00a0\u00a0se\u00a0encuentra \u00a0en\u00a0el\u00a0SIS,\u00a0pero\u00a0actualmente \u00a0se\u00a0est\u00e1\u00a0\nrealizando \u00a0la\u00a0depuraci\u00f3n \u00a0del\u00a0SIS,\u00a0\u00a0y\u00a0\u00a0s\u00f3lo\u00a0se\u00a0afiliando\u00a0para\u00a0el\u00a0nuevo\u00a0AUS\n53\u00a0sistema\u00a0que\u00a0es\u00a0m\u00e1s\u00a0restrictivo \u00a0que\u00a0\nel\u00a0anterior,\u00a0por\u00a0lo\u00a0cual\u00a0\u00a0se\u00a0va\u00a0a\u00a0incrementar \u00a0probablemente \u00a0el\u00a0n\u00famero\u00a0de\u00a0personas\u00a0que\u00a0tengan\u00a0\u00a0que\u00a0cubrir\u00a0\u00a0\nsus\u00a0gastos\u00a0relacionados \u00a0al\u00a0tratamiento \u00a0del\u00a0VIH,\u00a0dando\u00a0como\u00a0consecuencia \u00a0\u00a0un\u00a0mayor\u00a0gasto\u00a0de\u00a0bolsillo.\u00a0\n\u00a0\nLa\u00a0cantidad\u00a0de\u00a0personas\u00a0por\u00a0las\u00a0cuales\u00a0\u00a0los\u00a0establecimientos \u00a0solicitaron \u00a0reembolso \u00a0al\u00a0SIS\u00a0\u00a0en\u00a0diagn\u00f3sticos \u00a0\ndirectamente \u00a0relacionados \u00a0con\u00a0VIH\u00a0y\u00a0de\u00a0otros\u00a0diagn\u00f3sticos \u00a0relacionados \u00a0a\u00a0la\u00a0infecci\u00f3n\u00a0de\u00a0VIH\u00a0se\u00a0presenta\u00a0en\u00a0\nlos\u00a0siguientes \u00a0cuadros,\u00a0los\u00a0cuales\u00a0nos\u00a0dan\u00a0una\u00a0referencia \u00a0de\u00a0los\u00a0costos\u00a0que\u00a0deben\u00a0asumir\u00a0los\u00a0pacientes \u00a0de\u00a0\ntener\u00a0algunos\u00a0de\u00a0los\u00a0diagn\u00f3sticos \u00a0y\u00a0de\u00a0tener\u00a0que\u00a0asumirlos \u00a0con\u00a0sus\u00a0propios\u00a0recursos.\u00a0\u00a0Cabe\u00a0precisar\u00a0que\u00a0el\u00a0\nSIS\u00a0s\u00f3lo\u00a0reembolsa \u00a0los\u00a0costos\u00a0variables, \u00a0por\u00a0lo\u00a0cual\u00a0lo\u00a0que\u00a0en\u00a0el\u00a0caso\u00a0las\u00a0personas\u00a0tuvieran\u00a0pagar\u00a0con\u00a0sus\u00a0\npropios\u00a0recursos\u00a0el\u00a0costo\u00a0ser\u00eda\u00a0mayor.\u00a0\n\u00a0\nPoblaci\u00f3n \u00a0con\u00a0atenciones \u00a0reembolsadas \u00a0por\u00a0el\u00a0SIS\u00a0\u2013\u00a0A\u00f1o\u00a02010\u00a0\nDiagn\u00f3sticos \u00a0relacionados \u00a0 N\u00b0\u00a0personas\u00a0 Observaciones \u00a0\nTotal\u00a0VIH\u2010Directamente \u00a0relacionado \u00a0 3,269\u00a0 \u00a0\n\u00a0\u00a0Tamizaje\u00a0de\u00a0VIH\u00a0a\u00a0gestantes \u00a02,595\u00a067%\u00a0de\u00a0las\u00a0personas\u00a0tienen\u00a0entre\u00a0\n17\u00a0a\u00a030\u00a0a\u00f1os\u00a0\n\u00a0\u00a0Tratamiento \u00a0profil\u00e1ctico \u00a0a\u00a0ni\u00f1os\u00a0expuestos \u00a0al\u00a0VIH\u00a0 253\u00a0 1\u00a0a\u00f1o:199;\u00a02\u00a0a\u00f1o:55;\u00a03\u00a0a\u00f1os:\u00a02\u00a0\n\u00a0\u00a0Tratamiento \u00a0profil\u00e1ctico \u00a0para\u00a0gestante\u00a0positiva\u00a0\u00a0 15\u00a0 \u00a0\n\u00a0\u00a0Tratamiento \u00a0VIH/SIDA\u00a0(0\u201019\u00a0a\u00f1os)\u00a0 423\u00a0 \u00a0\nTotal\u00a0VIH\u2010Otro\u00a0relacionado \u00a0 563\u00a0 \u00a0\n\u00a0\u00a0Tratamiento \u00a0de\u00a0ITS\u00a0en\u00a0adolescentes \u00a0y\u00a0adultos\u00a0 563\u00a0 \u00a0\nFuente:\u00a0SIS\u00a0\n\u00a0\n\u00a0\nPoblaci\u00f3n \u00a0con\u00a0atenciones \u00a0reembolsadas \u00a0por\u00a0el\u00a0SIS\u00a0\nOtros\u00a0diagn\u00f3sticos \u00a0relacionados \u00a0a\u00a0la\u00a0infecci\u00f3n\u00a0de\u00a0VIH\u00a0\nDiagn\u00f3sticos \u00a0relacionados \u00a0 N\u00b0\u00a0personas\u00a0 Gasto\u00a0 Atenciones \u00a0\nSepticemia \u00a0debida\u00a0a\u00a0salmonella \u00a0 64\u00a0 2,402\u00a0 66\u00a0\nCriptosporidiosis \u00a0 104\u00a0 3,883\u00a0 104\u00a0\nIsosporiasis \u00a0 26\u00a0 2,178\u00a0 31\u00a0\nMeningitis \u00a0tuberculosa \u00a0(g01*)\u00a0 184\u00a0 226,111\u00a0 214\u00a0\nTuberculosis \u00a0del\u00a0sistema\u00a0nervioso,\u00a0no\u00a0especificada \u00a0 53\u00a0 21,026\u00a0 56\u00a0\nTuberculosis \u00a0miliar\u00a0aguda\u00a0de\u00a0un\u00a0solo\u00a0sitio\u00a0especifico \u00a0 2\u00a0 405\u00a0 3\u00a0\nInfecciones \u00a0por\u00a0micobacterias \u00a0pulmonares \u00a0 19\u00a0 315\u00a0 19\u00a0\nInfeccion\u00a0cutanea\u00a0por\u00a0micobacterias \u00a0 169\u00a0 1,276\u00a0 176\u00a0\nOtras\u00a0infecciones \u00a0por\u00a0micobacterias \u00a0 11\u00a0 113\u00a0 11\u00a0\nInfeccion\u00a0por\u00a0micobacteria, \u00a0no\u00a0especificada \u00a0 14\u00a0 161\u00a0 15\u00a0\n                                                 \n53 Bajo\u00a0el\u00a0marco\u00a0de\u00a0la\u00a0Ley\u00a0de\u00a0aseguramiento \u00a0universal   80 Diagn\u00f3sticos \u00a0relacionados \u00a0 N\u00b0\u00a0personas\u00a0 Gasto\u00a0 Atenciones \u00a0\nLeucoencefalopatia \u00a0multifocal \u00a0progresiva \u00a0 1\u00a0 21\u00a0 1\u00a0\nGingivoestomatitis \u00a0y\u00a0faringoamigdalitis \u00a0herp\u00e9tica \u00a0 14\u00a0 207\u00a0 14\u00a0\nMeningitis \u00a0debida\u00a0a\u00a0herpes\u00a0zoster\u00a0(g02.0*)\u00a0 74\u00a0 1,789\u00a0 76\u00a0\nNeumonitis \u00a0debida\u00a0a\u00a0virus\u00a0citomegalico \u00a0(j17.1*)\u00a0 5\u00a0 501\u00a0 5\u00a0\nPancreatitis \u00a0debida\u00a0a\u00a0virus\u00a0citomegalico \u00a0(k87.1*)\u00a0 36\u00a0 2,017\u00a0 37\u00a0\nOtras\u00a0enfermedades \u00a0debidas\u00a0a\u00a0virus\u00a0citomegalico \u00a0 2\u00a0 21\u00a0 2\u00a0\nEnfermedad \u00a0por\u00a0virus\u00a0citomegalico, \u00a0no\u00a0especificada \u00a0 82\u00a0 28,828\u00a0 91\u00a0\nCandidiasis \u00a0pulmonar \u00a0 50\u00a0 453\u00a0 50\u00a0\nCandidiasis \u00a0de\u00a0la\u00a0vulva\u00a0y\u00a0de\u00a0la\u00a0vagina\u00a0(n77.1*)\u00a0 5296\u00a0 216,642\u00a0 30,062\u00a0\nCandidiasis \u00a0de\u00a0otras\u00a0localizaciones \u00a0urogenitales \u00a0 304\u00a0 3,561\u00a0 309\u00a0\nMeningitis \u00a0debida\u00a0a\u00a0candida\u00a0(g02.1*)\u00a0 40\u00a0 343\u00a0 40\u00a0\nEndocarditis \u00a0debida\u00a0a\u00a0Candida\u00a0(I39.8*)\u00a0 43\u00a0 1,234\u00a0 43\u00a0\nSepticemia \u00a0debida\u00a0a\u00a0Candida\u00a0 82\u00a0 13,208\u00a0 85\u00a0\nCandidiasis \u00a0de\u00a0otros\u00a0Sitios\u00a0 668\u00a0 5,181\u00a0 696\u00a0\nCandidiasis, \u00a0no\u00a0Especificada \u00a0 3997\u00a0 30,141\u00a0 4,199\u00a0\nCoccidioidomicosis \u00a0Cutanea\u00a0 29\u00a0 936\u00a0 30\u00a0\nMeningitis \u00a0debida\u00a0a\u00a0Coccidioidomicosis \u00a0(G02.1*)\u00a0 11\u00a0 74\u00a0 11\u00a0\nCoccidioidomicosis \u00a0Diseminada \u00a0 2\u00a0 21\u00a0 2\u00a0\nOtras\u00a0Formas\u00a0De\u00a0Coccidioidomicosis \u00a0 4\u00a0 38\u00a0 4\u00a0\nCoccidioidomicosis, \u00a0No\u00a0Especificada \u00a0 135\u00a0 915\u00a0 137\u00a0\nInfeccion\u00a0Diseminada \u00a0debida\u00a0a\u00a0Histoplasma \u00a0Capsulatum \u00a0 17\u00a0 1,476\u00a0 17\u00a0\nHistoplasmosis \u00a0debida\u00a0a\u00a0Histoplasma \u00a0Capsulatum \u00a0 7\u00a0 1,169\u00a0 7\u00a0\nHistoplasmosis, \u00a0No\u00a0Especificada \u00a0 62\u00a0 1,147\u00a0 62\u00a0\nCriptocosis \u00a0Cerebral\u00a0 32\u00a0 18,274\u00a0 43\u00a0\nCriptococosis \u00a0Cut\u00e1nea\u00a0 9\u00a0 225\u00a0 12\u00a0\nCriptococosis \u00a0Diseminada \u00a0 3\u00a0 21\u00a0 3\u00a0\nOtras\u00a0Formas\u00a0de\u00a0Criptococosis \u00a0 4\u00a0 54\u00a0 4\u00a0\nCriptococosis, \u00a0no\u00a0Especificada \u00a0 25\u00a0 2,277\u00a0 26\u00a0\nMeningoencefalitis \u00a0debida\u00a0a\u00a0Toxoplasma \u00a0(G05.2*)\u00a0 40\u00a0 17,348\u00a0 45\u00a0\nSarcoma\u00a0de\u00a0Kaposi\u00a0de\u00a0Piel\u00a0 40\u00a0 7,362\u00a0 72\u00a0\nSarcoma\u00a0de\u00a0Kaposi\u00a0del\u00a0Tejido\u00a0Blando\u00a0 7\u00a0 1,754\u00a0 8\u00a0\nSarcoma\u00a0de\u00a0Kaposi\u00a0del\u00a0Paladar\u00a0 5\u00a0 494\u00a0 5\u00a0\nSarcoma\u00a0de\u00a0Kaposi\u00a0de\u00a0Ganglios\u00a0Linfaticos \u00a0 2\u00a0 308\u00a0 2\u00a0\nSarcoma\u00a0de\u00a0Kaposi\u00a0de\u00a0Otros\u00a0Sitios\u00a0Especificados \u00a0 14\u00a0 2,095\u00a0 26\u00a0\nSarcoma\u00a0de\u00a0Kaposi\u00a0de\u00a0Multiples \u00a0Organos\u00a0 5\u00a0 1,638\u00a0 27\u00a0\nSarcoma\u00a0de\u00a0Kaposi,\u00a0de\u00a0Sitio\u00a0no\u00a0Especificado \u00a0 25\u00a0 12,748\u00a0 64\u00a0\n\u00a0 11,818\u00a0 632,388\u00a0 37,012\u00a0\nFuente:\u00a0SIS\u00a0\n\u00a0\n\u00a0\n\u00a0 81 Gasto\u00a0de\u00a0bolsillo\u00a0\n\u00a0\nEl\u00a0grupo\u00a0poblacional \u00a0que\u00a0queda\u00a0\u00a0fuera\u00a0de\u00a0\u00a0de\u00a0las\u00a0alternativas \u00a0de\u00a0financiamiento \u00a0presenta\u00a0un\u00a0gasto\u00a0de\u00a0bolsillo\u00a0\u00a0\ncomo\u00a0fuente\u00a0de\u00a0financiamiento \u00a0en\u00a0salud\u00a0que\u00a0es\u00a0significativo, \u00a0con\u00a0efectos\u00a0adversos\u00a0sobre\u00a0la\u00a0efectividad \u00a0del\u00a0\ngasto\u00a0y\u00a0la\u00a0equidad\u00a0en\u00a0la\u00a0distribuci\u00f3n \u00a0de\u00a0los\u00a0costos\u00a0del\u00a0sistema.\u00a0\n\u00a0\nSe\u00a0estima\u00a0que\u00a0entre\u00a0los\u00a0a\u00f1os\u00a01995\u00a0al\u00a02005,\u00a0las\u00a0familias\u00a0financiaron \u00a0aproximadamente \u00a0entre\u00a0el\u00a035%\u00a0y\u00a0el\u00a045%\u00a0\u00a0\nde\u00a0los\u00a0gastos\u00a0en\u00a0salud\u00a0en\u00a0el\u00a0Per\u00fa.\u00a0(\u00a054\u00a0)\u00a0\u00a0\u00a0Mientras\u00a0que\u00a0en\u00a0el\u00a0caso\u00a0de\u00a0VIH,\u00a0el\u00a0estudio\u00a0de\u00a0Cuentas\u00a0Nacionales \u00a0en\u00a0\nVIH\u00a0realizado\u00a0\u00a0para\u00a0los\u00a0a\u00f1os\u00a01999\u20102000\u00a0(primeros \u00a0a\u00f1os\u00a0de\u00a0abordaje\u00a0de\u00a0la\u00a0epidemia) \u00a0encontr\u00f3\u00a0que\u00a0el\u00a0gasto\u00a0de\u00a0\nbolsillo\u00a0representaba \u00a0el\u00a083%\u00a0del\u00a0gasto\u00a0total,\u00a0situaci\u00f3n\u00a0que\u00a0se\u00a0mantuvo\u00a0hasta\u00a0el\u00a0a\u00f1o\u00a02004,\u00a0periodo\u00a0en\u00a0el\u00a0cual\u00a0\ncon\u00a0el\u00a0apoyo\u00a0del\u00a0FMSTM\u00a0se\u00a0entrega\u00a0el\u00a0tratamiento \u00a0para\u00a0VIH\u00a0de\u00a0forma\u00a0gratuita.\u00a0\n\u00a0\nEl\u00a0estudio\u00a0MEGAS\u00a0para\u00a0los\u00a0a\u00f1os\u00a0\u00a02005\u00a0al\u00a02007\u00a0inform\u00f3\u00a0que\u00a0luego\u00a0que\u00a0el\u00a0Estado\u00a0asumiera\u00a0parte\u00a0del\u00a0gasto\u00a0en\u00a0\ntratamiento \u00a0mediante \u00a0la\u00a0compra\u00a0de\u00a0antirretrovirales \u00a0\u00a0\u2010lo\u00a0cual\u00a0ocurri\u00f3\u00a0en\u00a0el\u00a02006\u2010\u00a0el\u00a0gasto\u00a0de\u00a0bolsillo\u00a0\nrepresentaba \u00a0el\u00a015%\u00a0del\u00a0gasto\u00a0total.\u00a0\u00a0\u00a0 Cabe\u00a0precisar\u00a0que\u00a0durante\u00a0est\u00e1\u00a0medici\u00f3n\u00a0se\u00a0encontraban \u00a0\nejecut\u00e1ndose \u00a0todos\u00a0los\u00a0\u201cproyectos \u00a0pa\u00eds\u201d\u00a0de\u00a0VIH\u00a0financiados \u00a0por\u00a0el\u00a0FMSTM\u00a0de\u00a02da,\u00a05ta\u00a0y\u00a06ta\u00a0ronda\u00a0y\u00a0los\u00a0\nproyectos \u00a0de\u00a0Tuberculosis \u00a0de\u00a02da\u00a0y\u00a05ta\u00a0ronda,\u00a0en\u00a0los\u00a0cuales\u00a0se\u00a0ha\u00a0proporcionado \u00a0tratamiento \u00a0para\u00a0\ninfecciones \u00a0oportunistas, \u00a0para\u00a0ITS,\u00a0reacciones \u00a0adversas\u00a0a\u00a0los\u00a0medicamentos \u00a0(RAM)\u00a0y\u00a0tuberculosis., \u00a0as\u00ed\u00a0como\u00a0\npreservativos, \u00a0lubricantes, \u00a0refuerzo\u00a0nutricional \u00a0a\u00a0las\u00a0personas, \u00a0entre\u00a0otros.\u00a0\u00a0\u00a0\n\u00a0\nA\u00a0este\u00a0\u00a0a\u00f1o\u00a02011\u00a0est\u00e1\u00a0en\u00a0su\u00a0\u00faltimo\u00a0a\u00f1o\u00a0el\u00a0programa \u00a0de\u00a0V\u00a0Ronda\u00a0y\u00a0en\u00a0el\u00a0cuarto\u00a0a\u00f1o\u00a0de\u00a0la\u00a0II\u00a0Fase\u00a0\u00a0el\u00a0programa \u00a0\u00a0\nde\u00a0VI\u00a0Ronda,\u00a0\u00a0por\u00a0lo\u00a0cual\u00a0se\u00a0espera\u00a0que\u00a0para\u00a0los\u00a0a\u00f1os\u00a0siguientes \u00a0el\u00a0gasto\u00a0de\u00a0bolsillo\u00a0se\u00a0incremente, \u00a0en\u00a0la\u00a0\nmedida\u00a0que\u00a0el\u00a0MINSA\u00a0empiece\u00a0a\u00a0asumir\u00a0y\u00a0a\u00a0cubrir\u00a0progresivamente \u00a0estos\u00a0costos,\u00a0tal\u00a0como\u00a0ocurriera\u00a0con\u00a0el\u00a0\nTARGA.\u00a0\n\u00a0\nActualmente, \u00a0existe\u00a0un\u00a0gasto\u00a0de\u00a0bolsillo,\u00a0alrededor \u00a0de\u00a0un\u00a014.5%\u00a0del\u00a0gasto\u00a0total\u00a0del\u00a0pa\u00eds\u00a0para\u00a0el\u00a02008\u20102010,\u00a0\nporcentaje \u00a0que\u00a0se\u00a0ha\u00a0incrementado \u00a0con\u00a0respecto\u00a0a\u00a0los\u00a0a\u00f1os\u00a02005\u20102008\u00a0en\u00a0la\u00a0que\u00a0ascendi\u00f3\u00a0a\u00a012.5%.\u00a0\u00a0El\u00a0gasto\u00a0\nde\u00a0bolsillo\u00a0principalmente \u00a0\u00a0corresponde \u00a0a\u00a0\u00a0la\u00a0compra\u00a0de\u00a0ARV,\u00a0\u00a0medicamentos \u00a0para\u00a0infecciones \u00a0oportunistas, \u00a0\u00a0\ncosto\u00a0de\u00a0hospitalizaciones, \u00a0consultas \u00a0en\u00a0el\u00a0sector\u00a0privado,\u00a0el\u00a0tamizaje\u00a0para\u00a0VIH\u00a0en\u00a0laboratorios \u00a0privados\u00a0y\u00a0la\u00a0\nadquisici\u00f3n \u00a0de\u00a0condones. \u00a0\u00a0\n\u00a0\nEn\u00a0nuestro\u00a0pa\u00eds\u00a0\u00a0con\u00a0un\u00a033%\u00a0de\u00a0\u00a0pobreza,\u00a0este\u00a0gasto\u00a0de\u00a0bolsillo\u00a0indica\u00a0que\u00a0la\u00a0carga\u00a0financiera \u00a0de\u00a0la\u00a0\nenfermedad \u00a0est\u00e1\u00a0afectando \u00a0el\u00a0presupuesto \u00a0de\u00a0los\u00a0hogares\u00a0y\u00a0compite\u00a0con\u00a0\u00a0la\u00a0satisfacci\u00f3n \u00a0de\u00a0las\u00a0necesidades \u00a0\u00a0\nb\u00e1sicas\u00a0primarias. \u00a0\u00a0\n\u00a0\nPorque\u00a0si\u00a0bien\u00a0el\u00a0TARGA\u00a0es\u00a0gratis\u00a0a\u00a0nivel\u00a0nacional,\u00a0hay\u00a0gastos\u00a0\u00a0que\u00a0son\u00a0asumidos \u00a0por\u00a0las\u00a0propias\u00a0personas\u00a0\ncomo:\u00a0\u00a0la\u00a0consulta\u00a0\u00a0en\u00a0los\u00a0establecimientos \u00a0de\u00a0salud,\u00a0la\u00a0apertura\u00a0de\u00a0Historia\u00a0cl\u00ednica,\u00a0los\u00a0ex\u00e1menes \u00a0para\u00a0\ndiagn\u00f3stico \u00a0de\u00a0VIH\u00a0(prueba\u00a0r\u00e1pida\u00a0o\u00a0ELISA),\u00a0Radiograf\u00eda \u00a0de\u00a0t\u00f3rax,\u00a0Pruebas\u00a0de\u00a0laboratorio \u00a0pre\u2010TARGA,\u00a0\npruebas\u00a0de\u00a0laboratorio \u00a0de\u00a0control\u00a0(hemograma, \u00a0hematocrito, \u00a0RPR,\u00a0pruebas\u00a0hep\u00e1ticas, \u00a0pruebas\u00a0para\u00a0\nhepatitis), \u00a0pruebas\u00a0de\u00a0diagn\u00f3stico \u00a0\u00a0y\u00a0tratamiento \u00a0para\u00a0\u00a0algunas\u00a0infecciones \u00a0oportunistas, \u00a0tratamiento \u00a0para\u00a0\nalgunas\u00a0infecciones \u00a0oportunistas, \u00a0gasto\u00a0en\u00a0hospitalizaciones, \u00a0compra\u00a0de\u00a0algunos\u00a0ARV,\u00a0consultas \u00a0en\u00a0el\u00a0sector\u00a0\nprivado\u00a0y\u00a0compra\u00a0de\u00a0condones \u00a0\u00a0\n\u00a0\n\u00a0\n\u00a0\nPrevenci\u00f3n \u00a0en\u00a0poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0\n\u00a0\nEn\u00a0el\u00a0caso\u00a0de\u00a0nuestro\u00a0pa\u00eds,\u00a0de\u00a0acuerdo\u00a0a\u00a0los\u00a0datos\u00a0m\u00e1s\u00a0recientes\u00a0de\u00a0vigilancia\u00a0epidemiol\u00f3gica, \u00a0la\u00a0epidemia \u00a0\ndel\u00a0VIH\u00a0contin\u00faa\u00a0concentrada \u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0trans\u00a0y\u00a0en\u00a0HSH,\u00a0con\u00a0tasas\u00a0de\u00a0incidencia \u00a0m\u00e1s\u00a0elevadas\u00a0sobre\u00a0\n                                                 \n54 Fuente:\u00a0MINSA\u00a0\u2010OGPP\u00a0/\u00a0CIES.\u00a0\u00a0Observatorio \u00a0de\u00a0la\u00a0Salud,\u00a0Cuentas\u00a0Nacionales \u00a0de\u00a0Salud\u00a01995\u20102005,\u00a02008,\u00a0Lima\u00a0Per\u00fa  82 todo\u00a0en\u00a0el\u00a0grupo\u00a0et\u00e1reo\u00a0m\u00e1s\u00a0joven.\u00a0\u00a0Este\u00a0perfil\u00a0epidemiol\u00f3gico \u00a0demanda \u00a0la\u00a0implementaci\u00f3n \u00a0de\u00a0acciones\u00a0de\u00a0\nprevenci\u00f3n \u00a0m\u00e1s\u00a0efectivas\u00a0dirigidas\u00a0a\u00a0reducir\u00a0las\u00a0nuevas\u00a0infecciones \u00a0en\u00a0esta\u00a0poblaci\u00f3n \u00a0n\u00facleo,\u00a0o\u00a0poblaci\u00f3n \u00a0en\u00a0\nmayor\u00a0riesgo\u00a0de\u00a0adquirir\u00a0VIH\u00a0y\u00a0que\u00a0se\u00a0encuentran \u00a0en\u00a0mayor\u00a0vulnerabilidad \u00a0al\u00a0mismo.\u00a0Se\u00a0aprecia\u00a0sin\u00a0embargo\u00a0\nque\u00a0la\u00a0tendencia \u00a0del\u00a0gasto\u00a0en\u00a0sida\u00a0en\u00a0el\u00a0pa\u00eds\u00a0es\u00a0incremental \u00a0en\u00a0el\u00a0rubro\u00a0de\u00a0tratamiento, \u00a0y\u00a0no\u00a0as\u00ed\u00a0en\u00a0\nprevenci\u00f3n. \u00a0\u00a0Antes\u00a0bien,\u00a0con\u00a0frecuencia \u00a0los\u00a0recursos\u00a0que\u00a0cubren\u00a0las\u00a0intervenciones \u00a0de\u00a0prevenci\u00f3n \u00a0en\u00a0estos\u00a0\ngrupos\u00a0provienen \u00a0de\u00a0la\u00a0cooperaci\u00f3n \u00a0internacional \u00a0y\u00a0de\u00a0organizaciones \u00a0no\u00a0gubernamentales. \u00a0\u00a0\n\u00a0\nCabe\u00a0anotar\u00a0sin\u00a0embargo\u00a0que\u00a0el\u00a0sistema\u00a0de\u00a0informaci\u00f3n \u00a0no\u00a0arroja\u00a0actualmente \u00a0la\u00a0informaci\u00f3n \u00a0desagregada \u00a0\nque\u00a0se\u00a0requiere\u00a0para\u00a0asignar\u00a0el\u00a0gasto\u00a0a\u00a0los\u00a0grupos\u00a0poblacionales \u00a0de\u00a0mayor\u00a0riesgo\u00a0frente\u00a0a\u00a0la\u00a0epidemia, \u00a0\ndejando\u00a0algunos\u00a0vac\u00edos\u00a0que\u00a0es\u00a0necesario \u00a0corregir\u00a0en\u00a0los\u00a0sistemas\u00a0de\u00a0registro\u00a0de\u00a0beneficiarios \u00a0de\u00a0las\u00a0\nintervenciones \u00a0para\u00a0poder\u00a0valorar\u00a0mejor\u00a0la\u00a0asignaci\u00f3n \u00a0del\u00a0gasto\u00a0en\u00a0los\u00a0rubros\u00a0referidos\u00a0a\u00a0la\u00a0prevenci\u00f3n \u00a0por\u00a0\ntipo\u00a0de\u00a0poblaci\u00f3n, \u00a0de\u00a0acuerdo\u00a0al\u00a0perfil\u00a0de\u00a0la\u00a0epidemia \u00a0que\u00a0tiene\u00a0el\u00a0pa\u00eds.\u00a0\u00a0\n\u00a0\nLa\u00a0estrategia \u00a0de\u00a0promotores \u00a0educadores \u00a0de\u00a0pares\u00a0conjuntamente \u00a0con\u00a0la\u00a0AMP\u00a0es\u00a0una\u00a0intervenci\u00f3n \u00a0\npreventiva \u00a0reconocida \u00a0como\u00a0de\u00a0alta\u00a0efectividad \u00a0para\u00a0la\u00a0poblaci\u00f3n \u00a0de\u00a0alto\u00a0riesgo\u00a0de\u00a0contraer\u00a0el\u00a0VIH,\u00a0sin\u00a0\nembargo, \u00a0\u00a0seg\u00fan\u00a0los\u00a0resultados \u00a0de\u00a0una\u00a0Evaluaci\u00f3n \u00a0de\u00a0la\u00a0estrategia \u00a0de\u00a0PEP\u00a0realizada\u00a0en\u00a0el\u00a0marco\u00a0de\u00a0los\u00a0\nprogramas \u00a0del\u00a0FMSTM\u00a0(INPPARES \u00a0et\u00a0al,\u00a02010),\u00a0al\u00a0a\u00f1o\u00a02010\u00a0la\u00a0eficacia\u00a0de\u00a0esta\u00a0estrategia \u00a0estaba\u00a0siendo\u00a0\nafectada\u00a0por\u00a0la\u00a0rotaci\u00f3n\u00a0constante \u00a0de\u00a0los\u00a0PEPs,\u00a0la\u00a0debilidad \u00a0en\u00a0el\u00a0seguimiento \u00a0o\u00a0acompa\u00f1amiento \u00a0t\u00e9cnico\u00a0a\u00a0\nlos\u00a0mismos\u00a0y\u00a0la\u00a0incertidumbre \u00a0respecto\u00a0de\u00a0su\u00a0sostenibilidad  55 \u00a0\u00a0\n\u00a0\nPrevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0vertical\u00a0\n\u00a0\nEl\u00a0acceso\u00a0a\u00a0los\u00a0servicios\u00a0de\u00a0salud\u00a0es\u00a0una\u00a0parte\u00a0importante \u00a0del\u00a0derecho\u00a0de\u00a0las\u00a0mujeres\u00a0a\u00a0la\u00a0igualdad\u00a0en\u00a0el\u00a0\ndisfrute\u00a0del\u00a0derecho\u00a0a\u00a0la\u00a0salud.\u00a0El\u00a0contar\u00a0con\u00a0seguros\u00a0de\u00a0salud\u00a0asegura\u00a0a\u00a0la\u00a0mujer,\u00a0especialmente, \u00a0que\u00a0sus\u00a0\notros\u00a0derechos\u00a0humanos \u00a0relacionados \u00a0con\u00a0su\u00a0integridad \u00a0no\u00a0se\u00a0vulneren\u00a0y\u00a0disfrutar\u00a0del\u00a0m\u00e1s\u00a0alto\u00a0nivel\u00a0posible\u00a0\nde\u00a0salud\u00a0f\u00edsica\u00a0y\u00a0mental.56\u00a0\n\u00a0Cabe\u00a0precisar\u00a0que\u00a0de\u00a0acuerdo\u00a0a\u00a0la\u00a0Encuesta\u00a0demogr\u00e1fica \u00a0y\u00a0de\u00a0salud\u00a0familiar\u00a0realizadas \u00a0en\u00a0el\u00a02007\u00a0al\u00a02010,\u00a0se\u00a0\nha\u00a0producido \u00a0un\u00a0importante \u00a0incremento \u00a0en\u00a0la\u00a0cobertura \u00a0de\u00a0salud\u00a0en\u00a0las\u00a0mujeres\u00a0en\u00a0edad\u00a0de\u00a0f\u00e9rtil,\u00a0\nfundamentalmente \u00a0en\u00a0el\u00a0seguro\u00a0integral\u00a0de\u00a0salud.\u00a0\u00a0La\u00a0mayor\u00a0parte\u00a0de\u00a0las\u00a0aseguradas \u00a0\nen\u00a0ESSALUD\u00a0cuenta\u00a0con\u00a0\neducaci\u00f3n \u00a0superior\u00a0y\u00a0se\u00a0encuentran \u00a0en\u00a0el\u00a0quintil\u00a0superior\u00a0de\u00a0ingresos,\u00a0mientras\u00a0que\u00a0la\u00a0mayor\u00eda\u00a0de\u00a0las\u00a0\naseguradas \u00a0al\u00a0SIS\u00a0\u00a0son\u00a0mujeres\u00a0sin\u00a0nivel\u00a0de\u00a0educaci\u00f3n \u00a0y\u00a0se\u00a0encuentran \u00a0en\u00a0el\u00a0quintil\u00a0inferior\u00a0de\u00a0ingresos.\u00a0\u00a0Este\u00a0\nincremento \u00a0de\u00a0cobertura, \u00a0garantiza\u00a0la\u00a0atenci\u00f3n\u00a0de\u00a0VIH\u00a0en\u00a0gestantes \u00a0(tamizaje, \u00a0profilaxis\u00a0y\u00a0consultas \u00a0\ndiversas), \u00a0de\u00a0las\u00a0aseguradas \u00a0al\u00a0SIS\u00a0sin\u00a0embargo\u00a0todav\u00eda\u00a0existe\u00a0un\u00a043.1%\u00a0de\u00a0mujeres\u00a0en\u00a0edad\u00a0f\u00e9rtil\u00a0que\u00a0no\u00a0\ncuentan\u00a0con\u00a0ning\u00fan\u00a0tipo\u00a0de\u00a0seguro.\u00a0\n\u00a0\nCobertura \u00a0de\u00a0seguros\u00a0en\u00a0salud\u00a0en\u00a0mujeres\u00a02007\u00a0al\u00a02010\u00a0(en\u00a0porcentaje) \u00a0\nMujeres\u00a0en\u00a0edad\u00a0f\u00e9rtil\u00a0(MEF)\u00a0 2007\u20102008\u00a0 2009\u00a0 2010\u00a0\nCon\u00a0seguro\u00a0de\u00a0salud\u00a0 29.0\u00a0 51.0\u00a0 56.9\u00a0\n\u2010\u00a0Seguro\u00a0integral\u00a0de\u00a0salud\u00a0 16.7\u00a0 27.4\u00a0 33.6\u00a0\n\u2010\u00a0ESSALUD\u00a0 19.0\u00a0 20.4\u00a0 20.3\u00a0\n\u00a0\u00a0 \u00a0 \u00a0\nAseguradas \u00a0en\u00a0ESSALUD\u00a0\u00a0 \u00a0 \u00a0\n\u2010\u00a0Con\u00a0educaci\u00f3n \u00a0superior\u00a0 34.8\u00a0 39.9\u00a0 40.6\u00a0\n\u2010\u00a0En\u00a0quintil\u00a0superior\u00a0 33.9\u00a0 43.7\u00a0 43.1\u00a0\nAseguradas \u00a0den\u00a0SIS\u00a0\u00a0 \u00a0 \u00a0\n\u2010\u00a0Sin\u00a0nivel\u00a0de\u00a0educaci\u00f3n \u00a0 34.4\u00a0 59.3\u00a0 65.3\u00a0\n                                                 \n55\u00a0Fuente:\u00a0INPPARES \u00a0et\u00a0al\u00a0(2010)\u00a0Evaluaci\u00f3n \u00a0de\u00a0la\u00a0estrategia \u00a0de\u00a0promotores \u00a0educadores \u00a0de\u00a0pares\u00a0(PEPs)\u00a0\u00a0HSH\u00a0y\u00a0TS\u00a0de\u00a0la\u00a0\nESN\u00a0PC\u00a0ITS\u00a0y\u00a0VIH/Sida. \u00a0\u00a0\n56\u00a0Fuente:\u00a0ENDES\u00a0\u2013\u00a0Encuesta\u00a0demogr\u00e1fica \u00a0y\u00a0de\u00a0salud\u00a0familiar\u00a02010\u00a0 83 Mujeres\u00a0en\u00a0edad\u00a0f\u00e9rtil\u00a0(MEF)\u00a0 2007\u20102008\u00a0 2009\u00a0 2010\u00a0\n\u2010\u00a0En\u00a0quintil\u00a0inferior\u00a0 40.7\u00a0 65.3\u00a0 74.0\u00a0\n\u00a0\nPor\u00a0otro\u00a0lado,\u00a0algunas\u00a0veces\u00a0el\u00a0mecanismo \u00a0de\u00a0financiamiento \u00a0puede\u00a0distorsionar \u00a0los\u00a0resultados \u00a0esperados \u00a0\nde\u00a0una\u00a0estrategia, \u00a0como\u00a0por\u00a0ejemplo\u00a0lo\u00a0correspondiente \u00a0a\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0vertical\u00a0cuyo\u00a0\nfinanciamiento \u00a0corresponde \u00a0al\u00a0SIS.\u00a0\u00a0\u00a0En\u00a0lo\u00a0que\u00a0respecta\u00a0a\u00a0los\u00a0reembolsos \u00a0que\u00a0se\u00a0generan\u00a0como\u00a0resultado \u00a0de\u00a0\nlos\u00a0servicios\u00a0prestados \u00a0a\u00a0usuarios\u00a0del\u00a0SIS\u00a0y\u00a0que\u00a0no\u00a0son\u00a0asignados \u00a0a\u00a0los\u00a0establecimientos \u00a0que\u00a0generan\u00a0los\u00a0\nrecursos,\u00a0no\u00a0existe\u00a0un\u00a0estimulo\u00a0para\u00a0atender\u00a0a\u00a0los\u00a0usuarios\u00a0del\u00a0SIS.\u00a0\u00a0\u00a0Toda\u00a0vez\u00a0que\u00a0no\u00a0existe\u00a0\u00a0una\u00a0\ncorrespondencia, \u00a0por\u00a0lo\u00a0expresado \u00a0anteriormente \u00a0entre\u00a0lo\u00a0que\u00a0se\u00a0gasta\u00a0en\u00a0los\u00a0establecimientos \u00a0y\u00a0los\u00a0\nrecursos\u00a0que\u00a0genera:\u00a0(1)\u00a0Reembolsos \u00a0del\u00a0SIS\u00a0y\u00a0(2)\u00a0recursos\u00a0directamente \u00a0recaudados \u00a0(pagos\u00a0realizados \u00a0por\u00a0\nlos\u00a0usuarios), \u00a0puede\u00a0ocurrir\u00a0que\u00a0la\u00a0falta\u00a0de\u00a0controles \u00a0administrativos \u00a0\u00a0sesguen\u00a0la\u00a0atenci\u00f3n\u00a0hacia\u00a0los\u00a0usuarios\u00a0\nque\u00a0pagan,\u00a0\u00a0por\u00a0la\u00a0disposici\u00f3n \u00a0de\u00a0efectivo\u00a0que\u00a0podr\u00eda\u00a0ocurrir\u00a0entre\u00a0los\u00a0encargados \u00a0del\u00a0cobro.\u00a0\u00a0\u00a0\n\u00a0\nEste\u00a0hecho\u00a0podr\u00eda\u00a0alterar\u00a0esta\u00a0estrategia \u00a0que\u00a0es\u00a0masiva\u00a0pues\u00a0afecta\u00a0a\u00a0todas\u00a0las\u00a0gestantes \u00a0que\u00a0se\u00a0atienden\u00a0en\u00a0\nlos\u00a0establecimientos \u00a0p\u00fablicos\u00a0de\u00a0salud,\u00a0\u00a0\u00a0en\u00a0los\u00a0cuales\u00a0se\u00a0puede\u00a0observar\u00a0que\u00a0inclusive\u00a0existen\u00a0cuotas\u00a0para\u00a0\natender\u00a0a\u00a0los\u00a0usuarios\u00a0del\u00a0SIS\u00a0(no\u00a0m\u00e1s\u00a0de\u00a05\u00a0por\u00a0d\u00eda,\u00a0por\u00a0ejemplo). \u00a0\n\u00a0Uno\u00a0de\u00a0los\u00a0fines\u00a0de\u00a0la\u00a0estrategia \u00a0de\u00a0\nprevenci\u00f3n \u00a0vertical\u00a0es\u00a0que\u00a0las\u00a0personas\u00a0que\u00a0se\u00a0acerquen \u00a0a\u00a0los\u00a0servicios\u00a0\npueden\u00a0acceder\u00a0a\u00a0una\u00a0prueba\u00a0r\u00e1pida,\u00a0conocer\u00a0los\u00a0resultados \u00a0de\u00a0inmediato, \u00a0con\u00a0el\u00a0\u00a0resultado \u00a0\u00a0de\u00a0una\u00a0menor\u00a0\ncantidad\u00a0de\u00a0oportunidades \u00a0p\u00e9rdidas\u00a0e\u00a0iniciar\u00a0inmediatamente \u00a0el\u00a0tratamiento. \u00a0\u00a0\u00a0Sin\u00a0embargo, \u00a0por\u00a0lo\u00a0menos\u00a0\nen\u00a0uno\u00a0de\u00a0los\u00a0gobiernos \u00a0regionales \u00a0se\u00a0compran\u00a0muy\u00a0pocas\u00a0pruebas\u00a0r\u00e1pidas,\u00a0\u00a0el\u00a0\u00fanico\u00a0que\u00a0puede\u00a0realizar\u00a0las\u00a0\npruebas\u00a0Elisa\u00a0es\u00a0el\u00a0laboratorio, \u00a0por\u00a0los\u00a0reembolso \u00a0del\u00a0Seguro\u00a0integral\u00a0de\u00a0salud\u00a0\u2010\u00a0SIS\u00a0\u00a0pues\u00a0si\u00a0comprara \u00a0\npruebas\u00a0r\u00e1pidas,\u00a0los\u00a0reembolsos \u00a0del\u00a0SIS\u00a0seria\u00a0ingresos\u00a0de\u00a0los\u00a0establecimiento \u00a0y\u00a0no\u00a0del\u00a0laboratorio. \u00a0\u00a0Este\u00a0tipo\u00a0\nde\u00a0pr\u00e1cticas\u00a0deben\u00a0ser\u00a0vigiladas\u00a0por\u00a0el\u00a0MINSA.\u00a0\u00a0\u00a0\n\u00a0\nSupervisiones \u00a0realizadas \u00a0por\u00a0la\u00a0estrategia \u00a0de\u00a0salud\u00a0sexual\u00a0y\u00a0reproductiva \u00a0indican\u00a0que\u00a0aun\u00a0se\u00a0debe\u00a0trabajar\u00a0\npara\u00a0lograr\u00a0que\u00a0los\u00a0establecimientos \u00a0de\u00a0salud\u00a0est\u00e9n\u00a0en\u00a0condiciones \u00a0de\u00a0realizar\u00a0las\u00a0actividades \u00a0de\u00a0prevenci\u00f3n \u00a0\nde\u00a0transmisi\u00f3n \u00a0vertical,\u00a0la\u00a0cual\u00a0requiere\u00a0que\u00a0se\u00a0encuentren \u00a0categorizadas \u00a0como\u00a0FON\u00a0B\u00a0y\u00a0en\u00a0tal\u00a0sentido\u00a0\ncuenten\u00a0con\u00a0personal\u00a0capacitado \u00a0y\u00a0los\u00a0insumos\u00a0requeridos \u00a0para\u00a0poder\u00a0atender\u00a0a\u00a0las\u00a0usuarias\u00a0que\u00a0se\u00a0\npresenten. \u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0 84 \u00a0\nH.\u00a0Conclusiones \u00a0\n\u00a0\nSe\u00a0necesita\u00a0realizar\u00a0un\u00a0enfoque\u00a0m\u00e1s\u00a0selectivo\u00a0y\u00a0estrat\u00e9gico \u00a0para\u00a0la\u00a0inversi\u00f3n\u00a0en\u00a0la\u00a0respuesta \u00a0nacional\u00a0a\u00a0la\u00a0\nepidemia \u00a0de\u00a0VIH/SIDA\u00a0(57)\u00a0que\u00a0permitir\u00e1 \u00a0en\u00a0el\u00a0largo\u00a0plazo\u00a0orientar\u00a0hacia\u00a0aquellas\u00a0intervenciones \u00a0que\u00a0\npermitan\u00a0ahorro\u00a0y\u00a0la\u00a0menor\u00a0cantidad\u00a0de\u00a0a\u00f1os\u00a0perdidos\u00a0por\u00a0muerte\u00a0o\u00a0discapacidad. \u00a0\u00a0Esto\u00a0requiere\u00a0invertir\u00a0en\u00a0\nuna\u00a0serie\u00a0de\u00a0estrategias \u00a0que\u00a0combinadas \u00a0representen \u00a0la\u00a0mayor\u00a0efectividad \u00a0por\u00a0lo\u00a0invertido\u00a0lo\u00a0que\u00a0lleva\u00a0a\u00a0\nconsiderar \u00a0en\u00a0un\u00a0planeamiento \u00a0que\u00a0va\u00a0m\u00e1s\u00a0all\u00e1\u00a0de\u00a0una\u00a0programaci\u00f3n \u00a0de\u00a0gastos\u00a0realizada\u00a0en\u00a0funci\u00f3n\u00a0de\u00a0\nproductos, \u00a0inclusive\u00a0con\u00a0la\u00a0programaci\u00f3n \u00a0realizada\u00a0en\u00a0el\u00a0presupuesto \u00a0por\u00a0resultados \u00a0que\u00a0considera \u00a0las\u00a0\nevidencias \u00a0para\u00a0la\u00a0incorporaci\u00f3n \u00a0de\u00a0una\u00a0intervenci\u00f3n \u00a0en\u00a0el\u00a0dise\u00f1o\u00a0de\u00a0los\u00a0programas \u00a0estrat\u00e9gicos. \u00a0\u00a0\n\u00a0\nAsimismo, \u00a0\u00a0dado\u00a0el\u00a0perfil\u00a0de\u00a0la\u00a0epidemia \u00a0en\u00a0el\u00a0Per\u00fa,\u00a0el\u00a0mayor\u00a0gasto\u00a0debe\u00a0estar\u00a0dirigido\u00a0hacia\u00a0las\u00a0poblaciones \u00a0\ncon\u00a0mayor\u00a0exposici\u00f3n \u00a0al\u00a0VIH58.\u00a0Si\u00a0bien\u00a0entre\u00a0los\u00a0a\u00f1os\u00a02005\u20102007\u00a0al\u00a02008\u20102010\u00a0se\u00a0ha\u00a0producido \u00a0un\u00a0\nincremento \u00a0en\u00a0la\u00a0estructura \u00a0de\u00a0gastos\u00a0orientadas \u00a0a\u00a0intervenciones \u00a0a\u00a0poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0(HSH\u00a0y\u00a0TS),\u00a0\nlas\u00a0mismas\u00a0\u00a0han\u00a0sido\u00a0principalmente \u00a0financiadas \u00a0por\u00a0fuentes\u00a0externas,\u00a0por\u00a0lo\u00a0cual\u00a0se\u00a0debe\u00a0prever\u00a0los\u00a0\nmecanismos \u00a0para\u00a0canalizar\u00a0los\u00a0recursos\u00a0hacia\u00a0estas\u00a0poblaciones, \u00a0para\u00a0los\u00a0a\u00f1os\u00a0siguientes \u00a0en\u00a0que\u00a0se\u00a0espera\u00a0\ndisminuya \u00a0las\u00a0fuente\u00a0de\u00a0financiamiento, \u00a0externas.\u00a0\n\u00a0\n\u00a0\n50.8%\n6.7%5.3% 5.4%7.9%21.6%\n2.2%\nPVV TS HSH Gestantes, \u00a0MEF Militar,PPL, \u00a0\njovenesPob.General Otras\u00bfC\u00f3mo\u00a0se\u00a0distribuye \u00a0el\u00a0gasto\u00a0por\u00a0poblaci\u00f3n \u00a0beneficiaria? \u00a0\n2005\u20102007\n \n \n \n                                                 \n57 Basado\u00a0en: Towards\u00a0an\u00a0improved \u00a0investment \u00a0approach \u00a0for\u00a0an\u00a0effective\u00a0response\u00a0to\u00a0HIV/AIDS, \u00a0June\u00a03,\u00a02011,\u00a0UNAIDS  \n58\u00a0Existe\u00a0literatura \u00a0cient\u00edfica\u00a0que\u00a0permite\u00a0extraer\u00a0evidencia \u00a0sobre\u00a0la\u00a0importancia \u00a0de\u00a0abordar\u00a0con\u00a0estrategias \u00a0efectivas\u00a0de\u00a0\nprevenci\u00f3n \u00a0a\u00a0las\u00a0poblaciones \u00a0en\u00a0m\u00e1s\u00a0alto\u00a0riesgo\u00a0a\u00a0fin\u00a0de\u00a0lograr\u00a0un\u00a0mayor\u00a0impacto\u00a0en\u00a0la\u00a0epidemia, \u00a0y\u00a0ello\u00a0implica,\u00a0\nciertamente, \u00a0destinar\u00a0recursos\u00a0a\u00a0estas\u00a0estrategias \u00a0de\u00a0intervenci\u00f3n. \u00a0\u00a0Ver\u00a0por\u00a0ejemplo:\u00a0Robert\u00a0Hecht,\u00a0Lori\u00a0Bollinger, \u00a0John\u00a0\nStover,\u00a0William\u00a0McGreevey, \u00a0Farzana\u00a0Muhib,\u00a0Callisto\u00a0Emas\u00a0Madavo,\u00a0and\u00a0David\u00a0de\u00a0Ferranti\u00a0(2009)\u00a0Critical\u00a0Choices\u00a0In\u00a0\nFinancing \u00a0The\u00a0Response \u00a0To\u00a0TheGlobal \u00a0HIV/AIDS \u00a0Pandemic. \u00a0Costs\u00a0could\u00a0rise\u00a0to\u00a0$35\u00a0billion\u00a0a\u00a0year\u00a0by\u00a02031\u2014unless \u00a0the\u00a0\nworld\u00a0takes\u00a0dramatic\u00a0steps\u00a0to\u00a0avert\u00a0the\u00a0worst\u00a0outcomes. \u00a0In:\u00a0HEALTH\u00a0A\u00a0F\u00a0FA\u00a0I\u00a0R\u00a0S\u00a0~\u00a0Vo\u00a0l\u00a0u\u00a0m\u00a0e\u00a02\u00a08\u00a0,\u00a0Nu\u00a0m\u00a0b\u00a0e\u00a0r\u00a06,\u00a02009.\u00a0\nPages\u00a01591\u20101605.\u00a0\u00a0Y\u00a0tambi\u00e8n\u00a0se\u00a0puede\u00a0revisar:\u00a0Bernhard \u00a0Schwartl\u00e4nder, \u00a0John\u00a0Stover,\u00a0Timothy\u00a0Hallett,\u00a0Rifat\u00a0Atun,\u00a0Carlos\u00a0\nAvila,\u00a0Eleanor\u00a0Gouws,\u00a0Michael\u00a0Bartos,\u00a0Peter\u00a0D\u00a0Ghys,\u00a0Marjorie\u00a0Opuni,\u00a0David\u00a0Barr,\u00a0Ramzi\u00a0Alsallaq,\u00a0Lori\u00a0Bollinger, \u00a0Marcelo\u00a0\nde\u00a0Freitas,\u00a0Geoff\u00a0rey\u00a0Garnett,\u00a0Charles\u00a0Holmes,\u00a0Ken\u00a0Legins,\u00a0Yogan\u00a0Pillay,\u00a0Anderson \u00a0Eduardo\u00a0Stanciole, \u00a0Craig\u00a0McClure,\u00a0\nGottfried\u00a0Hirnschall, \u00a0Marie\u00a0Laga,\u00a0Nancy\u00a0Padian\u00a0(2011)\u00a0Towards\u00a0an\u00a0improved \u00a0investment \u00a0approach \u00a0for\u00a0an\u00a0eff\u00a0ective\u00a0\nresponse\u00a0to\u00a0HIV/AIDS .\u00a0\u00a0\u00a0In:\u00a0\u00a0Health\u00a0Policy.\u00a0\u00a0www.thelancet.com \u00a0Published \u00a0online\u00a0June\u00a03,\u00a02011\u00a0DOI:10.1016/S0140 \u2010\n6736(11)60702 \u20102\u00a0\n  85 \n38%\n10%\n6%13%\n9%16%\n7%\nPVV TS HSH Gestantes, \u00a0MEF Militar,PPL, \u00a0\njovenesPob.General Otras\u00bfC\u00f3mo\u00a0se\u00a0distribuye \u00a0el\u00a0gasto\u00a0por\u00a0poblaci\u00f3n \u00a0beneficiaria? \u00a0\u00a0\u00a0\n2008\u20102010\n \n \n  \nDebe\u00a0contemplarse \u00a0la\u00a0inversi\u00f3n\u00a0estrat\u00e9gica \u00a0en\u00a0VIH,\u00a0entre\u00a0las\u00a0que\u00a0se\u00a0debe\u00a0destacar\u00a0la\u00a0generaci\u00f3n \u00a0de\u00a0un\u00a0\nentorno\u00a0favorable \u00a0y\u00a0el\u00a0desarrollo \u00a0de\u00a0seis\u00a0actividades \u00a0program\u00e1ticas \u00a0b\u00e1sicas\u00a0sugeridas \u00a0por\u00a0ONUSIDA: \u00a0\nprevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0vertical,\u00a0promoci\u00f3n \u00a0y\u00a0distribuci\u00f3n \u00a0de\u00a0preservativos, \u00a0prevenci\u00f3n \u00a0con\u00a0poblaci\u00f3n \u00a0\nm\u00e1s\u00a0expuesta\u00a0(HSH\u00a0y\u00a0TS),\u00a0atenci\u00f3n\u00a0y\u00a0tratamiento \u00a0en\u00a0PVV,\u00a0circuncisi\u00f3n \u00a0masculina59\u00a0y\u00a0programas \u00a0de\u00a0cambio\u00a0de\u00a0\ncomportamiento. \u00a0\n \nCon\u00a0respecto\u00a0al\u00a0financiamiento \u00a0futuro,\u00a0debe\u00a0tomarse\u00a0en\u00a0cuenta\u00a0que:\u00a0\n\uf02d Con\u00a0la\u00a0Ley\u00a0de\u00a0aseguramiento \u00a0universal\u00a0la\u00a0afiliaci\u00f3n\u00a0a\u00a0alg\u00fan\u00a0r\u00e9gimen\u00a0de\u00a0aseguramiento \u00a0en\u00a0salud\u00a0es\u00a0\nobligatoria \u00a0para\u00a0toda\u00a0la\u00a0poblaci\u00f3n, \u00a0por\u00a0lo\u00a0cual\u00a0es\u00a0importante \u00a0la\u00a0promoci\u00f3n \u00a0de\u00a0la\u00a0afiliaci\u00f3n\u00a0entre\u00a0la\u00a0\npoblaci\u00f3n \u00a0m\u00e1s\u00a0vulnerable. \u00a0\u00a0\n\uf02d En\u00a0el\u00a0sector\u00a0p\u00fablico\u00a0nacional\u00a0se\u00a0provee\u00a0Tratamiento \u00a0antirretroviral \u00a0desde\u00a0el\u00a0a\u00f1o\u00a02003,\u00a0los\u00a0\nantirretrovirales \u00a0por\u00a0su\u00a0toxicidad\u00a0en\u00a0el\u00a0mediano\u00a0y\u00a0largo\u00a0plazo,\u00a0producen \u00a0una\u00a0serie\u00a0de\u00a0complicaciones \u00a0\nque\u00a0representan \u00a0gasto,\u00a0cuando\u00a0el\u00a0paciente\u00a0pertenece \u00a0a\u00a0ESSALUD, \u00a0el\u00a0gasto\u00a0es\u00a0asumido\u00a0por\u00a0este,\u00a0pero\u00a0\ncuando\u00a0el\u00a0paciente\u00a0no\u00a0tiene\u00a0seguro\u00a0o\u00a0inclusive\u00a0si\u00a0pertenece \u00a0al\u00a0SIS\u00a0el\u00a0gasto\u00a0es\u00a0asumido\u00a0por\u00a0los\u00a0pacientes. \u00a0\u00a0\nLos\u00a0paquetes \u00a0que\u00a0se\u00a0dise\u00f1en\u00a0en\u00a0el\u00a0marco\u00a0del\u00a0PPR\u00a0debe\u00a0contemplar \u00a0la\u00a0evoluci\u00f3n \u00a0de\u00a0la\u00a0condici\u00f3n \u00a0de\u00a0salud\u00a0\nen\u00a0las\u00a0PVV,\u00a0como\u00a0resultado \u00a0de\u00a0las\u00a0reacciones \u00a0al\u00a0medicamento. \u00a0\n\uf02d La\u00a0funci\u00f3n\u00a0de\u00a0las\u00a0consejer\u00edas \u00a0que\u00a0se\u00a0brinda\u00a0en\u00a0los\u00a0CERITS\u00a0y\u00a0UAMP,\u00a0en\u00a0adici\u00f3n\u00a0al\u00a0tema\u00a0de\u00a0prevenci\u00f3n \u00a0en\u00a0\nITS,\u00a0tambi\u00e9n\u00a0est\u00e1\u00a0orientada \u00a0a\u00a0reforzar\u00a0la\u00a0autoestima \u00a0de\u00a0las\u00a0trabajadoras \u00a0sexuales\u00a0y\u00a0en\u00a0el\u00a0caso\u00a0de\u00a0los\u00a0HSH\u00a0\na\u00a0apoyarlos \u00a0en\u00a0la\u00a0construcci\u00f3n \u00a0de\u00a0una\u00a0nueva\u00a0identidad \u00a0sexual\u00a0dentro\u00a0de\u00a0la\u00a0diversidad \u00a0homosexual \u00a0(\u00a060\u00a0)\u00a0\u00a0\npara\u00a0este\u00a0fin\u00a0se\u00a0requiere\u00a0reforzar\u00a0con\u00a0sic\u00f3logos\u00a0y\u00a0siquiatras, \u00a0sin\u00a0embargo\u00a0es\u00a0exigencia \u00a0para\u00a0la\u00a0inclusi\u00f3n\u00a0\n                                                 \n59 La\u00a0circuncisi\u00f3n \u00a0masculina \u00a0es\u00a0recomendada \u00a0para\u00a0contextos \u00a0de\u00a0elevada\u00a0prevalencia \u00a0de\u00a0VIH\u00a0en\u00a0poblaci\u00f3n \u00a0general.\u00a0\u00a0No\u00a0es\u00a0\nel\u00a0caso\u00a0del\u00a0Per\u00fa,\u00a0donde\u00a0la\u00a0evidencia \u00a0epidemiol\u00f3gica \u00a0indica\u00a0que\u00a0la\u00a0epidemia \u00a0est\u00e1\u00a0concentrada \u00a0en\u00a0los\u00a0grupos\u00a0de\u00a0alto\u00a0\nriesgo.  \n60 Fuente:\u00a0\u201cCap\u00edtulo \u00a0te\u00f3rico\u2010metodol\u00f3gico \u00a0sobre\u00a0la\u00a0incorporaci\u00f3n \u00a0del\u00a0enfoque\u00a0de\u00a0g\u00e9nero\u00a0en\u00a0\u00a0las\u00a0cuentas\u00a0\nnacionales \u00a0referidas\u00a0a\u00a0ITS\u00a0y\u00a0VIH\u00a0y\u00a0los\u00a0estudios\u00a0MEGAS\u00a0para\u00a0la\u00a0gu\u00eda\u00a0metodol\u00f3gica \u00a0sobre\u00a0MEGAS\u201d.\u00a0\u00a0En\u00a0el\u00a0\ndocumento \u00a0refieren\u00a0la\u00a0entrevista \u00a0realizada\u00a0a\u00a0los\u00a0integrantes \u00a0de\u00a0la\u00a0ESN\u00a0PC\u00a0ITS/VIH/SIDA: \u00a0\u201c\u2026..\u00a0\u00a0esta\u00a0poblaci\u00f3n \u00a0\nnecesita\u00a0un\u00a0trabajo\u00a0que\u00a0va\u00a0m\u00e1s\u00a0all\u00e1\u00a0de\u00a0la\u00a0salud\u00a0mental,\u00a0y\u00a0que\u00a0durar\u00e1\u00a0probablemente \u00a0hasta\u00a0que\u00a0logren\u00a0\nconstruirse \u00a0un\u00a0concepto\u00a0de\u00a0g\u00e9nero\u00a0en\u00a0el\u00a0que\u00a0ellos\u00a0se\u00a0sientan\u00a0c\u00f3modos, \u00a0ya\u00a0que\u00a0al\u00a0parecer\u00a0hasta\u00a0ahora\u00a0solo\u00a0\nvendr\u00edan\u00a0captando \u00a0lo\u00a0que\u00a0se\u00a0dice\u00a0de\u00a0ellos\u00a0y\u00a0que\u00a0los\u00a0relaciona\u00a0generalmente \u00a0con\u00a0comportamientos \u00a0no\u00a0\naceptados \u00a0socialmente \u00a0y\u00a0sobre\u00a0los\u00a0cuales\u00a0procurar\u00edan \u00a0incidir.\u00a0(\u2026)\u00a0requiere\u00a0de\u00a0terapias,\u00a0por\u00a0ello\u00a0cada\u00a0regi\u00f3n\u00a0ya\u00a0\ncuenta\u00a0con\u00a0el\u00a0presupuesto \u00a0para\u00a0contratar \u00a0un\u00a0psic\u00f3logo \u00a0para\u00a0complementar \u00a0el\u00a0trabajo\u00a0de\u00a0las\u00a0consejer\u00edas \u00a0en\u00a0\ncada\u00a0CERITS\u00a0y\u00a0UAMP,\u00a0lo\u00a0que\u00a0no\u00a0implica\u00a0que\u00a0las\u00a0acciones\u00a0ser\u00edan\u00a0las\u00a0suficientes.\u201d \u00a0\n  86 en\u00a0el\u00a0esquema\u00a0del\u00a0presupuesto \u00a0por\u00a0resultados \u00a0mostrar\u00a0evidencias \u00a0sobre\u00a0\u00a0resultados \u00a0de\u00a0las\u00a0estrategias, \u00a0\u00a0\ncuando\u00a0esta\u00a0no\u00a0puede\u00a0ser\u00a0mostrada \u00a0no\u00a0puede\u00a0ser\u00a0incluida.  \n\uf02d Sobre\u00a0este\u00a0aspecto\u00a0\u00a0debe\u00a0considerarse \u00a0que\u00a0la\u00a0formulaci\u00f3n \u00a0de\u00a0acciones\u00a0dentro\u00a0del\u00a0marco\u00a0del\u00a0\nPresupuesto \u00a0por\u00a0resultados \u00a0para\u00a0incluir\u00a0el\u00a0enfoque\u00a0de\u00a0g\u00e9nero\u00a0puede\u00a0estar\u00a0orientada \u00a0a:\u00a0\u00a0 \n(a)\u00a0Potenciar \u00a0programas \u00a0o\u00a0acciones\u00a0ya\u00a0existentes \u00a0que\u00a0abordan\u00a0la\u00a0brecha\u00a0de\u00a0g\u00e9nero\u00a0priorizada \u00a0(lo\u00a0que\u00a0\npuede\u00a0implicar\u00a0su\u00a0redise\u00f1o) \u00a0o\u00a0\u00a0\u00a0\n(b)\u00a0\u00a0Crear\u00a0un\u00a0nuevo\u00a0programa \u00a0si\u00a0se\u00a0considera \u00a0necesario \u00a0para\u00a0atender\u00a0mejor\u00a0la\u00a0brecha,\u00a0\u00a0\nEn\u00a0ambos\u00a0casos\u00a0es\u00a0necesario \u00a0generar\u00a0estudios\u00a0o\u00a0sistematizar \u00a0informaci\u00f3n \u00a0que\u00a0demuestren \u00a0las\u00a0\nevidencias \u00a0de\u00a0intervenciones. \u00a0\n\u00a0 87 \u00a0\n\u00a0\nI.\u00a0Bibliograf\u00eda \u00a0\n\u00a0\n\uf02d Banco\u00a0Mundial,\u00a0Confronting \u00a0AIDS\u00a0by\u00a0Joseph\u00a0Stiglitz,\u00a01997,\u00a0Washington, \u00a0D.C.\u00a0\n\uf02d Banco\u00a0Mundial,\u00a0Compromiso \u00a0con\u00a0los\u00a0resultados: \u00a0mejorar\u00a0la\u00a0eficacia\u00a0de\u00a0la\u00a0asistencia \u00a0en\u00a0la\u00a0lucha\u00a0contra\u00a0el\u00a0\nVIH/SIDA, \u00a02005,\u00a0Washington, \u00a0D.C.\u00a0\n\uf02d CARE,\u00a0Evaluaci\u00f3n \u00a0de\u00a0los\u00a0\u00a0sistemas\u00a0de\u00a0distribuci\u00f3n \u00a0y\u00a0almacenamiento \u00a0de\u00a0\u00a0preservativos, \u00a02008\u00a0\n\uf02d Consorcio \u00a0Abriendo \u00a0Caminos/CARE/FMSTM, \u00a0Levantamiento \u00a0de\u00a0informaci\u00f3n \u00a0presupuestal \u00a0multisectorial \u00a0\n2004,\u00a02005,\u00a0Lima\u00a0Per\u00fa\u00a0\n\uf02d Consorcio \u00a0Abriendo \u00a0Caminos\u00a0/CARE/FMSTM, \u00a0Levantamiento \u00a0de\u00a0informaci\u00f3n \u00a0presupuestal \u00a0\nmultisectorial\u201d, \u00a02004,\u00a0Lima\u00a0Per\u00fa\u00a0\n\uf02d Consorcio \u00a0Abriendo \u00a0Caminos\u00a0/CARE/FMSTM, \u00a0Sub\u2010Estudio\u00a0cuantitativo \u00a0sobre\u00a0la\u00a0inversi\u00f3n\u00a0multisectorial \u00a0\nen\u00a0VIH/SIDA\u00a0y\u00a0Tuberculosis \u00a0en\u00a0los\u00a0a\u00f1os\u00a02005\u00a0y\u00a02006,\u00a02007,\u00a0Lima\u00a0Per\u00fa\u00a0\n\uf02d Hecht,\u00a0R.\u00a0et\u00a0al\u00a0(2009)\u00a0Critical\u00a0Choices\u00a0In\u00a0Financing \u00a0The\u00a0Response \u00a0To\u00a0TheGlobal \u00a0HIV/AIDS\u00a0Pandemic. \u00a0Costs\u00a0\ncould\u00a0rise\u00a0to\u00a0$35\u00a0billion\u00a0a\u00a0year\u00a0by\u00a02031\u2014unless \u00a0the\u00a0world\u00a0takes\u00a0dramatic\u00a0steps\u00a0to\u00a0avert\u00a0the\u00a0worst\u00a0\noutcomes. \u00a0In:\u00a0HEALTH\u00a0A\u00a0F\u00a0FA\u00a0I\u00a0R\u00a0S\u00a0~\u00a0Vo\u00a0l\u00a0u\u00a0m\u00a0e\u00a02\u00a08\u00a0,\u00a0Nu\u00a0m\u00a0b\u00a0e\u00a0r\u00a06,\u00a02009.\u00a0Pages\u00a01591\u20101605.\u00a0\u00a0\u00a0\n\uf02d INPPARES, \u00a0Asociaci\u00f3n \u00a0civil\u00a0V\u00eda\u00a0Libre,\u00a0Asociaci\u00f3n \u00a0civil\u00a0Selva\u00a0amaz\u00f3nica, \u00a0Evaluaci\u00f3n \u00a0de\u00a0la\u00a0Estrategia \u00a0de\u00a0\nPEPs,\u00a02010\u00a0\n\uf02d Kusunoki, \u00a0L.\u00a0y\u00a0Navarro,\u00a0C.\u00a0(2006)\u00a0Plan\u00a0para\u00a0alcanzar\u00a0el\u00a0acceso\u00a0universal\u00a0a\u00a0la\u00a0atenci\u00f3n\u00a0integral\u00a0en\u00a0VIH/sida\u00a0\n2006\u20102010.\u00a0\u00a0Lima:\u00a0\u00a0ONUSIDA. \u00a0\n\uf02d Ley\u00a0de\u00a0Presupuesto \u00a0del\u00a0Sector\u00a0p\u00fablico\u00a0para\u00a0el\u00a0a\u00f1o\u00a02007\u00a0\u2013\u00a0Ley\u00a028927,\u00a02007\u00a0\n\uf02d Ley\u00a0Marco\u00a0de\u00a0Aseguramiento \u00a0Universal \u00a0en\u00a0Salud\u2010\u00a0Ley\u00a029344,\u00a02009\u00a0\n\uf02d Ley\u00a0de\u00a0Bases\u00a0de\u00a0la\u00a0Descentralizaci\u00f3n \u00a0\u2010\u00a0Ley\u00a027783,\u00a02002\u00a0\n\uf02d Ley\u00a0de\u00a0Transparencia \u00a0y\u00a0acceso\u00a0a\u00a0la\u00a0Informaci\u00f3n \u00a0p\u00fablica\u00a0\u2010\u00a0Ley\u00a0\u00a027806,\u00a02002\u00a0\n\uf02d Ley\u00a0del\u00a0Ministerio \u00a0de\u00a0Salud\u00a0\u2010\u00a0Ley\u00a027657,\u00a02002\u00a0\n\uf02d Ley\u00a0que\u00a0exonera\u00a0del\u00a0pago\u00a0del\u00a0impuesto \u00a0general\u00a0a\u00a0las\u00a0ventas\u00a0y\u00a0de\u00a0los\u00a0derechos\u00a0arancelarios \u00a0a\u00a0los\u00a0\nmedicamentos \u00a0para\u00a0tratamiento \u00a0oncol\u00f3gico \u00a0y\u00a0VIH/SIDA\u00a0\u2010\u00a0Ley\u00a027450,\u00a02005\u00a0\n\uf02d MINSA\u00a0\u2010OGPP\u00a0/\u00a0CIES.\u00a0\u00a0Observatorio \u00a0de\u00a0la\u00a0Salud,\u00a0Cuentas\u00a0Nacionales \u00a0de\u00a0Salud\u00a01995\u20102005,\u00a02008,\u00a0Lima\u00a0\nPer\u00fa\u00a0\n\uf02d MINSA,\u00a0Plan\u00a0Estrat\u00e9gico \u00a0Multisectorial \u00a02007\u20102011\u00a0para\u00a0la\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0de\u00a0las\u00a0ITS,\u00a0VIH\u00a0y\u00a0SIDA,\u00a0\n2007,\u00a0Per\u00fa\u00a0\n\uf02d MINSA,\u00a0Resoluci\u00f3n \u00a0ministerial \u00a0752\u20102004/MINSA, \u00a0\u00a0\"Norma\u00a0T\u00e9cnica\u00a0para\u00a0la\u00a0Adherencia \u00a0al\u00a0Tratamiento \u00a0\nAntirretroviral \u00a0de\u00a0Gran\u00a0Actividad \u2010TARGA\u00a0\u2010\u00a0en\u00a0adultos\u00a0infectados \u00a0por\u00a0el\u00a0virus\u00a0de\u00a0la\u00a0inmunodeficiencia \u00a0\nhumana\", \u00a08\u00a0enero\u00a0del\u00a02004\u00a0\n\uf02d MINSA,\u00a0Decreto\u00a0supremo\u00a0N\u00b0\u00a0013\u20102003\u2010SA,\u00a0Reglamento \u00a0de\u00a0\u00a0la\u00a0Ley\u00a0N\u00b0\u00a027657\u00a0\u2010\u00a0Ley\u00a0del\u00a0Ministerio \u00a0de\u00a0Salud,\u00a0\n2003\u00a0\n\uf02d \u00a0MINSA,\u00a0Decreto\u00a0supremo\u00a0N\u00ba\u00a0017\u20102006\u2010SA,\u00a0\u00a0Reglamento \u00a0de\u00a0ensayos\u00a0cl\u00ednicos\u00a0en\u00a0el\u00a0Per\u00fa,\u00a02006\u00a0\n\uf02d OIT,\u00a0Encuesta\u00a0personas\u00a0que\u00a0viven\u00a0con\u00a0VIH\u00a0sobre\u00a0su\u00a0condici\u00f3n \u00a0laboral\u00a0en\u00a0Lima\u00a0y\u00a0Callao,\u00a02009\u00a0\n\uf02d ONUSIDA, \u00a0Informe\u00a0UNGASS,\u00a02008\u00a0\n\uf02d ONUSIDA, \u00a0MEGAS,\u00a0Medici\u00f3n \u00a0del\u00a0gasto\u00a0en\u00a0SIDA:\u00a0Clasificaci\u00f3n \u00a0y\u00a0definiciones, \u00a02009\u00a0\n\uf02d ONUSIDA, \u00a0Medici\u00f3n \u00a0de\u00a0Gasto\u00a0en\u00a0SIDA\u00a0en\u00a0el\u00a0Per\u00fa\u00a0\u00a0\u2013\u00a0MEGAS\u00a02005\u00a0al\u00a02007,\u00a02008,\u00a0Lima\u00a0Per\u00fa\u00a0\n\uf02d Schwartl\u00e4nder, \u00a0B.,\u00a0Stover,\u00a0J.\u00a0et\u00a0al\u00a0(2011)\u00a0Towards\u00a0an\u00a0improved \u00a0investment \u00a0approach \u00a0for\u00a0an\u00a0eff\u00a0ective\u00a0\nresponse\u00a0to\u00a0HIV/AIDS. \u00a0\u00a0\u00a0In:\u00a0\u00a0Health\u00a0Policy.\u00a0\u00a0www.thelancet.com \u00a0Published \u00a0online\u00a0June\u00a03,\u00a02011\u00a0\nDOI:10.1016/S0140 \u20106736(11)60702 \u20102\u00a0\n\uf02d SIDALAC/FUNSALUD, \u00a0Flujo\u00a0de\u00a0financiamiento \u00a0y\u00a0gasto\u00a0en\u00a0VIH\u00a0SIDA\u00a0\u2013\u00a0Cuentas\u00a0Nacionales \u00a0en\u00a0VIH\u00a0SIDA,\u00a0\n1999\u20102000,\u00a02001,\u00a0Per\u00fa\u00a0\u00a0\n\u00a0 88 \u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\u00a0\nAnexos\u00a0 89 \u00a0\n\u00a0\n\u00a0\nAnexo\u00a01\u00a0\u2013\u00a0Definiciones \u00a0(61\u00a0)\u00a0\n\u00a0\nEn\u00a0la\u00a0Medici\u00f3n \u00a0de\u00a0gasto\u00a0en\u00a0SIDA,\u00a0los\u00a0gastos\u00a0y\u00a0flujos\u00a0financieros \u00a0relacionados \u00a0con\u00a0la\u00a0respuesta \u00a0nacional\u00a0al\u00a0VIH\u00a0\nse\u00a0organizan \u00a0en\u00a0tres\u00a0dimensiones: \u00a0financiaci\u00f3n, \u00a0provisi\u00f3n\u00a0y\u00a0consumo. \u00a0La\u00a0clasificaci\u00f3n \u00a0de\u00a0las\u00a0tres\u00a0dimensiones \u00a0\ny\u00a0las\u00a0seis\u00a0categor\u00edas \u00a0conforman \u00a0el\u00a0marco\u00a0del\u00a0sistema\u00a0MEGAS.\u00a0Estas\u00a0dimensiones \u00a0incorporan \u00a0seis\u00a0categor\u00edas: \u00a0\n\u00a0\nFinanciaci\u00f3n \u00a0 1.\u00a0Los\u00a0agentes\u00a0de\u00a0financiaci\u00f3n \u00a0(FA)\u00a0son\u00a0entidades \u00a0que\u00a0combinan \u00a0recursos\u00a0financieros \u00a0\npara\u00a0costear\u00a0los\u00a0programas \u00a0de\u00a0prestaci\u00f3n \u00a0de\u00a0servicios\u00a0y\u00a0tambi\u00e9n\u00a0para\u00a0tomar\u00a0\ndecisiones \u00a0program\u00e1ticas \u00a0(comprador \u2010agente).\u00a0\n2.\u00a0Las\u00a0fuentes\u00a0de\u00a0financiaci\u00f3n \u00a0(FS)\u00a0son\u00a0entidades \u00a0que\u00a0proporcionan \u00a0dinero\u00a0a\u00a0los\u00a0\nagentes\u00a0de\u00a0financiaci\u00f3n. \u00a0\nProvisi\u00f3n\u00a0de\u00a0\nservicios\u00a0para\u00a0el\u00a0\nVIH\u00a03.\u00a0Los\u00a0proveedores \u00a0(PS)\u00a0son\u00a0entidades \u00a0que\u00a0participan \u00a0en\u00a0la\u00a0producci\u00f3n, \u00a0la\u00a0provisi\u00f3n\u00a0y\u00a0\nla\u00a0prestaci\u00f3n \u00a0de\u00a0servicios\u00a0del\u00a0VIH.\u00a0\n4.\u00a0Los\u00a0factores\u00a0de\u00a0producci\u00f3n/costos \u00a0de\u00a0recursos\u00a0(PF)\u00a0son\u00a0insumos\u00a0(mano\u00a0de\u00a0obra,\u00a0\ncapital,\u00a0recursos\u00a0naturales, \u00a0conocimiento \u00a0t\u00e9cnico\u00a0y\u00a0recursos\u00a0empresariales). \u00a0\nUso\u00a0 5.\u00a0Las\u00a0categor\u00edas \u00a0de\u00a0gasto\u00a0relativo\u00a0al\u00a0sida\u00a0(ASC)\u00a0son\u00a0intervenciones \u00a0y\u00a0actividades \u00a0\nrelacionadas \u00a0con\u00a0el\u00a0VIH.\u00a0\n6.\u00a0Los\u00a0segmentos \u00a0beneficiarios \u00a0de\u00a0la\u00a0poblaci\u00f3n \u00a0(BP),\u00a0es\u00a0decir,\u00a0hombres\u00a0que\u00a0tienen\u00a0\nrelaciones \u00a0sexuales\u00a0con\u00a0hombres, \u00a0consumidores \u00a0de\u00a0drogas\u00a0inyectables, \u00a0etc.\u00a0\n\u00a0\nCategor\u00edas \u00a0de\u00a0gasto\u00a0\n\u00a0\n1. Prevenci\u00f3n \u00a0\nLa\u00a0prevenci\u00f3n \u00a0se\u00a0define\u00a0como\u00a0un\u00a0conjunto\u00a0integral\u00a0de\u00a0actividades \u00a0o\u00a0programas \u00a0dise\u00f1ado\u00a0para\u00a0reducir\u00a0el\u00a0\ncomportamiento \u00a0de\u00a0riesgo.\u00a0Entre\u00a0los\u00a0resultados \u00a0se\u00a0encuentran \u00a0una\u00a0disminuci\u00f3n \u00a0en\u00a0las\u00a0infecciones \u00a0por\u00a0el\u00a0VIH\u00a0\nentre\u00a0la\u00a0poblaci\u00f3n \u00a0y\u00a0mejoras\u00a0en\u00a0la\u00a0calidad\u00a0y\u00a0la\u00a0seguridad \u00a0en\u00a0los\u00a0centros\u00a0de\u00a0salud\u00a0con\u00a0respecto\u00a0a\u00a0las\u00a0terapias\u00a0\nadministradas \u00a0en\u00a0forma\u00a0exclusiva\u00a0o\u00a0en\u00a0gran\u00a0medida\u00a0a\u00a0pacientes \u00a0con\u00a0VIH.\u00a0Los\u00a0servicios\u00a0de\u00a0prevenci\u00f3n \u00a0\ncomprenden \u00a0el\u00a0desarrollo, \u00a0la\u00a0difusi\u00f3n\u00a0y\u00a0la\u00a0evaluaci\u00f3n \u00a0de\u00a0material\u00a0adaptado \u00a0desde\u00a0el\u00a0punto\u00a0de\u00a0vista\u00a0\nling\u00fc\u00edstico, \u00a0cultural\u00a0y\u00a0de\u00a0la\u00a0edad\u00a0para\u00a0complementar \u00a0los\u00a0objetivos\u00a0del\u00a0programa. \u00a0\n\u00a0\n2. Atenci\u00f3n\u00a0y\u00a0tratamiento \u00a0\nAtenci\u00f3n\u00a0y\u00a0tratamiento \u00a0hace\u00a0referencia \u00a0a\u00a0todos\u00a0los\u00a0gastos,\u00a0las\u00a0compras,\u00a0las\u00a0transferencias \u00a0y\u00a0la\u00a0inversi\u00f3n\u00a0en\u00a0\nlos\u00a0que\u00a0se\u00a0incurri\u00f3\u00a0para\u00a0brindar\u00a0acceso\u00a0a\u00a0actividades \u00a0en\u00a0dispensarios, \u00a0hogares\u00a0o\u00a0la\u00a0comunidad \u00a0para\u00a0el\u00a0\ntratamiento \u00a0y\u00a0la\u00a0atenci\u00f3n\u00a0de\u00a0adultos\u00a0y\u00a0ni\u00f1os\u00a0VIH\u2010positivos. \u00a0El\u00a0componente \u00a0de\u00a0tratamiento \u00a0y\u00a0atenci\u00f3n\u00a0incluye\u00a0\nlas\u00a0siguientes \u00a0intervenciones \u00a0y\u00a0actividades. \u00a0\n\u00a0\n3. Hu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0vulnerables \u00a0\nUn\u00a0hu\u00e9rfano\u00a0se\u00a0define\u00a0como\u00a0un\u00a0menor\u00a0de\u00a018\u00a0a\u00f1os\u00a0que\u00a0ha\u00a0perdido\u00a0a\u00a0uno\u00a0o\u00a0ambos\u00a0progenitores, \u00a0\nindependientemente \u00a0del\u00a0apoyo\u00a0econ\u00f3mico \u00a0(ya\u00a0sea\u00a0que\u00a0se\u00a0relacione \u00a0o\u00a0no\u00a0con\u00a0el\u00a0programa \u00a0nacional\u00a0de\u00a0sida).\u00a0\nEn\u00a0el\u00a0contexto\u00a0de\u00a0las\u00a0MEGAS,\u00a0deben\u00a0incluirse\u00a0todos\u00a0los\u00a0gastos\u00a0para\u00a0sustituir\u00a0a\u00a0los\u00a0padres\u00a0en\u00a0el\u00a0cuidado\u00a0de\u00a0sus\u00a0\nhijos\u00a0porque\u00a0han\u00a0fallecido\u00a0a\u00a0causa\u00a0del\u00a0VIH;\u00a0gastos\u00a0incurridos \u00a0para\u00a0proporcionar \u00a0mitigaci\u00f3n \u00a0social\u00a0a\u00a0todos\u00a0los\u00a0\nhu\u00e9rfanos \u00a0dobles\u00a0y\u00a0la\u00a0mitad\u00a0de\u00a0los\u00a0hu\u00e9rfanos \u00a0o\u00a0los\u00a0hu\u00e9rfanos \u00a0de\u00a0un\u00a0solo\u00a0progenitor. \u00a0En\u00a0este\u00a0contexto, \u00a0ni\u00f1os\u00a0\nvulnerables \u00a0se\u00a0refiere\u00a0a\u00a0aquellos\u00a0que\u00a0est\u00e1n\u00a0pr\u00f3ximos \u00a0a\u00a0quedar\u00a0hu\u00e9rfanos \u00a0y\u00a0que\u00a0no\u00a0reciben\u00a0apoyo\u00a0como\u00a0tales\u00a0\nporque\u00a0al\u00a0menos\u00a0uno\u00a0de\u00a0sus\u00a0progenitores \u00a0est\u00e1\u00a0con\u00a0vida\u00a0pero\u00a0gravemente \u00a0enfermo\u00a0para\u00a0cuidarlos. \u00a0\n                                                 \n61 Programa \u00a0Conjunto\u00a0de\u00a0las\u00a0Naciones\u00a0Unidas\u00a0sobre\u00a0el\u00a0VIH/Sida\u00a0(ONUSIDA), \u00a0MEGAS\u00a0Medici\u00f3n \u00a0del\u00a0Gasto\u00a0en\u00a0Sida:\u00a0\nClasificaci\u00f3n \u00a0y\u00a0definiciones, \u00a02009  90 \u00a0\n4. Gesti\u00f3n\u00a0y\u00a0administraci\u00f3n \u00a0de\u00a0programas \u00a0\nLos\u00a0gastos\u00a0program\u00e1ticos \u00a0se\u00a0definen\u00a0como\u00a0aquellos\u00a0incurridos \u00a0en\u00a0los\u00a0niveles\u00a0administrativos \u00a0fuera\u00a0del\u00a0punto\u00a0\nde\u00a0prestaci\u00f3n \u00a0de\u00a0la\u00a0atenci\u00f3n\u00a0sanitaria.\u00a0Los\u00a0gastos\u00a0program\u00e1ticos \u00a0cubren\u00a0servicios\u00a0como\u00a0la\u00a0gesti\u00f3n\u00a0de\u00a0\nprogramas \u00a0de\u00a0sida,\u00a0vigilancia\u00a0y\u00a0evaluaci\u00f3n \u00a0(V+E),\u00a0sensibilizaci\u00f3n, \u00a0capacitaci\u00f3n \u00a0previa\u00a0al\u00a0servicio\u00a0y\u00a0mejora\u00a0de\u00a0\ninstalaciones \u00a0a\u00a0trav\u00e9s\u00a0de\u00a0la\u00a0compra\u00a0de\u00a0equipos\u00a0de\u00a0laboratorio \u00a0y\u00a0telecomunicaciones. \u00a0\u00a0Abarca\u00a0inversiones \u00a0de\u00a0\nm\u00e1s\u00a0largo\u00a0plazo,\u00a0como\u00a0construcci\u00f3n \u00a0de\u00a0servicios\u00a0sanitarios, \u00a0que\u00a0benefician \u00a0al\u00a0sistema\u00a0de\u00a0salud\u00a0en\u00a0conjunto. \u00a0\u00a0\n\u00a05. Recursos\u00a0humanos \u00a0\nSe\u00a0refiere\u00a0a\u00a0los\u00a0servicios\u00a0de\u00a0la\u00a0fuerza\u00a0laboral\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0enfoques \u00a0para\u00a0la\u00a0capacitaci\u00f3n,\n\u00a0la\u00a0contrataci\u00f3n, \u00a0la\u00a0\nretenci\u00f3n, \u00a0el\u00a0despliegue \u00a0y\u00a0la\u00a0recompensa \u00a0por\u00a0buen\u00a0desempe\u00f1o \u00a0de\u00a0directores \u00a0y\u00a0trabajadores \u00a0sanitarios \u00a0por\u00a0el\u00a0\ntrabajo\u00a0en\u00a0el\u00a0campo\u00a0del\u00a0VIH.\u00a0\u00a0La\u00a0fuerza\u00a0laboral\u00a0relacionada \u00a0con\u00a0el\u00a0VIH\u00a0no\u00a0se\u00a0limita\u00a0al\u00a0sistema\u00a0de\u00a0salud.\u00a0En\u00a0\nesta\u00a0categor\u00eda \u00a0se\u00a0incluye\u00a0el\u00a0pago\u00a0directo\u00a0de\u00a0beneficios \u00a0salariales\u00a0para\u00a0trabajadores \u00a0sanitarios. \u00a0Estos\u00a0gastos\u00a0\ntienen\u00a0como\u00a0finalidad\u00a0garantizar \u00a0la\u00a0disponibilidad \u00a0de\u00a0recursos\u00a0humanos \u00a0a\u00a0partir\u00a0de\u00a0los\u00a0existentes \u00a0\nactualmente \u00a0en\u00a0el\u00a0sector\u00a0salud.\u00a0Por\u00a0lo\u00a0tanto,\u00a0s\u00f3lo\u00a0apuntan\u00a0a\u00a0incluir\u00a0los\u00a0incentivos \u00a0adicionales \u00a0para\u00a0este\u00a0\nprop\u00f3sito. \u00a0El\u00a0costo\u00a0directo\u00a0asociado\u00a0con\u00a0los\u00a0recursos\u00a0humanos \u00a0se\u00a0incluye\u00a0en\u00a0los\u00a0costos\u00a0de\u00a0cada\u00a0una\u00a0de\u00a0las\u00a0\ndem\u00e1s\u00a0categor\u00edas \u00a0de\u00a0gasto.\u00a0\n\u00a0\n6. Protecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\nSe\u00a0refiere\u00a0a\u00a0las\u00a0funciones \u00a0de\u00a0organizaciones \u00a0gubernamentales \u00a0o\u00a0no\u00a0gubernamentales \u00a0relativas\u00a0a\u00a0la\u00a0provisi\u00f3n\u00a0\nde\u00a0beneficios \u00a0monetarios \u00a0y\u00a0beneficios \u00a0en\u00a0especie\u00a0a\u00a0categor\u00edas \u00a0de\u00a0personas\u00a0definidas\u00a0por\u00a0determinados \u00a0\nrequisitos \u00a0como\u00a0enfermedad, \u00a0vejez,\u00a0incapacidad, \u00a0desempleo, \u00a0exclusi\u00f3n \u00a0social,\u00a0etc.\u00a0La\u00a0protecci\u00f3n \u00a0social\u00a0\ncomprende \u00a0los\u00a0servicios\u00a0sociales\u00a0personales \u00a0y\u00a0la\u00a0seguridad \u00a0social.\u00a0Incluye\u00a0gastos\u00a0en\u00a0servicios\u00a0y\u00a0transferencias \u00a0\nproporcionados \u00a0no\u00a0s\u00f3lo\u00a0a\u00a0personas\u00a0individuales \u00a0sino\u00a0tambi\u00e9n\u00a0a\u00a0hogares,\u00a0adem\u00e1s\u00a0de\u00a0los\u00a0gastos\u00a0por\u00a0servicios\u00a0\nprestados \u00a0en\u00a0forma\u00a0colectiva. \u00a0\n\u00a0\n7. Entorno\u00a0favorable \u00a0\nIncluye\u00a0un\u00a0conjunto\u00a0completo \u00a0de\u00a0servicios\u00a0que\u00a0generan\u00a0un\u00a0espectro\u00a0m\u00e1s\u00a0amplio\u00a0y\u00a0de\u00a0mayor\u00a0alcance\u00a0de\u00a0\napoyo\u00a0de\u00a0los\u00a0principios \u00a0clave\u00a0y\u00a0las\u00a0acciones\u00a0esenciales \u00a0para\u00a0promover \u00a0la\u00a0prevenci\u00f3n \u00a0del\u00a0VIH\u00a0y\u00a0reducir\u00a0el\u00a0\nestigma\u00a0y\u00a0la\u00a0discriminaci\u00f3n. \u00a0\u00a0\nTambi\u00e9n\u00a0incluye:\u00a0programas \u00a0de\u00a0derechos\u00a0humanos \u00a0que\u00a0faculten\u00a0a\u00a0las\u00a0personas\u00a0a\u00a0reivindicar \u00a0sus\u00a0derechos\u00a0\nbrind\u00e1ndoles \u00a0conocimiento \u00a0y\u00a0compresi\u00f3n \u00a0de\u00a0sus\u00a0derechos\u00a0y\u00a0responsabilidades \u00a0en\u00a0virtud\u00a0de\u00a0los\u00a0derechos\u00a0\nhumanos \u00a0o\u00a0los\u00a0sistemas\u00a0jur\u00eddicos\u00a0nacionales; \u00a0provisi\u00f3n\u00a0de\u00a0servicios\u00a0jur\u00eddicos\u00a0y\u00a0asesoramiento \u00a0para\u00a0promover \u00a0\nel\u00a0acceso\u00a0a\u00a0la\u00a0prevenci\u00f3n, \u00a0la\u00a0atenci\u00f3n\u00a0y\u00a0el\u00a0tratamiento; \u00a0desarrollo \u00a0de\u00a0la\u00a0capacidad \u00a0en\u00a0derechos\u00a0humanos; \u00a0\nprogramas \u00a0espec\u00edficos \u00a0del\u00a0sida\u00a0orientados \u00a0a\u00a0las\u00a0mujeres\u00a0como\u00a0actividades \u00a0mejoradas \u00a0de\u00a0salud\u00a0reproductiva \u00a0y\u00a0\nprogramas \u00a0para\u00a0reducir\u00a0la\u00a0violencia\u00a0de\u00a0g\u00e9nero.\u00a0\u00a0\n\u00a0\n8. Investigaci\u00f3n \u00a0relacionada \u00a0con\u00a0el\u00a0VIH\u00a0\nLa\u00a0investigaci\u00f3n \u00a0relacionada \u00a0con\u00a0el\u00a0VIH\u00a0se\u00a0define\u00a0como\u00a0la\u00a0generaci\u00f3n \u00a0de\u00a0conocimiento \u00a0que\u00a0puede\u00a0utilizarse\u00a0\npara\u00a0prevenir\u00a0la\u00a0enfermedad \u00a0y\u00a0promover, \u00a0restablecer, \u00a0mantener, \u00a0proteger\u00a0y\u00a0mejorar\u00a0el\u00a0desarrollo \u00a0de\u00a0la\u00a0\npoblaci\u00f3n \u00a0y\u00a0el\u00a0bienestar \u00a0de\u00a0las\u00a0personas. \u00a0\u00a0Cubre\u00a0los\u00a0investigadores \u00a0y\u00a0profesionales \u00a0que\u00a0participan \u00a0en\u00a0la\u00a0\nconcepci\u00f3n \u00a0o\u00a0creaci\u00f3n\u00a0de\u00a0nuevos\u00a0conocimientos, \u00a0productos, \u00a0procesos, \u00a0m\u00e9todos\u00a0y\u00a0sistemas\u00a0para\u00a0el\u00a0VIH\u00a0y\u00a0en\u00a0\nla\u00a0gesti\u00f3n\u00a0de\u00a0programas \u00a0dedicados \u00a0al\u00a0VIH\u00a0y\u00a0el\u00a0sida.\u00a0Tambi\u00e9n\u00a0deben\u00a0incluirse\u00a0los\u00a0directores \u00a0y\u00a0administradores \u00a0\ncuando\u00a0dedican\u00a0al\u00a0menos\u00a010%\u00a0de\u00a0su\u00a0tiempo\u00a0en\u00a0apoyo\u00a0de\u00a0las\u00a0actividades \u00a0de\u00a0investigaci\u00f3n. \u00a0Los\u00a0investigadores \u00a0\nincluyen\u00a0estudiantes \u00a0de\u00a0posgrado \u00a0pero\u00a0no\u00a0t\u00e9cnicos.\u00a0Los\u00a0t\u00e9cnicos\u00a0y\u00a0personal\u00a0equivalente \u00a0son\u00a0personas\u00a0cuyas\u00a0\ntareas\u00a0principales \u00a0requieren \u00a0conocimiento \u00a0t\u00e9cnico\u00a0y\u00a0experiencia. \u00a0Participan \u00a0en\u00a0I+D\u00a0realizando \u00a0tareas\u00a0\ncient\u00edficas \u00a0y\u00a0t\u00e9cnicas\u00a0que\u00a0implican\u00a0la\u00a0aplicaci\u00f3n \u00a0de\u00a0conceptos \u00a0y\u00a0m\u00e9todos\u00a0operativos, \u00a0normalmente \u00a0bajo\u00a0la\u00a0\nsupervisi\u00f3n \u00a0de\u00a0los\u00a0investigadores. \u00a0Esta\u00a0categor\u00eda \u00a0excluye\u00a0la\u00a0investigaci\u00f3n \u00a0de\u00a0operaciones \u00a0sobre\u00a0sistemas\u00a0\nsanitarios \u00a0con\u00a0el\u00a0objeto\u00a0de\u00a0mejorar\u00a0los\u00a0resultados. \u00a0\n\u00a0\u00a0\n\u00a0\nAseguramiento \u00a0universal \u00a0en\u00a0salud\u00a0 91 El\u00a0aseguramiento \u00a0universal\u00a0es\u00a0un\u00a0proceso\u00a0orientado \u00a0a\u00a0lograr\u00a0que\u00a0toda\u00a0la\u00a0poblaci\u00f3n \u00a0residente \u00a0en\u00a0el\u00a0territorio\u00a0\nnacional\u00a0disponga\u00a0de\u00a0un\u00a0seguro\u00a0de\u00a0salud\u00a0que\u00a0le\u00a0permita\u00a0acceder\u00a0a\u00a0un\u00a0conjunto\u00a0de\u00a0prestaciones \u00a0de\u00a0salud\u00a0de\u00a0\ncar\u00e1cter\u00a0preventivo, \u00a0promocional, \u00a0recuperativo \u00a0y\u00a0de\u00a0rehabilitaci\u00f3n, \u00a0en\u00a0condiciones \u00a0adecuadas \u00a0de\u00a0eficiencia, \u00a0\nequidad,\u00a0oportunidad, \u00a0calidad\u00a0y\u00a0dignidad, \u00a0sobre\u00a0la\u00a0base\u00a0del\u00a0Plan\u00a0Esencial\u00a0de\u00a0Aseguramiento \u00a0en\u00a0Salud\u00a0(PEAS).\u00a0\n\u00a0\nLa\u00a0Ley\u00a0Marco\u00a0de\u00a0Aseguramiento \u00a0Universal \u00a0en\u00a0Salud\u00a0(LMAUS)\u00a0y\u00a0su\u00a0reglamento \u00a0establecen \u00a0normas\u00a0para\u00a0la\u00a0\nregulaci\u00f3n, \u00a0financiamiento, \u00a0prestaci\u00f3n \u00a0y\u00a0supervisi\u00f3n \u00a0del\u00a0Aseguramiento \u00a0en\u00a0Salud,\u00a0con\u00a0criterio\u00a0de\u00a0\nprogresividad \u00a0y\u00a0en\u00a0el\u00a0marco\u00a0del\u00a0proceso\u00a0de\u00a0descentralizaci\u00f3n. \u00a0\u00a0Tambi\u00e9n\u00a0establece \u00a0mecanismos \u00a0de\u00a0\narticulaci\u00f3n \u00a0e\u00a0integraci\u00f3n \u00a0de\u00a0los\u00a0agentes\u00a0que\u00a0participan, \u00a0as\u00ed\u00a0como\u00a0el\u00a0intercambio \u00a0de\u00a0informaci\u00f3n, \u00a0sistema\u00a0de\u00a0\nreferencia, \u00a0est\u00e1ndares, \u00a0r\u00e9gimen\u00a0de\u00a0sanciones \u00a0y\u00a0mecanismos \u00a0de\u00a0soluci\u00f3n\u00a0de\u00a0controversias. \u00a0\u00a0\u00a0\n\u00a0\nLa\u00a0implementaci\u00f3n \u00a0de\u00a0un\u00a0plan\u00a0b\u00e1sico\u00a0de\u00a0salud\u00a0(PEAS)\u00a0bajo\u00a0un\u00a0sistema\u00a0de\u00a0aseguramiento \u00a0universal\u00a0a\u00a0toda\u00a0la\u00a0\npoblaci\u00f3n \u00a0hace\u00a0necesaria \u00a0un\u00a0buen\u00a0manejo\u00a0de\u00a0informaci\u00f3n \u00a0para\u00a0evitar\u00a0subsidios\u00a0cruzados\u00a0y\u00a0optimizar \u00a0el\u00a0\nsistema\u00a0de\u00a0referencia, \u00a0as\u00ed\u00a0como\u00a0permitir\u00a0el\u00a0intercambio \u00a0de\u00a0prestaciones \u00a0entre\u00a0las\u00a0instituciones \u00a0\naseguradoras, \u00a0por\u00a0lo\u00a0cual\u00a0\u00a0se\u00a0requiere:\u00a0\n\uf02d Establecer \u00a0un\u00a0sistema\u00a0estandarizado \u00a0de\u00a0Informaci\u00f3n \u00a0prestacional \u00a0basado\u00a0en\u00a0un\u00a0conjunto\u00a0m\u00ednimo\u00a0de\u00a0\ndatos\u00a0homog\u00e9neos \u00a0para\u00a0todas\u00a0las\u00a0instituciones \u00a0prestadoras \u00a0de\u00a0salud,\u00a0considerando \u00a0como\u00a0elementos \u00a0\nobligatorios \u00a0la\u00a0identificaci\u00f3n \u00a0de\u00a0la\u00a0persona\u00a0(DNI).\u00a0\n\uf02d El\u00a0uso\u00a0del\u00a0CIE\u201010\u00a0para\u00a0identificar \u00a0diagn\u00f3sticos \u00a0\u00a0y\u00a0otros\u00a0mecanismos \u00a0para\u00a0identificar \u00a0procedimientos \u00a0de\u00a0\nsalud.\u00a0\n\uf02d Contar\u00a0con\u00a0un\u00a0sistema\u00a0estandarizado \u00a0de\u00a0informaci\u00f3n \u00a0financiera \u00a0y\u00a0facturaci\u00f3n \u00a0necesaria \u00a0para\u00a0las\u00a0\nevaluaciones \u00a0de\u00a0siniestralidad, \u00a0as\u00ed\u00a0como\u00a0un\u00a0sistema\u00a0de\u00a0facturaci\u00f3n \u00a0\u00fanico\u00a0para\u00a0viabilizar\u00a0el\u00a0sistema\u00a0de\u00a0\nintercambio \u00a0de\u00a0prestaciones \u00a0entre\u00a0aseguradores. \u00a0\n\u00a0\nEntidades \u00a0Prestadoras \u00a0de\u00a0Salud\u00a0(EPS)\u00a0\nSe\u00a0crearon\u00a0en\u00a0el\u00a0marco\u00a0de\u00a0la\u00a0Ley\u00a0de\u00a0modernizaci\u00f3n \u00a0de\u00a0la\u00a0salud\u00a0en\u00a0el\u00a0a\u00f1o\u00a01997,\u00a0que\u00a0estableci\u00f3 \u00a0que\u00a0el\u00a0Seguro\u00a0\nsocial\u00a0de\u00a0salud\u00a0(ESSALUD) \u00a0\u00a0otorga\u00a0cobertura \u00a0a\u00a0sus\u00a0asegurados \u00a0y\u00a0se\u00a0complementa \u00a0con\u00a0los\u00a0planes\u00a0y\u00a0programas \u00a0\nde\u00a0salud,\u00a0brindados \u00a0por\u00a0la\u00a0Entidades \u00a0Prestadoras \u00a0de\u00a0Salud\u00a0(EPS)\u00a0\u00a0debidamente \u00a0acreditadas. \u00a0Las\u00a0EPS\u00a0son\u00a0\nempresas \u00a0e\u00a0instituciones \u00a0p\u00fablicas\u00a0o\u00a0privadas,\u00a0distintas\u00a0a\u00a0ESSALUD, \u00a0cuyo\u00a0\u00fanico\u00a0fin\u00a0es\u00a0prestar\u00a0servicios\u00a0de\u00a0\natenci\u00f3n\u00a0de\u00a0salud,\u00a0con\u00a0infraestructura \u00a0propia\u00a0y/o\u00a0de\u00a0terceros,\u00a0sujet\u00e1ndose \u00a0a\u00a0los\u00a0controles \u00a0de\u00a0la\u00a0SUNASA.\u00a0Las\u00a0\nEPS\u00a0se\u00a0constituyen \u00a0como\u00a0personas\u00a0jur\u00eddicas,\u00a0organizadas \u00a0de\u00a0acuerdo\u00a0a\u00a0la\u00a0legislaci\u00f3n \u00a0peruana,\u00a0previa\u00a0\nautorizaci\u00f3n \u00a0de\u00a0organizaci\u00f3n \u00a0otorgada\u00a0por\u00a0la\u00a0SUNASA.\u00a0Para\u00a0el\u00a0inicio\u00a0de\u00a0sus\u00a0operaciones, \u00a0solicita\u00a0la\u00a0\nautorizaci\u00f3n \u00a0de\u00a0funcionamiento, \u00a0una\u00a0vez\u00a0cumplidos \u00a0los\u00a0requisitos \u00a0m\u00ednimos\u00a0establecidos \u00a0en\u00a0la\u00a0Ley\u00a0n\u00b0\u00a026790\u00a0y\u00a0\nsu\u00a0Reglamento. \u00a0\u00a0\n\u00a0\nEpidemia \u00a0concentrada, \u00a0generalizada \u00a0e\u00a0incipiente \u00a0(\u00a062\u00a0)\u00a0\nLos\u00a0epidemi\u00f3logos \u00a0han\u00a0clasificado \u00a0los\u00a0pa\u00edses\u00a0seg\u00fan\u00a0el\u00a0grado\u00a0de\u00a0infecci\u00f3n\u00a0de\u00a0diferentes \u00a0grupos\u00a0de\u00a0la\u00a0\npoblaci\u00f3n. \u00a0En\u00a0pa\u00edses\u00a0con\u00a0una\u00a0epidemia \u00a0incipiente, \u00a0la\u00a0propagaci\u00f3n \u00a0del\u00a0VIH\u00a0est\u00e1\u00a0pendiente, \u00a0aun\u00a0entre\u00a0quienes\u00a0\ntienen\u00a0patrones\u00a0de\u00a0comportamiento \u00a0de\u00a0alto\u00a0riesgo.\u00a0Una\u00a0epidemia \u00a0est\u00e1\u00a0concentrada \u00a0cuando\u00a0los\u00a0niveles\u00a0de\u00a0\ninfecci\u00f3n\u00a0han\u00a0aumentado \u00a0considerablemente \u00a0entre\u00a0las\u00a0personas\u00a0con\u00a0comportamiento \u00a0de\u00a0alto\u00a0riesgo,\u00a0pero\u00a0\ntodav\u00eda\u00a0est\u00e1\u00a0por\u00a0aumentar \u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0en\u00a0general\u00a0que\u00a0es\u00a0m\u00e1s\u00a0numerosa \u00a0y\u00a0est\u00e1\u00a0expuesta\u00a0a\u00a0poco\u00a0riesgo.\u00a0\nUna\u00a0epidemia \u00a0generalizada \u00a0es\u00a0aquella\u00a0en\u00a0que\u00a0el\u00a0VIH\u00a0se\u00a0ha\u00a0trasladado \u00a0de\u00a0las\u00a0poblaciones \u00a0con\u00a0\ncomportamiento \u00a0de\u00a0alto\u00a0riesgo\u00a0y\u00a0pasa\u00a0a\u00a0infectar\u00a0considerablemente \u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0expuesta\u00a0a\u00a0poco\u00a0riesgo.\u00a0\u00a0\nEn\u00a0realidad,\u00a0hay\u00a0un\u00a0continuo\u00a0en\u00a0las\u00a0tasas\u00a0de\u00a0infecci\u00f3n\u00a0en\u00a0diferentes \u00a0grupos;\u00a0estas\u00a0\u201cetapas\u201d\u00a0se\u00a0presentan \u00a0con\u00a0\nla\u00a0intenci\u00f3n \u00a0de\u00a0destacar\u00a0el\u00a0punto\u00a0en\u00a0que\u00a0se\u00a0encuentra \u00a0una\u00a0epidemia \u00a0en\u00a0relaci\u00f3n\u00a0con\u00a0ese\u00a0continuo. \u00a0\u00a0\n\u00a0\nEl\u00a0Banco\u00a0Mundial\u00a0utiliza\u00a0las\u00a0siguientes \u00a0definiciones: \u00a0una\u00a0epidemia \u00a0incipiente \u00a0se\u00a0define\u00a0como\u00a0aquella\u00a0en\u00a0que\u00a0\nla\u00a0prevalencia \u00a0de\u00a0infecci\u00f3n\u00a0por\u00a0el\u00a0VIH\u00a0es\u00a0menor\u00a0de\u00a05%\u00a0en\u00a0las\u00a0poblaciones \u00a0de\u00a0alto\u00a0riesgo.\u00a0Una\u00a0epidemia \u00a0\n                                                 \n62 Fuente:\u00a0Banco\u00a0Mundial,  Compromiso \u00a0con\u00a0los\u00a0resultados: \u00a0mejorar\u00a0la\u00a0eficacia\u00a0de\u00a0la\u00a0asistencia \u00a0en\u00a0la\u00a0lucha\u00a0contra\u00a0el\u00a0\nVIH/SIDA, \u00a02005,\u00a0Washington, \u00a0D.C.  92 concentrada \u00a0se\u00a0define\u00a0por\u00a0una\u00a0prevalencia \u00a0de\u00a0infecci\u00f3n\u00a0por\u00a0el\u00a0VIH\u00a0de\u00a0m\u00e1s\u00a0de\u00a05%\u00a0en\u00a0las\u00a0poblaciones \u00a0de\u00a0alto\u00a0\nriesgo,\u00a0pero\u00a0con\u00a0menos\u00a0de\u00a05%\u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0en\u00a0general,\u00a0y\u00a0una\u00a0epidemia \u00a0generalizada \u00a0se\u00a0define\u00a0por\u00a0una\u00a0\nprevalencia \u00a0de\u00a0infecci\u00f3n\u00a0por\u00a0el\u00a0VIH\u00a0de\u00a05%\u00a0o\u00a0m\u00e1s\u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0en\u00a0general.\u00a0\u00a0\u00a0\n\u00a0\nHay\u00a0diferentes \u00a0convenciones \u00a0para\u00a0establecer \u00a0el\u00a0l\u00edmite\u00a0de\u00a0la\u00a0prevalencia \u00a0del\u00a0VIH\u00a0para\u00a0definir\u00a0estas\u00a0etapas.\u00a0\nPara\u00a0una\u00a0epidemia \u00a0generalizada, \u00a0en\u00a0el\u00a0informe\u00a0del\u00a0Banco\u00a0Mundial\u00a0(2000)\u00a0se\u00a0emple\u00f3\u00a0un\u00a0umbral\u00a0de\u00a07%\u00a0en\u00a0la\u00a0\npoblaci\u00f3n \u00a0en\u00a0general;\u00a0en\u00a0el\u00a0otro\u00a0extremo,\u00a0el\u00a0ONUSIDA \u00a0ha\u00a0empleado \u00a0una\u00a0tasa\u00a0de\u00a0s\u00f3lo\u00a01%.\u00a0\u00a0\u00a0En\u00a0el\u00a0\u00a0informe\u00a0del\u00a0\nBanco\u00a0Mundial\u00a0\u201cCompromiso \u00a0con\u00a0los\u00a0resultados: \u00a0mejorar\u00a0la\u00a0eficacia\u00a0de\u00a0la\u00a0asistencia \u00a0en\u00a0la\u00a0lucha\u00a0contra\u00a0el\u00a0\nVIH/SIDA\u201d \u00a0se\u00a0usa\u00a0un\u00a0valor\u00a0intermedio \u00a0de\u00a05%,\u00a0el\u00a0mismo\u00a0empleado \u00a0en\u00a0el\u00a0informe\u00a0del\u00a0Banco\u00a0Mundial\u00a0(1997)\u00a0\nque\u00a0clasific\u00f3\u00a0a\u00a0todos\u00a0los\u00a0pa\u00edses\u00a0en\u00a0desarrollo \u00a0por\u00a0\u201cetapa\u201d\u00a0de\u00a0la\u00a0epidemia \u00a0en\u00a0\u00a01997\u00a0y\u00a0en\u00a0el\u00a0a\u00f1o\u00a01999,\u00a0en\u00a0una\u00a0\nedici\u00f3n\u00a0actualizada. \u00a0\n\u00a0\nPresupuesto \u00a0por\u00a0resultados \u00a0\u2013\u00a0PPR\u00a0\nEl\u00a0presupuesto \u00a0por\u00a0resultados \u00a0es\u00a0un\u00a0mecanismo \u00a0de\u00a0asignaci\u00f3n \u00a0de\u00a0recursos,\u00a0que\u00a0vincula\u00a0la\u00a0asignaci\u00f3n \u00a0de\u00a0\nrecursos\u00a0y\u00a0los\u00a0resultados \u00a0esperados \u00a0de\u00a0la\u00a0intervenci\u00f3n \u00a0del\u00a0Estado.\u00a0\u00a0\u00a0Establece \u00a0un\u00a0proceso\u00a0sistem\u00e1tico \u00a0de\u00a0\nvinculaci\u00f3n \u00a0de\u00a0resultados \u00a0con\u00a0productos, \u00a0acciones\u00a0y\u00a0medios\u00a0necesarios \u00a0para\u00a0su\u00a0ejecuci\u00f3n, \u00a0y\u00a0sustentados \u00a0\nsobre\u00a0la\u00a0base\u00a0de\u00a0la\u00a0informaci\u00f3n \u00a0y\u00a0experiencia \u00a0existente. \u00a0Este\u00a0proceso\u00a0permite\u00a0una\u00a0construcci\u00f3n \u00a0articulada \u00a0de\u00a0\nintervenciones \u00a0y\u00a0posibilita\u00a0una\u00a0mejora\u00a0de\u00a0los\u00a0niveles\u00a0de\u00a0eficacia\u00a0\u00a0y\u00a0eficiencia \u00a0\u00a0en\u00a0el\u00a0accionar\u00a0del\u00a0Estado.\u00a0\u00a0\n\u00a0\nAl\u00a0conjunto\u00a0de\u00a0intervenciones \u00a0dise\u00f1adas \u00a0bajo\u00a0este\u00a0proceso\u00a0se\u00a0le\u00a0denomina \u00a0\u201cPrograma \u00a0Estrat\u00e9gico\u201d, \u00a0al\u00a0igual\u00a0\nque\u00a0en\u00a0el\u00a0Programas \u00a0del\u00a0FMSTM\u00a0el\u00a0resultado \u00a0esperado \u00a0expresado \u00a0en\u00a0indicadores \u00a0es\u00a0la\u00a0persona\u00a0que\u00a0recibe\u00a0\natenci\u00f3n\u00a0o\u00a0servicios.\u00a0\u00a0\u00a0\n\u00a0\nSistemas\u00a0administrativos \u00a0de\u00a0informaci\u00f3n \u00a0financiera \u00a0\nEl\u00a0Per\u00fa\u00a0es\u00a0un\u00a0pa\u00eds\u00a0\u00a0que\u00a0cuenta\u00a0con\u00a0sistemas\u00a0de\u00a0informaci\u00f3n \u00a0financiera \u00a0detallada \u00a0y\u00a0fiable.\u00a0\u00a0\u00a0Esto\u00a0se\u00a0\u00a0debe\u00a0a\u00a0las\u00a0\ndisposiciones \u00a0\u00a0de\u00a0Transparencia \u00a0fiscal\u00a0que\u00a0exigen\u00a0la\u00a0difusi\u00f3n\u00a0\u00a0de\u00a0informaci\u00f3n \u00a0financiera \u00a0a\u00a0trav\u00e9s\u00a0de\u00a0las\u00a0\np\u00e1ginas\u00a0web\u00a0de\u00a0las\u00a0instituciones \u00a0(\u00a063\u00a0)\u00a0y\u00a0\u00a0tambi\u00e9n\u00a0se\u00a0debe\u00a0a\u00a0que\u00a0estos\u00a0sistemas\u00a0\u00a0incorporan \u00a0todas\u00a0las\u00a0fases\u00a0de\u00a0\nejecuci\u00f3n \u00a0financiera: \u00a0presupuestal, \u00a0programaci\u00f3n \u00a0de\u00a0compras\u00a0y\u00a0registro\u00a0de\u00a0pagos.\u00a0\u00a0\u00a0\n\u00a0\nEn\u00a0el\u00a0mismo\u00a0sentido,\u00a0se\u00a0cuentan\u00a0con\u00a0\u00a0registros\u00a0de\u00a0importaciones \u00a0sobre\u00a0productos \u00a0espec\u00edficos \u00a0(condones, \u00a0\nARV,\u00a0reactivos), \u00a0algunos\u00a0de\u00a0los\u00a0cuales\u00a0\u00a0se\u00a0encuentra \u00a0exonerados \u00a0de\u00a0impuestos, \u00a0tal\u00a0es\u00a0el\u00a0caso\u00a0de\u00a0los\u00a0\nmedicamentos \u00a0e\u00a0insumos\u00a0para\u00a0la\u00a0fabricaci\u00f3n \u00a0de\u00a0medicamentos \u00a0antirretrovirales. \u00a0(\u00a064\u00a0)\u00a0\n\uf02d Sistema\u00a0integrado \u00a0de\u00a0administraci\u00f3n \u00a0financiera \u00a0(SIAF)\u00a0\nA\u00a0partir\u00a0de\u00a0enero\u00a0de\u00a01999\u00a0el\u00a0SIAF\u00a0se\u00a0ha\u00a0constituido \u00a0en\u00a0el\u00a0Sistema\u00a0Oficial\u00a0de\u00a0registro\u00a0de\u00a0las\u00a0operaciones \u00a0de\u00a0\nGasto\u00a0e\u00a0Ingreso\u00a0de\u00a0las\u00a0Unidades \u00a0Ejecutoras \u00a0del\u00a0Sector\u00a0Publico\u00a0en\u00a0el\u00a0Per\u00fa,\u00a0sustituyendo \u00a0diversos\u00a0registros\u00a0y\u00a0\nreportes\u00a0de\u00a0la\u00a0Direcci\u00f3n \u00a0Nacional\u00a0de\u00a0Presupuesto \u00a0P\u00fablico\u00a0(DNPP),\u00a0la\u00a0Direcci\u00f3n \u00a0General\u00a0de\u00a0Tesoro\u00a0P\u00fablico\u00a0\u00a0y\u00a0\nla\u00a0Contabilidad \u00a0P\u00fablica\u00a0Nacional. \u00a0\u00a0\u00a0El\u00a0sistema\u00a0es\u00a0administrado \u00a0por\u00a0el\u00a0Ministerio \u00a0de\u00a0Econom\u00eda \u00a0y\u00a0Finanzas\u00a0\n(MEF).\u00a0\u00a0Cada\u00a0mes\u00a0las\u00a0Unidades \u00a0Ejecutoras \u00a0reciben,\u00a0a\u00a0trav\u00e9s\u00a0del\u00a0SIAF,\u00a0su\u00a0Calendario \u00a0de\u00a0Compromisos \u00a0\nelaborado \u00a0por\u00a0la\u00a0DNPP.\u00a0Las\u00a0Unidades \u00a0Ejecutoras \u00a0registran\u00a0en\u00a0el\u00a0SIAF\u00a0sus\u00a0operaciones \u00a0de\u00a0gastos\u00a0e\u00a0ingresos,\u00a0\ninformaci\u00f3n \u00a0que\u00a0luego\u00a0es\u00a0transmitida \u00a0al\u00a0MEF\u00a0para\u00a0su\u00a0verificaci\u00f3n \u00a0y\u00a0aprobaci\u00f3n. \u00a0La\u00a0informaci\u00f3n \u00a0es\u00a0actualizada \u00a0\npermanentemente \u00a0y\u00a0es\u00a0de\u00a0f\u00e1cil\u00a0acceso.\u00a0\n\u2010 Sistema\u00a0electr\u00f3nico \u00a0de\u00a0contrataciones \u00a0del\u00a0Estado\u00a0(SEACE)\u00a0\nEl\u00a0SEACE\u00a0es\u00a0un\u00a0sistema\u00a0que\u00a0registra\u00a0las\u00a0contrataciones \u00a0p\u00fablicas\u00a0mediante \u00a0el\u00a0uso\u00a0del\u00a0Internet,\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0su\u00a0\nplataforma \u00a0tecnol\u00f3gica \u00a0100%\u00a0web.\u00a0Es\u00a0administrado \u00a0por\u00a0el\u00a0MEF\u00a0y\u00a0ha\u00a0sido\u00a0desarrollado \u00a0bajo\u00a0tecnolog\u00eda \u00a0cliente\u00a0\n/\u00a0servidor.\u00a0\u00a0\u00a0Todas\u00a0las\u00a0Entidades \u00a0P\u00fablicas\u00a0\u00a0en\u00a0el\u00a0Per\u00fa\u00a0(2,730\u00a0aproximadamente) \u00a0est\u00e1n\u00a0obligadas \u00a0a\u00a0utilizar\u00a0el\u00a0\nSEACE.\u00a0Asimismo, \u00a0los\u00a0Proveedores \u00a0interesados \u00a0en\u00a0contratar \u00a0con\u00a0el\u00a0Estado\u00a0y\u00a0la\u00a0ciudadan\u00eda \u00a0en\u00a0general\u00a0tienen\u00a0\n                                                 \n63 Ley\u00a0de\u00a0transparencia \u00a0y\u00a0acceso\u00a0a\u00a0la\u00a0Informaci\u00f3n \u00a0p\u00fablica\u00a0\u2010\u00a0Ley\u00a0\u00a027806,\u00a02002\u00a0 \n64 Ley\u00a0que\u00a0exonera\u00a0del\u00a0pago\u00a0del\u00a0impuesto \u00a0general\u00a0a\u00a0las\u00a0ventas\u00a0y\u00a0de\u00a0los\u00a0derechos\u00a0arancelarios \u00a0a\u00a0los\u00a0medicamentos \u00a0para\u00a0\ntratamiento \u00a0oncol\u00f3gico \u00a0y\u00a0VIH/SIDA\u00a0\u2010\u00a0Ley\u00a027450,\u00a02005  93 acceso\u00a0a\u00a0la\u00a0informaci\u00f3n \u00a0contenida \u00a0en\u00a0el\u00a0SEACE.\u00a0Las\u00a0\u00a0transacciones \u00a0electr\u00f3nicas \u00a0realizadas \u00a0por\u00a0medio\u00a0del\u00a0\nSEACE\u00a0poseen\u00a0la\u00a0misma\u00a0validez\u00a0legal\u00a0y\u00a0eficacia\u00a0que\u00a0los\u00a0actos\u00a0realizados \u00a0por\u00a0medios\u00a0manuales. \u00a0\u00a0A\u00a0partir\u00a0de\u00a0\nsetiembre \u00a0del\u00a02006,\u00a0se\u00a0ha\u00a0integrado \u00a0la\u00a0informaci\u00f3n \u00a0del\u00a0SEACE\u00a0con\u00a0la\u00a0del\u00a0SIAF,\u00a0lo\u00a0cual\u00a0significa\u00a0\u00a0que\u00a0no\u00a0es\u00a0\nposible\u00a0registrar\u00a0compromisos \u00a0de\u00a0pagos\u00a0por\u00a0el\u00a0SIAF\u00a0(por\u00a0contrataciones \u00a0y/o\u00a0adquisiciones), \u00a0mientras\u00a0no\u00a0se\u00a0\nrealice\u00a0previamente \u00a0el\u00a0registro\u00a0del\u00a0contrato\u00a0en\u00a0el\u00a0SEACE.\u00a0\n\uf02d Sistema\u00a0Nacional\u00a0de\u00a0Inversi\u00f3n\u00a0Publica\u00a0(SNIP)\u00a0\nVigente\u00a0a\u00a0partir\u00a0de\u00a0junio\u00a0del\u00a0a\u00f1o\u00a02000,\u00a0el\u00a0SNIP\u00a0es\u00a0un\u00a0sistema\u00a0que\u00a0regula\u00a0la\u00a0declaraci\u00f3n \u00a0de\u00a0viabilidad \u00a0de\u00a0los\u00a0\nsistemas\u00a0de\u00a0inversi\u00f3n\u00a0ejecutados \u00a0por\u00a0las\u00a0instituciones \u00a0del\u00a0Estado.\u00a0En\u00a0el\u00a0Banco\u00a0de\u00a0proyectos, \u00a0herramienta \u00a0del\u00a0\nSNIP,\u00a0se\u00a0publica\u00a0informaci\u00f3n \u00a0resumida \u00a0y\u00a0estandarizada \u00a0de\u00a0la\u00a0totalidad\u00a0de\u00a0proyectos \u00a0de\u00a0Inversi\u00f3n\u00a0P\u00fablica\u00a0en\u00a0\nfase\u00a0de\u00a0pre\u2010inversi\u00f3n.(\u00a065\u00a0)\u00a0\u00a0Sirve\u00a0como\u00a0mecanismo \u00a0de\u00a0interacci\u00f3n \u00a0entre\u00a0las\u00a0entidades \u00a0formuladoras \u00a0y\u00a0las\u00a0\nevaluadoras \u00a0de\u00a0proyectos, \u00a0se\u00a0puede\u00a0consultar \u00a0en\u00a0l\u00ednea\u00a0en\u00a0la\u00a0web\u00a0del\u00a0MEF.\u00a0\u00a0En\u00a0los\u00a0\u00faltimos\u00a0se\u00a0han\u00a0registrado \u00a0\n10\u00a0PIP\u00a0relacionados \u00a0a\u00a0VIH:\u00a03\u00a0en\u00a0el\u00a02008,\u00a02\u00a0en\u00a0el\u00a02009\u00a0y\u00a05\u00a0en\u00a0el\u00a02010.\u00a0\n\u00a0\n                                                 \n65 Un\u00a0Proyecto\u00a0de\u00a0Inversi\u00f3n \u00a0P\u00fablica\u00a0(PIP),\u00a0es\u00a0toda\u00a0intervenci\u00f3n \u00a0limitada\u00a0en\u00a0el\u00a0tiempo\u00a0que\u00a0utiliza\u00a0total\u00a0o\u00a0parcialmente \u00a0\nrecursos\u00a0p\u00fablicos,\u00a0con\u00a0el\u00a0fin\u00a0de\u00a0crear,\u00a0ampliar,\u00a0mejorar,\u00a0modernizar \u00a0o\u00a0recuperar \u00a0la\u00a0capacidad \u00a0productora \u00a0de\u00a0bienes\u00a0o\u00a0\nservicios; \u00a0cuyos\u00a0beneficios \u00a0se\u00a0generen\u00a0durante\u00a0la\u00a0vida\u00a0\u00fatil\u00a0del\u00a0proyecto\u00a0y\u00a0\u00e9stos\u00a0sean\u00a0independientes \u00a0de\u00a0otros\u00a0proyectos.   Anexo\u00a02\u00a0\u2013\u00a0Evoluci\u00f3n \u00a0de\u00a0la\u00a0normatividad \u00a0en\u00a0SIDA\u00a01990\u00a0\u2013\u00a02010,\u00a0por\u00a0categor\u00edas \u00a0de\u00a0gasto\u00a0MEGAS\u00a0\nTema\u00a01990\u00a01995\u00a01996\u00a01997\u00a01998\u00a0 1999\u00a02000 2001\u00a0 2002\u00a0 2003\u00a0 2004\u00a0 2005\u00a0 2006\u00a0 2007\u00a02008\u00a0 2009\u00a0 2010\u00a0\n\u00a0\n\u00a0Desarrollo \u00a0comunitario \u00a0y\u00a0ambiente \u00a0mejorado \u00a0\nPlanes\u00a0VIH\u00a0Ley\u00a025275\u00a0\nDeclaran\u00a0\nprioridad\u00a0\u00a0\nVIH\u00a0\u00a0Ley\u00a026626\u00a0\nLey\u00a0Contra\u00a0\nSIDA\u00a0DS\u00a0004\u201097\u2010\nSA\u00a0\nReglamento \u00a0\nLey\u00a0SIDA\u00a0\u00a0 \u00a0Plan\u00a0VIH\u00a0\n2001\u20102004\u00a0\n(Web\u00a0\nMINSA)\u00a0\u00a0 \u00a0\u00a0 \u00a0Ley\u00a028243\u00a0\nModifica\u00a0Ley\u00a0SIDARM\u00a0721\u20102005/SA\u00a0\nPlan\u00a0ESN\u00a0VIH\u00a0\u00a0DS\u00a0005\u20102007\u2010\nSA\u00a0\nPEM\u00a0VIH\u00a0\u00a0\n2007\u20102011\u00a0Ord.\u00a0028\u20102008\nPERM\u00a0LoretoOrd.\u00a0059\u20102009\u00a0\nPrioridad\u00a0Cusco\nOrd.\u00a0023\u20102009\nPrioridad\u00a0Ancash\u00a0\nOrd.\u00a0017\u20102009\nPERM\u00a0Tumbes\u00a0Ord.031\u20102009\u00a0\nPERM\u00a0\nLambayeque \u00a0\nOrd.018\u20102009\u00a0\nPERM\u00a0Ucayali\u00a0\nOrd.187\u20102010\u00a0\nPERM\u00a0Piura\u00a0\nOrd.200\u2010MVES\u00a0\nPlan\u00a0prevenci\u00f3n \u00a0\nVilla\u00a0el\u00a0salvador\u00a0\nAdolescentes \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0Proyecto\u00a0Ley\u00a0\nadolescentes\n*\u00a0\u00a0Acceso\u00a0servicios\u00a0\nOrd.012\u20102009\u00a0\nLoreto,\u00a0\u00a0\nOrd.011\u20102009\u00a0\nUcayali\u00a0\nOrd.0005 \u20102009\u00a0\nIca\u00a0\u00a0\nTS\u00a0Y\u00a0HSH\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0Ord.\u00a0Decreto\u00a0010\nOrd.010\u00a0\nDDHH\u00a0TS\u00a0Callao\u00a0\n(2)\u00a0\u00a0\nPlanes\u00a0otros\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0DS\u00a0017\u20102001\u2010\nPROMUDEH \u00a0\nPlan\u00a0Violencia\u00a0\nsexual\u00a0DS\u00a0003\u20102002\u2010\nPROMUDEH \u00a0\nPlan\u00a0Infancia\u00a0y\u00a0\nadolescencia \u00a0\u00a0DS\u00a0005\u20102004\u2010\nMIMDES\u00a0Plan\u00a0\nFamilia\u00a0DS009\u20102005\u2010\nMIMDES\u00a0\nPlan\u00a0PIO\u00a0\u00a0\nRM068\u20102005\u2010ED\u00a0\nMINEDU\u00a0\nDS017\u201005\u2010JUS\u00a0\nPlan\u00a0DDHH\u00a0\nRM437\u20102005/SA\nGu\u00eda\u00a0Poblaciones\nexcluidos \u00a0DS\u00a0038\u20102006\u00a0\nPlan\u00a0Juventud\u00a0Ley\u00a028983\u00a0\u00a0\nPlan\u00a0PIO\u00a0\nRM\u00a0141\u2010\n2007/SA\u00a0\nGu\u00eda\u00a0Violencia\u00a0\nde\u00a0genero\u00a0\u00a0 \u00a0 \u00a0\nSalud\u00a0sexual\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0RM\u00a0290\u20102006/SA\nConsejer\u00eda \u00a0\u00a0RM\u00a0278\u2010\n2008/SA\u00a0\nAdecuaci\u00f3n \u00a0\ncultural\u00a0\nConsejer\u00eda \u00a0RS164\u20102009/SA\u00a0\nTamizaje\u00a0VIH\u00a0\nMEF\u00a0\u00a0\nLugares\u00a0\u00a0\nde\u00a0trabajo\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0RM\u00a0376\u20102008\u2010\nTR\u00a0Medidas\u00a0\nnacionales \u00a0\u00a0 \u00a0\nOrganizaci\u00f3n \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0RM\u00a0471\u00a0DE/SG\u00a0\nDS\u00a0012\u2010DE/SG\n\u00a0COPRECOS \u00a0\u00a0RM\u00a0278\u20102004\u2010\nDE/SG\u00a0RS\u00a0138\u2010\n2004\u2010DE/SG\u00a0\nCOPRECOS \u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nOtros\u00a0 \u00a0 \u00a0 \u00a0RS458\u201097RE\u00a0\nCurso\u00a0\ninternacion\nal\u00a0\u00a0RS\u00a0095\u201099\u2010RE\nCurso\u00a0\ninternacional\u00a0RM0638\u2010\n2001RE\u00a0\nCurso\u00a0\ninternacional \u00a0\u00a0\u00a0 \u00a0RM\u00a01050\u20102004\u2010\nRE\u00a0\nCurso\u00a0RS\u00a0537\u20102005\u2010RE\nCurso\u00a0\ninternacional \u00a0\nRM\u00a01199\u20102005\u2010\nRE\u00a0\u00a0 \u00a0RM787\u2010\n2008SA\u00a0Foro\u00a0\nVIH\u00a0R.0023\u20102009\u00a0\nInforme\u00a0\nDefensorial \u00a0\u00a0 Tema\u00a01990\u00a01995\u00a01996\u00a01997\u00a01998\u00a0 1999\u00a02000 2001\u00a0 2002\u00a0 2003\u00a0 2004\u00a0 2005\u00a0 2006\u00a0 2007\u00a02008\u00a0 2009\u00a0 2010\u00a0\ninternacional \u00a0\nRM\u00a01004\u20102004\u2010\nRE\u00a0\nCongreso \u00a0Evento\u00a0\nMCP\u00a0\nRepresentante\ns\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0DS\u00a0007\u20102004\u2010SA\u00a0\nCreaci\u00f3n\u00a0MCP\u00a0\n\u00a0\u00a0RM218\u20102005/SA\nReglamento \u00a0\nRM2433\u20102005\u2010IN\nRM288\u20102005\u2010JUS\nRM160\u20102005\u2010TR\nDS\u00a0005\u20102005\u2010SA\nRM005\u20102005\u2010JUS\n\u00a0\u00a0RM571\u20102006\u2010DE\nRM\u00a01067\u2010\n2006/SA\u00a0\nRM\u00a0427\u20102006\u2010TR\u00a0\n\u00a0RM307\u2010\n2007/SA\u00a0\nRM503\u2010\n2007DE\u00a0\n\u00a0\u00a0RM416\u2010\n2008/SA\u00a0\u00a0\n\u00a0\u00a0 \u00a0\n\u00a0\n\u00a0\n\u00a0Prevenci\u00f3n \u00a0\nBancos\u00a0de\u00a0\nsangre\u00a0\u00a0\u00a0Ley\u00a0\u00a026454\u00a0\nCrea\u00a0\nPRONA\u00a0\nHEBAS\u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nITS\u00a0 \u00a0 \u00a0RM\u00a0235\u201096\u2010\nSA\u00a0\nDoctrina\u00a0\u00a0RM306\u201098\u2010SA\u00a0\nConsejer\u00eda \u00a0\nRM428\u201098\u2010SA\u00a0\n\u00a0Manejo\u00a0ITS\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0RM\u00a0125\u20102004/SA\u00a0\nConsejer\u00eda \u00a0ITS\u00a0\u00a0 \u00a0 \u00a0 \u00a0RM\u00a0264\u20102009/SA\u00a0\nConsejer\u00eda \u00a0\nRM263\u20102009/SA\nManejo\u00a0ITS\u00a0\u00a0\u00a0\nTS\u00a0Y\u00a0HSH\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0RM\u00a0074\u20102004/SA\u00a0\nPEPs\u00a0\u00a0 \u00a0 \u00a0 \u00a0RM\u00a0650\u20102009/SA\u00a0\nAMP:\u00a0HSH\u00a0TS\u00a0\u00a0\nAdolescentes \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0RM107\u20102005/SA\nRM583\u20102005/SA\nRM633\u20102005/SA\nMINSA\u00a0\nRM\u00a0068\u20102005\u2010ED\nMINEDU\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nManejo\u00a0Ex\u00a0\npost\u00a0\nexposici\u00f3n \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0Gu\u00eda\u00a0\n(Web\u00a0SA)\u00a0\u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0RM\u00a0768\u00a0\u20102010\u2010SA\nRiesgo\u00a0\nocupacional \u00a0\nTransmisi\u00f3n \u00a0\nvertical\u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0D.005\u20102003\u2010SA\nManejo\u00a0ITS\u00a0\u00a0\u00a0RM\u00a0084\u20102005/SA\nNorma\u00a0t\u00e9cnica\u00a0\nTV\u00a0\u00a0\u00a0RM\u00a0463\u2010\n2007/SA\u00a0\nPlan\u00a0TV\u00a0RM\u00a0335\u2010\n2008/SA\u00a0NT\u00a0\nS\u00edfilis\u00a0\ncong\u00e9nita \u00a0\u00a0\u00a0 \u00a0\u00a0\n\u00a0\n\u00a0Tratamiento \u00a0\nAdherencia \u00a0y\u00a0\nConsejer\u00eda \u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0RM\u00a01328\u20102003\u2010\nSA\u00a0Consejer\u00eda \u00a0\nRM\u00a0752\u20102004/SA\u00a0\nAdherencia \u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nCo\u00a0infecci\u00f3n\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0RM\u00a0123\u20102004/SA\u00a0\nQumio\u2010profilaxisRM\u00a0162\u20102005/SA\nTB\u00a0RM1148\u2010\n2006/SA\u00a0\u00a0 \u00a0 \u00a0RM\u00a0485\u20102010/SA\u00a0\nHepatitis\u00a0 Tema\u00a01990\u00a01995\u00a01996\u00a01997\u00a01998\u00a0 1999\u00a02000 2001\u00a0 2002\u00a0 2003\u00a0 2004\u00a0 2005\u00a0 2006\u00a0 2007\u00a02008\u00a0 2009\u00a0 2010\u00a0\nTB\u00a0MDR\u00a0\u00a0\n\u00a0RM383\u20102006/SA\nCo\u00a0infecci\u00f3n\u00a0\u00a0\nMonitoreo \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0Monitoreo \u00a0CD4\n(Web\u00a0SA)\u00a0\u00a0NETLAB\u00a0\n(pagina\u00a0web)\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nNi\u00f1os\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0RM\u00a0619\u201099\u2010SA\nManejo\u00a0VIH\u00a0\u00a0 \u00a0 \u00a0\u00a0TARGA\u00a0ni\u00f1os\u00a0\n(Web\u00a0SA)\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nTARGA\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0RM\u00a0\u00a0081\u201099\u2010SA\nGu\u00eda\u00a0atenci\u00f3n\u00a0\nintegral\u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0RM124\u20102004/SA\u00a0\nRM939\u20102004/SA\nTARGA\u00a0\u00a0\u00a0\nRM1052\u20102004SA\u00a0\nReacciones \u00a0\nadversas\u00a0RM\u00a0311\u20102005/SA\nTARGA\u00a0Gu\u00eda\u00a0Atenci\u00f3n\u00a0\nintegral\u00a0\n(Web)\u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u00a0\n\u00a0Apoyo\u00a0social\u00a0y\u00a0econ\u00f3mico \u00a0\nOtros\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Proyecto\u00a0Ley\u00a0\ncentro\u00a0de\u00a0\nreposo\u00a0*\u00a0\u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0RM\u00a0779\u2010\n2007/SA\u00a0\nDenuncias \u00a0\ninfectados \u00a0\u00a0 \u00a0 \u00a0\n\u00a0\n\u00a0Gesti\u00f3n\u00a0de\u00a0programa \u00a0\nExoneraci\u00f3n \u00a0\nImpuestos \u00a0\nARV\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Ley\u00a027450\u00a0\nDS236\u20102001\u2010EF\nLey\u00a0y\u00a0lista\u00a0ARV\u00a0DS\u00a0143\u20102002\u2010EF\nDS\u00a0167\u20102002\u2010EF\nLista\u00a0ARV\u00a0\u00a0\nC.I.\u2010CR\u2010024\u20102002\u00a0\nC.I.\u2010CR\u201001\u20102002\nOtros\u00a0\u00a0DS\u00a0049\u20102003\u2010EF\u00a0\nLista\u00a0ARV\u00a0\u00a0\u00a0DS\u00a0041\u20102005\u2010EF\nLista\u00a0ARV\u00a0\u00a0DS\u00a0093\u20102006\u2010EF\nLista\u00a0ARV\u00a0\u00a0\u00a0DS008\u20102008\u2010\nEF\u00a0\nRM008\u20102009\u2010\nEF\u00a0\nLista\u00a0ARV\u00a0\u00a0DS004\u20102009\u2010SA\nLista\u00a0ARV\u00a0\u00a0DS006\u20102010\u2010SA\u00a0\nLista\u00a0ARV\u00a0\u00a0\nFinanciamient\no\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Ley\u00a027812\u00a0\nCreaci\u00f3n\u00a0SIS\u00a0\u00a0\nDS003\u20102002\u2010SA\nDS040\u20102002\u2010RE\nDS040\u20102002\u2010RE\nOtros\u00a0RS\u00a0105\u20102003\u2010EF\u00a0\nDonaci\u00f3n \u00a0DS\u00a0010\u20102004\u2010SA\u00a0\nPol\u00edtica\u00a0\nAseguramiento \u00a0RM\u00a0725\u20102005/SA\nSIS\u00a0\nRM\u00a0944\u20102005/SA\nOtros\u00a0\u00a0DS006\u20102006\u2010SA\nSIS\u00a0\u00a0RM608\u2010\n2007/SA\u00a0\nRM422\u2010\n2007/SA\u00a0\nRM315\u2010\n2007/SA\u00a0\nDS004\u20102007\u2010\nSA\u00a0\nSIS\u00a0\u00a0\u00a0\nRM316\u2010\n2007/SA\u00a0\nLista\u00a0\nAseguramient\no\u00a0\u00a0\nLey\u00a028927\u00a0\nPPR\u00a0\u00a0Ley\u00a029344\u00a0\u00a0\nLey\u00a0\naseguramiento \u00a0\nuniversal\u00a0\u00a0\nMedicamento\ns\u00a0estrat\u00e9gicos \u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0RM\u00a01753\u2010\n2002/SA\u00a0\nSISMED\u00a0Acuerdo\u00a012\u00a0y\u00a013\u00a0\nCallao\u00a0\nExonera\u00a0proceso\u00a0\nVIH\u00a0RM\u00a0110\u20102004/SA\u00a0\nLista\u00a0\nmedicamentos \u00a0RM\u00a0367\u20102005/SA\u00a0\nSISMED\u00a0\u00a0\u00a0\nRM\u00a0734\u20102005/SA\nLista\u00a0\u00a0RM\u00a0482\u2010\n2007/SA\u00a0\nLista\u00a0\u00a0RM\u00a0040\u2010\n2008/SA\u00a0\nExonera\u00a0\nproceso\u00a0\u00a0 \u00a0\nSME\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0RM\u00a0669\u20102005/SA\nNorma\u00a0\nSupervisi\u00f3n \u00a0\u00a0Norma\u00a0\nVigilancia \u00a0\nsuministro \u00a0\u00a0 RM\u00a0\u00a0436\u2010 \u00a0 Tema\u00a01990\u00a01995\u00a01996\u00a01997\u00a01998\u00a0 1999\u00a02000 2001\u00a0 2002\u00a0 2003\u00a0 2004\u00a0 2005\u00a0 2006\u00a0 2007\u00a02008\u00a0 2009\u00a0 2010\u00a0\nintegral\u00a0 ARV\u00a0\n(web)\u00a02009/SA\u00a0SMEI\u00a0\nSistema\u00a0M&E\u00a0\nContratos \u00a0\nFMSTM\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02\u00a0Ronda\u00a0Fase\u00a01\u00a0\ndiciembre \u00a0\u00a02\u00a0Ronda\u00a0Fase\u00a02\u00a0\ndiciembre \u00a05\u00a0Ronda\u00a0Fase\u00a01\u00a0\nset.\u00a06\u00a0Ronda\u00a0\u00a0Fase\u00a0\n1\u00a0oct.\u00a05\u00a0Ronda\u00a0Fase\u00a0\n2\u00a0set.\u00a06\u00a0Ronda\u00a0\u00a0Fase\u00a02\u00a0\noctubre\u00a0\u00a0\nConvenio \u00a0\nPer\u00fa\u2010Brasil\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0DS\u00a0123\u20102003\u2010RE\u00a0\nAcuerdo\u00a0\ncomplementario\u00a0Acuerdo\u00a0\ncomplementario\n(Web)\u00a0\u00a0 \u00a0 \u00a0DS\u00a0\u00a0047\u20102009\u2010RE\u00a0\nAcuerdo\u00a0\ncomplementario \u00a0\u00a0\nOrganizaci\u00f3n \u00a0\u00a0 \u00a0RM\u00a0491\u201096\u2010\nSA\u00a0\nResponsable \u00a0\nPlan\u00a0VIH:\u00a0\nDGSP\u00a0Ley\u00a026790\u00a0\nLey\u00a0de\u00a0\nmodernizaci\n\u00f3n\u00a0\nseguridad \u00a0\nen\u00a0salud\u00a0\u00a0Ley\u00a027056\u00a0\nLey\u00a0ESSALUD\u00a0RM\u00a0163\u20102001\u2010\nSA\u00a0\nReglamento \u00a0SARM\u00a0895\u20102002\u2010SA\nCLAS\u00a0\u00a0\nDS\u00a0\u00a0013\u20102002\u2010SA\nDS\u00a0\u00a0014\u20102002\u2010SA\nMINSA\u00a0\n\u00a0RM\u00a01239\u20102003\u2010\nSA/SG\u2010DM\u00a0\u00a0\nCLAS\u00a0RM\u00a0\u00a0769\u20102004\u2010SA\u00a0\nCategor\u00edas \u00a0\nRM\u00a0\u00a0771\u20102004/SA\nEstrategias \u00a0\nRM\u00a01069\u2010\n2004/SA\u00a0\nProvisi\u00f3n\u00a0\nservicios\u00a0\u00a0\nDS\u00a0\u00a0130\u20102004\u2010EF\u00a0\nFocalizaci\u00f3n \u00a0\u00a0 \u00a0 \u00a0 \u00a0RS219\u20102009\u2010\nDE/SG\u00a0\nCOPRECOS \u00a0\u00a0\nOtros\u00a0\n(eventos) \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0DS\u00a0345\u20102001\u2010\nRE\u00a0\u00a0\nDS\u00a0454\u20102001\u2010\nRE\u00a0\u00a0\nDS\u00a0311\u20102001\u2010\nPCM\u00a0\u00a0\nRS\u00a0071\u20102001\u2010\nTR\u00a0\u00a0\u00a0\u00a0RM530\u20102003\u2010RE\nRM\u00a0814\u20102003\u2010RE\n\u00a0\u00a0RM\u00a0023\u20102005\u2010SA\n\u00a0RM598\u20102006\u2010RE\nR\u00a01014/RE\u00a0\n\u00a0RM\u00a01275/RER.A.\u00a0301\u20102008\u2010\nCE\u2010PJ\u00a0\n\u00a0RM\u00a00870/RE\u00a0\u00a0 \u00a0\nN\u00b0\u00a0de\u00a0normas\u00a0 1\u00a0 1\u00a0 3\u00a0 3\u00a0 2\u00a0 6\u00a0 1\u00a0 9\u00a0 13\u00a0 14\u00a0 22\u00a0 31\u00a0 13\u00a0 19\u00a0 11\u00a0 20\u00a0 7\u00a0\n\u00a0 \u00a0\u00a0 Publicado \u00a0en\u00a0pagina\u00a0web\u00a0SA\u00a0 \u00a0\u00a0 Procedimiento \u00a0INS\u00a0 \u00a0\u00a0 Proyectos \u00a0no\u00a0aprobados \u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 98 Anexo\u00a0\u00a03\u00a0\u2010\u00a0Proyectos \u00a0de\u00a0inversi\u00f3n \u00a0p\u00fablica\u00a0\u00a0que\u00a0se\u00a0encuentran \u00a0registrado \u00a0\nen\u00a0el\u00a0SNIP.\u00a0Periodo\u00a0\u00a02004\u20102010\u00a0\n\u00a0\nSNIP\u00a0 Nombre\u00a0del\u00a0Proyecto\u00a0de\u00a0Inversi\u00f3n\u00a0P\u00fablica\u00a0 Monto\u00a0S/\u00a0 Pliego\u00a0 Situaci\u00f3n\u00a0 A\u00f1o\u00a0\n12221\u00a0Cuidados\u00a0integrales \u00a0de\u00a0atenci\u00f3n\u00a0en\u00a0VIH/sida\u00a0en\u00a0el\u00a0centro\u00a0materno\u00a0\ninfantil\u00a0San\u00a0Jos\u00e9\u00a0\u2010\u00a0Villa\u00a0el\u00a0salvador\u00a0612,976\u00a0Ministerio \u00a0de\u00a0\nsalud\u00a0Viable\u00a0 2004\u00a0\n21983\u00a0Fortalecimiento \u00a0de\u00a0capacidades \u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0enfermedades \u00a0\nde\u00a0transmisi\u00f3n \u00a0sexual\u00a0ETS/VIH/sida \u00a0\u2010Talara\u00a067,761\u00a0Municipalidad \u00a0\nprovincial \u00a0de\u00a0\nTalara\u00a0Viable\u00a0 2005\u00a0\n21983\u00a0Fortalecimiento \u00a0de\u00a0capacidades \u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0enfermedades \u00a0\nde\u00a0transmisi\u00f3n \u00a0sexual\u00a0ETS/VIH/sida \u00a0\u2013Talara\u00a067,761\u00a0Municipalidad \u00a0\nprovincial \u00a0de\u00a0\ntalara\u00a0Viable\u00a0 2005\u00a0\n23972\u00a0Disminuci\u00f3n \u00a0de\u00a0la\u00a0prevalencia \u00a0de\u00a0infecci\u00f3n\u00a0de\u00a0transmisi\u00f3n \u00a0sexual\u00a0y\u00a0virus\u00a0\nde\u00a0inmunodeficiencia \u00a0humana\u2010s\u00edndrome \u00a0de\u00a0inmuno\u00a0deficiencia \u00a0\nadquirida \u00a0en\u00a0la\u00a0regi\u00f3n\u00a0Ucayali\u00a01,573,274 \u00a0Gobierno \u00a0\nregional\u00a0Ucayali\u00a0Viable\u00a0 2005\u00a0\n30416\u00a0Formaci\u00f3n \u00a0educativa \u00a0de\u00a0adolescentes \u00a0de\u00a010\u00a0a\u00a019\u00a0a\u00f1os\u00a0de\u00a0edad\u00a0en\u00a0\nsituaci\u00f3n\u00a0de\u00a0extrema\u00a0pobreza\u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0la\u00a0salud\u00a0sexual\u00a0y\u00a0\nreproductiva \u00a0de\u00a0las\u00a0zonas\u00a0urbanas\u00a0y\u00a0urbanas\u00a0marginales \u00a0de\u00a0las\u00a0\nprovincias \u00a0de\u00a0Hu\u00e1nuco\u00a0y\u00a0Leoncio\u00a0Prado\u00a0490,000\u00a0Gobierno \u00a0\nregional\u00a0Hu\u00e1nuco\u00a0En\u00a0\nformulaci\u00f3n \u00a02006\u00a0\n36978\u00a0Fortalecimiento \u00a0de\u00a0las\u00a0acciones\u00a0preventivas \u00a0y\u00a0atenci\u00f3n\u00a0integral\u00a0a\u00a0las\u00a0\npersonas\u00a0con\u00a0VIH/sida\u00a0en\u00a0la\u00a0posta\u00a0de\u00a0alto\u00a0Ilo,\u00a0provincia\u00a0de\u00a0Ilo\u00a0\u2013\u00a0\nMoquegua \u00a0282,764\u00a0Municipalidad \u00a0\nprovincial \u00a0de\u00a0Ilo\u00a0Viable\u00a0 2006\u00a0\n44255\u00a0Mejoramiento \u00a0de\u00a0la\u00a0estrategia \u00a0sanitaria\u00a0de\u00a0salud\u00a0sexual\u00a0y\u00a0reproductiva \u00a0\nen\u00a0los\u00a0adolescentes \u00a0del\u00a0distrito\u00a0de\u00a0Moquegua, \u00a0provincia\u00a0de\u00a0mariscal\u00a0\nnieto\u00a0\u2010\u00a0Moquegua \u00a0864,852\u00a0Municipalidad \u00a0\nprovincial \u00a0de\u00a0\nmariscal\u00a0nieto\u00a0Viable\u00a0 2008\u00a0\n48573\u00a0Fortalecimiento \u00a0de\u00a0derechos\u00a0sexuales\u00a0y\u00a0reproductivos \u00a0en\u00a0ni\u00f1os,\u00a0ni\u00f1as\u00a0y\u00a0\nadolescentes \u00a0de\u00a0la\u00a0regi\u00f3n\u00a0Cusco\u00a0971,019\u00a0Gobierno \u00a0\nregional\u00a0cusco\u00a0Viable\u00a0 2008\u00a0\n70711\u00a0Fortalecimiento \u00a0com\u00fan\u00a0al\u00a0de\u00a0la\u00a0prevenci\u00f3n \u00a0del\u00a0VIH\u00a0del,\u00a0distrito\u00a0de\u00a0\nPunchana \u00a0\u2010\u00a0Maynas\u00a0\u2013\u00a0Loreto\u00a0117,470\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0\nPunchana \u00a0No\u00a0Viable\u00a02007\u00a0\n82594\u00a0Fortalecimiento \u00a0de\u00a0capacidades \u00a0en\u00a0salud\u00a0sexual\u00a0y\u00a0reproductiva \u00a0del\u00a0\u00e1rea\u00a0\nde\u00a0la\u00a0gerencia\u00a0de\u00a0desarrollo \u00a0educativo \u00a0y\u00a0salud\u00a0de\u00a0la\u00a0municipalidad \u00a0\ndistrital\u00a0de\u00a0Pichari,\u00a0distrito\u00a0de\u00a0Pichari\u00a0\u2010\u00a0la\u00a0Convenci\u00f3n \u00a0\u2013\u00a0Cusco\u00a03,871,562 \u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0\nPichari\u00a0Viable\u00a0 2010\u00a0\n84106\u00a0Instalaci\u00f3n, \u00a0acondicionamiento \u00a0del\u00a0tren\u00a0de\u00a0la\u00a0juventud\u00a0para\u00a0brindar\u00a0\nacceso\u00a0a\u00a0informaci\u00f3n \u00a0en\u00a0salud\u00a0sexual\u00a0a\u00a0los\u00a0adolescentes \u00a0y\u00a0j\u00f3venes\u00a0de\u00a0\nlas\u00a0seis\u00a0zonas,\u00a0distrito\u00a0de\u00a0ate\u00a0\u2010\u00a0Lima\u00a0\u2010\u00a0Lima\u00a0100,000\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0ate\u00a0En\u00a0\nevaluaci\u00f3n \u00a02008\u00a0\n90589\u00a0Mejoramiento \u00a0de\u00a0capacidades \u00a0a\u00a0estudiantes \u00a0de\u00a04to\u00a0y\u00a05to\u00a0de\u00a0secundaria \u00a0\nen\u00a0salud\u00a0sexual\u00a0reproductiva \u00a0a\u00a0trav\u00e9s\u00a0de\u00a0la\u00a0creaci\u00f3n\u00a0de\u00a0una\u00a0red\u00a0de\u00a0\npromotores \u00a0\u2010,\u00a0distrito\u00a0de\u00a0san\u00a0Juan\u00a0de\u00a0Lurigancho \u00a0\u2010\u00a0Lima\u00a0\u2013\u00a0Lima\u00a0184,492\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0san\u00a0\nJuan\u00a0de\u00a0\nLurigancho \u00a0Viable\u00a0 2010\u00a0\n91703\u00a0Mejoramiento \u00a0de\u00a0los\u00a0sistemas\u00a0de\u00a0informaci\u00f3n \u00a0sobre\u00a0participaci\u00f3n \u00a0\nciudadana \u00a0(pc),\u00a0salud\u00a0sexual\u00a0reproductiva, \u00a0identidad \u00a0cultural(ic) \u00a0y\u00a0\nemprendimientos \u00a0econ\u00f3micos \u00a0(ee),\u00a0dirigidos\u00a0a\u00a0los\u00a0adolescentes \u00a0y\u00a0\nj\u00f3venes\u00a0ate,\u00a0distrito\u00a0de\u00a0ate\u00a0\u2010\u00a0Lima\u00a0\u2013\u00a0Lima\u00a0101,330\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0ate\u00a0Viable\u00a0 2008\u00a0\n94407\u00a0Fortalecimiento \u00a0de\u00a0capacidades \u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0enfermedades \u00a0\nde\u00a0trasmisi\u00f3n \u00a0sexual\u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0joven\u00a0de\u00a0Punchana, \u00a0distrito\u00a0de\u00a0\nPunchana \u00a0\u2010\u00a0Maynas\u00a0\u2010\u00a0Loreto\u00a098,840\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0\nPunchana \u00a0NO\u00a0Viable\u00a02008\u00a0\n100238\u00a0Fortalecimiento \u00a0de\u00a0capacidades \u00a0en\u00a0el\u00a0manejo\u00a0del\u00a0VIH\u00a0SIDA\u00a0estigma\u00a0y\u00a0\ndiscriminaci\u00f3n \u00a0en\u00a0Ica,\u00a0provincia\u00a0de\u00a0Ica\u00a0\u2010\u00a0Ica\u00a042,833\u00a0Municipalidad \u00a0\nprovincial \u00a0de\u00a0Ica\u00a0Viable\u00a0 2008\u00a0\n103639\u00a0Fortalecimiento \u00a0de\u00a0los\u00a0problemas \u00a0en\u00a0salud\u00a0VIH\u2010sida\u00a0de\u00a0la\u00a0regi\u00f3n\u00a0Ica\u00a0 1,831,000 \u00a0Gobierno \u00a0\nregional\u00a0Ica\u00a0En\u00a0\nevaluaci\u00f3n \u00a02008\u00a0\n105839\u00a0Mejoramiento \u00a0de\u00a0las\u00a0capacidades \u00a0sobre\u00a0salud\u00a0sexual\u00a0y\u00a0reproductiva \u00a0en\u00a0\nlos\u00a0adolescentes \u00a0de\u00a0la\u00a0regi\u00f3n\u00a0Moquegua \u00a01,912,376 \u00a0Gobierno \u00a0\nregional\u00a0\nMoquegua \u00a0En\u00a0\nformulaci\u00f3n \u00a02008\u00a0\n107720\u00a0Mejorar\u00a0el\u00a0acceso\u00a0a\u00a0los\u00a0servicios\u00a0de\u00a0salud\u00a0preventivo \u00a0promocional \u00a0del\u00a0\nVIH\u2010sida\u00a0en\u00a0la\u00a0poblaci\u00f3n \u00a0adolescente \u00a0de\u00a0las\u00a0instituciones \u00a0educativas \u00a0966,743\u00a0Gobierno \u00a0\nregional\u00a0tumbes\u00a0Viable\u00a0 2009\u00a0 99 SNIP\u00a0 Nombre\u00a0del\u00a0Proyecto\u00a0de\u00a0Inversi\u00f3n\u00a0P\u00fablica\u00a0 Monto\u00a0S/\u00a0 Pliego\u00a0 Situaci\u00f3n\u00a0 A\u00f1o\u00a0\npublicas\u00a0del\u00a0nivel\u00a0secundario \u00a0del\u00a0distrito\u00a0de\u00a0tumbes\u00a0\u2010\u00a0micro\u00a0red\u00a0de\u00a0\npampa\u00a0grande\u00a0\u2010\u00a0red\u00a0tumbes\u00a0\n109277\u00a0Mejoramiento \u00a0de\u00a0los\u00a0sistemas\u00a0de\u00a0informaci\u00f3n \u00a0sobre\u00a0salud\u00a0sexual\u00a0y\u00a0\nreproductiva \u00a0en\u00a0las\u00a0instituciones \u00a0educativas \u00a0p\u00fablicas\u00a0de\u00a0nivel\u00a0\nsecundario \u00a0del\u00a0distrito\u00a0de\u00a0Cajamarca, \u00a0provincia\u00a0de\u00a0Cajamarca \u00a0\u2013\u00a0\nCajamarca \u00a0211,957\u00a0Municipalidad \u00a0\nprovincial \u00a0de\u00a0\nCajamarca \u00a0Viable\u00a0 2009\u00a0\n109637\u00a0Mejoramiento \u00a0de\u00a0la\u00a0estrategia \u00a0sanitaria\u00a0de\u00a0salud\u00a0sexual\u00a0y\u00a0reproductiva \u00a0\nen\u00a0los\u00a0adolescentes \u00a0de\u00a0Torata,\u00a0distrito\u00a0de\u00a0Torata\u00a0\u2010\u00a0mariscal\u00a0nieto\u00a0\u2013\u00a0\nMoquegua \u00a0761,200\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0Torata\u00a0Viable\u00a0 2009\u00a0\n113683\u00a0Mejoramiento \u00a0en\u00a0estilos\u00a0de\u00a0vida\u00a0responsable \u00a0en\u00a0salud\u00a0sexual\u00a0y\u00a0salud\u00a0\nreproductiva \u00a0para\u00a0los\u00a0y\u00a0las\u00a0adolescentes \u00a0y\u00a0j\u00f3venes\u00a0en\u00a017\u00a0\nestablecimientos \u00a0de\u00a0salud\u00a0de\u00a0las\u00a0redes\u00a01,\u00a02,\u00a03\u00a0y\u00a04\u00a0de\u00a0la\u00a0regi\u00f3n\u00a0Ucayali\u00a01,932,832 \u00a0Gobierno \u00a0\nregional\u00a0Ucayali\u00a0Viable\u00a0 2010\u00a0\n115027\u00a0Acondicionamiento \u00a0promoci\u00f3n \u00a0de\u00a0la\u00a0salud\u00a0sexual\u00a0y\u00a0reproductiva \u00a0a\u00a0nivel\u00a0\ndistrital.,\u00a0distrito\u00a0de\u00a0el\u00a0agustino\u00a0\u2010\u00a0Lima\u00a0\u2010\u00a0Lima\u00a0\u2010\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0el\u00a0\nagustino\u00a0Viable\u00a0 2009\u00a0\n121221\u00a0Fortalecimiento \u00a0de\u00a0capacidades \u00a0sobre\u00a0salud\u00a0sexual\u00a0y\u00a0reproductiva, \u00a0\ndirigido\u00a0a\u00a0la\u00a0poblaci\u00f3n \u00a0de\u00a0adolescentes \u00a0y\u00a0j\u00f3venes\u00a0,,\u00a0distrito\u00a0de\u00a0Bel\u00e9n\u00a0\u2010\u00a0\nMaynas\u00a0\u2010\u00a0Loreto\u00a039,530\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0bel\u00e9n\u00a0En\u00a0\nevaluaci\u00f3n \u00a02009\u00a0\n132001\u00a0Fortalecimiento \u00a0de\u00a0las\u00a0capacidades \u00a0de\u00a0los\u00a0docentes\u00a0y\u00a0padres\u00a0de\u00a0familia\u00a0\nen\u00a0educaci\u00f3n \u00a0sexual,\u00a0distrito\u00a0de\u00a0V\u00edctor\u00a0Larco\u00a0herrera\u00a0\u2010 \u00a0Trujillo\u00a0\u2010 \u00a0La\u00a0\nLibertad\u00a09,910\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0V\u00edctor\u00a0\nLarco\u00a0herrera\u00a0No\u00a0Viable\u00a02009\u00a0\n132225\u00a0Construcci\u00f3n \u00a0de\u00a0un\u00a0albergue\u00a0para\u00a0enfermos \u00a0de\u00a0tuberculosis \u00a0MDR\u00a0y\u00a0VIH\u00a0\nSIDA\u00a0en\u00a0la\u00a0regi\u00f3n\u00a0Tacna\u00a03,098,129 \u00a0Gobierno \u00a0\nregional\u00a0Tacna\u00a0En\u00a0\nformulaci\u00f3n \u00a02009\u00a0\n132616\u00a0Prevenci\u00f3n \u00a0promoci\u00f3n \u00a0y\u00a0control\u00a0de\u00a0las\u00a0ITS\u2010VIH\u00a0SIDA\u00a0 1,327,770 \u00a0Gobierno \u00a0\nregional\u00a0\namazonas \u00a0En\u00a0\nformulaci\u00f3n \u00a02009\u00a0\n143153\u00a0Fortalecimiento \u00a0de\u00a0capacidades \u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0las\u00a0ITS,\u00a0VIH\u00a0y\u00a0\nSIDA\u00a0en\u00a0las\u00a0provincias \u00a0de\u00a0Maynas,\u00a0Requena, \u00a0Alto\u00a0Amazonas \u00a0y\u00a0Mariscal\u00a0\nram\u00f3n\u00a0castilla,\u00a0en\u00a0la\u00a0regi\u00f3n\u00a0Loreto\u00a01,911,821 \u00a0Gobierno \u00a0\nregional\u00a0Loreto\u00a0En\u00a0\nevaluaci\u00f3n \u00a02010\u00a0\n143419\u00a0Mejoramiento \u00a0del\u00a0acceso\u00a0a\u00a0los\u00a0servicios\u00a0de\u00a0salud\u00a0preventivo \u00a0\npromocionales \u00a0de\u00a0la\u00a0poblaci\u00f3n \u00a0general\u00a0y\u00a0personas\u00a0al\u00a0VIH\u00a0SIDA,\u00a0ITS\u00a0y\u00a0\nviolencia\u00a0sexual\u00a0en\u00a0la\u00a0micro\u00a0red\u00a0de\u00a0corrales\u00a0\u2010\u00a0red\u00a0tumbes\u00a01,733,919 \u00a0Gobierno \u00a0\nregional\u00a0tumbes\u00a0En\u00a0\nevaluaci\u00f3n \u00a02010\u00a0\n143575\u00a0Instalaci\u00f3n \u00a0de\u00a0promotores \u00a0juveniles\u00a0de\u00a0la\u00a0salud\u00a0en\u00a0tuberculosis, \u00a0VIH\u2010\nsida\u00a0y\u00a0desnutrici\u00f3n \u00a0a\u00a0nivel\u00a0distrital,\u00a0distrito\u00a0de\u00a0El\u00a0Agustino\u00a0\u2010\u00a0Lima\u00a0\u2013\u00a0Lima\u00a015,000\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0el\u00a0\nagustino\u00a0Viable\u00a0 2010\u00a0\n143755\u00a0Fortalecimiento \u00a0de\u00a0la\u00a0salud\u00a0sexual\u00a0y\u00a0reproductiva \u00a0a\u00a0nivel\u00a0distrital,\u00a0\ndistrito\u00a0de\u00a0el\u00a0agustino\u00a0\u2010\u00a0Lima\u00a0\u2010\u00a0Lima\u00a026,500\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0el\u00a0\nagustino\u00a0Viable\u00a0 2010\u00a0\n147597\u00a0\u201cFortalecimiento \u00a0de\u00a0capacidades \u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0y\u00a0control\u00a0de\u00a0\ninfecciones \u00a0de\u00a0transmisi\u00f3n \u00a0sexual\u00a0y\u00a0VIH\u2010sida\u00a0en\u00a0el\u00a0centro\u00a0de\u00a0referencia \u00a0\nde\u00a0infecciones \u00a0de\u00a0transmisi\u00f3n \u00a0sexual\u00a0\u2013\u00a0\u00a0CERITS\u00a0del\u00a0centro\u00a0de\u00a0salud\u00a0san\u00a0\nJos\u00e9\u00a0del\u00a0distrito\u00a0y\u00a0provincia\u00a0de\u00a0Piura\u201d\u00a01,139,604 \u00a0Gobierno \u00a0\nregional\u00a0Piura\u00a0En\u00a0\nformulaci\u00f3n \u00a02010\u00a0\n148118\u00a0Fortalecimiento \u00a0de\u00a0capacidades \u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0las\u00a0ITS,\u00a0VIH\u00a0y\u00a0\nSIDA\u00a0en\u00a0las\u00a0provincias \u00a0de\u00a0Maynas,\u00a0Requena, \u00a0alto\u00a0amazonas \u00a0y\u00a0mariscal\u00a0\nRam\u00f3n\u00a0Castilla,\u00a0en\u00a0la\u00a0regi\u00f3n\u00a0Loreto\u00a01,911,821 \u00a0Gobierno \u00a0\nregional\u00a0Loreto\u00a0En\u00a0\nformulaci\u00f3n \u00a02010\u00a0\n150134\u00a0Fortalecimiento \u00a0para\u00a0la\u00a0implementaci\u00f3n \u00a0del\u00a0plan\u00a0comunicacional \u00a0en\u00a0los\u00a0\nprogramas \u00a0articuladas \u00a0a\u00a0nutrici\u00f3n\u00a0y\u00a0salud\u00a0sexual\u00a0reproductivo, \u00a0provincia\u00a0\nde\u00a0Tarma\u00a0\u2010\u00a0Jun\u00edn\u00a025,000\u00a0Municipalidad \u00a0\nprovincial \u00a0de\u00a0\nTarma\u00a0Viable\u00a0 2010\u00a0\n171405\u00a0Fortalecimiento \u00a0de\u00a0la\u00a0gesti\u00f3n\u00a0institucional \u00a0de\u00a0las\u00a0redes\u00a0de\u00a0salud\u00a0para\u00a0la\u00a0\natenci\u00f3n\u00a0preventivo \u00a0promocional \u00a0y\u00a0control\u00a0del\u00a0VIH\u00a0\u2010\u00a0SIDA\u00a0en\u00a0la\u00a0regi\u00f3n\u00a0\ntumbes\u00a02,839,433 \u00a0Gobierno \u00a0\nregional\u00a0tumbes\u00a0En\u00a0\nevaluaci\u00f3n \u00a02010\u00a0\n172689\u00a0Instalaci\u00f3n \u00a0de\u00a0red\u00a0de\u00a0consejeras \u00a0y\u00a0consejeros \u00a0para\u00a0la\u00a0prevenci\u00f3n \u00a0de\u00a0VIH\u00a0\n\u2010\u00a0SIDA\u00a0y\u00a0ITS\u00a0a\u00a0nivel\u00a0distrital.,\u00a0distrito\u00a0de\u00a0el\u00a0agustino\u00a0\u2010\u00a0Lima\u00a0\u2013\u00a0Lima\u00a020,000\u00a0Municipalidad \u00a0\ndistrital\u00a0de\u00a0el\u00a0\nagustino\u00a0Viable\u00a0 2011\u00a0\n\u00a0\nFuente:\u00a0Banco\u00a0de\u00a0proyectos \u00a0del\u00a0Sistema\u00a0de\u00a0inversi\u00f3n\u00a0P\u00fablica\u00a0\u2013\u00a0SNIP\u00a0\u00a0 www.mef.gob.pe 100 \u00a0\nAnexo\u00a04\u00a0\u2010\u00a0Ensayos\u00a0cl\u00ednicos\u00a0relacionados \u00a0al\u00a0VIH\u00a0registrados \u00a0por\u00a0el\u00a0INS\u00a0\ndesde\u00a0el\u00a0a\u00f1o\u00a01998\u00a0\u00a0\n\u00a0\n\u00a0\nC\u00f3digo\u00a0 Titulo\u00a0del\u00a0Ensayo\u00a0Cl\u00ednico\u00a0 Estado\u00a0 A\u00f1o\u00a0\n018\u201098\u00a0MESILATO \u00a0DE\u00a0MELAVIRDINA: \u00a0COMPARACI\u00d3N \u00a0FARMACOCIN\u00c9TICA, \u00a0RANDOMIZADA, \u00a0DE\u00a0GRUPOS\u00a0PARALELOS \u00a0\nY\u00a0MARBETE \u00a0ABIERTO\u00a0DE\u00a0SQV+3TC+AZT+DLV \u00a0DOS\u00a0O\u00a0TRES\u00a0VECES\u00a0DIARIAS\u00a0VS\u00a0SQV+3TC+AZT+DLV \u00a0EN\u00a0EL\u00a0\nTRATAMIENTO \u00a0DE\u00a0PACIENTES \u00a0VIH\u00a0POSITIVOS \u00a0Finalizado \u00a01998\u00a0\n024\u201099\u00a0ESTUDIO\u00a0ABIERTO\u00a0RANDOMIZADO \u00a0DE\u00a0SUPERIORIDAD \u00a0COMPARATIVA \u00a0ENTRE\u00a0EMTRICITABINA \u00a0Y\u00a0ABACAVIR \u00a0\nCON\u00a0TERAPIA\u00a0COMBINADA \u00a0DE\u00a0TRES\u00a0MEDICAMENTOS \u00a0EN\u00a0PACIENTES \u00a0CON\u00a0HIV\u20101\u00a0VIRGENES \u00a0DE\u00a0\nTRATAMIENTO \u00a0ANTIRETROVIRAL \u00a0Finalizado \u00a01999\u00a0\n025\u201099\u00a0ESTUDIO\u00a0ABIERTO\u00a0RANDOMIZADO \u00a0DE\u00a0SUPERIORIDAD \u00a0COMPARATIVA \u00a0ENTRE\u00a0EMTRICITABINA \u00a0Y\u00a0ABACAVIR \u00a0\nCON\u00a0TERAPIA\u00a0COMBINADA \u00a0DE\u00a0TRES\u00a0MEDICAMENTOS \u00a0EN\u00a0PACIENTES \u00a0CON\u00a0HIV\u20101\u00a0VIRGENES \u00a0DE\u00a0\nTRATAMIENTO \u00a0ANTIRETROVIRAL \u00a0Finalizado \u00a01999\u00a0\n036\u201001\u00a0ENSAYO\u00a0CLINICO\u00a0MULTICENTRICO \u00a0DE\u00a0FASE\u00a0II\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0CAPACIDAD \u00a0DE\u00a0GENERACION \u00a0DE\u00a0\nRESPUESTA \u00a0INMUNE\u00a0Y\u00a0LA\u00a0SEGURDAD \u00a0DE\u00a0LA\u00a0VACUNA\u00a0ALVAC\u2010HIVVCP1452 \u00a0ADMINSTRADA \u00a0SOLA\u00a0Y\u00a0EN\u00a0\nCOMBINACION \u00a0CON\u00a0LA\u00a0VACUNA\u00a0MN\u00a0RGP\u00a0120/HIV\u20101\u00a0Finalizado \u00a02001\u00a0\n031\u201002\u00a0ESTUDIO\u00a0MULTICENTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0DE\u00a0CUATRO\u00a0GRUPOS\u00a0PARALELOS, \u00a0ALEATORIZADO, \u00a0PARA\u00a0\nINVESTIGAR \u00a0LA\u00a0DOSIS\u00a0RESPUESTA \u00a0DE\u00a0MICAFUNGIN \u00a0(FK463)\u00a0COMPARADO \u00a0CON\u00a0FLUCONAZOL, \u00a0\nADMINISTRADOS \u00a0A\u00a0PACIENTES \u00a0VIH\u00a0POSITIVOS \u00a0CON\u00a0ESOFAGITIS \u00a0CANDIDIASICA \u00a0CONFIRMADA \u00a0Finalizado \u00a02002\u00a0\n027\u201002\u00a0ESTUDIO\u00a0FASE\u00a0IIA\u00a0DEL\u00a0DB289\u00a0PARA\u00a0EL\u00a0TRATAMIENTO \u00a0DE\u00a0SEGUNDA \u00a0LINEA\u00a0DE\u00a0LA\u00a0NEUMONIA \u00a0POR\u00a0\nPNEUMOCYSTIS \u00a0CARINII\u00a0EN\u00a0PACIENTES \u00a0CON\u00a0INFECCION \u00a0POR\u00a0VIH\u00a0Finalizado \u00a02002\u00a0\n033\u201002\u00a0ESTUDIO\u00a0MULTICENTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0DE\u00a0CUATRO\u00a0GRUPOS\u00a0PARALELOS, \u00a0ALEATORIZADO, \u00a0PARA\u00a0\nINVESTIGAR \u00a0LA\u00a0DOSIS\u00a0RESPUESTA \u00a0DE\u00a0MICAFUNGIN \u00a0(FK463)\u00a0COMPARADO \u00a0CON\u00a0FLUCONAZOL, \u00a0\nADMINISTRADOS \u00a0A\u00a0PACIENTES \u00a0VIH\u00a0POSITIVOS \u00a0CON\u00a0ESOFAGITIS \u00a0CANDIDIASICA \u00a0CONFIRMADA \u00a0Finalizado \u00a02002\u00a0\n081\u201002\u00a0ENSAYO\u00a0CLINICO,\u00a0RANDOMIZADO, \u00a0DOBLE\u00a0CIEGO,\u00a0CONTROLADO \u00a0CONTRA\u00a0PLACEBO\u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0\nPARA\u00a0LA\u00a0REDUCCION \u00a0DE\u00a0LA\u00a0ADQUISICION \u00a0DE\u00a0LA\u00a0INFECCION \u00a0CON\u00a0EL\u00a0VIRUS\u00a0DE\u00a0LA\u00a0INMUNODEFICIENCIA \u00a0\nHUMANA \u00a0(VIH)\u00a0EN\u00a0INDIVIDUOS \u00a0SEROPOSITIVOS \u00a0AL\u00a0VIRUS\u00a0DEL\u00a0HERPES\u00a0SIMPLE\u00a0TIPO\u00a02\u00a0Y\u00a0SERONEGATIVOS \u00a0AL\u00a0\nVIH\u00a0Finalizado \u00a02002\u00a0\n082\u201002\u00a0ENSAYO\u00a0CLINICO,\u00a0CRUZADO, \u00a0RANDOMIZADO, \u00a0DOBLE\u00a0CIEGO,\u00a0CONTROLADO \u00a0CONTRA\u00a0PLACEBO\u00a0UTILIZANDO \u00a0\nVALACICLOVIR \u00a0PARA\u00a0SUPRIMIR \u00a0LA\u00a0EXCRECION \u00a0DEL\u00a0VIRUS\u00a0HERPES\u00a0SIMPLE\u00a0(\u00a0VHS\u00a0)\u00a0Y\u00a0VIRUS\u00a0DE\u00a0LA\u00a0\nINMUNODEFICIENCIA \u00a0HUMANA \u00a0(VIH)\u00a0EN\u00a0INDIVIDUOS \u00a0COINFECTADOS \u00a0CON\u00a0EL\u00a0VIH\u00a0TIPO\u00a01\u00a0Y\u00a0EL\u00a0VHS\u00a0TIPO\u00a02\u00a0Finalizado \u00a02002\u00a0\n032\u201002\u00a0ESTUDIO\u00a0DE\u00a0FASE\u00a0III\u00a0DE\u00a0PEG\u2010INTRON\u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0POR\u00a0HIV\u00a0QUE\u00a0HAYAN\u00a0EXPERIMENTADO \u00a0\nMULTIPLES \u00a0TRATAMIENTOS \u00a0Finalizado \u00a02002\u00a0\n046\u201002\u00a0ESTUDIO\u00a0DE\u00a0FASE\u00a0II,\u00a0DOBLE\u00a0CIEGO\u00a0RANDIMIZADO, \u00a0CONTROLADO \u00a0CON\u00a0PACEBO,\u00a0SOBRE\u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0LA\u00a0\nEFICACIA\u00a0AL\u00a0AGREGAR \u00a0ENTECAVIR \u00a0A\u00a0LA\u00a0TERAPIA\u00a0ACTUAL\u00a0CON\u00a0LAMIVUDINA \u00a0EN\u00a0PACIENTES \u00a0CO\u2010\nINFECTADOS \u00a0CON\u00a0HIV\u00a0Y\u00a0VHB\u00a0QUE\u00a0PRESENTAN \u00a0VIREMIA\u00a0POR\u00a0HEPATITIS \u00a0B\u00a0DURANTE \u00a0EL\u00a0TRATAMIENTO \u00a0CON\u00a0\nLAMIVUDINA \u00a0Finalizado \u00a02002\u00a0\n069\u201002\u00a0ATAZANAVIR \u00a0(BMS\u2010232632)\u00a0PARA\u00a0EL\u00a0TRATAMIENTO \u00a0DE\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0HIV\u00a0QUE\u00a0\nCOMPLETARON \u00a0LOS\u00a0ENSAYOS \u00a0CLINICOS \u00a0CON\u00a0ATAZANAVIR: \u00a0UN\u00a0ESTUDIO\u00a0DE\u00a0ACCESO\u00a0EXTENDIDO \u00a0Finalizado \u00a02002\u00a0\n063\u201003\u00a0ESTUDIO\u00a0DE\u00a0FASE\u00a0III\u00a0B,\u00a0ABIERTO, \u00a0ALEATORIZADO \u00a0Y\u00a0MULTICENTRICO, \u00a0PARA\u00a0EVALUAR \u00a0EL\u00a0EFECTO\u00a0SOBRE\u00a0LOS\u00a0\nLIPIDOS\u00a0SERICOS\u00a0DE\u00a0UN\u00a0CAMBIO\u00a0AL\u00a0INHIBIDOR \u00a0DE\u00a0LA\u00a0PROTEASA \u00a0(IP)\u00a0ATAZANAVIR, \u00a0EN\u00a0PACIENTES \u00a0\nINFECTADOS \u00a0POR\u00a0EL\u00a0VIH\u20101\u00a0QUE\u00a0MUESTRAN \u00a0SUPRESION \u00a0VIROLOGICA \u00a0EN\u00a0SU\u00a0PRIMERA \u00a0TERAPIA\u00a0\nANTIRRETROVIRAL \u00a0QUE\u00a0CONTIENEN \u00a0IP\u00a0Finalizado \u00a02003\u00a0\n033\u201003\u00a0ESTUDIO\u00a0MUNDIAL \u00a0DE\u00a0FASE\u00a0I,\u00a0DE\u00a0DOSIS\u00a0ESCALADAS, \u00a0SOBRE\u00a0LA\u00a0SEGURIDAD, \u00a0TOLERABILIDAD \u00a0E\u00a0\nINMUNOGENICIDAD \u00a0DE\u00a0UN\u00a0REGIMEN \u00a0DE\u00a03\u00a0DOSIS\u00a0DE\u00a0LA\u00a0VACUNA\u00a0DE\u00a0GAG\u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0MRKAD5\u00a0EN\u00a0\nADULTOS \u00a0SALUDABLES \u00a0Finalizado \u00a02003\u00a0\n029\u201003\u00a0UN\u00a0ESTUDIO\u00a0LOCAL\u00a0DE\u00a048\u00a0SEMANAS, \u00a0EN\u00a0MODALIDAD \u00a0ABIERTA,\u00a0CON\u00a0UN\u00a0SOLO\u00a0GRUPO\u00a0DE\u00a0\nTRATAMIENTO,ACERCA \u00a0DE\u00a0LA\u00a0EFICACIA, \u00a0SEGURIDAD \u00a0Y\u00a0TOLERABILIDAD \u00a0DE\u00a0TRIZIVIR\u00a0(ABACAVIR, \u00a0300\u00a0\nMG/LAMIVUDINA, \u00a0150\u00a0MG/ZIDOVUDINA, \u00a0300\u00a0MG\u00a0EN\u00a0COMBINACION \u00a0EN\u00a0UNA\u00a0TERAPIA\u00a0DOS\u00a0VECES\u00a0POR\u00a0\nDIA)\u00a0ADMINISTRADA \u00a0A\u00a0SUJETOS\u00a0ADULTOS \u00a0HISPANOS \u00a0PERUANOS \u00a0INFECTADOS \u00a0POR\u00a0VIH\u20101\u00a0SIN\u00a0UN\u00a0\nTRATAMIENTO \u00a0ANTIRRETROVIRAL \u00a0PREVIO,CON \u00a0RECUENTOS \u00a0BASALES\u00a0DE\u00a0LINFOCITOS \u00a0CD4<400\u00a0\nCELULAS/MM3) \u00a0Finalizado \u00a02003\u00a0\n017\u201003\u00a0PROTOCOLO \u00a0DE\u00a0TRATAMIENTO \u00a0DEL\u00a0HIV\u00a0CON\u00a0PEG\u2010INTRON:\u00a0SUBESTUDIO \u00a0DEL\u00a0ESTUDIO\u00a0P00737\u00a0Y\u00a0DEL\u00a0\nESTUDIO\u00a0P00738\u00a0Finalizado \u00a02003\u00a0 101 C\u00f3digo\u00a0 Titulo\u00a0del\u00a0Ensayo\u00a0Cl\u00ednico\u00a0 Estado\u00a0 A\u00f1o\u00a0\n013\u201003\u00a0ESTUDIO\u00a0RANDOMIZADO, \u00a0DOBLE\u00a0CIEGO,\u00a0DE\u00a0TRES\u00a0GRUPOS\u00a0PARALELOS, \u00a0CONTROLADO \u00a0CON\u00a0PLACEBO, \u00a0DE\u00a0\nFASE\u00a03,\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0EFICACIA\u00a0Y\u00a0SEGURIDAD \u00a0CLINICA\u00a0DE\u00a0POLYPHENON\u00ae \u00a0E\u00a0EN\u00a0EL\u00a0TRATAMIENTO \u00a0DE\u00a0\nLAS\u00a0VERRUGAS \u00a0GENITALES \u00a0EXTERNAS \u00a0Activo\u00a0 2003\u00a0\n022\u201003\u00a0ESTUDIO\u00a0DE\u00a0FASE\u00a0III,\u00a0RANDOMIZADO, \u00a0DOBLE\u00a0CIEGO,\u00a0CONTROLADO \u00a0CON\u00a0PLACEBO, \u00a0SOBRE\u00a0SEGURIDAD \u00a0Y\u00a0\nEFICACIA\u00a0DEL\u00a0INTEFER\u00d3N \u00a0GAMMA\u20101B\u00a0SUBCUTANEO \u00a0(IFN\u2010Y\u00a01B)\u00a0EN\u00a0COMBINACION \u00a0CON\u00a0TERAPIA\u00a0\nANTIFUNGICA \u00a0ESTANDAR \u00a0PARA\u00a0EL\u00a0TRATAMIENTO \u00a0DE\u00a0MENINGITIS \u00a0CRIPTOC\u00d3CCICA \u00a0AGUDA\u00a0EN\u00a0PACIENTES \u00a0\nCON\u00a0SINDROME \u00a0DE\u00a0INMUNODEFICIENCIA \u00a0ADQUIRIDA \u00a0(SIDA)\u00a0Finalizado \u00a02003\u00a0\n025\u201003\u00a0ESTUDIO\u00a0DE\u00a0FASE\u00a0III,\u00a0RANDOMIZADO, \u00a0DOBLE\u00a0CIEGO,\u00a0CONTROLADO \u00a0CON\u00a0PLACEBO, \u00a0SOBRE\u00a0SEGURIDAD \u00a0Y\u00a0\nEFICACIA\u00a0DEL\u00a0INTEFER\u00d3N \u00a0GAMMA\u20101B\u00a0SUBCUTANEO \u00a0(IFN\u2010Y\u00a01B)\u00a0EN\u00a0COMBINACION \u00a0CON\u00a0TERAPIA\u00a0\nANTIFUNGICA \u00a0ESTANDAR \u00a0PARA\u00a0EL\u00a0TRATAMIENTO \u00a0DE\u00a0MENINGITIS \u00a0CRIPTOC\u00d3CCICA \u00a0AGUDA\u00a0EN\u00a0PACIENTES \u00a0\nCON\u00a0SINDROME \u00a0DE\u00a0INMUNODEFICIENCIA \u00a0ADQUIRIDA \u00a0(SIDA)\u00a0Finalizado \u00a02003\u00a0\n070\u201004\u00a0ESTUDIO\u00a05175:ESTUDIO \u00a0FASE\u00a0IV\u00a0PROSPECTIVO, \u00a0RANDOMIZADO \u00a0Y\u00a0ETIQUETA \u00a0ABIERTA\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0\nEFICACIA\u00a0DE\u00a0UN\u00a0ESQUEMA \u00a0UNA\u00a0VEZ\u00a0AL\u00a0DIA\u00a0CONTENIENDO \u00a0UN\u00a0INHIBIDOR \u00a0DE\u00a0LA\u00a0PROTEASA \u00a0Y\u00a0UN\u00a0\nESQUEMA \u00a0UNA\u00a0VEZ\u00a0AL\u00a0DIA\u00a0CONTENIENDO \u00a0UN\u00a0INHIBIDOR \u00a0NO\u2010NUCLE\u00d3SIDO \u00a0DE\u00a0LA\u00a0TRANSCRIPTASA \u00a0\nREVERSA\u00a0PARA\u00a0EL\u00a0TRATAMIENTO \u00a0INICIAL\u00a0DE\u00a0PERSONAS \u00a0INFECTADAS \u00a0POR\u00a0EL\u00a0VIH\u20101\u00a0EN\u00a0REGIONES \u00a0DE\u00a0\nRECURSOS \u00a0LIMITADOS. \u00a0ESTUDIO\u00a0\"PEARLS\". \u00a0VERSI\u00d3N\u00a0FINAL\u00a02.0,\u00a0DEL\u00a002\u00a0DE\u00a0AGOSTO,\u00a02006.\u00a0ESTUDIO\u00a0\nA5185S:EFECTO \u00a0DEL\u00a0TRATAMIENTO \u00a0ANTIRETROVIRAL \u00a0INICIAL\u00a0SOBRE\u00a0EL\u00a0VIH\u00a0DEL\u00a0COMPARTIMIENTO \u00a0\nGENITAL\u00a0EN\u00a0INDIVIDUOS \u00a0DE\u00a0REGIONES \u00a0DE\u00a0RECURSOS \u00a0LIMITADOS. \u00a0Activo\u00a0 2004\u00a0\n019\u201004\u00a0ESTUDIO\u00a0FASE\u00a0IV\u00a0RANDOMIZADO, \u00a0ABIERTO, \u00a0MULTICENTRICO, \u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0EFICACIA\u00a0ANTIVIRAL \u00a0Y\u00a0LA\u00a0\nSEGURIDAD \u00a0DE\u00a0ATAZANAVIR \u00a0CON\u00a0Y\u00a0SIN\u00a0RITONAVIR \u00a0EN\u00a0COMBINACI\u00d3N \u00a0CON\u00a0LAMIVUDINA \u00a0Y\u00a0STADUVINA \u00a0DE\u00a0\nLIBERACI\u00d3N \u00a0PROLONGADA \u00a0EN\u00a0PACIENTES \u00a0VIRGENES \u00a0DE\u00a0TRATAMIENTO \u00a0ANTIRRETROVIRAL \u00a0Finalizado \u00a02004\u00a0\n020\u201005\u00a0ESTUDIO\u00a0DE\u00a0COHORTE \u00a0PROSPECTIVO \u00a0DE\u00a0SEROCONVERTORES \u00a0EN\u00a0EL\u00a0HPTN\u00a0039:\u00a0EL\u00a0EFECTO\u00a0DE\u00a0LA\u00a0\nSUPRESI\u00d3N \u00a0DEL\u00a0VHS\u20102\u00a0EN\u00a0EL\u00a0SET\u00a0POINT\u00a0VIRAL\u00a0DEL\u00a0VIH\u20101\u00a0Finalizado \u00a02005\u00a0\n009\u201005\u00a0UN\u00a0ESTUDIO\u00a0DE\u00a0PRUEBA\u00a0DE\u00a0CONCEPTO \u00a0DE\u00a0FASE\u00a0II,\u00a0CONTROLADO \u00a0POR\u00a0PLACEBO, \u00a0MULTIC\u00c9NTRICO, \u00a0DOBLE\u00a0\nCIEGO\u00a0ALEATORIZADO, \u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0LA\u00a0EFICACIA\u00a0DE\u00a0UN\u00a0R\u00c9GIMEN \u00a0DE\u00a03\u00a0DOSIS\u00a0DE\u00a0LA\u00a0\nVACUNA\u00a0DE\u00a0GAG/POL/NEF \u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0ADENOVIRUS \u00a0SEROTIPO \u00a05\u00a0DE\u00a0MERCK\u00a0(MRKAD5) \u00a0EN\u00a0ADULTOS \u00a0EN\u00a0\nALTO\u00a0RIESGO\u00a0DE\u00a0INFECCI\u00d3N \u00a0POR\u00a0VIH\u20101\u00a0Finalizado \u00a02005\u00a0\n007\u201005\u00a0UN\u00a0ESTUDIO\u00a0MULTIC\u00c9NTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADO, \u00a0DE\u00a0DETERMINACI\u00d3N \u00a0DE\u00a0RANGO\u00a0DE\u00a0DOSIS\u00a0\nPARA\u00a0COMPARAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0ACTIVIDAD \u00a0DE\u00a0L\u2010000900612 \u00a0M\u00c1S\u00a0TENOFOVIR \u00a0Y\u00a0LAMIVUDINA \u00a0(3TC)\u00a0EN\u00a0\nCOMPARACI\u00d3N \u00a0CON\u00a0EFAVIRENZ \u00a0M\u00c1S\u00a0TENOFOVIR \u00a0Y\u00a0LAMIVUDINA \u00a0(3TC)\u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0\nVIH\u00a0NO\u00a0SOMETIDOS \u00a0A\u00a0ART\u00a0Finalizado \u00a02005\u00a0\n054\u201005\u00a0VICRIVIROC \u00a0(SCH\u00a0417690)\u00a0EN\u00a0EL\u00a0TRATAMIENTO \u00a0COMBINADO \u00a0CON\u00a0UN\u00a0R\u00c9GIMEN \u00a0ANTIRETROVIRAL \u00a0\nOPTIMIZADO \u00a0EN\u00a0SUJETOS\u00a0CON\u00a0TRATAMIENTO \u00a0ANTIRETROVIRAL \u00a0PREVIO\u00a0(ESTUDIO \u00a0VICTOR\u2010E1)\u00a0Finalizado \u00a02005\u00a0\n017\u201006\u00a0ESTUDIO\u00a0DE\u00a0FASE\u00a0II,\u00a0ALEATORIO, \u00a0DOBLE,\u00a0CONTROLADO \u00a0CONTRA\u00a0PLACEBO, \u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0PARA\u00a0\nLA\u00a0SUPRESION \u00a0DE\u00a0LA\u00a0CARGA\u00a0VIRAL\u00a0DEL\u00a0VIRUS\u00a0DE\u00a0INMUNODEFICIENCIA \u00a0HUMANA \u00a0TIPO\u00a01\u00a0(VIH\u20101)\u00a0Y\u00a0LA\u00a0\nEXCRECI\u00d3N \u00a0MUCOSA\u00a0DE\u00a0VIH\u20101\u00a0VIRUS\u00a0HERPES\u00a0SIMPLE\u00a0TIPO\u00a02\u00a0(VHS\u20102)\u00a0EN\u00a0MUJERES \u00a0CO\u2010INFECTADAS \u00a0Finalizado \u00a02006\u00a0\n007\u201006\u00a0ESTUDIO\u00a0MULTIC\u00c9NTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADO, \u00a0CONTROLADO \u00a0CON\u00a0PLACEBO\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0\nSEGURIDAD \u00a0Y\u00a0ACTIVIDAD \u00a0ANTIRETROVIRAL \u00a0DE\u00a0MK\u20100518\u00a0EN\u00a0COMBINACI\u00d3N \u00a0CON\u00a0UNA\u00a0TERAPIA\u00a0DE\u00a0FONDO\u00a0\nOPTIMIZADA \u00a0(OBT),\u00a0VERSUS\u00a0UNA\u00a0TERAPIA\u00a0DE\u00a0FONDO\u00a0OPTIMIZADA \u00a0SOLA\u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0\nVIH\u00a0CON\u00a0RESISTENCIA \u00a0DOCUMENTADA \u00a0A\u00a0POR\u00a0LO\u00a0MENOS\u00a01\u00a0F\u00c1RMACO \u00a0DE\u00a0CADA\u00a0UNA\u00a0DE\u00a0LAS\u00a03\u00a0CLASES\u00a0DE\u00a0\nTERAPIAS \u00a0ANTIRETROVIRALES \u00a0ORALES\u00a0AUTORIZADAS \u00a0Finalizado \u00a02006\u00a0\n020\u201006\u00a0ESTUDIO\u00a0INTERNACIONAL, \u00a0RANDOMIZADO, \u00a0CONTROLADO \u00a0DE\u00a0FASE\u00a03,\u00a0DE\u00a0DB289\u00a0EN\u00a0COMPARACI\u00d3N \u00a0CON\u00a0\nTRIMETOPRIMA \u2010SULFAMETOXAZOL \u00a0PARA\u00a0EL\u00a0TRATAMIENTO \u00a0DE\u00a0LA\u00a0NEUMON\u00cdA \u00a0AGUDA\u00a0POR\u00a0PNEUMOCISTIS \u00a0\nJIROVECI\u00a0(PCP)\u00a0EN\u00a0PACIENTES \u00a0CON\u00a0VIH/SIDA\u00a0Finalizado \u00a02006\u00a0\n089\u201006\u00a0ESTUDIO\u00a0PROSPECTIVO \u00a0ABIERTO, \u00a0MULTIC\u00c9NTRICO \u00a0DE\u00a0PREGABALINA \u00a0EN\u00a0EL\u00a0TRATAMIENTO \u00a0DEL\u00a0DOLOR\u00a0\nNEUROP\u00c1TICO \u00a0ASOCIADO \u00a0CON\u00a0LA\u00a0NEUROPATIA \u00a0PERIF\u00c9RICA \u00a0DIAB\u00c9TICA \u00a0NEURALGIA \u00a0POSTHERP\u00c9TICA, \u00a0\nDOLOR\u00a0NEUROP\u00c1TICO \u00a0PERIF\u00c9RICO \u00a0RELACIONADO \u00a0CON\u00a0EL\u00a0VIH\u00a0Y\u00a0DEL\u00a0DOLOR\u00a0NEUROP\u00c1TICO \u00a0PERIF\u00c9RICO \u00a0\nPROVOCADO \u00a0POR\u00a0QUIMIOTERAPIA \u00a0Finalizado \u00a02006\u00a0\n080\u201005\u00a0ESTUDIO\u00a0DE\u00a096\u00a0SEMANAS \u00a0DE\u00a0DURACI\u00d3N \u00a0QUE\u00a0COMPARA \u00a0LA\u00a0EFICACIA\u00a0ANTIVIRAL \u00a0Y\u00a0LA\u00a0SEGURIDAD \u00a0DE\u00a0\nATAZANAVIR/ \u00a0RITONAVIR \u00a0CON\u00a0LOPINAVIR/RITONAVIR, \u00a0CADA\u00a0UNO\u00a0COMBINADO \u00a0CON\u00a0DOSIS\u00a0FIJAS\u00a0DE\u00a0\nTENOFOVIR \u2010EMTRICITABINA, \u00a0ADMINISTRADAS \u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0VIH\u20101\u00a0QUE\u00a0SON\u00a0VIRGENES \u00a0\nDE\u00a0TRATAMIENTO \u00a0Finalizado \u00a02006\u00a0\n092\u201006\u00a0UN\u00a0ESTUDIO\u00a0MULTIC\u00c9NTRICO, \u00a0EN\u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADO, \u00a0CONTROLADO \u00a0CON\u00a0COMPARADOR \u00a0\nACTIVO\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0ACTIVIDAD \u00a0ANTIRRETROVIRAL \u00a0DE\u00a0MK\u20100518\u00a0EN\u00a0COMPARACI\u00d3N \u00a0\nCON\u00a0EFAVIRENZ \u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0VIH\u00a0NO\u00a0SOMETIDOS \u00a0A\u00a0TRATAMIENTO, \u00a0CADA\u00a0UNO\u00a0EN\u00a0\nCOMBINACI\u00d3N \u00a0CON\u00a0TRUVADATM \u00a0Activo\u00a0 2007\u00a0\n038\u201007\u00a0UN\u00a0ESTUDIO\u00a0MULTIC\u00c9NTRICO, \u00a0EN\u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADO, \u00a0CONTROLADO \u00a0CON\u00a0COMPARADOR \u00a0 Activo\u00a0 2007\u00a0 102 C\u00f3digo\u00a0 Titulo\u00a0del\u00a0Ensayo\u00a0Cl\u00ednico\u00a0 Estado\u00a0 A\u00f1o\u00a0\nACTIVO\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0ACTIVIDAD \u00a0ANTIRRETROVIRAL \u00a0DE\u00a0MK\u20100518\u00a0FRENTE\u00a0A\u00a0KALETRA\u00a0\nTM\u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0VIH\u00a0TRASLADADOS \u00a0DE\u00a0UN\u00a0R\u00c9GIMEN \u00a0ESTABLE\u00a0BASADO\u00a0EN\u00a0KALETRA\u00a0\nTM\u2010\u00a0ESTUDIO\u00a0B\u00a0\n068\u201007\u00a0VICRIVIROC \u00a0EN\u00a0EL\u00a0TRATAMIENTO \u00a0COMBINADO \u00a0CON\u00a0UN\u00a0R\u00c9GIMEN \u00a0ANTIRRETROVIRAL \u00a0OPTIMIZADO \u00a0EN\u00a0\nSUJETOS\u00a0INFECTADOS \u00a0CON\u00a0VIH\u00a0QUE\u00a0RECIBIERON \u00a0TRATAMIENTO \u00a0CON\u00a0ANTERIORIDAD. \u00a0(VICTOR\u00a0\u2013\u00a0E4)\u00a0Finalizado \u00a02007\u00a0\n072\u201006\u00a0QUIMIOPROFILAXIS \u00a0PARA\u00a0LA\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH\u00a0EN\u00a0HOMBRES \u00a0 Activo\u00a0 2007\u00a0\n008\u201007\u00a0ESTUDIO\u00a0CL\u00cdNICO\u00a0DE\u00a0FASE\u00a0IB\u00a0PARA\u00a0COMPARAR \u00a0LA\u00a0SEGURIDAD, \u00a0LA\u00a0TOLERABILIDAD \u00a0Y\u00a0LA\u00a0\nINMUNOGENICIDAD \u00a0DE\u00a0UNA\u00a0VACUNA\u00a0DE\u00a0REFUERZO \u00a0DEL\u00a0VECTOR\u00a0ADENOVIRAL \u00a0DEL\u00a0VIH\u20101\u00a0ADMINISTRADA \u00a0\nPOR\u00a0V\u00cdA\u00a0INTRAMUSCULAR, \u00a0INTRAD\u00c9RMICA \u00a0O\u00a0SUBCUT\u00c1NEA, \u00a0DESPU\u00c9S\u00a0DE\u00a0LA\u00a0ADMINISTRACI\u00d3N \u00a0POR\u00a0V\u00cdA\u00a0\nINTRAMUSCULAR \u00a0DE\u00a0UNA\u00a0VACUNA\u00a0DE\u00a0SENSIBILIZACI\u00d3N \u00a0DE\u00a0PL\u00c1SMIDOS \u00a0DE\u00a0ADN\u00a0DEL\u00a0VIH\u00a0A\u00a0PERSONAS \u00a0\nADULTAS \u00a0SANAS,\u00a0NO\u00a0INFECTADAS \u00a0POR\u00a0EL\u00a0VIH\u20101\u00a0Y\u00a0SEROPOSITIVAS \u00a0FRENTE\u00a0AL\u00a0ADENOVIRUS \u00a0TIPO\u00a05\u00a0Activo\u00a0 2007\u00a0\n011\u201007\u00a0ESTUDIO\u00a0MULTIC\u00c9NTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADO, \u00a0CONTROLADO \u00a0CON\u00a0PLACEBO\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0\nSEGURIDAD \u00a0Y\u00a0ACTIVIDAD \u00a0ANTIRRETROVIRAL \u00a0DE\u00a0MK\u20100518\u00a0EN\u00a0COMBINACI\u00d3N \u00a0CON\u00a0UNA\u00a0TERAPIA\u00a0DE\u00a0FONDO\u00a0\nOPTIMIZADA \u00a0(OBT)\u00a0VERSUS\u00a0UNA\u00a0TERAPIA\u00a0DE\u00a0FONDO\u00a0OPTIMIZADA \u00a0SOLA\u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0\nVIH\u00a0CON\u00a0RESISTENCIA \u00a0DOCUMENTADA \u00a0A\u00a0POR\u00a0LO\u00a0MENOS\u00a01\u00a0F\u00c1RMACO \u00a0DE\u00a0CADA\u00a0UNA\u00a0DE\u00a0LAS\u00a03\u00a0CLASES\u00a0DE\u00a0\nTERAPIAS \u00a0ANTIRRETROVIRALES \u00a0ORALES\u00a0AUTORIZADAS \u00a0Finalizado \u00a02007\u00a0\n039\u201007\u00a0UN\u00a0ESTUDIO\u00a0SOBRE\u00a0LA\u00a0ESTRATEGIA \u00a0DE\u00a0LA\u00a0INICIACI\u00d3N \u00a0INMEDIATA \u00a0VERSUS\u00a0INICIACI\u00d3N \u00a0DIFERIDO \u00a0DE\u00a0LA\u00a0\nTERAPIA\u00a0ANTIRRETROVIRAL \u00a0EN\u00a0PERSONAS \u00a0INFECTADAS \u00a0CON\u00a0VIH\u00a0TRATADAS \u00a0PARA\u00a0TUBERCULOSIS \u00a0CON\u00a0CD4\u00a0\n<\u00a0200\u00a0C\u00c9LULAS/MM3 \u00a0VERSI\u00d3N\u00a0FINAL\u00a01.0\u00a0DE\u00a014\u00a0DE\u00a0MARZO\u00a02005\u00a0Activo\u00a0 2007\u00a0\n007\u201008\u00a0EL\u00a0EFECTO\u00a0DE\u00a0UN\u00a0CURSO\u00a0CORTO\u00a0DE\u00a0COMBINACI\u00d3N \u00a0DE\u00a0TERAPIA\u00a0ANTIRETROVIRAL \u00a0PREVIA\u00a0ADMINISTRADA \u00a0\nPARA\u00a0LA\u00a0PREVENCI\u00d3N \u00a0DE\u00a0LA\u00a0TRANSMISI\u00d3N \u00a0DEL\u00a0VIH\u20101\u00a0DE\u00a0MADRE\u00a0A\u00a0HIJO\u00a0(PMTCT)\u00a0SOBRE\u00a0LA\u00a0EFICACIA\u00a0DE\u00a0\nUN\u00a0TRATAMIENTO \u00a0SUBSECUENTE \u00a0O\u00a0POSTERIOR \u00a0EN\u00a0PARTICIPANTES \u00a0\u201cCASI\u00a0NO\u00a0EXPUESTAS\u201d \u00a0A\u00a0\nTRATAMIENTO \u00a0Activo\u00a0 2008\u00a0\n021\u201008\u00a0ESTUDIO\u00a0FASE\u00a02B/3,\u00a0RANDOMIZADO, \u00a0DOBLE\u00a0CIEGO,\u00a0DE\u00a0CONFIRMACI\u00d3N \u00a0DE\u00a0DOSIS,\u00a0DE\u00a0SEGURIDAD, \u00a0\nEFICACIA\u00a0Y\u00a0TOLERABILIDAD \u00a0DE\u00a0APRICITABINA \u00a0VERSUS\u00a0LAMIVUDINA \u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0VIH\u20101\u00a0\nQUE\u00a0HAN\u00a0RECIBIDO \u00a0TRATAMIENTO \u00a0PREVIO,\u00a0Y\u00a0CON\u00a0MUTACI\u00d3N \u00a0M184V/I\u00a0EN\u00a0LA\u00a0TRANSCRIPTASA \u00a0REVERSA. \u00a0Finalizado \u00a02008\u00a0\n066\u201008\u00a0UN\u00a0ESTUDIO\u00a0MULTIC\u00c9NTRICO, \u00a0EN\u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADO, \u00a0CONTROLADO \u00a0CON\u00a0COMPARADOR \u00a0\nACTIVO\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0ACTIVIDAD \u00a0ANTIRRETROVIRAL \u00a0DE\u00a0MK\u20100518\u00a0EN\u00a0COMPARACI\u00d3N \u00a0\nCON\u00a0EFAVIRENZ \u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0VIH\u00a0NO\u00a0SOMETIDOS \u00a0A\u00a0TRATAMIENTO, \u00a0CADA\u00a0UNO\u00a0EN\u00a0\nCOMBINACI\u00d3N \u00a0CON\u00a0TRUVADA\u2122 \u00a0\u2010\u00a0ESTUDIO\u00a0DE\u00a0EXTENSI\u00d3N \u00a0Activo\u00a0 2008\u00a0\n054\u201008\u00a0ESTUDIO\u00a0MULTIC\u00c9NTRICO, \u00a0EN\u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADO, \u00a0DE\u00a0DETERMINACI\u00d3N \u00a0DEL\u00a0RANGO\u00a0DE\u00a0DOSIS\u00a0\nPARA\u00a0COMPARAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0ACTIVIDAD \u00a0DE\u00a0MK\u20100518\u00a0M\u00c1S\u00a0TENOFOVIR \u00a0Y\u00a0LAMIVUDINA \u00a0(3TC)\u00a0EN\u00a0\nCOMPARACI\u00d3N \u00a0CON\u00a0EFAVIRENZ \u00a0M\u00c1S\u00a0TENOFOVIR \u00a0Y\u00a0LAMIVUDINA \u00a0(3TC)\u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0\nVIH\u00a0NO\u00a0SOMETIDOS \u00a0A\u00a0ART\u2010\u00a0ESTUDIO\u00a0DE\u00a0EXTENSI\u00d3N \u00a0Finalizado \u00a02008\u00a0\n089\u201008\u00a0UN\u00a0ESTUDIO\u00a0MULTIC\u00c9NTRICO, \u00a0EN\u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADO, \u00a0CONTROLADO \u00a0CON\u00a0COMPARADOR \u00a0\nACTIVO\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0ACTIVIDAD \u00a0ANTIRRETROVIRAL \u00a0DE\u00a0MK\u20100518\u00a0FRENTE\u00a0A\u00a0KALETRA\u2122 \u00a0\nEN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0VIH\u00a0TRASLADADOS \u00a0DE\u00a0UN\u00a0R\u00c9GIMEN \u00a0ESTABLE\u00a0BASADO\u00a0EN\u00a0KALETRA\u2122 \u00a0\u2010\u00a0\nESTUDIO\u00a0B\u00a0Finalizado \u00a02008\u00a0\n124\u201008\u00a0UNA\u00a0PRUEBA\u00a0CLINICA\u00a0DE\u00a0FASE\u00a0III,\u00a0MULTIC\u00c9NTRICA, \u00a0EN\u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADA, \u00a0CONTROLADA \u00a0CON\u00a0\nCOMPARADOR \u00a0ACTIVO\u00a0PARA\u00a0ESTUDIAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0EFICACIA\u00a0DE\u00a0LA\u00a0ADMINISTRACI\u00d3N \u00a0UNA\u00a0VEZ\u00a0AL\u00a0\nD\u00cdA\u00a0DE\u00a0RALTEGRAVIR \u00a0(MK\u20100518)\u00a0FRENTE\u00a0A\u00a0LA\u00a0ADMINISTRACI\u00d3N \u00a0DOS\u00a0VECES\u00a0AL\u00a0D\u00cdA\u00a0DE\u00a0RALTEGRAVIR, \u00a0\nCADA\u00a0UNO\u00a0EN\u00a0COMBINACI\u00d3N \u00a0CON\u00a0TRUVADA, \u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0VIH\u00a0NO\u00a0SOMETIDOS \u00a0A\u00a0\nTRATAMIENTO \u00a0No\u00a0\nautorizado \u00a02008\u00a0\n008\u201008\u00a0ATAZANAVIR \u00a0(BMS\u2010232632)\u00a0PARA\u00a0EL\u00a0TRATAMIENTO \u00a0DE\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0HIV\u00a0QUE\u00a0HAN\u00a0\nCOMPLETADO \u00a0ESTUDIOS \u00a0CL\u00cdNICOS \u00a0DE\u00a0ATAZANAVIR: \u00a0UN\u00a0ESTUDIO\u00a0DE\u00a0ACCESO\u00a0EXTENDIDO \u00a0Activo\u00a0 2008\u00a0\n050\u201008\u00a0ESTUDIO\u00a0INTERNACIONAL \u00a0DE\u00a0TERAPIA\u00a0DIRECTAMENTE \u00a0OBSERVADA \u00a0MODIFICADA \u00a0VERSUS\u00a0TERAPIA\u00a0AUTO\u2010\nADMINISTRADA \u00a0PARA\u00a0PARTICIPANTES \u00a0EN\u00a0PRIMERA \u00a0FALLA\u00a0VIROL\u00d3GICA \u00a0A\u00a0TRATAMIENTO \u00a0ANTIRETROVIRAL \u00a0\nCON\u00a0UN\u00a0ESQUEMA \u00a0BASADO\u00a0EN\u00a0UN\u00a0INHIBIDOR \u00a0NO\u2010NUCLE\u00d3SIDO \u00a0DE\u00a0LA\u00a0TRANSCRIPTASA \u00a0REVERSA. \u00a0VERSI\u00d3N\u00a0\n1.0\u00a0FINAL,\u00a0FECHADA \u00a012/20/07 \u00a0Activo\u00a0 2008\u00a0\n001\u201009\u00a0ENSAYO\u00a0CL\u00cdNICO\u00a0DE\u00a0FASE\u00a02\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0SEGURIDAD \u00a0E\u00a0INMUNOGENICIDAD \u00a0DE\u00a0UN\u00a0R\u00c9GIMEN \u00a0DE\u00a0\nVACUNACI\u00d3N \u00a0DE\u00a0SENSIBILIZACI\u00d3N \u00a0Y\u00a0REFUERZO \u00a0CON\u00a0ADN\u00a0PGA2/JS7 \u00a0Y\u00a0MVA/HIV62, \u00a0ADMINISTRADO \u00a0A\u00a0\nPARTICIPANTES \u00a0ADULTOS \u00a0Y\u00a0SANOS,\u00a0QUE\u00a0NO\u00a0EST\u00c1N\u00a0INFECTADOS \u00a0CON\u00a0EL\u00a0VIH\u00a0Y\u00a0QUE\u00a0NO\u00a0HAN\u00a0RECIBIDO \u00a0\nNUNCA\u00a0UNA\u00a0VACCINIA \u00a0Activo\u00a0 2009\u00a0\n004\u201009\u00a0UNA\u00a0PRUEBA\u00a0CRUZADA \u00a0CONTROLADA \u00a0CON\u00a0PLACEBO\u00a0RANDOMIZADA \u00a0DE\u00a0VALACYCLOVIR \u00a0PARA\u00a0EL\u00a0\nTRATAMIENTO \u00a0DE\u00a0LA\u00a0INFECCI\u00d3N \u00a0DEL\u00a0VIH\u00a0Activo\u00a0 2009\u00a0\n173\u201008\u00a0ESTUDIO\u00a0MULTIC\u00c9NTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADO, \u00a0CONTROLADO \u00a0CON\u00a0PLACEBO\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0\nSEGURIDAD \u00a0Y\u00a0ACTIVIDAD \u00a0ANTIRRETROVIRAL \u00a0DE\u00a0MK\u20100518\u00a0EN\u00a0COMBINACI\u00d3N \u00a0CON\u00a0UNA\u00a0TERAPIA\u00a0DE\u00a0FONDO\u00a0Activo\u00a0 2009\u00a0 103 C\u00f3digo\u00a0 Titulo\u00a0del\u00a0Ensayo\u00a0Cl\u00ednico\u00a0 Estado\u00a0 A\u00f1o\u00a0\nOPTIMIZADA \u00a0(OBT),\u00a0VERSUS\u00a0UNA\u00a0TERAPIA\u00a0DE\u00a0FONDO\u00a0OPTIMIZADA \u00a0SOLA\u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0CON\u00a0\nVIH\u00a0CON\u00a0RESISTENCIA \u00a0DOCUMENTADA \u00a0A\u00a0POR\u00a0LO\u00a0MENOS\u00a01\u00a0F\u00c1RMACO \u00a0DE\u00a0CADA\u00a0UNA\u00a0DE\u00a0LAS\u00a03\u00a0CLASES\u00a0DE\u00a0\nTERAPIAS \u00a0ANTIRRETROVIRALES \u00a0ORALES\u00a0AUTORIZADAS \u00a0\n032\u201009\u00a0MOMENTO \u00a0ESTRATEGICO \u00a0PARA\u00a0EL\u00a0TRATAMIENTO \u00a0ANTIRRETROVIRAL \u00a0 Activo\u00a0 2009\u00a0\n074\u201009\u00a0STRIDE:\u00a0\u201cUN\u00a0ESTUDIO\u00a0SOBRE\u00a0LA\u00a0ESTRATEGIA \u00a0DE\u00a0LA\u00a0INICIACI\u00d3N \u00a0INMEDIATA \u00a0VERSUS\u00a0INICIACI\u00d3N \u00a0DIFERIDA \u00a0\nDE\u00a0LA\u00a0TERAPIA\u00a0ANTIRRETROVIRAL \u00a0PARA\u00a0LA\u00a0SUPERVIVENCIA \u00a0LIBRE\u00a0DE\u00a0LA\u00a0ENFERMEDAD \u00a0SIDA\u00a0EN\u00a0PERSONAS \u00a0\nINFECTADAS \u00a0CON\u00a0VIH\u00a0TRATADAS \u00a0PARA\u00a0TUBERCULOSIS \u00a0CON\u00a0CD4\u00a0<250\u00a0C\u00c9LULAS/MM3\u201d \u00a0VERSI\u00d3N\u00a0FINAL\u00a02.0,\u00a0\nDE\u00a0FECHA\u00a013/FEB/09 \u00a0Activo\u00a0 2009\u00a0\n031\u201010\u00a0UN\u00a0ENSAYO\u00a0ALEATORIZADO \u00a0DOBLE\u00a0CIEGO\u00a0DE\u00a0FASE\u00a01B\u00a0REALIZADO \u00a0PARA\u00a0EXAMINAR \u00a0LA\u00a0INFLUENCIA \u00a0DE\u00a0LA\u00a0\nCOMPETENCIA \u00a0ANTIGENICA \u00a0SOBRE\u00a0LA\u00a0INMUNOGENICIDAD \u00a0DE\u00a0VIH\u20101\u00a0GAG/POL. \u00a0UNA\u00a0COMPARACION \u00a0DE\u00a0\nRAD5\u00a0GAG/POL \u00a0ENV\u00a0A/B/C\u00a0CON\u00a0RAD5\u00a0GAG/POL \u00a0Activo\u00a0 2010\u00a0\n076\u201010\u00a0UN\u00a0ESTUDIO\u00a0ALEATORIZADO, \u00a0DOBLE\u00a0CIEGO,\u00a0CONTROLADO \u00a0CON\u00a0PLACEBO, \u00a0DE\u00a0GRUPO\u00a0PARALELO, \u00a0\nMULTIC\u00c9NTRICO \u00a0DE\u00a0PREGABALINA \u00a0VERSUS\u00a0PLACEBO\u00a0EN\u00a0EL\u00a0TRATAMIENTO \u00a0DEL\u00a0DOLOR\u00a0NEUROP\u00c1TICO \u00a0\nASOCIADO \u00a0CON\u00a0NEUROPAT\u00cdA \u00a0POR\u00a0VIH\u00a0(PREGABALINA \u00a0A0081244) \u00a0Activo\u00a0 2010\u00a0\n078\u201010\u00a0ESTUDIO\u00a0PROSPECTIVO \u00a0MULTIC\u00c9NTRICO \u00a0INTERNACIONAL \u00a0ABIERTO\u00a0DE\u00a0RAMA\u00a0UNICA\u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0\nSEGURIDAD \u00a0LA\u00a0EFICACIA\u00a0Y\u00a0LA\u00a0FARMACOCIN\u00c9TICA \u00a0DE\u00a0ATAZANAVIR \u00a0(ATV)\u00a0EN\u00a0POLVO\u00a0CON\u00a0RITONAVIR \u00a0(RTV)\u00a0\nCON\u00a0TERAPIA\u00a0DE\u00a0BASE\u00a0OPTIMA\u00a0EN\u00a0PACIENTES \u00a0PEDI\u00c1TRICOS \u00a0INFECTADOS \u00a0CON\u00a0VIH\u00a0CON\u00a0EDADES\u00a0\nCOMPRENDIDAS \u00a0ENTRE\u00a0LOS\u00a03\u00a0MESES\u00a0DE\u00a0VIDA\u00a0(INCLUIDOS) \u00a0Y\u00a0LOS\u00a06\u00a0A\u00d1OS\u00a0Activo\u00a0 2010\u00a0\n007\u201010\u00a0ESTUDIO\u00a0ALEATORIZADO \u00a0DE\u00a0ETIQUETA \u00a0ABIERTA\u00a0QUE\u00a0COMPARA \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0EFICACIA\u00a0DEL\u00a0LOPINAVIR \u00a0\nPOTENCIADO \u00a0CON\u00a0RITONAVIR \u00a0Y\u00a0EL\u00a0TRATAMIENTO \u00a0DE\u00a0BASE\u00a0CON\u00a02\u20103N(T)RTI\u00a0CON\u00a0EL\u00a0LOPINAVIR \u00a0\nPOTENCIADO \u00a0CON\u00a0RITONAVIR \u00a0Y\u00a0RALTEGRAVIR \u00a0EN\u00a0PARTICIPANTES \u00a0QUE\u00a0NO\u00a0HAN\u00a0TENIDO\u00a0EXITO\u00a0CON\u00a0EL\u00a0\nTRATAMIENTO \u00a0DE\u00a0PRIMERA \u00a0LINEA\u00a0CON\u00a0NNRTI/2N(T) \u00a0RTI\u00a0POR\u00a0CAUSA\u00a0VIROLOGICA. \u00a0ESTUDIO\u00a0DE\u00a02A.\u00a0LINEA\u00a0Activo\u00a0 2010\u00a0\n057\u201010\u00a0VERSI\u00d3N\u00a0EST\u00c1NDAR \u00a0DE\u00a0TARGA\u00a0DEL\u00a0ESTUDIO\u00a0PROMISE \u00a0(SIGLAS\u00a0EN\u00a0INGL\u00c9S\u00a0\u2010PROMOTING \u00a0MATERNAL \u00a0AND\u00a0\nINFANT\u00a0SURVIVAL \u00a0EVERYWHERE \u00a0)\u00a0[\u201cPROMESA\u201d] \u00a0(PROMOCI\u00d3N \u00a0DE\u00a0LA\u00a0SOBREVIDA \u00a0MATERNO \u2010INFANTIL\u00a0EN\u00a0\nTODAS\u00a0PARTES)\u00a0Activo\u00a0 2010\u00a0\n030\u201010\u00a0ESTUDIO\u00a0FASE\u00a0I/II\u00a0PARA\u00a0ENCONTRAR \u00a0LA\u00a0DOSIS\u00a0DEL\u00a0TRATAMIENTO \u00a0CON\u00a0FLUCONAZOL \u00a0A\u00a0ALTAS\u00a0DOSIS\u00a0EN\u00a0LA\u00a0\nMENINGITIS \u00a0CRIPTOCOC\u00d3CICA \u00a0ASOCIADA \u00a0AL\u00a0SIDA\u00a0Activo\u00a0 2010\u00a0\n001\u201005\u00a0SEGURIDAD \u00a0Y\u00a0EFICACIA\u00a0DEL\u00a0INMUNOMODULADOR \u00a0BIOMUN\u00a0FORTE\u00ae\u00a0EN\u00a0PACIENTES \u00a0CON\u00a0INFECCI\u00d3N \u00a0POR\u00a0\nEL\u00a0VIRUS\u00a0DE\u00a0LA\u00a0INMUNODEFICIENCIA \u00a0HUMANA \u00a0O\u00a0VIRUS\u00a0DE\u00a0LA\u00a0HEPATITIS \u00a0C\u00a0Y\u00a0PACIENTES \u00a0CON\u00a0NEOPLASIAS \u00a0\nEN\u00a0EL\u00a0CENTRO\u00a0M\u00c9DICO\u00a0NAVAL,\u00a0CALLAO\u2010PER\u00da\u00a02004\u00a0No\u00a0\nautorizado \u00a02005\u00a0\n\u00a0 104 \u00a0 Anexo\u00a05\u00a0\u2010\u00a0Financiamiento \u00a0correspondiente \u00a0a\u00a0fuentes\u00a0externas\u00a0diferentes \u00a0a\u00a0los\u00a0cooperantes \u00a0de\u00a0\nnaciones\u00a0unidas\u00a0\u00a0\nVIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\nAGENCIA \u00a0ADVENTISTA \u00a0\nPARA\u00a0EL\u00a0DESARROLLO \u00a0Y\u00a0\nRECURSOS \u00a0\nASISTENCIALES \u2010PERU\u00a0FUNDACION \u00a0SODIS\u00a0PROMOCI\u00d2N \u00a0DE\u00a0LA\u00a0SALUD\u00a0A\u00a0TRAV\u00c8S\u00a0DEL\u00a0CONSUMO \u00a0DE\u00a0AGUA\u00a0SEGURA\u00a0Y\u00a0\nLAVADO\u00a0DE\u00a0MANOS\u00a0EN\u00a0LAS\u00a0PROVINCIAS \u00a0EN\u00a0LA\u00a0\u00a0\u00a0\u00a0 12,133\u00a0\u00a0 \u00a0 \u00a0 12\nAPOYO\u00a0A\u00a0PROGRAMAS \u00a0\nDE\u00a0POBLACION \u00a0USAID\u00a0 MERCADEO \u00a0SOCIAL\u00a0DEL\u00a0CONDON \u00a0PARA\u00a0POBLACIONES \u00a0VULNERABLES \u00a0\u00a0 333,660 89,004\u00a0\u00a0 \u00a0 \u00a0 \u00a0 422\nUSAID\u00a0 PROYECTO \u00a0DEL\u00a0INCREMENTO \u00a0EN\u00a0AL\u00a0ACSESO\u00a0EN\u00a0LOS\u00a0SERVICIOS \u00a0DE\u00a0SALUD\u00a0\nPARA\u00a0LA\u00a0PREVENCION \u00a0DE\u00a0ITS/VIH\u00a0EN\u00a0LA\u00a0POBLACION \u00a0VULNERABLE \u00a0\u00a0 110,541 \u00a0\u00a0\u00a0 \u00a0 \u00a0 110ASOCIACION \u00a0CIVIL\u00a0\u2010\nCAYETANO \u00a0HEREDIA\u2010\u00a0\nSALUD\u00a0Y\u00a0EDUCACION \u00a0 UNIVERSIDAD \u00a0DE\u00a0\nWASHINGTON \u00a0ENSAYO\u00a0CLINICO\u00a0DE\u00a0FASE\u00a0III,\u00a0ALEATORIO, \u00a0DOBLE\u00a0CIEGO,\u00a0CONTROLADO \u00a0\nCONTRA\u00a0PLACEBO\u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0PARA\u00a0LA\u00a0REDUCCION \u00a0DE\u00a0LA\u00a0\nADQUISICION \u00a0DEL\u00a0VIH\u00a0ENTRE\u00a0INDIVIDUOS \u00a0SEROPOSITIVOS \u00a0AL\u00a0VHS\u20102\u00a0Y\u00a0\nSERONEGATIVOS \u00a0AL\u00a0VIH\u00a0936,371 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 936\nASOCIACION \u00a0CIVIL\u00a0\nIMPACTA \u00a0SALUD\u00a0Y\u00a0\nEDUCACION \u00a0FRED\u00a0HUTCHINSON \u00a0\nCANCER\u00a0RESEARCH \u00a0\nCENTER\u00a0ESTUDIO\u00a0DE\u00a0PRUEBA\u00a0DE\u00a0CONCEPTO \u00a0DE\u00a0FASE\u00a0II,\u00a0CONTROLADO \u00a0POR\u00a0\nPLACEBO, \u00a0MULTICENTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0ALEATORIZADO, \u00a0PARA\u00a0EVALUAR \u00a0\nLA\u00a0INOCUIDAD \u00a0Y\u00a0LA\u00a0EFICACIA\u00a0DE\u00a0UN\u00a0REGIMEN \u00a0DE\u00a03\u00a0DOSIS\u00a0DE\u00a0LA\u00a0VACUNA\u00a0\nMRKAD5\u00a0HIV\u20101\u00a0GAG/POL/NEF \u00a0EN\u00a0ADENVIRUS \u00a0TIPO\u00a05\u00a0EN\u00a0ADULTOS \u00a0EN\u00a0\nALTO\u00a0RIESG\u00a0\u00a0 267,336 440,624 1,661,416 \u00a0\u00a0\u00a0 2,36\n\u00a0\u00a0 EVALUACION \u00a0DE\u00a0LAS\u00a0RESPUESTAS \u00a0INMUNOLOGICAS \u00a0Y\u00a0VIROLOGICAS \u00a0\nESPECIFICAS \u00a0AL\u00a0VIH\u00a0EN\u00a0INDIVIDUOS \u00a0SERONEGATIVOS \u00a0CON\u00a0MULTIPLES \u00a0\nEXPOSICIONES \u00a0AL\u00a0VIH\u20101\u00a0(TRIPLE\u00a0X)\u00a0\u00a0 69,321\u00a0149,543 67,510\u00a0\u00a0 \u00a0 \u00a0 286\n\u00a0\u00a0 EVALUACION \u00a0MULTICENTRICA \u00a0DE\u00a0LA\u00a0HISTORIA \u00a0NATURAL \u00a0VIROLOGICA, \u00a0\nINMUNOLOGICA \u00a0Y\u00a0CL\u00ccNICA\u00a0DE\u00a0LOS\u00a0PARTICIPANTES \u00a0ENROLADOS \u00a0EN\u00a0\nPROTOCOLOS \u00a0DE\u00a0FASE\u00a0I\u00a0Y\u00a0FASE\u00a0II\u00a0PARA\u00a0VACUNAS \u00a0CONTRA\u00a0EL\u00a0VIH\u00a0O\u00a0DE\u00a0\nPREPARACION \u00a0DE\u00a0VACUNAS \u00a0CONTRA\u00a0EL\u00a0VIH\u00a0EN\u00a0COHORTES \u00a0QUE\u00a0\nDESARROLLARON \u00a0LA\u00a0INFE\u00a0\u00a0\u00a0 1,226\u00a0\u00a0 \u00a0 \u00a0 \u00a0 1,\n\u00a0\u00a0 Evaluaci\u00f3n \u00a0multic\u00e9ntrica \u00a0de\u00a0la\u00a0Historia\u00a0Natural\u00a0Virol\u00f3gica, \u00a0Inmunol\u00f3gica \u00a0y\u00a0\nCl\u00ecnica\u00a0de\u00a0los\u00a0participantes \u00a0enrolados \u00a0en\u00a0protocolos \u00a0de\u00a0Fase\u00a0I\u00a0y\u00a0Fase\u00a0II\u00a0para\u00a0\nvacunas\u00a0contra\u00a0el\u00a0VIH\u00a0o\u00a0de\u00a0preparacion \u00a0de\u00a0vacunas\u00a0contra\u00a0el\u00a0VIH\u00a0en\u00a0\ncohortes\u00a0que\u00a0desarrollaron \u00a0la\u00a0infe\u00a0\u00a0 3,939\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 3,\n\u00a0\u00a0 Un\u00a0estudio\u00a0de\u00a0prueba\u00a0de\u00a0concepto \u00a0de\u00a0Fase\u00a0II,\u00a0controlado \u00a0por\u00a0placebo,\u00a0\nmultic\u00e9ntrico, \u00a0doble\u00a0ciego,\u00a0aleatorizado, \u00a0para\u00a0evaluar\u00a0la\u00a0inocuidad \u00a0y\u00a0la\u00a0\neficacia\u00a0de\u00a0un\u00a0r\u00e9gimen\u00a0de\u00a03\u00a0dosis\u00a0de\u00a0la\u00a0vacuna\u00a0MRKAd5\u00a0HIV\u20101\u00a0gag/pol/nef \u00a0\nen\u00a0Adenovirus \u00a0tipo\u00a05\u00a0en\u00a0adultos\u00a0en\u00a0alto\u00a0r\u00a03,707,965 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 3,70\n\u00a0 INSTITUTE \u00a0FOR\u00a0\nCLINICAL\u00a0RESEARCH \u00a0\nINC.\u00a0MOMENTO \u00a0ESTRAT\u00c9GICO \u00a0PARA\u00a0EL\u00a0TRATAMIENTO \u00a0ANTIRETROVIRAL \u00a0\n(STRATEGIC \u00a0TIMING\u00a0OF\u00a0ANTIRETROVIRAL \u00a0TREATMENT) \u00a0\u2010\u00a0START\u00a0 \u00a0\u00a0\u00a0 91,973\u00a0\u00a0 \u00a0 \u00a0 91\n\u00a0 MASSACHUSETTS \u00a0\nGENERAL \u00a0HOSPITAL \u00a0IMPACTO \u00a0DE\u00a0LA\u00a0INFECCI\u00d3N \u00a0AGUDA\u00a0POR\u00a0VIH\u00a0EN\u00a0LA\u00a0INMUNIDAD \u00a0CELULAR\u00a0\nESPECIFICA \u00a0PARA\u00a0EL\u00a0VIRUS\u00a0EPSTEIN\u00a0BAR\u00a0\u00a0\u00a0 380,707 452,449 \u00a0\u00a0\u00a0 833\n\u00a0\u00a0 TIPIFICACION \u00a0DE\u00a0ANTIGENOS \u00a0HLA\u00a0Y\u00a0MAPEO\u00a0DE\u00a0EPITOPES \u00a0EN\u00a0EL\u00a0DISE\u00d1O\u00a0DE\u00a0\nVACUNAS \u00a0CONTRA\u00a0EL\u00a0VIRUS\u00a0DE\u00a0LA\u00a0INMUNODEFICIENCIA \u00a0HUMANA \u00a0(VHI)\u00a0511,067 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 511 VIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\n\u00a0\u00a0 TIPIFICACION \u00a0DE\u00a0ANTIGENOS \u00a0HLA\u00a0Y\u00a0MAPEO\u00a0DE\u00a0EPITOPES \u00a0EN\u00a0EL\u00a0DISE\u00d1O\u00a0DE\u00a0\nVACUNAS \u00a0CONTRA\u00a0EL\u00a0VIRUS\u00a0DE\u00a0LA\u00a0INMUNODEFICIENCIA \u00a0HUMANA \u00a0(VIH)\u00a0\u00a0 502,970 258,962 94,308\u00a0\u00a0 \u00a0 \u00a0 856\n\u00a0 NATIONAL \u00a0\nINSTITUTES \u00a0OF\u00a0\nHEALTH\u00a0\u2013\u00a0NIH\u00a0COMPPREHENSIVE \u00a0INTERNATIONAL \u00a0PROGRAM \u00a0FOR\u00a0RESEARCH \u00a0(CIPRA)\u00a0\n3,351,297 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 3,35\n\u00a0\u00a0 COMPREHENSIVE \u00a0INTERNATIONAL \u00a0PROGRAM \u00a0FOR\u00a0RESEARCH \u00a0(CIPRA)\u00a0\u00a0 1,144,303 806,083 \u00a0\u00a0 \u00a0 \u00a0 1,95\n\u00a0\u00a0 FACTIBILIDAD \u00a0DE\u00a0UN\u00a0SERVICIO \u00a0DE\u00a0TAMIZAJE \u00a0CON\u00a0CONSEJERIA \u00a0UTILIZANDO \u00a0\nLA\u00a0PRUEBA\u00a0RAPIDA\u00a0PARA\u00a0VIH\u00a0EN\u00a0LUGARES \u00a0DE\u00a0COMERCIO \u00a0SEXUAL\u00a0EN\u00a0\nLIMA,\u00a0PERU\u00a0118,070 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 118\n\u00a0\u00a0 PROGRAMA \u00a0UNIDAD\u00a0DE\u00a0ENSAYOS \u00a0CLINICOS \u00a0DE\u00a0IMPACTA, \u00a0PERU\u00a0(CTU)\u00a0\u00a0 7,913,554 6,336,410 6,025,706 \u00a0\u00a0\u00a0 20,2\n\u00a0 SOCIAL\u00a0&\u00a0SCIENTIFIC \u00a0\nSYSTEMS, \u00a0INC\u00a0ESTUDIO\u00a0DE\u00a0FASE\u00a0IV,\u00a0RANDOMIZADO, \u00a0DE\u00a0ETIQUETA \u00a0ABIERTA,\u00a0PARA\u00a0LA\u00a0\nEVALUACION \u00a0DE\u00a0LA\u00a0EFICACIA\u00a0DE\u00a0UNA\u00a0COMBI\u00a0\u00a0\u00a0 206,822 \u00a0\u00a0 \u00a0 \u00a0 206\n\u00a0\u00a0 ESTUDIO\u00a0DE\u00a0FASE\u00a0IV,\u00a0RANDOMIZADO, \u00a0DE\u00a0ETIQUETA \u00a0ABIERTA,\u00a0PARA\u00a0LA\u00a0\nEVALUACION \u00a0DE\u00a0LA\u00a0EFICACIA\u00a0DE\u00a0UNA\u00a0COMBIANCION \u00a0DIARIA\u00a0BASADA\u00a0EN\u00a0\nUN\u00a0INHIBIDOR \u00a0DE\u00a0LA\u00a0PROTEASA \u00a0Y\u00a0UNA\u00a0COMBINACION \u00a0DIARIA\u00a0BASADA\u00a0EN\u00a0\nUN\u00a0INHIBIDOR \u00a0NO\u2010NUCLEOSIDO \u00a0DE\u00a0LA\u00a0TRANSCRIPTASA \u00a0RESERVA\u00a0COMO\u00a0\nTERAPIA\u00a0\u00a0 260,569 \u00a0\u00a0\u00a0 \u00a0 \u00a0 260\n\u00a0\u00a0 ESTUDIO\u00a0FASE\u00a0III,\u00a0RANDOMIZADO, \u00a0DE\u00a0ETIQUETA \u00a0ABIERTA,\u00a0PARA\u00a0EVALUAR \u00a0\nLA\u00a0EFICACIA\u00a0DE\u00a0UNA\u00a0COMBINACION \u00a0QUE\u00a0CONTIENE \u00a0INHIBIDORES \u00a0DE\u00a0LA\u00a0\nPROTEASA \u00a0QUE\u00a0SE\u00a0TOMAN\u00a0UNA\u00a0VEZ\u00a0AL\u00a0DIA\u00a0Y\u00a0COMBINACIONES \u00a0QUE\u00a0\nCONTIENEN \u00a0INHIBIDORES \u00a0DE\u00a0LA\u00a0TRANSCRIPTASA \u00a0REVERSA\u00a0QUE\u00a0SE\u00a01,318,403 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 1,31\n\u00a0\u00a0 ESTUDIO\u00a0GRANDE\u00a0Y\u00a0SENCILLO \u00a0DE\u00a0COMPARACION \u00a0DE\u00a0DOS\u00a0ESTRATEGIAS \u00a0\nPARA\u00a0EL\u00a0MANEJO\u00a0DE\u00a0LA\u00a0TERAPIA\u00a0ANTIRRETROVIRAL \u00a0(ESTUDIO \u00a0SMART)\u00a0\n(CPCRA\u00a0065)\u00a0(VERSION \u00a02.0)\u00a0337,984 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 337\n\u00a0\u00a0 ESTUDIO\u00a0GRANDE\u00a0Y\u00a0SENCILLO \u00a0DE\u00a0COMPARACION \u00a0DE\u00a0DOS\u00a0ESTRATEGIAS \u00a0\nPARA\u00a0MANEJO\u00a0DE\u00a0LA\u00a0TERAPIA\u00a0ANTIRRETROVIRAL \u00a0(SMART)\u00a0\u00a0 272,484 251,095 \u00a0\u00a0 \u00a0 \u00a0 523\n\u00a0\u00a0 PROTOCOLO \u00a0A5199\u00a0\u2010\u00a0ESTUDIO\u00a0INTERNACIONAL \u00a0DE\u00a0NEUROLOG\u00cdA \u00a0\n(INTERNATIONAL \u00a0NEUROLOGICAL \u00a0STUDY)\u00a0\u2010\u00a0A5199\u00a0SSS\u00a0\u00a0\u00a0\u00a0 59,758\u00a0\u00a0 \u00a0 \u00a0 59\n\u00a0\u00a0 PROTOCOLO \u00a0A5221\u00a0?\u00a0ESTUDIO\u00a0SOBRE\u00a0LA\u00a0ESTRATEGIA \u00a0DE\u00a0LA\u00a0INICIACI\u00d3N \u00a0\nINMEDIATA \u00a0VERSUS\u00a0INICIACI\u00d3N \u00a0DIFERIDA \u00a0DE\u00a0LA\u00a0TERAPIA\u00a0\nANTIRRETROVIRAL \u00a0EN\u00a0PERSONAS \u00a0INFECTADAS \u00a0CON\u00a0EL\u00a0VIH\u00a0TRATADAS \u00a0\nPARA\u00a0TUBERCULOSIS \u00a0CON\u00a0CD4\u00a0<\u00a0200\u00a0C\u00c9LULAS/MM3 \u00a0\u2010\u00a0A5221\u00a0SSS\u00a0\u00a0\u00a0\u00a0 124,456 \u00a0\u00a0\u00a0 124\n\u00a0 THE\u00a0HARVARD \u00a0\nMEDICAL\u00a0SCHOOL\u00a0\nCENTER\u00a0FOR\u00a0AIDS\u00a0\nRESEARCH \u00a0IMPACTO \u00a0DE\u00a0LA\u00a0DIVERSIDAD \u00a0VIRAL\u00a0Y\u00a0LA\u00a0RESPUESTA \u00a0CELULAR\u00a0EN\u00a0LA\u00a0\nPATOGENESIS \u00a0DEL\u00a0VIH\u00a0\u00a0 312,547 4,273\u00a0\u00a0 \u00a0 \u00a0 \u00a0 316\n\u00a0\u00a0 IMPACTO \u00a0DE\u00a0LA\u00a0DIVERSIDAD \u00a0VIRAL\u00a0Y\u00a0LA\u00a0RESPUESTA \u00a0CELULAR\u00a0EN\u00a0LA\u00a0\nPATOG\u00c9NESIS \u00a0DEL\u00a0VIH\u00a0110,779 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 110\n\u00a0 THE\u00a0J.\u00a0DAVID\u00a0\nGLADSTONE \u00a0\nINSTITUTES \u00a0QUIMIOPROFILAXIS \u00a0PARA\u00a0LA\u00a0PREVENCION \u00a0DEL\u00a0VIH\u00a0EN\u00a0HOMBRES \u00a0\n889,080 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 889\n\u00a0\u00a0 Quimioprofilaxis \u00a0para\u00a0la\u00a0prevencion \u00a0del\u00a0ViH\u00a0en\u00a0Hombres\u00a0Quimioprofilaxis \u00a0\npara\u00a0la\u00a0prevencion \u00a0del\u00a0ViH\u00a0en\u00a0Hombres\u00a0\u00a0 1,696,267 2,937,792 3,332,998 \u00a0\u00a0\u00a0 7,96 VIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\n\u00a0 UNIVERSITY \u00a0OF\u00a0\nWASHINGTON \u00a0ENSAYO\u00a0CLINICO\u00a0DE\u00a0FASE\u00a0III,\u00a0ALEATORIO, \u00a0DOBLE\u00a0CIEGO,\u00a0CONTROLADO \u00a0\nCONTRA\u00a0PALCEBO\u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0P\u00a0\u00a0\u00a0 1,858,585 \u00a0\u00a0 \u00a0 \u00a0 1,85\n\u00a0\u00a0 ENSAYO\u00a0CLINICO\u00a0DE\u00a0FASE\u00a0III,\u00a0ALEATORIO, \u00a0DOBLE\u00a0CIEGO,\u00a0CONTROLADO \u00a0\nCONTRA\u00a0PALCEBO\u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0PARA\u00a0LA\u00a0REDUCCION \u00a0DE\u00a0LA\u00a0\nADQUISICION \u00a0DEL\u00a0VIH\u00a0ENTRE\u00a0INDIFVIDUOS \u00a0SEROPOSITIVOS \u00a0AL\u00a0VHS\u20102\u00a0Y\u00a0\nSERONEGATIVOS \u00a0AL\u00a0VIH\u00a0(HPTN039 \u2010CORE)\u00a0\u00a0 2,383,821 \u00a0\u00a0\u00a0 \u00a0 \u00a0 2,38\n\u00a0\u00a0 ENSAYO\u00a0CLINICO\u00a0DE\u00a0FASE\u00a0III,\u00a0ALEATORIO, \u00a0DOBLE\u00a0CIEGO,\u00a0CONTROLADO \u00a0\nCONTRA\u00a0PLACEBO\u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0PARA\u00a0REDUCCION \u00a0DE\u00a0LA\u00a0\nADQUISICION \u00a0DEL\u00a0VIH\u00a0ENTRE\u00a0INDIVIDUOS \u00a0SEROPOSITIVOS \u00a0AL\u00a0VHS\u20102\u00a0Y\u00a0\nSERONEGATIVOS \u00a0AL\u00a0VIH\u00a05,404,751 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 5,40\nASOCIACION \u00a0CIVIL\u00a0SELVA\u00a0\nAMAZONICA \u00a0FRED\u00a0HUTCHINSON \u00a0\nCANCER\u00a0RESEARCH \u00a0\nCENTER\u00a0ENSAYO\u00a0DE\u00a0VACUNAS \u00a0CONTRA\u00a0EL\u00a0VIH:\u00a0FASE\u00a0I\u00a0\n84,214\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 84\n\u00a0\u00a0 ENSAYO\u00a0DE\u00a0VACUNAS \u00a0CONTRA\u00a0EL\u00a0VIH:\u00a0FASE\u00a0IB,\u00a0PARA\u00a0COMPARAR \u00a0LA\u00a0\nSEGURIDAD \u00a0Y\u00a0LA\u00a0TOLERABILIDAD \u00a0A\u00a0PERSONAS \u00a0ADULTAS \u00a0SANAS,\u00a0NO\u00a0\nINFECTADAS \u00a0POR\u00a0EL\u00a0VIH\u00a0\u00a0\u00a0 413,952 539,596 \u00a0\u00a0\u00a0 953\n\u00a0\u00a0 UN\u00a0ESTUDIO\u00a0DE\u00a0PRUEBA\u00a0DE\u00a0CONCEPTO \u00a0DE\u00a0FASE\u00a0II\u00a0CONTROLADO \u00a0POR\u00a0\nPLACEBO\u00a0MULTICENTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0ALEATORIZADO, \u00a0PARA\u00a0EVALUAR \u00a0\nLA\u00a0SEGURIDAD \u00a0Y\u00a0LA\u00a0EFICACIA\u00a0DE\u00a0UN\u00a0REGIMEN \u00a0DE\u00a03\u00a0DOSIS\u00a0DE\u00a0LA\u00a0VACUNA\u00a0\nDE\u00a0GAG/POL/NEF \u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0ADENOVIRUS \u00a0SEROTIPO \u00a05\u00a0DE\u00a0MERCK\u00a0\n(MRKAD5) \u00a0868,062 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 868\n\u00a0\u00a0 UN\u00a0ESTUDIO\u00a0DE\u00a0PRUEBA\u00a0DE\u00a0CONCEPTO \u00a0DE\u00a0FASE\u00a0II,\u00a0CONTROLADO \u00a0POR\u00a0\nPLACEBO, \u00a0MULTICENTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0ALEATORIZADO, \u00a0PARA\u00a0EVALUAR \u00a0\nLA\u00a0SEGURIDAD \u00a0Y\u00a0LA\u00a0EFICACIA\u00a0DE\u00a0UN\u00a0REGIMEN \u00a0DE\u00a03\u00a0DOSIS\u00a0DE\u00a0LA\u00a0\nVACUNAQ \u00a0DE\u00a0GAG/POL/NEF \u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0ADENOVIRUS \u00a0SEROTIPO \u00a05\u00a0DE\u00a0\nMERCK\u00a0(MRKAD\u00a0\u00a0\u00a0 1,069,395 530,793 \u00a0\u00a0\u00a0 1,60\n\u00a0 NATIONAL \u00a0\nINSTITUTES \u00a0OF\u00a0\nHEALTH\u00a0\u2010\u00a0NIH\u00a0ENSAYO\u00a0DE\u00a0VACUNAS \u00a0CONTRA\u00a0EL\u00a0VIH:\u00a0FASE\u00a0IB,\u00a0PARA\u00a0COMPARAR \u00a0LA\u00a0\nSEGURIDAD \u00a0Y\u00a0LA\u00a0TOLERABILIDAD \u00a0A\u00a0PERSONAS \u00a0ADULTAS \u00a0SANAS,\u00a0NO\u00a0\nINFECTADAS \u00a0POR\u00a0EL\u00a0VIH\u00a0\u00a0 629,215 \u00a0\u00a0\u00a0 \u00a0 \u00a0 629\n\u00a0\u00a0 UN\u00a0ESTUDIO\u00a0DE\u00a0PRUEBA\u00a0DE\u00a0CONCEPTO \u00a0DE\u00a0FASE\u00a0II,\u00a0CONTROLADO \u00a0POR\u00a0\nPLACEBO, \u00a0MULTICENTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0ALEATORIZADO, \u00a0PARA\u00a0EVALUAR \u00a0\nLA\u00a0SEGURIDAD \u00a0Y\u00a0LA\u00a0EFICACIA\u00a0DE\u00a0UN\u00a0REGIMEN \u00a0DE\u00a03\u00a0DOSIS\u00a0DE\u00a0LA\u00a0\nVACUNAQ \u00a0DE\u00a0GAG/POL/NEF \u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0ADENOVIRUS \u00a0SEROTIPO \u00a05\u00a0DE\u00a0\nMERCK\u00a0(MRKAD\u00a0\u00a0 1,520,198 \u00a0\u00a0\u00a0 \u00a0 \u00a0 1,52\n\u00a0 THE\u00a0J.\u00a0DAVID\u00a0\nGLADSTONE \u00a0\nINSTITUTES \u00a0QUIMIOPROFILAXIS \u00a0PARA\u00a0LA\u00a0PREVENCION \u00a0DEL\u00a0VIH\u00a0EN\u00a0HOMBRES \u00a0\n\u00a0 1,273,407 2,698,842 4,547,225 \u00a0\u00a0\u00a0 8,51\nASOCIACION \u00a0DE\u00a0\nCOMUNICADORES \u00a0\nSOCIALES \u00a0CALANDRIA \u00a0FUNDACION \u00a0AVINA\u00a0COMUNICACION \u00a0PARA\u00a0EL\u00a0DESARROLLO \u00a0Y\u00a0LA\u00a0DEMOCRACIA \u00a0\n\u00a0\u00a0 14,059\u00a0\u00a0 \u00a0 \u00a0 \u00a0 14\nASOCIACION \u00a0DE\u00a0\nDESARROLLO \u00a0DE\u00a0LA\u00a0\nEDUCACION \u00a0Y\u00a0LA\u00a0SALUD\u00a0STICHTING \u00a0\nVRIENDEN \u00a0VAN\u00a0\nADESA\u00a0CENTRI\u00a0DE\u00a0REHABILITACION \u00a0DISCAPACITADOS \u00a0COMAS\u00a0\n\u00a0\u00a0\u00a0 10,484\u00a0\u00a0 \u00a0 \u00a0 10 VIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\n\u00a0\u00a0 VIH\u00a0 \u00a0 4,719\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 4,\nASOCIACI\u00d3N \u00a0GRUPO\u00a0DE\u00a0\nTRABAJO \u00a0REDES\u00a0COMISION \u00a0EUROPEA \u00a0SALUD\u00a0SEXUAL\u00a0Y\u00a0REPRODUCTIVA, \u00a0Y\u00a0EMPODERAMIENTO \u00a0DE\u00a0\nADOLESCENTES \u00a0TRABAJADORAS \u00a0DEL\u00a0HOGAR\u00a0EN\u00a0SAN\u00a0JUAN\u00a0DE\u00a0MIRAFLORES12,225\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 12\nASOCIACION \u00a0KALLPA\u00a0\nPARA\u00a0LA\u00a0PROMOCION \u00a0\nINTEGRAL \u00a0DE\u00a0LA\u00a0SALUD\u00a0Y\u00a0\nEL\u00a0DESARROLLO \u00a0TERRE\u00a0DES\u00a0HOMMES \u00a0HABILIDADES \u00a0PARA\u00a0LA\u00a0VIDA\u00a0EN\u00a0TUMBES\u00a0\u2010\u00a0UNA\u00a0PROPUESTA \u00a0DE\u00a0\nPARTICIPACION \u00a0\u00a0 151,395 \u00a0\u00a0\u00a0 \u00a0 \u00a0 151\n\u00a0\u00a0 PROYECTO \u00a0DE\u00a0PREVENCION \u00a0DE\u00a0ITS/VIH/SIDA/ \u00a0Y\u00a0EMBARAZO \u00a0NO\u00a0DESEADO \u00a0\nEN\u00a0ADOLESCENTES \u00a0DE\u00a0CENTROS \u00a0E\u00a0INSTITUTOS \u00a0EDUCATIVOS \u00a0NOCTURNOS \u00a0\nDE\u00a0LA\u00a0CIUDAD\u00a0DE\u00a0IQUITOS\u00a0\u2010\u00a0PERU\u00a0\u00a0 132,701 \u00a0\u00a0\u00a0 \u00a0 \u00a0 132\n\u00a0 Iglesia\u00a0Sueca\u00a0 PROTAGONISMO \u00a0JUVENIL\u00a0PARA\u00a0LA\u00a0CONCERTACION \u00a0LOCAL\u00a0SOBRE\u00a0ITS\u00a0VIH\u2010\nSIDA\u00a0160,201 204,663 \u00a0\u00a0\u00a0 \u00a0 \u00a0 364\n\u00a0 ICCO\u00a0 MUNICIPIOS \u00a0SALUDABLES \u00a0EN\u00a0SALUD\u00a0SEXUAL\u00a0REPRODUCTIVA \u00a0Y\u00a0VIH\u00a0SIDA\u00a0\u00a0\u00a0\u00a0 276,649 \u00a0\u00a0\u00a0 276\n\u00a0\u00a0 PARTICIPACION \u00a0CIUDADANA \u00a0Y\u00a0JOVENES\u00a0EN\u00a0LA\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0SIDA\u00a0\u00a0 470,345 525,392 \u00a0\u00a0 \u00a0 \u00a0 995\nASOCIACION \u00a0MINGA\u00a0\nPERU\u00a0HIVOS\u00a0 74)MUJERES \u00a0Y\u00a0ADOLESCENTES \u00a0LIDERES\u00a0PROMOTORAS \u00a0DE\u00a0LA\u00a0EQUIDAD, \u00a0LA\u00a0\nPREVENCI\u00d3N \u00a0DE\u00a0LA\u00a0VIOLENCIA \u00a0Y\u00a0EL\u00a0VIH/S\u00a0\u00a0\u00a0\u00a0 13,053\u00a0\u00a0 \u00a0 \u00a0 13\n\u00a0 MATCH\u00a0\nINTERNATIONAL \u00a0\nCENTRE\u00a046)\u00a0CONSOLIDACION \u00a0Y\u00a0PROYECCION \u00a0DEL\u00a0TRABAJO\u00a0DE\u00a0CORRESPONSALES \u00a0Y\u00a0\nPROMOTORAS \u00a0TECNICAS \u00a0AGROFORESTALES \u00a0EN\u00a0\u00a0 \u00a0 10,419\u00a0\u00a0 \u00a0 \u00a0 \u00a0 10\n\u00a0\u00a0 61)\u00a0USO\u00a0Y\u00a0GESTI\u00d3N\u00a0DE\u00a0ALTO\u00a0PARLANTES \u00a0COMUNALES \u00a0PARA\u00a0LA\u00a0\nPRODUCCI\u00d3N \u00a0DESCENTRALIZADA \u00a0DE\u00a0MENSAJES \u00a0SOBRE\u00a0S\u00a0\u00a0\u00a0 10,585\u00a0\u00a0 \u00a0 \u00a0 \u00a0 10\n\u00a0 FUNDACION \u00a0AVINA\u00a0INICIATIVA \u00a0PARA\u00a0LA\u00a0INCLUSION \u00a0DE\u00a0COMUNIDADES \u00a0RURALES\u00a0AMAZONICAS \u00a0\nEN\u00a0EL\u00a0MERCADO \u00a0INTERNACIONAL \u00a0RESPONSALBE \u00a0DE\u00a0ARTESANIAS \u00a0\u00a0 13,811\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 13\n\u00a0 THE\u00a0GLOBAL\u00a0FUND\u00a0\nFOR\u00a0WOMEN\u00a050)\u00a0ACOMPA\u00d1AMIENTO \u00a0A\u00a0LA\u00a0LABOR\u00a0DE\u00a0LOS\u00a0CORRESPONSALES \u00a0RADIALES \u00a0\nEN\u00a0COMUNIDADES \u00a0RURALES\u00a0\u00a0\u00a0 9,404\u00a0\u00a0 \u00a0 \u00a0 \u00a0 9,\n\u00a0 FIA\u00a0 32B)\u00a0FORTALECIMIENTO \u00a0DE\u00a0LA\u00a0RED\u00a0DE\u00a0MUJERES \u00a0DEL\u00a0R\u00cdO\u00a0MARA\u00d1\u00d3N \u00a0Y\u00a0\nTIGRE\u00a0A\u00a0TRAV\u00c9S\u00a0DEL\u00a0MODELO\u00a0INTEGRADO \u00a0DE\u00a0C\u00a0\u00a0\u00a0 32,074\u00a0\u00a0 \u00a0 \u00a0 \u00a0 32\n\u00a0\u00a0 68)\u00a0INTERCAMBIO \u00a0DE\u00a0EXPERIENCIAS \u00a0EN\u00a0MICROCREDITO \u00a0RURAL\u00a0Y\u00a0\nTECNICAS \u00a0ESPECIALIZADAS \u00a0EN\u00a0RECAUDACION \u00a0\u00a0\u00a0\u00a0 9,963\u00a0\u00a0 \u00a0 \u00a0 9,\nASOCIACION \u00a0PERUANA \u00a0\nPARA\u00a0LA\u00a0PREVENCION \u00a0DE\u00a0\nEMBARAZOS \u00a0NO\u00a0\nDESEADOS \u00a0Agencia\u00a0Canadiense \u00a0Prevenci\u00f3n \u00a0de\u00a0Embarazos \u00a0No\u00a0Planificados \u00a0e\u00a0Infecciones \u00a0de\u00a0Transmisi\u00f3n \u00a0\nSexual\u00a0y\u00a0VIH\u00a0Sida\u00a0en\u00a0Adolescent \u00a0\u00a0\u00a0 22,242\u00a0\u00a0 \u00a0 \u00a0 \u00a0 22\n\u00a0 Fondo\u00a0Canada\u00a0 PREVENCION \u00a0DE\u00a0EMBARAZOS \u00a0E\u00a0INFECCIONES \u00a0DE\u00a0TRANSMIS\u00d3N \u00a0SEXUAL\u00a0\nCON\u00a0ENFASIS\u00a0EN\u00a0ADOLESCENTES \u00a0\u00a0\u00a0\u00a0 39,622\u00a0\u00a0 \u00a0 \u00a0 39\nASOCIACION \u00a0SAN\u00a0LUCAS\u00a0\u2010\u00a0\nSAN\u00a0MARTIN\u00a0LUKE\u00a0SOCIETY\u00a0 ?PREVENCI\u00d3N \u00a0DE\u00a0VIH\u2010SIDA\u00a0E\u00a0ITS\u00a0Y\u00a0PROMOCI\u00d3N \u00a0DE\u00a0PR\u00c1CTICAS \u00a0DE\u00a0\nCONDUCTAS \u00a0SALUDABLES? \u00a0\u00a0 59,476\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 59\nASOCIACION \u00a0VIA\u00a0LIBRE\u00a0ALLIANCE \u00a0 CENTRO\u00a0REGIONAL \u00a0DE\u00a0ASISTENCIA \u00a0T\u00c9CNICA\u00a0 \u00a0\u00a0 112,170 211,639 \u00a0\u00a0\u00a0 323\n\u00a0\u00a0 INCIDENCIA \u00a0POLITICA\u00a0EN\u00a0VIH\u00a0Y\u00a0SIDA\u00a0CON\u00a0POBLACIONES \u00a0CLAVE\u00a0 \u00a0 431,602 \u00a0\u00a0\u00a0 \u00a0 \u00a0 431\n\u00a0\u00a0 VEEDURIA \u00a0EN\u00a0SALUD\u00a0DE\u00a0LAS\u00a0POBLACIONES \u00a0CLAVE,\u00a0UNA\u00a0RESPUESTA \u00a0\nPOSITIVA \u00a0Y\u00a0PREVENTIVA \u00a0AL\u00a0VIH.\u00a0\u00a0\u00a0 311,909 221,322 \u00a0\u00a0\u00a0 533 VIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\n\u00a0 HIVOS\u00a0 PROYECTO \u00a0INSTITUCIONAL \u00a02006\u00a0\u2010\u00a02008\u00a0 \u00a0 345,436 306,358 \u00a0\u00a0 \u00a0 \u00a0 651\n\u00a0\u00a0 PROYECTO \u00a0INSTITUCIONAL \u00a02006\u20102008/\u00a0ADENDA\u00a02009\u20102010\u00a0 \u00a0\u00a0\u00a0 204,156 \u00a0\u00a0\u00a0 204\n\u00a0 TERRE\u00a0DES\u00a0HOMMES \u00a0ADOLESCENTES \u00a0EN\u00a0SITUACION \u00a0DE\u00a0EXPLOTACION \u00a0SEXUAL\u00a0COMERCIAL \u00a0\nPREVINIENDO \u00a0EL\u00a0VIH\u00a0E\u00a0ITS\u00a0EN\u00a0LIMA\u00a0METROPOLI \u00a0\u00a0\u00a0 133,733 \u00a0\u00a0 \u00a0 \u00a0 133\n\u00a0\u00a0 HIROSHIMA: \u00a0LOS\u00a0ADOLESCENTES \u00a0GESTIONAN \u00a0SU\u00a0CAMBIO\u00a0 \u00a0 3\u00a0 155,606 \u00a0\u00a0 \u00a0 \u00a0 155\n\u00a0\u00a0 NI\u00d1OS\u00a0Y\u00a0NI\u00d1AS\u00a0POR\u00a0LA\u00a0VIDA\u00a0CREANDO \u00a0UN\u00a0ENTORNO \u00a0FAVORABLE \u00a0EN\u00a0\nVIH/SIDA\u00a0129,881 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 129\n\u00a0\u00a0 NI\u00d1OS\u00a0Y\u00a0NI\u00d1AS\u00a0POR\u00a0LA\u00a0VIDA,\u00a0CREANDO \u00a0UN\u00a0ENTORNO \u00a0FAVORABLE \u00a0EN\u00a0\nVIH/SIDA\u00a0\u00a0 138,472 123,301 139,327 \u00a0\u00a0\u00a0 401\n\u00a0\u00a0 PROMOTORES \u00a0PARES\u00a0ADOLESCENTES \u00a0PROMOVIENDO \u00a0UNA\u00a0COMUNIDAD \u00a0\nSALUDABLE \u00a0EN\u00a0SALUD\u00a0SEXUAL\u00a0CON\u00a0\u00c9NFASIS\u00a0EN\u00a0VIH\u00a0\u00a0\u00a0\u00a0 175,619 \u00a0\u00a0\u00a0 175\n\u00a0\u00a0 PROMOVIENDO \u00a0CONDICIONES \u00a0FAVORABLES \u00a0PARA\u00a0DISMINUIR \u00a0LA\u00a0\nVULNERABILIDAD \u00a0Y\u00a0EL\u00a0IMPACTO \u00a0DE\u00a0LA\u00a0EXPLOTACION \u00a0S\u00a0\u00a0\u00a0 136,742 146,886 \u00a0\u00a0\u00a0 283\n\u00a0\u00a0 PROMOVIENDO \u00a0CONDICIONES \u00a0FAVORABLES \u00a0PARA\u00a0DISMINUIR \u00a0LA\u00a0\nVULNERABILIDAD \u00a0Y\u00a0EL\u00a0IMPACTO \u00a0DE\u00a0LA\u00a0EXPLOTACI\u00d3N \u00a0SEXUAL\u00a0COMERCIAL \u00a0\nINFANTIL\u00a0Y\u00a0ADOLESCENTE \u00a0(ESCIA),\u00a0UNA\u00a0INICIATIVA \u00a0ENFOCADA \u00a0A\u00a0EVITAR\u00a0\nLA\u00a0RE\u2010VICTIMIZACI\u00d3N \u00a0DE\u00a0LOS\u00a0NI\u00d1OS,\u00a0NI\u00d1AS\u00a0Y\u00a0ADOLESCENTES \u00a0EN\u00a0LIMA\u00a0\nMETROPOLITA \u00a0\u00a0\n142,832 \u00a0\u00a0\u00a0 \u00a0 \u00a0 142\n\u00a0 COMISION \u00a0EUROPEA \u00a0MEJORANDO \u00a0EL\u00a0ENTORNO \u00a0SOCIAL\u00a0Y\u00a0EL\u00a0ACCESO\u00a0A\u00a0LOS\u00a0SERVICIOS \u00a0DE\u00a0\nPOBLACIONES \u00a0DE\u00a0HSH\u00a0VIVIENDO \u00a0CON\u00a0O\u00a0VULNERABLES \u00a0AL\u00a0VIH\u00a0\u2010\u00a0SIDA\u00a0\u00a0 770,588 1,011,328 1,309,166 \u00a0\u00a0\u00a0 3,09\n\u00a0 MERCK\u00a0SHARP\u00a0&\u00a0\nDOHME\u00a0ESTUDIO\u00a0DE\u00a096\u00a0SEMANAS \u00a0DE\u00a0DURACI\u00d3N \u00a0QUE\u00a0COMPARA \u00a0LA\u00a0EFICACIA\u00a0\nANTIVIRAL \u00a0Y\u00a0LA\u00a0SEGURIDAD \u00a0DE\u00a0ATAZANVIR/RITONAVIR \u00a0CON\u00a0\nLOPINAVIR/RITONAVIR, \u00a0CADA\u00a0UNO\u00a0COMBINADO \u00a0CON\u00a0DOSIS\u00a0FIJAS\u00a0DE\u00a0\nTENOFIVIR \u2010EMTRICITABINA, \u00a0ADMINISTRADAS \u00a0EN\u00a0PACIENTES \u00a0INFECTADOS \u00a0\nCON\u00a0VIH\u20101\u00a0QUE\u00a0SON\u00a0V\u00cdRGE\u00a03\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u00a0\u00a0 UN\u00a0ESTUDIO\u00a0DE\u00a0PRUEBA\u00a0DE\u00a0CONCEPTO \u00a0DE\u00a0FASE\u00a0II,\u00a0CONTROLADO \u00a0POR\u00a0\nPLACEBO, \u00a0MULTIC\u00c9NTRICO, \u00a0DOBLE\u00a0CIEGO,\u00a0RANDOMIZADO, \u00a0PARA\u00a0\nEVALUAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0LA\u00a0EFICACIA\u00a0DE\u00a0UN\u00a0R\u00c9GIMEN \u00a0DE\u00a03\u00a0DOSIS\u00a0DE\u00a0LA\u00a0\nVACUNA\u00a0DE\u00a0GAG/POL/NEF \u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0ADENOVIRUS \u00a0SEROTIPO \u00a05\u00a0DE\u00a0\nMERCK\u00a0(MRKAD5 \u00a0226,123 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 226\n\u00a0 CHILDREN \u00a0AFFECTED \u00a0\nBY\u00a0AIDS\u00a0\nFOUNDACION \u00a0BOYS\u00a0AND\u00a0GIRLS\u00a0FOR\u00a0LIFE,\u00a0CREATING \u00a0A\u00a0FAVORABLE \u00a0ENVIRONMENT \u00a0FOR\u00a0\nHIV/AIDS\u00a0\u00a0 21,306\u00a014,633\u00a0\u00a0 \u00a0 \u00a0 \u00a0 35\n\u00a0 GESTOS\u00a0BRASIL\u00a0 MONITOREO \u00a0DE\u00a0LOS\u00a0DERECHOS \u00a0SEXUALES \u00a0Y\u00a0REPRODUCTIVOS \u00a0EN\u00a0LOS\u00a0\nPLANES\u00a0NACIONALES \u00a0VIH/SIDA, \u00a0EN\u00a0BASE\u00a0A\u00a0UNGASS\u00a0\u00a0 23,863\u00a04,041\u00a0\u00a0 \u00a0 \u00a0 \u00a0 27\n\u00a0 PACT\u00a0 CONTRIBUYENDO \u00a0A\u00a0LA\u00a0MEJORA\u00a0EN\u00a0LA\u00a0COBERTURA, \u00a0EL\u00a0ACCESO\u00a0Y\u00a0LA\u00a0\nCALIDAD\u00a0DE\u00a0LOS\u00a0ACTUALES \u00a0SERVICIOS \u00a0VIH\u00a0PARA\u00a0\u00a0\u00a0 134,330 \u00a0\u00a0 \u00a0 \u00a0 134\n\u00a0\u00a0 CONTRIBUYENDO \u00a0A\u00a0LA\u00a0MEJORA\u00a0EN\u00a0LA\u00a0COBERTURA, \u00a0EL\u00a0ACCESO\u00a0Y\u00a0LA\u00a0\nCALIDAD\u00a0DE\u00a0LOS\u00a0ACTUALES \u00a0SERVICIOS \u00a0VIH\u00a0PARA\u00a0TRABAJADORES/AS \u00a0\nSEXUALES, \u00a0HSH\u00a0Y\u00a0LA\u00a0POBLACI\u00d3N \u00a0TRANSG\u00c9NERO \u00a0EN\u00a0UNA\u00a0ACCI\u00d3N\u00a0\nCONJUNTA \u00a0ENTRE\u00a0UN\u00a0CENTRO\u00a0DE\u00a0SALUD\u00a0Y\u00a0UNA\u00a0ONG\u00a0DE\u00a0LIMA/CALLAO. \u00a0\u00a0 70,420\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 70\n\u00a0\u00a0 POLICIA\u00a0SEGURA:\u00a0REDES\u00a0DE\u00a0PROMOTORES \u00a0POLICIAS\u00a0EN\u00a0PREVENCION \u00a0DE\u00a0\u00a0\u00a0 167,137 \u00a0\u00a0 \u00a0 \u00a0 167 VIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\nVIH/SIDA\u00a0EN\u00a0LA\u00a0POBLACION \u00a0POLICIAL\u00a0PERU\u00a0\n\u00a0\u00a0 POLICIA\u00a0SEGURA:\u00a0REDES\u00a0DE\u00a0PROMOTORES \u00a0POLICIAS\u00a0EN\u00a0PREVENCI\u00d3N \u00a0DE\u00a0\nVIH/SIDA\u00a0EN\u00a0LA\u00a0POBLACI\u00d3N \u00a0POLICIAL\u00a0PERUANA \u00a0Y\u00a0EN\u00a0PROYECCI\u00d3N \u00a0A\u00a0LA\u00a0\nCOMUNIDAD \u00a0\u00a0 119,926 \u00a0\u00a0\u00a0 \u00a0 \u00a0 119\nCATHOLIC \u00a0INSTITUTE \u00a0FOR\u00a0\nINTERNATIONAL \u00a0\nRELATIONS \u00a0CATHOLIC \u00a0INSTITUTE \u00a0\nFOR\u00a0\nINTERNATIONAL \u00a0\nRELATIONS \u00a0FORTALECIENDO \u00a0EL\u00a0PROGRAMA \u00a0DE\u00a0SOPORTE \u00a0A\u00a0LA\u00a0AUTOAYUDA \u00a0DE\u00a0\nPERSONAS \u00a0VIVIENDO \u00a0CON\u00a0VIH/SIDA\u00a065,279\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 65\nCATHOLIC \u00a0RELIEF\u00a0\nSERVICES \u00a0CATHOLIC \u00a0RELIEF\u00a0\nSERVICES \u00a0\u00a0PROMOVIENDO \u00a0ESTILOS\u00a0DE\u00a0VIDA\u00a0SALUDABLES \u00a0PARA\u00a0PREVENIR \u00a0EL\u00a0VIH\u00a0Y\u00a0\nSIDA\u00a0EN\u00a0ADOLESCENTES \u00a0Y\u00a0JOVENES\u00a0\u00a0 61,400\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 61\nCENTRO\u00a0DE\u00a0ESTUDIOS \u00a0DE\u00a0\nPROBLEMAS \u00a0\nECONOMICOS \u00a0Y\u00a0SOCIALES \u00a0\nDE\u00a0LA\u00a0JUVENTUD \u00a0Ayuntamientos \u00a0\nEspa\u00f1a\u00a0INTERVENCION \u00a0EDUCATIVA \u00a0EN\u00a0TRABAJADORAS \u00a0SEXUALES \u00a0PARA\u00a0PREVENIR \u00a0\nLA\u00a0ITS,\u00a0VIH\u00a0Y\u00a0SIDA\u00a074,040\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 74\nCENTRO\u00a0DE\u00a0\nINFORMACION \u00a0Y\u00a0\nEDUCACION \u00a0PARA\u00a0LA\u00a0\nPREVENCION \u00a0DEL\u00a0ABUSO\u00a0\nDE\u00a0DROGAS\u00a0GTZ\u00a0 ARMONIZACION \u00a0DE\u00a0LAS\u00a0POLITICAS \u00a0PUBLICAS \u00a0SOBRE\u00a0EDUCACION \u00a0SEXUALY\u00a0\nPREVENCION \u00a0DEL\u00a0VIH/SIDA\u00a0Y\u00a0DROGAS\u00a0\n\u00a0 437,985 \u00a0\u00a0\u00a0 \u00a0 \u00a0 437\n\u00a0\u00a0 ARMONIZACION \u00a0DE\u00a0POLITICAS \u00a0PUBLICAS \u00a0PARA\u00a0LA\u00a0EDUCACION \u00a0SEXUAL\u00a0Y\u00a0\nLA\u00a0PREVENCION \u00a0DEL\u00a0VIH\u2010SIDA\u00a0Y\u00a0DROGAS\u00a0\u00a0\u00a0 359,288 \u00a0\u00a0 \u00a0 \u00a0 359\nCENTRO\u00a0DE\u00a0\nINVESTIGACION, \u00a0\nDOCUMENTACION, \u00a0\nEDUCACION, \u00a0ASESORIA \u00a0Y\u00a0\nSERVICIOS. \u00a0Agencia\u00a0Suiza\u00a0 VALORACION \u00a0ECONOMICA \u00a0Y\u00a0ECOLOGICA \u00a0DE\u00a0LA\u00a0BIODIVERSIDAD \u00a0EN\u00a0EL\u00a0\nMARCO\u00a0DE\u00a0LOS\u00a0S\u00a0ISTEMAS\u00a0BIOCULTURALES \u00a0Y\u00a0EL\u00a0\n\u00a0\u00a0\u00a0 7,905\u00a0\u00a0 \u00a0 \u00a0 7,\nCENTRO\u00a0DE\u00a0PROMOCION \u00a0\nDE\u00a0LA\u00a0MUJER\u00a0MICAELA \u00a0\nBASTIDAS \u00a0LEBENCHANCEN \u00a0\nINTERNACIONAL \u00a0FORTALECIMIENTO \u00a0DE\u00a0CAPACIDADES \u00a0LOCALES\u00a0PARA\u00a0EL\u00a0EJERCICIO \u00a0DE\u00a0\nDERECHOS \u00a0SEXUALES \u00a0Y\u00a0REPRODUCTIVOS \u00a0 \u00a0\u00a0\u00a0 9,318\u00a0\u00a0 \u00a0 \u00a0 9,\nCENTRO\u00a0PARROQUIAL \u00a0\nECUMENICO \u00a0ROSA\u00a0\nBLANCA\u00a0ICCO\u00a0 PROYECTO \u00a0GLOBAL\u00a0ROSA\u00a0BLANCA\u00a02004\u20102008\u00a0\n\u00a0 792,794 \u00a0\u00a0\u00a0 \u00a0 \u00a0 792\nCHRISTIAN \u2010AID\u00a0 CHRISTIAN \u00a0AID\u00a0 PREVENCION \u00a0DE\u00a0VIH\u00a0SIDA\u00a0EN\u00a0CENTROS \u00a0EDUCATIVOS. \u00a0 \u00a0 79,820\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 79\nCOMUNICACIONES \u00a0\nALIADAS\u00a0GLOBAL\u00a0\nGREENGRANTS \u00a0\nFOUNDATION \u00a0INCIDENCIA \u00a0PUBLICA\u00a0Y\u00a0FORTALECIMIENTO \u00a0DE\u00a0CAPACIDADES \u00a0PARA\u00a0LA\u00a0\nPROMOCION \u00a0Y\u00a0DEFENSA\u00a0DE\u00a0DERECHOS \u00a0\u00a0 \u00a0 11,598\u00a0\u00a0 \u00a0 \u00a0 \u00a0 11\nCOOPERAZIONE \u00a0\nINTERNAZIONALE \u00a0FONDO\u00a0ITALO\u00a0\u2010\u00a0\nPERUANO \u00a0DESARROLLO \u00a0DE\u00a0UN\u00a0SERVICIO \u00a0DE\u00a0ASISTENCIA \u00a0DOMICILIARIA \u00a0EN\u00a0LA\u00a0\nCIUDAD\u00a0DE\u00a0LIMA\u00a0A\u00a0LAS\u00a0PERSONAS \u00a0VIVIENDO \u00a0\u00a0\u00a0 1,046,943 \u00a0\u00a0 \u00a0 \u00a0 1,04\n\u00a0\u00a0 DESARROLLO \u00a0DE\u00a0UN\u00a0SERVICIO \u00a0DE\u00a0ASISTENCIA \u00a0DOMICILIARIA \u00a0EN\u00a0LA\u00a0\nCIUDAD\u00a0de\u00a0Lima\u00a0a\u00a0las\u00a0personas\u00a0viviendo\u00a0con\u00a0VIH/SIDA\u00a0\u00a0 3,168,759 \u00a0\u00a0\u00a0 \u00a0 \u00a0 3,16\n\u00a0\u00a0 DESARROLLO \u00a0DE\u00a0UN\u00a0SERVICIO \u00a0DE\u00a0ASISTENCIA \u00a0DOMICILIARIA \u00a0EN\u00a0LA\u00a0\nCIUDAD\u00a0DE\u00a0LIMA\u00a0A\u00a0LAS\u00a0PERSONAS \u00a0VIVIENDO \u00a0CON\u00a0VIH/SIDA\u00a0N\u00b0CF\u2010021\u2010\n2005\u2010FIP\u00a01,043,670 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 1,04 VIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\nCOORDINADORA \u00a0\nNACIONAL \u00a0DE\u00a0DERECHOS \u00a0\nHUMANOS \u00a0HIVOS\u00a0 AFIRMANDO \u00a0LA\u00a0DEFENSA\u00a0Y\u00a0PROMOCION \u00a0DE\u00a0LOS\u00a0DERECHOS \u00a0HUMANOS \u00a0EN\u00a0\nEL\u00a0PERU\u00a0(HIVOS)\u00a0 \u00a0\u00a0\u00a0 176,071 \u00a0\u00a0\u00a0 176\nCOORDINADORA \u00a0POR\u00a0LOS\u00a0\nDERECHOS \u00a0DEL\u00a0NI\u00d1O\u00a0\nCUSCO\u00a0Save\u00a0the\u00a0children\u00a0PREVINIENDO \u00a0EL\u00a0VIH/SIDA\u00a0\u2010\u00a0ITS\u00a0EN\u00a0L\u00cdDERES\u00a0ADOLESCENTES \u00a0DE\u00a0LA\u00a0REGI\u00d3N\u00a0\nCUSCO\u00a0 54,140\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 54\nDEFENSORIA \u00a0DEL\u00a0PUEBLO\u00a0USAID\u00a0 DERECHOS \u00a0HUMANOS \u00a0EN\u00a0PERSONAS \u00a0M\u00c1S\u00a0AFECTADAS \u00a0Y\u00a0VIVIENDO \u00a0CON\u00a0\nVIH:LUCHA \u00a0CONTRA\u00a0EL\u00a0ESTIGMA \u00a0Y\u00a0DISCRIMINACI\u00d3N, \u00a0PROMOCI\u00d3N \u00a0DE\u00a0LA\u00a0\nPROTECCI\u00d3N \u00a0DE\u00a0DERECHOS \u00a0Y\u00a0ACCESO\u00a0A\u00a0LA\u00a0CIUDADAN\u00cdA \u00a0\u00a0 54,533\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 54\nDEUTSCHE \u00a0\nWELTHUNGERHILFE \u00a0\n(AGRO\u00a0ACCION\u00a0\nALEMANA) \u00a0Agro\u00a0acci\u00f3n\u00a0\nAlemana\u00a0AMPLIANDO \u00a0ESPACIOS \u00a0DE\u00a0INFORMACI\u00d3N \u00a0Y\u00a0COMUNICACI\u00d3N \u00a0PARA\u00a0LA\u00a0\nPREVENCI\u00d3N \u00a0DEL\u00a0VIH/SIDA\u00a0EN\u00a0LAS\u00a0REGIONES \u00a0DE\u00a0MAYOR\u00a0INCIDENCIA \u00a0\u00a0 145,672 \u00a0\u00a0\u00a0 \u00a0 \u00a0 145\nESPIGAS\u00a0ASOCIACION \u00a0DE\u00a0\nPROMOCION \u00a0PARA\u00a0EL\u00a0\nDESARROLLO \u00a0Pan\u00a0para\u00a0el\u00a0mundo\u00a0TALLER\u00a0SOBRE\u00a0VIH/SIDA\u00a0EN\u00a0AMERICA \u00a0LATINA\u00a0\n131,469 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 131\nFEDERACION \u00a0\nLATINOAMERICANA \u00a0DE\u00a0\nFACULTADES \u00a0DE\u00a0\nCOMUNICACION \u00a0SOCIAL\u00a0Konrad\u00a0Adenauer \u00a0FORO\u00a0INTERNACIONAL \u00a0JOVENES\u00a0Y\u00a0TECNOLOGIAS \u00a0DE\u00a0INFORMACION \u00a0Y\u00a0\nCOMUNICACION \u00a0EN\u00a0LA\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0VIH\u00a0\u2010\u00a0SIDA\u00a07,799\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 7,\nFEDERACION \u00a0PROVINCIAL \u00a0\nDE\u00a0MUJERES \u00a0DE\u00a0ICA\u00a0WOMANKIND \u00a0\nWORDWIDE \u00a0DESARROLLANDO \u00a0CAPACIDADES \u00a0EN\u00a0MUJERES \u00a0JOVENES\u00a0PARA\u00a0LA\u00a0\nINCIDENCIA \u00a0Y\u00a0PREVENCION \u00a0DEL\u00a0VIH\u2010SIDA\u00a0\u00a0\u00a0\u00a0 85,149\u00a0\u00a0 \u00a0 \u00a0 85\nFOMENTO \u00a0DE\u00a0LA\u00a0VIDA\u00a0OXFAM\u00a0 VIGILANCIA \u00a0SOCIAL\u00a0EN\u00a0SERVICIOS \u00a0INTEGRALES \u00a0DE\u00a0SALUD,\u00a0UNA\u00a0\nPERSPECTIVA \u00a0DE\u00a0DERECHOS \u00a0DE\u00a0LAS\u00a0PERSONAS \u00a0VIVI\u00a0\u00a0\u00a0\u00a0 27,503\u00a0\u00a0 \u00a0 \u00a0 27\n\u00a0 DKA\u00a0 VIGILANCIA \u00a0SOCIAL\u00a0EN\u00a0SERVICIOS \u00a0INTEGRALES \u00a0DE\u00a0SALUD,\u00a0UNA\u00a0\nPERSPECTIVA \u00a0DE\u00a0DERECHOS \u00a0DE\u00a0LAS\u00a0PERSONAS \u00a0VIVI\u00a0\u00a0\u00a0 87,183\u00a0158,895 \u00a0\u00a0\u00a0 246\nIBIS\u00a0 IBIS\u00a0 BASES\u00a0PARA\u00a0PROMOVER \u00a0LA\u00a0PREVENCION \u00a0DE\u00a0LAS\u00a0ITS,\u00a0VIH/SIDA\u00a0EN\u00a0\nCOMUNIDADES \u00a0SHIPIBO\u00a0KONIBO\u00a0DE\u00a0LA\u00a0CIUDAD\u00a0DE\u00a0PUCALLPA \u00a0\u00a0 28,020\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 28\nINSTITUTO \u00a0\nAGROPECUARIO \u00a0ANDINO\u00a0\n\u2010\u00a0PIURA\u00a0CHRISTIAN \u00a0AID\u00a0 PREVENCION \u00a0DE\u00a0ITS\u00a0\u2010\u00a0VIH\u00a0SIDA\u00a0CON\u00a0JOVENES\u00a0DE\u00a0CINCO\u00a0CENTROS \u00a0\nEDUCATIVOS \u00a0\u00a0 79,820\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 79\n\u00a0\u00a0 PREVENCION \u00a0DE\u00a0ITS\u00a0\u2010\u00a0VIH\u00a0SIDA,\u00a0CON\u00a0JOVENES\u00a0DE\u00a0CINCO\u00a0CENTROS \u00a0\nEDUCATIVOS \u00a082,000\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 82\n\u00a0\u00a0 PROYECTO \u00a0PREVENTIVO \u00a0Y\u00a0SALUD\u00a0REPRODUCTIVA \u00a0Y\u00a0AFECTIVA \u00a0E\u00a0ITS\u2010\u00a0VIH\u00a0\nSIDA,\u00a0DIRIGIDO \u00a0A\u00a0ADOSLESCENTES \u00a0DE\u00a0CIN\u00a0\u00a0\u00a0 66,354\u00a075,319\u00a0\u00a0 \u00a0 \u00a0 141\nINSTITUTO \u00a0DE\u00a0\nEDUCACION \u00a0Y\u00a0SALUD\u00a0GTZ\u00a0 PROCESOS \u00a0DE\u00a0FORMACI\u00d3N \u00a0DE\u00a0CAPACITACI\u00d3N: \u00a0TEACH\u00a0VIPY\u00a0Y\u00a0Y\u00a0FAMILIAS \u00a0\nFUERTES\u00a0AMPR\u00a0Y\u00a0LIMITES\u00a0\u00a0\u00a0 11,349\u00a0\u00a0 \u00a0 \u00a0 \u00a0 11\nINSTITUTO \u00a0DE\u00a0\nEDUCACION \u00a0Y\u00a0SALUD\u00a0\u2010\u00a0IES\u00a0CATHOLIC \u00a0AGENCY\u00a0\nFOR\u00a0OVERSEAS \u00a0\nDEVELOPMENT \u00a0FORTALECIENDO \u00a0EL\u00a0ACCESO\u00a0A\u00a0INFORMACION \u00a0Y\u00a0LA\u00a0PARTICIPACION \u00a0DE\u00a0\nACTORES\u00a0CLAVE\u00a0PARA\u00a0DISMINUIR \u00a0EL\u00a0IMPACTO \u00a0SOCIAL\u00a0DE\u00a0LA\u00a0EPIDEMIA \u00a0\nDEL\u00a0VIH\u2010SIDA\u00a0EN\u00a0EL\u00a0PERU\u00a0\u00a0 92,100\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 92\n\u00a0\u00a0 FORTALECIENDO \u00a0EL\u00a0ACCESO\u00a0A\u00a0INFORMACION \u00a0Y\u00a0LA\u00a0PARTICIPACION \u00a0DE\u00a0\nACTORES\u00a0CLAVES\u00a0PARA\u00a0DISMINUIR \u00a0EL\u00a0IMPACTO \u00a0SOCIAL\u00a0DE\u00a0LA\u00a0EPIDEMIA \u00a0\nDEL\u00a0VIH\u2010SIDA\u00a0EN\u00a0EL\u00a0PERU\u00a098,400\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 98 VIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\n\u00a0 INSTITUTE \u00a0FOR\u00a0\nCONNECTIVITY \u00a0IN\u00a0\nTHE\u00a0AMERICAS \u00a0Punto\u00a0J:\u00a0Un\u00a0Portal\u00a0para\u00a0educar\u00a0de\u00a0Joven\u00a0a\u00a0Joven\u00a0en\u00a0salud\u00a0y\u00a0VIH/SIDA\u00a0\n215,890 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 215\n\u00a0 IDRC\u00a0 ADOLESCENTES, \u00a0J\u00d3VENES\u00a0Y\u00a0TICS\u00a0EN\u00a0RESPUESTA \u00a0A\u00a0LA\u00a0EPIDEMIA \u00a0DEL\u00a0VIH\u2010\nSIDA\u00a0EN\u00a0LATINOAM\u00c9RICA \u00a0Y\u00a0EL\u00a0CARIBE\u00a0\u00a0\u00a0 770,622 700,107 \u00a0\u00a0\u00a0 1,47\nINSTITUTO \u00a0DE\u00a0ESTUDIOS \u00a0\nEN\u00a0SALUD,\u00a0SEXUALIDAD \u00a0Y\u00a0\nDESARROLLO \u00a0HUMANO \u00a0AMFAR\u00a0THE\u00a0\nFOUNDATION \u00a0FOR\u00a0\nAIDS\u00a0RESEARCH \u00a0La\u00a0situaci\u00f3n\u00a0de\u00a0la\u00a0poblaci\u00f3n \u00a0Trans\u00a0en\u00a0el\u00a0Per\u00fa\u00a0en\u00a0el\u00a0contexto\u00a0del\u00a0acceso\u00a0\nuniversal\u00a0a\u00a0prevenci\u00f3n, \u00a0trat\u00a0\u00a0 \u00a0 233\u00a0 44,831\u00a0\u00a0 \u00a0 \u00a0 45\n\u00a0 HIVOS\u00a0 Activismo \u00a0Cultural\u00a0para\u00a0combatir\u00a0el\u00a0Estigma\u00a0y\u00a0la\u00a0Discriminaci\u00f3n \u00a0asociados \u00a0\nal\u00a0VIH/SIDA\u00a02007\u20102009\u00a0\u00a0\u00a0 253,710 158,764 \u00a0\u00a0\u00a0 412\n\u00a0\u00a0 ACTIVISMO \u00a0CULTURAL \u00a0PARA\u00a0COMBATIR \u00a0EL\u00a0ESTIGMA \u00a0Y\u00a0LA\u00a0\nDISCRIMINACI\u00d3N \u00a0ASOCIADOS \u00a0AL\u00a0VIH/SIDA\u00a0FASE\u00a0II\u00a0\u00a0\u00a0\u00a0 107,983 \u00a0\u00a0\u00a0 107\n\u00a0 MINSA\u00a0ARGENTINA \u00a0Foro\u00a0Latinoamericano \u00a0y\u00a0del\u00a0Caribe\u00a0en\u00a0VIH/SIDA\u00a0e\u00a0ITS\u00a02009\u00a0 \u00a0\u00a0 8,946\u00a019,977\u00a0\u00a0 \u00a0 \u00a0 28\n\u00a0 UNIVERSITY \u00a0OF\u00a0\nKWAZULU \u00a0Elaboraci\u00f3n \u00a0del\u00a0Proyecto\u00a0\"HIV/AIDS, \u00a0Funding\u00a0and\u00a0Public\u00a0Policy:\u00a0Crossroads \u00a0\nbetween\u00a0Economic \u00a0Flow\u00a0and\u00a0\u00a0\u00a0 5,855\u00a0\u00a0 \u00a0 \u00a0 \u00a0 5,\nINSTITUTO \u00a0DE\u00a0SALUD\u00a0\nMSC\u00a0CRISTOFORIS \u00a0\nDENEKE\u00a0MISSIO\u00a0 FORTALECIMIENTO \u00a0DE\u00a0LA\u00a0ORGANIZACION \u00a0DE\u00a0AGENTES \u00a0PASTORALES \u00a0DE\u00a0\nSALUD\u00a0 \u00a0\u00a0\u00a0 7,928\u00a0\u00a0 \u00a0 \u00a0 7,\nINSTITUTO \u00a0PERUANO \u00a0DE\u00a0\nPATERNIDAD \u00a0\nRESPONSABLE \u00a0TERRE\u00a0DES\u00a0HOMMES \u00a0PREVENCION \u00a0DE\u00a0ITS\u00a0,\u00a0VIH\u00a0Y\u00a0SIDA\u00a0Y\u00a0EMBARAZOS \u00a0NO\u00a0DESEADOS \u00a0EN\u00a0IQUITOS\n510\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 5\n\u00a0 INTERNATIONAL \u00a0\nPLANNED \u00a0\nPARETHOOD \u00a0\nFEDERATION \u00a0IGUALMENTE \u00a0DIFERENTES: \u00a0EXPANDIENDO \u00a0EL\u00a0TRABAJO\u00a0CON\u00a0POBLACIONES \u00a0\nSEXUALMENTE \u00a0DIVERSAS \u00a0EN\u00a0PERU\u00a0\u00a0\u00a0 24,148\u00a0\u00a0 \u00a0 \u00a0 \u00a0 24\n\u00a0\u00a0 IGUALMENTE \u00a0DIFERENTES: \u00a0EXPANDIENDO \u00a0EL\u00a0TRABAJO\u00a0CON\u00a0POBLACIONES \u00a0\nSEXUALMENTE \u00a0DIVERSAS \u00a0EN\u00a0PER\u00da\u00a0\u00a0 13,662\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 13\n\u00a0\u00a0 ITS/VIH\u2010SIDA\u00a0SISTEMA\u00a0DE\u00a0INTERVENCI\u00d3N \u00a0INTEGRAL. \u00a0 51,557\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 51\n\u00a0\u00a0 MASCULINIDAD \u00a0Y\u00a0SALUD:\u00a0ESTRATEGIAS \u00a0PARA\u00a0COMPRENDER, \u00a0ATENDERE \u00a0\nINVOLUCRAR \u00a0A\u00a0LOS\u00a0HOMBRES \u00a0EN\u00a0SALUD\u00a0SEXUAL\u00a0Y\u00a0REPRODUCTIVA \u00a011,379\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 11\nINVESTIGACIONES \u00a0\nMEDICAS \u00a0EN\u00a0SALUD\u00a0AMFAR\u00a0THE\u00a0\nFOUNDATION \u00a0FOR\u00a0\nAIDS\u00a0RESEARCH \u00a0PREVENCION \u00a0DEL\u00a0VIH\u00a0DESDE\u00a0UN\u00a0SISTEMA\u00a0DE\u00a0BASE\u00a0COMUNITARIA \u00a0TRANS,\u00a0\nGAY\u00a0Y\u00a0BISEXUAL \u00a0(TGB)\u00a0\u2010\u00a0CONSORCIO \u00a0FORT\u00a0\u00a0 \u00a0 4,191\u00a0116,195 \u00a0\u00a0\u00a0 120\n\u00a0 EMBAJADA \u00a0USA\u00a0 EPIDEMIOLOGIA \u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0SUDAMERICA \u00a0 \u00a0 3,131\u00a0240,319 159,290 \u00a0\u00a0\u00a0 402\n\u00a0 NATIONAL \u00a0\nINSTITUTES \u00a0OF\u00a0\nHEALTH\u00a0\u2010\u00a0NIH\u00a0A\u00a0STEP\u00a0FORWARD \u00a0FOR\u00a0A\u00a0LATIN\u00a0AMERICAN \u00a0AIDS\u00a0RESEARCH \u00a0AND\u00a0TRANINIG \u00a0\nPROGRAM \u00a0 \u00a0\u00a0\u00a0 33,113\u00a0\u00a0 \u00a0 \u00a0 33\n\u00a0\u00a0 CTU\u00a0INMENSA \u00a0 \u00a0 103,560 \u00a0\u00a0\u00a0 \u00a0 \u00a0 103\n\u00a0\u00a0 PEARLS:\u00a0A5175\u00a0 \u00a0 1,251,326 \u00a0\u00a0\u00a0 \u00a0 \u00a0 1,25\n\u00a0 SOCIAL\u00a0&\u00a0SCIENTIFIC \u00a0\nSYSTEMS, \u00a0INC\u00a0A5199\u00a0SSS\u00a0\u00a0\u00a0\u00a0 27,597\u00a0\u00a0 \u00a0 \u00a0 27 VIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\n\u00a0\u00a0 A5221\u00a0SSS\u00a0 \u00a0\u00a0\u00a0 110,628 \u00a0\u00a0\u00a0 110\n\u00a0 THE\u00a0J.\u00a0DAVID\u00a0\nGLADSTONE \u00a0\nINSTITUTES \u00a0QUIMIOPROFILAXIS \u00a0PARA\u00a0LA\u00a0PREVENCION \u00a0DEL\u00a0VIH\u00a0EN\u00a0HOMBRES \u00a0\n\u00a0 2,397,550 5,444,560 5,371,995 \u00a0\u00a0\u00a0 13,2\n\u00a0 TIDES\u00a0FOUNDATION \u00a0CAMPA\u00d1A \u00a0DE\u00a0ADVOCACY \u00a0PARA\u00a0LA\u00a0SOSTENIBILIDAD \u00a0DEL\u00a0TRATAMIENTO \u00a0\nDEL\u00a0ARV\u00a0EN\u00a0LATINOAMERICA \u00a0\u00a0\u00a0\u00a0 24,132\u00a0\u00a0 \u00a0 \u00a0 24\n\u00a0\u00a0 V\u00a0LATIN\u00a0AMERICAN \u00a0AND\u00a0CARIBBEAN \u00a0FORUM\u00a0ON\u00a0HIV/\u00a0AIDS\u00a0AND\u00a0SEXUALLY \u00a0\nTRASMITED \u00a0INFECTIONS \u00a0(FORO\u00a02009)\u00a0\u00a0\u00a0\u00a0 188,296 \u00a0\u00a0\u00a0 188\n\u00a0 UNIVERSITY \u00a0OF\u00a0\nWASHINGTON \u00a0CFAR\u00a0INTERNATIONAL \u00a0CORE\u00a0\u00a0 15,350\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15\n\u00a0\u00a0 CTU\u00a0INMENSA \u00a0 \u00a0\u00a0 1,716,470 1,962,275 \u00a0\u00a0\u00a0 3,67\n\u00a0\u00a0 FORMATIVE \u00a0RESEARCH \u00a0TO\u00a0ASSESS\u00a0MSM\u00a0ACCEPTABILITY \u00a0AND\u00a0WILLINGNESS \u00a0\nTO\u00a0PARTICIPATE \u00a0IN\u00a0A\u00a0CIRCUMCISION \u00a0TRIAL\u00a0\u00a0\u00a0\u00a0 12,772\u00a0\u00a0 \u00a0 \u00a0 12\n\u00a0\u00a0 HPTN\u00a0039:\u00a0ENSAYO\u00a0CL\u00cdNICO\u00a0DE\u00a0FASE\u00a0III,\u00a0ALEATORIO, \u00a0DOBLE\u00a0CIEGO,\u00a0\nCONTROLADO \u00a0CONTRA\u00a0PLACEBO\u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0PARA\u00a0LA\u00a0\nREDUCCI\u00d3N \u00a0DE\u00a0LA\u00a0ADQUISICI\u00d3N \u00a0DEL\u00a0VIH\u00a0ENTRE\u00a0INDIVIDUOS \u00a0\nSEROPOSITIVOS \u00a0AL\u00a0VHS\u20102\u00a0Y\u00a0SERONEGATIVOS \u00a0AL\u00a0VIH\u00a03\u00a0 3\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u00a0\u00a0 MECHANISM \u2010PREDICTORS \u00a0OF\u00a0GENITAL\u00a0\u2010RECTAL\u00a0HIV\u00a0 \u00a0 135,768 242,479 252,860 \u00a0\u00a0\u00a0 631\nKUSKA\u00a0TARPUY\u00a0 ASOCIACION \u00a0KUSKA\u00a0\nTARPUY\u00a0Pacientes \u00a0de\u00a0TBC\u00a0\u00a0\u00a0 12,789\u00a0\u00a0 \u00a0 \u00a0 \u00a0 12\nLA\u00a0CASA\u00a0DE\u00a0LA\u00a0MUJER\u00a0 Pan\u00a0para\u00a0el\u00a0mundo\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH/SIDA\u00a0Y\u00a0LA\u00a0VIOLENCIA \u00a0CONTRA\u00a0LA\u00a0MUJER\u00a0COMO\u00a0\nPOL\u00cdTICA\u00a0P\u00d9BLICA\u00a0\u00a0\u00a0 63,273\u00a0148,050 \u00a0\u00a0\u00a0 211\nLUTHERAN \u00a0WORLD\u00a0RELIEF\u00a0\n\u2010\u00a0USA\u00a0LUTHERAN \u00a0WORLD\u00a0\nRELIEF\u00a0CAMPA\u00d1A \u00a0DE\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0VIH\u00a0\u2010\u00a0SIDA\u00a0EN\u00a0EL\u00a0PERU\u2010\u00a0LA\u00a0PER\u2010007\u201005\u00a026,240\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 26\n\u00a0\u00a0 CAMPA\u00d1A \u00a0DE\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0VIH\u2010SIDA\u00a0EN\u00a0EL\u00a0PERU\u00a0 \u00a0 20,247\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 20\nMEDICOS \u00a0SIN\u00a0FRONTERAS \u00a0\n\u2010\u00a0BELGICA\u00a0M\u00e9dicos\u00a0sin\u00a0frontera\u00a0CONTROL \u00a0DE\u00a0LAS\u00a0INFECCIONES \u00a0DE\u00a0TRANSMISION \u00a0SEXUAL\u00a0(ITS)\u00a0Y\u00a0VIH/SIDA\u00a0\nEN\u00a0LE\u00a0ESTABLECIMIENTO \u00a0DE\u00a0REGIMEN \u00a0CERRADO \u00a0ORDINARIO \u00a0DE\u00a0\nLURIGANCHO(EPRCIOL) \u00a0455,848 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 455\n\u00a0\u00a0 CONTROL \u00a0DE\u00a0LAS\u00a0INFECCIONES \u00a0DE\u00a0TRANSMISSION \u00a0SEXUAL\u00a0(ITS)\u00a0EN\u00a0EL\u00a0\nESTABLECIMIENTO \u00a0PENITENCIARIO \u00a0DE\u00a0REGIMEN \u00a0CERRADO \u00a0ORINARIO \u00a0\n(EPRCOL) \u00a0\u00a0 250,693 \u00a0\u00a0\u00a0 \u00a0 \u00a0 250\n\u00a0\u00a0 CUIDADES \u00a0INTEGRALES \u00a0EN\u00a0VIH\u2010SIDA\u00a0EN\u00a0EL\u00a0CENTRO\u00a0DE\u00a0SALUD\u00a0DE\u00a0SAN\u00a0\nJOSE,\u00a0DISTRITO \u00a0DE\u00a0VILLA\u00a0EL\u00a0SALVADOR \u00a0\u00a0 2,261,687 \u00a0\u00a0\u00a0 \u00a0 \u00a0 2,26\n\u00a0\u00a0 CUIDADO \u00a0INTEGRALES \u00a0A\u00a0PERSONAS \u00a0VIVIENDO \u00a0CON\u00a0VIH\u00a0SIDA\u00a0EN\u00a0EL\u00a0\nCENTRO\u00a0MATERNO \u00a0INFANTIL\u00a0SAN\u00a0JOSE\u00a0DE\u00a0VILLA\u00a0EL\u00a0SALVADOR \u00a0(2004)\u00a03,106,439 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 3,10\nMINISTERIO \u00a0DE\u00a0\nEDUCACI\u00d3N \u00a0GTZ\u00a0 ARMONIZACI\u00d3N \u00a0DE\u00a0POL\u00cdTICAS \u00a0P\u00daBLICAS \u00a0PARA\u00a0LA\u00a0EDUCACI\u00d3N \u00a0SEXUAL\u00a0Y\u00a0\nLA\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH/SIDA\u00a0Y\u00a0DROGAS\u00a0EN\u00a0\u00a0\u00a0 359,288 \u00a0\u00a0 \u00a0 \u00a0 359\nMOVIMIENTO \u00a0MANUELA \u00a0\nRAMOS\u00a0Agro\u00a0acci\u00f3n\u00a0\nAlemana\u00a0AMPLIANDO \u00a0ESPACIOS \u00a0DE\u00a0INFORMACI\u00d3N \u00a0Y\u00a0COMUNICACI\u00d3N \u00a0PARA\u00a0LA\u00a0\nPREVENCI\u00d3N \u00a0DEL\u00a0VIH\u2010SIDA\u00a0EN\u00a0LAS\u00a0REGIONES \u00a0DE\u00a0MAYOR\u00a0INCIDENCIA \u00a0\u00a0 145,672 \u00a0\u00a0\u00a0 \u00a0 \u00a0 145\nMOVIMIENTO \u00a0MANUELA \u00a0\nRAMOS.\u00a0INTERNATIONAL \u00a0\nWOMEN'S \u00a0HEALTH\u00a0\nCOALITION \u00a0PROMOVIENDO \u00a0LOS\u00a0DERECHOS \u00a0SEXUALES \u00a0Y\u00a0REPRODUCTIVOS \u00a0DE\u00a0LAS\u00a0\nMUJERES \u00a0Y\u00a0ADOLESCENTES \u00a0PARA\u00a0LA\u00a0PREVENCI\u00d3N \u00a0D\u00a0\u00a0 \u00a0 9,144\u00a0\u00a0 \u00a0 \u00a0 \u00a0 9, VIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\n\u00a0 Agro\u00a0acci\u00f3n\u00a0\nAlemana\u00a0AMPLIANDO \u00a0ESPACIOS \u00a0DE\u00a0INFORMACI\u00d3N \u00a0Y\u00a0COMUNICACI\u00d3N \u00a0PARA\u00a0LA\u00a0\nPREVENCI\u00d3N \u00a0DEL\u00a0VIH\u2010SIDA\u00a0EN\u00a0LAS\u00a0REGIONES \u00a0DE\u00a0\u00a0\u00a0 336,276 \u00a0\u00a0 \u00a0 \u00a0 336\nONG\u00a0CENTRO\u00a0DE\u00a0\nPROMOCION \u00a0Y\u00a0DEFENSA \u00a0\nDE\u00a0LOS\u00a0DERECHOS \u00a0\nSEXUALES \u00a0Y\u00a0\nREPRODUCTIVOS \u00a0HIVOS\u00a0 NUEVAS\u00a0ESTRATEGIAS \u00a0PARA\u00a0MONITOREAR \u00a0LAS\u00a0POLITICAS \u00a0EN\u00a0SALUD\u00a0\nSEXUAL\u00a0Y\u00a0REPRODUCTIVA \u00a0EN\u00a0EL\u00a0PERU\u00a0\n10,184\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 10\n\u00a0 Ayuntamientos \u00a0\nEspa\u00f1a\u00a0PREVENCION \u00a0DE\u00a0VIH/SIDA\u00a0Y\u00a0PROMOCION \u00a0DE\u00a0LOS\u00a0DERECHOS \u00a0HUMANOS \u00a0\nENTRE\u00a0LA\u00a0POBLACION \u00a0TLGB\u00a0DE\u00a0LIMA\u00a0\u00a0\u00a0\u00a0 172,918 \u00a0\u00a0\u00a0 172\n\u00a0 INTERNATIONAL \u00a0\nWOMEN'S \u00a0HEALTH\u00a0\nCOALITION \u00a0FORTALECIENDO \u00a0LA\u00a0AGENDA\u00a0DE\u00a0LAS\u00a0MUJERES \u00a0EN\u00a0VIH/SIDA\u00a0\n\u00a0\u00a0 17,121\u00a042,660\u00a0\u00a0 \u00a0 \u00a0 59\n\u00a0 PATHFINDER \u00a0\nINTERNACIONAL \u00a0SOCIEDAD \u00a0CIVIL\u00a0FORTALECIDA \u00a0PARA\u00a0DEMANDAR \u00a0SUS\u00a0DERECHOS \u00a0\nSEXUALES \u00a0Y\u00a0REPRODUCTIVOS \u00a0EN\u00a0AREQUIPA \u00a0Y\u00a0CUSCO\u00a0\u00a0\u00a0\u00a0 10,537\u00a0\u00a0 \u00a0 \u00a0 10\nPACHAMAMA \u00a0PARA\u00a0LA\u00a0\nVIDA\u00a0Y\u00a0EL\u00a0CIUDADO \u00a0DEL\u00a0\nMEDIO\u00a0AMBIENTE \u00a0CHRISTIAN \u00a0AID\u00a0 SOSTENIBILIDAD \u00a0Y\u00a0FORTALECIMIENTO \u00a0DE\u00a0LA\u00a0MESA\u00a0DE\u00a0CONCERTACION \u00a0\nPARA\u00a0EL\u00a0CUIDADO \u00a0Y\u00a0DEFENSA\u00a0DEL\u00a0MEDIO\u00a0AMBI\u00a0\u00a0 \u00a0 8,780\u00a0\u00a0 \u00a0 \u00a0 \u00a0 8,\nPACT\u00a0PERU\u00a0 USAID\u00a0 FORTALECIMIENTO \u00a0INSTITUCIONAL \u00a0DE\u00a0ORGANIZACIONES \u00a0SOCIAS\u00a0DEL\u00a0\nPROYECTO, \u00a0Y\u00a0APOYO\u00a0A\u00a0LA\u00a0CREACI\u00d3N \u00a0Y\u00a0FUNCIONAMIENTO \u00a0DEL\u00a0CONSEJO \u00a0\nEPRESARIAL \u00a0DE\u00a0LA\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0VIH\u00a0/\u00a0SID\u00a0\u00a0 149,770 \u00a0\u00a0\u00a0 \u00a0 \u00a0 149\nPROGRAMA \u00a0DE\u00a0SOPORTE \u00a0\nA\u00a0LA\u00a0AUTOAYUDA \u00a0DE\u00a0\nPERSONAS \u00a0\nSEROPOSITIVAS \u00a0USAID\u00a0 ALTERNATIVAS \u00a0DE\u00a0PREVENCION \u00a0EN\u00a0VIH\u00a0Y\u00a0SIDA\u00a0\n\u00a0 147,360 40,972\u00a0\u00a0 \u00a0 \u00a0 \u00a0 188\n\u00a0\u00a0 PREVENCION \u00a0Y\u00a0CONTROL \u00a0DE\u00a0ITS/VIH\u00a0EN\u00a0ESTABLECIMIENTOS \u00a0\nPENITENCIARIOS \u00a0DEL\u00a0PERU\u00a0\u00a0 91,486\u00a0152,768 \u00a0\u00a0 \u00a0 \u00a0 244\nRED\u00a0SIDA\u00a0PERU\u00a0 TERRE\u00a0DES\u00a0HOMMES \u00a0MEJORAR \u00a0LAS\u00a0POL\u00cdTICAS \u00a0DE\u00a0SEXUALIDAD \u00a0Y\u00a0VIH\u00a0PARA\u00a0LOS\u00a0Y\u00a0LAS\u00a0\nADOLESCENTES \u00a0A\u00a0TRAV\u00c9S\u00a0DEL\u00a0FORTALECIMIENTO \u00a0D\u00a0\u00a0\u00a0\u00a0 160,680 \u00a0\u00a0\u00a0 160\n\u00a0 Plan\u00a0internacional \u00a0FORTALECIENDO \u00a0LAS\u00a0ACCIONES \u00a0DE\u00a0INCIDENCIA \u00a0Y\u00a0POLITICA\u00a0DE\u00a0LA\u00a0RED\u00a0SIDA\u00a0\nPERU\u00a0\u00a0\u00a0 8,148\u00a0\u00a0 \u00a0 \u00a0 \u00a0 8,\nSAVE\u00a0THE\u00a0CHILDREN \u00a0\nSUECIA\u00a0THE\u00a0SAVE\u00a0THE\u00a0\nCHILDREN \u00a0FUND\u00a0EDUCACI\u00d3N \u00a0INCLUSIVA \u00a0PARA\u00a0NI\u00d1OS\u00a0DE\u00a0LA\u00a0ZONA\u00a0RURAL\u00a0EN\u00a0AYACUCHO \u00a0\u00a0\u00a0 10,723\u00a0\u00a0 \u00a0 \u00a0 \u00a0 10\n\u00a0 Save\u00a0the\u00a0children\u00a0DERECHOS \u00a0DEL\u00a0NI\u00d1O\u00a0\u2010\u00a0PROGRAMA \u00a0UNIFICADO \u00a0EN\u00a0PERU\u00a0 \u00a0\u00a0\u00a0 212,097 \u00a0\u00a0\u00a0 212\n\u00a0\u00a0 REALIZACI\u00d3N \u00a0DE\u00a0GRUPOS\u00a0FOCALES, \u00a0ENTREVISTAS \u00a0Y\u00a0REVISI\u00d3N \u00a0DE\u00a0\nDOCUMENTOS \u00a0SOBRE\u00a0VIGILANCIA \u00a0SOCIAL\u00a0E\u00a0INDICA\u00a0\u00a0\u00a0 9,652\u00a0\u00a0 \u00a0 \u00a0 \u00a0 9,\n\u00a0\u00a0 RESPUESTA \u00a0DE\u00a0EMERGENCIA \u00a0A\u00a0TRAVES\u00a0DE\u00a0LA\u00a0PREVENCI\u00d3N \u00a0Y\u00a0PROMOCI\u00d3N \u00a0\nDE\u00a0LOS\u00a0DERECHOS \u00a0DE\u00a0LA\u00a0INFANCIA \u00a0EN\u00a0LAS\u00a0\u00a0\u00a0 13,658\u00a0\u00a0 \u00a0 \u00a0 \u00a0 13\nSERVICIO \u00a0DE\u00a0MEDICINAS \u00a0\nPRO\u2010VIDA\u00a0MISEREOR \u00a0 PROMOCI\u00d3N \u00a0DEL\u00a0USO\u00a0RACIONAL \u00a0DEL\u00a0MEDICAMENTO, \u00a0SALUD\u00a0MATERNO \u00a0\u2010\u00a0\nINFANTIL\u00a0Y\u00a0PATICIPACI\u00d3N \u00a0COMUNITARIA \u00a0EN\u00a0CHACHAPOYAS: \u00a0\nAUTOSOSTENIBILIDAD \u00a014,343\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 14\nSI,\u00a0DA\u00a0VIDA\u00a0 CATHOLIC \u00a0RELIEF\u00a0\nSERVICES \u00a0\u00a0EDUCACI\u00d3N \u00a0Y\u00a0PREVENCI\u00d3N \u00a0DE\u00a0VIH/SIDA\u00a0EN\u00a0EL\u00a0PER\u00da\u00a0\u00a0\u00a0 8,224\u00a012,533\u00a0\u00a0 \u00a0 \u00a0 20\n\u00a0 MISEAN\u00a0CARA\u00a0 EDUCACI\u00d3N \u00a0Y\u00a0PREVENCI\u00d3N \u00a0DE\u00a0VIH/SIDA\u00a0EN\u00a0EL\u00a0PER\u00da\u00a0 \u00a0\u00a0 54,894\u00a0\u2010 \u00a0 \u00a0 \u00a0 \u00a0 54 VIH\u00a0 VIH\u00a0\u2010\u00a0TB\u00a0 Instituci\u00f3n \u00a0receptora \u00a0\n\u00a0(agente\u00a0de\u00a0gasto)\u00a0Fuente\u00a0de\u00a0\nfinanciamiento \u00a0Proyecto\u00a0\n2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2007\u00a02008\u00a02009\u00a0To\nMISSION\u00a0SUPPORT \u00a0\nFROM\u00a0IRELAND\u00a0\n\u00a0 CATHOLIC \u00a0DIOCESE\u00a0\nOF\u00a0JEFFERSON \u00a0\nCITY'S\u00a0EDUCACI\u00d3N \u00a0Y\u00a0PREVENCI\u00d3N \u00a0DE\u00a0VIH/SIDA\u00a0EN\u00a0EL\u00a0PER\u00da\u00a0\n\u00a0\u00a0 88,910\u00a0140,602 \u00a0\u00a0\u00a0 229\nSOCIOS\u00a0EN\u00a0SALUD\u00a0\u2010\u00a0\nSUCURSAL \u00a0PERU\u00a0PARTNERS \u00a0IN\u00a0\nHEALTH\u00a0AMPLIANDO \u00a0LA\u00a0COBERTURA \u00a0DE\u00a0INGRESOS \u00a0AL\u00a0TARGA\u00a0DE\u00a0PADRES\u00a0DE\u00a0\nFAMILIA\u00a0QUE\u00a0VIENE\u00a0CON\u00a0VIH/SIDA\u00a0EN\u00a0LAS\u00a0PROVI\u00a0\u00a0\u00a0 314,134 391,788 \u00a0\u00a0\u00a0 705\n\u00a0\u00a0 DETECCI\u00d3N \u00a0BASADA\u00a0EN\u00a0LA\u00a0COMUNIDAD \u00a0DE\u00a0VIH\u2010TB\u00a0EN\u00a0UN\u00a0SITIO\u00a0URBANO\u00a0\nDE\u00a0BAJOS\u00a0RECURSOS \u00a0\u2010\u00a0LIMA\u00a0ESTE,\u00a0PER\u00da\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 13,862\u00a013\n\u00a0\u00a0 FORTALECIENDO \u00a0LA\u00a0GESTI\u00d3N\u00a0DE\u00a0LA\u00a0ESTRATEGIA \u00a0SANITARIA \u00a0NACIONAL \u00a0DE\u00a0\nVIH/SIDA\u00a0Y\u00a0EL\u00a0ACCESO\u00a0AL\u00a0TARGA\u00a0DE\u00a0LAS\u00a0PERSONAS \u00a0POBRES\u00a0QUE\u00a0VIVEN\u00a0\nCON\u00a0VIH\u00a0EN\u00a0EL\u00a0PER\u00da\u00a0\u00a0 545,932 \u00a0\u00a0\u00a0 \u00a0 \u00a0 545\n\u00a0\u00a0 GENERACI\u00d3N \u00a0DE\u00a0INGRESOS \u00a0EN\u00a0PERSONAS \u00a0AFECTADAS \u00a0CON\u00a0TB\u00a0MDR\u00a0y\u00a0VIH\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 226,048\u00a0226\n\u00a0\u00a0 PROYECTO \u00a0COLABORATIVO \u00a0MINSA\u2010UNICEF\u2010SES\u00a0:\u00a0\"AMPLIANDO \u00a0LA\u00a0\nCOBERTURA \u00a0DE\u00a0TRATAMIENTO \u00a0A\u00a0LOS\u00a0NI\u00d1OS\u00a0CON\u00a0VIH\"\u00a0\u00a0\u00a0 301,978 398,848 \u00a0\u00a0\u00a0 700\n\u00a0\u00a0 PROYECTO \u00a0PILOTO\u00a0TARGA\u00a0PLUS\u00a0EN\u00a0PERSONAS \u00a0QUE\u00a0VIVEN\u00a0CON\u00a0EL\u00a0VIH\u2010TB\u00a0\nEN\u00a0LA\u00a0DISA\u00a0LIMA\u00a0ESTE\u00a0\u2010\u00a0PERU\u00a0\u00a0\u00a0\u00a0\u00a0 566,393 494,614\u00a093,282\u00a01,15\nSTICHTING \u00a0TERRE\u00a0DES\u00a0\nHOMMES \u2010NEDERLAND \u00a0TERRE\u00a0DES\u00a0HOMMES \u00a0HABILIDADES \u00a0PARA\u00a0LA\u00a0VIDA\u00a0EN\u00a0TUMBES:\u00a0UNA\u00a0PROPUESTA \u00a0DE\u00a0\nPARTICIPACION \u00a0\u00a0 151,395 \u00a0\u00a0\u00a0 \u00a0 \u00a0 151\n\u00a0\u00a0 NI\u00d1OS\u00a0Y\u00a0NI\u00d1AS\u00a0POR\u00a0LA\u00a0VIDA\u00a0CREANDO \u00a0UN\u00a0ENTORNO \u00a0FAVORABLE \u00a0EN\u00a0\nVIH/SIDA\u00a032,041\u00a0138,472 \u00a0\u00a0\u00a0 \u00a0 \u00a0 170\n\u00a0\u00a0 PREVENCION \u00a0DE\u00a0ITS,\u00a0VIH\u00a0SIDA\u00a0Y\u00a0EMBARAZO \u00a0NO\u00a0DESEADO \u00a0EN\u00a0\nADOLESCENTES \u00a0DE\u00a0LA\u00a0CIUDAD\u00a0DE\u00a0IQUITOS\u00a0\u00a0 132,701 \u00a0\u00a0\u00a0 \u00a0 \u00a0 132\n\u00a0\u00a0 PROYECTO \u00a0DE\u00a0PREVENCION \u00a0DE\u00a0ITS/VIH/SIDA \u00a0Y\u00a0EMBARAZO \u00a0NO\u00a0DESEADO \u00a0\nEN\u00a0ADOLESCENTES \u00a0DE\u00a0CENTROS \u00a0E\u00a0INSTITUTOS \u00a0EDUCATIVOS \u00a0NOCTURNOS \u00a0\nDE\u00a0LA\u00a0CIUDAD\u00a0DE\u00a0IQUITOS\u00a0\u2010\u00a0PERU\u00a0157,672 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 157\nTHE\u00a0SAVE\u00a0THE\u00a0CHILDREN \u00a0\nFUND\u00a0THE\u00a0SAVE\u00a0THE\u00a0\nCHILDREN \u00a0FUND\u00a0ACTUALIZACI\u00d3N \u00a0Y\u00a0MANTENIMIENTO \u00a0PORTALE\u00a0WEB\u00a0PUNTO\u00a0J\u00a0(\u00a0UN\u00a0PORTAL\u00a0\nPARA\u00a0EDUCAR\u00a0DE\u00a0JOVEN\u00a0A\u00a0JOVEN\u00a0EN\u00a0SALUD\u00a0Y\u00a0VIH/SIDA) \u00a02,952\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 2,\n\u00a0\u00a0 L\u00cdDERES\u00a0ESCOLARES \u00a0ACTUANDO \u00a0PARA\u00a0LA\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH/\u00a0SIDA\u2010\u00a0ITS\u00a0\nEN\u00a0LA\u00a0REGI\u00d3N\u00a0CUSCO\u00a067,260\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 67\nWORLD\u00a0VISION\u00a0\nINTERNATIONAL \u00a0WORLD\u00a0VISION\u00a0 LUDOTECA \u00a0EDULI\u00a0\u00a0\u00a0 13,931\u00a0\u00a0 \u00a0 \u00a0 \u00a0 13\n\u00a0\u00a0 PROYECTO \u00a0ESPECIAL\u00a0VIDA\u00a0 \u00a0\u00a0 560,584 602,603 \u00a0\u00a0\u00a0 1,16\n\u00a0 \u00a0\nAnexo\u00a06\u00a0\u2010\u00a0Importaciones \u00a0de\u00a0ARV\u00a0realizadas \u00a0entre\u00a0el\u00a02008\u00a0y\u00a0el\u00a02010\u00a0(\u00a0en\u00a0US\u00a0d\u00f3lares)\u00a0\u00a0\nTotal\u00a0Kilos\u00a0 Monto\u00a0en\u00a0US$\u00a0CIF\u00a0Componente \u00a0Activo\u00a02008\u00a0 2009\u00a0 2010\u00a0 Total\u00a0 2008\u00a0 2009\u00a0 2010\u00a0 Total\u00a0\nABACAVIR 832\u00a0 1,486\u00a0 1,716\u00a0 4,035\u00a0 197,037\u00a0 362,404\u00a0 1,296,426 \u00a0 1,855,867 \u00a0\nABACAVIR \u00a0\u00a0+\u00a0LAMIVUDINA \u00a0\u00a0+\u00a0ZIDOVUDINA 4\u00a0 8\u00a0 4\u00a0 16\u00a0 10,080\u00a0 20,851\u00a0 10,883\u00a0 41,814\u00a0\nABACAVIR \u00a0,\u00a0ESTAVUDINA, \u00a0EFAVIRENZ 1\u00a0\u00a0\u00a0 1\u00a0 31\u00a0\u00a0 \u00a0 31\u00a0\nATAZANAVIR 745\u00a0 1,418\u00a0 803\u00a0 2,966\u00a0 1,821,157 \u00a0 3,560,409 \u00a0 1,806,576 \u00a0 7,188,142 \u00a0\nDARUNAVIR \u00a0 6\u00a0 71\u00a0 77\u00a0\u00a0 9,626\u00a0 86,501\u00a0 96,127\u00a0\nDIDANOSINA 948\u00a0 230\u00a0 273\u00a0 1,451\u00a0 365,580\u00a0 49,363\u00a0 56,957\u00a0 471,900\u00a0\nEFAVIRENZ 1,305\u00a0 4,697\u00a0 2,283\u00a0 8,285\u00a0 573,893\u00a0 698,758\u00a0 336,621\u00a0 1,609,271 \u00a0\nEMTRICITABINA \u00a0,\u00a0ZIDIVUDINA \u00a0+\u00a0LAMIVUDINA, \u00a0\nNEVIPARINA\u00a0 1\u00a0\u00a0 1\u00a0\u00a0 33\u00a0\u00a0 33\u00a0\nEMTRICITABINA \u00a0+\u00a0TENOFOVIR \u00a0 53\u00a0 75\u00a0 128\u00a0\u00a0 323,517\u00a0 362,334\u00a0 685,851\u00a0\nESTAVUDINA 453\u00a0 144\u00a0\u00a0 597\u00a0 120,652\u00a0 55,112\u00a0\u00a0 175,763\u00a0\nESTAVUDINA \u00a0+LAMIVUDINA \u00a0+NEVIPARINA 770\u00a0\u00a0 \u00a0 770\u00a0 50,435\u00a0\u00a0 \u00a0 50,435\u00a0\nFOSAMPRENAVIR 0\u00a0\u00a0\u00a0 0\u00a0 4\u00a0\u00a0\u00a0 4\u00a0\nFUZEON 383\u00a0 363\u00a0 368\u00a0 1,115\u00a0 272,280\u00a0 221,203\u00a0 220,458\u00a0 713,941\u00a0\nINDINAVIR 950\u00a0\u00a0 \u00a0 950\u00a0 364,615\u00a0\u00a0 \u00a0 364,615\u00a0\nKIT\u00a0RALTEGRAVIR \u00a0,\u00a0EFIVARENZ \u00a0 40\u00a0 57\u00a0 97\u00a0\u00a0 145,016\u00a0 217,018\u00a0 362,034\u00a0\nLAMIVUDINA 4,739\u00a0 2,646\u00a0 574\u00a0 7,958\u00a0 403,147\u00a0 557,113\u00a0 136,617\u00a0 1,096,877 \u00a0\nLAMIVUDINA \u00a0\u00a0+\u00a0ESTAVUDINA \u00a0+\u00a0NEVIPARINA 107\u00a0\u00a0 22\u00a0 129\u00a0 21,816\u00a0\u00a0 1,683\u00a0 23,499\u00a0\nLAMIVUDINA \u00a0+\u00a0ESTAVUDINA 26\u00a0\u00a0\u00a0 26\u00a0 3,033\u00a0\u00a0 \u00a0 3,033\u00a0\nLAMIVUDINA \u00a0+\u00a0ZIDOVUDINA 1,778\u00a0 1,567\u00a0 44\u00a0 3,388\u00a0 323,048\u00a0 266,158\u00a0 93,328\u00a0 682,534\u00a0\nLAMIVUDINA \u00a0+\u00a0ZIDOVUDINA \u00a0+\u00a0NEVIPARINA 2,021\u00a0\u00a0 23\u00a0 2,045\u00a0 281,410\u00a0\u00a0 2,671\u00a0 284,082\u00a0\nLOPINAVIR 3\u00a0 0\u00a0\u00a0 3\u00a0 51\u00a0 15\u00a0\u00a0 66\u00a0\nLOPINAVIR \u00a0+\u00a0RITONAVIR 3,706\u00a0 8,587\u00a0 6,334\u00a0 18,626\u00a0 1,335,529 \u00a0 1,492,194 \u00a0 1,168,018 \u00a0 3,995,740 \u00a0\nNELFINAVIR 4,119\u00a0\u00a0 \u00a0 4,119\u00a0 831,646\u00a0\u00a0 \u00a0 831,646\u00a0\nNEVIRAPINA 3,282\u00a0 798\u00a0 3\u00a0 4,084\u00a0 314,566\u00a0 137,329\u00a0 522\u00a0 452,418\u00a0\nRALTEGRAVIR \u00a0 33\u00a0 56\u00a0 89\u00a0\u00a0 22,683\u00a0 40,457\u00a0 63,140\u00a0\nRITONAVIR 1,061\u00a0 1,112\u00a0 2,002\u00a0 4,175\u00a0 128,834\u00a0 127,912\u00a0 241,221\u00a0 497,966\u00a0\nSAQUINAVIR 949\u00a0 1,180\u00a0 492\u00a0 2,620\u00a0 349,888\u00a0 634,560\u00a0 433,669\u00a0 1,418,117 \u00a0\nTENOFOVIR 35\u00a0 58\u00a0 173\u00a0 266\u00a0 17,444\u00a0 129,198\u00a0 129,460\u00a0 276,103\u00a0\nTOSAMPRENAVIR 0\u00a0\u00a0\u00a0 0\u00a0 4\u00a0\u00a0\u00a0 4\u00a0\nZIDOVUDINA 3,309\u00a0 2,544\u00a0 962\u00a0 6,814\u00a0 518,854\u00a0 744,845\u00a0 276,931\u00a0 1,540,629 \u00a0\nTotal\u00a0general 31,526\u00a0 26,971\u00a0 16,336\u00a0 74,832\u00a0 8,305,035 \u00a0 9,558,298 \u00a0 6,918,351 \u00a0 24,781,684 \u00a0\n\u00a0 \u00a0\nAnexo\u00a07\u00a0\u2010\u00a0Gasto\u00a0en\u00a0medicamentos \u00a0realizado \u00a0del\u00a02005\u00a0al\u00a02010\u00a0(En\u00a0nuevos\u00a0soles)\u00a0\n\u00a0 Presentaci\u00f3n \u00a0 Concentraci\u00f3n \u00a0 Datos\u00a0 2,004\u00a0 2,005\u00a0 2,006\u00a0 2,007\u00a0 2,008\u00a0 2,009\u00a0 2,010\u00a0 Total\u00a0\u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0\u00a0 58,490\u00a0\u00a0 \u00a0 58,490\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 \u00a0 5.21\u00a0\u00a0 \u00a0 5.21\u00a0 Soluci\u00f3n\u00a0 20mg/ml\u00a0x\u00a0240ml\u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 \u00a0 11,232\u00a0\u00a0 \u00a0 11,232\u00a0\nGasto\u00a0\u00a0 32,688\u00a0 94,550\u00a0 \u00a0\u00a0\u00a0\u00a0 127,238\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 22.70\u00a0 18.76\u00a0 \u00a0\u00a0\u00a0\u00a0 21.39\u00a0 300\u00a0mg/150mg/300mg \u00a0\nCantidad\u00a0\u00a0 1,440\u00a0 5,040\u00a0 \u00a0\u00a0\u00a0\u00a0 6,480\u00a0\nGasto\u00a0\u00a0 160,348\u00a0 822,287\u00a0 648,416\u00a0 709,458\u00a0 68,839\u00a0 350,806\u00a0 2,760,153 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 14.05\u00a0 11.26\u00a0 8.13\u00a0 2.69\u00a0 2.25\u00a0 1.15\u00a0 7.48\u00a0 300mg\u00a0\nCantidad\u00a0\u00a0 11,400\u00a0 257,280\u00a0 88,090\u00a0 427,040\u00a0 46,576\u00a0 536,660\u00a0 1,367,046 \u00a0\nGasto\u00a0\u00a0 8,304\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 8,304\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 13.84\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 13.84\u00a0ABACAVIR \u00a0\n600mg\u00a0\nCantidad\u00a0\u00a0 600\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 600\u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0\u00a0 9,995\u00a0\u00a0 \u00a0 9,995\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 \u00a0 27.76\u00a0\u00a0 \u00a0 27.76\u00a0 AMPRENAVIR \u00a0 700mg\u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 \u00a0 360\u00a0\u00a0 \u00a0 360\u00a0\nGasto\u00a0\u00a0 64,021\u00a0 977,963\u00a0 2,827,820 \u00a01,724,276 \u00a09,233,237 \u00a0 19,215\u00a0 14,846,532 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 21.33\u00a0 21.11\u00a0 20.71\u00a0 21.33\u00a0 20.61\u00a0 21.35\u00a0 21.00\u00a0 150mg\u00a0\nCantidad\u00a0\u00a0 3,000\u00a0 51,510\u00a0 177,910\u00a0 80,845\u00a0 515,990\u00a0 900\u00a0 830,155\u00a0\nGasto\u00a0\u00a0 111,408\u00a0 514,821\u00a0 1,502,835 \u00a0810,499\u00a05,438,772 \u00a0\u00a0 8,378,335 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 21.34\u00a0 21.35\u00a0 21.35\u00a0 21.31\u00a0 23.13\u00a0\u00a0 21.78\u00a0 200mg\u00a0\nCantidad\u00a0\u00a0 5,220\u00a0 24,120\u00a0 70,430\u00a0 38,055\u00a0 253,345\u00a0\u00a0 391,170\u00a0\nGasto\u00a0\u00a0\u00a0 19,216\u00a0 \u00a0\u00a0\u00a0\u00a0 19,216\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 21.35\u00a0 \u00a0\u00a0\u00a0\u00a0 21.35\u00a0 250mg\u00a0\nCantidad\u00a0\u00a0 \u00a0 900\u00a0 \u00a0\u00a0\u00a0\u00a0 900\u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0 12,851,910 \u00a0 12,851,910 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 29.69\u00a0\u00a0 29.69\u00a0ATAZANAVIR \u00a0\n300mg\u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 432,870\u00a0\u00a0 432,870\u00a0\nGasto\u00a0\u00a0 5,119\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 5,119\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 21.33\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 21.33\u00a0ATAZANAVIR \u00a0\n+LOPINAVIR \u00a0150mg\u00a0\nCantidad\u00a0\u00a0 240\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 240\u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0 93,224\u00a0 181,094\u00a0 274,318\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 16\u00a0 15\u00a0 15\u00a0 DARUNAVIR \u00a0 300mg\u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 6,120\u00a0 12,420\u00a0 18,540\u00a0\nGasto\u00a0\u00a0 674,475\u00a0 180,888\u00a0 3,726\u00a0 4,180\u00a0\u00a0 \u00a0 863,268\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 1.07\u00a0 0.95\u00a0 1.24\u00a0 1.67\u00a0\u00a0 \u00a0 1.05\u00a0 100mg\u00a0\nCantidad\u00a0\u00a0 1,635,829 \u00a0 296,859\u00a0 3,000\u00a0 2,500\u00a0\u00a0 \u00a0 1,938,188 \u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0\u00a0 21,204\u00a0\u00a0 \u00a0 21,204\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 \u00a0 1.55\u00a0\u00a0 \u00a0 1.55\u00a0 200mg\u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 \u00a0 13,680\u00a0\u00a0 \u00a0 13,680\u00a0DIDANOSINA \u00a0Tableta\u00a0\n250mg\u00a0 Gasto\u00a0\u00a0 11,772\u00a0 7,848\u00a0 \u00a0\u00a0\u00a0\u00a0 19,620\u00a0 \u00a0 Presentaci\u00f3n \u00a0 Concentraci\u00f3n \u00a0 Datos\u00a0 2,004\u00a0 2,005\u00a0 2,006\u00a0 2,007\u00a0 2,008\u00a0 2,009\u00a0 2,010\u00a0 Total\u00a0\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 10.90\u00a0 10.90\u00a0 \u00a0\u00a0\u00a0\u00a0 10.90\u00a0\nCantidad\u00a0\u00a0 1,080\u00a0 720\u00a0 \u00a0\u00a0\u00a0\u00a0 1,800\u00a0\nGasto\u00a0\u00a0 446,412\u00a0 704,398\u00a0 166,102\u00a01,699,499 \u00a0453,193\u00a02,342,844 \u00a05,812,449 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 17.30\u00a0 9.98\u00a0 15.67\u00a0 10.23\u00a0 7.54\u00a0 2.60\u00a0 12.01\u00a0 400mg\u00a0\nCantidad\u00a0\u00a0 25,570\u00a0 323,530\u00a0 10,600\u00a0 728,080\u00a0 396,960\u00a0 965,430\u00a0 2,450,170 \u00a0\nGasto\u00a0\u00a0 4,478,737 \u00a0 552,956\u00a0 6,403\u00a0 22,614\u00a0 27,200\u00a0\u00a0 5,087,910 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 1.75\u00a0 1.35\u00a0 1.86\u00a0 0.86\u00a0 1.70\u00a0\u00a0 1.56\u00a0 200mg\u00a0\nCantidad\u00a0\u00a0 3,096,572 \u00a0 533,590\u00a0 3,280\u00a0 26,280\u00a0 16,000\u00a0\u00a0 3,675,722 \u00a0\nGasto\u00a0\u00a0 189,236\u00a0 2,014,138 \u00a0 357,857\u00a02,185,634 \u00a02,334,172 \u00a0 27,813\u00a0 7,108,850 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 7.54\u00a0 4.17\u00a0 2.98\u00a0 1.74\u00a0 1.60\u00a0 2.19\u00a0 3.77\u00a0EFAVIRENZ \u00a0\n600mg\u00a0\nCantidad\u00a0\u00a0 25,110\u00a0 1,261,010 \u00a0 153,022\u00a015,117,060 1,507,140 \u00a0 12,700\u00a0 18,076,042 \u00a0\nGasto\u00a0\u00a0\u00a0 1,734\u00a0 50,237\u00a0 118,979\u00a0 149,270\u00a0\u00a0 320,220\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 0.89\u00a0 0.37\u00a0 0.31\u00a0 0.10\u00a0\u00a0 0.41\u00a0 30mg\u00a0\nCantidad\u00a0\u00a0 \u00a0 2,100\u00a0 347,360\u00a01,056,600 \u00a01,569,150 \u00a0\u00a0 2,975,210 \u00a0\nGasto\u00a0\u00a0 221,858\u00a0 139,893\u00a0 15,402\u00a0 62,119\u00a0\u00a0 \u00a0 439,272\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 1.86\u00a0 0.68\u00a0 0.42\u00a0 0.24\u00a0\u00a0 \u00a0 0.87\u00a0ESTAVUDINA \u00a0\n40mg\u00a0\nCantidad\u00a0\u00a0 871,934\u00a0 733,228\u00a0 34,940\u00a0 437,020\u00a0\u00a0 \u00a0 2,077,122 \u00a0\nGasto\u00a0\u00a0 1,286,922 \u00a0 35,433\u00a0\u00a0 581,143\u00a0\u00a0 \u00a0 1,903,497 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 1.22\u00a0 1.48\u00a0\u00a0 0.87\u00a0\u00a0 \u00a0 1.25\u00a0 INDINAVIR \u00a0 400\u00a0mg\u00a0\nCantidad\u00a0\u00a0 1,638,604 \u00a0 24,500\u00a0\u00a0 667,980\u00a0\u00a0 \u00a0 2,331,084 \u00a0\nGasto\u00a0\u00a0 14,579\u00a0 39,152\u00a0 \u00a0\u00a0\u00a0\u00a0 53,731\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 99.22\u00a0 61.82\u00a0 \u00a0\u00a0\u00a0\u00a0 75.84\u00a0 10mg/ml\u00a0240ml\u00a0\nCantidad\u00a0\u00a0 146\u00a0 626\u00a0 \u00a0\u00a0\u00a0\u00a0 772\u00a0\nGasto\u00a0\u00a0 675\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 675\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 21.09\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 21.09\u00a0 50mg/5ml \u00a0\nCantidad\u00a0\u00a0 32\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 32\u00a0\nGasto\u00a0\u00a0\u00a0 14,170\u00a0 \u00a0\u00a0\u00a0\u00a0 14,170\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 56.33\u00a0 \u00a0\u00a0\u00a0\u00a0 56.33\u00a0 50mg/5ml \u00a0100ml\u00a0\nCantidad\u00a0\u00a0 \u00a0 245\u00a0 \u00a0\u00a0\u00a0\u00a0 245\u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0 6,560\u00a0 \u00a0\u00a0\u00a0 6,560\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 82.00\u00a0 \u00a0\u00a0\u00a0 82.00\u00a0 50mg/5ml \u00a0120ml\u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 80\u00a0 \u00a0\u00a0\u00a0 80\u00a0\nGasto\u00a0\u00a0\u00a0 24,823\u00a0 326,323\u00a0 583,464\u00a0 337,598\u00a0\u00a0 1,272,209 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 62.50\u00a0 50.97\u00a0 39.49\u00a0 9.32\u00a0\u00a0 49.36\u00a0Soluci\u00f3n\u00a0\n50mg/5ml \u00a0240ml\u00a0\nCantidad\u00a0\u00a0 \u00a0 392\u00a0 7,131\u00a0 24,096\u00a0 36,216\u00a0\u00a0 67,835\u00a0\nGasto\u00a0\u00a0 1,157,225 \u00a0 302,389\u00a0 145,447\u00a0 602,714\u00a0 514,620\u00a0 242,655\u00a0 2,965,051 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 0.55\u00a0 0.54\u00a0 0.87\u00a0 0.16\u00a0 0.15\u00a0 0.10\u00a0 0.58\u00a0 150mg\u00a0\nCantidad\u00a0\u00a0 3,542,000 \u00a0 1,249,874 \u00a0 553,990\u00a03,851,180 \u00a03,442,275 \u00a02,337,676 \u00a014,976,995 \u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0 9,600\u00a0 \u00a0\u00a0\u00a0 9,600\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 40.00\u00a0 \u00a0\u00a0\u00a0 40.00\u00a0 50mg/5ml \u00a0240ml\u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 240\u00a0 \u00a0\u00a0\u00a0 240\u00a0\nGasto\u00a0\u00a0 3,340\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 3,340\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 2.42\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 2.42\u00a0LAMIVUDINA \u00a0\nTableta\u00a0\n300mg/150mg \u00a0\nCantidad\u00a0\u00a0 1,380\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 1,380\u00a0 \u00a0 Presentaci\u00f3n \u00a0 Concentraci\u00f3n \u00a0 Datos\u00a0 2,004\u00a0 2,005\u00a0 2,006\u00a0 2,007\u00a0 2,008\u00a0 2,009\u00a0 2,010\u00a0 Total\u00a0\u00a0\nGasto\u00a0\u00a0\u00a0 14,133\u00a0 255,710\u00a0 502,539\u00a0 684,000\u00a0\u00a0 1,456,382 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 0.54\u00a0 0.52\u00a0 0.45\u00a0 0.36\u00a0\u00a0 0.48\u00a0 150\u00a0mg/30mg/200mg \u00a0\nCantidad\u00a0\u00a0 \u00a0 26,220\u00a0 562,440\u00a01,140,600 \u00a01,900,000 \u00a0\u00a0 3,629,260 \u00a0\nGasto\u00a0\u00a0 134,200\u00a0 254,776\u00a0 148,042\u00a0 \u00a0\u00a0\u00a0 537,018\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 4.58\u00a0 0.57\u00a0 0.47\u00a0 \u00a0\u00a0\u00a0 1.52\u00a0LAMIVUDINA \u00a0+\u00a0\nESTAVUDINA \u00a0+\u00a0\nNEVIRAPINA \u00a0150mg/40mg/200mg \u00a0\nCantidad\u00a0\u00a0 29,280\u00a0 449,340\u00a0 275,940\u00a0 \u00a0\u00a0\u00a0 754,560\u00a0\nGasto\u00a0\u00a0 255,645\u00a0 1,903,072 \u00a0 50,373\u00a0 1,289,623 \u00a02,742,729 \u00a0 26,601\u00a0 6,268,043 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 6.65\u00a0 4.06\u00a0 0.97\u00a0 0.63\u00a0 0.44\u00a0 0.86\u00a0 4.13\u00a0LAMIVUDINA \u00a0+\u00a0\nZIDOVUDINA \u00a0150mg/300mg \u00a0\nCantidad\u00a0\u00a0 66,804\u00a0 2,116,800 \u00a0 52,200\u00a0 2,835,800 \u00a06,233,475 \u00a0 31,000\u00a0 11,336,079 \u00a0\nGasto\u00a0\u00a0\u00a0 2,392,123 \u00a0 150,860\u00a03,360,717 \u00a0\u00a0 2,613,433 \u00a08,517,133 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 1.15\u00a0 1.17\u00a0 0.95\u00a0\u00a0 0.53\u00a0 0.95\u00a0LAMIVUDINA \u00a0+\u00a0\nZIDOVUDINA \u00a0+\u00a0\nNEVIRAPINA \u00a0150mg/300mg/200mg \u00a0\nCantidad\u00a0\u00a0 \u00a0 2,080,107 \u00a0 128,940\u00a03,186,600 \u00a0\u00a0 4,952,100 \u00a010,347,747 \u00a0\nGasto\u00a0\u00a0\u00a0 15,999\u00a0\u00a0 20,954\u00a0\u00a0 58,847\u00a0 95,801\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 348.60\u00a0\u00a0 174.62\u00a0\u00a0 174.62\u00a0 224.33\u00a0400mg/100mg/5ml \u00a0\n160ml\u00a0Cantidad\u00a0\u00a0 \u00a0 46\u00a0\u00a0 120\u00a0\u00a0 337\u00a0 503\u00a0\nGasto\u00a0\u00a0\u00a0 105,958\u00a0 100,242\u00a0 55,643\u00a0\u00a0 \u00a0 261,842\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 498.89\u00a0 269.83\u00a0 217.77\u00a0\u00a0 \u00a0 349.53\u00a0Soluci\u00f3n\u00a0\n80mg/20mgx160ml \u00a0\nCantidad\u00a0\u00a0 \u00a0 264\u00a0 392\u00a0 289\u00a0\u00a0 \u00a0 945\u00a0\nGasto\u00a0\u00a0 168,480\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 168,480\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 7.80\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 7.80\u00a0 100mg/33.3mg \u00a0\nCantidad\u00a0\u00a0 21,600\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 21,600\u00a0\nGasto\u00a0\u00a0 2,622,158 \u00a0 10,168,210 \u00a0 475,076\u00a0 232,294\u00a0\u00a0 \u00a0 13,497,738 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 7.38\u00a0 5.08\u00a0 3.50\u00a0 1.51\u00a0\u00a0 \u00a0 5.51\u00a0 133.3mg/33.3mg \u00a0\nCantidad\u00a0\u00a0 355,750\u00a0 3,092,592 \u00a0 137,880\u00a0 153,360\u00a0\u00a0 \u00a0 3,739,582 \u00a0\nGasto\u00a0 7,852\u00a0\u00a0 117,288\u00a0 627,253\u00a06,422,165 \u00a04,538,262 \u00a0\u00a0 11,712,821 \u00a0\nPrecio\u00a0promedio \u00a0 3.00\u00a0\u00a0 5.43\u00a0 3.70\u00a0 2.12\u00a0 1.71\u00a0\u00a0 2.69\u00a0 200mg/50mg \u00a0\nCantidad\u00a0 2,617\u00a0\u00a0 21,600\u00a0 188,618\u00a03,104,500 \u00a04,254,825 \u00a0\u00a0 7,572,160 \u00a0\nGasto\u00a0\u00a0 8,327\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 8,327\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 7.71\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 7.71\u00a0LOPINAVIR \u00a0+\u00a0\nRITONAVIR \u00a0\nTableta\u00a0\n80mg/20mg \u00a0\nCantidad\u00a0\u00a0 1,080\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 1,080\u00a0\nGasto\u00a0\u00a0\u00a0 6,336\u00a0 \u00a0\u00a0\u00a0\u00a0 6,336\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 140.80\u00a0 \u00a0\u00a0\u00a0\u00a0 140.80\u00a0 250mg\u00a0\nCantidad\u00a0\u00a0 \u00a0 45\u00a0\u00a0\u00a0\u00a0\u00a0 45\u00a0\nGasto\u00a0\u00a0 125,326\u00a0 30,822\u00a0 15,206\u00a0 \u00a0\u00a0\u00a0 171,355\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 129.20\u00a0 126.43\u00a0 140.80\u00a0 \u00a0\u00a0\u00a0 132.69\u00a0Soluci\u00f3n\u00a0\n50mg/144g \u00a0\nCantidad\u00a0\u00a0 947\u00a0 255\u00a0 108\u00a0 \u00a0\u00a0\u00a0 1,310\u00a0\nGasto\u00a0\u00a0 4,083,229 \u00a0 1,877,026 \u00a0 961,333\u00a02,258,587 \u00a0\u00a0 \u00a0 9,180,175 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 2.71\u00a0 2.35\u00a0 1.78\u00a0 1.51\u00a0\u00a0 \u00a0 2.22\u00a0NELFINAVIR \u00a0\nTableta\u00a0 250mg\u00a0\nCantidad\u00a0\u00a0 2,759,187 \u00a0 961,360\u00a0 655,932\u00a03,070,670 \u00a0\u00a0 \u00a0 7,447,149 \u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0\u00a0 69,264\u00a0\u00a0 \u00a0 69,264\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 \u00a0 26.00\u00a0\u00a0 \u00a0 26.00\u00a0 50mg/5mlx240ml \u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 \u00a0 2,664\u00a0\u00a0 \u00a0 2,664\u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0\u00a0 11,445\u00a0\u00a0 \u00a0 11,445\u00a0NEVIRAPINA \u00a0 Soluci\u00f3n\u00a0\n50mg/5mlx100ml \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 \u00a0 36.80\u00a0\u00a0 \u00a0 36.80\u00a0 \u00a0 Presentaci\u00f3n \u00a0 Concentraci\u00f3n \u00a0 Datos\u00a0 2,004\u00a0 2,005\u00a0 2,006\u00a0 2,007\u00a0 2,008\u00a0 2,009\u00a0 2,010\u00a0 Total\u00a0\u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 \u00a0 311\u00a0\u00a0 \u00a0 311\u00a0\nGasto\u00a0\u00a0 28,714\u00a0 100,989\u00a0 155,368\u00a0 24,798\u00a0 35,000\u00a0\u00a0 344,870\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 1.77\u00a0 1.43\u00a0 1.18\u00a0 0.40\u00a0 0.35\u00a0\u00a0 1.05\u00a0 200mg\u00a0\nCantidad\u00a0\u00a0 34,780\u00a0 352,360\u00a0 256,798\u00a0 61,995\u00a0 100,000\u00a0\u00a0 805,933\u00a0\nGasto\u00a0\u00a0 522,649\u00a0 2,409,644 \u00a0 146,381\u00a0 333,513\u00a0 252,732\u00a01,098,175 \u00a04,763,095 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 5.92\u00a0 3.97\u00a0 2.66\u00a0 1.56\u00a0 2.40\u00a0 1.70\u00a0 3.94\u00a0 RITONAVIR \u00a0 100mg\u00a0\nCantidad\u00a0\u00a0 86,699\u00a0 989,676\u00a0 72,910\u00a0 3,169,440 \u00a0106,420\u00a0 671,880\u00a0 5,097,025 \u00a0\nGasto\u00a0\u00a0 926,850\u00a0 2,769,252 \u00a0 326,591\u00a0 583,856\u00a0\u00a0 \u00a0 4,606,549 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 1.88\u00a0 1.89\u00a0 1.84\u00a0 1.58\u00a0\u00a0 \u00a0 1.85\u00a0 200mg\u00a0\nCantidad\u00a0\u00a0 499,130\u00a0 1,505,350 \u00a0 181,450\u00a04,537,200 \u00a0\u00a0 \u00a0 6,723,130 \u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0 7,200\u00a0 545,328\u00a01,815,250 \u00a02,819,150 \u00a05,186,928 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 5.00\u00a0 5.00\u00a0 5.00\u00a0 4.99\u00a0 5.00\u00a0SAQUINAVIR \u00a0\n500mg\u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 1,440\u00a0 109,080\u00a0 363,503\u00a0 564,960\u00a0 1,038,983 \u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0\u00a0 57,600\u00a0\u00a0 162,552\u00a0 220,152\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 \u00a0 10\u00a0\u00a0 5\u00a0 7\u00a0 TENOFOVIR \u00a0Tableta\u00a0\n300mg\u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 \u00a0 5,760\u00a0\u00a0 33,600\u00a0 39,360\u00a0\nGasto\u00a0\u00a0 224,138\u00a0 217,557\u00a0 358,828\u00a0 484,762\u00a0 179,568\u00a0 29,120\u00a0 1,493,973 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 64.27\u00a0 57.97\u00a0 49.41\u00a0 35.47\u00a0 74.82\u00a0 28.00\u00a0 50.52\u00a0 50mg/5mlx240ml \u00a0\nCantidad\u00a0\u00a0 3,987\u00a0 4,021\u00a0 8,733\u00a0 17,140\u00a0 2,400\u00a0 1,040\u00a0 37,321\u00a0\nGasto\u00a0\u00a0\u00a0 27,477\u00a0\u00a0 19,800\u00a0\u00a0 \u00a0 47,277\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 62.55\u00a0\u00a0 51.18\u00a0\u00a0 \u00a0 56.86\u00a0 50mg/5mlx100ml \u00a0\nCantidad\u00a0\u00a0 \u00a0 650\u00a0\u00a0 636\u00a0\u00a0 \u00a0 1,286\u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0\u00a0 5,000\u00a0\u00a0 \u00a0 5,000\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 \u00a0 50.00\u00a0\u00a0 \u00a0 50.00\u00a0 50mg/5mlx200ml \u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 \u00a0 100\u00a0\u00a0 \u00a0 100\u00a0\nGasto\u00a0\u00a0\u00a0 \u00a0\u00a0 390\u00a0\u00a0 \u00a0 390\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 \u00a0 \u00a0 \u00a0 65.00\u00a0\u00a0 \u00a0 65.00\u00a0Soluci\u00f3n\u00a0\n50mg/5mlx120ml \u00a0\nCantidad\u00a0\u00a0 \u00a0 \u00a0 \u00a0 6\u00a0\u00a0 \u00a0 6\u00a0\nGasto\u00a0\u00a0 1,676,027 \u00a0 409,431\u00a0 42,613\u00a0 577,503\u00a0 59,560\u00a0\u00a0 2,765,134 \u00a0\nPrecio\u00a0promedio \u00a0\u00a0 0.36\u00a0 0.68\u00a0 0.71\u00a0 0.29\u00a0 0.20\u00a0\u00a0 0.47\u00a0 100mg\u00a0\nCantidad\u00a0\u00a0 6,612,234 \u00a0 1,491,156 \u00a0 90,040\u00a0 3,619,960 \u00a0297,800\u00a0\u00a0 12,111,190 \u00a0\nGasto\u00a0\u00a0 8,341\u00a0 1,260\u00a0 182,502\u00a0 55,207\u00a0\u00a0 \u00a0 247,310\u00a0\nPrecio\u00a0promedio \u00a0\u00a0 2.32\u00a0 2.10\u00a0 1.43\u00a0 0.62\u00a0\u00a0 \u00a0 1.10\u00a0ZIDOVUDINA \u00a0\nTableta\u00a0\n300mg\u00a0\nCantidad\u00a0\u00a0 3,600\u00a0 600\u00a0 242,183\u00a0 126,515\u00a0\u00a0 \u00a0 372,898\u00a0\nTotal\u00a0Gasto\u00a0 7,852\u00a0 19,651,203 \u00a029,268,013 \u00a010,070,308 26,105,255 41,809,136 9,972,306 \u00a0136,884,073 \u00a0\nFuente:\u00a0SEACE,\u00a0procesos\u00a0registrados \u00a0hasta\u00a0diciembre \u00a0del\u00a02010 121 Anexo\u00a08\u00a0\u2010\u00a0Informe\u00a0de\u00a0campo\u00a0\u00a0por\u00a0DISA/DIRESA \u00a0\u00a0\n\u00a0\nLambayeque \u00a0\nPrincipales \u00a0hallazgos \u00a0\nEste\u00a0departamento \u00a0es\u00a0la\u00a0\u00a0sede\u00a0del\u00a0Objetivo\u00a03\u00a0dedicado\u00a0a\u00a0prevenir\u00a0la\u00a0transmisi\u00f3n \u00a0vertical\u00a0en\u00a0la\u00a0macro\u00a0regi\u00f3n\u00a0norte.\u00a0En\u00a0el\u00a0\n2008\u00a0se\u00a0capacit\u00f3\u00a0a\u00a0personal\u00a0de\u00a0ESSALUD\u00a0en\u00a0prevenci\u00f3n \u00a0de\u00a0la\u00a0transmisi\u00f3n \u00a0vertical\u00a0\u00a0(en\u00a0toda\u00a0la\u00a0regi\u00f3n\u00a0macro\u00a0norte)\u00a0pero\u00a0no\u00a0\nten\u00edan\u00a0los\u00a0insumos.\u00a0A\u00a0la\u00a0fecha\u00a0ya\u00a0han\u00a0sido\u00a0adquiridas \u00a0las\u00a0pruebas\u00a0r\u00e1pidas\u00a0para\u00a0VIH.\u00a0A\u00a0partir\u00a0de\u00a0setiembre \u00a0del\u00a02009\u00a0\nempezaron \u00a0a\u00a0solicitarlo \u00a0en\u00a0su\u00a0plan,\u00a0han\u00a0puesto\u00a0meta\u00a0de\u00a0tamizaje\u00a0de\u00a0100%.\u00a0\u00a0Al\u00a0inicio,\u00a0como\u00a0era\u00a0una\u00a0actividad\u00a0nueva,\u00a0hab\u00eda\u00a0\nresistencia \u00a0de\u00a0algunas\u00a0profesionales \u00a0que\u00a0no\u00a0quer\u00edan\u00a0hacer\u00a0tamizaje,\u00a0porque\u00a0les\u00a0daba\u00a0temor\u00a0de\u00a0encontrar \u00a0a\u00a0una\u00a0\u00a0persona\u00a0VIH\u00a0\npositiva\u00a0\u00a0y\u00a0no\u00a0la\u00a0iban\u00a0a\u00a0saber\u00a0manejar.\u00a0\nEn\u00a0el\u00a0caso\u00a0de\u00a0las\u00a0gestantes, \u00a0el\u00a0SIS\u00a0solo\u00a0reembolsaba \u00a0las\u00a0pruebas\u00a0Elisa,\u00a0no\u00a0las\u00a0pruebas\u00a0r\u00e1pidas.\u00a0Despu\u00e9s\u00a0de\u00a0la\u00a0incidencia \u00a0que\u00a0se\u00a0\nrealiz\u00f3,\u00a0modificaron \u00a0el\u00a0tarifario\u00a02009.\u00a0\u00a0Con\u00a0respecto\u00a0a\u00a0la\u00a0adquisici\u00f3n \u00a0de\u00a0pruebas\u00a0r\u00e1pidas,\u00a0existen\u00a0muchos\u00a0problemas \u00a0con\u00a0el\u00a0\npersonal\u00a0de\u00a0Piura,\u00a0lo\u00a0cual\u00a0atrasa\u00a0la\u00a0programaci\u00f3n. \u00a0Con\u00a0respecto\u00a0a\u00a0Tumbes,\u00a0\u00a0compran\u00a0muy\u00a0pocas\u00a0pruebas\u00a0r\u00e1pidas,\u00a0por\u00a0que\u00a0el\u00a0\nreembolso \u00a0del\u00a0SIS\u00a0lo\u00a0recibe\u00a0el\u00a0laboratorio \u00a0y\u00a0no\u00a0los\u00a0establecimientos. \u00a0\u00a0\nESSALUD\u00a0\nHasta\u00a0el\u00a0a\u00f1o\u00a01990\u00a0se\u00a0trabaj\u00f3\u00a0y\u00a0luego\u00a0decay\u00f3,\u00a0retom\u00e1ndose \u00a0nuevamente \u00a0\u00a0en\u00a01996;\u00a0\u00a0se\u00a0form\u00f3\u00a0un\u00a0GAM,\u00a0con\u00a0psic\u00f3logo \u00a0y\u00a0\nasistenta\u00a0social.\u00a0Se\u00a0organizaban \u00a0reuniones \u00a0para\u00a0que\u00a0\u00a0los\u00a0pacientes \u00a0vengan\u00a0a\u00a0recoger\u00a0informaci\u00f3n, \u00a0eran\u00a0los\u00a0primeros\u00a0casos.\u00a0\nCon\u00a0la\u00a0asistenta\u00a0social,\u00a0hac\u00edan\u00a0el\u00a0seguimiento \u00a0de\u00a0los\u00a0casos\u00a0\u00a0y\u00a0de\u00a0toda\u00a0la\u00a0familia.\u00a0Quisieron \u00a0iniciar\u00a0el\u00a0proyecto\u00a0con\u00a0el\u00a0tema\u00a0de\u00a0\nla\u00a0mujer,\u00a0porque\u00a0es\u00a0m\u00e1s\u00a0fuerte\u00a0ella,\u00a0es\u00a0la\u00a0que\u00a0sobrevive, \u00a0pues\u00a0al\u00a0morir\u00a0\u00a0el\u00a0var\u00f3n,\u00a0ella\u00a0\u00a0tiene\u00a0que\u00a0sustentar \u00a0a\u00a0la\u00a0familia,\u00a0\u00a0\nrequiere\u00a0\u00a0soporte\u00a0emocional. \u00a0Se\u00a0realiz\u00f3\u00a0\u00a0\u00a0una\u00a0\u00a0propuesta \u00a0trabajo\u00a0de\u00a0pares,\u00a0pero\u00a0no\u00a0se\u00a0lleg\u00f3\u00a0a\u00a0implementar. \u00a0\nActualmente \u00a0est\u00e1n\u00a0viendo\u00a0como\u00a0incorporar \u00a0la\u00a0propuesta \u00a0del\u00a0\u00a0Sr\u00a0Humberto \u00a0Esteves\u00a0(l\u00edder\u00a0PVV),\u00a0\u00a0que\u00a0es\u00a0una\u00a0propuesta \u00a0\norientada \u00a0a\u00a0reforzar\u00a0el\u00a0tema\u00a0de\u00a0consejer\u00eda. \u00a0\u00a0\u00a0\n\u00a0\nCERITS\u00a0Jos\u00e9\u00a0Olaya\u00a0\nLos\u00a0HSH\u00a0dicen\u00a0que\u00a0no\u00a0quieren\u00a0ir\u00a0al\u00a0Hospital\u00a0de\u00a0las\u00a0Mercedes \u00a0porque\u00a0all\u00ed\u00a0los\u00a0ven\u00a0y\u00a0los\u00a0pueden\u00a0identificar, \u00a0y\u00a0prefieren \u00a0\u00a0que\u00a0les\u00a0\nprovean\u00a0\u00a0el\u00a0TARGA\u00a0en\u00a0el\u00a0CERITS.\u00a0\u00a0En\u00a0general,\u00a0se\u00a0han\u00a0detectado \u00a0personas\u00a0con\u00a0VIH,\u00a0pero\u00a0no\u00a0toman\u00a0tratamiento \u00a0ni\u00a0se\u00a0cuidan,\u00a0lo\u00a0\ncual\u00a0hace\u00a0que\u00a0se\u00a0re\u2010infecten.\u00a0Son\u00a0pocos\u00a0los\u00a0que\u00a0son\u00a0conscientes, \u00a0algunos\u00a0los\u00a0padres\u00a0los\u00a0aceptan\u00a0as\u00ed.\u00a0Hay\u00a0j\u00f3venes\u00a0\u00a0que\u00a0vienen\u00a0\u00a0\na\u00a0pesar\u00a0de\u00a0tener\u00a0\u00a018\u00a0a\u00f1os\u00a0,\u00a0vienen\u00a0con\u00a0la\u00a0mam\u00e1\u00a0a\u00a0la\u00a0consulta\u00a0y\u00a0sus\u00a0controles; \u00a0\u00a0los\u00a0de\u00a0la\u00a0calle\u00a0bien\u00a0dif\u00edcil,\u00a0viven\u00a0hacinados, \u00a0\nviven\u00a0pagando\u00a0hotel\u00a0no\u00a0tienen\u00a0personas\u00a0en\u00a0quien\u00a0confiar,\u00a0que\u00a0les\u00a0sirva\u00a0de\u00a0apoyo.\u00a0\nLA\u00a0PVV\u00a0muchas\u00a0veces\u00a0\u00a0no\u00a0hablan\u00a0de\u00a0deberes,\u00a0solo\u00a0hablan\u00a0de\u00a0derechos. \u00a0\u00a0El\u00a0\u00a0CERITS\u00a0funciona\u00a0desde\u00a01998\u00a0s\u00f3lo\u00a0con\u00a0HSH\u00a0hasta\u00a0\u00a0\ndiciembre \u00a0de\u00a02007\u00a0en\u00a0que\u00a0se\u00a0hace\u00a0extensiva \u00a0la\u00a0atenci\u00f3n\u00a0a\u00a0las\u00a0TS,\u00a0pues\u00a0antes\u00a0ellas\u00a0\u00a0eran\u00a0atendidas \u00a0en\u00a0el\u00a0hospital\u00a0\u00a0Las\u00a0\nMercedes. \u00a0\nEn\u00a0la\u00a0Regi\u00f3n\u00a0Lambayeque \u00a0se\u00a0han\u00a0desarrollado \u00a0los\u00a0siguientes \u00a0proyectos: \u00a0\nINSTITUCION \u00a0 Fuente\u00a0 NOMBRE\u00a0PROYECTO \u00a0 2007 2008 2009\nDEFENSORIA \u00a0DEL\u00a0PUEBLO\u00a0 ONUSIDA \u00a0 DERECHOS \u00a0HUMANOS \u00a0EN\u00a0PERSONAS \u00a0M\u00c1S\u00a0AFECTADAS \u00a0Y\u00a0VIVIENDO \u00a0\nCON\u00a0VIH.\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0ESTIGMA \u00a0Y\u00a0DISCRIMINACI\u00d3N, \u00a0\nPROMOCI\u00d3N \u00a0DE\u00a0LA\u00a0PROTECCI\u00d3N \u00a0DE\u00a0DERECHOS \u00a0Y\u00a0ACCESO\u00a0A\u00a0LA\u00a0\nCIUDADANIA \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nx\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nx\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nx\u00a0\u00a0\nASOCIACION \u00a0DE\u00a0\nCOMUNICADORES \u00a0SOCIALES \u00a0\nCALANDRIA \u00a0FUNDACION \u00a0AVINA\u00a0 COMUNICACION \u00a0PARA\u00a0EL\u00a0DESARROLLO \u00a0Y\u00a0LA\u00a0DEMOCRACIA \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nx\u00a0\u00a0\u00a0\nASOCIACION \u00a0VIA\u00a0LIBRE\u00a0 ALLIANCE \u00a0 INCIDENCIA \u00a0POLITICA\u00a0EN\u00a0VIH\u00a0Y\u00a0SIDA\u00a0CON\u00a0POBLACIONES \u00a0CLAVE\u00a0 x\u00a0\u00a0 \u00a0 \u00a0\n\u00a0\u00a0 VEEDURIA \u00a0EN\u00a0SALUD\u00a0DE\u00a0LAS\u00a0POBLACIONES \u00a0CLAVE,\u00a0UNA\u00a0RESPUESTA \u00a0\nPOSITIVA \u00a0Y\u00a0PREVENTIVA \u00a0AL\u00a0VIH.\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nx\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nx\u00a0\u00a0\nSOCIOS\u00a0EN\u00a0SALUD\u00a0\u2010\u00a0\nSUCURSAL \u00a0PERU\u00a0PARTNERS \u00a0IN\u00a0HEALTH\u00a0AMPLIANDO \u00a0LA\u00a0COBERTURA \u00a0DE\u00a0INGRESOS \u00a0AL\u00a0TARGA\u00a0DE\u00a0PADRES\u00a0DE\u00a0\nFAMILIA\u00a0QUE\u00a0VIENE\u00a0CON\u00a0VIH/SIDA\u00a0EN\u00a0LAS\u00a0PROVI\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nx\u00a0\u00a0\u00a0\n\u00a0\u00a0 PROYECTO \u00a0COLABORATIVO \u00a0MINSA\u2010UNICEF\u2010SES\u00a0:\u00a0\u201cAMPLIANDO \u00a0LA\u00a0\nCOBERTURA \u00a0DE\u00a0TRATAMIENTO \u00a0A\u00a0LOS\u00a0NI\u00d1OS\u00a0CON\u00a0VIH\u201d\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nx\u00a0\u00a0\u00a0\n\u00a0 \u00a0 \u00a0 2\u00a0\u00a0 7\u00a0\u00a0 2\u00a0\u00a0\n\u00a0 122 \u00a0\nLoreto\u00a0\nPrincipales \u00a0hallazgos \u00a0\nDurante\u00a0el\u00a0a\u00f1o\u00a02010\u00a0ha\u00a0existido\u00a0una\u00a0disminuci\u00f3n \u00a0del\u00a0apoyo\u00a0realizado\u00a0por\u00a0el\u00a0Gobierno \u00a0Regional\u00a0de\u00a0Loreto\u00a0por\u00a0la\u00a0disminuci\u00f3n \u00a0\ndel\u00a0canon\u00a0petrolero. \u00a0\u00a0Los\u00a0recursos\u00a0directamente \u00a0recaudados \u00a0tambi\u00e9n\u00a0han\u00a0disminuido \u00a0por\u00a0lo\u00a0que\u00a0no\u00a0ha\u00a0podido\u00a0transferir \u00a0\nrecursos\u00a0\u00a0a\u00a014\u00a0entidades \u00a0\u00a0entre\u00a0ellas\u00a0\u00a0a\u00a0\u201cAlgo\u00a0bello\u00a0de\u00a0Dios\u201d\u00a0(Proyecto \u00a0de\u00a0la\u00a0Parroquia \u00a0San\u00a0Martin\u00a0de\u00a0Porres),\u00a0\u00a0\u201cLazos\u00a0de\u00a0vida\u201d\u00a0\ny\u00a0\u00a0\u00a0Asociaci\u00f3n \u00a0La\u00a0restinga\u201d. \u00a0\u00a0Para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0las\u00a0instituciones \u00a0han\u00a0generado \u00a0deudas\u00a0para\u00a0poder\u00a0seguir\u00a0brindado\u00a0los\u00a0servicios\u00a0\nque\u00a0realizaban, \u00a0para\u00a0el\u00a02011\u00a0el\u00a0GOREL\u00a0\u00a0ha\u00a0suspendido \u00a0los\u00a0convenios \u00a0y\u00a0piensa\u00a0cancelar\u00a0las\u00a0deudas\u00a0con\u00a0las\u00a0instituciones, \u00a0\nalgunas\u00a0de\u00a0las\u00a0cuales\u00a0como\u00a0Lazos\u00a0de\u00a0vida\u00a0ha\u00a0suspendido \u00a0alguna\u00a0de\u00a0las\u00a0actividades \u00a0que\u00a0realizaba\u00a0(reparto\u00a0de\u00a0canastas,\u00a0\ncomedor). \u00a0\u00a0Se\u00a0encuentran \u00a0en\u00a0riesgo\u00a0las\u00a0actividades \u00a0realizadas \u00a0por\u00a0estas\u00a0instituciones. \u00a0\nSi\u00a0bien\u00a0el\u00a0TARGA,\u00a0el\u00a0tamizaje\u00a0\u00a0no\u00a0tienen\u00a0costo\u00a0para\u00a0las\u00a0PVV\u00a0tanto\u00a0en\u00a0el\u00a0MINSA\u00a0como\u00a0en\u00a0ESSALUD\u00a0\u00a0\u00a0al\u00a0igual\u00a0\u00a0que\u00a0las\u00a0gestantes \u00a0\u00a0\ny\u00a0MEF\u00a0tienen\u00a0paquete\u00a0gratis\u00a0que\u00a0incluye\u00a0Prueba\u00a0r\u00e1pida\u00a0para\u00a0VIH\u00a0y\u00a0RPR;\u00a0pero\u00a0\u00a0hay\u00a0costos\u00a0asumidos \u00a0por\u00a0las\u00a0propias\u00a0personas\u00a0\ncomo\u00a0la\u00a0hospitalizaci\u00f3n \u00a0por\u00a0Infecciones \u00a0oportunistas, \u00a0\u00a0reacciones \u00a0adversas, \u00a0el\u00a0pago\u00a0de\u00a0la\u00a0consulta\u00a0\u00a0cuando\u00a0no\u00a0tienen\u00a0SIS.\u00a0\nAproximadamente \u00a0\u00a0el\u00a010%\u00a0no\u00a0tienen\u00a0SIS.\u00a0Todos\u00a0pagan\u00a0la\u00a0\u00a01\u00b0\u00a0consulta.\u00a0\u00a0\nA\u00a0veces\u00a0tambi\u00e9n\u00a0la\u00a0persona\u00a0con\u00a0VIH\u00a0tiene\u00a0que\u00a0asumir\u00a0el\u00a0gasto\u00a0cuando\u00a0\u00a0hay\u00a0desabastecimiento \u00a0de\u00a0insumos\u00a0\u00a0como\u00a0en\u00a0el\u00a0a\u00f1o\u00a0\n2010\u00a0que\u00a0\u00a0ha\u00a0habido\u00a0desabastecimiento \u00a0de\u00a0condones, \u00a0EFV\u00a0y\u00a0\u00a0en\u00a0el\u00a0caso\u00a0de\u00a0DDI\u00a0que\u00a0se\u00a0cambi\u00f3\u00a0por\u00a0Abacavir\u00a0\nEn\u00a0la\u00a0Regi\u00f3n\u00a0los\u00a0actores\u00a0principales \u00a0en\u00a0la\u00a0lucha\u00a0contra\u00a0el\u00a0VIH\u00a0tenemos\u00a0al\u00a0MINSA,\u00a0\u00a0ESSALUD\u00a0y\u00a0las\u00a0ONG\u00a0e\u00a0Instituciones. \u00a0\nAsociaci\u00f3n \u00a0Civil\u00a0Selva\u00a0Amaz\u00f3nica \u00a0(ACSA)\u00a0que\u00a0se\u00a0dedica\u00a0\u00a0a\u00a0\u00a0estudios\u00a0de\u00a0vacuna\u00a0financiados \u00a0por\u00a0el\u00a0HVTN,\u00a0provisi\u00f3n\u00a0de\u00a0TARGA\u00a0\nen\u00a0el\u00a0MINSA\u00a0y\u00a0prevenci\u00f3n \u00a0con\u00a0financiamiento \u00a0del\u00a0FM.\u00a0Trabaja\u00a0a\u00a0nivel\u00a0de\u00a0poblaci\u00f3n \u00a0HSH,\u00a0TS,\u00a0TRANS;\u00a0en\u00a0el\u00a0fortalecimiento \u00a0de\u00a0\nUAMP,\u00a0material\u00a0de\u00a0escritorio, \u00a0kit\u00a0de\u00a0prevenci\u00f3n. \u00a0\n\u00a0ADAR\u00a0que\u00a0se\u00a0dedica\u00a0al\u00a0fortalecimiento \u00a0de\u00a0las\u00a0competencias \u00a0del\u00a0profesional \u00a0m\u00e9dico\u00a0y\u00a0t\u00e9cnico\u00a0sobre\u00a0todo\u00a0relacionado \u00a0con\u00a0las\u00a0\nITS.\u00a0\n\u00a0CEPESJU ,\u00a0realiza\u00a0actividades \u00a0de\u00a0la\u00a0V\u00a0Ronda\u00a0del\u00a0FMSTMy\u00a0va\u00a0a\u00a0los\u00a0lugares\u00a0m\u00e1s\u00a0alejados:\u00a0San\u00a0Lorenzo,\u00a0Caballococha. \u00a0\nCEPCO ,\u00a0es\u00a0el\u00a0consorcio \u00a0\nde\u00a0la\u00a0VI\u00a0Ronda\u00a0del\u00a0FM\u00a0\n\u00a0\n\u00a0AECID\u00a0\u00a0particip\u00f3\u00a0en\u00a0el\u00a0D\u00eda\u00a0Mundial\u00a0de\u00a0Lucha\u00a0contra\u00a0el\u00a0Sida\u00a0con\u00a0S/4,000.000 \u00a0\u00a0para\u00a0actividades \u00a0en\u00a0Iquitos\u00a0y\u00a0Nauta.\u00a0\n\u00a0\nUSAID ,\u00a0con\u00a0el\u00a0Proyecto\u00a0Calidad\u00a0en\u00a0Salud,\u00a0cuyo\u00a0objetivo\u00a0es\u00a0fortalecer \u00a0competencias \u00a0y\u00a0tratar\u00a0\u00a0de\u00a0hacer\u00a0una\u00a0sede\u00a0docente\u00a0en\u00a0el\u00a0\nHospital\u00a0Regional\u00a0en\u00a0TARGA\u00a0\u00a0e\u00a0Infecciones \u00a0oportunistas. \u00a0\nCOREMUSA ,\u00a0\u00a0ha\u00a0formado\u00a0equipos\u00a0\u00a0que\u00a0est\u00e1n\u00a0revisando \u00a0los\u00a0temas\u00a0del\u00a0centro\u00a0de\u00a0formaci\u00f3n \u00a0\nONUSIDA, \u00a0que\u00a0se\u00a0dedica\u00a0a\u00a0la\u00a0capacitaci\u00f3n \u00a0del\u00a0personal. \u00a0Para\u00a0este\u00a0\u00a0a\u00f1o\u00a02011\u00a0van\u00a0a\u00a0fortalecer \u00a0\u00a05\u00a0UAMP\u00a0de\u00a0la\u00a0Regi\u00f3n,\u00a0van\u00a0a\u00a0\ntrabajar\u00a0m\u00e1s\u00a0la\u00a0parte\u00a0preventiva, \u00a0con\u00a0familia,\u00a0adolescentes \u00a0y\u00a0escuelas;\u00a0un\u00a0carro\u00a0m\u00f3vil\u00a0para\u00a0equipo\u00a0itinerante. \u00a0\n\u00a0\u00a0ESSALUD\u00a0tiene\u00a033\u00a0PVV\u00a0en\u00a0TARGA\u00a0que\u00a0maneja\u00a0\u00a0esquemas \u00a0diferentes, \u00a0no\u00a0env\u00edan\u00a0reportes\u00a0al\u00a0MINSA.\u00a0No\u00a0tienen\u00a0poblaci\u00f3n \u00a0HSH.\u00a0\nSMEII\u00a0no\u00a0ayuda\u00a0para\u00a0estad\u00edstica. \u00a0En\u00a0la\u00a0Regi\u00f3n\u00a0\u00a0tenemos\u00a0los\u00a0siguientes \u00a0establecimientos \u00a0\u00a0y\u00a0ONG\u00a0que\u00a0brindan\u00a0TARGA\u00a0adem\u00e1s\u00a0\nde\u00a0ESSALUD: \u00a0\n\u00a0\nHospital\u00a0Regional\u00a0\nHospital\u00a0de\u00a0Iquitos\n\u00a0\nHospital\u00a0Santa\u00a0Gema\u00a0de\u00a0Yurimaguas \u00a0\nAsociaci\u00f3n \u00a0Civil\u00a0Selva\u00a0Amaz\u00f3nica \u00a0\n\u00a0En\u00a0los\u00a0establecimientos \u00a0del\u00a0MINSA,\u00a0existe\u00a0un\u00a0equipo\u00a0que\u00a0provee\u00a0TARGA\u00a0(Realizan\u00a0atenci\u00f3n\u00a0integral\u00a0de\u00a0la\u00a0familia)\u00a0\u00a0que\u00a0est\u00e1\u00a0\nconformado \u00a0por:\u00a0\n2\u00a0enfermeras \u00a0\n1\u00a0obstetriz\u00a0consultorio \u00a0\n1\u00a0obstetriz\u00a0hospitalizaci\u00f3n \u00a0\n1\u00a0interno\u00a0de\u00a0psicolog\u00eda \u00a0\n1\u00a0trabajadora \u00a0social\u00a0\n4\u00a0infect\u00f3logos \u00a0que\u00a0se\u00a0turnan\u00a0\nla\u00a0atenci\u00f3n\u00a0\n1\u00a0consejero \u00a0de\u00a0par\u00a0 123 1\u00a0nutricionista \u00a0\n1\u00a0laboratorista \u00a0\n1\u00a0qu\u00edmico\u00a0farmac\u00e9utico \u00a0\n1\u00a0odont\u00f3logo \u00a0\n\u00a0\nEl\u00a0presupuesto \u00a0de\u00a0la\u00a0DIRESA\u00a0para\u00a0el\u00a0\u00a0a\u00f1o\u00a02010\u00a0\u00a0fue\u00a0de\u00a0\u00a0S/\u00a074,000\u00a0y\u00a0le\u00a0sirvi\u00f3\u00a0\u00a0para\u00a0pagar\u00a0a:\u00a0\nPEPs:\u00a0\u00a015\u00a0\u00a0HSH\u00a0(MINSA:\u00a05,\u00a0FM:\u00a010),\u00a0\u00a09\u00a0TS\u00a0(MINSA:\u00a04;\u00a0FM:\u00a05),\u00a02\u00a0\u00a0monitores, \u00a0Profesionales \u00a0del\u00a0CERITS\u00a0\nT\u00e9cnica\u00a0del\u00a0CERITS\u00a0\n\u00a0\nHospital\u00a0Regional\u00a0\nEn\u00a0el\u00a0\u00a0Hospital\u00a0todos\u00a0los\u00a0pacientes \u00a0tienen\u00a0SIS\u00a0por\u00a0lo\u00a0que\u00a0es\u00a0gratis\u00a0el\u00a0tamizaje,\u00a0hematocrito, \u00a0bater\u00eda\u00a0pre\u00a0targa.\u00a0Las\u00a0\ntransaminasas \u00a0son\u00a0asumidas \u00a0por\u00a0los\u00a0pacientes \u00a0y\u00a0lo\u00a0hacen\u00a0en\u00a0laboratorio \u00a0particular. \u00a0Ex\u00e1menes \u00a0para\u00a0\u00a0algunas\u00a0IO\u00a0se\u00a0hacen\u00a0los\u00a0\npacientes \u00a0aparte.\u00a0El\u00a0tratamiento \u00a0de\u00a0IO\u00a0\u00a0ha\u00a0estado\u00a0siendo\u00a0asumido\u00a0por\u00a0los\u00a0subreceptores \u00a0(FM)\u00a0pero\u00a0ahora\u00a0ya\u00a0han\u00a0pasado\u00a0al\u00a0\nMinisterio \u00a0y\u00a0no\u00a0tienen\u00a0la\u00a0seguridad \u00a0si\u00a0van\u00a0a\u00a0tener\u00a0disponibilidad \u00a0de\u00a0\u00a0los\u00a0tratamientos. \u00a0Es\u00a0asumido\u00a0por\u00a0el\u00a0paciente\u00a0el\u00a0pago\u00a0de\u00a0\nla\u00a0consulta\u00a0\u00a0y\u00a0todo\u00a0lo\u00a0que\u00a0no\u00a0lo\u00a0asume\u00a0el\u00a0SIS\u00a0especialmente \u00a0en\u00a0el\u00a0tratamiento \u00a0de\u00a0algunas\u00a0IO\u00a0\n\u00a0\nUsualmente \u00a0el\u00a0TARGA\u00a0es\u00a0gratis\u00a0y\u00a0continuo, \u00a0pues\u00a0\u00a0reciben\u00a0los\u00a0medicamentos \u00a0\u00a0del\u00a0nivel\u00a0central\u00a0y\u00a0cuando\u00a0hay\u00a0\ndesabastecimiento \u00a0lo\u00a0sacan\u00a0a\u00a0trav\u00e9s\u00a0del\u00a0SIS.\u00a0La\u00a0compra\u00a0de\u00a0vitaminas \u00a0que\u00a0son\u00a0indicadas \u00a0por\u00a0el\u00a0m\u00e9dico\u00a0durante\u00a0el\u00a0seguimiento \u00a0\ndel\u00a0TARGA\u00a0es\u00a0asumido\u00a0por\u00a0el\u00a0paciente, \u00a0pues\u00a0eso\u00a0no\u00a0est\u00e1\u00a0comprendido \u00a0en\u00a0el\u00a0SIS.\u00a0De\u00a0\u00a0todos\u00a0los\u00a0PVV\u00a0a\u00a0quienes\u00a0se\u00a0les\u00a0receta\u00a0\nvitaminas, \u00a0s\u00f3lo\u00a0el\u00a020%\u00a0lo\u00a0compra.\u00a0\u00a0\n\u00a0\nLa\u00a0consejer\u00eda \u00a0es\u00a0realizada\u00a0por\u00a0dos\u00a0enfermeras \u00a0(Una\u00a0ve\u00a0HSH,\u00a0poblaci\u00f3n \u00a0general\u00a0y\u00a0las\u00a0otra\u00a0ve\u00a0ni\u00f1os)\u00a0y\u00a0una\u00a0obstetriz\u00a0que\u00a0hace\u00a0a\u00a0\npoblaci\u00f3n \u00a0\u00a0general.\u00a0\n\u00a0\nEl\u00a0\u00a0establecimiento \u00a0cuenta\u00a0con\u00a0insumos\u00a0o\u00a0medicamentos \u00a0que\u00a0entregan\u00a0normalmente \u00a0de\u00a0forma\u00a0gratuita\u00a0a\u00a0los\u00a0usuarios.\u00a0Es\u00a0\npermanente \u00a0durante\u00a0\u00a0\u00a0todo\u00a0el\u00a0a\u00f1o.\u00a0S\u00f3lo\u00a0\u00a0durante\u00a0el\u00a0a\u00f1o\u00a02010\u00a0ha\u00a0habido\u00a0desabastecimiento \u00a0de\u00a0condones \u00a0por\u00a0lo\u00a0cual\u00a0\u00a0ya\u00a0casi\u00a0\nno\u00a0estaban\u00a0entregando \u00a0condones. \u00a0Actualmente \u00a0entregan\u00a020\u00a0condones \u00a0a\u00a0cada\u00a0PVV\u00a0cuando\u00a0viene\u00a0a\u00a0la\u00a0visita\u00a0de\u00a0control.\u00a0ARV\u00a0\npedi\u00e1tricos \u00a0hacen\u00a0compra\u00a0conjunta\u00a0entre\u00a0Ucayali,\u00a0Loreto\u00a0y\u00a0San\u00a0Mart\u00edn\u00a0a\u00a0fin\u00a0de\u00a0bajar\u00a0costos.\u00a0\n\u00a0\nCERITS\u00a0San\u00a0Juan\u00a0\nEn\u00a0el\u00a0CERITS\u00a0se\u00a0atiende\u00a0\u00a0a\u00a0HSH,\u00a0TS\u00a0y\u00a0poblaci\u00f3n \u00a0general.\u00a0Se\u00a0realiza\u00a0AMP\u00a0a\u00a0\u00a0HSH\u00a0y\u00a0TS;\u00a0no\u00a0se\u00a0realiza\u00a0KOH,\u00a0ELISA\u00a0para\u00a0Clamydia\u00a0\nporque\u00a0no\u00a0mandan\u00a0insumos\u00a0desde\u00a0el\u00a0nivel\u00a0central,\u00a0\u00b4pero\u00a0tampoco\u00a0las\u00a0pacientes \u00a0van\u00a0a\u00a0otro\u00a0lado\u00a0a\u00a0hacerse\u00a0la\u00a0prueba.\u00a0La\u00a0\npoblaci\u00f3n \u00a0HSH\u00a0adem\u00e1s\u00a0de\u00a0atenderse \u00a0en\u00a0el\u00a0CERITS\u00a0tambi\u00e9n\u00a0lo\u00a0hacen\u00a0en\u00a0la\u00a0UAMP\u00a0que\u00a0es\u00a0del\u00a0Ministerio \u00a0y\u00a0en\u00a0la\u00a0Asociaci\u00f3n \u00a0Civil\u00a0\nSelva\u00a0Amaz\u00f3nica. \u00a0\u00a0\u00a0\n\u00a0\nEl\u00a0paciente\u00a0asume\u00a0la\u00a0apertura\u00a0de\u00a0HC\u00a0que\u00a0son\u00a0S/.\u00a03.00\u00a0por\u00a0\u00fanica\u00a0vez.\u00a0Durante\u00a0el\u00a0a\u00f1o\u00a02010\u00a0han\u00a0estado\u00a0recibiendo \u00a0\u00a0\u00a0\u00a05\u00a0\ncondones \u00a0por\u00a0visita\u00a0y\u00a0\u00a0reci\u00e9n\u00a0est\u00e1n\u00a0entregando \u00a050\u00a0condones. \u00a0EL\u00a0CERITS\u00a0no\u00a0tiene\u00a0consolidado \u00a0cu\u00e1ntos\u00a0\u00a0HSH\u00a0son\u00a0PVV.\u00a0\n\u00a0\nLos\u00a0pacientes \u00a0\u00a0asumen\u00a0la\u00a0apertura\u00a0de\u00a0HC.\u00a0La\u00a0poblaci\u00f3n \u00a0general\u00a0\u00a0tiene\u00a0que\u00a0asumir\u00a0su\u00a0tamizaje\u00a0para\u00a0VIH,\u00a0cuando\u00a0no\u00a0va\u00a0\nasociado\u00a0a\u00a0\u00a0conductas \u00a0de\u00a0riesgo\u00a0y\u00a0tiene\u00a0que\u00a0ir\u00a0al\u00a0hospital.\u00a0\n\u00a0\nEl\u00a0CERITS\u00a0tiene\u00a0insumos,\u00a0excepto\u00a0KOH,\u00a0Elisa\u00a0para\u00a0Clamydia, \u00a0y\u00a0actualmente \u00a0ya\u00a0tienen\u00a0condones. \u00a0\n\u00a0\nESSALUD\u00a0\nEl\u00a0TARGA\u00a0es\u00a0gratis\u00a0en\u00a0el\u00a0Hospital\u00a0de\u00a0ESSALUD. \u00a0No\u00a0se\u00a0da\u00a0en\u00a0los\u00a0policl\u00ednicos. \u00a0\u00a0En\u00a0Iquitos\u00a0s\u00f3lo\u00a0se\u00a0da\u00a0los\u00a0esquemas \u00a0iniciales\u00a0de\u00a0\nTARGA,\u00a0Rescate\u00a0lo\u00a0asume\u00a0el\u00a0Seguro\u00a0de\u00a0Lima;\u00a0el\u00a0paciente\u00a0tiene\u00a0que\u00a0viajar\u00a0cada\u00a0vez\u00a0que\u00a0tiene\u00a0su\u00a0control\u00a0a\u00a0la\u00a0ciudad\u00a0de\u00a0Lima.\u00a0El\u00a0\npaciente\u00a0asume\u00a0CD4\u00a0y\u00a0CV\u00a0al\u00a0inicio\u00a0y\u00a0en\u00a0cada\u00a0uno\u00a0de\u00a0sus\u00a0controles, \u00a0algunos\u00a0se\u00a0\u00a0realizan\u00a0en\u00a0el\u00a0MINSA\u00a0y\u00a0la\u00a0mayor\u00eda\u00a0no\u00a0se\u00a0\u00a0hacen\u00a0\nestas\u00a0pruebas\u00a0inici\u00e1ndose \u00a0el\u00a0TARGA\u00a0\u00a0con\u00a0solo\u00a0\u00a0cuadro\u00a0cl\u00ednico.\u00a0Ex\u00e1menes \u00a0pre\u00a0TARGA\u00a0se\u00a0hacen\u00a0en\u00a0ESSALUD\u00a0cada\u00a06\u00a0meses.\u00a0La\u00a0\nPVV\u00a0tambi\u00e9n\u00a0asume\u00a0el\u00a0costo\u00a0del\u00a0Anfotericin \u00a0B\u00a0si\u00a0es\u00a0que\u00a0lo\u00a0necesitaran. \u00a0\n\u00a0\n\u00a0El\u00a0diagn\u00f3stico \u00a0de\u00a0VIH\u00a0le\u00a0hacen\u00a0con\u00a0dos\u00a0ELISAS\u00a0y\u00a0la\u00a0confirmaci\u00f3n \u00a0la\u00a0hacen\u00a0en\u00a0el\u00a0laboratorio \u00a0referencial \u00a0del\u00a0MINSA.\u00a0Gestantes \u00a0\u00a0\ntienen\u00a0paquete\u00a0gratis\u00a0que\u00a0incluye\u00a0Prueba\u00a0r\u00e1pida\u00a0para\u00a0VIH\u00a0y\u00a0RPR.\u00a0RN\u00a0recibe\u00a0AZT\u00a0al\u00a0nacimiento. \u00a0Los\u00a0PVV\u00a0reciben\u00a020\u00a0condones \u00a0\nen\u00a0la\u00a0consulta\u00a0 124 \u00a0\nPCR\u00a0no\u00a0tienen\u00a0disponible \u00a0para\u00a0los\u00a0reci\u00e9n\u00a0nacidos\u00a0expuestos \u00a0perinatalmente, \u00a0por\u00a0lo\u00a0que\u00a0el\u00a0Diagn\u00f3stico \u00a0\u00a0le\u00a0hacen\u00a0reci\u00e9n\u00a0al\u00a0a\u00f1o\u00a0\ny\u00a0medio\u00a0\n\u00a0ESSALUD\u00a0cuenta\u00a0con\u00a0Tratamiento \u00a0e\u00a0insumos\u00a0en\u00a0forma\u00a0permanente \u00a0pues\u00a0cuando\u00a0al\u00a0paciente\u00a0le\u00a0falta\u00a0un\u00a0medicamento \u00a0del\u00a0\nesquema\u00a0que\u00a0est\u00e1\u00a0recibiendo \u00a0le\u00a0\u00a0reemplazan \u00a0por\u00a0un\u00a0equivalente, \u00a0lo\u00a0\ncual\u00a0implica\u00a0que\u00a0el\u00a0paciente\u00a0no\u00a0deja\u00a0\u00a0de\u00a0tomar\u00a0pastillas.\u00a0\n\u00a0\nAsociaci\u00f3n \u00a0Civil\u00a0Selva\u00a0Amaz\u00f3nica \u00a0\u2010\u00a0ACSA\u00a0\n\u00a0\nACSA\u00a0hace\u00a0investigaci\u00f3n \u00a0para\u00a0vacuna\u00a0de\u00a0VIH\u00a0\u00a0como\u00a0miembro\u00a0del\u00a0HVTN\u00a0y\u00a0provee\u00a0TARGA\u00a0\u00a0del\u00a0Ministerio \u00a0de\u00a0Salud.\u00a0Es\u00a0parte\u00a0del\u00a0\nconsorcio \u00a0del\u00a0Objetivo\u00a06\u00a0del\u00a0FMSTMy\u00a0hacen\u00a0trabajos\u00a0de\u00a0prevenci\u00f3n \u00a0\nRecibe\u00a0la\u00a0\u00b4provisi\u00f3n \u00a0de\u00a0medicamentos \u00a0ARV\u00a0\u00a0para\u00a0los\u00a0pacientes \u00a0que\u00a0se\u00a0controlan \u00a0en\u00a0su\u00a0Instituci\u00f3n, \u00a0adem\u00e1s\u00a0como\u00a0unidad\u00a0\nnotificante \u00a0de\u00a0ITS/VIH\u00a0recibe\u00a0medicamentos \u00a0para\u00a0ITS\u00a0y\u00a0condones. \u00a0\n\u00a0\nEl\u00a0tamizaje\u00a0para\u00a0las\u00a0personas\u00a0\u00a0de\u00a0poblaci\u00f3n \u00a0general\u00a0que\u00a0acuden\u00a0\u00a0en\u00a0forma\u00a0voluntaria \u00a0tiene\u00a0un\u00a0costo\u00a0al\u00a0igual\u00a0que\u00a0la\u00a0consulta.\u00a0\nPero\u00a0son\u00a0muy\u00a0pocos,\u00a02\u00a0\u00f3\u00a03.\u00a0Cuando\u00a0el\u00a0tamizaje\u00a0es\u00a0reactivo,\u00a0\u00a0para\u00a0la\u00a0confirmaci\u00f3n \u00a0\u00a0env\u00edan\u00a0\u00a0la\u00a0muestra\u00a0al\u00a0laboratorio \u00a0\nreferencial \u00a0del\u00a0MINSA.\u00a0Cuando\u00a0son\u00a0personas\u00a0que\u00a0son\u00a0enroladas \u00a0para\u00a0los\u00a0estudios,\u00a0el\u00a0tamizaje\u00a0no\u00a0les\u00a0cuesta.\u00a0Los\u00a0ex\u00e1menes \u00a0\nde\u00a0laboratorio \u00a0pre\u00a0TARGA\u00a0o\u00a0\u00a0los\u00a0de\u00a0seguimiento \u00a0la\u00a0Asociaci\u00f3n \u00a0se\u00a0hace\u00a0cargo.\u00a0S\u00f3lo\u00a0CD4\u00a0y\u00a0CV\u00a0es\u00a0asumido\u00a0por\u00a0el\u00a0MINSA.\u00a0El\u00a0RPR\u00a0\nse\u00a0hace\u00a0en\u00a0ACSA\u00a0y\u00a0si\u00a0es\u00a0positivo\u00a0tambi\u00e9n\u00a0le\u00a0dan\u00a0tratamiento \u00a0que\u00a0es\u00a0enviado\u00a0por\u00a0el\u00a0MINSA\u00a0\n\u00a0\nAl\u00a0comienzo \u00a0(2008)\u00a0la\u00a0Asociaci\u00f3n \u00a0realizaba\u00a0los\u00a0CD4\u00a0y\u00a0la\u00a0CV,\u00a0pero\u00a0todo\u00a0este\u00a0a\u00f1o\u00a0lo\u00a0env\u00edan\u00a0al\u00a0MINSA.\u00a0Provee\u00a0TARGA\u00a0\nespecialmente \u00a0a\u00a0poblaci\u00f3n \u00a0HSH.\u00a0\u00a0\n\u00a0\nLos\u00a0Proyectos \u00a0desarrollados \u00a0en\u00a0la\u00a0Regi\u00f3n\u00a0son\u00a0los\u00a0siguientes: \u00a0\u00a0\n\u00a0\nInstituci\u00f3n \u00a0 Financiador \u00a0 Proyecto\u00a0 2006\u00a02007\u00a02008\u00a02009\u00a0\nASOCIACION \u00a0MINGA\u00a0PERU\u00a0UNFPA\u00a0 PROYECTO \u00a0EDUCATIVO \u00a0RADIAL\u00a0INTERCULTURAL \u00a0DE\u00a0LUCHA\u00a0\nCONTRA\u00a0LA\u00a0VIOLENCIA \u00a0Y\u00a0VIH/SIDA\u00a0EN\u00a0COMUNIDADES \u00a0Y\u00a0\nESCUELAS \u00a0RURALES\u00a0DE\u00a0LA\u00a0AMAZONIA \u00a0x\u00a0 x\u00a0 x\u00a0\u00a0\nDEFENSORIA \u00a0DEL\u00a0PUEBLO\u00a0 ONUSIDA \u00a0 DERECHOS \u00a0HUMANOS \u00a0EN\u00a0PERSONAS \u00a0M\u00c1S\u00a0AFECTADAS \u00a0Y\u00a0\nVIVIENDO \u00a0CON\u00a0VIH.\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0ESTIGMA \u00a0Y\u00a0\nDISCRIMINACI\u00d3N, \u00a0PROMOCI\u00d3N \u00a0DE\u00a0LA\u00a0PROTECCI\u00d3N \u00a0DE\u00a0\nDERECHOS \u00a0Y\u00a0ACCESO\u00a0A\u00a0LA\u00a0CIUDADANIA \u00a0\u00a0 x\u00a0\u00a0\u00a0\nMINISTERIO \u00a0DE\u00a0SALUD\u00a0 UNICEF\u00a0 VIH/SIDA\u00a0Y\u00a0NI\u00d1EZ\u00a0\u00a0 x\u00a0 x\u00a0 x\u00a0\nAPOYO\u00a0A\u00a0PROGRAMAS \u00a0DE\u00a0\nPOBLACION \u00a0USAID\u00a0 MERCADEO \u00a0SOCIAL\u00a0DEL\u00a0CONDON \u00a0PARA\u00a0POBLACIONES \u00a0\nVULNERABLES \u00a0\u00a0 x\u00a0\u00a0\u00a0\nASOCIACION \u00a0CIVIL\u00a0IMPACTA \u00a0\nSALUD\u00a0Y\u00a0EDUCACION \u00a0NATIONAL \u00a0\nINSTITUTES \u00a0OF\u00a0\nHEALTH\u00a0\u2013\u00a0NIH\u00a0PROGRAMA \u00a0UNIDAD\u00a0DE\u00a0ENSAYOS \u00a0CLINICOS \u00a0DE\u00a0IMPACTA, \u00a0\nPERU\u00a0(CTU)\u00a0\u00a0 \u00a0 x\u00a0 x\u00a0\n\u00a0 UNIVERSITY \u00a0OF\u00a0\nWASHINGTON \u00a0ENSAYO\u00a0CLINICO\u00a0DE\u00a0FASE\u00a0III,\u00a0ALEATORIO, \u00a0DOBLE\u00a0CIEGO,\u00a0\nCONTROLADO \u00a0CONTRA\u00a0PALCEBO \u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0P\u00a0\u00a0 x\u00a0 x\u00a0\u00a0\nASOCIACION \u00a0CIVIL\u00a0SELVA\u00a0\nAMAZONICA \u00a0FRED\u00a0HUTCHINSON \u00a0\nCANCER\u00a0RESEARCH \u00a0\nCENTER\u00a0ENSAYO\u00a0DE\u00a0VACUNAS \u00a0CONTRA\u00a0EL\u00a0VIH:\u00a0FASE\u00a0IB,\u00a0PARA\u00a0\nCOMPARAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0LA\u00a0TOLERABILIDAD \u00a0A\u00a0\nPERSONAS \u00a0ADULTAS \u00a0SANAS,\u00a0NO\u00a0INFECTADAS \u00a0POR\u00a0EL\u00a0VIH\u00a0\u00a0 x\u00a0 x\u00a0 x\u00a0\n\u00a0\u00a0 UN\u00a0ESTUDIO\u00a0DE\u00a0PRUEBA\u00a0DE\u00a0CONCEPTO \u00a0DE\u00a0FASE\u00a0II,\u00a0\nCONTROLADO \u00a0POR\u00a0PLACEBO, \u00a0MULTICENTRICO, \u00a0DOBLE\u00a0\nCIEGO,\u00a0ALEATORIZADO, \u00a0PARA\u00a0EVALUAR \u00a0LA\u00a0SEGURIDAD \u00a0Y\u00a0LA\u00a0\nEFICACIA\u00a0DE\u00a0UN\u00a0REGIMEN \u00a0DE\u00a03\u00a0DOSIS\u00a0DE\u00a0LA\u00a0VACUNAQ \u00a0DE\u00a0\nGAG/POL/NEF \u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0ADENOVIRUS \u00a0SEROTIPO \u00a05\u00a0DE\u00a0\nMERCK\u00a0(MRKAD\u00a0\u00a0\u00a0 x\u00a0\u00a0\n\u00a0 THE\u00a0J.\u00a0DAVID\u00a0\nGLADSTONE \u00a0\nINSTITUTES \u00a0QUIMIOPROFILAXIS \u00a0PARA\u00a0LA\u00a0PREVENCION \u00a0DEL\u00a0VIH\u00a0EN\u00a0\nHOMBRES \u00a0\u00a0 x\u00a0\u00a0\u00a0\nASOCIACION \u00a0DE\u00a0\nCOMUNICADORES \u00a0SOCIALES \u00a0\nCALANDRIA \u00a0FUNDACION \u00a0AVINA\u00a0 COMUNICACION \u00a0PARA\u00a0EL\u00a0DESARROLLO \u00a0Y\u00a0LA\u00a0DEMOCRACIA \u00a0\nx\u00a0\u00a0\u00a0\u00a0\nASOCIACION \u00a0LA\u00a0RESTINGA \u00a0 FUNDACION \u00a0\nSTROMME \u00a0CREA\u00a0BELEN\u00a0x\u00a0\u00a0\u00a0\u00a0\nASOCIACION \u00a0MINGA\u00a0PERU\u00a0HIVOS\u00a0 74)MUJERES \u00a0Y\u00a0ADOLESCENTES \u00a0LIDERES\u00a0PROMOTORAS \u00a0DE\u00a0LA\u00a0\u00a0 \u00a0 x\u00a0 x\u00a0 125 Instituci\u00f3n \u00a0 Financiador \u00a0 Proyecto\u00a0 2006\u00a02007\u00a02008\u00a02009\u00a0\nEQUIDAD, \u00a0LA\u00a0PREVENCI\u00d3N \u00a0DE\u00a0LA\u00a0VIOLENCIA \u00a0Y\u00a0EL\u00a0VIH/S\u00a0\n\u00a0 MATCH\u00a0\nINTERNATIONAL \u00a0\nCENTRE\u00a046)\u00a0CONSOLIDACION \u00a0Y\u00a0PROYECCION \u00a0DEL\u00a0TRABAJO\u00a0DE\u00a0\nCORRESPONSALES \u00a0Y\u00a0PROMOTORAS \u00a0TECNICAS \u00a0\nAGROFORESTALES \u00a0EN\u00a0x\u00a0\u00a0\u00a0\u00a0\n\u00a0\u00a0 61)\u00a0USO\u00a0Y\u00a0GESTI\u00d3N\u00a0DE\u00a0ALTO\u00a0PARLANTES \u00a0COMUNALES \u00a0PARA\u00a0\nLA\u00a0PRODUCCI\u00d3N \u00a0DESCENTRALIZADA \u00a0DE\u00a0MENSAJES \u00a0SOBRE\u00a0S\u00a0\u00a0\u00a0 x\u00a0 x\u00a0\n\u00a0 THE\u00a0GLOBAL\u00a0FUND\u00a0\nFOR\u00a0WOMEN\u00a0ACOMPA\u00d1AMIENTO \u00a0A\u00a0LA\u00a0LABOR\u00a0DE\u00a0LOS\u00a0CORRESPONSALES \u00a0\nRADIALES \u00a0EN\u00a0COMUNIDADES \u00a0RURALES\u00a0\u00a0 x\u00a0\u00a0\u00a0\n\u00a0 FIA\u00a0 32B)\u00a0FORTALECIMIENTO \u00a0DE\u00a0LA\u00a0RED\u00a0DE\u00a0MUJERES \u00a0DEL\u00a0R\u00cdO\u00a0\nMARA\u00d1\u00d3N \u00a0Y\u00a0TIGRE\u00a0A\u00a0TRAV\u00c9S\u00a0DEL\u00a0MODELO\u00a0INTEGRADO \u00a0DE\u00a0\nC\u00a0\u00a0 x\u00a0\u00a0\u00a0\nASOCIACION \u00a0VIA\u00a0LIBRE\u00a0 ALLIANCE \u00a0 VEEDURIA \u00a0EN\u00a0SALUD\u00a0DE\u00a0LAS\u00a0POBLACIONES \u00a0CLAVE,\u00a0UNA\u00a0\nRESPUESTA \u00a0POSITIVA \u00a0Y\u00a0PREVENTIVA \u00a0AL\u00a0VIH.\u00a0\u00a0 x\u00a0 x\u00a0 x\u00a0\n\u00a0 PACT\u00a0 POLICIA\u00a0SEGURA:\u00a0REDES\u00a0DE\u00a0PROMOTORES \u00a0POLICIAS\u00a0EN\u00a0\nPREVENCION \u00a0DE\u00a0VIH/SIDA\u00a0EN\u00a0LA\u00a0POBLACION \u00a0POLICIAL\u00a0PERU\u00a0\u00a0\u00a0 x\u00a0\u00a0\nINVESTIGACIONES \u00a0MEDICAS \u00a0\nEN\u00a0SALUD\u00a0EMBAJADA \u00a0USA\u00a0 EPIDEMIOLOG\u00cdA \u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0SUDAM\u00c9RICA \u00a0\u00a0 x\u00a0\u00a0\u00a0\nMOVIMIENTO \u00a0MANUELA \u00a0\nRAMOS.\u00a0Agro\u00a0acci\u00f3n\u00a0Alemana\u00a0AMPLIANDO \u00a0ESPACIOS \u00a0DE\u00a0INFORMACI\u00d3N \u00a0Y\u00a0COMUNICACI\u00d3N \u00a0\nPARA\u00a0LA\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH\u2010SIDA\u00a0EN\u00a0LAS\u00a0REGIONES \u00a0DE\u00a0\u00a0\u00a0 x\u00a0 x\u00a0\nSAVE\u00a0THE\u00a0CHILDREN \u00a0SUECIA\u00a0SAVE\u00a0THE\u00a0CHILDREN \u00a0DERECHOS \u00a0DEL\u00a0NI\u00d1O\u00a0\u2010\u00a0PROGRAMA \u00a0UNIFICADO \u00a0EN\u00a0PERU\u00a0\u00a0 \u00a0 \u00a0 x\u00a0\n\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\n\u00a0 126 \u00a0\nUcayali\u00a0\nEn\u00a0los\u00a0EESS\u00a0\u00a0I1\u00a0\u2013\u00a0I4\u00a0\u00a0para\u00a0gestantes \u00a0y\u00a0MEF\u00a0se\u00a0utilizan\u00a0pruebas\u00a0r\u00e1pidas\u00a0que\u00a0\u00a0compran\u00a0los\u00a0establecimientos \u00a0y\u00a0el\u00a0SIS\u00a0no\u00a0\nreembolsa. \u00a0Tiene\u00a0una\u00a0deuda\u00a0de\u00a012\u00a0millones\u00a0de\u00a0soles.\u00a0Establecimientos \u00a0II\u00a01\u00a0y\u00a0II2\u00a0realizan\u00a0ELISA\u00a0que\u00a0tambi\u00e9n\u00a0lo\u00a0compran\u00a0y\u00a0el\u00a0\nSIS\u00a0no\u00a0reembolsa. \u00a0\nEl\u00a0tamizaje\u00a0para\u00a0VIH\u00a0en\u00a0\u00a0HSH\u00a0y\u00a0TS\u00a0Tamizaje\u00a0\u00a0es\u00a0gratis,\u00a0cada\u00a0\u00a06\u00a0meses\u00a0y\u00a0RPR\u00a0cada\u00a03\u00a0meses;\u00a0as\u00ed\u00a0como\u00a0tambi\u00e9n\u00a0para\u00a0las\u00a0\ngestantes. \u00a0La\u00a0confirmaci\u00f3n, \u00a0CD4\u00a0y\u00a0CV\u00a0asumido\u00a0por\u00a0el\u00a0MINSA.\u00a0Los\u00a0costos\u00a0asumidos \u00a0por\u00a0los\u00a0pacientes \u00a0son\u00a0los\u00a0\u00a0an\u00e1lisis\u00a0basales\u00a0\nde\u00a0laboratorio \u00a0pre\u00a0TARGA,\u00a0Radiograf\u00eda \u00a0\u00a0u\u00a0otros\u00a0ex\u00e1menes \u00a0adicionales. \u00a0\n\u00a0\nEs\u00a0asumido\u00a0por\u00a0el\u00a0paciente\u00a0el\u00a0pago\u00a0de\u00a0la\u00a0consulta,\u00a0el\u00a0pago\u00a0de\u00a0los\u00a0ex\u00e1menes \u00a0de\u00a0laboratorio \u00a0basales\u00a0S/.20\u00a0y\u00a0el\u00a0pago\u00a0de\u00a0alg\u00fan\u00a0\notro\u00a0examen\u00a0auxiliar\u00a0que\u00a0necesitaran \u00a0\n\u00a0\nLos\u00a0insumos\u00a0y\u00a0medicamentos \u00a0est\u00e1n\u00a0permanentes \u00a0durante\u00a0\u00a0\u00a0todo\u00a0el\u00a0a\u00f1o,\u00a0s\u00f3lo\u00a0que\u00a0en\u00a0Ucayali\u00a0se\u00a0maneja\u00a0\u00a0a\u00a0trav\u00e9s\u00a0de\u00a0stocks\u00a0o\u00a0\u00a0\nsolicita\u00a0a\u00a0otras\u00a0ESN\u00a0\n\u00a0\nAc\u00e1\u00a0en\u00a0Ucayali,\u00a0s\u00f3lo\u00a0se\u00a0\u00a0da\u00a0prestaci\u00f3n \u00a0en\u00a0el\u00a0MINSA.\u00a0Gestante\u00a0asegurada \u00a0es\u00a0cesareada \u00a0en\u00a0el\u00a0MINSA.\u00a0TARGA\u00a0s\u00f3lo\u00a0\u00a0entrega\u00a0el\u00a0\nMINSA.\u00a0El\u00a0reci\u00e9n\u00a0nacido\u00a0de\u00a0\u00a0madre\u00a0VIH\u00a0positiva\u00a0\u00a0recibe\u00a0f\u00f3rmula\u00a0l\u00e1ctea\u00a0por\u00a0s\u00f3lo\u00a02\u00a0meses\u00a0\n\u00a0\nLos\u00a0principales \u00a0actores\u00a0en\u00a0el\u00a0tema\u00a0de\u00a0VIH\u00a0en\u00a0la\u00a0Regi\u00f3n\u00a0son:\u00a0\u00a0\nFM:\u00a0I\u00a0y\u00a0II\u00a0objetivo\u00a0V\u00a0Ronda\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 I,\u00a0II,\u00a0III,\u00a0IV\u00a0objetivo\u00a0VI\u00a0Ronda\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Medicamentos, \u00a0pruebas\u00a0r\u00e1pidas\u00a0para\u00a0VIH\u00a0y\u00a0S\u00edfilis,\u00a0equipo\u00a0de\u00a0laboratorio \u00a0(Microscopio) \u00a0\nUSAID:\u00a0se\u00a0dedica\u00a0a\u00a0capacitaci\u00f3n, \u00a0calidad\u00a0\nUNFPA:\u00a0se\u00a0dedica\u00a0a\u00a0capacitaci\u00f3n \u00a0\nUNICEF:\u00a0su\u00a0poblaci\u00f3n \u00a0objetivo\u00a0son\u00a0\u00a0ni\u00f1os\u00a0e\u00a0ind\u00edgenas \u00a0\nMINEDU: \u00a0dedicado\u00a0a\u00a0prevenci\u00f3n \u00a0\nGobierno \u00a0Regional: \u00a0dedicado\u00a0a\u00a0prevenci\u00f3n \u00a0\nMIMDES: \u00a0su\u00a0poblaci\u00f3n \u00a0objetivo\u00a0son\u00a0los\u00a0adolescentes \u00a0y\u00a0vulnerabilidad \u00a0\n\u00a0\u00a0\nLos\u00a0proyectos \u00a0desarrollados \u00a0en\u00a0la\u00a0Regi\u00f3n\u00a0son:\u00a0\nINSTITUCION \u00a0 Fuente\u00a0 NOMBRE\u00a0PROYECTO \u00a0 2006\u00a02007\u00a02008\u00a02009\nASOCIACION \u00a0INTER\u00a0\u2010\u00a0\nETNICA\u00a0DE\u00a0\nDESARROLLO \u00a0DE\u00a0LA\u00a0\nSELVA\u00a0PERUANA \u00a0UNICEF\u00a0REUNION \u00a0DE\u00a0SENSIBILIZACION \u00a0Y\u00a0PRESENTACION \u00a0DE\u00a0PROTOCOLO \u00a0DE\u00a0\nINVESTIGACION \u00a0ORGANIZACIONES \u00a0NACIONALES \u00a0Y\u00a0\u00a0\u00a0 x\u00a0\u00a0\nMINISTERIO \u00a0DE\u00a0SALUD\u00a0 UNFPA\u00a0ATENCION \u00a0INTEGRAL \u00a0EN\u00a0SR\u2010ASISTENCIA \u00a0TECNICA\u00a0DGSP\u00a0(ESNSSR,\u00a0\nESNPCITS/VIH \u00a0Y\u00a0EVA)\u2010PER7R54A \u00a0\u00a0\u00a0 x\u00a0\u00a0\n\u00a0 UNICEF\u00a0 VIH/SIDA\u00a0Y\u00a0NI\u00d1EZ\u00a0\u00a0 \u00a0 x\u00a0 x\u00a0\nAPOYO\u00a0A\u00a0PROGRAMAS \u00a0\nDE\u00a0POBLACION \u00a0USAID\u00a0MERCADEO \u00a0SOCIAL\u00a0DEL\u00a0CONDON \u00a0PARA\u00a0POBLACIONES \u00a0\nVULNERABLES \u00a0\u00a0 x\u00a0 x\u00a0\u00a0\nASOCIACION \u00a0CIVIL\u00a0\u2010\nCAYETANO \u00a0HEREDIA\u2010\u00a0\nSALUD\u00a0Y\u00a0EDUCACION \u00a0USAID\u00a0PROYECTO \u00a0DEL\u00a0INCREMENTO \u00a0EN\u00a0AL\u00a0ACSESO\u00a0EN\u00a0LOS\u00a0SERVICIOS \u00a0DE\u00a0\nSALUD\u00a0PARA\u00a0LA\u00a0PREVENCION \u00a0DE\u00a0ITS/VIH\u00a0EN\u00a0LA\u00a0POBLACION \u00a0\nVULNERABLE \u00a0\u00a0 x\u00a0\u00a0\u00a0\n\u00a0UNIVERSIDAD \u00a0DE\u00a0\nWASHINGTON \u00a0ENSAYO\u00a0CLINICO\u00a0DE\u00a0FASE\u00a0III,\u00a0ALEATORIO, \u00a0DOBLE\u00a0CIEGO,\u00a0\nCONTROLADO \u00a0CONTRA\u00a0PLACEBO \u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0PARA\u00a0LA\u00a0\nREDUCCION \u00a0DE\u00a0LA\u00a0ADQUISICION \u00a0DEL\u00a0VIH\u00a0ENTRE\u00a0INDIVIDUOS \u00a0\nSEROPOSITIVOS \u00a0AL\u00a0VHS\u20102\u00a0Y\u00a0SERONEGATIVOS \u00a0AL\u00a0VIH\u00a0x\u00a0\u00a0 \u00a0 \u00a0\nASOCIACION \u00a0CIVIL\u00a0\nIMPACTA \u00a0SALUD\u00a0Y\u00a0\nEDUCACION \u00a0UNIVERSITY \u00a0OF\u00a0\nWASHINGTON \u00a0ENSAYO\u00a0CLINICO\u00a0DE\u00a0FASE\u00a0III,\u00a0ALEATORIO, \u00a0DOBLE\u00a0CIEGO,\u00a0\nCONTROLADO \u00a0CONTRA\u00a0PLACEBO \u00a0\u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0PARA\u00a0LA\u00a0\nREDUCCION \u00a0DE\u00a0LA\u00a0ADQUISICION \u00a0DEL\u00a0VIH\u00a0ENTRE\u00a0INDIFVIDUOS \u00a0\nSEROPOSITIVOS \u00a0AL\u00a0VHS\u20102\u00a0Y\u00a0SERONEGATIVOS \u00a0AL\u00a0VIH\u00a0(HPTN039 \u2010\nCORE\u00a0\u00a0\u00a0 x\u00a0\u00a0\n\u00a0\u00a0ENSAYO\u00a0CLINICO\u00a0DE\u00a0FASE\u00a0III,\u00a0ALEATORIO, \u00a0DOBLE\u00a0CIEGO,\u00a0\nCONTROLADO \u00a0CONTRA\u00a0PLACEBO \u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0PARA\u00a0LA\u00a0\nREDUCCION \u00a0DE\u00a0LA\u00a0ADQUISICION \u00a0DEL\u00a0VIH\u00a0ENTRE\u00a0INDIFVIDUOS \u00a0\nSEROPOSITIVOS \u00a0AL\u00a0VHS\u20102\u00a0Y\u00a0SERONEGATIVOS \u00a0AL\u00a0VIH\u00a0(HPTN039 \u2010\nCORE)\u00a0\u00a0 x\u00a0\u00a0\u00a0 127 \u00a0\u00a0ENSAYO\u00a0CLINICO\u00a0DE\u00a0FASE\u00a0III,\u00a0ALEATORIO, \u00a0DOBLE\u00a0CIEGO,\u00a0\nCONTROLADO \u00a0CONTRA\u00a0PLACEBO \u00a0UTILIZANDO \u00a0ACICLOVIR \u00a0PARA\u00a0\nREDUCCION \u00a0DE\u00a0LA\u00a0ADQUISICION \u00a0DEL\u00a0VIH\u00a0ENTRE\u00a0INDIVIDUOS \u00a0\nSEROPOSITIVOS \u00a0AL\u00a0VHS\u20102\u00a0Y\u00a0SERONEGATIVOS \u00a0AL\u00a0VIH\u00a0x\u00a0\u00a0 \u00a0 \u00a0\nASOCIACION \u00a0VIA\u00a0LIBRE\u00a0 PACT\u00a0POLICIA\u00a0SEGURA:\u00a0REDES\u00a0DE\u00a0PROMOTORES \u00a0POLICIAS\u00a0EN\u00a0\nPREVENCION \u00a0DE\u00a0VIH/SIDA\u00a0EN\u00a0LA\u00a0POBLACION \u00a0POLICIAL\u00a0PERU\u00a0\u00a0\u00a0 x\u00a0\u00a0\n\u00a0\u00a0POLICIA\u00a0SEGURA:\u00a0REDES\u00a0DE\u00a0PROMOTORES \u00a0POLICIAS\u00a0EN\u00a0\nPREVENCI\u00d3N \u00a0DE\u00a0VIH/SIDA\u00a0EN\u00a0LA\u00a0POBLACI\u00d3N \u00a0POLICIAL\u00a0PERUANA \u00a0Y\u00a0\nEN\u00a0PROYECCI\u00d3N \u00a0A\u00a0LA\u00a0COMUNIDAD \u00a0\u00a0 x\u00a0\u00a0\u00a0\nCATHOLIC \u00a0RELIEF\u00a0\nSERVICES \u00a0CATHOLIC \u00a0RELIEF\u00a0\nSERVICES \u00a0PROMOVIENDO \u00a0ESTILOS\u00a0DE\u00a0VIDA\u00a0SALUDABLES \u00a0PARA\u00a0PREVENIR \u00a0EL\u00a0\nVIH\u00a0Y\u00a0SIDA\u00a0EN\u00a0ADOLESCENTES \u00a0Y\u00a0JOVENES\u00a0\u00a0 x\u00a0\u00a0\u00a0\nCENTRO\u00a0DE\u00a0\nINFORMACION \u00a0Y\u00a0\nEDUCACION \u00a0PARA\u00a0LA\u00a0\nPREVENCION \u00a0DEL\u00a0\nABUSO\u00a0DE\u00a0DROGAS\u00a0GTZ\u00a0ARMONIZACION \u00a0DE\u00a0LAS\u00a0POLITICAS \u00a0PUBLICAS \u00a0SOBRE\u00a0EDUCACION \u00a0\nSEXUALY\u00a0PREVENCION \u00a0DEL\u00a0VIH/SIDA\u00a0Y\u00a0DROGAS\u00a0\u00a0 x\u00a0\u00a0\u00a0\nDEFENSORIA \u00a0DEL\u00a0\nPUEBLO\u00a0USAID\u00a0DERECHOS \u00a0HUMANOS \u00a0EN\u00a0PERSONAS \u00a0M\u00c1S\u00a0AFECTADAS \u00a0Y\u00a0VIVIENDO \u00a0\nCON\u00a0VIH:LUCHA \u00a0CONTRA\u00a0EL\u00a0ESTIGMA \u00a0Y\u00a0DISCRIMINACI\u00d3N, \u00a0\nPROMOCI\u00d3N \u00a0DE\u00a0LA\u00a0PROTECCI\u00d3N \u00a0DE\u00a0DERECHOS \u00a0Y\u00a0ACCESO\u00a0A\u00a0LA\u00a0\nCIUDADAN\u00cdA \u00a0\u00a0 x\u00a0\u00a0\u00a0\nDEUTSCHE \u00a0\nWELTHUNGERHILFE \u00a0\n(AGRO\u00a0ACCION\u00a0\nALEMANA) \u00a0Agro\u00a0acci\u00f3n\u00a0\nAlemana\u00a0AMPLIANDO \u00a0ESPACIOS \u00a0DE\u00a0INFORMACI\u00d3N \u00a0Y\u00a0COMUNICACI\u00d3N \u00a0PARA\u00a0\nLA\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH/SIDA\u00a0EN\u00a0LAS\u00a0REGIONES \u00a0DE\u00a0MAYOR\u00a0\nINCIDENCIA \u00a0\u00a0 x\u00a0\u00a0\u00a0\nIBIS\u00a0 IBIS\u00a0BASES\u00a0PARA\u00a0PROMOVER \u00a0LA\u00a0PREVENCION \u00a0DE\u00a0LAS\u00a0ITS,\u00a0VIH/SIDA\u00a0EN\u00a0\nCOMUNIDADES \u00a0SHIPIBO\u00a0KONIBO\u00a0DE\u00a0LA\u00a0CIUDAD\u00a0DE\u00a0PUCALLPA \u00a0\u00a0 x\u00a0\u00a0\u00a0\nINVESTIGACIONES \u00a0\nMEDICAS \u00a0EN\u00a0SALUD\u00a0EMBAJADA \u00a0USA\u00a0 EPIDEMIOLOGIA \u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0SUDAMERICA \u00a0\u00a0 x\u00a0\u00a0\u00a0\n\u00a0\u00a0 EPIDEMIOLOG\u00cdA \u00a0DEL\u00a0VIH\u20101\u00a0EN\u00a0SUDAM\u00c9RICA \u00a0\u00a0 \u00a0 x\u00a0 x\u00a0\nMEDICOS \u00a0SIN\u00a0\nFRONTERAS \u00a0\u2010\u00a0BELGICA\u00a0M\u00e9dicos\u00a0sin\u00a0\nfrontera\u00a0CUIDADO \u00a0INTEGRALES \u00a0A\u00a0PERSONAS \u00a0VIVIENDO \u00a0CON\u00a0VIH\u00a0SIDA\u00a0EN\u00a0EL\u00a0\nCENTRO\u00a0MATERNO \u00a0INFANTIL \u00a0SAN\u00a0JOSE\u00a0DE\u00a0VILLA\u00a0EL\u00a0SALVADOR \u00a0\n(2004)\u00a0x\u00a0\u00a0 \u00a0 \u00a0\nMINISTERIO \u00a0DE\u00a0\nEDUCACI\u00d3N \u00a0GTZ\u00a0ARMONIZACI\u00d3N \u00a0DE\u00a0POL\u00cdTICAS \u00a0P\u00daBLICAS \u00a0PARA\u00a0LA\u00a0EDUCACI\u00d3N \u00a0\nSEXUAL\u00a0Y\u00a0LA\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH/SIDA \u00a0Y\u00a0DROGAS\u00a0EN\u00a0\u00a0\u00a0 x\u00a0\u00a0\nMOVIMIENTO \u00a0\nMANUELA \u00a0RAMOS\u00a0Agro\u00a0acci\u00f3n\u00a0\nAlemana\u00a0AMPLIANDO \u00a0ESPACIOS \u00a0DE\u00a0INFORMACI\u00d3N \u00a0Y\u00a0COMUNICACI\u00d3N \u00a0PARA\u00a0\nLA\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH\u2010SIDA\u00a0EN\u00a0LAS\u00a0REGIONES \u00a0DE\u00a0MAYOR\u00a0\nINCIDENCIA \u00a0\u00a0 x\u00a0\u00a0\u00a0\nMOVIMIENTO \u00a0\nMANUELA \u00a0RAMOS.\u00a0INTERNATIONAL \u00a0\nWOMEN\u2019S \u00a0HEALTH\u00a0\nCOALITION \u00a0PROMOVIENDO \u00a0LOS\u00a0DERECHOS \u00a0SEXUALES \u00a0Y\u00a0REPRODUCTIVOS \u00a0DE\u00a0\nLAS\u00a0MUJERES \u00a0Y\u00a0ADOLESCENTES \u00a0PARA\u00a0LA\u00a0PREVENCI\u00d3N \u00a0D\u00a0\u00a0\u00a0 x\u00a0\u00a0\n\u00a0Agro\u00a0acci\u00f3n\u00a0\nAlemana\u00a0AMPLIANDO \u00a0ESPACIOS \u00a0DE\u00a0INFORMACI\u00d3N \u00a0Y\u00a0COMUNICACI\u00d3N \u00a0PARA\u00a0\nLA\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH\u2010SIDA\u00a0EN\u00a0LAS\u00a0REGIONES \u00a0DE\u00a0\u00a0\u00a0 x\u00a0\u00a0\nPACT\u00a0PERU\u00a0 USAID\u00a0FORTALECIMIENTO \u00a0INSTITUCIONAL \u00a0DE\u00a0ORGANIZACIONES \u00a0SOCIAS\u00a0\nDEL\u00a0PROYECTO, \u00a0Y\u00a0APOYO\u00a0A\u00a0LA\u00a0CREACI\u00d3N \u00a0Y\u00a0FUNCIONAMIENTO \u00a0DEL\u00a0\nCONSEJO \u00a0EPRESARIAL \u00a0DE\u00a0LA\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0VIH\u00a0/\u00a0SID\u00a0\u00a0 x\u00a0\u00a0\u00a0\nPROGRAMA \u00a0DE\u00a0\nSOPORTE \u00a0A\u00a0LA\u00a0\nAUTOAYUDA \u00a0DE\u00a0\nPERSONAS \u00a0\nSEROPOSITIVAS \u00a0USAID\u00a0 ALTERNATIVAS \u00a0DE\u00a0PREVENCION \u00a0EN\u00a0VIH\u00a0Y\u00a0SIDA\u00a0\u00a0 x\u00a0\u00a0\u00a0\n\u00a0\u00a0PREVENCION \u00a0Y\u00a0CONTROL \u00a0DE\u00a0ITS/VIH\u00a0EN\u00a0ESTABLECIMIENTOS \u00a0\nPENITENCIARIOS \u00a0DEL\u00a0PERU\u00a0\u00a0 x\u00a0\u00a0\u00a0\n\u00a0 \u00a0 \u00a0 3\u00a0 14\u00a0 10\u00a0 2\u00a0\n\u00a0 128 \u00a0\nIca\u00a0\nA\u00a0pesar\u00a0de\u00a0haber\u00a0cumplido \u00a0con\u00a0todas\u00a0las\u00a0exigencias \u00a0formales\u00a0sugeridas \u00a0por\u00a0los\u00a0encargados \u00a0de\u00a0brindar\u00a0la\u00a0informaci\u00f3n, \u00a0\nalgunas\u00a0instituciones \u00a0no\u00a0nos\u00a0permitieron \u00a0obtener\u00a0la\u00a0data\u00a0necesaria \u00a0para\u00a0el\u00a0estudio.\u00a0\u00a0En\u00a0el\u00a0caso\u00a0del\u00a0\u00e1rea\u00a0de\u00a0Estad\u00edstica \u00a0del\u00a0\nHospital\u00a0Regional\u00a0de\u00a0Ica\u00a0nos\u00a0indicaron \u00a0que\u00a0ya\u00a0hab\u00edan\u00a0tenido\u00a0denuncias \u00a0y\u00a0procesos\u00a0por\u00a0brindar\u00a0informaci\u00f3n \u00a0relacionada \u00a0al\u00a0\nVIH\u2010SIDA.\u00a0\nProyectos \u00a0desarrollados \u00a0en\u00a0la\u00a0Regi\u00f3n\u00a0\nINSTITUCION \u00a0 Fuente\u00a0 NOMBRE\u00a0PROYECTO \u00a0 2007\u00a02008 2009\nAPOYO\u00a0A\u00a0PROGRAMAS \u00a0DE\u00a0\nPOBLACION \u00a0UNFPA\u00a0 PLAN\u00a0DE\u00a0MERCADEO \u00a0SOCIAL\u00a0DEL\u00a0CONDON \u00a0DEL\u00a0PERU\u00a0AL\u00a02011\u00a0\u00a0 \u00a0 2\u00a0\n\u00a0\u00a0PREVENCI\u00d3N \u00a0DE\u00a0ITS,\u00a0VIH\u00a0SIDA\u00a0Y\u00a0USO\u00a0DEL\u00a0COND\u00d3N \u00a0EN\u00a0ZONAS\u00a0DE\u00a0\nEMERGENCIA \u00a0\u2010\u00a0TERREMOTO \u00a0DEL\u00a015.08.07\u00a0\u00a0 x\u00a0\u00a0\nASOCIACION \u00a0KALLPA\u00a0\nPARA\u00a0LA\u00a0PROMOCION \u00a0\nINTEGRAL \u00a0DE\u00a0LA\u00a0SALUD\u00a0Y\u00a0\nEL\u00a0DESARROLLO \u00a0UNFPA\u00a0ACUERDO \u00a0DE\u00a0COOPERACION \u00a0PARA\u00a0EL\u00a0PROYECTO \u00a0CELEBRADO \u00a0\nENTRE\u00a0UNICEF\u00a0Y\u00a0LA\u00a0ASOCIACION \u00a0KALLPA\u00a0PARA\u00a0LA\u00a0PROMOCION \u00a0DE\u00a0\nLA\u00a0SALUD\u00a0Y\u00a0EL\u00a0DESARROLLO \u00a0x\u00a0\u00a0\u00a0\nDEFENSORIA \u00a0DEL\u00a0PUEBLO\u00a0 ONUSIDA \u00a0DERECHOS \u00a0HUMANOS \u00a0EN\u00a0PERSONAS \u00a0M\u00c1S\u00a0AFECTADAS \u00a0Y\u00a0VIVIENDO \u00a0\nCON\u00a0VIH.\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0ESTIGMA \u00a0Y\u00a0DISCRIMINACI\u00d3N, \u00a0\nPROMOCI\u00d3N \u00a0DE\u00a0LA\u00a0PROTECCI\u00d3N \u00a0DE\u00a0DERECHOS \u00a0Y\u00a0ACCESO\u00a0A\u00a0LA\u00a0\nCIUDADANIA \u00a0x\u00a0 x\u00a0 X\u00a0\n\u00a0 PNUD\u00a0DERECHOS \u00a0HUMANOS \u00a0EN\u00a0PERSONAS \u00a0M\u00c1S\u00a0AFECTADAS \u00a0Y\u00a0VIVIENDO \u00a0\nCON\u00a0VIH.\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0ESTIGMA \u00a0Y\u00a0DISCRIMINACI\u00d3N, \u00a0\nPROMOCI\u00d3N \u00a0DE\u00a0LA\u00a0PROTECCI\u00d3N \u00a0DE\u00a0DERECHOS \u00a0Y\u00a0ACCESO\u00a0A\u00a0LA\u00a0\nCIUDADANIA \u00a0x\u00a0\u00a0\u00a0\n\u00a0\u00a0INCORPORACI\u00d3N \u00a0DE\u00a0LA\u00a0PERSPECTIVA \u00a0DE\u00a0DERECHOS \u00a0EN\u00a0LA\u00a0\nRESPUESTA \u00a0DESDE\u00a0EL\u00a0ESTADO\u00a0FRENTE\u00a0A\u00a0LA\u00a0EPIDEMIA \u00a0DEL\u00a0VIH/SIDA\u00a0\u00a0\u00a0 X\u00a0\nMINISTERIO \u00a0DE\u00a0SALUD\u00a0 UNFPA\u00a0ATENCION \u00a0INTEGRAL \u00a0EN\u00a0SR\u2010ASISTENCIA \u00a0TECNICA\u00a0DGSP\u00a0(ESNSSR,\u00a0\nESNPCITS/VIH \u00a0Y\u00a0EVA)\u2010PER7R23A \u00a0\u00a0 x\u00a0\u00a0\n\u00a0 UNICEF\u00a0 VIH/SIDA\u00a0Y\u00a0NI\u00d1EZ\u00a0\u00a0 x\u00a0 X\u00a0\nASOCIACION \u00a0CIVIL\u00a0\nIMPACTA \u00a0SALUD\u00a0Y\u00a0\nEDUCACION \u00a0NATIONAL \u00a0\nINSTITUTES \u00a0OF\u00a0\nHEALTH\u00a0\u2013\u00a0NIH\u00a0COMPREHENSIVE \u00a0INTERNATIONAL \u00a0PROGRAM \u00a0FOR\u00a0RESEARCH \u00a0\n(CIPRA)\u00a0x\u00a0\u00a0\u00a0\nASOCIACION \u00a0DE\u00a0\nCOMUNICADORES \u00a0\nSOCIALES \u00a0CALANDRIA \u00a0FUNDACION \u00a0\nAVINA\u00a0COMUNICACION \u00a0PARA\u00a0EL\u00a0DESARROLLO \u00a0Y\u00a0LA\u00a0DEMOCRACIA \u00a0\u00a0 x\u00a0\u00a0\nASOCIACION \u00a0KALLPA\u00a0\nPARA\u00a0LA\u00a0PROMOCION \u00a0\nINTEGRAL \u00a0DE\u00a0LA\u00a0SALUD\u00a0Y\u00a0\nEL\u00a0DESARROLLO \u00a0ICCO\u00a0MUNICIPIOS \u00a0SALUDABLES \u00a0EN\u00a0SALUD\u00a0SEXUAL\u00a0REPRODUCTIVA \u00a0Y\u00a0VIH\u00a0\nSIDA\u00a0\u00a0\u00a0 X\u00a0\nASOCIACION \u00a0VIA\u00a0LIBRE\u00a0 ALLIANCE \u00a0 INCIDENCIA \u00a0POLITICA\u00a0EN\u00a0VIH\u00a0Y\u00a0SIDA\u00a0CON\u00a0POBLACIONES \u00a0CLAVE\u00a0 x\u00a0\u00a0\u00a0\n\u00a0\u00a0VEEDURIA \u00a0EN\u00a0SALUD\u00a0DE\u00a0LAS\u00a0POBLACIONES \u00a0CLAVE,\u00a0UNA\u00a0RESPUESTA \u00a0\nPOSITIVA \u00a0Y\u00a0PREVENTIVA \u00a0AL\u00a0VIH.\u00a0\u00a0 x\u00a0 X\u00a0\n\u00a0COMISION \u00a0\nEUROPEA \u00a0MEJORANDO \u00a0EL\u00a0ENTORNO \u00a0SOCIAL\u00a0Y\u00a0EL\u00a0ACCESO\u00a0A\u00a0LOS\u00a0SERVICIOS \u00a0DE\u00a0\nPOBLACIONES \u00a0DE\u00a0HSH\u00a0VIVIENDO \u00a0CON\u00a0O\u00a0VULNERABLES \u00a0AL\u00a0VIH\u00a0\u2013\u00a0\nSIDA\u00a0x\u00a0 x\u00a0 X\u00a0\nCENTRO\u00a0DE\u00a0\nINFORMACION \u00a0Y\u00a0\nEDUCACION \u00a0PARA\u00a0LA\u00a0\nPREVENCION \u00a0DEL\u00a0ABUSO\u00a0\nDE\u00a0DROGAS\u00a0GTZ\u00a0ARMONIZACION \u00a0DE\u00a0LAS\u00a0POLITICAS \u00a0PUBLICAS \u00a0SOBRE\u00a0EDUCACION \u00a0\nSEXUALY\u00a0PREVENCION \u00a0DEL\u00a0VIH/SIDA\u00a0Y\u00a0DROGAS\u00a0x\u00a0\u00a0\u00a0\nCENTRO\u00a0PARROQUIAL \u00a0\nECUMENICO \u00a0ROSA\u00a0\nBLANCA\u00a0ICCO\u00a0 PROYECTO \u00a0GLOBAL\u00a0ROSA\u00a0BLANCA\u00a02004\u20102008\u00a0 x\u00a0\u00a0\u00a0\nFEDERACION \u00a0PROVINCIAL \u00a0\nDE\u00a0MUJERES \u00a0DE\u00a0ICA\u00a0WOMANKIND \u00a0\nWORDWIDE \u00a0DESARROLLANDO \u00a0CAPACIDADES \u00a0EN\u00a0MUJERES \u00a0JOVENES\u00a0PARA\u00a0LA\u00a0\nINCIDENCIA \u00a0Y\u00a0PREVENCION \u00a0DEL\u00a0VIH\u2010SIDA\u00a0\u00a0\u00a0 x\u00a0\nINSTITUTO \u00a0DE\u00a0\nEDUCACION \u00a0Y\u00a0SALUD\u00a0\u2010\u00a0IES\u00a0IDRC\u00a0ADOLESCENTES, \u00a0J\u00d3VENES\u00a0Y\u00a0TICS\u00a0EN\u00a0RESPUESTA \u00a0A\u00a0LA\u00a0EPIDEMIA \u00a0DEL\u00a0\nVIH\u2010SIDA\u00a0EN\u00a0LATINOAM\u00c9RICA \u00a0Y\u00a0EL\u00a0CARIBE\u00a0\u00a0 x\u00a0 X\u00a0\nINSTITUTO \u00a0PERUANO \u00a0DE\u00a0\nPATERNIDAD \u00a0\nRESPONSABLE \u00a0INTERNATIONAL \u00a0\nPLANNED \u00a0\nPARETHOOD \u00a0\nFEDERATION \u00a0IGUALMENTE \u00a0DIFERENTES: \u00a0EXPANDIENDO \u00a0EL\u00a0TRABAJO\u00a0CON\u00a0\nPOBLACIONES \u00a0SEXUALMENTE \u00a0DIVERSAS \u00a0EN\u00a0PER\u00da\u00a0x\u00a0\u00a0\u00a0\nMINISTERIO \u00a0DE\u00a0 GTZ\u00a0 ARMONIZACI\u00d3N \u00a0DE\u00a0POL\u00cdTICAS \u00a0P\u00daBLICAS \u00a0PARA\u00a0LA\u00a0EDUCACI\u00d3N \u00a0\u00a0 x\u00a0\u00a0 129 INSTITUCION \u00a0 Fuente\u00a0 NOMBRE\u00a0PROYECTO \u00a0 2007\u00a02008 2009\nEDUCACI\u00d3N \u00a0 SEXUAL\u00a0Y\u00a0LA\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH/SIDA \u00a0Y\u00a0DROGAS\u00a0EN\u00a0\nSAVE\u00a0THE\u00a0CHILDREN \u00a0\nSUECIA\u00a0Save\u00a0the\u00a0\nchildren\u00a0DERECHOS \u00a0DEL\u00a0NI\u00d1O\u00a0\u2010\u00a0PROGRAMA \u00a0UNIFICADO \u00a0EN\u00a0PERU\u00a0\u00a0 \u00a0 X\u00a0\nSOCIOS\u00a0EN\u00a0SALUD\u00a0\u2010\u00a0\nSUCURSAL \u00a0PERU\u00a0PARTNERS \u00a0IN\u00a0\nHEALTH\u00a0AMPLIANDO \u00a0LA\u00a0COBERTURA \u00a0DE\u00a0INGRESOS \u00a0AL\u00a0TARGA\u00a0DE\u00a0PADRES\u00a0DE\u00a0\nFAMILIA\u00a0QUE\u00a0VIENE\u00a0CON\u00a0VIH/SIDA\u00a0EN\u00a0LAS\u00a0PROVI\u00a0\u00a0 x\u00a0\u00a0\n\u00a0\u00a0PROYECTO \u00a0COLABORATIVO \u00a0MINSA\u2010UNICEF\u2010SES\u00a0:\u00a0\u201cAMPLIANDO \u00a0LA\u00a0\nCOBERTURA \u00a0DE\u00a0TRATAMIENTO \u00a0A\u00a0LOS\u00a0NI\u00d1OS\u00a0CON\u00a0VIH\u201d\u00a0\u00a0 x\u00a0\u00a0\nWORLD\u00a0VISION\u00a0\nINTERNATIONAL \u00a0WORLD\u00a0VISION\u00a0 PROYECTO \u00a0ESPECIAL \u00a0VIDA\u00a0\u00a0 x\u00a0 X\u00a0\n\u00a0 \u00a0 \u00a0 9\u00a0 12\u00a0 12\u00a0\n\u00a0 130 \u00a0\nJun\u00edn\u00a0\nEn\u00a0Jun\u00edn\u00a0uno\u00a0de\u00a0los\u00a0lugares\u00a0que\u00a0recientemente \u00a0se\u00a0han\u00a0inaugurado \u00a0es\u00a0la\u00a0Casa\u00a0de\u00a0acogida\u00a0San\u00a0Juan\u00a0Diego\u00a0que\u00a0atiende\u00a0a\u00a060\u00a0\nni\u00f1os\u00a0VIH\u00a0+\u00a0\u00a0(20\u00a0internos)\u00a0con\u00a0donaciones \u00a0a\u00a0las\u00a0parroquias \u00a0y\u00a0en\u00a0el\u00a0Arzobispado \u00a0de\u00a0Huancayo. \u00a0El\u00a0Gobierno \u00a0Regional\u00a0se\u00a0ha\u00a0\ncomprometido \u00a0a\u00a0construir\u00a0y\u00a0a\u00a0implementar \u00a0la\u00a0casa\u00a0de\u00a0acogida\u00a0que\u00a0se\u00a0construir\u00e1 \u00a0\u00a0con\u00a0la\u00a0donaci\u00f3n \u00a0de\u00a0la\u00a0Iglesia\u00a0de\u00a0un\u00a0terreno\u00a0\nde\u00a03\u00a0112\u00a0m2\u00a0de\u00a0terreno.\u00a0(5\u00a0millones\u00a0949\u00a0mil\u00a0624\u00a0nuevos\u00a0soles,\u00a0luego\u00a0de\u00a0obtener\u00a0la\u00a0licencia\u00a0de\u00a0construcci\u00f3n \u00a0de\u00a0la\u00a0\nMunicipalidad \u00a0Distrital\u00a0de\u00a0El\u00a0Tambo,\u00a0afirm\u00f3\u00a0Cerr\u00f3n\u00a0Rojas)\u00a0\n\u00a0\nLa\u00a0Casa\u00a0Acogida\u00a0beneficiar\u00e1 \u00a0a\u00a0m\u00e1s\u00a0de\u00a0setenta\u00a0ni\u00f1os,\u00a0j\u00f3venes\u00a0y\u00a0adolescentes \u00a0afectados \u00a0por\u00a0el\u00a0VIH\u00a0Sida,\u00a0quienes\u00a0actualmente \u00a0\nse\u00a0encuentran \u00a0en\u00a0un\u00a0espacio\u00a0reducido\u00a0que\u00a0acondicionaron \u00a0\u00a0de\u00a0buena\u00a0fe\u00a0los\u00a0representantes \u00a0de\u00a0la\u00a0iglesia\u00a0cat\u00f3lica.\u00a0\u00a0\n\u00a0\nProyectos \u00a0desarrollados \u00a0en\u00a0la\u00a0Regi\u00f3n\u00a0\nINSTITUCION \u00a0 Fuente\u00a0 NOMBRE\u00a0PROYECTO \u00a02007\u00a02008 2009\nDEFENSORIA \u00a0DEL\u00a0PUEBLO\u00a0 PNUD\u00a0 INCORPORACI\u00d3N \u00a0DE\u00a0LA\u00a0PERSPECTIVA \u00a0DE\u00a0DERECHOS \u00a0EN\u00a0LA\u00a0\nRESPUESTA \u00a0DESDE\u00a0EL\u00a0ESTADO\u00a0FRENTE\u00a0A\u00a0LA\u00a0EPIDEMIA \u00a0DEL\u00a0\nVIH/SIDA\u00a0\u00a0\u00a0 X\u00a0\nASOCIACION \u00a0VIA\u00a0LIBRE\u00a0 CHILDREN \u00a0\nAFFECTED \u00a0BY\u00a0\nAIDS\u00a0\nFOUNDACION \u00a0BOYS\u00a0AND\u00a0GIRLS\u00a0FOR\u00a0LIFE,\u00a0CREATING \u00a0A\u00a0FAVORABLE \u00a0\nENVIRONMENT \u00a0FOR\u00a0HIV/AIDS\u00a0x\u00a0\u00a0\u00a0\nCENTRO\u00a0DE\u00a0INFORMACION \u00a0Y\u00a0\nEDUCACION \u00a0PARA\u00a0LA\u00a0\nPREVENCION \u00a0DEL\u00a0ABUSO\u00a0DE\u00a0\nDROGAS\u00a0GTZ\u00a0 ARMONIZACION \u00a0DE\u00a0POLITICAS \u00a0PUBLICAS \u00a0PARA\u00a0LA\u00a0\nEDUCACION \u00a0SEXUAL\u00a0Y\u00a0LA\u00a0PREVENCION \u00a0DEL\u00a0VIH\u2010SIDA\u00a0Y\u00a0\nDROGAS\u00a0x\u00a0 x\u00a0\u00a0\nDEFENSORIA \u00a0DEL\u00a0PUEBLO\u00a0 USAID\u00a0 DERECHOS \u00a0HUMANOS \u00a0EN\u00a0PERSONAS \u00a0M\u00c1S\u00a0AFECTADAS \u00a0Y\u00a0\nVIVIENDO \u00a0CON\u00a0VIH:LUCHA \u00a0CONTRA\u00a0EL\u00a0ESTIGMA \u00a0Y\u00a0\nDISCRIMINACI\u00d3N, \u00a0PROMOCI\u00d3N \u00a0DE\u00a0LA\u00a0PROTECCI\u00d3N \u00a0DE\u00a0\nDERECHOS \u00a0Y\u00a0ACCESO\u00a0A\u00a0LA\u00a0CIUDADAN\u00cdA \u00a0x\u00a0\u00a0\u00a0\nINSTITUTO \u00a0DE\u00a0EDUCACION \u00a0Y\u00a0\nSALUD\u00a0\u2013\u00a0IES\u00a0IDRC\u00a0 ADOLESCENTES, \u00a0J\u00d3VENES\u00a0Y\u00a0TICS\u00a0EN\u00a0RESPUESTA \u00a0A\u00a0LA\u00a0\nEPIDEMIA \u00a0DEL\u00a0VIH\u2010SIDA\u00a0EN\u00a0LATINOAM\u00c9RICA \u00a0Y\u00a0EL\u00a0CARIBE\u00a0\u00a0 x\u00a0 X\u00a0\nSAVE\u00a0THE\u00a0CHILDREN \u00a0SUECIA\u00a0 Save\u00a0the\u00a0children\u00a0DERECHOS \u00a0DEL\u00a0NI\u00d1O\u00a0\u2010\u00a0PROGRAMA \u00a0UNIFICADO \u00a0EN\u00a0PERU\u00a0\u00a0 \u00a0 X\u00a0\nSOCIOS\u00a0EN\u00a0SALUD\u00a0\u2010\u00a0SUCURSAL \u00a0\nPERU\u00a0PARTNERS \u00a0IN\u00a0\nHEALTH\u00a0AMPLIANDO \u00a0LA\u00a0COBERTURA \u00a0DE\u00a0INGRESOS \u00a0AL\u00a0TARGA\u00a0DE\u00a0\nPADRES\u00a0DE\u00a0FAMILIA\u00a0QUE\u00a0VIENE\u00a0CON\u00a0VIH/SIDA\u00a0EN\u00a0LAS\u00a0PROVI\u00a0\u00a0 x\u00a0\u00a0\n\u00a0\u00a0 PROYECTO \u00a0COLABORATIVO \u00a0MINSA\u2010UNICEF\u2010SES\u00a0:\u00a0\n\u201cAMPLIANDO \u00a0LA\u00a0COBERTURA \u00a0DE\u00a0TRATAMIENTO \u00a0A\u00a0LOS\u00a0\nNI\u00d1OS\u00a0CON\u00a0VIH\u201d\u00a0\u00a0 x\u00a0\u00a0\n\u00a0 \u00a0 \u00a0 3\u00a0 4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n3\u00a0\u00a0\n\u00a0\n\u00a0 131 \u00a0\nAncash\u00a0\nEn\u00a0Ancash\u00a0se\u00a0visito\u00a0la\u00a0ciudad\u00a0de\u00a0Chimbote \u00a0por\u00a0que\u00a0es\u00a0la\u00a0que\u00a0reporta\u00a0m\u00e1s\u00a0casos.\u00a0El\u00a0trabajo\u00a0de\u00a0campo\u00a0dur\u00f3\u00a05\u00a0d\u00edas;\u00a0\ny\u00a0encontramos \u00a0que\u00a0la\u00a0ubicaci\u00f3n \u00a0de\u00a0los\u00a0lugares\u00a0de\u00a0atenci\u00f3n\u00a0se\u00a0encontraban \u00a0muy\u00a0alejados\u00a0y\u00a0los\u00a0costos\u00a0del\u00a0\ntransporte \u00a0eran\u00a0\u00a0muy\u00a0elevados. \u00a0En\u00a0ese\u00a0lapso\u00a0se\u00a0visit\u00f3\u00a0los\u00a0servicios\u00a0en\u00a0donde\u00a0se\u00a0brinda\u00a0Atenci\u00f3n\u00a0Medica\u00a0Peri\u00f3dica \u00a0\ny\u00a0Targa.\u00a0Se\u00a0visito\u00a0el\u00a0Hospital\u00a0Regional\u00a0y\u00a0se\u00a0trabajo\u00a0espec\u00edficamente \u00a0en\u00a0el\u00a0Hospital\u00a0La\u00a0Caleta\u00a0que\u00a0funciona\u00a0como\u00a0\nCERIT\u00a0el\u00a0cual\u00a0\u00a0brinda\u00a0atenci\u00f3n\u00a0medida\u00a0peri\u00f3dica \u00a0y\u00a0TARGA.\u00a0\u00a0Asimismo \u00a0se\u00a0visitaron\u00a0algunos\u00a0establecimientos \u00a0de\u00a0\nsalud\u00a0como\u00a0\u00a0El\u00a0Progreso\u00a0y\u00a0Magdalena. \u00a0De\u00a0otro\u00a0lado\u00a0se\u00a0nos\u00a0menciono \u00a0la\u00a0existencia \u00a0de\u00a0una\u00a0de\u00a0la\u00a0UAMP\u00a0de\u00a0\nHuarmey\u00a0ubicada\u00a0fuera\u00a0de\u00a0la\u00a0ciudad\u00a0de\u00a0Chimbote \u00a0seg\u00fan\u00a0nos\u00a0refirieron \u00a0se\u00a0encontraba \u00a0ubicada\u00a0a\u00a05\u00a0horas\u00a0fuera\u00a0de\u00a0\nChimbote, \u00a0la\u00a0cual\u00a0no\u00a0se\u00a0pudo\u00a0visitar.\u00a0\n\u00a0\u00a0\nINSTITUCION \u00a0 Fuente\u00a0 NOMBRE\u00a0PROYECTO \u00a0 2007\u00a02008 2009\nDEFENSORIA \u00a0DEL\u00a0PUEBLO\u00a0ONUSIDA \u00a0DERECHOS \u00a0HUMANOS \u00a0EN\u00a0PERSONAS \u00a0M\u00c1S\u00a0AFECTADAS \u00a0Y\u00a0VIVIENDO \u00a0\nCON\u00a0VIH.\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0ESTIGMA \u00a0Y\u00a0DISCRIMINACI\u00d3N, \u00a0\nPROMOCI\u00d3N \u00a0DE\u00a0LA\u00a0PROTECCI\u00d3N \u00a0DE\u00a0DERECHOS \u00a0Y\u00a0ACCESO\u00a0A\u00a0LA\u00a0\nCIUDADANIA \u00a0 x\u00a0 X\u00a0 X\u00a0\n\u00a0 PNUD\u00a0DERECHOS \u00a0HUMANOS \u00a0EN\u00a0PERSONAS \u00a0M\u00c1S\u00a0AFECTADAS \u00a0Y\u00a0VIVIENDO \u00a0\nCON\u00a0VIH.\u00a0LUCHA\u00a0CONTRA\u00a0EL\u00a0ESTIGMA \u00a0Y\u00a0DISCRIMINACI\u00d3N, \u00a0\nPROMOCI\u00d3N \u00a0DE\u00a0LA\u00a0PROTECCI\u00d3N \u00a0DE\u00a0DERECHOS \u00a0Y\u00a0ACCESO\u00a0A\u00a0LA\u00a0\nCIUDADANIA \u00a0 x\u00a0\u00a0 X\u00a0\nMINISTERIO \u00a0DE\u00a0SALUD\u00a0 UNFPA\u00a0ATENCION \u00a0INTEGRAL \u00a0EN\u00a0SR\u2010ASISTENCIA \u00a0TECNICA\u00a0DGSP\u00a0(ESNSSR,\u00a0\nESNPCITS/VIH \u00a0Y\u00a0EVA)\u2010PER7R23A \u00a0\u00a0 X\u00a0\u00a0\nAGENCIA\u00a0ADVENTISTA \u00a0\nPARA\u00a0EL\u00a0DESARROLLO \u00a0Y\u00a0\nRECURSOS \u00a0\nASISTENCIALES \u2010PERU\u00a0FUNDACION \u00a0\nSODIS\u00a0PROMOCI\u00d2N \u00a0DE\u00a0LA\u00a0SALUD\u00a0A\u00a0TRAV\u00c8S\u00a0DEL\u00a0CONSUMO \u00a0DE\u00a0AGUA\u00a0\nSEGURA\u00a0Y\u00a0LAVADO\u00a0DE\u00a0MANOS\u00a0EN\u00a0LAS\u00a0PROVINCIAS \u00a0EN\u00a0LA\u00a0 \u00a0\u00a0 X\u00a0\nASOCIACION \u00a0DE\u00a0\nCOMUNICADORES \u00a0\nSOCIALES \u00a0CALANDRIA \u00a0FUNDACION \u00a0\nAVINA\u00a0 COMUNICACION \u00a0PARA\u00a0EL\u00a0DESARROLLO \u00a0Y\u00a0LA\u00a0DEMOCRACIA \u00a0\u00a0 X\u00a0\u00a0\nCENTRO\u00a0PARROQUIAL \u00a0\nECUMENICO \u00a0ROSA\u00a0\nBLANCA\u00a0 ICCO\u00a0 PROYECTO \u00a0GLOBAL\u00a0ROSA\u00a0BLANCA\u00a02004\u20102008\u00a0 x\u00a0\u00a0\u00a0\nCOMUNICACIONES \u00a0\nALIADAS\u00a0GLOBAL\u00a0\nGREENGRANTS \u00a0\nFOUNDATION \u00a0INCIDENCIA \u00a0PUBLICA\u00a0Y\u00a0FORTALECIMIENTO \u00a0DE\u00a0CAPACIDADES \u00a0PARA\u00a0LA\u00a0\nPROMOCION \u00a0Y\u00a0DEFENSA\u00a0DE\u00a0DERECHOS \u00a0\u00a0 X\u00a0\u00a0\nINSTITUTO \u00a0PERUANO \u00a0DE\u00a0\nPATERNIDAD \u00a0\nRESPONSABLE \u00a0INTERNATIONAL \u00a0\nPLANNED \u00a0\nPARETHOOD \u00a0\nFEDERATION \u00a0IGUALMENTE \u00a0DIFERENTES: \u00a0EXPANDIENDO \u00a0EL\u00a0TRABAJO\u00a0CON\u00a0\nPOBLACIONES \u00a0SEXUALMENTE \u00a0DIVERSAS \u00a0EN\u00a0PER\u00da\u00a0 x\u00a0\u00a0\u00a0\nLA\u00a0CASA\u00a0DE\u00a0LA\u00a0MUJER\u00a0Pan\u00a0para\u00a0el\u00a0\nmundo\u00a0PREVENCI\u00d3N \u00a0DEL\u00a0VIH/SIDA\u00a0Y\u00a0LA\u00a0VIOLENCIA \u00a0CONTRA\u00a0LA\u00a0MUJER\u00a0COMO\u00a0\nPOL\u00cdTICA\u00a0P\u00d9BLICA\u00a0\u00a0 X\u00a0 X\u00a0\nSOCIOS\u00a0EN\u00a0SALUD\u00a0\u2010\u00a0\nSUCURSAL \u00a0PERU\u00a0PARTNERS \u00a0IN\u00a0\nHEALTH\u00a0AMPLIANDO \u00a0LA\u00a0COBERTURA \u00a0DE\u00a0INGRESOS \u00a0AL\u00a0TARGA\u00a0DE\u00a0PADRES\u00a0DE\u00a0\nFAMILIA\u00a0QUE\u00a0VIENE\u00a0CON\u00a0VIH/SIDA\u00a0EN\u00a0LAS\u00a0PROVI\u00a0\u00a0 X\u00a0\u00a0\n\u00a0\u00a0PROYECTO \u00a0COLABORATIVO \u00a0MINSA\u2010UNICEF\u2010SES\u00a0:\u00a0\u201cAMPLIANDO \u00a0LA\u00a0\nCOBERTURA \u00a0DE\u00a0TRATAMIENTO \u00a0A\u00a0LOS\u00a0NI\u00d1OS\u00a0CON\u00a0VIH\u201d\u00a0\u00a0 X\u00a0\u00a0\nWORLD\u00a0VISION\u00a0\nINTERNATIONAL \u00a0 WORLD\u00a0VISION\u00a0PROYECTO \u00a0ESPECIAL \u00a0VIDA\u00a0\u00a0 X\u00a0 X\u00a0\n\u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n5\u00a0\u00a0 Resultados \u00a0de\u00a0la\u00a0aplicaci\u00f3n \u00a0de\u00a0encuestas \u00a0y\u00a0entrevistas \u00a0\nLa\u00a0primera\u00a0ciudad\u00a0visitada\u00a0fue\u00a0Chiclayo\u00a0a\u00a0partir\u00a0de\u00a0la\u00a0cual\u00a0se\u00a0ha\u00a0estandarizado \u00a0la\u00a0informaci\u00f3n \u00a0para\u00a0el\u00a0resto\u00a0de\u00a0ciudades. \u00a0\u00a0La\u00a0informaci\u00f3n \u00a0\u00a0recopilada \u00a0en\u00a0el\u00a0trabajo\u00a0de\u00a0campo\u00a0ha\u00a0sido\u00a0\ncomplementada \u00a0con\u00a0la\u00a0informaci\u00f3n \u00a0proporcionada \u00a0\u00a0por\u00a0la\u00a0Estrategia \u00a0Sanitaria\u00a0Nacional\u00a0de\u00a0Prevenci\u00f3n \u00a0y\u00a0Control\u00a0de\u00a0ITS/VIH/SIDA \u00a0a\u00a0diciembre \u00a0del\u00a02010\u00a0\n\u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\nCiudad\u00a0visitada\u00a0 Chiclayo\u00a0 Iquitos\u00a0 Pucallpa\u00a0 Ica\u00a0 Huancayo \u00a0 Chimbote\nDirecci\u00f3n \u00a0de\u00a0salud\u00a0 x\u00a0 x\u00a0 x\u00a0 x\u00a0 X\u00a0 x\u00a0\nEstrategia \u00a0Sanitaria\u00a0\u00a0 x\u00a0 x\u00a0 x\u00a0 x\u00a0 X\u00a0 x\u00a0\nHospital\u00a0MINSA\u00a0 X\u00a0 x\u00a0 x\u00a0 x\u00a0 X\u00a0 x\u00a0\nHospital\u00a0ESSALUD\u00a0 x\u00a0 x\u00a0\u00a0\u00a0\u00a0 x\u00a0\nCERITS\u00a0UAMP\u00a0 CERITS\u00a0CS\u00a0Olaya\u00a0 x\u00a0 x\u00a0 x\u00a0 X\u00a0 x\u00a0\nSub\u2010receptores \u00a0FM\u00a0 X\u00a0 x\u00a0\u00a0\u00a0\u00a0\u00a0\nONG\u00a0 X\u00a0 x\u00a0 x\u00a0 x\u00a0 X\u00a0 x\u00a0\nDensidad \u00a0de\u00a0RRHH\u00a0\ndel\u00a0sector\u00a0salud\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nTratamiento \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nEntrevistados \u00a0 Dr.\u00a0Julio\u00a0Lamadrid \u00a0Figueroa\u00a0\nEnfermera \u00a0Lita\u00a0Alarcon\u00a0\u00a0\nEnfermera \u00a0Reyna\u00a0Mayta\u00a0\nHospital\u00a0Las\u00a0Mercedes \u00a0Dr.\u00a0Ramal\u00a0\u00a0infect\u00f3logo \u00a0\nEnfermera \u00a0Lizbeth\u00a0\nHospital\u00a0regional\u00a0Dr.\u00a0Ricardo\u00a0Mu\u00f1ante\u00a0 \u00a0 Eusebia\u00a0Poma\u00a0Encargada \u00a0\ndel\u00a0TARGA\u00a0Hospital\u00a0El\u00a0\nCarmen\u00a0\nLic.\u00a0Hermelinda \u00a0Lara\u00a0\nCoordinadora \u00a0de\u00a0VIH\u2010\nSIDA/TARGA \u00a0del\u00a0Hospital\u00a0\nRegional\u00a0Daniel\u00a0Alcides\u00a0\nCarri\u00f3n\u00a0\nLic.\u00a0Elsa\u00a0Solano\u00a0Enfermera \u00a0\nde\u00a0VIH\u2010SIDA/TARGA \u00a0del\u00a0\nHospital\u00a0Regional\u00a0Daniel\u00a0\nAlcides\u00a0Carri\u00f3n\u00a0\u00a0\nLugares\u00a0de\u00a0atenci\u00f3n\u00a0\ntratamiento \u00a0\nantirretroviral \u00a0Hospital\u00a0Las\u00a0Mercedes \u00a0\nHospital\u00a0ESSALUD\u00a0Hospital\u00a0Regional\u00a0de\u00a0Loreto\u00a0\nHospital\u00a0Apoyo\u00a0Iquitos\u00a0\nHospital\u00a0Apoyo\u00a0Santa\u00a0Gema\u00a0\n\u2010Yurimaguas \u00a0\nAsociaci\u00f3n \u00a0Civil\u00a0Selva\u00a0\nAmaz\u00f3nica \u00a0\u00a0(ACSA).\u00a0\nHospital\u00a0ESSALUD\u00a0Hospital\u00a0Regional\u00a0de\u00a0\nPucallpa\u00a0\nHospital\u00a0ESSALUD\u00a0Hospital\u00a0Regional\u00a0de\u00a0Ica\u00a0\nHospital\u00a0ESSALUD\u00a0Hospital\u00a0Daniel\u00a0Alcides\u00a0\nCarri\u00f3n\u00a0(Huancayo) \u00a0\nHospital\u00a0El\u00a0Carmen\u00a0\n(Huancayo) \u00a0\nHospital\u00a0Tarma\u00a0\nHospital\u00a0Chanchamayo \u00a0\nHospital\u00a0ESSALUD\u00a0Hospital\u00a0V\u00edctor\u00a0Ram\nGuardia\u00a0\nHospital\u00a0La\u00a0Caleta\u00a0\n(Chimbote) \u00a0\nHospital\u00a0ESSALUD\u00a0\nPacientes \u00a0enrolados \u00a0 432\u00a0 1025\u00a0 246\u00a0 334\u00a0 265\u00a0 218\u00a0\nEn\u00a0Tratamiento \u00a0 301\u00a0 752\u00a0 179\u00a0 263\u00a0 179\u00a0 156\u00a0\nFallecidos \u00a0 77\u00a0 167\u00a0 32\u00a0 0\u00a0 43\u00a0 44\u00a0\nEspera\u00a0Inicio\u00a0ARV\u00a0 101\u00a0(150\u00a0seg\u00fan\u00a0enfermera) \u00a0 24\u00a0 2\u00a0 4\u00a0 8\u00a0 9\u00a0\nProceso\u00a0de\u00a0\nEvaluaci\u00f3n \u00a00\u00a0 529\u00a0 132\u00a0 4\u00a0 14\u00a0 66\u00a0\nEquipo\u00a0TARGA\u00a02\u00a0enfermeras \u00a0\n1\u00a0psicolog\u00eda \u00a0\n1\u00a0trabajadora \u00a0social\u00a02\u00a0enfermeras \u00a0\n1\u00a0obstetriz\u00a0consultorio \u00a0\n1\u00a0obstetriz\u00a0hospitalizaci\u00f3n \u00a01\u00a0enfermera \u00a0\n1\u00a0medico\u00a01\u00a0enfermera \u00a0\n1\u00a0sic\u00f3loga\u00a0\n2\u00a0m\u00e9dico\u00a0Hospital\u00a0Carri\u00f3n:\u00a0\n2 enfermeras \u00a0\n1\u00a0interna\u00a0de\u00a0enfermer\u00eda \u00a0En\u00a0Chimbo t\n1\u00a0obstetri z\n1\u00a0t\u00e9cnica\u00a0 \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\n1\u00a0infect\u00f3logos \u00a0\u00a0\n1\u00a0nutricionista \u00a0\n1\u00a0laboratorista \u00a0\n1\u00a0qu\u00edmico\u00a0farmac\u00e9utico \u00a0\n1\u00a0odont\u00f3logo \u00a0\n2\u00a0serumistas \u00a0\nAtiende\u00a0el\u00a0m\u00e9dico\u00a0solo\u00a010\u00a0\nd\u00edas\u00a0y\u00a0otros\u00a0d\u00edas\u00a0son\u00a0para\u00a0\nevaluaci\u00f3n, \u00a03\u00a0enfermeras \u00a0\nque\u00a0se\u00a0turnan\u00a0(hacen\u00a0\nconsejer\u00eda \u00a0y\u00a0registro)\u00a0y\u00a02\u00a0\ninternas\u00a0\n\u00a01\u00a0interno\u00a0de\u00a0psicolog\u00eda \u00a0\n1\u00a0trabajadora \u00a0social\u00a0\n4\u00a0infect\u00f3logos \u00a0que\u00a0se\u00a0\nturnan\u00a0\u00a0\n1\u00a0consejero \u00a0de\u00a0par\u00a0\n1\u00a0nutricionista \u00a0\n1\u00a0laboratorista \u00a0\n1\u00a0qu\u00edmico\u00a0farmac\u00e9utico \u00a0\n1\u00a0odont\u00f3logo \u00a0\n\u00a0\nLa\u00a0consejer\u00eda \u00a0es\u00a0realizada\u00a0\npor\u00a0dos\u00a0enfermeras \u00a0(Una\u00a0ve\u00a0\nHSH,\u00a0poblaci\u00f3n \u00a0general\u00a0y\u00a0\nlas\u00a0otra\u00a0ve\u00a0ni\u00f1os)\u00a0y\u00a0una\u00a0\nobstetriz\u00a0que\u00a0atiende\u00a0a\u00a0\npoblaci\u00f3n \u00a0\u00a0general.\u00a01sicologa \u00a0\n1\u00a0laboratorista \u00a0(del\u00a0\nhospital)\u00a0\nFunciona\u00a0el\u00a0CERITS\u00a0y\u00a0TARGA\u00a0\njuntos\u00a01\u00a0t\u00e9cnica\u00a0\nNo\u00a0hay\u00a0equipo\u00a0\nmultidisciplinario \u00a0\n\u00a0\n\u00a03 Promotores \u00a0educadores \u00a0\nde\u00a0pares\u00a0\n1\u00a0infect\u00f3logo \u00a0\n1\u00a0psicolog\u00eda \u00a0\n1\u00a0Trabajadora \u00a0social\u00a0\n1\u00a0nutricionista \u00a0\nHospital\u00a0El\u00a0Carmen:\u00a0\n2\u00a0enfermeras \u00a0\n1\u00a0trabajadora \u00a0social\u00a0\n1\u00a0psicolog\u00eda \u00a0\n1\u00a0m\u00e9dico\u00a0\u00a0\nNo\u00a0hay\u00a0PEPS\u00a0\n\u00a01\u00a0sic\u00f3loga\nNo\u00a0hay\u00a0equi\nmultidisciplin a\nFunciona\u00a0el\u00a0UAMP\u00a0\njuntos\u00a0\nSe\u00a0inscribe\u00a0a\u00a0\npacientes \u00a0al\u00a0SIS?\u00a0Si.\u00a0No\u00a0se\u00a0oferta\u00a0el\u00a0SIS\u00a0\nsemicontributivo. \u00a0Si\u00a0 Si\u00a0 Si\u00a0 Si\u00a0 Si\u00a0\nFinanciado \u00a0por\u00a0el\u00a0\nSIS\u00a0Casi\u00a0todos\u00a0los\u00a0an\u00e1lisis\u00a0 Tamizaje, \u00a0hematocrito, \u00a0\nbater\u00eda\u00a0pre\u00a0TARGA.\u00a0Lo\u00a0incluidos\u00a0LPIS\u00a0 Lo\u00a0incluidos\u00a0LPIS\u00a0 Hospital\u00a0Carri\u00f3n:\u00a08\u00a0\npacientes \u00a0\nHospital\u00a0El\u00a0Carmen:\u00a015\u00a0\npacientes \u00a0Lo\u00a0incluidos\u00a0LPIS\u00a0\nGastos\u00a0asumidos \u00a0por\u00a0los\u00a0pacientes \u00a0en\u00a0tratamiento \u00a0 \u00a0 \u00a0 \u00a0\nPago\u00a0de\u00a0consulta\u00a0 Si\u00a0al\u00a0inicio,\u00a0despu\u00e9s\u00a0no.\u00a0\nInterconsulta \u00a0es\u00a010\u00a0soles\u00a0\nsino\u00a0est\u00e1n\u00a0en\u00a0el\u00a0SIS.\u00a0Si\u00a0 Es\u00a0asumido\u00a0por\u00a0el\u00a0paciente\u00a0\nel\u00a0pago\u00a0de\u00a0la\u00a0consulta,\u00a0el\u00a0\npago\u00a0de\u00a0los\u00a0ex\u00e1menes \u00a0de\u00a0\nlaboratorio \u00a0basales\u00a0S/.20\u00a0y\u00a0\nel\u00a0pago\u00a0de\u00a0alg\u00fan\u00a0otro\u00a0\nexamen\u00a0auxiliar\u00a0que\u00a0\nnecesitaran. \u00a0\u00a0Si,\u00a0al\u00a0inicio\u00a0 Hospital\u00a0Carri\u00f3n:\u00a0consulta\u00a03\u00a0\nsoles.La\u00a0primera\u00a0vez\u00a0pagan\u00a0\n3\u00a0soles\u00a0de\u00a0apertura\u00a0de\u00a0\nhistoria\u00a0cl\u00ednica\u00a0\nHospital\u00a0El\u00a0Carmen:primera \u00a0\nconsulta\u00a010\u00a0soles,\u00a0consultas \u00a0\nposteriores \u00a07\u00a0soles\u00a0Si,\u00a0al\u00a0inicio\u00a0\nPrueba\u00a0r\u00e1pida\u00a0 Si,\u00a0si\u00a0no\u00a0es\u00a0afiliado\u00a0al\u00a0SIS\u00a0 Si,\u00a0si\u00a0no\u00a0es\u00a0afiliado\u00a0al\u00a0SIS\u00a0 Si,\u00a0si\u00a0no\u00a0es\u00a0afiliado\u00a0al\u00a0SIS\u00a0 Si,\u00a0si\u00a0no\u00a0es\u00a0afiliado\u00a0al\u00a0SIS\u00a0 10\u00a0soles\u00a0 Si,\u00a0si\u00a0no\u00a0es\u00a0afiliado\u00a0\nPrueba\u00a0Elisa\u00a0 Prueba\u00a0Elisa\u00a0de\u00a0inicio,\u00a0si\u00a0es\u00a0\nind\u00edgena\u00a0la\u00a0asistenta\u00a0social,\u00a0\nle\u00a0mandamos \u00a0un\u00a0\ndocumentos, \u00a0a\u00a0laboratorio \u00a0\ny\u00a0los\u00a0exonerado. \u00a0\u00a0\u00a0Si,\u00a0al\u00a0inicio\u00a0\n\u00a0Si,\u00a0al\u00a0inicio\u00a0\n\u00a0Si,\u00a0al\u00a0inicio\u00a0\n\u00a020\u00a0soles,\u00a0si\u00a0es\u00a0positivo\u00a0\nincluye\u00a0el\u00a0Wester\u00a0blot\u00a0Si,\u00a0al\u00a0inicio\u00a0\n\u00a0\nConfirmatoria \u00a0 Lo\u00a0env\u00edan\u00a0al\u00a0laboratorio \u00a0\nreferencial \u00a0Lo\u00a0env\u00edan\u00a0al\u00a0laboratorio \u00a0\nreferencial \u00a0Lo\u00a0env\u00edan\u00a0a\u00a0Lima\u00a0 Lo\u00a0env\u00edan\u00a0a\u00a0Lima\u00a0 Lo\u00a0env\u00edan\u00a0a\u00a0Lima\u00a0 Lo\u00a0env\u00edan\u00a0a\u00a0Lima\u00a0\nPruebas\u00a0y\u00a0an\u00e1lisis\u00a0\nm\u00e1s\u00a0comunes\u00a0Las\u00a0pruebas\u00a0de\u00a0rigor\u00a0son\u00a0\nBater\u00eda\u00a0de\u00a0bioqu\u00edmica, \u00a0\nexamen\u00a0de\u00a0orinas,\u00a0heces,\u00a0\nradiograf\u00eda \u00a0de\u00a0pulmones, \u00a0\nhepatitis\u00a0(desde\u00a0mayo\u00a0no\u00a0\ngratis)\u00a0esto\u00a0todo\u00a0es\u00a070\u00a0soles\u00a0\n,\u00a0sin\u00a0la\u00a0hepatitis. \u00a0De\u00a0acuerdo\u00a0al\u00a0tarifario\u00a0 De\u00a0acuerdo\u00a0al\u00a0tarifario\u00a0 De\u00a0acuerdo\u00a0al\u00a0tarifario\u00a0 Hospital\u00a0Carri\u00f3n:\u00a0\n*Paquete \u00a0de\u00a0\u00a0bater\u00eda\u00a0\nbioqu\u00edmica, \u00a0hemograma, \u00a0\norina,\u00a0heces,\u00a0perfil\u00a0hep\u00e1tico\u00a0\n110\u00a0soles\u00a0\n*Para\u00a0CV\u00a0y\u00a0CD4\u00a0pagan\u00a0\nguantes,\u00a0tubos\u00a0y\u00a0agujas:\u00a05\u00a0De\u00a0acuerdo\u00a0al\u00a0tarifa \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\nsoles\u00a0\nHospital\u00a0El\u00a0Carmen:\u00a0\n*Paquete \u00a0de\u00a0bater\u00eda\u00a0\nbioqu\u00edmica, \u00a0hemograma, \u00a0\norina\u00a0heces,\u00a0perfil\u00a0hep\u00e1tico: \u00a0\n80\u00a0soles\u00a0\n*Para\u00a0CV\u00a0y\u00a0CD4\u00a0guantes,\u00a0\naguja\u00a0y\u00a0tubos:\u00a05\u00a0soles\u00a0\nRadiograf\u00eda \u00a0de\u00a0t\u00f3rax\u00a0Si,\u00a0al\u00a0inicio\u00a0y\u00a0cada\u00a06\u00a0meses.\u00a0\n15\u00a0soles\u00a0en\u00a0el\u00a0hospital\u00a0y\u00a0De\u00a0\n15\u00a0a\u00a030\u00a0soles\u00a0en\u00a0privado.\u00a0No\u00a0cubre\u00a0 No\u00a0cubre\u00a0 No\u00a0cubre\u00a0 Hospital\u00a0Carri\u00f3n:\u00a025\u00a0soles\u00a0\nHospital\u00a0El\u00a0Carmen:\u00a020\u00a0\nsoles\u00a0\n\u00a0No\u00a0cubre\u00a0\nPaquete\u00a0los\u00a0\nex\u00e1menes \u00a0\nhemograma \u00a0\ncompleto \u00a0glucosa,\u00a0\ncreatinina, \u00a0TGP,\u00a0\nfosfatasa\u00a0alcalina,\u00a0\nRPR.\u00a0\nEl\u00a0SIS\u00a0no\u00a0reconoce, \u00a0\nuno\u00a0 de\u00a0 ellos\u00a0\nfosfatasa\u00a0 y\u00a0\nprefieren \u00a0darle\u00a0el\u00a0\npaquete\u00a0 como\u00a0\noferta\u00a0Costo\u00a010\u00a0soles.\u00a0\nHemograma \u00a0cada\u00a03\u00a0meses.\u00a0\u00a0\nEsto\u00a0es\u00a0solo\u00a05\u00a0soles,\u00a0pero\u00a0se\u00a0\nle\u00a0ofrece\u00a0todo\u00a0el\u00a0paquete.\u00a0\nEn\u00a0el\u00a0mismo\u00a0d\u00eda\u00a0se\u00a0hace\u00a0\ntodo\u00a0y\u00a0al\u00a0d\u00eda\u00a0siguiente\u00a0el\u00a0\nresultado. \u00a0\u00a0\nTodo\u00a0los\u00a0an\u00e1lisis\u00a0ser\u00e1\u00a0como\u00a0\n40\u00a0o\u00a050\u00a0soles.\u00a0En\u00a0el\u00a0privado\u00a0\nseria\u00a0m\u00e1s,\u00a0el\u00a0hemograma \u00a0\n15\u00a0soles\u00a0glucosa\u00a010\u00a0\ncreatinina \u00a020,\u00a0fosfatasa\u00a020,\u00a0\nel\u00a0RPR\u00a010.\u00a0\u00a0\n\u00a0Seg\u00fan\u00a0tarifario\u00a0 Los\u00a0costos\u00a0asumidos \u00a0por\u00a0los\u00a0\npacientes \u00a0son\u00a0los\u00a0\u00a0an\u00e1lisis\u00a0\nde\u00a0laboratorio \u00a0basales\u00a0pre\u00a0\nTARGA,\u00a0RX\u00a0u\u00a0otros\u00a0\nex\u00e1menes \u00a0adicionales \u00a0Seg\u00fan\u00a0tarifario\u00a0 Los\u00a0costos\u00a0asumidos \u00a0por\u00a0los\u00a0\npacientes \u00a0son\u00a0los\u00a0\u00a0an\u00e1lisis\u00a0\nde\u00a0laboratorio \u00a0basales\u00a0pre\u00a0\nTARGA,\u00a0RX\u00a0,\u00a0perfil\u00a0hep\u00e1tico\u00a0\nu\u00a0otros\u00a0ex\u00e1menes \u00a0\nadicionales \u00a0\n\u00a0Seg\u00fan\u00a0tarifario\u00a0\nHepatitis\u00a0B\u00a0y\u00a0\nhepatitis\u00a0C.\u00a0m\u00e1s\u00a0\ncarga\u00a0viral\u00a0y\u00a0CD4.\u00a0Todo\u00a0gratuito.\u00a0\nHepatitis\u00a0en\u00a0el\u00a0privado\u00a050\u00a0\nsoles.\u00a0\n\u00a0Seg\u00fan\u00a0tarifario\u00a0 Seg\u00fan\u00a0tarifario\u00a0 Seg\u00fan\u00a0tarifario\u00a0 Hepatitis\u00a035\u00a0soles,\u00a0lo\u00a0hace\u00a0\nel\u00a0laboratorio \u00a0referencial \u00a0Seg\u00fan\u00a0tarifario\u00a0\nQuimioprofilaxis \u00a0\u00a0\n(tuberculosis) \u00a0Para\u00a0 quimioprofilaxis, \u00a0\ntienen\u00a0que\u00a0tomar\u00a0sus\u00a0\npastillas\u00a0durante\u00a0un\u00a0a\u00f1o\u00a0le\u00a0\ndan\u00a0receta\u00a0para\u00a0que\u00a0\ncompren, \u00a0 porque\u00a0 el\u00a0\nhospital\u00a0no\u00a0compra.\u00a0\nCotrimozal \u00a0antes\u00a0se\u00a0daba\u00a0\nahora\u00a0no.\u00a0En\u00a0farmacia\u00a0las\u00a0\n30\u00a0tabletas\u00a04.5\u00a0y\u00a0son\u00a0\u00a012\u00a0\nmeses.\u00a0\u00a0\u00a0\nDepende\u00a0del\u00a0criterio\u00a0\nm\u00e9dico,\u00a0descarte\u00a0de\u00a0TB,\u00a0eso\u00a0\nes\u00a0por\u00a0a\u00f1o\u00a0isoniazida. \u00a0\u00a0\u00a0Gratuito\u00a0\n\u00a0\u00a0 Gratuito\u00a0\n\u00a0Para\u00a0quimioprofilaxis \u00a0es\u00a0\ngratuito,\u00a0lo\u00a0da\u00a0el\u00a0programa \u00a0\nde\u00a0TB\u00a0No\u00a0es\u00a0gratuito\u00a0\nTratamiento \u00a0 y\u00a0\ndiagn\u00f3stico \u00a0 de\u00a0Lo\u00a0asumen\u00a0los\u00a0pacientes. \u00a0\nSi\u00a0 hay\u00a0 infecciones \u00a0Tratamiento \u00a0de\u00a0algunas\u00a0\nInfecciones \u00a0oportunistas. \u00a0Lo\u00a0asumen\u00a0los\u00a0pacientes. \u00a0 Lo\u00a0asumen\u00a0los\u00a0pacientes. \u00a0 Lo\u00a0asumen\u00a0los\u00a0pacientes. \u00a0 Lo\u00a0asumen\u00a0los\u00a0paci \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\nInfecciones \u00a0\noportunistas. \u00a0\u00a0\n\u00a0oportunistas \u00a0 neumon\u00eda \u00a0\ntoxoplasmosis, \u00a0\u00a0una\u00a0vez\u00a0que\u00a0\nse\u00a0afilia\u00a0al\u00a0SIS\u00a0disminuye \u00a0sus\u00a0\ncostos.\u00a0\u00a0\u00a0Las\u00a0transaminasas \u00a0\u00a0(en\u00a0\nlaboratorio \u00a0particular) \u00a0\nEx\u00e1menes \u00a0para\u00a0\u00a0algunas\u00a0IO\u00a0\u00a0\n\u00a0\n\u00a0 Nota:\u00a0El\u00a0tratamiento \u00a0de\u00a0IO\u00a0\u00a0ha\u00a0estado\u00a0siendo\u00a0asumido\u00a0por\u00a0los\u00a0sub\u2010receptores \u00a0(FM)\u00a0pero\u00a0ahora\u00a0ya\u00a0han\u00a0pasado\u00a0al\u00a0Ministerio \u00a0y\u00a0no\u00a0tienen\u00a0la\u00a0seguridad \u00a0si\u00a0van\u00a0a\u00a0tener\u00a0disponibilida d\ntratamientos. \u00a0\nReacciones \u00a0\nadversas\u00a0Lo\u00a0asume\u00a0el\u00a0paciente. \u00a0\u00a0\nLos\u00a0que\u00a0inician\u00a0deben\u00a0\nevaluarse \u00a0en\u00a0la\u00a0semana,\u00a0por\u00a0\nque\u00a0el\u00a0medicamento \u00a0es\u00a0\nmuy\u00a0toxico.\u00a0\n\u00a0Si\u00a0no\u00a0le\u00a0da,\u00a0le\u00a0dan\u00a0la\u00a0\nconsulta\u00a0al\u00a0mes,\u00a0en\u00a0la\u00a0\nconsejer\u00eda \u00a0se\u00a0le\u00a0dice,\u00a0solo\u00a0se\u00a0\ninforma\u00a0las\u00a0severas,\u00a0el\u00a0\nnotificante \u00a0no\u00a0solo\u00a0es\u00a0el\u00a0\nm\u00e9dico,\u00a0al\u00a0comienzo, \u00a0debe\u00a0\nser\u00a0la\u00a0semana,\u00a0luego\u00a0a\u00a0la\u00a0\nquincena\u00a0al\u00a0mes.\u00a0Lo\u00a0asume\u00a0el\u00a0paciente\u00a0 Lo\u00a0asume\u00a0el\u00a0paciente\u00a0 Lo\u00a0asume\u00a0el\u00a0paciente\u00a0 Lo\u00a0asume\u00a0el\u00a0paciente\u00a0 Lo\u00a0asume\u00a0el\u00a0pacien\nVitaminas \u00a0\n(Son\u00a0indicadas \u00a0por\u00a0\nel\u00a0m\u00e9dico\u00a0durante\u00a0\nel\u00a0seguimiento \u00a0del\u00a0\nTARGA\u00a0)\u00a0\n\u00a0El\u00a0AZT\u00a0produce\u00a0anemia,\u00a0por\u00a0\neso\u00a0las\u00a0recetan.\u00a0Tienen\u00a0que\u00a0\nmanejar\u00a0su\u00a0anemia.\u00a0De\u00a0\u00a0todos\u00a0los\u00a0PVV\u00a0a\u00a0quienes\u00a0\nse\u00a0les\u00a0receta\u00a0vitaminas, \u00a0s\u00f3lo\u00a0\nel\u00a020%\u00a0lo\u00a0compra.\u00a0\n(es\u00a0asumido\u00a0por\u00a0el\u00a0\npaciente, \u00a0pues\u00a0eso\u00a0no\u00a0est\u00e1\u00a0\ncomprendido \u00a0en\u00a0el\u00a0SIS)\u00a0Lo\u00a0asumen\u00a0los\u00a0pacientes. \u00a0 Lo\u00a0asumen\u00a0los\u00a0pacientes. \u00a0 Lo\u00a0asumen\u00a0los\u00a0pacientes. \u00a0 Lo\u00a0asumen\u00a0los\u00a0paci\nOtros\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nDisponibilidad \u00a0de\u00a0\ninsumos\u00a0 y\u00a0\nmedicamentos \u00a0\n(El\u00a0TARGA\u00a0es\u00a0gratis\u00a0\ny\u00a0 usualmente \u00a0\ncontinuo, \u00a0 pues\u00a0\u00a0\nreciben\u00a0 los\u00a0\nmedicamentos \u00a0\u00a0del\u00a0\nnivel\u00a0central\u00a0y\u00a0\ncuando\u00a0hay\u00a0des\u00a0\nabastecimiento \u00a0lo\u00a0\nsacan\u00a0a\u00a0trav\u00e9s\u00a0del\u00a0\nSIS\u00a0(de\u00a0lo\u00a0que\u00a0\nrecuperan \u00a0por\u00a0el\u00a0\nSIS).\u00a0Nunca\u00a0ha\u00a0habido\u00a0\ndesabastecimiento \u00a0la\u00a0\nencargada \u00a0es\u00a0muy\u00a0\npreocupada \u00a0qu\u00edmico\u00a0\nfarmac\u00e9utica. \u00a0S\u00f3lo\u00a0\u00a0durante\u00a0el\u00a0a\u00f1o\u00a02010\u00a0\nha\u00a0 habido\u00a0\ndesabastecimiento \u00a0 de\u00a0\ncondones \u00a0por\u00a0lo\u00a0cual\u00a0\u00a0ya\u00a0\ncasi\u00a0no\u00a0estaban\u00a0entregando \u00a0\ncondones. \u00a0 Actualmente \u00a0\nentregan\u00a020\u00a0condones \u00a0a\u00a0\ncada\u00a0PVV\u00a0cuando\u00a0viene\u00a0a\u00a0la\u00a0\nvisita\u00a0de\u00a0control.\u00a0El\u00a0a\u00f1o\u00a0\n2010\u00a0 ha\u00a0 habido\u00a0\ndesabastecimiento \u00a0de\u00a0EFV\u00a0y\u00a0\nDDI\u00a0que\u00a0se\u00a0cambi\u00f3\u00a0por\u00a0\nAbacavir\u00a0\n\u00a0Es\u00a0permanente \u00a0durante\u00a0\u00a0\u00a0\ntodo\u00a0el\u00a0a\u00f1o,\u00a0s\u00f3lo\u00a0que\u00a0en\u00a0\nUcayali\u00a0se\u00a0maneja\u00a0\u00a0a\u00a0trav\u00e9s\u00a0\nde\u00a0stocks\u00a0o\u00a0\u00a0solicita\u00a0a\u00a0otras\u00a0\nESN.\u00a0\u00a0\u00a0\u00a0\nObservaciones \u00a0 Costo\u00a0ELISA\u00a020\u00a0soles.\u00a0\nParejas\u00a0discordantes \u00a03\u00a0de\u00a0\n104\u00a0casos\u00a0en\u00a0a\u00f1os.\u00a0En\u00a0una\u00a0\nmuestra\u00a0de\u00a023\u00a0pacientes \u00a0Hacen\u00a0compra\u00a0conjunta\u00a0de\u00a0\nARV\u00a0pedi\u00e1tricos \u00a0entre\u00a0\nUcayali,\u00a0Loreto\u00a0y\u00a0San\u00a0\nMart\u00edn\u00a0a\u00a0fin\u00a0de\u00a0bajar\u00a0costos.\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\nson\u00a03\u00a0bisexuales \u00a0y\u00a01\u00a0es\u00a0\nhomosexual \u00a0SMEII\u00a0no\u00a0ayuda\u00a0para\u00a0\nestad\u00edstica \u00a0\nPrevenci\u00f3n \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nEntrevistados \u00a0 Bi\u00f3loga\u00a0Carola\u00a0Cuzquen\u00a0 Carmina\u00a0Pena\u2010\u00a0Obstetriz\u00a0\n\u00a0Obstetriz\u00a0Golda\u00a0 Enf.\u00a0Irene\u00a0Mori\u00a0Mendoza \u00a0\nJavier\u00a0Urbie\u00a0Godoy\u00a0\u00a0\u00a0\nLugares\u00a0de\u00a0atenci\u00f3n\u00a0\nITS\u00a0CERITS\u00a0\nCS\u00a0Jose\u00a0Olaya\u00a0CERITS\u00a0\u00a0\nCentro\u00a0de\u00a0Salud\u00a0San\u00a0Juan\u00a0\n\u00a0\nUAMP\u00a0\u00a0\nHospital\u00a0Santa\u00a0\u00a0Gema\u00a0de\u00a0\nYurimaguas \u00a0\nSan\u00a0Antonio\u00a0\u2013\u00a0C.S.\u00a0San\u00a0\nAntonio\u00a0\nNauta\u00a0\u2013\u00a0C.S.\u00a0Nauta\u00a0\nRequena\u00a0\u2013\u00a0C.S.\u00a0Requena\u00a0\nCaballococha \u00a0 \u2013\u00a0 C.S.\u00a0\nCaballococha \u00a0CERITS\u00a0\u00a0\nHospital\u00a0Regional\u00a0de\u00a0\nPucallpa\u00a0\n\u00a0\nUAMP\u00a0\u00a0\nHospital\u00a0de\u00a0Apoyo\u00a0\nYarinacocha \u00a0CERITS\u00a0\u00a0\nHospital\u00a0Regional\u00a0de\u00a0Ica\u00a0\n\u00a0UAMP\u00a0\u00a0\nHospital\u00a0San\u00a0Juan\u00a0de\u00a0Dios\u00a0\nPisco\u00a0\nHospital\u00a0San\u00a0Jos\u00e9\u00a0de\u00a0\nChincha\u00a0\nC.S.\u00a0La\u00a0Palma\u00a0\nC.S.Sunampe \u00a0\nC.S.\u00a0Marcona\u00a0\nHosp.\u00a0Nazca\u00a0CERITS\u00a0\u00a0\nHospital\u00a0Daniel\u00a0A.\u00a0Carri\u00f3n\u00a0\n\u00a0UAMP\u00a0\u00a0\nHospital\u00a0El\u00a0Carmen\u00a0\u2010\u00a0\nHuancayo \u00a0\nC.S.\u00a0Pichanaki \u00a0\nHospital\u00a0Jauja\u00a0\nHospital\u00a0Olabegoya \u00a0\u2010\u00a0Tarma\u00a0\nHospital\u00a0La\u00a0Merced\u00a0\u2010\u00a0\u00a0\nChanchamayo \u00a0\nHospital\u00a0Higaraki\u00a0\u2010\u00a0Satipo\u00a0\nCS.\u00a0Oroya\u00a0\nHospital\u00a0El\u00a0Carmen\u00a0\n(Funciona \u00a0como\u00a0tal\u00a0pero\u00a0no\u00a0\nest\u00e1\u00a0reconocido) \u00a0CERITS\u00a0\u00a0\nHospital\u00a0Apoyo\u00a0La\u00a0\nC\nChimbote \u00a0\n\u00a0\nUAMP\u00a0\u00a0\nHospital\u00a0V\u00edctor\u00a0Ram\nGuardia\u00a0\u2013\u00a0Huaraz\u00a0\u00a0\n\u00a0\nPEPS\u00a0HSH\u00a0 11\u00a0 25\u00a0 11\u00a0 25\u00a0 10\u00a0 9\u00a0\nPEPS\u00a0TS\u00a0 4\u00a0 9\u00a0 7\u00a0 5\u00a0 3\u00a0 4\u00a0\nAtenci\u00f3n\u00a0en\u00a0el\u00a0\nservicio\u00a0En\u00a0las\u00a0ma\u00f1anas\u00a0hombres\u00a0\u00a0\nlunes\u00a0a\u00a0viernes\u00a0y\u00a0en\u00a0la\u00a0tarde\u00a0\nmujeres,\u00a0s\u00e1bado\u00a0Hombres\u00a0y\u00a0\nmujeres.\u00a0Los\u00a0resultados \u00a0de\u00a0\nlas\u00a0pruebas\u00a0se\u00a0las\u00a0entregan\u00a0\nde\u00a030\u00a0a\u00a045\u00a0minutos.\u00a0\u00a0La\u00a0\nprueba\u00a0IFI\u00a0es\u00a0en\u00a0el\u00a0INS.\u00a0\u00a0 En\u00a0el\u00a0hospital\u00a0regional,\u00a0\nM\u00e9dico\u00a0Atiende\u00a0lunes,\u00a0\nmartes,\u00a0jueves\u00a0y\u00a0s\u00e1bado\u00a0y\u00a0\nno\u00a0toda\u00a0la\u00a0ma\u00f1ana\u00a0\nEnfermera \u00a0atiende\u00a0todos\u00a0\nlos\u00a0d\u00edas\u00a0\nPsic\u00f3loga \u00a0atiende\u00a0todos\u00a0los\u00a0\nd\u00edas\u00a0\u00a0en\u00a0horario\u00a0completo \u00a0\nLaboratorista \u00a0est\u00e1\u00a0en\u00a0el\u00a0\nCERITSS\u00a0de\u00a0lunes\u00a0a\u00a0viernes,\u00a0\ntoma\u00a0las\u00a0muestras \u00a0para\u00a0\nRPR,\u00a0para\u00a0VIH,\u00a0lee\u00a0las\u00a0\nmuestras \u00a0en\u00a0fresco\u00a0de\u00a0las\u00a0\nTS\u00a0\nUAMP\u00a0Yarinacocha \u00a0\nAtiende\u00a0alrededor \u00a0de\u00a014\u00a0\nHSH\u00a0por\u00a0d\u00eda,\u00a0de\u00a0lunes\u00a0a\u00a0\ns\u00e1bado\u00a0\nTiene\u00a012\u00a0PEPS,\u00a06\u00a0MINSA,\u00a06\u00a0\nFM\u00a0Para\u00a0la\u00a0AMP\u00a0,\u00a0trabaja\u00a0con\u00a0\nAMP\u00a0con\u00a0TS\u00a0y\u00a0HSH,\u00a0el\u00a0\nhospital\u00a0atiende\u00a0los\u00a0l\u00a0y\u00a0\nmi\u00e9rcoles \u00a0con\u00a0TS\u00a0y\u00a0jueves\u00a0\ncon\u00a0HSH\u00a0por\u00a0la\u00a0tarde\u00a0\u00a0Lunes\u00a0a\u00a0s\u00e1bado\u00a0de\u00a07\u00a0am\u00a0a\u00a01\u00a0\nam\u00a0\u00a0 \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\nAtenci\u00f3n\u00a0por\u00a0Obstetra\u00a0que\u00a0\nest\u00e1\u00a0todos\u00a0los\u00a0d\u00edas\u00a0en\u00a0forma\u00a0\npermanente; \u00a0la\u00a0enfermera \u00a0\ny\u00a0el\u00a0m\u00e9dico\u00a0atienden\u00a0de\u00a0\nacuerdo\u00a0a\u00a0la\u00a0disponibilidad \u00a0\nde\u00a0tiempo\u00a0que\u00a0tengan\u00a0\nCostos\u00a0asumidos \u00a0\npor\u00a0los\u00a0pacientes \u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\nConsultas, \u00a0apertura\u00a0\nde\u00a0Historia\u00a0cl\u00ednica\u00a01\u00a0sol\u00a0por\u00a0apertura\u00a0de\u00a0la\u00a0\nhistoria\u00a0para\u00a01.5\u00a0como\u00a0\nmulta\u00a0por\u00a0haber\u00a0olvidado\u00a0el\u00a0\nn\u00famero\u00a0de\u00a0historia.\u00a0\u00a0\n\u00a0El\u00a0paciente\u00a0asume\u00a0la\u00a0\napertura\u00a0de\u00a0HC\u00a0que\u00a0son\u00a0\n3.00\u00a0por\u00a0\u00fanica\u00a0vez.\u00a0Hospital\u00a0regional.\u00a0\nUsualmente \u00a0las\u00a0pacientes \u00a0\nno\u00a0pagan\u00a0nada,\u00a0s\u00f3lo\u00a0el\u00a0\ncarn\u00e9\u00a0que\u00a0es\u00a0por\u00a0una\u00a0sola\u00a0\nvez\u00a0S/.\u00a02.00.\u00a0S\u00f3lo\u00a0se\u00a0\ncontrolan \u00a0a\u00a0TS\u00a0mujeres\u00a0en\u00a0\nAMP\u00a0(7\u201010\u00a0por\u00a0d\u00eda),\u00a0\ngestantes \u00a0y\u00a0su\u00a0RN.\u00a0\u00a0\nTienen\u00a06\u00a0PEPs\u00a0(5\u00a0MINSA,\u00a01\u00a0\nFM)\u00a0\n\u00a0Apertura\u00a0de\u00a0HC\u00a0 Hospital\u00a0Carri\u00f3n:\u00a0\u00a0\n3\u00a0soles\u00a0por\u00a0apertura\u00a0de\u00a0\nhistoria\u00a0cl\u00ednica\u00a0\nConsulta: \u00a03\u00a0soles\u00a0\nHospital\u00a0El\u00a0Carmen:\u00a0\nPrimera\u00a0consulta:\u00a010\u00a0soles\u00a0\nConsultas \u00a0posteriores: \u00a07\u00a0\nsoles\u00a0Apertura\u00a0de\u00a0\nTamizaje\u00a0\u00a0 Gratuita\u00a0 Gratuita\u00a0 HSH\u00a0y\u00a0TS\u00a0Tamizaje\u00a0gratis,\u00a0\nVIH\u00a0cada\u00a0\u00a06\u00a0meses\u00a0y\u00a0RPR\u00a0\ncada\u00a03\u00a0meses.\u00a0\nEn\u00a0caso\u00a0de\u00a0AMP\u00a0las\u00a0\npacientes \u00a0no\u00a0asumen\u00a0\nning\u00fan\u00a0costo.\u00a0Un\u00a0buen\u00a0\nn\u00famero\u00a0est\u00e1n\u00a0en\u00a0el\u00a0SIS\u00a0Prueba\u00a0r\u00e1pida\u00a0\u00a0es\u00a0gratuita\u00a0y\u00a0\nRPR\u00a0pagan\u00a05.20\u00a0soles\u00a0,\u00a0las\u00a0\nTS\u00a0compran\u00a0una\u00a0constancia \u00a0\u00a0\nde\u00a0AMP\u00a0que\u00a0cuesta\u00a04.4\u00a0a\u00a0la\u00a0\n1\u00a0pm\u00a0pasan\u00a0a\u00a0triaje\u00a0con\u00a0la\u00a0\nevaluaci\u00f3n \u00a0cl\u00ednica\u00a0\u00a0que\u00a0\nrealiza\u00a0el\u00a0m\u00e9dico\u00a0y\u00a0toma\u00a0de\u00a0\nmuestra\u00a0,\u00a0luego\u00a0que\u00a0se\u00a0\ntermina\u00a0se\u00a0llevan\u00a0al\u00a0\nlaboratorio \u00a0y\u00a0los\u00a0resultados \u00a0\nsalen\u00a0en\u00a0una\u00a0hora\u00a0y\u00a0luego\u00a0\npasan\u00a0por\u00a0consejer\u00eda \u00a0post\u00a0\ntest\u00a0en\u00a0PR\u00a0y\u00a0la\u00a0consejer\u00eda \u00a0de\u00a0\ncambio\u00a0de\u00a0comportamiento \u00a0\u00a0\na\u00a0la\u00a0sanas\u00a0\u00a0se\u00a0le\u00a0da\u00a0\nconstancia \u00a0firmada\u00a0por\u00a0el\u00a0\nm\u00e9dico\u00a0y\u00a0se\u00a0da\u00a0nueva\u00a0cita,\u00a0\u00a0\nse\u00a0le\u00a0entrega\u00a0folleter\u00eda\u00a0de\u00a0\nITS,\u00a0PR,\u00a0\u00a0en\u00a0AMP\u00a0para\u00a0TS\u00a0y\u00a0\nHSH.\u00a0En\u00a0CERITs\u00a0pagan\u00a0la\u00a0prueba\u00a0\nr\u00e1pida\u00a010\u00a0soles,\u00a0m\u00e1s\u00a0\nguantes\u00a0y\u00a0aguja\u00a02\u00a0soles\u00a0Prueba\u00a0r\u00e1pida\u00a0gr\nCondones \u00a0 Gratuito\u00a0 Gratuito\u00a0\u00a0\nDurante\u00a0este\u00a0a\u00f1o\u00a0han\u00a0\nestado\u00a0recibiendo \u00a0\u00a0\u00a0\u00a0 5\u00a0\ncondones \u00a0por\u00a0visita\u00a0y\u00a0\u00a0\nreci\u00e9n\u00a0est\u00e1n\u00a0entregando \u00a050\u00a0\ncondones. \u00a0\n\u00a0Gratuito\u00a0 Gratuito\u00a0 Gratuito\u00a0\u00a0\nActualmente \u00a0se\u00a0entrega\u00a050\u00a0\ncondones \u00a0Gratuito\u00a0 \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\nDisponibilidad \u00a0de\u00a0\ninsumos\u00a0y\u00a0\nmedicamentos \u00a0A\u00a0veces\u00a0faltan\u00a0insumos\u00a0 Si\u00a0tienen\u00a0insumos,\u00a0excepto\u00a0\nKOH,\u00a0Elisa\u00a0para\u00a0Clamydia, \u00a0y\u00a0\nactualmente \u00a0que\u00a0ya\u00a0tienen\u00a0\ncondones \u00a0 (2010\u00a0\nintermitente) \u00a0Usualmente \u00a0tienen\u00a0un\u00a0\npeque\u00f1o\u00a0stock\u00a0de\u00a0todo.\u00a0En\u00a0\nmarzo\u00a0de\u00a0este\u00a0a\u00f1o\u00a0cuando\u00a0\nfaltaba\u00a0\u00a0RPR,\u00a0se\u00a0les\u00a0indicaba\u00a0\na\u00a0las\u00a0TS\u00a0para\u00a0que\u00a0paguen\u00a0y\u00a0\nse\u00a0hagan\u00a0la\u00a0prueba,\u00a0la\u00a0\nmayor\u00eda\u00a0no\u00a0pagaba\u00a0por\u00a0lo\u00a0\ntanto\u00a0no\u00a0se\u00a0hac\u00edan.\u00a0A\u00a0veces\u00a0faltan\u00a0insumos\u00a0 Si\u00a0cuentan\u00a0con\u00a0insumos,\u00a0\ntienen\u00a0problemas \u00a0con\u00a0el\u00a0SIS\u00a0\npara\u00a0el\u00a0reconocimiento \u00a0de\u00a0\nla\u00a0leche\u00a0maternizada \u00a0A\u00a0veces\u00a0faltan\u00a0in\nPrevenci\u00f3n \u00a0\u00a0en\u00a0\nsector\u00a0privado\u00a0\u00a0 La\u00a0poblaci\u00f3n \u00a0HSH\u00a0adem\u00e1s\u00a0\nde\u00a0atenderse \u00a0en\u00a0el\u00a0CERITS\u00a0\ntambi\u00e9n\u00a0lo\u00a0hace\u00a0en\u00a0la\u00a0\nUAMP\u00a0que\u00a0es\u00a0del\u00a0Ministerio \u00a0\ny\u00a0en\u00a0la\u00a0Asociaci\u00f3n \u00a0Civil\u00a0\nSelva\u00a0 Amaz\u00f3nica \u00a0 y\u00a0\ndesconoce \u00a0los\u00a0costos\u00a0de\u00a0la\u00a0\natenci\u00f3n\u00a0\u00a0asumidos \u00a0por\u00a0la\u00a0\nInstituci\u00f3n \u00a0y\u00a0los\u00a0asumidos \u00a0\npor\u00a0los\u00a0pacientes. \u00a0\u00a0 No\u00a0conocen\u00a0 Laboratorios \u00a0privados\u00a0para\u00a0\ndiagn\u00f3stico: \u00a0\n\u2010Cl\u00ednica\u00a0San\u00a0Pablo\u00a0\n\u2010Cl\u00ednica\u00a0Ortega\u00a0\n\u2010Cl\u00ednica\u00a0Municipal \u00a0\n\u00a0No\u00a0conoce\nPrevenci\u00f3n \u00a0\ntransmisi\u00f3n \u00a0vertical\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nPrueba\u00a0r\u00e1pida\u00a0para\u00a0\nVIH\u00a0y\u00a0RPR\u00a0en\u00a0\ngestantes \u00a0y\u00a0MEF\u00a0Gratuito\u00a0\u00a0 Gratuito\u00a0\u00a0 Gratuito.\u00a0\nPoblaci\u00f3n \u00a0general\u00a0paga\u00a0\ntamizaje\u00a0para\u00a0VIH,\u00a0excepto\u00a0\ngestante\u00a0y\u00a0pareja\u00a0de\u00a0\ngestante\u00a0VIH+\u00a0\nGestantes \u00a0\u00a0tambi\u00e9n\u00a0gratis\u00a0el\u00a0\ntamizaje\u00a0y\u00a0confirmaci\u00f3n \u00a0\nCD4\u00a0y\u00a0CV\u00a0asumido\u00a0por\u00a0el\u00a0\nMINSA\u00a0\nEn\u00a0el\u00a0caso\u00a0del\u00a0RN\u00a0le\u00a0hacen\u00a0\nPCR\u00a0a\u00a0los\u00a03\u00a0y\u00a06\u00a0meses\u00a0(estas\u00a0\npruebas\u00a0son\u00a0enviadas\u00a0a\u00a0\nLima\u00a0por\u00a0la\u00a0DIRESA);\u00a0a\u00a0los\u00a0\n18\u00a0meses\u00a0se\u00a0les\u00a0hace\u00a0ELISA.\u00a0\nTodos\u00a0los\u00a0RN\u00a0hijo\u00a0de\u00a0madre\u00a0\nVIH\u00a0+\u00a0son\u00a0seguidos\u00a0por\u00a0los\u00a0\npromotores \u00a0de\u00a0pares\u00a0de\u00a0\nPVV\u00a0que\u00a0son\u00a0voluntarios \u00a0y\u00a0\nson\u00a07.\u00a0Gratuito\u00a0\u00a0 Gratuito\u00a0\u00a0 Gratuito\u00a0\u00a0\nMedicamentos \u00a0 Reciben\u00a0del\u00a0nivel\u00a0central\u00a0 Reciben\u00a0del\u00a0nivel\u00a0central\u00a0 Reciben\u00a0del\u00a0nivel\u00a0central.\u00a0\nPedi\u00e1tricos \u00a0compra\u00a0el\u00a0\nhospital\u00a0Reciben\u00a0del\u00a0nivel\u00a0central\u00a0 Reciben\u00a0del\u00a0nivel\u00a0central\u00a0 Reciben\u00a0del\u00a0nivel\u00a0ce\nAtenci\u00f3n\u00a0 en\u00a0\nESSALUD\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\n\u00a0 Obstetriz\u00a0Juana\u00a0Rojas\u00a0\nEnfermera \u00a0TARGA\u00a0Doris\u00a0\nPic\u00f3n\u00a0\nEpidemiologia \u00a0\u00a0Dra.\u00a0Dafne\u00a0\nMoreno\u00a0\n\u00a0Luz\u00a0Gutarra.\u00a0Enfermera \u00a0\u00a0 \u00a0 Lic.\u00a0Mercedes \u00a0Mart\u00ednez\u00a0\nEncargada \u00a0\u00a0Servicio\u00a0\nTransmisibles \u00a0TB\u00a0VIH\u00a0\u2013\u00a0\nESSALUD\u00a0\u00a0\nPacientes \u00a0 de\u00a0\nESSALUD\u00a0en\u00a0MINSA\u00a0La\u00a0DIRESA\u00a0tienen\u00a010\u00a0\npacientes \u00a0de\u00a0ESSALUD\u00a0que\u00a0\nprefieren \u00a0atenderse \u00a0en\u00a0el\u00a0\nMINSA\u00a0\u00a0 No\u00a0se\u00a0sabe\u00a0 No\u00a0se\u00a0sabe\u00a0\u00a0 No\u00a0se\u00a0sabe\u00a0\nPacientes \u00a0 de\u00a0\nESSALUD\u00a0Chiclayo\u00a0atiende\u00a0a\u00a0\npacientes \u00a0de\u00a0la\u00a0macro\u2010\nregi\u00f3n.\u00a0\n\u00a0\u00a0ESSALUD\u00a0tiene\u00a033\u00a0PVV\u00a0en\u00a0\nTARGA,\u00a0los\u00a0esquemas \u00a0son\u00a0\ndiferentes, \u00a0no\u00a0env\u00edan\u00a0\nreportes\u00a0al\u00a0MINSA.\u00a0No\u00a0\ntienen\u00a0\u00b4poblaci\u00f3n \u00a0HSH.\u00a0\nTarga\u00a0es\u00a0gratis\u00a0en\u00a0el\u00a0\nHospital\u00a0de\u00a0ESSALUD. \u00a0No\u00a0se\u00a0\nda\u00a0en\u00a0los\u00a0policl\u00ednicos. \u00a0\u00a0\u00a0\u00a0 Los\u00a0env\u00edan\u00a0a\u00a0Lima\u00a0al\u00a0\nHospital\n\u00a0Almenara, \u00a0para\u00a0\nevaluaci\u00f3n \u00a0y\u00a0recibir\u00a0su\u00a0\ntratamiento \u00a0\u00a0\nAtenci\u00f3n\u00a0 ESSALUD\u00a0\u00a0no\u00a0tiene\u00a0\nprograma \u00a0de\u00a0VIH.\u00a0Primero\u00a0\u00a0\nla\u00a0persona\u00a0\u00a0tiene\u00a0que\u00a0ser\u00a0\nasegurada, \u00a0\u00a0si\u00a0es\u00a0que\u00a0la\u00a0\npersona\u00a0tiene\u00a0que\u00a0llegar\u00a0al\u00a0\nTARGA\u00a0se\u00a0lo\u00a0van\u00a0a\u00a0dar,\u00a0sin\u00a0\nembargo\u00a0tiene\u00a0que\u00a0esperar\u00a0\na\u00a0que\u00a0se\u00a0le\u00a0haga\u00a0la\u00a0\nreferencia \u00a0del\u00a0policl\u00ednico \u00a0\npara\u00a0pasar\u00a0al\u00a0hospital,\u00a0esto\u00a0\nes\u00a0lo\u00a0que\u00a0\u00a0est\u00e1\u00a0en\u00a0la\u00a0\nreferencia. \u00a0\u00a0Las\u00a0enfermeras \u00a0\ntratan\u00a0de\u00a0\u00a0buscar\u00a0un\u00a0cupo\u00a0\ncomo\u00a0adicional\u00a0para\u00a0que\u00a0el\u00a0\nm\u00e9dico\u00a0las\u00a0atienda\u00a0y\u00a0poder\u00a0\natenderlas \u00a0lo\u00a0antes\u00a0posible.\u00a0\u00a0\nPara\u00a0el\u00a0control\u00a0mensual\u00a0a\u00a0\nChiclayo\u00a0viajan\u00a0los\u00a0\npacientes \u00a0desde\u00a0Amazonas, \u00a0\nTumbes,\u00a0Piura,\u00a0San\u00a0Mart\u00edn\u00a0\ny\u00a0Cajamarca. \u00a0\u00a0A\u00a0los\u00a0que\u00a0\nviene\u00a0de\u00a0provincias \u00a0\nESSALUD\u00a0les\u00a0da\u00a0para\u00a0el\u00a0\npasaje\u00a0pero\u00a0no\u00a0para\u00a0la\u00a0\ncomida.\u00a0En\u00a0Iquitos\u00a0s\u00f3lo\u00a0se\u00a0da\u00a0los\u00a0\nesquemas \u00a0iniciales\u00a0de\u00a0\nTARGA,\u00a0Rescate\u00a0lo\u00a0asume\u00a0el\u00a0\nSeguro\u00a0de\u00a0Lima;\u00a0el\u00a0paciente\u00a0\ntiene\u00a0que\u00a0viajar\u00a0cada\u00a0vez\u00a0\nque\u00a0tiene\u00a0su\u00a0control\u00a0a\u00a0la\u00a0\nciudad\u00a0de\u00a0Lima.\u00a0\n\u00a0\u00a0\u00a0 Los\u00a0pacientes \u00a0son\u00a0enviados\u00a0\na\u00a0Lima\u00a0para\u00a0su\u00a0tratamiento \u00a0\u00a0\u00a0\nCostos\u00a0asumidos \u00a0por\u00a0los\u00a0pacientes \u00a0de\u00a0ESSALUD\u00a0 \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\nEx\u00e1menes \u00a0 pre\u00a0\nTARGA\u00a0Gratuito\u00a0 Gratuitos \u00a0\nEx\u00e1menes \u00a0pre\u00a0TARGA\u00a0se\u00a0\nhacen\u00a0en\u00a0ESSALUD\u00a0cada\u00a06\u00a0\nmeses.\u00a0El\u00a0diagn\u00f3stico \u00a0de\u00a0\nVIH\u00a0le\u00a0hacen\u00a0con\u00a0dos\u00a0ELISAS\u00a0\ny\u00a0la\u00a0confirmaci\u00f3n \u00a0la\u00a0hacen\u00a0\nen\u00a0el\u00a0laboratorio \u00a0referencial \u00a0\ndel\u00a0MINSA.\u00a0\u00a0\u00a0 Gratuitos, \u00a0los\u00a0pacientes \u00a0\nviajan\u00a0cada\u00a03\u00a0o\u00a06\u00a0meses\u00a0a\u00a0\nLima\u00a0para\u00a0hacerse\u00a0las\u00a0\npruebas\u00a0pata\u00a0ingreso\u00a0a\u00a0\nTARGA\u00a0y\u00a0de\u00a0monitoreo \u00a0\u00a0\nCondones \u00a0\u00a0 Gratuito\u00a0\nLos\u00a0PVV\u00a0reciben\u00a020\u00a0\ncondones \u00a0en\u00a0la\u00a0consulta\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\nMedicamentos \u00a0para\u00a0\ntratamiento \u00a0Gratuito\u00a0 Gratuito\u00a0\nEn\u00a0caso\u00a0el\u00a0paciente\u00a0\nnecesitara \u00a0Anfotericin \u00a0B,\u00a0\nasume\u00a0el\u00a0paciente\u00a0\nPCR\u00a0no\u00a0tienen\u00a0disponible \u00a0\npara\u00a0los\u00a0RN\u00a0expuestos \u00a0\nperinatalmente, \u00a0por\u00a0lo\u00a0que\u00a0\nel\u00a0Dx\u00a0le\u00a0hacen\u00a0reci\u00e9n\u00a0al\u00a0a\u00f1o\u00a0\ny\u00a0medio\u00a0\u00a0\u00a0 Gratuito\u00a0\u00a0\nGestantes \u00a0\u00a0 Gestantes \u00a0\u00a0tienen\u00a0paquete\u00a0\ngratis\u00a0que\u00a0incluye\u00a0Prueba\u00a0\nr\u00e1pida\u00a0para\u00a0VIH\u00a0y\u00a0RPR.\u00a0RN\u00a0\nrecibe\u00a0AZT\u00a0al\u00a0nacimiento. \u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\nDisponibilidad \u00a0de\u00a0\nmedicamentos \u00a0\u00a0 ESSALUD\u00a0cuenta\u00a0con\u00a0\nTratamiento \u00a0e\u00a0insumos\u00a0en\u00a0\nforma\u00a0permanente \u00a0pues\u00a0\ncuando\u00a0al\u00a0paciente\u00a0le\u00a0falta\u00a0\nun\u00a0medicamento \u00a0del\u00a0\nesquema\u00a0 que\u00a0 est\u00e1\u00a0\nrecibiendo \u00a0le\u00a0\u00a0reemplazan \u00a0\npor\u00a0un\u00a0equivalente, \u00a0lo\u00a0cual\u00a0\nimplica\u00a0que\u00a0el\u00a0paciente\u00a0no\u00a0\ndeja\u00a0\u00a0de\u00a0tomar\u00a0pastillas.\u00a0\u00a0\u00a0 ESSALUD\u00a0entrega\u00a0los\u00a0\nmedicamentos \u00a0en\u00a0Lima,\u00a0\ncuando\u00a0el\u00a0paciente\u00a0viene\u00a0a\u00a0\nrealizar\u00a0las\u00a0pruebas\u00a0de\u00a0\nmonitoreo \u00a0\u00a0\nCD4\u00a0Y\u00a0Carga\u00a0viral\u00a0 Los\u00a0realizan\u00a0en\u00a0el\u00a0\nlaboratorio \u00a0referencial \u00a0del\u00a0\nMINSA\u00a0El\u00a0paciente\u00a0asume\u00a0CD4\u00a0y\u00a0\nCV,\u00a0algunos\u00a0se\u00a0\u00a0realizan\u00a0en\u00a0\nel\u00a0MINSA\u00a0y\u00a0la\u00a0mayor\u00eda\u00a0no\u00a0se\u00a0\u00a0\nhacen\u00a0estas\u00a0pruebas\u00a0\ninici\u00e1ndose \u00a0el\u00a0TARGA\u00a0\u00a0con\u00a0\nsolo\u00a0\u00a0cuadro\u00a0cl\u00ednico.\u00a0\n\u00a0\u00a0\u00a0 Los\u00a0realizan\u00a0en\u00a0Lima\u00a0el\u00a0\nHospital\u00a0de\u00a0referencia \u00a0para\u00a0\nHuancayo \u00a0es\u00a0el\u00a0\u00a0Hospital\u00a0\nAlmenara \u00a0\u00a0\nSector\u00a0privado\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nDiagn\u00f3stico \u00a0sector\u00a0 Los\u00a0laboratorios \u00a0privados\u00a0 Solo\u00a0en\u00a0ACSA.\u00a0 No.\u00a0 No\u00a0 Sector\u00a0privado\u00a0solo\u00a0realiza\u00a0 No\u00a0 \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\nprivado\u00a0 est\u00e1n\u00a0obligados \u00a0a\u00a0\ncomunicar \u00a0a\u00a0la\u00a0estrategia \u00a0\n(pero\u00a0no\u00a0se\u00a0sabe\u00a0si\u00a0\ncumplen). \u00a0El\u00a0tamizaje\u00a0para\u00a0las\u00a0\npersonas\u00a0\u00a0de\u00a0poblaci\u00f3n \u00a0\ngeneral\u00a0que\u00a0acuden\u00a0\u00a0en\u00a0\nforma\u00a0voluntaria \u00a0\u00a0es\u00a0S/\u00a0\n15.00\u00a0y\u00a0la\u00a0consulta\u00a0es\u00a0\nS/40.00.\u00a0Pero\u00a0son\u00a0muy\u00a0\npocos,\u00a02\u00f33.\u00a0\nCuando\u00a0el\u00a0tamizaje\u00a0es\u00a0\nreactivo,\u00a0\u00a0para\u00a0la\u00a0\nconfirmaci\u00f3n \u00a0\u00a0env\u00edan\u00a0\u00a0la\u00a0\nmuestra\u00a0al\u00a0laboratorio \u00a0\nreferencial \u00a0del\u00a0MINSA.\u00a0\nCuando\u00a0son\u00a0personas\u00a0que\u00a0\nson\u00a0enroladas \u00a0para\u00a0los\u00a0\nestudios,\u00a0el\u00a0tamizaje\u00a0no\u00a0les\u00a0\ncuesta.\u00a0Los\u00a0ex\u00e1menes \u00a0de\u00a0\nlaboratorio \u00a0pre\u00a0TARGA\u00a0o\u00a0\u00a0\nlos\u00a0de\u00a0seguimiento \u00a0la\u00a0\nAsociaci\u00f3n \u00a0se\u00a0hace\u00a0cargo.\u00a0\nS\u00f3lo\u00a0CD4\u00a0y\u00a0CV\u00a0es\u00a0asumido\u00a0\npor\u00a0el\u00a0MINSA.\u00a0\u00a0Al\u00a0comienzo \u00a0\n(2008)\u00a0la\u00a0Asociaci\u00f3n \u00a0\nrealizaba\u00a0los\u00a0CD4\u00a0y\u00a0la\u00a0CV,\u00a0\npero\u00a0todo\u00a0este\u00a0a\u00f1o\u00a0lo\u00a0\nenv\u00edan\u00a0al\u00a0MINSA.\u00a0\u00a0 diagn\u00f3stico \u00a0\nTratamiento \u00a0ARV\u00a0en\u00a0\nla\u00a0pr\u00e1ctica\u00a0privada\u00a0Si\u00a0 Si.\u00a0\u00a0 No.\u00a0\n\u00a0No\u00a0 No\u00a0 No\u00a0\n\u00a0 Se\u00a0conoce\u00a03\u00a0\u00a0m\u00e9dicos\u00a0que\u00a0\natienden\u00a0en\u00a0el\u00a0sector\u00a0\nprivado.\u00a0\nPero\u00a0los\u00a0pacientes \u00a0no\u00a0son\u00a0\nmuchos.\u00a0\nOtros\u00a0\u00a0pacientes \u00a0tienen\u00a0\npara\u00a0unos\u00a0meses\u00a0y\u00a0despu\u00e9s\u00a0\nno\u00a0contin\u00faan \u00a0y\u00a0tiene\u00a0que\u00a0\nentrar\u00a0al\u00a0TARGA.\u00a0\nTienen\u00a0un\u00a0paciente\u00a0que\u00a0\nrecibe\u00a0ARV\u00a0en\u00a0AIDS\u00a0for\u00a0\nAIDS,\u00a0pero\u00a0no\u00a0la\u00a0carga\u00a0viral,\u00a0\ncada\u00a0vez\u00a0se\u00a0tiene\u00a0que\u00a0hacer\u00a0\nuna\u00a0coordinaci\u00f3n \u00a0especial\u00a0\npara\u00a0que\u00a0autoricen \u00a0S\u00f3lo\u00a0en\u00a0ACSA.\u00a0Tamizaje\u00a0(S/\u00a0\n15)\u00a0\u00a0y\u00a0consulta\u00a0(S/40.00)\u00a0\ncuando\u00a0no\u00a0es\u00a0integrante \u00a0de\u00a0\nalg\u00fan\u00a0protocolo \u00a0de\u00a0la\u00a0\ninstituci\u00f3n. \u00a0\nRecibe\u00a0la\u00a0\u00b4provisi\u00f3n \u00a0de\u00a0\nmedicamentos \u00a0ARV\u00a0\u00a0para\u00a0\nlos\u00a0pacientes \u00a0que\u00a0se\u00a0\ncontrolan \u00a0en\u00a0su\u00a0Instituci\u00f3n, \u00a0\nadem\u00e1s\u00a0como\u00a0unidad\u00a0\nnotificante \u00a0de\u00a0ITS/VIH\u00a0\nrecibe\u00a0medicamentos \u00a0para\u00a0\nITS\u00a0y\u00a0condones. \u00a0\nEl\u00a0RPR\u00a0se\u00a0hace\u00a0en\u00a0ACSA\u00a0y\u00a0si\u00a0\nes\u00a0positivo\u00a0tambi\u00e9n\u00a0le\u00a0dan\u00a0\ntratamiento \u00a0que\u00a0es\u00a0enviado\u00a0\npor\u00a0el\u00a0MINSA\u00a0En\u00a0Ucayali,\u00a0s\u00f3lo\u00a0se\u00a0\u00a0da\u00a0\nprestaci\u00f3n \u00a0en\u00a0el\u00a0MINSA.\u00a0\nGestante\u00a0asegurada \u00a0tiene\u00a0\nces\u00e1rea\u00a0en\u00a0el\u00a0MINSA.\u00a0\nTARGA\u00a0s\u00f3lo\u00a0\u00a0entrega\u00a0el\u00a0\nMINSA.\u00a0El\u00a0RN\u00a0hijo\u00a0de\u00a0madre\u00a0\nVIH\u00a0recibe\u00a0f\u00f3rmula\u00a0l\u00e1ctea\u00a0\npor\u00a0s\u00f3lo\u00a02\u00a0meses\u00a0\u00a0 \u00a0 \u00a0\nONG\u00a0locales\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nInstituciones \u00a0locales\u00a0Asociaci\u00f3n \u00a0viviendo\u00a0en\u00a0 \u201cAlgo\u00a0bello\u00a0de\u00a0Dios\u201d\u00a0\u00a0 \u00a0 Casa\u00a0de\u00a0acogida\u00a0San\u00a0Juan\u00a0\u00a0 \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\nque\u00a0son\u00a0apoyadas \u00a0\npor\u00a0diferentes \u00a0\nfuentes\u00a0de\u00a0\nfinanciamiento \u00a0\n\u00a0positivo\u00a0por\u00a0V\u00eda\u00a0libre\u00a0\u2010\u00a0\nONUSIDA, \u00a0LGTB\u00a0\nLambayeque \u00a0\u00a0por\u00a0\u00a0\u00a0\u00a0\nImpares,\u00a0Alma\u00a0Chiclayo\u00a0por\u00a0\nFMSTM\u00a0y\u00a0Grupo\u00a0\nhomosexual \u00a0Leonardino. \u00a0(Proyecto \u00a0de\u00a0la\u00a0Parroquia \u00a0\nSan\u00a0Martin\u00a0de\u00a0Porres),\u00a0\u00a0\n\u201cLazos\u00a0de\u00a0vida\u201d\u00a0y\u00a0\u00a0\u00a0\nAsociaci\u00f3n \u00a0La\u00a0restinga\u201d\u00a0\napoyados \u00a0por\u00a0Gobierno \u00a0\nRegional\u00a0Loreto\u00a0Diego\u00a0que\u00a0atiende\u00a0a\u00a020\u00a0\nni\u00f1os\u00a0VIH\u00a0+\u00a0con\u00a0donaciones \u00a0\na\u00a0las\u00a0parroquias \u00a0y\u00a0en\u00a0el\u00a0\nArzobispado \u00a0de\u00a0Huancayo. \u00a0\nEl\u00a0Gobierno \u00a0Regional\u00a0se\u00a0ha\u00a0\ncomprometido \u00a0a\u00a0construir\u00a0\nla\u00a0nueva\u00a0casa.\u00a0\nQue\u00a0se\u00a0les\u00a0financia\u00a0 S\u00f3lo\u00a0para\u00a0las\u00a0fechas\u00a0claves,\u00a0\npara\u00a0actividades, \u00a0\nconferencias, \u00a0afiches,\u00a0\ntr\u00edpticos\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nEn\u00a0que\u00a0teman\u00a0\ntrabajan\u00a0Derechos \u00a0humanos \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nCon\u00a0quienes\u00a0\ncoordinan \u00a0DIRESA\u00a0\nDefensor\u00eda \u00a0del\u00a0Pueblo\u00a0\u00a0\u00a0\u00a0 DIRESA\u00a0\nArzobispado \u00a0de\u00a0Huancayo \u00a0\u00a0\nPrincipales \u00a0actores\u00a0\nen\u00a0VIH\u00a0FM:\u00a0SR\u00a0de\u00a0objetivos\u00a01,2\u00a0y\u00a03\u00a0\nde\u00a0VI\u00a0Ronda\u00a0Asociaci\u00f3n \u00a0Civil\u00a0Selva\u00a0\nAmaz\u00f3nica: \u00a0Estudios\u00a0de\u00a0\nvacuna,\u00a0TARGA\u00a0y\u00a0a\u00a0\nprevenci\u00f3n \u00a0Estudios\u00a0de\u00a0\nvacuna\u00a0financiados \u00a0por\u00a0el\u00a0\nHVTN,\u00a0TARGA\u00a0entrega\u00a0ARV\u00a0\ndel\u00a0MINSA\u00a0y\u00a0prevenci\u00f3n \u00a0\ncon\u00a0financiamiento \u00a0del\u00a0\nFMSTM\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nTrabaja\u00a0a\u00a0nivel\u00a0de\u00a0poblaci\u00f3n \u00a0\nHSH,\u00a0TS,\u00a0TRANS;\u00a0en\u00a0el\u00a0\nfortalecimiento \u00a0de\u00a0UAMP,\u00a0\nmaterial\u00a0de\u00a0escritorio, \u00a0kit\u00a0\nde\u00a0prevenci\u00f3n. \u00a0\nADAR:\u00a0Fortalecimiento \u00a0de\u00a0\nlas\u00a0competencias \u00a0del\u00a0\nprofesional \u00a0m\u00e9dico\u00a0y\u00a0\nt\u00e9cnico,\u00a0 sobre\u00a0 todo\u00a0\nrelacionado \u00a0con\u00a0las\u00a0ITS\u00a0\u00a0\u00a0\u00a0\nCEPESJU\u00a0Con\u00a0la\u00a0V\u00a0Ronda\u00a0del\u00a0\nFMSTMy\u00a0va\u00a0a\u00a0los\u00a0lugares\u00a0\nm\u00e1s\u00a0alejados:\u00a0San\u00a0Lorenzo,\u00a0\nCaballococha \u00a0\u00a0\nCEPCO\u00a0\u00a0\u00a0De\u00a0Tarapoto\u00a0y\u00a0es\u00a0el\u00a0\nconsorcio \u00a0de\u00a0la\u00a0VI\u00a0ronda\u00a0del\u00a0\nFMSTM\u00a0\u00a0\nCOREMUSA \u00a0:\u00a0Equipos\u00a0que\u00a0\nest\u00e1n\u00a0revisando \u00a0los\u00a0temas\u00a0\ndel\u00a0centro\u00a0de\u00a0formaci\u00f3n \u00a0\u00a0\u00a0\u00a0\u00a0\nONUSIDA \u00a0\u00a0capacitaciones \u00a0\ndel\u00a0personal. \u00a0Para\u00a0el\u00a0a\u00f1o\u00a0FM:\u00a01\u00a0y\u00a02\u00a0objetivo\u00a0V\u00a0\nRonda1,2,3 \u00a0y\u00a04\u00a0objetivo\u00a0VI\u00a0\nRonda:\u00a0\u00a0\nMedicamentos, \u00a0pruebas\u00a0\nr\u00e1pidas\u00a0para\u00a0VIH\u00a0y\u00a0S\u00edfilis,\u00a0\nequipo\u00a0de\u00a0laboratorio \u00a0\n(Microscopio) \u00a0\nUNFPA:\u00a0capacitaci\u00f3n \u00a0\nUNICEF:\u00a0ni\u00f1os,\u00a0ind\u00edgenas \u00a0\nMINEDU: \u00a0prevenci\u00f3n \u00a0\nGobierno \u00a0 Regional: \u00a0\u00a0\nprevenci\u00f3n \u00a0\nMIMDES: \u00a0adolescentes \u00a0y\u00a0\nvulnerabilidad \u00a0FM:\u00a0SR\u00a0de\u00a0objetivos\u00a01,2\u00a0y\u00a03\u00a0\nde\u00a0VI\u00a0Ronda\u00a0\u2010Casa\u00a0de\u00a0Acogida\u00a0Juan\u00a0\nDiego,\u00a0regentada \u00a0por\u00a0el\u00a0\nArzobispado \u00a0\n\u2010Centro\u00a0de\u00a0la\u00a0Mujer\u00a0\nPeruana\u00a0Flora\u00a0Trist\u00e1n:\u00a0\nTrasmisi\u00f3n \u00a0vertical\u2010\u00a0\nObjetivo\u00a03\u00a0de\u00a0la\u00a06ta\u00a0Ronda\u00a0\n\u2010V\u00eda\u00a0Libre\u00a0\n\u2010Inppares\u00a0\u2013\u00a0Objetivo\u00a04\u00a0&ta\u00a0\nRonda\u00a0FM:\u00a0SR\u00a0de\u00a0objetivo s\nde\u00a0VI\u00a0Ronda\u00a0 \u00a0 Lambayeque \u00a0 Loreto\u00a0 Ucayali\u00a0 Ica\u00a0 Jun\u00edn\u00a0 Ancash\u00a0\n201\u00a01\u00a0van\u00a0a\u00a0fortalecer \u00a0las\u00a05\u00a0\nUAMP\u00a0de\u00a0la\u00a0Regi\u00f3n,\u00a0van\u00a0a\u00a0\ntrabajar\u00a0m\u00e1s\u00a0la\u00a0parte\u00a0\npreventiva, \u00a0con\u00a0familia,\u00a0\nadolescentes \u00a0y\u00a0escuelas;\u00a0un\u00a0\ncarro\u00a0m\u00f3vil\u00a0para\u00a0equipo\u00a0\nitinerante \u00a0 144 \u00a0\nAnexo\u00a09\u00a0\u2010\u00a0Resultados \u00a0de\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0historias\u00a0cl\u00ednicas\u00a0\u00a0en\u00a0CERITS\u00a0\u00a0\n\u00a0\nPREVENCI\u00d3N \u00a0\nLa\u00a0siguiente\u00a0informaci\u00f3n \u00a0se\u00a0presenta\u00a0ordenada \u00a0seg\u00fan\u00a0fecha\u00a0de\u00a0asistencia \u00a0y\u00a0nos\u00a0permite\u00a0ver\u00a0el\u00a0n\u00famero\u00a0de\u00a0visitas\u00a0que\u00a0\nrealizan\u00a0los\u00a0usuarios.\u00a0\nCumplimiento \u00a0en\u00a0la\u00a0asistencia \u00a0\nCasos\u00a0por\u00a0a\u00f1o\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nCasos\u00a0 A\u00f1o\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 2003\u00a0 2004\u00a0 2005\u00a0 2006\u00a0 2007\u00a0 2008\u00a0 2009\u00a0 2010\u00a0 Total\u00a0\n2003\u00a0 7\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 7\u00a0\n2004\u00a0\u00a0 \u00a0 32\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 32\u00a0\n2005\u00a0\u00a0 \u00a0 \u00a0 31\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 31\u00a0\n2006\u00a0\u00a0 \u00a0 \u00a0 \u00a0 53\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 53\u00a0\n2007\u00a0\u00a0 \u00a0 \u00a0 \u00a0 1\u00a0 57\u00a0 0\u00a0 0\u00a0 0\u00a0 58\u00a0\n2008\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 118\u00a0 0\u00a0 0\u00a0 118\u00a0\n2009\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 107\u00a0 1\u00a0 108\u00a0\n2010\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 57\u00a0 57\u00a0\nTotal\u00a0 7\u00a0 32\u00a0 31\u00a0 54\u00a0 57\u00a0 118\u00a0 107\u00a0 58\u00a0 464\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nAtendidos \u00a0por\u00a0a\u00f1o\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nAtendidos \u00a0 A\u00f1o\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 2003\u00a0 2004\u00a0 2005 2006 2007 2008 2009 2010\u00a0Total\u00a0\n2003\u00a0 7\u00a0 3\u00a0 1\u00a0 3\u00a0 5\u00a0 6\u00a0 6\u00a0 6\u00a0 37\u00a0\n2004\u00a0\u00a0 \u00a0 32\u00a0 10\u00a0 11\u00a0 4\u00a0 8\u00a0 12\u00a0 12\u00a0 89\u00a0\n2005\u00a0\u00a0 \u00a0 \u00a0 31\u00a0 15\u00a0 11\u00a0 8\u00a0 11\u00a0 14\u00a0 90\u00a0\n2006\u00a0\u00a0 \u00a0 \u00a0 \u00a0 53\u00a0 14\u00a0 16\u00a0 14\u00a0 8\u00a0 105\u00a0\n2007\u00a0\u00a0 \u00a0 \u00a0 \u00a0 1\u00a0 58\u00a0 17\u00a0 17\u00a0 17\u00a0 110\u00a0\n2008\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 118\u00a0 61\u00a0 48\u00a0 227\u00a0\n2009\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 107\u00a0 42\u00a0 149\u00a0\n2010\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 57\u00a0 57\u00a0\nTotal\u00a0 7\u00a0 35\u00a0 42\u00a0 83\u00a0 92\u00a0 173\u00a0 228\u00a0 204\u00a0 864\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nVisitas\u00a0por\u00a0a\u00f1o\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nVisitas\u00a0 A\u00f1o\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 2003\u00a0 2004\u00a0 2005 2006 2007 2008 2009 2010\u00a0Total\u00a0\n2003\u00a0 10\u00a0 5\u00a0 5 20 30 24 21 13\u00a0128\u00a0\n2004\u00a0\u00a0 \u00a0 61\u00a0 44 44 32 53 61 55\u00a0350\u00a0\n2005\u00a0\u00a0 \u00a0 \u00a0 102 74 54 49 83 56\u00a0418\u00a0\n2006\u00a0\u00a0 \u00a0 \u00a0 \u00a0 122 61 67 65 26\u00a0341\u00a0\n2007\u00a0\u00a0 \u00a0 \u00a0 \u00a0 1 156 98 96 86\u00a0437\u00a0\n2008\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 350 314 225\u00a0889\u00a0\n2009\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 328 168\u00a0496\u00a0\n2010\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 169\u00a0169\u00a0\nTotal\u00a0 10\u00a0 66\u00a0 151 261 333 641 968 798\u00a03228\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nAMP\u00a0completas \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nAMP\u00a0 A\u00f1o\u00a0atenci\u00f3n\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 2003\u00a0 2004\u00a0 2005 2006 2007 2008 2009 2010\u00a0Total\u00a0\n2003\u00a0 4\u00a0 3\u00a0 1 10 16 15 16 8\u00a0 73\u00a0\n2004\u00a0\u00a0 \u00a0 6\u00a0 24 16 15 30 36 31\u00a0158\u00a0\n2005\u00a0\u00a0 \u00a0 \u00a0 38 30 34 37 65 42\u00a0246\u00a0\n2006\u00a0\u00a0 \u00a0 \u00a0 \u00a0 40 27 28 50 19\u00a0164\u00a0\n2007\u00a0\u00a0 \u00a0 \u00a0 \u00a0 0 44 55 62 61\u00a0222\u00a0\n2008\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 254 262 203\u00a0719\u00a0\n2009\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 196 125\u00a0321\u00a0\n2010\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 121\u00a0121\u00a0\nTotal\u00a0 4\u00a0 9\u00a0 63 96 136 419 687 610\u00a02024\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nCon\u00a0evaluaci\u00f3n \u00a0cl\u00ednica\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nEvaluaci\u00f3n \u00a0 A\u00f1o\u00a0atenci\u00f3n\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 2003\u00a0 2004\u00a0 2005 2006 2007 2008 2009 2010\u00a0Total\u00a0 145 2003\u00a0 7\u00a0 5\u00a0 5 19 29 23 21 11\u00a0120\u00a0\n2004\u00a0\u00a0 \u00a0 51\u00a0 41 42 32 53 58 50\u00a0327\u00a0\n2005\u00a0\u00a0 \u00a0 \u00a0 91 64 53 48 80 55\u00a0391\u00a0\n2006\u00a0\u00a0 \u00a0 \u00a0 \u00a0 102 48 58 61 25\u00a0294\u00a0\n2007\u00a0\u00a0 \u00a0 \u00a0 \u00a0 1 128 94 94 85\u00a0402\u00a0\n2008\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 325 308 221\u00a0854\u00a0\n2009\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 305 158\u00a0463\u00a0\n2010\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 154\u00a0154\u00a0\nTotal\u00a0 7\u00a0 56\u00a0 137 228 290 601 927 759\u00a03005\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nConsejer\u00eda \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nConsejer\u00eda \u00a0 A\u00f1o\u00a0atenci\u00f3n\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 2003\u00a0 2004\u00a0 2005 2006 2007 2008 2009 2010\u00a0Total\u00a0\n2003\u00a0 9\u00a0 5\u00a0 3 18 28 24 21 13\u00a0121\u00a0\n2004\u00a0\u00a0 \u00a0 39\u00a0 42 39 32 49 54 52\u00a0307\u00a0\n2005\u00a0\u00a0 \u00a0 \u00a0 69 58 51 48 77 51\u00a0354\u00a0\n2006\u00a0\u00a0 \u00a0 \u00a0 \u00a0 101 53 55 60 23\u00a0292\u00a0\n2007\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 126 93 89 77\u00a0385\u00a0\n2008\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 306 297 217\u00a0820\u00a0\n2009\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 273 153\u00a0426\u00a0\n2010\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 134\u00a0134\u00a0\nTotal\u00a0 9\u00a0 44\u00a0 114 216 290 575 871 720\u00a02839\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nCon\u00a0laboratorio \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nLaboratorio \u00a0 A\u00f1o\u00a0atenci\u00f3n\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 2003\u00a0 2004\u00a0 2005 2006 2007 2008 2009 2010\u00a0Total\u00a0\n2003\u00a0 4\u00a0 3\u00a0 1 10 16 15 16 8\u00a0 73\u00a0\n2004\u00a0\u00a0 \u00a0 11\u00a0 25 16 15 33 38 31\u00a0169\u00a0\n2005\u00a0\u00a0 \u00a0 \u00a0 53 39 34 37 67 42\u00a0272\u00a0\n2006\u00a0\u00a0 \u00a0 \u00a0 \u00a0 50 35 36 55 22\u00a0198\u00a0\n2007\u00a0\u00a0 \u00a0 \u00a0 \u00a0 1 55 57 65 64\u00a0242\u00a0\n2008\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 279 273 208\u00a0760\u00a0\n2009\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 222 136\u00a0358\u00a0\n2010\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 139\u00a0139\u00a0\nTotal\u00a0 4\u00a0 14\u00a0 79 116 155 457 736 650\u00a02211\u00a0\n\u00a0\nLa\u00a0siguiente\u00a0informaci\u00f3n \u00a0se\u00a0presenta\u00a0ordenada \u00a0seg\u00fan\u00a0el\u00a0primer\u00a0a\u00f1o\u00a0que\u00a0acudieron \u00a0al\u00a0CERITS\u00a0o\u00a0\nUAMP.\u00a0\nCasos\u00a0seg\u00fan\u00a0n\u00famero\u00a0de\u00a0a\u00f1os\u00a0asistiendo \u00a0al\u00a0CERITS\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\nCasos\u00a0 A\u00f1os\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 1\u00a0 2\u00a0 3\u00a0 4\u00a0 5\u00a0 6\u00a0 7\u00a0 8\u00a0 Total\u00a0\n2003\u00a0 7\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 7\u00a0\n2004\u00a0 32\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0\u00a0 32\u00a0\n2005\u00a0 31\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0\u00a0 \u00a0 31\u00a0\n2006\u00a0 53\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0\u00a0 \u00a0 \u00a0 53\u00a0\n2007\u00a0 58\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0\u00a0 \u00a0 \u00a0 58\u00a0\n2008\u00a0 118\u00a0 0\u00a0 0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 118\u00a0\n2009\u00a0 108\u00a0 0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 108\u00a0\n2010\u00a0 57\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 57\u00a0\nTotal\u00a0 464\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 0\u00a0 464\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nAtendidos \u00a0seg\u00fan\u00a0n\u00famero\u00a0de\u00a0a\u00f1os\u00a0asistiendo \u00a0al\u00a0CERITS\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\nAtendidos \u00a0 A\u00f1os\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 1\u00a0 2\u00a0 3\u00a0 4\u00a0 5\u00a0 6\u00a0 7\u00a0 8\u00a0 Total\u00a0\n2003\u00a0 7\u00a0 3\u00a0 1\u00a0 3\u00a0 5\u00a0 6\u00a0 6\u00a0 6\u00a0 37\u00a0\n2004\u00a0 32\u00a0 10\u00a0 11\u00a0 4\u00a0 8\u00a0 12\u00a0 12\u00a0\u00a0 89\u00a0\n2005\u00a0 31\u00a0 15\u00a0 11\u00a0 8\u00a0 11\u00a0 14\u00a0\u00a0 \u00a0 90\u00a0\n2006\u00a0 53\u00a0 14\u00a0 16\u00a0 14\u00a0 8\u00a0\u00a0 \u00a0 \u00a0 105\u00a0\n2007\u00a0 58\u00a0 17\u00a0 17\u00a0 17\u00a0 1\u00a0\u00a0 \u00a0 \u00a0 110\u00a0\n2008\u00a0 118\u00a0 61\u00a0 48\u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 227\u00a0\n2009\u00a0 108\u00a0 41\u00a0\u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 149\u00a0\n2010\u00a0 57\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 57\u00a0\nTotal\u00a0 464\u00a0 161\u00a0 104\u00a0 46\u00a0 33\u00a0 32\u00a0 18\u00a0 6\u00a0 864\u00a0 146 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nVisitas\u00a0\u00a0seg\u00fan\u00a0n\u00famero\u00a0de\u00a0a\u00f1os\u00a0asistiendo \u00a0al\u00a0\nCERITS\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\nVisitas\u00a0 A\u00f1os\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 1\u00a0 2\u00a0 3\u00a0 4\u00a0 5\u00a0 6\u00a0 7\u00a0 8\u00a0 Total\u00a0\n2003\u00a0 10\u00a0 5\u00a0 5\u00a0 20\u00a0 30\u00a0 24\u00a0 21\u00a0 13\u00a0 128\u00a0\n2004\u00a0 61\u00a0 44\u00a0 44\u00a0 32\u00a0 53\u00a0 61\u00a0 55\u00a0\u00a0 350\u00a0\n2005\u00a0 102\u00a0 74\u00a0 54\u00a0 49\u00a0 83\u00a0 56\u00a0\u00a0 \u00a0 418\u00a0\n2006\u00a0 122\u00a0 61\u00a0 67\u00a0 65\u00a0 26\u00a0\u00a0 \u00a0 \u00a0 341\u00a0\n2007\u00a0 155\u00a0 97\u00a0 96\u00a0 80\u00a0 9\u00a0\u00a0 \u00a0 \u00a0 437\u00a0\n2008\u00a0 350\u00a0 314\u00a0 225\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 889\u00a0\n2009\u00a0 334\u00a0 162\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 496\u00a0\n2010\u00a0 169\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 169\u00a0\nTotal\u00a0 1303\u00a0 757\u00a0 491\u00a0 246\u00a0 201\u00a0 141\u00a0 76\u00a0 13\u00a0 3228\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nAMP\u00a0completas \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\nAMP\u00a0 Antig\u00fcedad \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 1\u00a0 2\u00a0 3 4 5 6 7\u00a0 8 Total\u00a0\n2003\u00a0 4\u00a0 3\u00a0 1 10 16 15 16\u00a0 8 73\u00a0\n2004\u00a0 6\u00a0 24\u00a0 16 15 30 36 31\u00a0\u00a0 158\u00a0\n2005\u00a0 38\u00a0 30\u00a0 34 37 65 42\u00a0\u00a0 246\u00a0\n2006\u00a0 40\u00a0 27\u00a0 28 50 19\u00a0\u00a0\u00a0 164\u00a0\n2007\u00a0 43\u00a0 53\u00a0 62 55 9\u00a0\u00a0\u00a0 222\u00a0\n2008\u00a0 254\u00a0 262\u00a0 203\u00a0 \u00a0\u00a0\u00a0\u00a0 719\u00a0\n2009\u00a0 202\u00a0 119\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 321\u00a0\n2010\u00a0 121\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 121\u00a0\nTotal\u00a0 708\u00a0 518\u00a0 344 167 139 93 47\u00a0 8 2024\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nCon\u00a0evaluaci\u00f3n \u00a0cl\u00ednica\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\nEvaluaci\u00f3n \u00a0 Antig\u00fcedad \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 1\u00a0 2\u00a0 3 4 5 6 7\u00a0 8 Total\u00a0\n2003\u00a0 7\u00a0 5\u00a0 5 19 29 23 21\u00a0 11 120\u00a0\n2004\u00a0 51\u00a0 41\u00a0 42 32 53 58 50\u00a0\u00a0 327\u00a0\n2005\u00a0 91\u00a0 64\u00a0 53 48 80 55\u00a0\u00a0 391\u00a0\n2006\u00a0 102\u00a0 48\u00a0 58 61 25\u00a0\u00a0\u00a0 294\u00a0\n2007\u00a0 127\u00a0 93\u00a0 94 79 9\u00a0\u00a0\u00a0 402\u00a0\n2008\u00a0 325\u00a0 308\u00a0 221\u00a0 \u00a0\u00a0\u00a0\u00a0 854\u00a0\n2009\u00a0 311\u00a0 152\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 463\u00a0\n2010\u00a0 154\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 154\u00a0\nTotal\u00a0 1168\u00a0 711\u00a0 473 239 196 136 71\u00a0 11 3005\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nConsejer\u00eda \u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\nConsejer\u00eda \u00a0 Antig\u00fcedad \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 1\u00a0 2\u00a0 3 4 5 6 7\u00a0 8 Total\u00a0\n2003\u00a0 9\u00a0 5\u00a0 3 18 28 24 21\u00a0 13 121\u00a0\n2004\u00a0 39\u00a0 42\u00a0 39 32 49 54 52\u00a0\u00a0 307\u00a0\n2005\u00a0 69\u00a0 58\u00a0 51 48 77 51\u00a0\u00a0 354\u00a0\n2006\u00a0 101\u00a0 53\u00a0 55 60 23\u00a0\u00a0\u00a0 292\u00a0\n2007\u00a0 125\u00a0 91\u00a0 89 71 9\u00a0\u00a0\u00a0 385\u00a0\n2008\u00a0 306\u00a0 297\u00a0 217\u00a0 \u00a0\u00a0\u00a0\u00a0 820\u00a0\n2009\u00a0 279\u00a0 147\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 426\u00a0\n2010\u00a0 134\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 134\u00a0\nTotal\u00a0 1062\u00a0 693\u00a0 454 229 186 129 73\u00a0 13 2839\u00a0\n\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nCon\u00a0laboratorio \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\nLaboratorio \u00a0 Antig\u00fcedad \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\nA\u00f1o\u00a0caso\u00a0 1\u00a0 2\u00a0 3 4 5 6 7\u00a0 8 Total\u00a0\n2003\u00a0 4\u00a0 3\u00a0 1 10 16 15 16\u00a0 8 73\u00a0\n2004\u00a0 11\u00a0 25\u00a0 16 15 33 38 31\u00a0\u00a0 169\u00a0\n2005\u00a0 53\u00a0 39\u00a0 34 37 67 42\u00a0\u00a0 272\u00a0\n2006\u00a0 50\u00a0 35\u00a0 36 55 22\u00a0\u00a0\u00a0 198\u00a0\n2007\u00a0 54\u00a0 56\u00a0 65 58 9\u00a0\u00a0\u00a0 242\u00a0\n2008\u00a0 279\u00a0 273\u00a0 208\u00a0 \u00a0\u00a0\u00a0\u00a0 760\u00a0 147 2009\u00a0 228\u00a0 130\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0 358\u00a0\n2010\u00a0 139\u00a0 \u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 139\u00a0\nTotal\u00a0 818\u00a0 561\u00a0 360 175 147 95 47\u00a0 8 2211\u00a0\n\u00a0 148 \u00a0\nAnexo\u00a010\u00a0\u00a0\u2010\u00a0Resultados \u00a0encuesta\u00a0aplicada\u00a0en\u00a0CERITS\u00a0y\u00a0UAMP\u00a0\n\u00a0\nDe\u00a0las\u00a0encuestas \u00a0\u00a0realizadas \u00a0\u00a0el\u00a0mayor\u00a0n\u00famero\u00a0\u00a0(60%)\u00a0se\u00a0realiz\u00f3\u00a0en\u00a0mujeres\u00a0y\u00a0el\u00a030%\u00a0en\u00a0hombres. \u00a0\u00a0El\u00a036%\u00a0de\u00a0\nlos\u00a0encuestados \u00a0estaban\u00a0recibiendo \u00a0TARGA\u00a0entre\u00a01\u00a0y\u00a02\u00a0a\u00f1os.;\u00a0y\u00a0m\u00e1s\u00a0de\u00a010\u00a0a\u00f1os\u00a0el\u00a018%.\u00a0El\u00a032%\u00a0luego\u00a0de\u00a0\nhaber\u00a0\u00a0iniciado\u00a0tratamiento \u00a0\u00a0acuden\u00a0tambi\u00e9n\u00a0a\u00a0otros\u00a0establecimientos \u00a0\u00a0p\u00fablicos\u00a0o\u00a0privados.\u00a0\nDatos\u00a0de\u00a0la\u00a0muestra\u00a0\nTiempo\u00a0tratamiento \u00a0 Hombre\u00a0 Mujer\u00a0 Total\u00a0general\u00a0\nMenos\u00a0de\u00a01\u00a0a\u00f1o\u00a0 6\u00a0 4 10\nEntre\u00a01\u00a0y\u00a02\u00a0a\u00f1os\u00a0 3\u00a0 17 20\nEntre\u00a03\u00a0y\u00a05\u00a0a\u00f1os\u00a0 7\u00a0 10 17\nMas\u00a0de\u00a06\u00a0a\u00f1os\u00a0 3\u00a0 7 10\nTotal\u00a0general\u00a0 19\u00a0 38 57\n\u00a0\n\u00a0\nEdad\u00a0de\u00a0los\u00a0encuestados \u00a0 Hombre\u00a0 Mujer\u00a0 Total\u00a0general\u00a0\nMenos\u00a0de\u00a020\u00a0a\u00f1os\u00a0\u00a0 \u00a0 2 2\nDe\u00a020\u00a0a\u00a030\u00a0a\u00f1os\u00a0 8\u00a0 19 27\nDe\u00a030\u00a0a\u00a040\u00a0a\u00f1os\u00a0 8\u00a0 11 19\nDe\u00a040\u00a0a\u00a050\u00a0a\u00f1os\u00a0 2\u00a0 4 6\nDe\u00a050\u00a0a\u00a060\u00a0a\u00f1os\u00a0 1\u00a0 1 2\nM\u00e1s\u00a0de\u00a060\u00a0a\u00f1os\u00a0\u00a0 \u00a0 1 1\nTotal\u00a0general\u00a0 19\u00a0 38 57\n\u00a0\nDesde\u00a0que\u00a0sigue\u00a0\u00a0tratamiento \u00a0\u00bfAcude\u00a0a\u00a0otros\u00a0servicios\u00a0de\u00a0salud\u00a0p\u00fablicos\u00a0o\u00a0privados? \u00a0\nRespuesta \u00a0 Total\u00a0\nSi\u00a0 18\u00a0\nNo\u00a0 38\u00a0\nNo\u00a0contesto\u00a0 1\u00a0\nTotal\u00a0general\u00a0 57\u00a0\n\u00a0\n\u00a0 149 \u00a0\nAnexo\u00a011\u00a0\u2010\u00a0Resultados \u00a0de\u00a0la\u00a0revisi\u00f3n\u00a0de\u00a0historias\u00a0cl\u00ednicas\u00a0\u00a0de\u00a0PVV\u00a0en\u00a0\nTARGA \u00a0\n\u00a0\nSe\u00a0presentan \u00a0en\u00a0primer\u00a0lugar\u00a0seg\u00fan\u00a0a\u00f1o\u00a0en\u00a0que\u00a0se\u00a0atendieron \u00a0y\u00a0seg\u00fan\u00a0a\u00f1o\u00a0en\u00a0que\u00a0iniciaron\u00a0el\u00a0TARGA.\u00a0\u00a0Si\u00a0en\u00a0el\u00a0cuadro\u00a0\naparece\u00a0(\u20101\u00a0)\u00a0significa\u00a0que\u00a0es\u00a0el\u00a0a\u00f1o\u00a0anterior\u00a0al\u00a0que\u00a0empezara \u00a0el\u00a0TARGA.\u00a0\n\u00a0\n\u00a0\nDatos\u00a0de\u00a0la\u00a0muestra\u00a0\u00a0 Atendidas \u00a0por\u00a0a\u00f1o\u00a0 Visitas\u00a0por\u00a0a\u00f1o\u00a0 \u00a0\u00a0Promedio \u00a0visitas\u00a0\n9\u00a0 H\u00a0M\u00a0 T\u00a0\u00a0 9\u00a0 H\u00a0M\u00a0T\u00a0 9\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0H\u00a0 M\u00a0 T\u00a0\n2002\u00a04\u00a0\u00a0 4\u00a0\u00a02002\u00a04\u00a0\u00a0 4\u00a0 2002\u00a011\u00a0\u00a0 11\u00a0\u00a02.8\u00a0\u00a0 2.8\u00a0\n2003\u00a04\u00a0 3\u00a0 7\u00a0\u00a02003\u00a06\u00a03\u00a0 9\u00a0 2003\u00a012\u00a0 8\u00a0 20\u00a0\u00a02.0\u00a02.7\u00a02.2\u00a0\n2004\u00a04\u00a0 3\u00a0 7\u00a0\u00a02004\u00a08\u00a05\u00a013\u00a0 2004\u00a021\u00a0 8\u00a0 29\u00a0\u00a02.6\u00a01.6\u00a02.2\u00a0\n2005\u00a09\u00a0 2\u00a0 11\u00a0\u00a02005\u00a014\u00a04\u00a018\u00a0 2005\u00a028\u00a0 7\u00a0 35\u00a0\u00a02.0\u00a01.8\u00a01.9\u00a0\n2006\u00a019\u00a013\u00a0 32\u00a0\u00a02006\u00a026\u00a017\u00a043\u00a0 2006\u00a0158\u00a0 62\u00a0 220\u00a0\u00a06.1\u00a03.6\u00a05.1\u00a0\n2007\u00a021\u00a07\u00a0 28\u00a0\u00a02007\u00a046\u00a023\u00a069\u00a0 2007\u00a0405\u00a0210\u00a0 615\u00a0\u00a08.8\u00a09.1\u00a08.9\u00a0\n2008\u00a031\u00a08\u00a0 39\u00a0\u00a02008\u00a083\u00a032\u00a0115 2008\u00a0823\u00a0298\u00a0 1121\u00a0\u00a09.9\u00a09.3\u00a09.7\u00a0\n2009\u00a017\u00a09\u00a0 26\u00a0\u00a02009\u00a0101\u00a044\u00a0145 2009\u00a01123 576\u00a0 1699\u00a0\u00a011.1\u00a013.1 11.7\u00a0\n2010\u00a014\u00a08\u00a0 22\u00a0\u00a02010\u00a0119\u00a053\u00a0172 2010\u00a01236 662\u00a0 1898\u00a0\u00a010.4\u00a012.5 11.0\u00a0\n2011\u00a0\u00a0\u00a0\u00a0\u00a02011\u00a03\u00a04\u00a0 7\u00a0 2011\u00a0 3\u00a0 4\u00a0 7\u00a0\u00a01.0\u00a01.0\u00a01.0\u00a0\nT\u00a0123\u00a053\u00a0176\u00a0\u00a0 T\u00a0 410\u00a0185 595 T\u00a0 3820 1835\u00a0 5655\u00a0\u00a09.3\u00a09.9\u00a09.5\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\nDatos\u00a0de\u00a0la\u00a0muestra\u00a0\u00a0 Atendidas \u00a0por\u00a0a\u00f1o\u00a0 Visitas\u00a0por\u00a0a\u00f1o\u00a0 \u00a0\u00a0Promedio \u00a0visitas\u00a0\n32\u00a0 H\u00a0M\u00a0 T\u00a0\u00a032\u00a0 H\u00a0 M\u00a0T\u00a0 32\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0H\u00a0 M\u00a0 T\u00a0\n\u20108\u00a0 1\u00a0\u00a0 1\u00a0\u00a0\u20108\u00a0 1\u00a0\u00a0 1\u00a0\u20108\u00a0 1\u00a0\u00a0 1\u00a0\u00a01.0\u00a0\u00a0 1.0\u00a0\n\u20107\u00a0 2\u00a0 1\u00a0 3\u00a0\u00a0\u20107\u00a0 2\u00a0 1\u00a0 3\u00a0\u20107\u00a0 9\u00a0 5\u00a0 14\u00a0\u00a04.5\u00a05.0\u00a04.7\u00a0\n\u20106\u00a0 3\u00a0\u00a0 3\u00a0\u00a0\u20106\u00a0 4\u00a0 1\u00a0 5\u00a0\u20106\u00a0 11\u00a0 2\u00a0 13\u00a0\u00a02.8\u00a02.0\u00a02.6\u00a0\n\u20105\u00a0 2\u00a0 3\u00a0 5\u00a0\u00a0\u20105\u00a0 3\u00a0 4\u00a0 7\u00a0\u20105\u00a0 5\u00a0 6\u00a0 11\u00a0\u00a01.7\u00a01.5\u00a01.6\u00a0\n\u20104\u00a0 8\u00a0 3\u00a0 11\u00a0\u00a0\u20104\u00a0 12\u00a0 5\u00a017\u00a0\u20104\u00a0 23\u00a0 8\u00a0 31\u00a0\u00a01.9\u00a01.6\u00a01.8\u00a0\n\u20103\u00a0 8\u00a0 5\u00a0 13\u00a0\u00a0\u20103\u00a0 13\u00a0 7\u00a020\u00a0\u20103\u00a0 30\u00a0 12\u00a0 42\u00a0\u00a02.3\u00a01.7\u00a02.1\u00a0\n\u20102\u00a012\u00a08\u00a0 20\u00a0\u00a0\u20102\u00a0 21\u00a013\u00a034\u00a0\u20102\u00a0 95\u00a0 54\u00a0 149\u00a0\u00a04.5\u00a04.2\u00a04.4\u00a0\n\u20101\u00a033\u00a012\u00a0 45\u00a0\u00a0\u20101\u00a0 55\u00a027\u00a082\u00a0\u20101\u00a0 300\u00a0132\u00a0 432\u00a0\u00a05.5\u00a04.9\u00a05.3\u00a0\n1\u00a0 54\u00a021\u00a0 75\u00a0\u00a01\u00a0 123\u00a053\u00a0176 1\u00a0 1656 760\u00a0 2416\u00a0\u00a013.5\u00a014.3 13.7\u00a0\n2\u00a0\u00a0\u00a0\u00a0\u00a02\u00a0 91\u00a040\u00a0131 2\u00a0 923\u00a0479\u00a0 1402\u00a0\u00a010.1\u00a012.0 10.7\u00a0\n3\u00a0\u00a0\u00a0\u00a0\u00a03\u00a0 62\u00a023\u00a085\u00a0 3\u00a0 575\u00a0268\u00a0 843\u00a0\u00a09.3\u00a011.7 9.9\u00a0\n4\u00a0\u00a0\u00a0\u00a0\u00a04\u00a0 22\u00a010\u00a032\u00a0 4\u00a0 191\u00a0108\u00a0 299\u00a0\u00a08.7\u00a010.8 9.3\u00a0\n5\u00a0\u00a0\u00a0\u00a0\u00a05\u00a0 1\u00a0 1\u00a0 2\u00a0 5\u00a0 1\u00a0 1\u00a0 2\u00a0\u00a01.0\u00a01.0\u00a01.0\u00a0\nT\u00a0123\u00a053\u00a0176\u00a0\u00a0T\u00a0 410\u00a0185 595 T\u00a0 3820 1835\u00a0 5655\u00a0\u00a09.3\u00a09.9\u00a09.5\u00a0\n\u00a0\u00a0\u00a0 43%\u00a0\u00a0\u00a0\u00a0\u00a030% \u00a0\u00a0\u00a0 43%\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\n \n\u00a0Revisi\u00f3n\u00a0de\u00a0HC\u00a0\n\u00a0\n\u00a0 D\u00edas\u00a0hospitalizaci\u00f3n \u00a0\u00a0\u00a0 N\u00b0\u00a0hospitalizaciones \u00a0\u00a0\u00a0 Promedio \u00a0\u00a0\u00a0\n\u00a0 9\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0 9\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\n\u00a0 2002\u00a0 5\u00a0\u00a0 5\u00a0\u00a0 2002\u00a0 1\u00a0\u00a0 1\u00a0\u00a0 5.0\u00a0\u00a0 5.0\u00a0\u00a0\n\u00a0 2003\u00a0\u00a0 \u00a0\u00a0 \u00a0 2003\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\n\u00a0 2004\u00a0\u00a0 \u00a0\u00a0 \u00a0 2004\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 150 \u00a0 2005\u00a0\u00a0 \u00a0\u00a0 \u00a0 2005\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\n\u00a0 2006\u00a0 38\u00a0 3\u00a0 41\u00a0\u00a0 2006\u00a0 4\u00a0 1\u00a0 5\u00a0\u00a0 9.5\u00a0 3.0\u00a0 8.2\u00a0\u00a0\n\u00a0 2007\u00a0 35\u00a0 6\u00a0 41\u00a0\u00a0 2007\u00a0 4\u00a0 2\u00a0 6\u00a0\u00a0 8.8\u00a0 3.0\u00a0 6.8\u00a0\u00a0\n\u00a0 2008\u00a0 122\u00a0 3\u00a0 125\u00a0\u00a0 2008\u00a0 11\u00a0 1\u00a0 12\u00a0\u00a0 11.1\u00a03.0\u00a010.4\u00a0\u00a0\n\u00a0 2009\u00a0 36\u00a0 28\u00a0 64\u00a0\u00a0 2009\u00a0 5\u00a0 4\u00a0 9\u00a0\u00a0 7.2\u00a0 7.0\u00a0 7.1\u00a0\u00a0\n\u00a0 2010\u00a0 49\u00a0 75\u00a0 124\u00a0\u00a0 2010\u00a0 6\u00a0 12\u00a018\u00a0\u00a0 8.2\u00a0 6.3\u00a0 6.9\u00a0\u00a0\n\u00a0 2011\u00a0\u00a0 \u00a0\u00a0 \u00a0 2011\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\n\u00a0 T\u00a0 285\u00a0 115\u00a0400\u00a0\u00a0 T\u00a0 31\u00a0 20\u00a051\u00a0\u00a0 9.2\u00a0 5.8\u00a0 7.8\u00a0\u00a0\n\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0 D\u00edas\u00a0hospitalizaci\u00f3n \u00a0\u00a0\u00a0 N\u00b0\u00a0hospitalizaciones \u00a0\u00a0\u00a0 Promedio \u00a0\u00a0\u00a0\n\u00a0 32\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0 32\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\n\u00a0\u2010 8\u00a0 5\u00a0\u00a0 5\u00a0\u00a0\u2010 8\u00a0 1\u00a0\u00a0 1\u00a0\u00a0 5.0\u00a0\u00a0 5.0\u00a0\u00a0\n\u00a0\u2010 7\u00a0\u00a0\u00a0 \u00a0 \u00a0\u2010 7\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\n\u00a0\u2010 6\u00a0\u00a0\u00a0 \u00a0 \u00a0\u2010 6\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\n\u00a0\u2010 5\u00a0\u00a0\u00a0 \u00a0 \u00a0\u2010 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\n\u00a0\u2010 4\u00a0\u00a0 3\u00a0 3\u00a0\u00a0\u2010 4\u00a0\u00a0 1\u00a0 1\u00a0\u00a0\u00a0 3.0\u00a0 3.0\u00a0\u00a0\n\u00a0\u2010 3\u00a0\u00a0 3\u00a0 3\u00a0\u00a0\u2010 3\u00a0\u00a0 1\u00a0 1\u00a0\u00a0\u00a0 3.0\u00a0 3.0\u00a0\u00a0\n\u00a0\u2010 2\u00a0\u00a0\u00a0 \u00a0 \u00a0\u2010 2\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\n\u00a0\u2010 1\u00a0 54\u00a0 5\u00a0 59\u00a0\u00a0\u2010 1\u00a0 6\u00a0 1\u00a0 7\u00a0\u00a0 9.0\u00a0 5.0\u00a0 8.4\u00a0\u00a0\n\u00a0 1\u00a0 222\u00a0 61\u00a0 283\u00a0\u00a0 1\u00a0 23\u00a0 10\u00a033\u00a0\u00a0 9.7\u00a0 6.1\u00a0 8.6\u00a0\u00a0\n\u00a0 2\u00a0 4\u00a0 27\u00a0 31\u00a0\u00a0 2\u00a0 1\u00a0 5\u00a0 6\u00a0\u00a0 4.0\u00a0 5.4\u00a0 5.2\u00a0\u00a0\n\u00a0 3\u00a0\u00a0 16\u00a0 16\u00a0\u00a0 3\u00a0\u00a0 2\u00a0 2\u00a0\u00a0\u00a0 8.0\u00a0 8.0\u00a0\u00a0\n\u00a0 4\u00a0\u00a0 \u00a0 \u00a0 \u00a0 4\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\n\u00a0 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0\n\u00a0 T\u00a0 285\u00a0 115\u00a0400\u00a0\u00a0 T\u00a0 31\u00a0 20\u00a051\u00a0\u00a0 9.2\u00a0 5.8\u00a0 7.8\u00a0\u00a0\n\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0 151 \u00a0\n\u00a0\nEvaluaci\u00f3n \u00a0cl\u00ednica\u00a0\u00a0\u00a0\u00a0\u00a0Consejer\u00eda \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Laboratorio \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Enfermer\u00eda \u00a0\u00a0\u00a0\u00a0\u00a0\nR\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0T\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0T\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0 T\u00a0\n2002\u00a0 2\u00a0\u00a0 \u00a0 2\u00a0\u00a0\u00a02002\u00a0 6\u00a0\u00a0 \u00a0 6\u00a02002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02002\u00a0 1\u00a0\u00a0 \u00a0 1\n2003\u00a0 5\u00a0\u00a0 \u00a0 5\u00a0\u00a0\u00a02003\u00a0 5\u00a0 4 9\u00a02003\u00a0 1\u00a0\u00a0 1\u00a02003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n2004\u00a0 1\u00a0\u00a0 \u00a0 1\u00a0\u00a0\u00a02004\u00a0 3\u00a0\u00a0 \u00a0 3\u00a02004\u00a0 1 1 2\u00a02004\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n2005\u00a0 5\u00a0\u00a0 \u00a0 5\u00a0\u00a0\u00a02005\u00a0 5\u00a0 1 6\u00a02005\u00a0 2 3 5\u00a02005\u00a0 1\u00a0\u00a0 \u00a0 1\n2006\u00a0 45\u00a015\u00a0 60\u00a0\u00a0\u00a02006\u00a0 16\u00a013 29\u00a02006\u00a0 17 10 27\u00a02006\u00a0 4\u00a0 2 6\n2007\u00a0 160\u00a072\u00a0232\u00a0\u00a0\u00a02007\u00a0 37\u00a018 55\u00a02007\u00a0 61 26 87\u00a02007\u00a0 30\u00a0 18 48\n2008\u00a0 220\u00a0102\u00a0322\u00a0\u00a0\u00a02008\u00a0 198\u00a060 258\u00a02008\u00a0 99 40 139\u00a02008\u00a0 147\u00a0 50 197\n2009\u00a0 332\u00a0178\u00a0510\u00a0\u00a0\u00a02009\u00a0 312\u00a0154 466\u00a02009\u00a0 137 64 201\u00a02009\u00a0 233\u00a0107 340\n2010\u00a0 437\u00a0225\u00a0662\u00a0\u00a0\u00a02010\u00a0 482\u00a0251 733\u00a02010\u00a0 152 58 210\u00a02010\u00a0 157\u00a0100 257\n2011\u00a0 2\u00a0 1\u00a0 3\u00a0\u00a0\u00a02011\u00a0\u00a0 \u00a0 1 1\u00a02011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02011\u00a0 1\u00a0 1 2\nT\u00a0 1209\u00a0593\u00a01802\u00a0\u00a0\u00a0T\u00a0 1064\u00a0502 1566\u00a0T\u00a0 470 202 672\u00a0T\u00a0 574\u00a0278 852\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02.9\u00a0\u00a0\u00a0\u00a03.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a03.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n2.6\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n2.7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02.6\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n1.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n1.1\u00a0\u00a0\u00a01.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n1.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n1.5\u00a0\u00a0\u00a0\u00a01.4\u00a0\nEvaluaci\u00f3n \u00a0cl\u00ednica\u00a0\u00a0\u00a0\u00a0\u00a0Consejer\u00eda \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Laboratorio \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Enfermer\u00eda \u00a0\u00a0\u00a0\u00a0\u00a0\n32\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a032\u00a0 H\u00a0 M\u00a0T\u00a0\u00a032\u00a0 H\u00a0 M\u00a0T\u00a0\u00a032\u00a0 H\u00a0 M\u00a0 T\u00a0\n\u20108\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 8\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 8\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 8\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u20107\u00a0 2\u00a0\u00a0 \u00a0 2\u00a0\u00a0\u00a0 \u2010 7\u00a0 6\u00a0 4 10\u00a0\u2010 7\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 7\u00a0 1\u00a0\u00a0 \u00a0 1\n\u20106\u00a0 4\u00a0\u00a0 \u00a0 4\u00a0\u00a0\u00a0 \u2010 6\u00a0 4\u00a0\u00a0 \u00a0 4\u00a0\u2010 6\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 6\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u20105\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 5\u00a0 3\u00a0\u00a0 \u00a0 3\u00a0\u2010 5 1 1 2\u00a0\u2010 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u20104\u00a0 4\u00a0\u00a0 \u00a0 4\u00a0\u00a0\u00a0 \u2010 4\u00a0 5\u00a0\u00a0 \u00a0 5\u00a0\u2010 4 3 1 4\u00a0\u2010 4\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u20103\u00a0 7\u00a0 2\u00a0 9\u00a0\u00a0\u00a0 \u2010 3\u00a0 3\u00a0 2 5\u00a0\u2010 3 2 3 5\u00a0\u2010 3\u00a0 1\u00a0\u00a0 \u00a0 1\n\u20102\u00a0 28\u00a010\u00a0 38\u00a0\u00a0\u00a0 \u2010 2\u00a0 9\u00a0 6 15\u00a0\u2010 2 7 9 16\u00a0\u2010 2\u00a0 3\u00a0 12 15\n\u20101\u00a0 88\u00a040\u00a0128\u00a0\u00a0\u00a0 \u2010 1\u00a0 39\u00a015 54\u00a0\u2010 1 30 25 55\u00a0\u2010 1\u00a0 15\u00a0 7 22\n1\u00a0514\u00a0237\u00a0751\u00a0\u00a0\u00a0 1\u00a0372\u00a0177 549\u00a0 1 205 81 286\u00a0 1\u00a0205\u00a0 75 280\n2\u00a0288\u00a0172\u00a0460\u00a0\u00a0\u00a0 2\u00a0314\u00a0150 464\u00a0 2 127 42 169\u00a0 2\u00a0213\u00a0108 321\n3\u00a0200\u00a082\u00a0282\u00a0\u00a0\u00a0 3\u00a0197\u00a083 280\u00a0 3 73 31 104\u00a0 3\u00a0124\u00a0 75 199\n4\u00a0 73\u00a049\u00a0122\u00a0\u00a0\u00a0 4\u00a0112\u00a065 177\u00a0 4 22 9 31\u00a0 4\u00a0 12\u00a0 1 13\n5\u00a0 1\u00a0 1\u00a0 2\u00a0\u00a0\u00a0 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nT\u00a0 1209\u00a0593\u00a01802\u00a0\u00a0\u00a0T\u00a0 1064\u00a0502 1566\u00a0T\u00a0 470 202 672\u00a0T\u00a0 574\u00a0278 852\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02.9\u00a0\u00a0\u00a0\u00a03.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n2.6\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n2.7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02.6\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n1.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n1.1\u00a0\u00a0\u00a01.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n1.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n1.5\u00a0\u00a0\u00a0\u00a01.4\u00a0\n\u00a0 152 \u00a0\nTrabajo\u00a0\nsocial\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0Sicolog\u00eda\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Nutrici\u00f3n \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Total\u00a0consultas \u00a0 \u00a0\u00a0\nR\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0T\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0T\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0 T\u00a0\n2002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02002\u00a0 2\u00a0\u00a0 \u00a0 2\u00a02002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02002\u00a0 6\u00a0\u00a0 \u00a0 6\n2003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02003\u00a0 7\u00a0 4\u00a0 11\n2004\u00a0 1\u00a0\u00a0 \u00a0 1\u00a0\u00a02004\u00a0 3\u00a0\u00a0 \u00a0 3\u00a02004\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02004\u00a0 8\u00a0 1\u00a0 9\n2005\u00a0 1\u00a0\u00a0 \u00a0 1\u00a0\u00a02005\u00a0 3\u00a0\u00a0 \u00a0 3\u00a02005\u00a0 2\u00a0\u00a0 2\u00a02005\u00a0 14\u00a0 4\u00a0 18\n2006\u00a0 8\u00a0 3\u00a0 11\u00a0\u00a02006\u00a0 7\u00a07 14\u00a02006\u00a0 2\u00a0\u00a0 2\u00a02006\u00a0 84\u00a0 36\u00a0 120\n2007\u00a0 20\u00a0 7\u00a0 27\u00a0\u00a02007\u00a0 22\u00a08 30\u00a02007\u00a0 4 7 11\u00a02007\u00a0 277\u00a0130\u00a0 407\n2008\u00a0 31\u00a0 3\u00a0 34\u00a0\u00a02008\u00a0 35\u00a019 54\u00a02008\u00a0 11 4 15\u00a02008\u00a0 592\u00a0219\u00a0 811\n2009\u00a0 35\u00a0 14\u00a0 49\u00a0\u00a02009\u00a0 60\u00a025 85\u00a02009\u00a0 9 6 15\u00a02009\u00a0 862\u00a0428\u00a01290\n2010\u00a0 33\u00a0 11\u00a0 44\u00a0\u00a02010\u00a0 61\u00a020 81\u00a02010\u00a0 12 9 21\u00a02010\u00a0 989\u00a0521\u00a01510\n2011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02011\u00a0 3\u00a0 3\u00a0 6\nT\u00a0 129\u00a0 38\u00a0167\u00a0\u00a0T\u00a0 193\u00a079 272\u00a0T\u00a0 40 26 66\u00a0T\u00a0 2842\u00a01346\u00a04188\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a00.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.5\u00a0\u00a0##\u00a0\u00a0\u00a00.5\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n6.9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n7.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a07.0\u00a0\u00a0\nTrabajo\u00a0\nsocial\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0Sicolog\u00eda\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Nutrici\u00f3n \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Total\u00a0consultas \u00a0 \u00a0\u00a0\n32\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a032\u00a0 H\u00a0 M\u00a0T\u00a0\u00a032\u00a0 H\u00a0 M\u00a0T\u00a0\u00a032\u00a0 H\u00a0 M\u00a0 T\u00a0\n\u20108\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 8\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 8\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 8\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u20107\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 7\u00a0 2\u00a0\u00a0 \u00a0 2\u00a0\u2010 7\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 7\u00a0 6\u00a0 4\u00a0 10\n\u20106\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 6\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 6\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 6\u00a0 4\u00a0\u00a0 \u00a0 4\n\u20105\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 5\u00a0 4\u00a0 1\u00a0 5\n\u20104\u00a0 1\u00a0\u00a0 \u00a0 1\u00a0\u00a0\u2010 4\u00a0 4\u00a0\u00a0 \u00a0 4\u00a0\u2010 4 2\u00a0\u00a0 2\u00a0\u2010 4\u00a0 13\u00a0 1\u00a0 14\n\u20103\u00a0 2\u00a0\u00a0 \u00a0 2\u00a0\u00a0\u2010 3\u00a0 3\u00a02 5\u00a0\u2010 3\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 3\u00a0 16\u00a0 6\u00a0 22\n\u20102\u00a0 1\u00a0\u00a0 \u00a0 1\u00a0\u00a0\u2010 2\u00a0 2\u00a0\u00a0 \u00a0 2\u00a0\u2010 2\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 2\u00a0 41\u00a0 32\u00a0 73\n\u20101\u00a0 11\u00a0 9\u00a0 20\u00a0\u00a0\u2010 1\u00a014\u00a016 30\u00a0\u2010 1 2 2 4\u00a0\u2010 1\u00a0171\u00a0 91\u00a0 262\n1\u00a0 82\u00a0 16\u00a0 98\u00a0\u00a0 1\u00a0116\u00a042 158\u00a0 1 28 22 50\u00a0 1\u00a01143\u00a0496\u00a01639\n2\u00a0 19\u00a0 10\u00a0 29\u00a0\u00a0 2\u00a024\u00a015 39\u00a0 2 6\u00a0\u00a0 6\u00a0 2\u00a0773\u00a0394\u00a01167\n3\u00a0 12\u00a0 2\u00a0 14\u00a0\u00a0 3\u00a026\u00a02 28\u00a0 3 2 1 3\u00a0 3\u00a0495\u00a0223\u00a0 718\n4\u00a0 1\u00a0 1\u00a0 2\u00a0\u00a0 4\u00a0 2\u00a02 4\u00a0 4\u00a0\u00a0 1 1\u00a0 4\u00a0175\u00a0 97\u00a0 272\n5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 5\u00a0 1\u00a0 1\u00a0 2\nT\u00a0 129\u00a0 38\u00a0167\u00a0\u00a0T\u00a0 193\u00a079 272\u00a0T\u00a0 40 26 66\u00a0T\u00a0 2842\u00a01346\u00a04188\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a00.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.5\u00a0\u00a0##\u00a0\u00a0\u00a00.5\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n6.9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n7.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a07.0\u00a0\u00a0\n\u00a0 153 \u00a0\nOtras\u00a0instituciones \u00a0 \u00a0\u00a0 Interconsultas \u00a0 \u00a0\u00a0\u00a0\u00a0 Laboratorio \u00a0privado\u00a0\nR\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0 R\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0 R\u00a0 H\u00a0 M\u00a0 T\u00a0\n2002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2002\u00a0 1\u00a0\u00a0 1\u00a0\u00a0 2002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n2003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2003\u00a0 3 4 7\u00a0\u00a0 2003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n2004\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2004\u00a0 9 3 12\u00a0\u00a0 2004\u00a0 1\u00a0\u00a0 1\u00a0\n2005\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2005\u00a0 5 2 7\u00a0\u00a0 2005\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n2006\u00a0 1\u00a0 1\u00a0 2\u00a0\u00a0\u00a0 2006\u00a0 25 4 29\u00a0\u00a0 2006\u00a0 10 1\u00a011\u00a0\n2007\u00a0\u00a0 \u00a0 1\u00a0 1\u00a0\u00a0\u00a0 2007\u00a0 25 19 44\u00a0\u00a0 2007\u00a0 3 4\u00a0 7\u00a0\n2008\u00a0 3\u00a0 2\u00a0 5\u00a0\u00a0\u00a0 2008\u00a0 57 19 76\u00a0\u00a0 2008\u00a0 18 1\u00a019\u00a0\n2009\u00a0\u00a0 \u00a0 3\u00a0 3\u00a0\u00a0\u00a0 2009\u00a0 73 41 114\u00a0\u00a0 2009\u00a0 13 13\u00a026\u00a0\n2010\u00a0 3\u00a0 2\u00a0 5\u00a0\u00a0\u00a0 2010\u00a0 81 68 149\u00a0\u00a0 2010\u00a0 24 14\u00a038\u00a0\n2011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2011\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0\u00a0 2011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nT\u00a0 7\u00a0 9\u00a016\u00a0\u00a0\u00a0 T\u00a0 279 160 439\u00a0\u00a0 T\u00a0 69 33\u00a0102\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.9\u00a0\u00a0\u00a0\u00a00.7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\nOtras\u00a0instituciones \u00a0 \u00a0\u00a0 Interconsultas \u00a0 \u00a0\u00a0\u00a0\u00a0 Laboratorio \u00a0privado\u00a0\n32\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0 32\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0 32\u00a0 H\u00a0 M\u00a0 T\u00a0\n\u20108\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 8\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0\u00a0 \u2010 8\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20107\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 7\u00a0 1 3 4\u00a0\u00a0 \u2010 7\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20106\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 6\u00a0 3 2 5\u00a0\u00a0 \u2010 6 1\u00a0\u00a0 1\u00a0\n\u20105\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 5\u00a0 1 3 4\u00a0\u00a0 \u2010 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20104\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 4\u00a0 9 2 11\u00a0\u00a0 \u2010 4\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20103\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 3\u00a0 5 1 6\u00a0\u00a0 \u2010 3\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20102\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 2\u00a0 22 2 24\u00a0\u00a0 \u2010 2 1 3\u00a0 4\u00a0\n\u20101\u00a0 2\u00a0 3\u00a0 5\u00a0\u00a0\u00a0 \u2010 1\u00a0 29 8 37\u00a0\u00a0 \u2010 1 14 1\u00a015\u00a0\n1\u00a0 3\u00a0 1\u00a0 4\u00a0\u00a0\u00a0 1\u00a0 122 73 195\u00a0\u00a0 1 46 25\u00a071\u00a0\n2\u00a0 2\u00a0\u00a0 \u00a0 2\u00a0\u00a0\u00a0 2\u00a0 59 41 100\u00a0\u00a0 2 4 4\u00a0 8\u00a0\n3\u00a0\u00a0 \u00a0 5\u00a0 5\u00a0\u00a0\u00a0 3\u00a0 25 22 47\u00a0\u00a0 3 3\u00a0\u00a0 3\u00a0\n4\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 4\u00a0 3 3 6\u00a0\u00a0 4\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 5\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0\u00a0 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nT\u00a0 7\u00a0 9\u00a016\u00a0\u00a0\u00a0 T\u00a0 279 160 439\u00a0\u00a0 T\u00a0 69 33\u00a0102\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.9\u00a0\u00a0\u00a0\u00a00.7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\n\u00a0 154 \u00a0\nPrueba\u00a0r\u00e1pida\u00a0 \u00a0\u00a0\u00a0\u00a0Prueba\u00a0Elisa\u00a0 \u00a0\u00a0\u00a0WB\u00a0/IFI\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0CD4\u00a0y\u00a0Carga\u00a0viral\u00a0 \u00a0\u00a0\nR\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0 T\u00a0\n2002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02002\u00a0 2\u00a0\u00a0 2\u00a02002\u00a0 1\u00a0\u00a0 1\u00a0\u00a0\u00a02002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n2003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02003\u00a0 2\u00a0\u00a0 2\u00a02003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n2004\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02004\u00a0 1 2 3\u00a02004\u00a0 1\u00a0\u00a0 1\u00a0\u00a0\u00a02004\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n2005\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02005\u00a0 4 2 6\u00a02005\u00a0\u00a0 \u00a0 1 1\u00a0\u00a0\u00a02005\u00a0 1 1 2\n2006\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02006\u00a0 11 7 18\u00a02006\u00a0 1 4 5\u00a0\u00a0\u00a02006\u00a0 10 6 16\n2007\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02007\u00a0 17 5 22\u00a02007\u00a0 3 2 5\u00a0\u00a0\u00a02007\u00a0 49 22 71\n2008\u00a0 1\u00a0 2\u00a0 3\u00a0\u00a0\u00a02008\u00a0 29 9 38\u00a02008\u00a0 12 3 15\u00a0\u00a0\u00a02008\u00a0 86 36 122\n2009\u00a0 1\u00a0 1\u00a0 2\u00a0\u00a0\u00a02009\u00a0 17 11 28\u00a02009\u00a0 12 5 17\u00a0\u00a0\u00a02009\u00a0 121 54 175\n2010\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02010\u00a0 25 9 34\u00a02010\u00a0 4 2 6\u00a0\u00a0\u00a02010\u00a0 133 56 189\n2011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nT\u00a0 2\u00a0 3\u00a0 5\u00a0\u00a0\u00a0T\u00a0 108 45 153\u00a0T\u00a0 34 17 51\u00a0\u00a0\u00a0T\u00a0 400 175 575\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.3\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a00.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.9\u00a0\u00a0\u00a0\u00a01.0\u00a0\u00a0\nPrueba\u00a0r\u00e1pida\u00a0 \u00a0\u00a0\u00a0\u00a0Prueba\u00a0Elisa\u00a0 \u00a0\u00a0\u00a0WB\u00a0/IFI\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0CD4\u00a0y\u00a0Carga\u00a0viral\u00a0 \u00a0\u00a0\n32\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a032\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a032\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a032\u00a0 H\u00a0 M\u00a0 T\u00a0\n\u20108\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 8\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 8\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u2010 8\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u20107\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 7\u00a0 2\u00a0\u00a0 2\u00a0\u2010 7\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u2010 7\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u20106\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 6\u00a0 1\u00a0\u00a0 1\u00a0\u2010 6 1\u00a0\u00a0 1\u00a0\u00a0\u00a0 \u2010 6\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u20105\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 5\u00a0 1 1 2\u00a0\u2010 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u2010 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n\u20104\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 4\u00a0 4 1 5\u00a0\u2010 4 1 1 2\u00a0\u00a0\u00a0 \u2010 4\u00a0 1\u00a0\u00a0 1\n\u20103\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 3\u00a0 2 2 4\u00a0\u2010 3 1 1 2\u00a0\u00a0\u00a0 \u2010 3\u00a0 1 2 3\n\u20102\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 2\u00a0 9 4 13\u00a0\u2010 2 2 2 4\u00a0\u00a0\u00a0 \u2010 2\u00a0 4 5 9\n\u20101\u00a0\u00a0 \u00a0 2\u00a0 2\u00a0\u00a0\u00a0 \u2010 1\u00a0 25 9 34\u00a0\u2010 1 9 4 13\u00a0\u00a0\u00a0 \u2010 1\u00a0 22 20 42\n1\u00a0 2\u00a0 1\u00a0 3\u00a0\u00a0\u00a0 1\u00a0 62 27 89\u00a0 1 18 9 27\u00a0\u00a0\u00a0 1\u00a0 169 69 238\n2\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2\u00a0 1\u00a0\u00a0 1\u00a0 2 2\u00a0\u00a0 2\u00a0\u00a0\u00a0 2\u00a0 111 42 153\n3\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 3\u00a0\u00a0 \u00a0 1 1\u00a0 3\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 3\u00a0 70 28 98\n4\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 4\u00a0 1\u00a0\u00a0 1\u00a0 4\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 4\u00a0 22 9 31\n5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nT\u00a0 2\u00a0 3\u00a0 5\u00a0\u00a0\u00a0T\u00a0 108 45 153\u00a0T\u00a0 34 17 51\u00a0\u00a0\u00a0T\u00a0 400 175 575\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.3\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a00.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.9\u00a0\u00a0\u00a0\u00a01.0\u00a0\u00a0\n\u00a0 155 \u00a0\nBaciloscop\u00edas \u00a0\u00a0\u00a0\u00a0\u00a0Rayos\u00a0X\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0RPR;\u00a0Glucosa,\u00a0Hemograma, \u00a0Creatinina \u00a0Hematolog\u00eda \u00a0\u00a0\u00a0\u00a0\u00a0\nR\u00a0 H\u00a0 M\u00a0T\u00a0\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0 T\u00a0\n2002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02002\u00a0 1\u00a0\u00a0 \u00a0 1\u00a02002\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0\u00a02002\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0\n2003\u00a0 1\u00a0 1\u00a0 2\u00a0\u00a0\u00a02003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02003\u00a0\u00a0 \u00a0 1 1\u00a0\u00a0\u00a02003\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0\n2004\u00a0\u00a0 \u00a0 2\u00a0 2\u00a0\u00a0\u00a02004\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02004\u00a0 3 1 4\u00a0\u00a0\u00a02004\u00a0 2\u00a0\u00a0 2\n2005\u00a0 2\u00a0\u00a0 \u00a0 2\u00a0\u00a0\u00a02005\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02005\u00a0 3\u00a0\u00a0 3\u00a0\u00a0\u00a02005\u00a0 2\u00a0\u00a0 2\n2006\u00a0 19\u00a011\u00a0 30\u00a0\u00a0\u00a02006\u00a0 5\u00a0 3 8\u00a02006\u00a0 12 10 22\u00a0\u00a0\u00a02006\u00a0 6 3 9\n2007\u00a0 36\u00a016\u00a0 52\u00a0\u00a0\u00a02007\u00a0 13\u00a0 5 18\u00a02007\u00a0 46 25 71\u00a0\u00a0\u00a02007\u00a0 10 10 20\n2008\u00a0 65\u00a013\u00a0 78\u00a0\u00a0\u00a02008\u00a0 20\u00a0 14 34\u00a02008\u00a0 95 32 127\u00a0\u00a0\u00a02008\u00a0 35 17 52\n2009\u00a0 76\u00a020\u00a0 96\u00a0\u00a0\u00a02009\u00a0 21\u00a0 9 30\u00a02009\u00a0 93 68 161\u00a0\u00a0\u00a02009\u00a0 47 23 70\n2010\u00a0 60\u00a024\u00a0 84\u00a0\u00a0\u00a02010\u00a0 15\u00a0 10 25\u00a02010\u00a0 112 54 166\u00a0\u00a0\u00a02010\u00a0 75 23 98\n2011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02011\u00a0\u00a0 \u00a0 1 1\u00a0\u00a0\u00a02011\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0\nT\u00a0 259\u00a087\u00a0346\u00a0\u00a0\u00a0T\u00a0 75\u00a0 41 116\u00a0T\u00a0 364 192 556\u00a0\u00a0\u00a0T\u00a0 177 76 253\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.6\u00a0\u00a00.1\u00a0\u00a0\u00a00.6\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a00.9\u00a0\u00a0\u00a0\u00a01.0\u00a0\u00a0\u00a0\u00a00.9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.4\u00a0\u00a0\u00a0\u00a00.4\u00a0\u00a0\nBaciloscop\u00edas \u00a0\u00a0\u00a0\u00a0\u00a0Rayos\u00a0X\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0RPR;\u00a0Glucosa,\u00a0Hemograma, \u00a0Creatinina \u00a0Hematolog\u00eda \u00a0\u00a0\u00a0\u00a0\u00a0\n32\u00a0 H\u00a0 M\u00a0T\u00a0\u00a0\u00a032\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a032\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a032\u00a0 H\u00a0 M\u00a0 T\u00a0\n\u20108\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 8\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 8\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u2010 8\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20107\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 7\u00a0 1\u00a0\u00a0 \u00a0 1\u00a0\u2010 7\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u2010 7\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20106\u00a0 1\u00a0\u00a0 \u00a0 1\u00a0\u00a0\u00a0 \u2010 6\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 6 1\u00a0\u00a0 1\u00a0\u00a0\u00a0 \u2010 6\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20105\u00a0\u00a0 \u00a0 1\u00a0 1\u00a0\u00a0\u00a0 \u2010 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 5\u00a0\u00a0 1 1\u00a0\u00a0\u00a0 \u2010 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20104\u00a0\u00a0 \u00a0 2\u00a0 2\u00a0\u00a0\u00a0 \u2010 4\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 4 1 3 4\u00a0\u00a0\u00a0 \u2010 4 1 1 2\n\u20103\u00a0 4\u00a0 2\u00a0 6\u00a0\u00a0\u00a0 \u2010 3\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u2010 3 2\u00a0\u00a0 2\u00a0\u00a0\u00a0 \u2010 3 1\u00a0\u00a0 1\n\u20102\u00a0 9\u00a0 5\u00a0 14\u00a0\u00a0\u00a0 \u2010 2\u00a0 3\u00a0 1 4\u00a0\u2010 2 10 6 16\u00a0\u00a0\u00a0 \u2010 2 7 3 10\n\u20101\u00a037\u00a0 9\u00a0 46\u00a0\u00a0\u00a0 \u2010 1\u00a0 7\u00a0 5 12\u00a0\u2010 1 25 20 45\u00a0\u00a0\u00a0 \u2010 1 11 7 18\n1\u00a0136\u00a045\u00a0181\u00a0\u00a0\u00a0 1\u00a0 38\u00a0 18 56\u00a0 1 193 95 288\u00a0\u00a0\u00a0 1 94 45 139\n2\u00a047\u00a014\u00a0 61\u00a0\u00a0\u00a0 2\u00a0 19\u00a0 14 33\u00a0 2 68 41 109\u00a0\u00a0\u00a0 2 36 15 51\n3\u00a019\u00a0 3\u00a0 22\u00a0\u00a0\u00a0 3\u00a0 5\u00a0 2 7\u00a0 3 47 23 70\u00a0\u00a0\u00a0 3 21 2 23\n4\u00a0 6\u00a0 6\u00a0 12\u00a0\u00a0\u00a0 4\u00a0 2\u00a0 1 3\u00a0 4 17 3 20\u00a0\u00a0\u00a0 4 6 3 9\n5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nT\u00a0 259\u00a087\u00a0346\u00a0\u00a0\u00a0T\u00a0 75\u00a0 41 116\u00a0T\u00a0 364 192 556\u00a0\u00a0\u00a0T\u00a0 177 76 253\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.6\u00a0\u00a0 ##\u00a0\u00a0\u00a00.6\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a00.9\u00a0\u00a0\u00a0\u00a01.0\u00a0\u00a0\u00a0\u00a00.9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.4\u00a0\u00a0\u00a0\u00a00.4\u00a0\u00a0\nBioqu\u00edmico: \u00a0creatinina, \u00a0glucosa,\u00a0\nPrueba\u00a0funci\u00f3n\u00a0hep\u00e1tica\u00a0 Orina\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Heces\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Hepatitis\u00a0B\u00a0\u00a0\u00a0\u00a0\u00a0\nR\u00a0 H\u00a0 M\u00a0T\u00a0\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0T\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0T\u00a0\u00a0R\u00a0 H\u00a0 M\u00a0T\u00a0\n2002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02002\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a02002\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a02002\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\n2003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02003\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a02003\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a02003\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\n2004\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02004\u00a0 1\u00a0\u00a0 1\u00a02004\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a02004\u00a0 1\u00a0\u00a0 \u00a0 1\n2005\u00a0 1\u00a0\u00a0 \u00a0 1\u00a0\u00a0\u00a02005\u00a0 1\u00a0\u00a0 1\u00a02005\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a02005\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\n2006\u00a0 3\u00a0 1\u00a0 4\u00a0\u00a0\u00a02006\u00a0 4 3 7\u00a02006\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a02006\u00a0 4\u00a0 2 6\n2007\u00a0 3\u00a0 7\u00a0 10\u00a0\u00a0\u00a02007\u00a0 4 4 8\u00a02007\u00a0 2 6 8\u00a02007\u00a0 4\u00a0 3 7\n2008\u00a0 12\u00a0 8\u00a0 20\u00a0\u00a0\u00a02008\u00a0 22 4 26\u00a02008\u00a0 5 2 7\u00a02008\u00a0 5\u00a0 3 8 156 2009\u00a0 17\u00a0 7\u00a0 24\u00a0\u00a0\u00a02009\u00a0 17 5 22\u00a02009\u00a0 3 4 7\u00a02009\u00a0 4\u00a0 1 5\n2010\u00a0 26\u00a0 6\u00a0 32\u00a0\u00a0\u00a02010\u00a0 32 12 44\u00a02010\u00a0 6\u00a0\u00a0 6\u00a02010\u00a0 4\u00a0 2 6\n2011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a02011\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a02011\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a02011\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\nT\u00a0 62\u00a029\u00a0 91\u00a0\u00a0\u00a0T\u00a0 81 28 109\u00a0T\u00a0 16 12 28\u00a0T\u00a0 22\u00a011 33\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\nBioqu\u00edmico: \u00a0creatinina, \u00a0glucosa,\u00a0\nPrueba\u00a0funci\u00f3n\u00a0hep\u00e1tica\u00a0 Orina\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Heces\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Hepatitis\u00a0B\u00a0\u00a0\u00a0\u00a0\u00a0\n32\u00a0 H\u00a0 M\u00a0T\u00a0\u00a0\u00a032\u00a0 H\u00a0 M\u00a0T\u00a0\u00a032\u00a0 H\u00a0 M\u00a0T\u00a0\u00a032\u00a0 H\u00a0 M\u00a0T\u00a0\n\u20108\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 8\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0\u2010 8\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 8\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\n\u20107\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 7\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0\u2010 7\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 7\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\n\u20106\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 6\u00a0 1\u00a0\u00a0 1\u00a0\u2010 6\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 6\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\n\u20105\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 5\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0\u2010 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 5\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\n\u20104\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 4\u00a0\u00a0 \u00a0 2 2\u00a0\u2010 4\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 4\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\n\u20103\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 3\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0\u2010 3\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 3\u00a0 1\u00a0\u00a0 \u00a0 1\n\u20102\u00a0 1\u00a0\u00a0 \u00a0 1\u00a0\u00a0\u00a0 \u2010 2\u00a0 2 4 6\u00a0\u2010 2\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\u2010 2\u00a0\u00a0 \u00a0 1 1\n\u20101\u00a0 4\u00a0 5\u00a0 9\u00a0\u00a0\u00a0 \u2010 1\u00a0 9 2 11\u00a0\u2010 1\u00a0\u00a0 1 1\u00a0\u2010 1\u00a0 4\u00a0 3 7\n1\u00a0 31\u00a014\u00a0 45\u00a0\u00a0\u00a0 1\u00a041 11 52\u00a0 1 14 11 25\u00a0 1\u00a013\u00a0 6 19\n2\u00a0 15\u00a0 9\u00a0 24\u00a0\u00a0\u00a0 2\u00a015 3 18\u00a0 2\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 2\u00a0 2\u00a0 1 3\n3\u00a0 10\u00a0\u00a0 \u00a0 10\u00a0\u00a0\u00a0 3\u00a010 4 14\u00a0 3 1\u00a0\u00a0 1\u00a0 3\u00a0 2\u00a0\u00a0 \u00a0 2\n4\u00a0 1\u00a0 1\u00a0 2\u00a0\u00a0\u00a0 4\u00a0 3 2 5\u00a0 4 1\u00a0\u00a0 1\u00a0 4\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\n5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 5\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 \u00a0 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0 5\u00a0 \u00a0 \u00a0\u00a0 \u00a0\u00a0 \u00a0\nT\u00a0 62\u00a029\u00a0 91\u00a0\u00a0\u00a0T\u00a0 81 28 109\u00a0T\u00a0 16 12 28\u00a0T\u00a0 22\u00a011 33\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.1\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\n\u00a0 157 \u00a0\nExamen\u00a0parasit\u00f3logo \u00a0\u00a0\u00a0\u00a0\u00a0 Aglutinaciones \u00a0\u00a0\u00a0\u00a0\u00a0 Otros\u00a0an\u00e1lisis\u00a0\u00a0\u00a0 \u00a0\u00a0\nR\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0 R\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0 R\u00a0 H\u00a0 M\u00a0 T\u00a0\n2002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2002\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n2003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2003\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n2004\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2004\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2004\u00a0 2\u00a0\u00a0 2\u00a0\n2005\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2005\u00a0 1\u00a0\u00a0 1\u00a0\u00a0 2005\u00a0 1\u00a0\u00a0 1\u00a0\n2006\u00a0 2\u00a0 1\u00a0 3\u00a0\u00a0\u00a0 2006\u00a0 1\u00a0\u00a0 1\u00a0\u00a0 2006\u00a0 8\u00a0\u00a0 8\u00a0\n2007\u00a0 7\u00a0 1\u00a0 8\u00a0\u00a0\u00a0 2007\u00a0 1\u00a0\u00a0 1\u00a0\u00a0 2007\u00a0 13 4\u00a0 17\u00a0\n2008\u00a0 5\u00a0 1\u00a0 6\u00a0\u00a0\u00a0 2008\u00a0 1\u00a0\u00a0 1\u00a0\u00a0 2008\u00a0 16 8\u00a0 24\u00a0\n2009\u00a0 7\u00a0\u00a0 \u00a0 7\u00a0\u00a0\u00a0 2009\u00a0\u00a0 \u00a0 1 1\u00a0\u00a0 2009\u00a0 20 11\u00a0 31\u00a0\n2010\u00a0 11\u00a0 13\u00a0 24\u00a0\u00a0\u00a0 2010\u00a0 8 2 10\u00a0\u00a0 2010\u00a0 12 18\u00a0 30\u00a0\n2011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 2011\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\nT\u00a0 32\u00a0 16\u00a0 48\u00a0\u00a0\u00a0 T\u00a0 12 3 15\u00a0\u00a0 T\u00a0 72 41\u00a0113\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\nExamen\u00a0parasit\u00f3logo \u00a0\u00a0\u00a0\u00a0\u00a0 Aglutinaciones \u00a0\u00a0\u00a0\u00a0\u00a0 Otros\u00a0an\u00e1lisis\u00a0\u00a0\u00a0 \u00a0\u00a0\n32\u00a0 H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0 32\u00a0H\u00a0 M\u00a0 T\u00a0\u00a0\u00a0 32\u00a0 H\u00a0 M\u00a0 T\u00a0\n\u20108\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 8\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 8\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20107\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 7\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 7\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20106\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 6\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 6 1\u00a0\u00a0 1\u00a0\n\u20105\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20104\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 4\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 4\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\n\u20103\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 3\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u2010 3 1\u00a0\u00a0 1\u00a0\n\u20102\u00a0 1\u00a0\u00a0 \u00a0 1\u00a0\u00a0\u00a0 \u2010 2\u00a0 1\u00a0\u00a0 1\u00a0\u00a0 \u2010 2 4 2\u00a0 6\u00a0\n\u20101\u00a0 7\u00a0 1\u00a0 8\u00a0\u00a0\u00a0 \u2010 1\u00a0 2\u00a0\u00a0 2\u00a0\u00a0 \u2010 1 13 2\u00a0 15\u00a0\n1\u00a0 14\u00a0 13\u00a0 27\u00a0\u00a0\u00a0 1\u00a0 2 1 3\u00a0\u00a0 1 40 27\u00a0 67\u00a0\n2\u00a0 6\u00a0 1\u00a0 7\u00a0\u00a0\u00a0 2\u00a0 5\u00a0\u00a0 5\u00a0\u00a0 2 6 3\u00a0 9\u00a0\n3\u00a0 3\u00a0\u00a0 \u00a0 3\u00a0\u00a0\u00a0 3\u00a0 2 1 3\u00a0\u00a0 3 6 6\u00a0 12\u00a0\n4\u00a0 1\u00a0 1\u00a0 2\u00a0\u00a0\u00a0 4\u00a0\u00a0 \u00a0 1 1\u00a0\u00a0 4 1 1\u00a0 2\u00a0\n5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 5\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 5\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\nT\u00a0 32\u00a0 16\u00a0 48\u00a0\u00a0\u00a0 T\u00a0 12 3 15\u00a0\u00a0 T\u00a0 72 41\u00a0113\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\u00a0\u00a00.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n0.0\u00a0\u00a0\u00a0\u00a00.0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0\u00a0\u00a00.2\u00a0\u00a0 158 \u00a0\nOtros\u00a0an\u00e1lisis\u00a0o\u00a0ex\u00e1menes \u00a0H\u00a0 M\u00a0 T\u00a0\nAnatom\u00eda \u00a0patol\u00f3gica \u00a0\u00a0 \u00a0 2\u00a0 2\nBilirrubina \u00a0 2\u00a0 1\u00a0 3\nColesterol \u00a0 6\u00a0 1\u00a0 7\ncontrol\u00a0hormonal \u00a0 2\u00a0\u00a0 \u00a0 2\nCriptococcus \u00a0 1\u00a0\u00a0 \u00a0 1\nEcograf\u00eda\u00a0 43\u00a0 28\u00a071\nEndoscopia \u00a0 2\u00a0\u00a0 \u00a0 2\nGota\u00a0gruesa\u00a0 2\u00a0 1\u00a0 3\nHerpes\u00a0\u00a0 \u00a0 1\u00a0 1\nPapanicolao \u00a0 1\u00a0\u00a0 \u00a0 1\nParasitologico \u00a0\u00a0 \u00a0 1\u00a0 1\nPatolog\u00eda \u00a0cl\u00ednica\u00a0\u00a0 \u00a0 1\u00a0 1\nPCR\u00a0\u00a0 \u00a0 1\u00a0 1\nPPD\u00a0 1\u00a0\u00a0 \u00a0 1\nResonancia \u00a0magnetica \u00a0 1\u00a0\u00a0 \u00a0 1\nTomograf\u00eda \u00a0 6\u00a0 1\u00a0 7\nToxoplasmosis \u00a0\u00a0 \u00a0 1\u00a0 1\nTransaminasa \u00a0 1\u00a0\u00a0 \u00a0 1\nUrocultivo \u00a0 4\u00a0 2\u00a0 6\nT\u00a0 72\u00a0 41\u00a0113\n\u00a0\n\u00a0 159 \u00a0\nAnexo\u00a012\u00a0\u2010\u00a0Matrices\u00a0\nPor\u00a0fuentes\u00a0de\u00a0financiamiento \u00a0y\u00a0Categor\u00eda \u00a0de\u00a0gasto\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nPrevenci\u00f3n \u00a0 2,892\u00a0 11,038\u00a0 4,781\u00a0 18,711\u00a0\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 14,611\u00a0 3,105\u00a0 3,095\u00a0 20,812\u00a0\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a0\u00a0191\u00a0\u00a0191\u00a0\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0 \u00a016\u00a0\u00a016\u00a0\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0\nAdministraci\u00f3n \u00a0290\u00a0 2,894\u00a0\u00a03,184\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0\u00a01,498\u00a0\u00a01,498\u00a0\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0mejorado \u00a0\u00a01,852\u00a0\u00a01,852\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0(excluye\u00a0\ninvestigaci\u00f3n \u00a0operativa) \u00a018\u00a0 9,315\u00a0\u00a09,333\u00a0\nTotal\u00a0General\u00a0 17,812\u00a0 29,910\u00a0 7,876\u00a0\u00a0 55,598\u00a0\n\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nPrevenci\u00f3n \u00a0 2,486\u00a0 12,800\u00a0 4,714\u00a0 20,000\u00a0\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 20,990\u00a0 769\u00a0 3,099\u00a0 24,857\u00a0\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a0\u00a0 52\u00a0\u00a0 52\u00a0\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0\u00a0 8\u00a0\u00a0 8\u00a0\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0\nAdministraci\u00f3n \u00a0615\u00a0 4,020\u00a0\u00a0 4,635\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0\u00a0 1,278\u00a0\u00a0 1,278\u00a0\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0mejorado \u00a0 568\u00a0 2,053\u00a0\u00a0 2,621\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0(excluye\u00a0\ninvestigaci\u00f3n \u00a0operativa) \u00a0228\u00a0 8,564\u00a0\u00a0 8,792\u00a0\nTotal\u00a0General\u00a0 24,887\u00a0 29,543\u00a0 7,813\u00a0 62,242\u00a0\n\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nPrevenci\u00f3n \u00a0 4,301\u00a0 6,714\u00a0 5,110\u00a0 16,125\u00a0\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 9,063\u00a0 123\u00a0 3,402\u00a0 12,587\u00a0\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a0\u00a0 17\u00a0\u00a0 17\u00a0\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0\u00a0 9\u00a0\u00a0 9\u00a0\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0\nAdministraci\u00f3n \u00a0305\u00a0 2,647\u00a0\u00a0 2,952\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0\u00a0 549\u00a0\u00a0 549\u00a0\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0mejorado \u00a0 1,762\u00a0 1,170\u00a0\u00a0 2,932\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0(excluye\u00a0\ninvestigaci\u00f3n \u00a0operativa) \u00a011\u00a0 1,245\u00a0\u00a0 1,256\u00a0 160 Total\u00a0General\u00a0 15,441\u00a0 12,474\u00a0 8,512\u00a0 36,427\u00a0\n\u00a0\nPor\u00a0fuentes\u00a0de\u00a0financiamiento \u00a0y\u00a0Beneficiarios \u00a0\n\u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0un\u00a0\ndiagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0sida)\u00a012,693\u00a0 5,422\u00a0 2,791\u00a0 20,906\u00a0\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 315\u00a0 9,950\u00a0 467\u00a0\u00a0 10,733\u00a0\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 593\u00a0 1,980\u00a0\u00a02,573\u00a0\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0 3,741\u00a0 2,284\u00a0 888\u00a0 6,913\u00a0\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 253\u00a0 6,948\u00a0 3,730\u00a0\u00a0 10,931\u00a0\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 216\u00a0 3,002\u00a0\u00a03,219\u00a0\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0\nclasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a0\u00a0323\u00a0\u00a0323\u00a0\nTotal\u00a0general\u00a0 17,812\u00a0 29,910\u00a0 7,876\u00a0\u00a0 55,598\u00a0\n\u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0un\u00a0\ndiagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0sida)\u00a020,327\u00a0 2,460\u00a0 2,804\u00a0 25,590\u00a0\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 315\u00a0 7,724\u00a0 573\u00a0 8,613\u00a0\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 763\u00a0 3,481\u00a0\u00a0 4,244\u00a0\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0 2,383\u00a0 4,607\u00a0 877\u00a0 7,867\u00a0\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 337\u00a0 6,107\u00a0 3,559\u00a0 10,003\u00a0\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 761\u00a0 4,784\u00a0\u00a0 5,545\u00a0\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0\nclasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a0\u00a0 380\u00a0\u00a0 380\u00a0\nTotal\u00a0general\u00a0 24,887\u00a0 29,543\u00a0 7,813\u00a0 62,242\u00a0\n\u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0un\u00a0\ndiagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0sida)\u00a07,208\u00a0 1,605\u00a0 3,087\u00a0 11,900\u00a0\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 1,854\u00a0 3,234\u00a0 701\u00a0 5,788\u00a0\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 598\u00a0 1,269\u00a0\u00a0 1,867\u00a0\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0 2,963\u00a0 2,037\u00a0 964\u00a0 5,963\u00a0\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 2,607\u00a0 1,380\u00a0 3,761\u00a0 7,747\u00a0\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 205\u00a0 2,581\u00a0\u00a0 2,786\u00a0\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0\nclasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a05\u00a0 369\u00a0\u00a0 374\u00a0\nTotal\u00a0general\u00a0 15,441\u00a0 12,474\u00a0 8,512\u00a0 36,427\u00a0\n\u00a0 161 \u00a0\nPor\u00a0fuentes\u00a0de\u00a0financiamiento \u00a0y\u00a0Recursos\u00a0\n\u00a0\nRecursos\u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nRecursos\u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nAntirretrovirales \u00a0 8,920\u00a0 937\u00a0 144\u00a0 10,001\u00a0\nCondones \u00a0 244\u00a0 2,097\u00a0 4,314\u00a0 6,655\u00a0\nGastos\u00a0de\u00a0capital\u00a0 7\u00a0 2,773\u00a0 1,290\u00a0 4,070\u00a0\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 2,971\u00a0 4,461\u00a0\u00a0 7,431\u00a0\nOtros\u00a0gastos\u00a0corrientes \u00a0 410\u00a0 17,788\u00a0 1,824\u00a0 20,002\u00a0\nReactivos \u00a0y\u00a0materiales \u00a0 5,260\u00a0 1,854\u00a0 304\u00a0 7,418\u00a0\nTotal\u00a0general\u00a0 17,812\u00a0 29,910\u00a0 7,876\u00a0 55,598\u00a0\n\u00a0\nRecursos\u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nRecursos\u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nAntirretrovirales \u00a0 13,877\u00a0 62\u00a0 144\u00a0 14,083\u00a0\nCondones \u00a0 526\u00a0\u00a0 4,141\u00a0 4,667\u00a0\nGastos\u00a0de\u00a0capital\u00a0 56\u00a0 3,109\u00a0 1,253\u00a0 4,418\u00a0\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 3,284\u00a0 7,298\u00a0\u00a0 10,581\u00a0\nOtros\u00a0gastos\u00a0corrientes \u00a0 1,040\u00a0 18,614\u00a0 1,980\u00a0 21,634\u00a0\nReactivos \u00a0y\u00a0materiales \u00a0 6,103\u00a0 461\u00a0 295\u00a0 6,859\u00a0\nTotal\u00a0general\u00a0 24,887\u00a0 29,543\u00a0 7,813\u00a0 62,242\u00a0\n\u00a0\nRecursos\u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nRecursos\u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nAntirretrovirales \u00a0 3,529\u00a0 4\u00a0 144\u00a0 3,677\u00a0\nCondones \u00a0 3,212\u00a0\u00a0 4,410\u00a0 7,621\u00a0\nGastos\u00a0de\u00a0capital\u00a0 112\u00a0 43\u00a0 1,336\u00a0 1,491\u00a0\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 3,222\u00a0 4,609\u00a0\u00a0 7,831\u00a0\nOtros\u00a0gastos\u00a0corrientes \u00a0 911\u00a0 7,818\u00a0 2,308\u00a0 11,038\u00a0\nReactivos \u00a0y\u00a0materiales \u00a0 4,455\u00a0\u2010 \u00a0 314\u00a0 4,770\u00a0\nTotal\u00a0general\u00a0 15,441\u00a0 12,474\u00a0 8,512\u00a0 36,427\u00a0\n\u00a0 162 \u00a0\nPor\u00a0fuentes\u00a0de\u00a0financiamiento \u00a0y\u00a0Proveedor \u00a0\nProveedores \u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nProveedor \u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nProveedores \u00a0P\u00fablicos\u00a0 16,797\u00a0 14,940\u00a0 2,360\u00a0 34,097\u00a0\nProveedores \u00a0Privados\u00a0\u00a0 14,970\u00a0 4,458\u00a0 19,428\u00a0\nLaboratorios \u00a0P\u00fablicos\u00a0 983\u00a0\u00a0 1,058\u00a0 2,041\u00a0\nBanco\u00a0P\u00fablico\u00a0de\u00a0sangre\u00a0 32\u00a0\u00a0 \u00a0 32\u00a0\nTotal\u00a0general\u00a0 17,812\u00a0 29,910\u00a0 7,876\u00a0 55,598\u00a0\n\u00a0\nProveedores \u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nProveedor \u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nProveedores \u00a0P\u00fablicos\u00a0 19,907\u00a0 15,616\u00a0 2,500\u00a0 38,023\u00a0\nProveedores \u00a0Privados\u00a0\u00a0 13,927\u00a0 4,285\u00a0 18,212\u00a0\nLaboratorios \u00a0P\u00fablicos\u00a0 4,951\u00a0\u00a0 1,028\u00a0 5,979\u00a0\nBanco\u00a0P\u00fablico\u00a0de\u00a0sangre\u00a0 29\u00a0\u00a0 \u00a0 29\u00a0\nTotal\u00a0general\u00a0 24,887\u00a0 29,543\u00a0 7,813\u00a0 62,242\u00a0\n\u00a0\nProveedores \u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nProveedor \u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nProveedores \u00a0P\u00fablicos\u00a0 13,164\u00a0 8,520\u00a0 2,862\u00a0 24,546\u00a0\nProveedores \u00a0Privados\u00a0\u00a0 3,954\u00a0 4,554\u00a0 8,508\u00a0\nLaboratorios \u00a0P\u00fablicos\u00a0 2,129\u00a0\u00a0 1,096\u00a0 3,225\u00a0\nBanco\u00a0P\u00fablico\u00a0de\u00a0sangre\u00a0 148\u00a0\u00a0 \u00a0 148\u00a0\nTotal\u00a0general\u00a0 15,441\u00a0 12,474\u00a0 8,512\u00a0 36,427\u00a0\n\u00a0 163 \u00a0\nPor\u00a0fuente\u00a0de\u00a0financiamiento \u00a0y\u00a0Agente\u00a0\nAgentes\u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nAgentes\u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nSeguridad \u00a0Social\u00a0 4,121\u00a0\u00a0 \u00a0 4,121\u00a0\nSector\u00a0P\u00fablico\u00a0 13,683\u00a0 557\u00a0\u00a0 14,240\u00a0\nSector\u00a0Privado\u00a0\u00a0 27,488\u00a0\u00a0 27,488\u00a0\nOrganizaciones \u00a0Internacionales \u00a0 7\u00a0 1,864\u00a0\u00a0 1,872\u00a0\nHogares\u00a0\u00a0 \u00a0 7,876\u00a0 7,876\u00a0\nTotal\u00a0general\u00a0 17,812\u00a0 29,910\u00a0 7,876\u00a0 55,598\u00a0\n\u00a0\nAgentes\u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nAgentes\u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nSeguridad \u00a0Social\u00a0 5,452\u00a0\u00a0 \u00a0 5,452\u00a0\nSector\u00a0P\u00fablico\u00a0 19,426\u00a0 629\u00a0\u00a0 20,055\u00a0\nSector\u00a0Privado\u00a0\u00a0 26,641\u00a0\u00a0 26,641\u00a0\nOrganizaciones \u00a0Internacionales \u00a0 8\u00a0 2,273\u00a0\u00a0 2,281\u00a0\nHogares\u00a0\u00a0 \u00a0 7,813\u00a0 7,813\u00a0\nTotal\u00a0general\u00a0 24,887\u00a0 29,543\u00a0 7,813\u00a0 62,242\u00a0\n\u00a0\nAgentes\u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nAgentes\u00a0 Sector\u00a0P\u00fablico\u00a0 Internacional \u00a0 Sector\u00a0Privado\u00a0 Total\u00a0\nSeguridad \u00a0Social\u00a0 3,551\u00a0\u00a0 \u00a0 3,551\u00a0\nSector\u00a0P\u00fablico\u00a0 11,880\u00a0 573\u00a0\u00a0 12,453\u00a0\nSector\u00a0Privado\u00a0\u00a0 11,130\u00a0\u00a0 11,130\u00a0\nOrganizaciones \u00a0Internacionales \u00a0 10\u00a0 771\u00a0\u00a0 781\u00a0\nHogares\u00a0\u00a0 \u00a0 8,512\u00a0 8,512\u00a0\nTotal\u00a0general\u00a0 15,441\u00a0 12,474\u00a0 8,512\u00a0 36,427\u00a0\n\u00a0\n\u00a0 164 \u00a0\nPor\u00a0agentes\u00a0de\u00a0financiamiento \u00a0y\u00a0Categor\u00eda \u00a0de\u00a0gasto\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Hogares\u00a0 Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0\nPrivado\u00a0Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0\u00a0\n4,781 294\u00a0 10,212\u00a0 3,144\u00a0\u00a0 280\u00a0 18,711\u00a0\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a03,095 60\u00a0 3,045\u00a0 10,770\u00a0\u00a0 3,841\u00a0 20,812\u00a0\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a0 191\u00a0\u00a0 191\u00a0\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a06\u00a0 11\u00a0\u00a0 16\u00a0\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0\nAdministraci\u00f3n \u00a0 105\u00a0 2,771\u00a0 308\u00a0\u00a0 3,184\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0 698\u00a0 801\u00a0\u00a0 1,498\u00a0\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0mejorado \u00a01,852\u00a0\u00a0 1,852\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0\n(excluye\u00a0investigaci\u00f3n \u00a0operativa) \u00a0 709\u00a0 8,606\u00a0 18\u00a0\u00a0 9,333\u00a0\nTotal\u00a0General\u00a07,876\u00a0 1,872\u00a0 27,488\u00a0 14,240\u00a0\u00a0 4,121\u00a0 55,598\u00a0\n\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Hogares\u00a0 Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0\nPrivado\u00a0Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 4,714 370 11,812 2,673\u00a0 431 20,000\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 3,099 62 707 15,969\u00a0 5,021 24,857\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a052 \u00a0 52\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0\u2010 8 \u00a0 8\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0\nAdministraci\u00f3n \u00a0253 3,765 617\u00a0 4,635\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0668 610 \u00a0 1,278\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0mejorado \u00a0 2,053 568\u00a0 2,621\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0\n(excluye\u00a0investigaci\u00f3n \u00a0operativa) \u00a0929 7,635 228\u00a0 8,792\nTotal\u00a0General\u00a0 7,813 2,281 26,641 20,055\u00a0 5,452 62,242\n\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Hogares\u00a0 Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0\nPrivado\u00a0Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 5,110 57 6,108 4,723\u00a0 127 16,125\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 3,402 4 119 5,638\u00a0 3,424 12,587\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a017 \u00a0 17\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0 9 \u00a0 9\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0\nAdministraci\u00f3n \u00a090 2,543 319\u00a0 2,952\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0410 139 \u00a0 549\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0mejorado \u00a0 1,170 1,762\u00a0 2,932\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0\n(excluye\u00a0investigaci\u00f3n \u00a0operativa) \u00a0220 1,025 11\u00a0 1,256 165 Total\u00a0General\u00a0 8,512 781 11,130 12,453\u00a0 3,551 36,427\nPor\u00a0agentes\u00a0de\u00a0financiamiento \u00a0y\u00a0Beneficiarios \u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Hogares\u00a0Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0\nPrivado\u00a0Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0un\u00a0\ndiagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0sida)\u00a02,791 763 4,623 10,746\u00a0 1,982 20,906\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 467 709 8,838 719\u00a0 10,733\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 69 1,902 598\u00a0 5 2,573\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0 888 170 2,071 1,649\u00a0 2,135 6,913\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 3,730 55 6,835 311\u00a0 10,931\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 3,001 218\u00a0 3,219\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0\nclasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a0105 218 \u00a0 323\nTotal\u00a0general\u00a0 7,876 1,872 27,488 14,240\u00a0 4,121 55,598\n\u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Hogares\u00a0Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0\nPrivado\u00a0Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0un\u00a0\ndiagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0sida)\u00a02,804 729 1,698 16,231\u00a0 4,130 25,590\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 573 929 6,373 738\u00a0 8,613\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 64 3,416 759\u00a0 4 4,244\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0 877 193 4,325 1,153\u00a0 1,319 7,867\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 3,559 112 5,920 412\u00a0 10,003\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 13 4,770 762\u00a0 5,545\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0\nclasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a0240 140 \u00a0 380\nTotal\u00a0general\u00a0 7,813 2,281 26,641 20,055\u00a0 5,452 62,242\n\u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Hogares\u00a0Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0\nPrivado\u00a0Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0un\u00a0\ndiagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0sida)\u00a03,087 414 1,158 5,655\u00a0 1,586 11,900\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 701 220 2,596 2,272\u00a0 5,788\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 47 1,222 528\u00a0 70 1,867\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0espec\u00edficas \u00a0 964 2,034 1,071\u00a0 1,895 5,963\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 3,761 10 1,262 2,715\u00a0 7,747\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 2,580 207\u00a0 2,786\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0\nclasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a090 279 5\u00a0 374\nTotal\u00a0general\u00a0 8,512 781 11,130 12,453\u00a0 3,551 36,427\n\u00a0 166 \u00a0\nPor\u00a0agentes\u00a0de\u00a0financiamiento \u00a0y\u00a0Recursos \u00a0\nRecursos\u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nRecursos\u00a0 Hogares\u00a0Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0\nPrivado\u00a0Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nAntirretrovirales \u00a0 144 60 877 6,939\u00a0 1,981\u00a0 10,001\nCondones \u00a0 4,314 2,097 11\u00a0 233\u00a0 6,655\nGastos\u00a0de\u00a0capital\u00a0 1,290 2,773 7\u00a0\u00a0 4,070\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 55 3,930 3,441\u00a0 5\u00a0 7,431\nOtros\u00a0gastos\u00a0corrientes \u00a0 1,824 1,757 15,956 485\u00a0 0\u00a0 20,022\nReactivos \u00a0y\u00a0materiales \u00a0 304 1,854 3,358\u00a0 1,902\u00a0 7,418\nTotal\u00a0general\u00a0 7,876 1,872 27,488 14,240\u00a0 4,121\u00a0 55,598\n\u00a0\nRecursos\u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nRecursos\u00a0 Hogares\u00a0Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0\nPrivado\u00a0Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nAntirretrovirales \u00a0 144 62 9,759\u00a0 4,118\u00a0 14,083\nCondones \u00a0 4,141 156\u00a0 369\u00a0 4,667\nGastos\u00a0de\u00a0capital\u00a0 1,253 3,109 45\u00a0 11\u00a0 4,418\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 136 6,614 3,828\u00a0 4\u00a0 10,581\nOtros\u00a0gastos\u00a0corrientes \u00a0 1,980 2,084 16,459 1,112\u00a0\u00a0 21,634\nReactivos \u00a0y\u00a0materiales \u00a0 295 461 5,154\u00a0 950\u00a0 6,859\nTotal\u00a0general\u00a0 7,813 2,281 26,641 20,055\u00a0 5,452\u00a0 62,242\n\u00a0\nRecursos\u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nRecursos\u00a0 Hogares\u00a0Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0\nPrivado\u00a0Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nAntirretrovirales \u00a0 144 4 1,943\u00a0 1,586\u00a0 3,677\nCondones \u00a0 4,410 3,212\u00a0\u00a0 7,621\nGastos\u00a0de\u00a0capital\u00a0 1,336 43 108\u00a0 4\u00a0 1,491\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 10 4,069 3,750\u00a0 2\u00a0 7,831\nOtros\u00a0gastos\u00a0corrientes \u00a0 2,308 767 7,018 876\u00a0 68\u00a0 11,038\nReactivos \u00a0y\u00a0materiales \u00a0 314 \u2010 2,564\u00a0 1,891\u00a0 4,770\nTotal\u00a0general\u00a0 8,512 781 11,130 12,453\u00a0 3,551\u00a0 36,427\n\u00a0 167 \u00a0\nPor\u00a0agentes\u00a0de\u00a0financiamiento \u00a0y\u00a0Proveedor \u00a0\nProveedores \u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nProveedor \u00a0 Hogares\u00a0Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0Privado Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nProveedores \u00a0P\u00fablicos\u00a0 2,360 359 14,030 13,226\u00a0 4,121\u00a0 34,097\nProveedores \u00a0Privados\u00a0 4,458 1,512 13,458 \u00a0\u00a0 19,428\nLaboratorios \u00a0P\u00fablicos\u00a0 1,058 983\u00a0\u00a0 2,041\nBanco\u00a0P\u00fablico\u00a0de\u00a0sangre\u00a0 32\u00a0\u00a0 32\nTotal\u00a0general\u00a0 7,876 1,872 27,488 14,240\u00a0 4,121\u00a0 55,598\n\u00a0\nProveedores \u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nProveedor \u00a0 Hogares\u00a0Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0Privado Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nProveedores \u00a0P\u00fablicos\u00a0 2,500 444 14,551 15,075\u00a0 5,452\u00a0 38,023\nProveedores \u00a0Privados\u00a0 4,285 1,837 12,090 \u00a0\u00a0 18,212\nLaboratorios \u00a0P\u00fablicos\u00a0 1,028 4,951\u00a0\u00a0 5,979\nBanco\u00a0P\u00fablico\u00a0de\u00a0sangre\u00a0 29\u00a0\u00a0 29\nTotal\u00a0general\u00a0 7,813 2,281 26,641 20,055\u00a0 5,452\u00a0 62,242\n\u00a0\nProveedores \u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nProveedor \u00a0 Hogares\u00a0Organizaciones \u00a0\nInternacionales \u00a0Sector\u00a0Privado Sector\u00a0\nP\u00fablico\u00a0Seguridad \u00a0\nSocial\u00a0Total\u00a0\nProveedores \u00a0P\u00fablicos\u00a0 2,862 61 7,896 10,175\u00a0 3,551\u00a0 24,546\nProveedores \u00a0Privados\u00a0 4,554 720 3,234 \u00a0\u00a0 8,508\nLaboratorios \u00a0P\u00fablicos\u00a0 1,096 2,129\u00a0\u00a0 3,225\nBanco\u00a0P\u00fablico\u00a0de\u00a0sangre\u00a0 148\u00a0\u00a0 148\nTotal\u00a0general\u00a0 8,512 781 11,130 12,453\u00a0 3,551\u00a0 36,427\n\u00a0\n\u00a0 168 \u00a0\nPor\u00a0proveedor \u00a0y\u00a0Categor\u00eda \u00a0de\u00a0gasto\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Banco\u00a0P\u00fablico\u00a0de\u00a0\nSangre\u00a0Laboratorios \u00a0\nP\u00fablicos\u00a0Proveedores \u00a0\nPrivados\u00a0Proveedores \u00a0\nP\u00fablicos\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 0 6,094\u00a0 12,618 18,711\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 32 2,033 144\u00a0 18,603 20,812\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a082\u00a0 109 191\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0\u00a0 16 16\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0\nAdministraci\u00f3n \u00a01,379\u00a0 1,805 3,184\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0921\u00a0 577 1,498\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0mejorado \u00a0 1,493\u00a0 359 1,852\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0(excluye\u00a0\ninvestigaci\u00f3n \u00a0operativa) \u00a08 9,315\u00a0 10 9,333\nTotal\u00a0General\u00a0 32 2,041 19,428\u00a0 34,097 55,598\n\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Banco\u00a0P\u00fablico\u00a0de\u00a0\nSangre\u00a0Laboratorios \u00a0\nP\u00fablicos\u00a0Proveedores \u00a0\nPrivados\u00a0Proveedores \u00a0\nP\u00fablicos\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 29 5,137\u00a0 14,835 20,000\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 5,702 162\u00a0 18,994 24,857\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a018\u00a0 34 52\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0\u00a0 8 8\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0\nAdministraci\u00f3n \u00a049 1,662\u00a0 2,924 4,635\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a01,063\u00a0 215 1,278\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0mejorado \u00a0 1,607\u00a0 1,014 2,621\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0(excluye\u00a0\ninvestigaci\u00f3n \u00a0operativa) \u00a0228 8,564\u00a0 8,792\nTotal\u00a0General\u00a0 29 5,979 18,212\u00a0 38,023 62,242\n\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Banco\u00a0P\u00fablico\u00a0de\u00a0\nSangre\u00a0Laboratorios \u00a0\nP\u00fablicos\u00a0Proveedores \u00a0\nPrivados\u00a0Proveedores \u00a0\nP\u00fablicos\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 123 5,431\u00a0 10,571 16,125\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 26 3,159 144\u00a0 9,258 12,587\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a017\u00a0 17\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0\u00a0 9 9\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0de\u00a0la\u00a0\nAdministraci\u00f3n \u00a055 754\u00a0 2,134 2,952\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0410\u00a0 139 549\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0mejorado \u00a0 506\u00a0 2,426 2,932\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0(excluye\u00a0\ninvestigaci\u00f3n \u00a0operativa) \u00a011 1,245\u00a0 1,256 169 Total\u00a0General\u00a0 148 3,225 8,508\u00a0 24,546 36,427\n\u00a0\nPor\u00a0proveedor \u00a0y\u00a0Beneficiarios \u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Banco\u00a0P\u00fablico\u00a0de\u00a0\nSangre\u00a0Laboratorios \u00a0\nP\u00fablicos\u00a0Proveedores \u00a0\nPrivados\u00a0Proveedores \u00a0\nP\u00fablicos\u00a0Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0un\u00a0\ndiagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0sida)\u00a032 1,721 1,802 17,351 20,906\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 5,011 5,721 10,733\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 4 52 2,517 2,573\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0\nespec\u00edficas \u00a0308 1,445 5,160 6,913\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 8,980 1,951 10,931\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 7 1,937 1,275 3,219\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0\nclasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a032 2,041 19,428 34,097 55,598\nTotal\u00a0general\u00a0\n\u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Banco\u00a0P\u00fablico\u00a0de\u00a0\nSangre\u00a0Laboratorios \u00a0\nP\u00fablicos\u00a0Proveedores \u00a0\nPrivados\u00a0Proveedores \u00a0\nP\u00fablicos\u00a0Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0un\u00a0\ndiagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0sida)\u00a05,680 1,295 18,615 25,590\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 4,210 4,403 8,613\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 4,244 4,244\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0\nespec\u00edficas \u00a0299 582 6,986 7,867\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 29 9,401 574 10,003\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 2,346 3,198 5,545\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0\nclasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a0377 3 380\nTotal\u00a0general\u00a0 29 5,979 18,212 38,023 62,242\n\u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Banco\u00a0P\u00fablico\u00a0de\u00a0\nSangre\u00a0Laboratorios \u00a0\nP\u00fablicos\u00a0Proveedores \u00a0\nPrivados\u00a0Proveedores \u00a0\nP\u00fablicos\u00a0Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0un\u00a0\ndiagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0sida)\u00a026 2,905 782 8,188 11,900\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 1,550 4,239 5,788\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 1,867 1,867\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0\nespec\u00edficas \u00a090 314 649 4,909 5,963\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 32 4,529 3,186 7,747\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 629 2,158 2,786\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0sin\u00a0\nclasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a05 369 374\nTotal\u00a0general\u00a0 148 3,225 8,508 24,546 36,427\n\u00a0 170 \u00a0\nPor\u00a0proveedor \u00a0y\u00a0Recursos \u00a0\nRecursos\u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nRecursos\u00a0 Banco\u00a0P\u00fablico\u00a0de\u00a0\nSangre\u00a0Laboratorios \u00a0\nP\u00fablicos\u00a0Proveedores \u00a0\nPrivados\u00a0Proveedores \u00a0\nP\u00fablicos\u00a0Total\u00a0\nAntirretrovirales \u00a0 144\u00a0 9,857 10,001\nCondones \u00a0 4,314\u00a0 2,341 6,655\nGastos\u00a0de\u00a0capital\u00a0 5 2,626\u00a0 1,440 4,070\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 20 2,066\u00a0 5,345 7,431\nOtros\u00a0gastos\u00a0corrientes \u00a0 762 10,278\u00a0 8,983 20,022\nReactivos \u00a0y\u00a0materiales \u00a0 32 1,254 \u00a0 6,132 7,418\nTotal\u00a0general\u00a0 32 2,041 19,428\u00a0 34,097 55,598\n\u00a0\nRecursos\u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nRecursos\u00a0 Banco\u00a0P\u00fablico\u00a0de\u00a0\nSangre\u00a0Laboratorios \u00a0\nP\u00fablicos\u00a0Proveedores \u00a0\nPrivados\u00a0Proveedores \u00a0\nP\u00fablicos\u00a0Total\u00a0\nAntirretrovirales \u00a0 144\u00a0 13,939 14,083\nCondones \u00a0 4,141\u00a0 526 4,667\nGastos\u00a0de\u00a0capital\u00a0 4 2,854\u00a0 1,560 4,418\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 91 2,178\u00a0 8,311 10,581\nOtros\u00a0gastos\u00a0corrientes \u00a0 29 801 8,894\u00a0 11,910 21,634\nReactivos \u00a0y\u00a0materiales \u00a0 5,082 \u00a0 1,777 6,859\nTotal\u00a0general\u00a0 29 5,979 18,212\u00a0 38,023 62,242\n\u00a0\nRecursos\u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nRecursos\u00a0 Banco\u00a0P\u00fablico\u00a0de\u00a0\nSangre\u00a0Laboratorios \u00a0\nP\u00fablicos\u00a0Proveedores \u00a0\nPrivados\u00a0Proveedores \u00a0\nP\u00fablicos\u00a0Total\u00a0\nAntirretrovirales \u00a0 144\u00a0 3,533 3,677\nCondones \u00a0 4,410\u00a0 3,212 7,621\nGastos\u00a0de\u00a0capital\u00a0 57\u00a0 1,434 1,491\nIngresos\u00a0laborales\u00a0y\u00a0no\u00a0laborales\u00a0 11 868\u00a0 6,952 7,831\nOtros\u00a0gastos\u00a0corrientes \u00a0 123 781 3,029\u00a0 7,104 11,038\nReactivos \u00a0y\u00a0materiales \u00a0 26 2,433 \u2010\u00a0 2,311 4770\nTotal\u00a0general\u00a0 148 3,225 8,508\u00a0 24,546 36,427\n\u00a0 171 \u00a0\nPor\u00a0\u00a0recursos\u00a0y\u00a0Categor\u00eda \u00a0de\u00a0gasto\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Anti\u00a0\nrretroviralesCondones Gastos\u00a0\nde\u00a0\nCapital\u00a0Ingresos\u00a0\nlaborales\u00a0y\u00a0\nno\u00a0laboralesOtros\u00a0\ngastos\u00a0\ncorrientes \u00a0Reactivos \u00a0y\u00a0\nmateriales \u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 268 6,655 47 3,059 6,424\u00a0 2,258\u00a018,711\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 9,733 1,372 1,950 2,626\u00a0 5,129\u00a020,812\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a0191\u00a0\u00a0 191\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0 16\u00a0\u00a0 16\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0\nde\u00a0la\u00a0Administraci\u00f3n \u00a0228 410 2,516\u00a0 31\u00a03,184\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a065 1,434\u00a0\u00a0 1,498\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0\nmejorado \u00a042 54 1,756\u00a0\u00a0 1,852\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0\n(excluye\u00a0investigaci\u00f3n \u00a0operativa) \u00a02,381 1,893 5,059\u00a0\u00a0 9,333\nTotal\u00a0General\u00a0 10,001 6,655 4,070 7,431 20,022\u00a0 7,418\u00a055,598\n\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Anti\u00a0\nrretroviralesCondones Gastos\u00a0\nde\u00a0\nCapital\u00a0Ingresos\u00a0\nlaborales\u00a0y\u00a0\nno\u00a0laboralesOtros\u00a0\ngastos\u00a0\ncorrientes \u00a0Reactivos \u00a0y\u00a0\nmateriales \u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 16 4,667 5 4,642 10,148\u00a0 522\u00a020,000\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 14,067 1,319 1,264 1,988\u00a0 6,219\u00a024,857\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a052\u00a0\u00a0 52\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0 8\u00a0\u00a0 8\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0\nde\u00a0la\u00a0Administraci\u00f3n \u00a0\u00a0\u00a0 236 2,619 1,730\u00a0 49\u00a04,635\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0\u2010 1,278\u00a0\u00a0 1,278\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0\nmejorado \u00a0299 40 2,281\u00a0\u00a0 2,621\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0\n(excluye\u00a0investigaci\u00f3n \u00a0operativa) \u00a02,560 2,016 4,149\u00a0 68\u00a08,792\nTotal\u00a0General\u00a0 14,083 4,667 4,418 10,518 21,634\u00a0 6,859\u00a062,242\n\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 Anti\u00a0\nrretroviralesCondones Gastos\u00a0\nde\u00a0\nCapitalIngresos\u00a0\nlaborales\u00a0y\u00a0\nno\u00a0\nlaborales\u00a0Otros\u00a0\ngastos\u00a0\ncorrientes \u00a0Reactivos \u00a0y\u00a0\nmateriales \u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 21 5,859 6 5,213 4,867\u00a0 159\u00a016,125\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 3,656 1,398 1,290 1,687\u00a0 4,556\u00a012,587\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a017\u00a0\u00a0 17\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0 9\u00a0\u00a0 9\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0\nde\u00a0la\u00a0Administraci\u00f3n \u00a083 607 2,207\u00a0 55\u00a02,952\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a04 545\u00a0\u00a0 549\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0\nmejorado \u00a01,762 3 667 500\u00a0\u00a0 2,932\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0SIDA\u00a0 51 1,205\u00a0\u00a0 1,256 172 (excluye\u00a0investigaci\u00f3n \u00a0operativa) \u00a0\nTotal\u00a0General\u00a0 3,677 7,621 1,491 7,831 11,038\u00a0 4,770\u00a036,427\n\u00a0\nPor\u00a0\u00a0recursos\u00a0y\u00a0Beneficiarios \u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Anti\u00a0\nrretroviralesCondones \u00a0Gastos\u00a0\nde\u00a0\nCapitalIngresos\u00a0\nlaborales\u00a0\ny\u00a0no\u00a0\nlaborales\u00a0Otros\u00a0\ngastos\u00a0\ncorrientes \u00a0Reactivos \u00a0y\u00a0\nmateriales \u00a0Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0\nun\u00a0diagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0\nsida)\u00a09,733\u00a0 1,332 1,890 5,005\u00a0 2,946\u00a020,906\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 2,108 969 1,877 5,407\u00a0 372\u00a010,733\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 268 702 1,563\u00a0 40\u00a02,573\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0\nespec\u00edficas \u00a0818 15 870 2,297\u00a0 2,914\u00a06,913\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 3,730\u00a01,518 1,490 3,059\u00a0 1,135\u00a010,931\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 228 639 2,340\u00a0 11\u00a03,219\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0\nespec\u00edficas \u00a0sin\u00a0clasificar\u00a0en\u00a0otras\u00a0\ncategor\u00edas \u00a09 (38) 352\u00a0\u00a0 323\nTotal\u00a0general\u00a0 10,001 6,655 4,070 7,431 20,022\u00a0 7,418\u00a055,598\n\u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Anti\u00a0\nrretroviralesCondones Gastos\u00a0\nde\u00a0\nCapitalIngresos\u00a0\nlaborales\u00a0\ny\u00a0no\u00a0\nlaboralesOtros\u00a0\ngastos\u00a0\ncorrientes \u00a0Reactivos \u00a0y\u00a0\nmateriales \u00a0Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0\nun\u00a0diagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0\nsida)\u00a014,067 1,374 1,395 3,625\u00a0 5,129\u00a025,590\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 825 1,809 5,979\u00a0\u00a0 8,613\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 16 127 1,438 2,642\u00a0 22\u00a04,244\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0\nespec\u00edficas \u00a0981 5 1,918 3,255\u00a0 1,708\u00a07,867\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 3,559 1,763 1,740 2,941\u00a0\u00a0 10,003\nBP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 451 2,278 2,815\u00a0\u00a0 5,545\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0espec\u00edficas \u00a0\nsin\u00a0clasificar\u00a0en\u00a0otras\u00a0categor\u00edas \u00a03 377\u00a0\u00a0 380\nTotal\u00a0general\u00a0 14,083 4,667 4,418 10,581 21,634\u00a0 6,859\u00a062,242\n\u00a0\nBeneficiarios \u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nBeneficiarios \u00a0 Anti\u00a0\nrretroviralesCondones \u00a0Gastos\u00a0\nde\u00a0\nCapital\u00a0Ingresos\u00a0\nlaborales\u00a0\ny\u00a0no\u00a0\nlaborales\u00a0Otros\u00a0\ngastos\u00a0\ncorrientes \u00a0Reactivos \u00a0y\u00a0\nmateriales \u00a0Total\u00a0\nBP.01\u00a0Personas\u00a0que\u00a0viven\u00a0con\u00a0el\u00a0VIH\u00a0\n(independientemente \u00a0de\u00a0que\u00a0tengan\u00a0\nun\u00a0diagn\u00f3stico \u00a0m\u00e9dico/cl\u00ednico \u00a0del\u00a0\nsida)\u00a03,656 1,347\u00a0\n\u00a0\u00a01,458 3,002\u00a0 2,438\u00a011,900\nBP.02\u00a0Poblaciones \u00a0m\u00e1s\u00a0expuestas \u00a0 1,449 89 1,395 2,846\u00a0 8\u00a05,788\nBP.03\u00a0Otras\u00a0poblaciones \u00a0clave\u00a0 21 974\u00a0 809\u00a0 63\u00a01,867\nBP.04\u00a0Poblaciones \u00a0\u00abaccesibles\u00bb \u00a0\nespec\u00edficas \u00a0649\u00a0 4 2,851 199\u00a0 2,261\u00a05,963\nBP.05\u00a0Poblaci\u00f3n \u00a0general\u00a0 5,523\u00a0\u00a0 \u00a0 11 605 1,609\u00a0\u00a0 7,747 173 BP.06\u00a0Intervenciones \u00a0no\u00a0dirigidas\u00a0 40\u00a0\u00a0 542 2,204\u00a0\u00a0 2,786\nBP.99\u00a0Poblaciones \u00a0objetivo\u00a0\nespec\u00edficas \u00a0sin\u00a0clasificar\u00a0en\u00a0otras\u00a0\ncategor\u00edas \u00a05 369\u00a0\u2010 \u00a0 374\nTotal\u00a0general\u00a0 3,677\u00a0 7,621 1,491 7,831 11,038\u00a0 4,770\u00a036,427\n\u00a0\n\u00a0\nPor\u00a0beneficiario \u00a0y\u00a0Categor\u00eda \u00a0de\u00a0gasto\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02008\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 BP.01\u00a0 BP.02\u00a0BP.03\u00a0BP.04\u00a0BP.05\u00a0BP.06\u00a0BP.99\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 148 4,777\u00a02,338 4,599\u00a06,448\u00a0 184\u00a0218\u00a018,711\u00a0\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 18,381\u00a0 96\u00a0 131\u00a02,186\u00a0\u00a018\u00a0\u00a020,812\u00a0\u00a0\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a0\u00a0\u00a0 \u00a06\u00a0185\u00a0\u00a0191\u00a0\u00a0\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0 16\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a016\u00a0\u00a0\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0\nde\u00a0la\u00a0Administraci\u00f3n \u00a0(126) 849\u00a0 101\u00a0\u00a073\u00a02,182\u00a0105\u00a0\u00a03,184\u00a0\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a01,275\u00a0\u00a0\u00a0\u00a0224\u00a0\u00a0\u00a01,498\u00a0\u00a0\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0\nmejorado \u00a0547\u00a0 139\u00a0\u00a0123\u00a0 393\u00a0 650\u00a0\u00a01,852\u00a0\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0\nSIDA\u00a0(excluye\u00a0investigaci\u00f3n \u00a0operativa) \u00a0664\u00a04,872\u00a0 4\u00a0\u00a03,793\u00a0\u00a0\u00a09,333\u00a0\u00a0\nTotal\u00a0General\u00a0 20,906\u00a010,733\u00a02,573\u00a06,913\u00a010,931\u00a03,219\u00a0323\u00a0\u00a055,598\u00a0\u00a0\n\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02009\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 BP.01\u00a0BP.02\u00a0BP.03\u00a0BP.04 BP.05\u00a0BP.06\u00a0 BP.99\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 162\u00a04,378 3,846 6,649 4,785 40 140\u00a020,000\u00a0\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 23,481\u00a0 25 138 1,213 \u00a024,857\u00a0\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a0\u00a0 52 \u00a0 52\u00a0\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0 8\u00a0\u00a0 8\u00a0\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0\nde\u00a0la\u00a0Administraci\u00f3n \u00a062\u00a0\u2010 260 175 3,898 240\u00a04,635\u00a0\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0877\u00a0 5 396 \u00a01,278\u00a0\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0\nmejorado \u00a0622\u00a0 195 248 1,556 \u00a02,621\u00a0\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0\nSIDA\u00a0(excluye\u00a0investigaci\u00f3n \u00a0operativa) \u00a0378\u00a04,015 4,399 \u00a08,792\u00a0\nTotal\u00a0General\u00a0 25,590\u00a08,613 4,244 7,867 10,003 5,545 380\u00a062,242\u00a0\n\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0para\u00a0el\u00a0a\u00f1o\u00a02010\u00a0(en\u00a0miles\u00a0US$)\u00a0\nCategor\u00eda \u00a0de\u00a0gasto\u00a0 BP.01\u00a0 BP.02\u00a0 BP.03\u00a0BP.04\u00a0BP.05 BP.06\u00a0BP.99\u00a0Total\u00a0\nPrevenci\u00f3n \u00a0 154\u00a0 4,391 1,861 3,786 5,581 72 279\u00a0 16,125\nAtenci\u00f3n\u00a0y\u00a0Tratamiento \u00a0 10,357\u00a0 48 6 2,177 \u00a0 12,587\nContrataci\u00f3n \u00a0de\u00a0Recursos\u00a0Humanos \u00a0e\u00a0\nIncentivos \u00a0de\u00a0Retenci\u00f3n \u00a0\u00a0 17 \u00a0 17\nHu\u00e9rfanos \u00a0y\u00a0ni\u00f1os\u00a0m\u00e1s\u00a0vulnerables \u00a0 9\u00a0\u00a0 9\nGesti\u00f3n\u00a0de\u00a0Programa \u00a0y\u00a0fortalecimiento \u00a0\nde\u00a0la\u00a0Administraci\u00f3n \u00a057\u00a0 32 76 2,697 90\u00a0 2,952\nProtecci\u00f3n \u00a0social\u00a0y\u00a0servicios\u00a0sociales\u00a0\n(excluyendo \u00a0hu\u00e9rfanos) \u00a0549\u00a0\u00a0 549\nDesarrollo \u00a0Comunitario \u00a0y\u00a0Ambiente \u00a0\nmejorado \u00a0664\u00a0 502 1,766 \u00a0 2,932\nInvestigaci\u00f3n \u00a0relacionada \u00a0con\u00a0VIH\u00a0 110\u00a0 816 324 5\u00a0 1,256 174 SIDA\u00a0(excluye\u00a0investigaci\u00f3n \u00a0operativa) \u00a0\nTotal\u00a0General\u00a0 11,900\u00a0 5,788 1,867 5,963 7,747 2,786 374\u00a0 36,427\n\u00a0\n\u00a0\n\u00a0", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}